{"questions": [{"body": "List the results of mutated casein kinase 1 epsilon. ", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24744456", "http://www.ncbi.nlm.nih.gov/pubmed/20507565", "http://www.ncbi.nlm.nih.gov/pubmed/19142762", "http://www.ncbi.nlm.nih.gov/pubmed/18522517", "http://www.ncbi.nlm.nih.gov/pubmed/11076012"], "triples": [], "ideal_answer": "We now demonstrate that the mutation results in a heightened sensitivity to light.Mutations of ck1epsilon found in breast cancer can suppress wnt as well as promote the wnt and wnt pathways, thus contributing to breast cancer development via effects on cell adhesion and migration these results in a short circadian period, abnormal entrainment to light cycles, and support csnk1e as a causal gene in the sleep qtl on chromosome 15.We now demonstrate that the mutation results in a heightened sensitivity to light, suggesting that CK1epsilon also regulates the photic entrainment pathway.Results demonstrate a role for csnk1e in regulating not only the timing of sleep, but also the rem sleep amount and nrem sleep architecture, and support csnk1e as a causal gene in the sleep qtl on chromosome 15.", "exact_answer": [["short circadian period"], ["abnormal entrainment to light cycles"], ["potentiated resetting responses to light"], ["REM sleep amount"], ["NREM sleep architecture"], ["effects on cell adhesion"], ["effects on cell migration"], ["timing of sleep"]], "concepts": [], "type": "list", "id": "56e460d051531f7e33000019", "snippets": [{"offsetInBeginSection": 290, "offsetInEndSection": 410, "text": "results in a short circadian period, abnormal entrainment to light cycles, and potentiated resetting responses to light. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19142762", "endSection": "abstract"}, {"offsetInBeginSection": 521, "offsetInEndSection": 677, "text": "We now demonstrate that the mutation results in a heightened sensitivity to light, suggesting that CK1epsilon also regulates the photic entrainment pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19142762", "endSection": "abstract"}, {"offsetInBeginSection": 1461, "offsetInEndSection": 1678, "text": "These results demonstrate a role for Csnk1e in regulating not only the timing of sleep, but also the REM sleep amount and NREM sleep architecture, and support Csnk1e as a causal gene in the sleep QTL on chromosome 15. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24744456", "endSection": "abstract"}, {"offsetInBeginSection": 1812, "offsetInEndSection": 2038, "text": "mutations of CK1epsilon found in breast cancer can suppress Wnt/beta-catenin as well as promote the Wnt/Rac-1/JNK and Wnt/NFAT pathways, thus contributing to breast cancer development via effects on cell adhesion and migration ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20507565", "endSection": "abstract"}]}, {"body": "Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20345238", "http://www.ncbi.nlm.nih.gov/pubmed/20544857", "http://www.ncbi.nlm.nih.gov/pubmed/20476562", "http://www.ncbi.nlm.nih.gov/pubmed/22703519", "http://www.ncbi.nlm.nih.gov/pubmed/22664218", "http://www.ncbi.nlm.nih.gov/pubmed/21915648", "http://www.ncbi.nlm.nih.gov/pubmed/25624825", "http://www.ncbi.nlm.nih.gov/pubmed/23658829", "http://www.ncbi.nlm.nih.gov/pubmed/24491879", "http://www.ncbi.nlm.nih.gov/pubmed/24642455"], "triples": [], "ideal_answer": "Conclusion : the increased expression of neuroglobin in traumatic brain injury informed us that neuroglobin had anti-apoptosis action in post-injury neuron.OBJECTIVES : The aim of this study was to investigate rat neuroglobin ( rNGB ) expression level after traumatic brain injury ( TBI ) and further study its neuroprotective effects in TBI when it was overexpressed in adenoviral vector.Neuroglobin upregulation offers neuroprotection in traumatic brain injury.Various studies seem to indicate that neuroglobin is a neuroprotective agent when overexpressed, acting as a potent inhibitor of oxidative and nitrosative stress.Accumulating evidence has demonstrated that over-expression of neuroglobin ( ngb ) is neuroprotective against hypoxic brain injury informed us that neuroglobin had anti-apoptosis action in post-injury neuron.It could protect the neuron from traumatic stress and secondary ischemia and hypoxia insults during ultra-early and acute stages.Neuroglobin has shown rich neuroprotective effects against cerebral hypoxia, and therefore has the potential to impact outcomes after traumatic brain injury ( tbi ).", "exact_answer": "yes", "concepts": [], "type": "yesno", "id": "56c1d846ef6e39474100002e", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 74, "text": "Neuroglobin upregulation offers neuroprotection in traumatic brain injury. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22664218", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 71, "text": "Neuroglobin-overexpression reduces traumatic brain lesion size in mice. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22703519", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 100, "text": "Neuroglobin (Ngb) is proposed to be a neuron-specific, hypoxia-responsive, neuroprotective protein. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20544857", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 153, "text": "BACKGROUND: Accumulating evidence has demonstrated that over-expression of Neuroglobin (Ngb) is neuroprotective against hypoxic/ischemic brain injuries. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22703519", "endSection": "abstract"}, {"offsetInBeginSection": 1101, "offsetInEndSection": 1189, "text": "This study suggested that rNGB overexpression may be a new strategy for treating of TBI. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22664218", "endSection": "abstract"}, {"offsetInBeginSection": 955, "offsetInEndSection": 1060, "text": "CONCLUSIONS: NGB was upregulated in TBI and overexpressed rNGB had a significant neuroprotection in TBI. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22664218", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 140, "text": "Accumulating evidence has demonstrated that over-expression of Neuroglobin (Ngb) is neuroprotective against hypoxic/ischemic brain injuries. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22703519", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 163, "text": "Neuroglobin has shown rich neuroprotective effects against cerebral hypoxia, and therefore has the potential to impact outcomes after traumatic brain injury (TBI). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20345238", "endSection": "abstract"}, {"offsetInBeginSection": 1071, "offsetInEndSection": 1201, "text": "CONCLUSION: Ngb over-expression reduced traumatic lesion volume, which might partially be achieved by decreasing oxidative stress. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22703519", "endSection": "abstract"}, {"offsetInBeginSection": 171, "offsetInEndSection": 334, "text": "Various studies seem to indicate that neuroglobin is a neuroprotective agent when overexpressed, acting as a potent inhibitor of oxidative and nitrosative stress. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24491879", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 216, "text": "The aim of this study was to investigate rat neuroglobin (rNGB) expression level after traumatic brain injury (TBI) and further study its neuroprotective effects in TBI when it was overexpressed in adenoviral vector. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22664218", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 228, "text": "OBJECTIVES: The aim of this study was to investigate rat neuroglobin (rNGB) expression level after traumatic brain injury (TBI) and further study its neuroprotective effects in TBI when it was overexpressed in adenoviral vector. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22664218", "endSection": "abstract"}, {"offsetInBeginSection": 796, "offsetInEndSection": 1081, "text": "CONCLUSION: The increased expression of neuroglobin in traumatic brain injury informed us that neuroglobin had anti-apoptosis action in post-injury neuron. It could protect the neuron from traumatic stress and secondary ischemia and hypoxia insults during ultra-early and acute stages. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20476562", "endSection": "abstract"}]}, {"body": "What gene test is recommended for clopidogrel?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22974536", "http://www.ncbi.nlm.nih.gov/pubmed/22674970", "http://www.ncbi.nlm.nih.gov/pubmed/22624833", "http://www.ncbi.nlm.nih.gov/pubmed/22464343", "http://www.ncbi.nlm.nih.gov/pubmed/22154242", "http://www.ncbi.nlm.nih.gov/pubmed/22088980", "http://www.ncbi.nlm.nih.gov/pubmed/21803320", "http://www.ncbi.nlm.nih.gov/pubmed/20435227", "http://www.ncbi.nlm.nih.gov/pubmed/20083681", "http://www.ncbi.nlm.nih.gov/pubmed/19706858", "http://www.ncbi.nlm.nih.gov/pubmed/18577829", "http://www.ncbi.nlm.nih.gov/pubmed/18004210", "http://www.ncbi.nlm.nih.gov/pubmed/17681590"], "triples": [{"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0070166", "o": "http://linkedlifedata.com/resource/umls/label/A0173515"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0173515", "o": "clopidogrel"}, {"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A12101557", "o": "http://www.w3.org/2008/05/skos-xl#Label"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12785306", "o": "Clopidogrel"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A0173516", "o": "MeSH"}, {"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A10928568", "o": "http://www.w3.org/2008/05/skos-xl#Label"}], "ideal_answer": "Cyp2c19, but not pon1 or abcb1, is a significant determinant of the pharmacodynamic effects of clopidogrel and several platelet function tests are available to measure platelet response.( Genotype Information and Functional Testing Study [ GIFT ]; NCT00992420 ).The cytochrome p450 ( cyp ) 2c19*2 loss-of-function allele has been associated with impaired clopidogrel pharmacokinetics.To identify gene variants that influence clopidogrel and several platelet function tests are available to measure platelet response.Polymorphisms in the cyp2c19 gene affect clopidogrel response and worse prognosis in clopidogrel-treated patients.Although both drugs have pharmacogenomic tests available for clinical use, however, genotyping is only one aspect of predicting response to clopidogrel, both early and late after pci.Polymorphisms in the cyp2c19 gene variants that influence clopidogrel response.", "exact_answer": ["CYP2C19 genotyping"], "concepts": ["http://www.biosemantics.org/jochem#4260620", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005796", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005820", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003955"], "type": "factoid", "id": "5156be04d24251bc05000085", "snippets": [{"offsetInBeginSection": 333, "offsetInEndSection": 395, "text": "To identify gene variants that influence clopidogrel response. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19706858", "endSection": "sections.0"}, {"offsetInBeginSection": 607, "offsetInEndSection": 677, "text": "polymorphisms in the CYP2C19 gene affect clopidogrel pharmacokinetics. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22674970", "endSection": "sections.0"}, {"offsetInBeginSection": 260, "offsetInEndSection": 337, "text": "to test the influence of the CYP 2C19*2 allele on clopidogrel responsiveness. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17681590", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "Genetic polymorphisms significantly influence responses to warfarin and clopidogrel. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22674970", "endSection": "sections.0"}, {"offsetInBeginSection": 893, "offsetInEndSection": 977, "text": "identify genes and mutations with known associations with disease and drug response. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20435227", "endSection": "sections.0"}, {"offsetInBeginSection": 1654, "offsetInEndSection": 1753, "text": "The patient had a heterozygous null mutation in CYP2C19 suggesting probable clopidogrel resistance, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20435227", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 116, "text": "Coexisting polymorphisms of the genes affecting clopiogrel resistance may influence platelet activation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18577829", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 164, "text": "The cytochrome P450 (CYP) 2C19*2 loss-of-function allele has been associated with impaired clopidogrel response and worse prognosis in clopidogrel-treated patients. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21803320", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 212, "text": "This study sought to evaluate the influence of single nucleotide polymorphisms (SNPs) on the pharmacodynamic effect of high- or standard-dose clopidogrel after percutaneous coronary intervention (PCI). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22624833", "endSection": "sections.0"}, {"offsetInBeginSection": 37, "offsetInEndSection": 285, "text": "to evaluate the effect of polymorphisms affecting the clopidogrel metabolism (CYP3A4 IVS10+12G/A and CYP2C19*2) and the P2Y12 receptor (P2Y12 T744C) on modulating platelet function in acute coronary syndrome patients on dual antiplatelet treatment. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18004210", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 286, "text": "A recent clinical trial has demonstrated that patients with acute coronary syndromes (ACS) and the reduced function allele CYP2C19*2 (*2 allele), who are treated with thienopyridines, have an increased risk of adverse cardiac events with clopidogrel, but not with prasugrel. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22974536", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 324, "text": "Variants in the CYP2C19 gene influence the pharmacologic and clinical response to the standard 75-mg daily maintenance dose of the antiplatelet drug clopidogrel. OBJECTIVE: To test whether higher doses (up to 300 mg daily) improve the response to clopidogrel in the setting of loss-of-function CYP2C19 genotypes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22088980", "endSection": "sections.0"}, {"offsetInBeginSection": 357, "offsetInEndSection": 637, "text": "The present study was designed to evaluate the benefit of tailored therapy with a higher maintenance dose according to CYP2C19 genotypes in patients identified as nonresponders who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21803320", "endSection": "sections.0"}, {"offsetInBeginSection": 607, "offsetInEndSection": 920, "text": "polymorphisms in the CYP2C19 gene affect clopidogrel pharmacokinetics. These polymorphisms may be useful to identify clopidogrel nonresponders who may benefit from taking an alternative antiplatelet agent such as prasugrel and ticagrelor. Although both drugs have pharmacogenomic tests available for clinical use, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22674970", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 344, "text": "The cytochrome P450 (CYP) 2C19 isoenzyme plays an important role in clopidogrel metabolization. A recently explored CYP2C19*17 allelic variant has been linked to increased transcriptional activity, resulting in extensive metabolization of CYP2C19 substrates, which may lead to an enhanced platelet response to clopidogrel treatment. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20083681", "endSection": "sections.0"}, {"offsetInBeginSection": 608, "offsetInEndSection": 973, "text": "A genome-wide association study was performed followed by genotyping the loss-of-function cytochrome P450 (CYP) 2C19*2 variant (rs4244285). Findings in the PAPI Study were extended by examining the relation of CYP2C19*2 genotype to platelet function and cardiovascular outcomes in an independent sample of 227 patients undergoing percutaneous coronary intervention. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19706858", "endSection": "sections.0"}, {"offsetInBeginSection": 136, "offsetInEndSection": 497, "text": "The CYP2C19*2 allele is a common genetic variant associated with increased rates of major adverse events in individuals given clopidogrel after percutaneous coronary intervention (PCI). We used a novel point-of-care genetic test to identify carriers of the CYP2C19*2 allele and aimed to assess a pharmacogenetic approach to dual antiplatelet treatment after PCI ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22464343", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 401, "text": "The antiplatelet effect of clopidogrel has been linked to cytochrome P450 2C19 (CYP2C19) carrier status. The presence of loss of function and gain of function variants were found to have a gene-dose effect on clopidogrel metabolism. However, genotyping is only one aspect of predicting response to clopidogrel and several platelet function tests are available to measure platelet response. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22154242", "endSection": "sections.0"}, {"offsetInBeginSection": 439, "offsetInEndSection": 754, "text": "Genotyping revealed 7 carriers of both the C allele of P2Y12 and A allele of CYP2C19 (group 1), 14 carriers of the T allele of P2Y12 and A allele of CYP2C19 (group 2), 17 carriers of the C allele of P2Y12 and G allele of CYP2C19 (group 3) and 67 carriers of the T allele of P2Y12 and G allele of CYP2C19 (controls). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18577829", "endSection": "sections.0"}, {"offsetInBeginSection": 1621, "offsetInEndSection": 2056, "text": "CYP2C19, but not PON1 or ABCB1, is a significant determinant of the pharmacodynamic effects of clopidogrel, both early and late after PCI. In patients with high OTR identified by platelet function testing, the CYP2C19 genotype provides limited incremental information regarding the risk of persistently high reactivity with clopidogrel 150-mg maintenance dosing. (Genotype Information and Functional Testing Study [GIFT]; NCT00992420). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22624833", "endSection": "sections.0"}]}, {"body": "Is olaparib effective for prostate cancer?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26510020", "http://www.ncbi.nlm.nih.gov/pubmed/25616434", "http://www.ncbi.nlm.nih.gov/pubmed/25583815", "http://www.ncbi.nlm.nih.gov/pubmed/25366685", "http://www.ncbi.nlm.nih.gov/pubmed/24789362", "http://www.ncbi.nlm.nih.gov/pubmed/24225019", "http://www.ncbi.nlm.nih.gov/pubmed/23847380", "http://www.ncbi.nlm.nih.gov/pubmed/25127709"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0106149", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0090893", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0106148", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0091054", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0290426", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0290427", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0290428", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0290425", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A7786660", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0667486", "o": "D011471"}], "ideal_answer": "We hypothesized that metastatic, castration-resistant prostate cancer cells to saha and olaparib.We hypothesized that metastatic, castration-resistant prostate cancers.We hypothesized that metastatic prostate cancer.The specificity of the biomarker suite was 94 %.Silencing rad51 sensitized prostate cancers with dna-repair defects would respond to poly ( adenosine diphosphate [ adp ] -ribose ) polymerase ( parp ) inhibition with olaparib alone.A phase ii study of the parp inhibitor olaparib ( astrazeneca ) for cancer patients with inherited brca1 and brca2 gene mutations confirmed earlier results showing clinical benefit for advanced breast and ovarian cancers, and demonstrated evidence of effectiveness against pancreatic and prostate cancers.Dna-repair defects and olaparib in metastatic prostate cancer is a heterogeneous disease, but current treatments are not based on molecular stratification.", "exact_answer": "yes", "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:10283", "http://www.disease-ontology.org/api/metadata/DOID:10286", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011471"], "type": "yesno", "id": "56c02883ef6e394741000017", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 62, "text": "DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "title"}, {"offsetInBeginSection": 512, "offsetInEndSection": 703, "text": "Olaparib, one of the most studied PARPis, has demonstrated activity in BRCA1/2(MUT+) and BRCA-like sporadic ovarian and breast cancers, and looks promising in prostate and pancreatic cancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24225019", "endSection": "abstract"}, {"offsetInBeginSection": 305, "offsetInEndSection": 501, "text": "We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 2035, "offsetInEndSection": 2244, "text": "CONCLUSIONS: Treatment with the PARP inhibitor olaparib in patients whose prostate cancers were no longer responding to standard treatments and who had defects in DNA-repair genes led to a high response rate. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 236, "text": "In a phase II study, researchers found that the PARP inhibitor olaparib led to stable disease or tumor regressions in patients with advanced breast, ovarian, pancreatic, and prostate cancers who had germline mutations in BRCA1 or BRCA2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25583815", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 303, "text": "A phase II study of the PARP inhibitor olaparib (AstraZeneca) for cancer patients with inherited BRCA1 and BRCA2 gene mutations confirmed earlier results showing clinical benefit for advanced breast and ovarian cancers, and demonstrated evidence of effectiveness against pancreatic and prostate cancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23847380", "endSection": "abstract"}, {"offsetInBeginSection": 1398, "offsetInEndSection": 1646, "text": "Silencing RAD51 sensitized prostate cancer cells to SAHA and olaparib alone. Collectively, cotreatment with HDACi and PARPi downregulated HR-related protein expression and concomitantly increased DNA damage, resulting in prostate cancer cell death. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "endSection": "abstract"}, {"offsetInBeginSection": 383, "offsetInEndSection": 647, "text": "Eligibility included ovarian cancer resistant to prior platinum; breast cancer with \u2265 three chemotherapy regimens for metastatic disease; pancreatic cancer with prior gemcitabine treatment; or prostate cancer with progression on hormonal and one systemic therapy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25366685", "endSection": "abstract"}, {"offsetInBeginSection": 511, "offsetInEndSection": 768, "text": " In addition, phase III trials in breast, gastric and pancreatic cancer are underway/planned, and phase I/II investigation is being conducted in other malignancies, including prostate cancer, non-small cell lung cancer, Ewing's sarcoma and advanced cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25616434", "endSection": "abstract"}, {"offsetInBeginSection": 512, "offsetInEndSection": 768, "text": "In addition, phase III trials in breast, gastric and pancreatic cancer are underway/planned, and phase I/II investigation is being conducted in other malignancies, including prostate cancer, non-small cell lung cancer, Ewing's sarcoma and advanced cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25616434", "endSection": "abstract"}, {"offsetInBeginSection": 552, "offsetInEndSection": 829, "text": "Prostate cancer cells cotreated with the HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index<0.9), whereas normal prostatic cells did not. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 307, "text": "Prostate cancer is a heterogeneous disease, but current treatments are not based on molecular stratification. We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 815, "offsetInEndSection": 1093, "text": "Prostate cancer cells cotreated with the HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index < 0.9), whereas normal prostatic cells did not. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "endSection": "abstract"}, {"offsetInBeginSection": 541, "offsetInEndSection": 822, "text": "Prostate cancer cells cotreated with the HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index &lt; 0.9), whereas normal prostatic cells did not. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "endSection": "abstract"}, {"offsetInBeginSection": 122, "offsetInEndSection": 496, "text": "We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib.METHODS: We conducted a phase 2 trial in which patients with metastatic, castration-resistant prostate cancer were treated with olaparib tablets at a dose of 400 mg twice a day. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 1809, "offsetInEndSection": 2244, "text": "The specificity of the biomarker suite was 94%. Anemia (in 10 of the 50 patients [20%]) and fatigue (in 6 [12%]) were the most common grade 3 or 4 adverse events, findings that are consistent with previous studies of olaparib.CONCLUSIONS: Treatment with the PARP inhibitor olaparib in patients whose prostate cancers were no longer responding to standard treatments and who had defects in DNA-repair genes led to a high response rate. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 496, "text": "BACKGROUND: Prostate cancer is a heterogeneous disease, but current treatments are not based on molecular stratification. We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib.METHODS: We conducted a phase 2 trial in which patients with metastatic, castration-resistant prostate cancer were treated with olaparib tablets at a dose of 400 mg twice a day. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 698, "offsetInEndSection": 1301, "text": "It is increasingly clear that there are molecularly distinct subtypes of various common cancers, with different therapeutic approaches required for each subtype, for example, the use of the monoclonal antibodies (trastuzumab and cetuximab) in HER2-positive breast cancer and wild-type KRAS colorectal cancer; tyrosine kinase inhibitors (imatinib, gefitinib, erlotinib and crizotinib) in chronic myeloid leukaemia, gastrointestinal stromal tumours and non-small-cell lung cancer and intracellular agents (vemurafenib and olaparib) in metastatic malignant melanoma and ovarian, breast and prostate cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789362", "endSection": "abstract"}, {"offsetInBeginSection": 825, "offsetInEndSection": 1427, "text": "The tumor response rate was 26.2% (78 of 298; 95% CI, 21.3 to 31.6) overall and 31.1% (60 of 193; 95% CI, 24.6 to 38.1), 12.9% (eight of 62; 95% CI, 5.7 to 23.9), 21.7% (five of 23; 95% CI, 7.5 to 43.7), and 50.0% (four of eight; 95% CI, 15.7 to 84.3) in ovarian, breast, pancreatic, and prostate cancers, respectively. Stable disease \u2265 8 weeks was observed in 42% of patients (95% CI, 36.0 to 47.4), including 40% (95% CI, 33.4 to 47.7), 47% (95% CI, 34.0 to 59.9), 35% (95% CI, 16.4 to 57.3), and 25% (95% CI, 3.2 to 65.1) of those with ovarian, breast, pancreatic, or prostate cancer, respectively. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25366685", "endSection": "abstract"}]}, {"body": "What is the role of eteplirsen in DMD patients?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22086232", "http://www.ncbi.nlm.nih.gov/pubmed/23907995", "http://www.ncbi.nlm.nih.gov/pubmed/23075107", "http://www.ncbi.nlm.nih.gov/pubmed/24282529", "http://www.ncbi.nlm.nih.gov/pubmed/23995279"], "triples": [], "ideal_answer": "The present study used a double-blind placebo-controlled protocol to test eteplirsen's ability to induce dystrophin production and improve distance walked on the 6-minute walk test ( 6MWT ).Placebo patients switched to 30 or 50 mg eteplirsen's ability to induce dystrophin production and improve distance walked on the 6-minute walk test ( 6mwt ).We also analysed in muscle biopsies of dmd patients included in a single dose intramuscular eteplirsen that induces skipping of exon 51 in the dystrophin gene there was no significant difference in the level of the dystromirs in bmd compared to controls.Morpholino ao to skip exon 51, eteplirsen ( avi-4658 ).Injection the dystromirs were also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of dmd patients treated systemically for 12 weeks with antisense oligomer eteplirsen clinical trial.Placebo patients switched to 30 or 50 mg eteplirsen ( n=2 ) at week 25; treatment was open label thereafter.", "exact_answer": [["skipping of dystrophin exon 51"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020388", "http://www.disease-ontology.org/api/metadata/DOID:11723", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009137", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009136"], "type": "factoid", "id": "56a24dfffe92d6fd19000002", "snippets": [{"offsetInBeginSection": 949, "offsetInEndSection": 1002, "text": "morpholino AO to skip exon 51, eteplirsen (AVI-4658). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23075107", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 180, "text": "Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23075107", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 202, "text": "In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907995", "endSection": "abstract"}, {"offsetInBeginSection": 1232, "offsetInEndSection": 1477, "text": "We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24282529", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 271, "text": "We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22086232", "endSection": "abstract"}, {"offsetInBeginSection": 739, "offsetInEndSection": 1003, "text": "Here we describe the development of a Taqman quantitative (q)RT-PCR assay to quantify exon skipping and highlight its use to determine the levels of exon skipping in DMD patients treated intramuscularly with a morpholino AO to skip exon 51, eteplirsen (AVI-4658). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23075107", "endSection": "abstract"}, {"offsetInBeginSection": 995, "offsetInEndSection": 1239, "text": "We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24282529", "endSection": "abstract"}, {"offsetInBeginSection": 71, "offsetInEndSection": 381, "text": "Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, restores the open reading frame and induces dystrophin protein expression after intramuscular (i.m.) injection ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22086232", "endSection": "abstract"}, {"offsetInBeginSection": 403, "offsetInEndSection": 660, "text": "METHODS: DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n\u2009=\u20094/group). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907995", "endSection": "abstract"}, {"offsetInBeginSection": 996, "offsetInEndSection": 1377, "text": "We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene. The dystromirs were also analysed in muscle biopsies of DMD patients included in a single dose intramuscular eteplirsen clinical trial. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24282529", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 371, "text": "We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, restores the open reading frame and induces dystrophin protein expression after intramuscular (i.m.) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22086232", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 397, "text": "In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51. The present study used a double-blind placebo-controlled protocol to test eteplirsen&apos;s ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907995", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 403, "text": "OBJECTIVE: In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51. The present study used a double-blind placebo-controlled protocol to test eteplirsen's ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907995", "endSection": "abstract"}, {"offsetInBeginSection": 398, "offsetInEndSection": 761, "text": "DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n\u2009=\u20094/group). Placebo patients switched to 30 or 50 mg/kg eteplirsen (n=2/group) at week 25; treatment was open label thereafter. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907995", "endSection": "abstract"}, {"offsetInBeginSection": 899, "offsetInEndSection": 1377, "text": "There was no significant difference in the level of the dystromirs in BMD compared to controls. We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene. The dystromirs were also analysed in muscle biopsies of DMD patients included in a single dose intramuscular eteplirsen clinical trial. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24282529", "endSection": "abstract"}, {"offsetInBeginSection": 204, "offsetInEndSection": 645, "text": "The present study used a double-blind placebo-controlled protocol to test eteplirsen&apos;s ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT). DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n\u2009=\u20094/group). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907995", "endSection": "abstract"}, {"offsetInBeginSection": 204, "offsetInEndSection": 645, "text": "The present study used a double-blind placebo-controlled protocol to test eteplirsen&apos;s ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT).DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n\u2009=\u20094/group). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907995", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 702, "text": "We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, restores the open reading frame and induces dystrophin protein expression after intramuscular (i.m.) injection. We now show that this dystrophin expression was accompanied by an elevated expression of \u03b1-sarcoglycan, \u03b2-dystroglycan (BDG) and--in relevant cases--neuronal nitric oxide synthase (nNOS) at the sarcolemma, each of which is a component of a different subcomplex of the dystrophin-associated glycoprotein complex (DAPC). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22086232", "endSection": "abstract"}]}, {"body": "Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18816693", "http://www.ncbi.nlm.nih.gov/pubmed/18941145", "http://www.ncbi.nlm.nih.gov/pubmed/17702273", "http://www.ncbi.nlm.nih.gov/pubmed/17303592", "http://www.ncbi.nlm.nih.gov/pubmed/11912113", "http://www.ncbi.nlm.nih.gov/pubmed/12217621", "http://www.ncbi.nlm.nih.gov/pubmed/21783505", "http://www.ncbi.nlm.nih.gov/pubmed/16092100"], "triples": [], "ideal_answer": "Rem sleep behavior disorder in patients had levodopa-resistant parkinsonism, a tauopathy.Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.In Guadeloupe, there is an abnormally high frequency of atypical parkinsonism.Pdc patients had levodopa-resistant parkinsonism in the caribbean island of guadeloupe : etiological role of the mitochondrial complex i inhibitor annonacin.They also have hallucinations, dysautonomia, which are not characteristic of PSP.We characterize the clinical features of parkinson & apos; s syndrome on guadeloupe and describe possible environmental causes.Atypical parkinsonism associated with frontosubcortical dementia, 52 % of these patients had hallucinations, but, importantly, none had oculomotor dysfunction.Rem sleep behavior disorder in patients with guadeloupean parkinsonism associated with frontosubcortical dementia, 52 % of these patients had hallucinations, but, importantly, none had oculomotor dysfunction.", "concepts": [], "type": "summary", "id": "56c1f033ef6e39474100004f", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 125, "text": "We characterize the clinical features of Parkinson&apos;s syndrome on Guadeloupe and describe possible environmental causes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16092100", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 78, "text": "In Guadeloupe, there is an abnormally high frequency of atypical parkinsonism. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17303592", "endSection": "abstract"}, {"offsetInBeginSection": 508, "offsetInEndSection": 591, "text": "The subjects were 265 patients with Parkinson&apos;s syndrome living on Guadeloupe, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16092100", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 86, "text": "Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16092100", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 94, "text": "Atypical parkinsonism is extremely frequent in Guadeloupe and may have an environmental cause. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18941145", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 86, "text": "Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11912113", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Atypical parkinsonism on Guadeloupe, comparison with the parkinsonism-dementia complex of Guam, and environmental toxic hypotheses. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21783505", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702273", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 93, "text": "Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17303592", "endSection": "title"}, {"offsetInBeginSection": 1947, "offsetInEndSection": 2037, "text": "Guadeloupean parkinsonism may prove to be a tauopathy identical or closely related to PSP. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11912113", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12217621", "endSection": "title"}, {"offsetInBeginSection": 1502, "offsetInEndSection": 1599, "text": "CONCLUSION: Although Gd-PSP is a tauopathy, most patients experience REM sleep behavior disorder. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702273", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18816693", "endSection": "title"}, {"offsetInBeginSection": 147, "offsetInEndSection": 299, "text": " Now on Guadeloupe in the Carribbean French West Indies, Caparros-Lefebvre is identifying many patients with similar clinical and histological features. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12217621", "endSection": "abstract"}, {"offsetInBeginSection": 79, "offsetInEndSection": 299, "text": "Only one-third of the patients that develop parkinsonian symptoms were reported to present the classical features of idiopathic Parkinson disease and one-third a syndrome resembling progressive supranuclear palsy (PSP). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17303592", "endSection": "abstract"}, {"offsetInBeginSection": 757, "offsetInEndSection": 920, "text": "Two hundred and twenty consecutive patients with Parkinson's syndrome seen by the neurology service at Pointe \u00e0 Pitre, Guadeloupe University Hospital were studied. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11912113", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 222, "text": ": On Guadeloupe, atypical parkinsonism is abnormally frequent, and represents 75% of progressive parkinsonism while Parkinson's disease (PD) accounts for only 25%, which is an inversed percentage in comparison with Europe. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21783505", "endSection": "abstract"}, {"offsetInBeginSection": 2496, "offsetInEndSection": 2716, "text": "The development of atypical parkinsonism in Guadeloupe and probably elsewhere, could result from synergistic toxicity, but acetogenins are probably the most potent neurotoxin, acting as mitochondrial complex I inhibitor. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16092100", "endSection": "abstract"}, {"offsetInBeginSection": 1502, "offsetInEndSection": 1730, "text": "In conclusion, Gd-PSP patients have cortical myoclonus and cortical oculomotor impairments, but only minor signs of brainstem oculomotor dysfunction, suggesting that cortical dysfunction predominates over brainstem impairments. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18941145", "endSection": "abstract"}, {"offsetInBeginSection": 296, "offsetInEndSection": 583, "text": "The clinical entity was a unique combination of levodopa-resistant parkinsonism, tremor, myoclonus, hallucinations, REM sleep behavior disorder and fronto-subcortical dementia. Based on the presence or the absence of supranuclear gaze palsy, two subgroups of patients were distinguished. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18816693", "endSection": "abstract"}, {"offsetInBeginSection": 128, "offsetInEndSection": 380, "text": "Postural instability with early falls, prominent frontal lobe dysfunction and pseudo-bulbar palsy were common and three-quarters of the patients were L-dopa unresponsive. One-third of all patients seen had probable progressive supranuclear palsy (PSP). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11912113", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 253, "text": "STUDY OBJECTIVE: To describe sleep characteristics and rapid eye movement (REM) sleep behavior disorder in patients with Guadeloupean atypical parkinsonism (Gd-PSP), a tauopathy resembling progressive supranuclear palsy that mainly affects the midbrain. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702273", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 295, "text": "On the French West Indian island of Guadeloupe, atypical parkinsonian patients represent two-thirds of all cases of parkinsonism, which is exceptionally frequent compared to epidemiological data from European countries where atypical parkinsonism accounts for only approximately 5% of all cases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18816693", "endSection": "abstract"}, {"offsetInBeginSection": 742, "offsetInEndSection": 1033, "text": "RESULTS: REM sleep behavior disorder was found in 78% patients with Gd-PSP (43% of patients reported having this disorder several years before the onset of parkinsonism), 44% of patients with idiopathic Parkinson disease, 33% of patients with progressive supranuclear palsy, and no controls. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702273", "endSection": "abstract"}, {"offsetInBeginSection": 95, "offsetInEndSection": 494, "text": "One-half of the patients with this tauopathy have dopa-resistant parkinsonism, tremor, subcortical dementia and abnormal eye movements suggestive of progressive supranuclear palsy (PSP). They also have hallucinations, dysautonomia, which are not characteristic of PSP. Furthermore, the oculomotor abnormalities and the tremor, which is jerky, differ from what is observed in classical PSP patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18941145", "endSection": "abstract"}, {"offsetInBeginSection": 1183, "offsetInEndSection": 1679, "text": "Patients with a PSP-like syndrome developed levodopa-resistant parkinsonism, associated with early postural instability and supranuclear oculomotor dysfunction. They differed, however, from classical PSP patients by the frequency of tremor (>50%), dysautonomia (50%) and the occurrence of hallucinations (59%). PDC patients had levodopa-resistant parkinsonism associated with frontosubcortical dementia, 52% of these patients had hallucinations, but, importantly, none had oculomotor dysfunction. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17303592", "endSection": "abstract"}, {"offsetInBeginSection": 1754, "offsetInEndSection": 2450, "text": "Cerebral atrophy was seen in the majority of the PSP-like and PDC patients, with enlargement of the third ventricle and marked T2-hypointensity in the basal ganglia, particularly the substantia nigra. Consumption of soursop was significantly greater in both PSP-like and PDC patients than in controls and Parkinson's disease patients. In conclusion, atypical Guadeloupean parkinsonism comprises two forms of parkinsonism and dementia that differ clinically by the presence of oculomotor signs, but have similar cognitive profiles and neuroimaging features, suggesting that they may constitute a single disease entity, and both were similarly exposed to annonaceous neurotoxins, notably annonacin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17303592", "endSection": "abstract"}]}, {"body": "Does the concentration of protein HIF-1\u03b1 increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20334641", "http://www.ncbi.nlm.nih.gov/pubmed/17852557", "http://www.ncbi.nlm.nih.gov/pubmed/14574457", "http://www.ncbi.nlm.nih.gov/pubmed/24147016", "http://www.ncbi.nlm.nih.gov/pubmed/21452059", "http://www.ncbi.nlm.nih.gov/pubmed/21875443", "http://www.ncbi.nlm.nih.gov/pubmed/19478935"], "triples": [{"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/intervention/5132", "o": "Intervention #5132 (Drug:Ethyol (Amifostine))"}], "ideal_answer": "Complete response was obtained in 85.2 % of patients and hif1alpha was marginally related with persistent disease after rt ( p = 0.05 ).We demonstrated that the treatment of several human cancer cell lines with therapeutical doses of wr-1065 led to a strong induction of different vegf-a mrna isoforms independently of hif-1alpha since it is doubtful whether dephosphorylation of amifostine to the active metabolite wr-1065 occurs within tumoral tissues ( an acidic environment that lacks vascular alkaline phosphatase activity ), intracellular hypoxia and upregulation of hif1 alpha represents an additional, normal tissue-specific, amifostine cytoprotective pathway.MDA468 breast tumor cell lines were incubated with a high amifostine concentration ( 10 m M ) to overcome the natural resistance of cancer cells to influx of the non-hydrolyzed WR-2721, and the HIF1 alpha protein levels were determined by Western blot analysis the glucose and oxygen levels in the peripheral blood of patients receiving 1000 mg amifostine were determined at various time-points in order to investigate the metabolic changes induced by amifostine.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004999", "http://www.biosemantics.org/jochem#4277891", "http://www.biosemantics.org/jochem#4217067", "http://www.uniprot.org/uniprot/HIF1A_ONCMY", "http://www.uniprot.org/uniprot/HIF1A_EOSBA", "http://www.uniprot.org/uniprot/HIF1A_BOSMU", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011355"], "type": "yesno", "id": "533eb89fc45e133714000012", "snippets": [{"offsetInBeginSection": 1319, "offsetInEndSection": 1394, "text": ". Incubation of cell lines with amifostine resulted in HIF1 alpha induction ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574457", "endSection": "abstract"}, {"offsetInBeginSection": 161, "offsetInEndSection": 364, "text": "e investigated the involvement of hypoxia-regulated proteins (Hypoxia inducible factors HIF1alpha, HIF2alpha and carbonic anhydrase CA9) in HNC resistance to accelerated and hypofractionated radiotherapy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17852557", "endSection": "abstract"}, {"offsetInBeginSection": 933, "offsetInEndSection": 1126, "text": "We demonstrated that the treatment of several human cancer cell lines with therapeutical doses of WR-1065 led to a strong induction of different VEGF-A mRNA isoforms independently of HIF-1alpha ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20334641", "endSection": "abstract"}, {"offsetInBeginSection": 1518, "offsetInEndSection": 1854, "text": "Since it is doubtful whether dephosphorylation of amifostine to the active metabolite WR-1065 occurs within tumoral tissues (an acidic environment that lacks vascular alkaline phosphatase activity), intracellular hypoxia and upregulation of HIF1 alpha represents an additional, normal tissue-specific, amifostine cytoprotective pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574457", "endSection": "abstract"}, {"offsetInBeginSection": 1509, "offsetInEndSection": 1867, "text": "In accord with previously reported studies, high levels of the hypoxia regulated proteins HIF1alpha and CA9 in HNC predict resistance to platinum based radio-chemotherapy. Whether HIF2alpha expressing tumors are more sensitive to larger radiotherapy fractions, compared to standard radiotherapy fractionation, is an issue that deserves further investigation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17852557", "endSection": "abstract"}, {"offsetInBeginSection": 413, "offsetInEndSection": 875, "text": " The glucose and oxygen levels in the peripheral blood of patients receiving 1000 mg amifostine were determined at various time-points in order to investigate the metabolic changes induced by amifostine. MDA468 breast tumor cell lines were incubated with a high amifostine concentration (10 m M) to overcome the natural resistance of cancer cells to influx of the non-hydrolyzed WR-2721, and the HIF1 alpha protein levels were determined by Western blot analysis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574457", "endSection": "abstract"}, {"offsetInBeginSection": 874, "offsetInEndSection": 1413, "text": "HIF1alpha and HIF2alpha were expressed in the nuclei and cytoplasm of cancer cells, while CA9 had a membrane reactivity. A high expression of HIF1alpha, HIF2alpha and CA9 was noted in 21/39 (53.8%), 20/39 (51.3%) and 23/39 (58.9%) cases, respectively. Complete response was obtained in 85.2% of patients and HIF1alpha was marginally related with persistent disease after RT (p = 0.05). HIF1alpha was significantly associated with poor local relapse free survival (LRFS) (p = 0.006) and overall survival (p = 0.008), whilst HIF2alpha was no ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17852557", "endSection": "abstract"}]}, {"body": "Which diseases can Oncotype DX be used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23371261", "http://www.ncbi.nlm.nih.gov/pubmed/22590486", "http://www.ncbi.nlm.nih.gov/pubmed/22361999", "http://www.ncbi.nlm.nih.gov/pubmed/21934103", "http://www.ncbi.nlm.nih.gov/pubmed/21479927", "http://www.ncbi.nlm.nih.gov/pubmed/21370017", "http://www.ncbi.nlm.nih.gov/pubmed/21278441", "http://www.ncbi.nlm.nih.gov/pubmed/21221771", "http://www.ncbi.nlm.nih.gov/pubmed/21176237", "http://www.ncbi.nlm.nih.gov/pubmed/22811953", "http://www.ncbi.nlm.nih.gov/pubmed/20877447", "http://www.ncbi.nlm.nih.gov/pubmed/20564629", "http://www.ncbi.nlm.nih.gov/pubmed/20200857", "http://www.ncbi.nlm.nih.gov/pubmed/23074401", "http://www.ncbi.nlm.nih.gov/pubmed/19946260", "http://www.ncbi.nlm.nih.gov/pubmed/19536946", "http://www.ncbi.nlm.nih.gov/pubmed/19125125", "http://www.ncbi.nlm.nih.gov/pubmed/19101988", "http://www.ncbi.nlm.nih.gov/pubmed/18347556", "http://www.ncbi.nlm.nih.gov/pubmed/18942607", "http://www.ncbi.nlm.nih.gov/pubmed/18072276"], "triples": [{"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A10812803", "o": "Oncotype DX"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A7568412", "o": "NCI Thesaurus"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0012634", "o": "http://linkedlifedata.com/resource/umls/label/A0049608"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0015570", "o": "Diseases"}, {"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A18169310", "o": "http://www.w3.org/2008/05/skos-xl#Label"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0015569", "o": "Diseases"}], "ideal_answer": "78 women, treated for early-stage, estrogen receptor-positive breast cancer with 0-3 positive lymph nodes, whose medical records indicated they received oncotype dx testing earlier.78 women, treated for early-stage, estrogen receptor-positive breast cancer with 0-3 positive lymph nodes, whose medical records indicated they received oncotype dx recurrence score with disease recurrence and adequate evidence for response to chemotherapy.Luminal b class the ewg found adequate evidence regarding the association of the oncotype dx gene expression profile rA high score on the Oncotype DX gene expression profile r", "exact_answer": [["breast cancer"], ["colon cancer"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001941", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003108", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003109"], "type": "list", "id": "514a11add24251bc05000054", "snippets": [{"offsetInBeginSection": 316, "offsetInEndSection": 331, "text": "luminal B class ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22590486", "endSection": "sections.0"}, {"offsetInBeginSection": 243, "offsetInEndSection": 276, "text": "Prognostic and predictive markers ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23371261", "endSection": "sections.0"}, {"offsetInBeginSection": 1222, "offsetInEndSection": 1325, "text": "The oncotype DX\u00ae genomic assay has also been used to help prognosis estimation and treatment decisions. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21278441", "endSection": "sections.0"}, {"offsetInBeginSection": 366, "offsetInEndSection": 440, "text": "Oncotype DX\u00ae currently allow avoidance of an over therapy or under therapy ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23371261", "endSection": "sections.0"}, {"offsetInBeginSection": 191, "offsetInEndSection": 267, "text": "poor-prognosis ER-positive breast cancers in need of more aggressive therapy ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22590486", "endSection": "sections.0"}, {"offsetInBeginSection": 432, "offsetInEndSection": 489, "text": "a high score on the Oncotype DX gene expression profile r ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22590486", "endSection": "sections.0"}, {"offsetInBeginSection": 359, "offsetInEndSection": 485, "text": "In this report we compare the prognostic and predictive utility of these two tools in node-negative, ER-positive breast cancer ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21221771", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 148, "text": "The 21-gene signature has been intensively studied and incorporated into major guidelines for treatment decision in early breast cancer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20564629", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "The Oncotype DX Recurrence Score (RS) is a validated genomic predictor of outcome and response to adjuvant chemotherapy in ER-positive breast cancer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21221771", "endSection": "sections.0"}, {"offsetInBeginSection": 1920, "offsetInEndSection": 2089, "text": "The EWG found adequate evidence regarding the association of the Oncotype DX Recurrence Score with disease recurrence and adequate evidence for response to chemotherapy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19125125", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 186, "text": "Over several decades, investigators working through National Cancer Institute-sponsored Cooperative Groups have contributed to major advances in the endocrine treatment of breast cancer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18072276", "endSection": "sections.0"}, {"offsetInBeginSection": 1467, "offsetInEndSection": 1611, "text": "Among early-stage breast cancer patients who received Oncotype DX, we found low knowledge about many aspects of genomic recurrence risk testing. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20200857", "endSection": "sections.0"}, {"offsetInBeginSection": 586, "offsetInEndSection": 775, "text": "Cooperative Group studies have contributed to the development of a molecular profiling test, Oncotype Dx, which identifies women who have an excellent prognosis with hormonal therapy alone. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18072276", "endSection": "sections.0"}, {"offsetInBeginSection": 230, "offsetInEndSection": 424, "text": "confirmed the clinical validity of the Oncotype DX breast cancer assay, not only as a way to predict recurrence but also as a tool for determining therapeutic benefit from adjuvant chemotherapy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18347556", "endSection": "sections.0"}, {"offsetInBeginSection": 53, "offsetInEndSection": 239, "text": "EWG) found insufficient evidence to make a recommendation for or against the use of tumor gene expression profiles to improve outcomes in defined populations of women with breast cancer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19125125", "endSection": "sections.0"}, {"offsetInBeginSection": 1546, "offsetInEndSection": 1763, "text": "Node-negative breast cancer does not automatically suggest a good prognosis, or the preclusion of chemotherapy benefits, and additional biomarkers are needed to help identify patients who do benefit from chemotherapy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21278441", "endSection": "sections.0"}, {"offsetInBeginSection": 297, "offsetInEndSection": 478, "text": "78 women, treated for early-stage, estrogen receptor-positive breast cancer with 0-3 positive lymph nodes, whose medical records indicated they received Oncotype DX testing earlier. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20200857", "endSection": "sections.0"}, {"offsetInBeginSection": 226, "offsetInEndSection": 427, "text": "A retrospective chart review of 58 T1/T2, node-negative, estrogen-receptor positive breast cancer patients that underwent Oncotype DX gene assay testing between January and December 2006 was performed. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18942607", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 232, "text": "The 21-gene recurrence score (Oncotype DX: RS) appears to augment clinico-pathologic prognostication and is predictive of adjuvant chemotherapy benefit in node-negative (N-) and node-positive (N+), endocrine-sensitive breast cancer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22361999", "endSection": "sections.0"}, {"offsetInBeginSection": 620, "offsetInEndSection": 879, "text": "Molecular tests such as the Oncotype DX(\u00ae) breast cancer test are proving to be more effective tools for individualized patient stratification and treatment planning than traditional methods such as patient demographic variables and histopathology indicators. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21370017", "endSection": "sections.0"}, {"offsetInBeginSection": 270, "offsetInEndSection": 503, "text": "We hypothesized that a distinct network of immune function genes at the tumor site can predict a low risk versus high risk of distant relapse in breast cancer patients regardless of the status of ER, PR, or HER-2/neu in their tumors. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21479927", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 263, "text": "Half of all breast cancers are early stage, lymph node negative, and hormone receptor positive. A 21-gene (Oncotype DX\u00ae; Genomic Health, Inc., Redwood City, CA) recurrence score (RS) is prognostic for recurrence and predictive of chemotherapy benefit. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21934103", "endSection": "sections.0"}, {"offsetInBeginSection": 1350, "offsetInEndSection": 1694, "text": "Real-time RT-PCR confirmed the 5-gene prognostic signature that was distinct from an FDA-cleared 70-gene signature of MammaPrint panel and from the Oncotype DX recurrence score assay panel. These data suggest that neoadjuvant immunotherapy in patients with high risk of relapse may reduce tumor recurrence by inducing the immune function genes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21479927", "endSection": "sections.0"}, {"offsetInBeginSection": 699, "offsetInEndSection": 1137, "text": "the gene expression signatures that define specific prognostic subtypes in other breast cancer datasets, such as luminal A and B, basal, normal-like, and ERBB2+, and prognostic signatures including MammaPrint and Oncotype DX, predicted genomic instability in our samples. This remarkable congruence suggests a biological interdependence of poor-prognosis gene signatures, breast cancer subtypes, genomic instability, and clinical outcome. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19101988", "endSection": "sections.0"}, {"offsetInBeginSection": 30, "offsetInEndSection": 485, "text": "the use of the Oncotype DX assay in estrogen receptor-positive node-negative breast cancer patients were incorporated into guidelines from both the American Society of Clinical Oncology and the National Comprehensive Cancer Network. The Oncotype DX assay is a diagnostic test which measures changes in a set of 21 genes in order to predict the likelihood of disease recurrence and also to predict which patients are most likely to respond to chemotherapy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19536946", "endSection": "sections.0"}, {"offsetInBeginSection": 2732, "offsetInEndSection": 3135, "text": "The Oncotype-DX Breast Cancer Assay (Genomic Health, Redwood City, CA) quantifies gene expression for 21 genes in breast cancer tissue by performing reverse transcription polymerase chain reaction (RT-PCR) on formalin-fixed paraffin-embedded (FFPE) tumour blocks that are obtained during initial surgery (lumpectomy, mastectomy, or core biopsy) of women with early breast cancer that is newly diagnosed. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23074401", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 453, "text": "The Oncotype DX assay is one of the molecular tests that provide predictive and prognostic information to breast cancer patients with estrogen receptor (ER)-positive and node-negative disease. This study evaluates the association of Forkhead-box protein A1 (FOXA1) and GATA-binding protein 3 (GATA3) expressions with Oncotype DX recurrences scores in 77 cases of patients with ER-positive node-negative breast carcinomas diagnosed at Indiana University. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19946260", "endSection": "sections.0"}]}, {"body": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22398368", "http://www.ncbi.nlm.nih.gov/pubmed/7536414", "http://www.ncbi.nlm.nih.gov/pubmed/22170584", "http://www.ncbi.nlm.nih.gov/pubmed/20808780", "http://www.ncbi.nlm.nih.gov/pubmed/20139415", "http://www.ncbi.nlm.nih.gov/pubmed/19467223", "http://www.ncbi.nlm.nih.gov/pubmed/19322801", "http://www.ncbi.nlm.nih.gov/pubmed/12368098", "http://www.ncbi.nlm.nih.gov/pubmed/12206775", "http://www.ncbi.nlm.nih.gov/pubmed/11838638", "http://www.ncbi.nlm.nih.gov/pubmed/9925782", "http://www.ncbi.nlm.nih.gov/pubmed/9628353", "http://www.ncbi.nlm.nih.gov/pubmed/9207024", "http://www.ncbi.nlm.nih.gov/pubmed/9153756", "http://www.ncbi.nlm.nih.gov/pubmed/23444399", "http://www.ncbi.nlm.nih.gov/pubmed/23125037", "http://www.ncbi.nlm.nih.gov/pubmed/23085465", "http://www.ncbi.nlm.nih.gov/pubmed/23007409", "http://www.ncbi.nlm.nih.gov/pubmed/22382314", "http://www.ncbi.nlm.nih.gov/pubmed/22320963", "http://www.ncbi.nlm.nih.gov/pubmed/22280363", "http://www.ncbi.nlm.nih.gov/pubmed/22259221", "http://www.ncbi.nlm.nih.gov/pubmed/22203734", "http://www.ncbi.nlm.nih.gov/pubmed/21981419", "http://www.ncbi.nlm.nih.gov/pubmed/21842375", "http://www.ncbi.nlm.nih.gov/pubmed/21805123", "http://www.ncbi.nlm.nih.gov/pubmed/21796622", "http://www.ncbi.nlm.nih.gov/pubmed/21791605"], "ideal_answer": "Although 5-aza-cdr is known to be incorporated into dna ( cytosine-5- ) -methyltransferases by 5-azacytosine is likely to involve methyl transfer to the inhibitor.Although 5-aza-cdr is known to be incorporated into dna and inhibit dna ( cytosine-5- ) -methyltransferases, the precise mechanisms underlying the drug's antineoplastic activity remain unclear.The inhibitors showed selectivity for c5 dna methyltransferases.The mechanism of inhibition of dna methyltransferase inhibitors are known to reactivate silenced genes; including 5-azacytidine and 2- ( 1h ) -pyrimidinone riboside ( zebularine ).These findings are valuable in guiding the rational design and virtual screening of novel dnmt inhibitors showed selectivity for c5 dna methyltransferases.Currently, there are only a few dnmt1 inhibitors with potential application as therapeutic agents or research tools.", "exact_answer": [["5-azacytidine", "5-aza-CR", "Vidaza\u00ae"], ["5-azadeoxycytidine", "5-aza-CdR", "Dacogen\u00ae", "5-aza-2'-deoxycytidine", "Decitabine"], ["5-azacytosine", "ZCyt"], ["5-fluorodeoxycytidine", "FdC"], ["5,6-dihydro-5-azacytosine", "DZCyt"], ["4'-thio-2'-deoxycytidine"], ["hydralazine"], ["2-(1H)-pyrimidinone riboside", "zebularine"], ["2-(1H)-pyrimidinone", "zebularine aglycon"], ["procaine"], ["procainamide"], ["RSC133"], ["Psammaplin A"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004248", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004791", "http://www.uniprot.org/uniprot/DCM_ECOLI"], "type": "list", "id": "5165932e298dcd4e51000059", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 67, "text": "Rapid synthesis of new DNMT inhibitors derivatives of procainamide. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22170584", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "DNA containing 4'-thio-2'-deoxycytidine inhibits methylation by HhaI methyltransferase. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9207024", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "The mechanism of inhibition of DNA (cytosine-5-)-methyltransferases by 5-azacytosine is likely to involve methyl transfer to the inhibitor. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7536414", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "Mechanism of inhibition of DNA (cytosine C5)-methyltransferases by oligodeoxyribonucleotides containing 5,6-dihydro-5-azacytosine. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9925782", "endSection": "title"}, {"offsetInBeginSection": 120, "offsetInEndSection": 236, "text": "Currently, there are only a few DNMT1 inhibitors with potential application as therapeutic agents or research tools. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21805123", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 104, "text": "Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12206775", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "The incorporation of 5-azacytosine residues into DNA causes potent inhibition of DNA (Cytosine-C5) methyltransferases. T ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11838638", "endSection": "sections.0"}, {"offsetInBeginSection": 297, "offsetInEndSection": 463, "text": "Structurally, however, gemcitabine has similarities to             5-aza-2-deoxycytidine (decitabine/Dacogen\u00ae), a DNA methyltransferase inhibitor             (DNMTi). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23007409", "endSection": "sections.0"}, {"offsetInBeginSection": 342, "offsetInEndSection": 444, "text": "Thus, it is important to understand the critical mechanistic determinants of ZCyt's inhibitory action. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12368098", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Synthesis of oligonucleotide inhibitors of DNA (Cytosine-C5) methyltransferase containing 5-azacytosine residues at specific sites. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11838638", "endSection": "title"}, {"offsetInBeginSection": 931, "offsetInEndSection": 1085, "text": "With increasing 5-Aza-CdR concentrations, the expression of DNA methyltransferases, DNMT3A and DNMT3B, significantly decreased in a dose-dependent manner. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22320963", "endSection": "sections.0"}, {"offsetInBeginSection": 102, "offsetInEndSection": 260, "text": "Diverse DNA methyltransferase inhibitors are being studied as potential anticancer drugs, and there is interest in developing novel and more effective DNMTIs. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21842375", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 136, "text": "Analysis of DNA methylation processes related to the inhibition of DNA synthesis by 5-azacytidine in Streptomyces antibioticus ETH 7451. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9628353", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 152, "text": "The presence of 5-azacytosine (ZCyt) residues in DNA leads to potent inhibition of DNA (cytosine-C5) methyltranferases (C5-MTases) in vivo and in vitro. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12368098", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 157, "text": "DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19467223", "endSection": "title"}, {"offsetInBeginSection": 376, "offsetInEndSection": 546, "text": "The effects of the deoxycytidine analogue decitabine (5-aza-2'-deoxycytidine), which depletes DNA methyl transferase 1 (DNMT1), on melanoma differentiation were examined. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21796622", "endSection": "sections.0"}, {"offsetInBeginSection": 166, "offsetInEndSection": 355, "text": "Although 5-Aza-CdR is known to be incorporated into DNA and inhibit DNA (cytosine-5)-methyltransferases, the precise mechanisms underlying the drug's antineoplastic activity remain unclear. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22398368", "endSection": "sections.0"}, {"offsetInBeginSection": 234, "offsetInEndSection": 386, "text": "Cooperative action of HDACi and DNA methylation inhibitors (DNMTi) has been reported, making combined treatment an attractive choice for cancer therapy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21791605", "endSection": "sections.0"}, {"offsetInBeginSection": 1492, "offsetInEndSection": 1660, "text": "Defining the parameters of zebularine-mediated tumor inhibition may advance the future development of DNA methyltransferase inhibitors as an effective cancer treatment. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22203734", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 173, "text": "Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22280363", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 268, "text": "The mechanism of inhibition of DNA (cytosine-5-)-methyltransferases by the mechanism-based inhibitor 5-azacytosine has remained unclear, mainly because of the unavailability of a substrate in which the inhibitor, but not normal cytosine, is present at the target site. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7536414", "endSection": "sections.0"}, {"offsetInBeginSection": 1022, "offsetInEndSection": 1215, "text": "Our results suggest that some of the 5-azacytidine effects on DNA and RNA synthesis might indeed be related to the complex formation and inhibition of a cytosine-specific DNA methyltransferase. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9628353", "endSection": "sections.0"}, {"offsetInBeginSection": 877, "offsetInEndSection": 1084, "text": "These results suggest that, when the enzyme binds to 5-azacytosine in the presence of the cofactor, a methyl group is transferred to the N-5 position of the base, resulting in the inactivation of the enzyme. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7536414", "endSection": "sections.0"}, {"offsetInBeginSection": 185, "offsetInEndSection": 379, "text": "Inhibitors of DNA methyltransferase (Dnmt) enzymes have been advocated as a means to promote and stabilize Foxp3 expression in Tregs undergoing expansion in vitro before their injection in vivo. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23444399", "endSection": "sections.0"}, {"offsetInBeginSection": 1080, "offsetInEndSection": 1260, "text": "The inhibitory effect of the 4'sulfur atom on enzymatic activity may be traced to perturbation of a step in the methylation reaction after DNA binding but prior to methyl transfer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9207024", "endSection": "sections.0"}, {"offsetInBeginSection": 856, "offsetInEndSection": 1059, "text": "Substitution of DZCyt for target cytosines in C-G dinucleotides of single-stranded or double-stranded oligodeoxyribonucleotide substrates led to complete inhibition of methylation by murine DNA C5-MTase. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9925782", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 187, "text": "Booster of pluripotency: RSC133, a new synthetic derivative of indoleacrylic acid/indolepropionic acid, exhibits dual activity by inhibiting histone deacetylase and DNA methyltransferase. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23125037", "endSection": "sections.0"}, {"offsetInBeginSection": 1216, "offsetInEndSection": 1458, "text": "Oligodeoxyribonucleotides containing DZCyt formed a tight but reversible complex with M.HhaI, and were consistently more potent as inhibitors of DNA methylation than oligodeoxyribonucleotides identical in sequence containing 5-fluorocytosine. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9925782", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 194, "text": "Treatment of Schizosaccharomyces pombe with the C5 DNA methyltransferase (C5Mtase) inhibitor 5-azacytidine (5-azaC) has previously been shown to induce G2 checkpoint-dependent cell cycle arrest. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9153756", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 229, "text": "Inhibition of HhaI DNA (Cytosine-C5) methyltransferase by oligodeoxyribonucleotides containing 5-aza-2'-deoxycytidine: examination of the intertwined roles of co-factor, target, transition state structure and enzyme conformation. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12368098", "endSection": "title"}, {"offsetInBeginSection": 1927, "offsetInEndSection": 2154, "text": "These results indicate that DZCyt can occupy the active site of M.HhaI as a transition state mimic and, because of the high degree of affinity of its interaction with the enzyme, it can act as a potent inhibitor of methylation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9925782", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 252, "text": "DNA methyltransferases (DNMTs) are a family of enzymes that methylate DNA at the C5 position of cytosine residues, and their inhibition is a promising strategy for the treatment of various developmental and proliferative diseases, particularly cancers. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19322801", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 250, "text": "DNA methyltransferase inhibitors (DNMTIs), including decitabine (DAC) and azacitidine (AZA), have recently been highlighted for the treatment of high-risk myelodysplastic syndrome (MDS); however, their action mechanisms have not been clearly defined. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23085465", "endSection": "sections.0"}, {"offsetInBeginSection": 244, "offsetInEndSection": 475, "text": "Six compounds resulted in potent inhibitors of the murine catalytic Dnmt3A/3L complex and of human DNMT1, at least 50 times greater than that of the parent compounds. The inhibitors showed selectivity for C5 DNA methyltransferases. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22170584", "endSection": "sections.0"}, {"offsetInBeginSection": 275, "offsetInEndSection": 488, "text": "Human colon cancer cell lines (HCT116, HT29, SW48, SW480) were treated with 5-aza-2'-deoxycytidine (DAC), as a DNA methyltransferase inhibitor, followed by trichostatin A (TSA), as a histone deacetylase inhibitor. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22382314", "endSection": "sections.0"}, {"offsetInBeginSection": 577, "offsetInEndSection": 813, "text": "The inhibitory activity of hydralazine toward DNMT may be rationalized at the molecular level by similar interactions within the binding pocket (e.g., by a similar pharmacophore) as established by substrate-like deoxycytidine analogues. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19322801", "endSection": "sections.0"}, {"offsetInBeginSection": 110, "offsetInEndSection": 346, "text": "A number of DNA methyltransferase inhibitors are known to reactivate silenced genes; including 5-azacytidine and 2-(1H)-pyrimidinone riboside (zebularine). Zebularine is a more stable, less cytotoxic inhibitor compared to 5-azacytidine. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19467223", "endSection": "sections.0"}, {"offsetInBeginSection": 192, "offsetInEndSection": 474, "text": "The inhibition of cytosine-[C5]-specific DNA methyltransferases (C5 MTases) by oligodeoxynucleotides containing 5-azadeoxycytidine (AzadC) and 5-fluorodeoxycytidine (FdC) provides a well-documented example of mechanism-based inhibition of enzymes central to nucleic acid metabolism. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12206775", "endSection": "sections.0"}, {"offsetInBeginSection": 983, "offsetInEndSection": 1307, "text": "Despite the different scaffolds of other non-nucleoside DNMT inhibitors such as procaine and procainamide, the current modeling work reveals that these drugs exhibit similar interactions within the DNMT1 binding site. These findings are valuable in guiding the rational design and virtual screening of novel DNMT inhibitors. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19322801", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 355, "text": "5-Aza-2'-deoxycytidine (5-Aza-CdR), a nucleoside analog that can inhibit DNA cytosine methylation, possesses potent antitumorigenic activities for myeloid disorders. Although 5-Aza-CdR is known to be incorporated into DNA and inhibit DNA (cytosine-5)-methyltransferases, the precise mechanisms underlying the drug's antineoplastic activity remain unclear. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22398368", "endSection": "sections.0"}, {"offsetInBeginSection": 1133, "offsetInEndSection": 1470, "text": "Since methyl transfer can occur only in the presence of AdoMet, these results suggest (1) that the inhibitory capacity of ZCyt in DNA is based on its ability to induce a stable, tightly closed conformation of M.HhaI that prevents DNA and co-factor release and (2) that methylation of ZCyt in DNA is not required for inhibition of M.HhaI. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12368098", "endSection": "sections.0"}, {"offsetInBeginSection": 868, "offsetInEndSection": 1272, "text": "The DNA methyltransferase inhibitor (5-aza-2-deoxycytidine) and the histone deacetylase inhibitor [trichostatin A (TSA)] both significantly up-regulated miR-146a transcriptional activation by altering the DNA-binding activity of NF-\u03baB in macrophages isolated from aged mice, which suggests that DNA methylation and histone acetylation are involved in the suppression of age-dependent miR-146a expression. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21981419", "endSection": "sections.0"}, {"offsetInBeginSection": 1010, "offsetInEndSection": 1549, "text": "ODNs containing 2-(1H)-pyrimidinone at the enzymatic target site are competitive inhibitors of both prokaryotic and mammalian DNA C5 methyltransferases. We determined that the ternary complexes between the enzymes, 2-(1H)-pyrimidinone inhibitor, and the cofactor S-adenosyl methionine are maintained through the formation of a reversible covalent interaction. The differing stability and reversibility of the covalent bonds may partially account for the observed differences in cytotoxicity between zebularine and 5-azacytidine inhibitors. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19467223", "endSection": "sections.0"}]}, {"body": "Describe armoured brain syndrome.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24403965", "http://www.ncbi.nlm.nih.gov/pubmed/23421586", "http://www.ncbi.nlm.nih.gov/pubmed/21319032", "http://www.ncbi.nlm.nih.gov/pubmed/19902386", "http://www.ncbi.nlm.nih.gov/pubmed/1580196"], "triples": [], "ideal_answer": "High-field magnetic resonance image of a huge calcified chronic subdural haematoma, so-called \"armoured brain\".Calcification of chronic subdural haematoma is called \"armoured brain\" when it covers most of the cortical surface.The optimal surgical procedure for patients with calcified and organized chronic subdural collection ( armoured brain ) is a known long-standing complication of shunt overdrainage.Results : a patient with a bilateral symptomatic calcified chronic subdural hematoma, or so-called \"armoured brain\" when it covers most of the cortical surface.Calcification of chronic subdural haematoma is called \"armoured brain\", was admitted to our intensive care unit with clinical signs of increased intracranial pressure.Armoured brain\", has not been established because it is difficult to obtain good re-expansion of the brain after surgery.The optimal surgical procedure for patients with calcified and organized chronic subdural haematoma ( csdh ), or \"armoured brain is a rare condition where dense calcification occurs over the brain.Armoured brain due to chronic subdural collections masking underlying hydrocephalus.", "concepts": [], "type": "summary", "id": "54cf42bdf693c3b16b000007", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 82, "text": "Armoured brain is a rare condition where dense calcification occurs over the brain ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24403965", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 83, "text": "Armoured brain is a rare condition where dense calcification occurs over the brain. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24403965", "endSection": "abstract"}, {"offsetInBeginSection": -1, "offsetInEndSection": 83, "text": "Armoured brain due to chronic subdural collections masking underlying hydrocephalus. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23421586", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "Calcification of chronic subdural haematoma is called \"armoured brain\" when it covers most of the cortical surface. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1580196", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "Calcified chronic subdural collection (armoured brain) is a known long-standing complication of shunt overdrainage. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23421586", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "Calcified chronic subdural collection (armoured brain) is a known long-standing complication of shunt overdrainage ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23421586", "endSection": "abstract"}, {"offsetInBeginSection": -1, "offsetInEndSection": 110, "text": "High-field magnetic resonance image of a huge calcified chronic subdural haematoma, so-called \"armoured brain\". ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1580196", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 232, "text": "The optimal surgical procedure for patients with calcified and organized chronic subdural haematoma (CSDH), or \"armoured brain\", has not been established because it is difficult to obtain good re-expansion of the brain after surgery ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21319032", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 234, "text": "The optimal surgical procedure for patients with calcified and organized chronic subdural haematoma (CSDH), or \"armoured brain\", has not been established because it is difficult to obtain good re-expansion of the brain after surgery. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21319032", "endSection": "abstract"}, {"offsetInBeginSection": 436, "offsetInEndSection": 647, "text": "RESULTS: A patient with a bilateral symptomatic calcified chronic subdural hematoma, or so-called \"armoured brain\", was admitted to our intensive care unit with clinical signs of increased intracranial pressure. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19902386", "endSection": "abstract"}]}, {"body": "Which are the main histone modifications associated with enhancers?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22270183", "http://www.ncbi.nlm.nih.gov/pubmed/20621055", "http://www.ncbi.nlm.nih.gov/pubmed/19021773"], "ideal_answer": "H3K4 methylation to monovalent and bivalent domains hyperacetylation of histones H3 and H4, a mark of active chromatin, is established broadly across target loci by enhancers that function over long distances using H3K4me2 as a mark for active enhancers the enhancer region itself was marked by mono-methylation at K4 and K9, distinguishing it from the methyl marks in the gene coding region", "exact_answer": [["Histone 3 lysine 4 mono-methylation (H3K4me1)"], ["Histone 3 lysine 4 di-methylation (H3K4me2)"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D056545"], "type": "list", "id": "5131bef65274a5fb07000008", "snippets": [{"offsetInBeginSection": 202, "offsetInEndSection": 246, "text": "Using H3K4me2 as a mark for active enhancers ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22270183", "endSection": "sections.0"}, {"offsetInBeginSection": 300, "offsetInEndSection": 351, "text": "H3K4 methylation to monovalent and bivalent domains ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20621055", "endSection": "sections.0"}, {"offsetInBeginSection": 881, "offsetInEndSection": 1018, "text": "The enhancer region itself was marked by mono-methylation at K4 and K9, distinguishing it from the methyl marks in the gene coding region ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19021773", "endSection": "sections.0"}, {"offsetInBeginSection": 101, "offsetInEndSection": 257, "text": "Hyperacetylation of histones H3 and H4, a mark of active chromatin, is established broadly across target loci by enhancers that function over long distances ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19021773", "endSection": "sections.0"}]}, {"body": "What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/9773038", "http://www.ncbi.nlm.nih.gov/pubmed/8437381", "http://www.ncbi.nlm.nih.gov/pubmed/8690305", "http://www.ncbi.nlm.nih.gov/pubmed/1394244", "http://www.ncbi.nlm.nih.gov/pubmed/1317658", "http://www.ncbi.nlm.nih.gov/pubmed/2127684", "http://www.ncbi.nlm.nih.gov/pubmed/2112565", "http://www.ncbi.nlm.nih.gov/pubmed/3018425", "http://www.ncbi.nlm.nih.gov/pubmed/8221703"], "triples": [], "ideal_answer": "Since s. konno and h. wakui published cases of myelinolysis who dramatically improved after trh treatment, the patient was given 0.6 mg i.v daily of trh for six weeks.Reversed the pentobarbital-induced narcosis in a dose-dependent manner.However, the patient was given 0.6 mg i.v daily of trh for six weeks.Ns-3 shortened the latent periods to the recovery of the righting reflex ( 0.03-0.1 mg, i.v. )However, the remaining two BD patients, who had spinal reflexes, exhibited an elevation in MBP.Following the head concussion.These results indicate that in comatose patients, the hemodynamic effects of trh may differ depending on impairments in the central nervous system; the results support previous reports indicating a mediation of the central sympathetic nervous system in the development of pressor effects of trh.The direct trh ( thyrotropin releasing hormone ) stimulation to the anterior lobe was responded to well.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013973", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003128", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013812", "http://www.uniprot.org/uniprot/TRH_PIG", "http://www.uniprot.org/uniprot/TRH_SHEEP", "http://www.uniprot.org/uniprot/TRH_NOTVI", "http://www.uniprot.org/uniprot/TRH_BOMOR", "http://www.biosemantics.org/jochem#4272308"], "type": "summary", "id": "530f7d7fe3eabad021000002", "snippets": [{"offsetInBeginSection": 594, "offsetInEndSection": 697, "text": "The direct TRH (thyrotropin releasing hormone) stimulation to the anterior lobe was responded to well. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1317658", "endSection": "abstract"}, {"offsetInBeginSection": 817, "offsetInEndSection": 927, "text": "His CNS symptoms improved dramatically after administration of thyrotropin-releasing hormone tartrate (TRH-T). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8437381", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "[Montirelin hydrate (NS-3), a TRH analog, improved the disturbance of consciousness caused by head concussion and pentobarbital in mice]. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8690305", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 226, "text": "A 46-year-old female motorcyclist, who suffered injuries to the brain stem in a traffic accident, showed hypotensive and bradycardiac responses to thyrotropin-releasing hormone (TRH) given to counter consciousness disturbance. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1394244", "endSection": "abstract"}, {"offsetInBeginSection": 982, "offsetInEndSection": 1275, "text": "Taken together with the finding that NS-3 did not bind to dopamine, adrenaline or muscarine receptors, it is suggested that NS-3 may restore the disturbance of consciousness by activating the brain dopamine, noradrenaline and acetylcholine neurons without stimulating these receptors directly. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8690305", "endSection": "abstract"}, {"offsetInBeginSection": 1066, "offsetInEndSection": 1362, "text": "These results indicate that in comatose patients, the hemodynamic effects of TRH may differ depending on impairments in the central nervous system; the results support previous reports indicating a mediation of the central sympathetic nervous system in the development of pressor effects of TRH. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8221703", "endSection": "abstract"}, {"offsetInBeginSection": 291, "offsetInEndSection": 714, "text": "NS-3 shortened the latent periods to the recovery of the righting reflex (0.03-0.1 mg/kg, i.v.) and spontaneous motor activity (0.1 mg/kg, i.v.) following the head concussion. In the case of TRH, higher doses were needed to induce such effects. NS-3 (0.1-0.3 mg/kg, i.v.) reversed the pentobarbital-induced narcosis in a dose-dependent manner. A similar effect was elicited by 30- to 100-fold higher doses of TRH than NS-3. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8690305", "endSection": "abstract"}, {"offsetInBeginSection": 459, "offsetInEndSection": 879, "text": "In the vegetative group, TRH caused significant increases in MBP (from 91 +/- 8 mm Hg to 110 +/- 10 mm Hg) at 2 min after the injection [p < 0.05, analysis of variance (ANOVA) with a Scheff\u00e9 F-test]. In contrast, five of the seven BD patient showed no alterations in the measured parameter in response to the TRH injection. However, the remaining two BD patients, who had spinal reflexes, exhibited an elevation in MBP. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8221703", "endSection": "abstract"}, {"offsetInBeginSection": 332, "offsetInEndSection": 835, "text": "Despite the correction of these metabolic disorders, the patient became comatose, and MRI, on T2 weighted image, showed hyperintense signals in the basal ganglia consistent with extra-pontine myelinolysis. The patient's state remained unchanged for six weeks. Since S. Konno and H. Wakui published cases of myelinolysis who dramatically improved after TRH treatment, the patient was given 0.6 mg i.v daily of TRH for six weeks. Improvement began within a few days, and continued until complete recovery. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9773038", "endSection": "abstract"}, {"offsetInBeginSection": 759, "offsetInEndSection": 1853, "text": "The neuropharmacological activities of TRH include an interesting arousal effect and an analeptic action on generalized depression of the CNS whether this depression is of natural origin, such as hibernation, or induced pharmacologically (barbiturates, ethanol) or of a traumatic origin (coma). This analeptic action is attributable to stimulation of cholinergic neurons in the septo-hippocampal area and to the presence of terminals containing TRH in the lateral septum and TRH receptors concentrated especially in the medial septum and diagonal band of Broca. It has also been suggested that TRH localized in the pineal gland has a part in activating the neuronal mechanisms of arousal. Associated with the arousal effect and especially evident in variously originated shock conditions are the activating effects of TRH on vegetative functions (body temperature, circulation, the gastrointestinal tract). These stimulatory activities on the CNS were the rationale for therapeutic use of TRH in the initial treatment of coma due to brain trauma and for the treatment of endogenous depression. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2127684", "endSection": "abstract"}]}, {"body": "Do Conserved noncoding elements act as enhancers?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21629789", "http://www.ncbi.nlm.nih.gov/pubmed/21081479", "http://www.ncbi.nlm.nih.gov/pubmed/21047394", "http://www.ncbi.nlm.nih.gov/pubmed/20494938", "http://www.ncbi.nlm.nih.gov/pubmed/19805301", "http://www.ncbi.nlm.nih.gov/pubmed/19782672", "http://www.ncbi.nlm.nih.gov/pubmed/19704032", "http://www.ncbi.nlm.nih.gov/pubmed/19492354", "http://www.ncbi.nlm.nih.gov/pubmed/19171877", "http://www.ncbi.nlm.nih.gov/pubmed/19073165", "http://www.ncbi.nlm.nih.gov/pubmed/18562680", "http://www.ncbi.nlm.nih.gov/pubmed/18047696", "http://www.ncbi.nlm.nih.gov/pubmed/17989259", "http://www.ncbi.nlm.nih.gov/pubmed/17940009", "http://www.ncbi.nlm.nih.gov/pubmed/17210927", "http://www.ncbi.nlm.nih.gov/pubmed/16533910", "http://www.ncbi.nlm.nih.gov/pubmed/15859353"], "ideal_answer": "The acnes are rich in tissue-specific enhancers we identify and characterize highly conserved noncoding sequences ( cns ) upstream of coup-tfii ( cns-62kb and cns-66kb ).Conserved noncoding elements ( cnes ) in vertebrate genomes often act as developmental enhancers,Conserved noncoding elements functioned as enhancers, several transcriptional enhancers are conserved between amphioxus and vertebrates -- a very wide phylogenetic distance.Transgenic zebrafish assay of some human CNE enhancers that have been lost in teleosts eight of the 15 distal candidate elements functioned as enhancers,Conserved noncoding elements functioned as enhancers,Transgenic zebrafish assay of some human cne enhancers we identify and characterize highly conserved noncoding elements flanking the tnf gene, which undergo activation-dependent intrachromosomal interactions.Uncovered two anciently conserved noncoding elements flanking the tnf gene, which undergo activation-dependent intrachromosomal interactions.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004742", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0035326", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017124", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D024861", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D026801"], "type": "yesno", "id": "5139ec51bee46bd34c000006", "snippets": [{"offsetInBeginSection": 1169, "offsetInEndSection": 1216, "text": "The aCNEs are rich in tissue-specific enhancers ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21081479", "endSection": "sections.0"}, {"offsetInBeginSection": 688, "offsetInEndSection": 762, "text": "Besides developmental regulators that are likely targets of HCNE enhancers ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17989259", "endSection": "sections.0"}, {"offsetInBeginSection": 382, "offsetInEndSection": 463, "text": "We recently described GRBs in vertebrates, where most HCNEs function as enhancers ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17989259", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "Conserved noncoding elements (CNEs) in vertebrate genomes often act as developmental enhancers, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20494938", "endSection": "sections.0"}, {"offsetInBeginSection": 585, "offsetInEndSection": 677, "text": "HCNEs of both human and zebrafish function as specific developmental enhancers in zebrafish. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19073165", "endSection": "sections.0"}, {"offsetInBeginSection": 1397, "offsetInEndSection": 1483, "text": "Transgenic zebrafish assay of some human CNE enhancers that have been lost in teleosts ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21081479", "endSection": "sections.0"}, {"offsetInBeginSection": 1048, "offsetInEndSection": 1165, "text": "several transcriptional enhancers are conserved between amphioxus and vertebrates--a very wide phylogenetic distance. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18562680", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 141, "text": "Animal genomes possess highly conserved cis-regulatory sequences that are often found near genes that regulate transcription and development. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19704032", "endSection": "sections.0"}, {"offsetInBeginSection": 755, "offsetInEndSection": 914, "text": "We test 42 of our PCNEs in transgenic zebrafish assays--including examples from vertebrates and amphioxus--and find that the majority are functional enhancers. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19704032", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 214, "text": "The genomes of vertebrates, flies, and nematodes contain highly conserved noncoding elements (CNEs). CNEs cluster around genes that regulate development, and where tested, they can act as transcriptional enhancers. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19492354", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 216, "text": "Pan-vertebrate developmental cis-regulatory elements are discernible as highly conserved noncoding elements (HCNEs) and are often dispersed over large areas around the pleiotropic genes whose expression they control. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19073165", "endSection": "sections.0"}, {"offsetInBeginSection": 635, "offsetInEndSection": 887, "text": "Comparisons of noncoding sequences of the elephant shark and human Hox clusters have identified a large number of conserved noncoding elements (CNEs), which represent putative cis-regulatory elements that may be involved in the regulation of Hox genes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19805301", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 305, "text": "Fish-mammal genomic comparisons have proved powerful in identifying conserved noncoding elements likely to be cis-regulatory in nature, and the majority of those tested in vivo have been shown to act as tissue-specific enhancers associated with genes involved in transcriptional regulation of development. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16533910", "endSection": "sections.0"}, {"offsetInBeginSection": 1278, "offsetInEndSection": 1530, "text": "If these ancient CNEs are indeed enhancers directing tissue-specific expression of Hox genes, divergence of their sequences in vertebrate lineages might have led to altered expression patterns and presumably the functions of their associated Hox genes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19805301", "endSection": "sections.0"}, {"offsetInBeginSection": 749, "offsetInEndSection": 1016, "text": "uncovered two anciently conserved noncoding sequences (CNS) upstream of COUP-TFII (CNS-62kb and CNS-66kb). Testing these two elements using reporter constructs in liver cells (HepG2) revealed that CNS-66kb, but not CNS-62kb, yielded robust in vitro enhancer activity. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15859353", "endSection": "sections.0"}, {"offsetInBeginSection": 1433, "offsetInEndSection": 1727, "text": "In all four cases where the zebra fish and human CNE display a similar expression pattern in zebra fish, the human CNE also displays a similar expression pattern in mouse. This suggests that the endogenous enhancer activity of \u223c30% of human CNEs can be determined from experiments in zebra fish ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20494938", "endSection": "sections.0"}, {"offsetInBeginSection": 1032, "offsetInEndSection": 1420, "text": "We used the sequence signatures identified by this approach to successfully assign tissue-specific predictions to approximately 328,000 human-mouse conserved noncoding elements in the human genome. By overlapping these genome-wide predictions with a data set of enhancers validated in vivo, in transgenic mice, we were able to confirm our results with a 28% sensitivity and 50% precision. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17210927", "endSection": "sections.0"}, {"offsetInBeginSection": 443, "offsetInEndSection": 1004, "text": ", we identified 17 highly conserved noncoding elements, 9 of which revealed specific acetylation marks in chromatin-immunoprecipitation and microarray (ChIP-chip) assays performed across 250 kb of the Lmo2 locus in 11 cell types covering different stages of hematopoietic differentiation. All candidate regulatory regions were tested in transgenic mice. An extended LMO2 proximal promoter fragment displayed strong endothelial activity, while the distal promoter showed weak forebrain activity. Eight of the 15 distal candidate elements functioned as enhancers, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19171877", "endSection": "sections.0"}, {"offsetInBeginSection": 144, "offsetInEndSection": 734, "text": "We identify and characterize highly conserved noncoding elements flanking the TNF gene, which undergo activation-dependent intrachromosomal interactions. These elements, hypersensitive site (HSS)-9 and HSS+3 (9 kb upstream and 3 kb downstream of the TNF gene, respectively), contain DNase I hypersensitive sites in naive, T helper 1, and T helper 2 primary T cells. Both HSS-9 and HSS+3 inducibly associate with acetylated histones, indicative of chromatin remodeling, bind the transcription factor nuclear factor of activated T cells (NFAT)p in vitro and in vivo, and function as enhancers ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17940009", "endSection": "sections.0"}]}, {"body": "Can the iPS cell technology be used in Fanconi anemia therapy?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20224565", "http://www.ncbi.nlm.nih.gov/pubmed/19483674"], "triples": [], "ideal_answer": "We explain a protocol for the reproducible generation of genetically corrected ipscs starting from the skin biopsies of fanconi anaemia patients using retroviral transduction with oct4, sox2 and klf4 these cell lines appear indistinguishable from human embryonic stem cells and ips cells from healthy individuals most importantly, we show that corrected fanconi-anaemia-specific ips cells.Here we show that corrected fanconi-anaemia-specific ips cells can give rise to haematopoietic progenitors of the myeloid and erythroid lineages that are phenotypically normal, that is, disease-free disease-corrected haematopoietic progenitors from fanconi anaemia patients using retroviral transduction with oct4, sox2 and klf4 these cell lines appear indistinguishable from human embryonic stem cells.Here we show that, on correction of the genetic defect, somatic cells from Fanconi anaemia patients can be reprogrammed to pluripotency to generate patient-specific iPS cells.We explain a protocol for the reproducible generation of genetically corrected ipscs starting from the skin biopsies of fanconi anemia patients can be reprogrammed to pluripotency to generate patient-specific ips cells from fanconi anaemia induced pluripotent stem cells before reprogramming, the fibroblasts and keratinocytes of the patients are genetically corrected with lentiviruses expressing fanca.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005199", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D057026", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051856", "http://www.disease-ontology.org/api/metadata/DOID:13636", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D064987"], "type": "yesno", "id": "54edef0594afd6150400000d", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19483674", "endSection": "title"}, {"offsetInBeginSection": 509, "offsetInEndSection": 645, "text": "Before reprogramming, the fibroblasts and/or keratinocytes of the patients are genetically corrected with lentiviruses expressing FANCA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20224565", "endSection": "abstract"}, {"offsetInBeginSection": 612, "offsetInEndSection": 823, "text": "Most importantly, we show that corrected Fanconi-anaemia-specific iPS cells can give rise to haematopoietic progenitors of the myeloid and erythroid lineages that are phenotypically normal, that is, disease-free ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19483674", "endSection": "abstract"}, {"offsetInBeginSection": 309, "offsetInEndSection": 507, "text": "We explain a protocol for the reproducible generation of genetically corrected iPSCs starting from the skin biopsies of Fanconi anemia patients using retroviral transduction with OCT4, SOX2 and KLF4 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20224565", "endSection": "abstract"}, {"offsetInBeginSection": 322, "offsetInEndSection": 610, "text": "Here we show that, on correction of the genetic defect, somatic cells from Fanconi anaemia patients can be reprogrammed to pluripotency to generate patient-specific iPS cells. These cell lines appear indistinguishable from human embryonic stem cells and iPS cells from healthy individuals ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19483674", "endSection": "abstract"}]}, {"body": "Which drug is considered as the first line treatment of fibromyalgia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17653994", "http://www.ncbi.nlm.nih.gov/pubmed/23235657", "http://www.ncbi.nlm.nih.gov/pubmed/21975791", "http://www.ncbi.nlm.nih.gov/pubmed/18840008"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#broader", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:1526", "o": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:1526", "o": "panniculitis"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "NCI2009_04D:C50566"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "UMLS_CUI:C0016053"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:203082005"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:203102006"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:1304004"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "MSH2010_2010_02_22:D005356"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:56557000"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:203101004"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:13612005"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:156727006"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:24693007"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:247365004"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:268107007"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:203111006"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "SNOMEDCT_2010_1_31:203138004"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:631", "o": "fibromyalgia"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00125892", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00125892", "o": "Trial NCT00125892"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00596674", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00596674", "o": "Trial NCT00596674"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00086047", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00086047", "o": "Trial NCT00086047"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00106275", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00106275", "o": "Trial NCT00106275"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00236925", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00236925", "o": "Trial NCT00236925"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00314249", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00314249", "o": "Trial NCT00314249"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00032461", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00032461", "o": "Trial NCT00032461"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00710918", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00710918", "o": "Trial NCT00710918"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00545649", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00545649", "o": "Trial NCT00545649"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00423605", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00423605", "o": "Trial NCT00423605"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00000423", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00000423", "o": "Trial NCT00000423"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00424892", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00424892", "o": "Trial NCT00424892"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00697398", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00697398", "o": "Trial NCT00697398"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00754221", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00754221", "o": "Trial NCT00754221"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00071708", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00071708", "o": "Trial NCT00071708"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00000398", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00000398", "o": "Trial NCT00000398"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00383084", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00383084", "o": "Trial NCT00383084"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00000397", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00000397", "o": "Trial NCT00000397"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00468013", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00468013", "o": "Trial NCT00468013"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00000428", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00000428", "o": "Trial NCT00000428"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00256893", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00256893", "o": "Trial NCT00256893"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00001983", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00001983", "o": "Trial NCT00001983"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00612170", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00612170", "o": "Trial NCT00612170"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00515008", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00515008", "o": "Trial NCT00515008"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00704899", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00704899", "o": "Trial NCT00704899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00264628", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00264628", "o": "Trial NCT00264628"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00313885", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00313885", "o": "Trial NCT00313885"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00302887", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00302887", "o": "Trial NCT00302887"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00752505", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00752505", "o": "Trial NCT00752505"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00398255", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00398255", "o": "Trial NCT00398255"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00689052", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00689052", "o": "Trial NCT00689052"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00723671", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00723671", "o": "Trial NCT00723671"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00001415", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00001415", "o": "Trial NCT00001415"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00301431", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00301431", "o": "Trial NCT00301431"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00229294", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00229294", "o": "Trial NCT00229294"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00645398", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00645398", "o": "Trial NCT00645398"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00151528", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00151528", "o": "Trial NCT00151528"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00445705", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00445705", "o": "Trial NCT00445705"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00282997", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00282997", "o": "Trial NCT00282997"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00088777", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00088777", "o": "Trial NCT00088777"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00279942", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00279942", "o": "Trial NCT00279942"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00437411", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00437411", "o": "Trial NCT00437411"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00377039", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00377039", "o": "Trial NCT00377039"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00650715", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00650715", "o": "Trial NCT00650715"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00568919", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00568919", "o": "Trial NCT00568919"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00080184", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00080184", "o": "Trial NCT00080184"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00366535", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00366535", "o": "Trial NCT00366535"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00294281", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00294281", "o": "Trial NCT00294281"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00615654", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00615654", "o": "Trial NCT00615654"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00000422", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00000422", "o": "Trial NCT00000422"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00750854", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00750854", "o": "Trial NCT00750854"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00167271", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00167271", "o": "Trial NCT00167271"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00098124", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00098124", "o": "Trial NCT00098124"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00498264", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00498264", "o": "Trial NCT00498264"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00423631", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00423631", "o": "Trial NCT00423631"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00381199", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00381199", "o": "Trial NCT00381199"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00142597", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00142597", "o": "Trial NCT00142597"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00423813", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00423813", "o": "Trial NCT00423813"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00222209", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00222209", "o": "Trial NCT00222209"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00524420", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00524420", "o": "Trial NCT00524420"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00321659", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00321659", "o": "Trial NCT00321659"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00116129", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00116129", "o": "Trial NCT00116129"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00755521", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00755521", "o": "Trial NCT00755521"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00057278", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00057278", "o": "Trial NCT00057278"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00618956", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00618956", "o": "Trial NCT00618956"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00151489", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00151489", "o": "Trial NCT00151489"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00497562", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00497562", "o": "Trial NCT00497562"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00177320", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00177320", "o": "Trial NCT00177320"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00051428", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00051428", "o": "Trial NCT00051428"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00071162", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00071162", "o": "Trial NCT00071162"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00324441", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00324441", "o": "Trial NCT00324441"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00554320", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00554320", "o": "Trial NCT00554320"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00677157", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00677157", "o": "Trial NCT00677157"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00321451", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00321451", "o": "Trial NCT00321451"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00392041", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00392041", "o": "Trial NCT00392041"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00535587", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00535587", "o": "Trial NCT00535587"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00222690", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00222690", "o": "Trial NCT00222690"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00268606", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00268606", "o": "Trial NCT00268606"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_id", "s": "http://data.linkedct.org/resource/condition/4899", "o": "4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00489073", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00489073", "o": "Trial NCT00489073"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00272207", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00272207", "o": "Trial NCT00272207"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00230776", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00230776", "o": "Trial NCT00230776"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00087555", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00087555", "o": "Trial NCT00087555"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00374673", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00374673", "o": "Trial NCT00374673"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00566514", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00566514", "o": "Trial NCT00566514"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00086060", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00086060", "o": "Trial NCT00086060"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00569218", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00569218", "o": "Trial NCT00569218"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00312234", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00312234", "o": "Trial NCT00312234"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00456898", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00456898", "o": "Trial NCT00456898"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00346034", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00346034", "o": "Trial NCT00346034"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00550641", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00550641", "o": "Trial NCT00550641"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00673452", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00673452", "o": "Trial NCT00673452"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00750230", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00750230", "o": "Trial NCT00750230"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00573612", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00573612", "o": "Trial NCT00573612"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00568555", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00568555", "o": "Trial NCT00568555"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00450905", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00450905", "o": "Trial NCT00450905"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00512590", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00512590", "o": "Trial NCT00512590"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00696787", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00696787", "o": "Trial NCT00696787"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00190866", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00190866", "o": "Trial NCT00190866"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00233025", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00233025", "o": "Trial NCT00233025"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00176163", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00176163", "o": "Trial NCT00176163"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00067405", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00067405", "o": "Trial NCT00067405"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00496886", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00496886", "o": "Trial NCT00496886"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00254657", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00254657", "o": "Trial NCT00254657"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00600574", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00600574", "o": "Trial NCT00600574"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00259636", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00259636", "o": "Trial NCT00259636"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00607256", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00607256", "o": "Trial NCT00607256"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00523302", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00523302", "o": "Trial NCT00523302"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00333866", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00333866", "o": "Trial NCT00333866"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00371137", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00371137", "o": "Trial NCT00371137"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00115804", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00115804", "o": "Trial NCT00115804"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00065702", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00065702", "o": "Trial NCT00065702"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://data.linkedct.org/resource/linkedct/condition", "s": "http://data.linkedct.org/resource/trials/NCT00379496", "o": "http://data.linkedct.org/resource/condition/4899"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Fibromyalgia"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/4899", "o": "Condition #4899 (Fibromyalgia)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00379496", "o": "Trial NCT00379496"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "D005356"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646438"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "Fibromyalgias, Primary"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "Primary Fibromyalgias"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "Fibromyalgia, Primary"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646442"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "Primary Fibromyalgia"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A7798131"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "D005356"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646438"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "Fibromyalgias, Primary"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "Primary Fibromyalgias"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "Fibromyalgia, Primary"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646442"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "Primary Fibromyalgia"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A7798131"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "D005356"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646438"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "Fibromyalgias, Primary"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "Primary Fibromyalgias"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "Fibromyalgia, Primary"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646442"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "Primary Fibromyalgia"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A7798131"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "D005356"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646438"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "Fibromyalgias, Primary"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "Primary Fibromyalgias"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "Fibromyalgia, Primary"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646442"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "Primary Fibromyalgia"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A7798131"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646438"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "Fibromyalgias, Primary"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "Primary Fibromyalgias"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "Fibromyalgia, Primary"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646442"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "Primary Fibromyalgia"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A7798131"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646438"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "Fibromyalgias, Primary"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "Primary Fibromyalgias"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "Fibromyalgia, Primary"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646442"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "Primary Fibromyalgia"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A7798131"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646438"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "Fibromyalgias, Primary"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "Primary Fibromyalgias"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "Fibromyalgia, Primary"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646442"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "Primary Fibromyalgia"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A7798131"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646438"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646441", "o": "Fibromyalgias, Primary"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646442", "o": "Primary Fibromyalgias"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7798131", "o": "Fibromyalgia, Primary"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646442"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A1646441"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1646438", "o": "Primary Fibromyalgia"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0751152", "o": "http://linkedlifedata.com/resource/umls/label/A7798131"}], "ideal_answer": "Multimodal approaches seem to be the treatment of choice in fibromyalgia in the primary care setting.Amitriptyline should continue to be used as part of the treatment of neuropathic pain or fibromyalgia.Valproic acid and its sodium salt ( sodium valproate ) are antiepileptic drugs that are sometimes used to treat chronic neuropathic pain and fibromyalgia, although they are not licensed for this use.Pregabalin is, therefore, a valuable option in the first-line treatment of patients with fibromyalgia.A multidisciplinary program included education ( seven sessions ) and physical therapy ( 25 sessions ).Oral pregabalin, a calcium channel alpha ( 2 ) delta-subunit ligand with analgesic, anxiolytic and antiepileptic activity, has shown efficacy in the treatment of fibromyalgia, although they are not licensed for this use.Pregabalin is, therefore, a valuable option in the first-line treatment of neuropathic pain or fibromyalgia, but only a minority of patients will achieve satisfactory pain relief.The program was developed and implemented for patients with fibromyalgia in the primary care setting.", "exact_answer": ["Pregabalin"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005356", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013812", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015673"], "type": "factoid", "id": "5324ce779b2d7acc7e00001e", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 62, "text": "Amitriptyline for neuropathic pain and fibromyalgia in adults. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23235657", "endSection": "title"}, {"offsetInBeginSection": 78, "offsetInEndSection": 150, "text": "Multimodal approaches seem to be the treatment of choice in fibromyalgia ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17653994", "endSection": "abstract"}, {"offsetInBeginSection": 837, "offsetInEndSection": 939, "text": "Pregabalin is, therefore, a valuable option in the first-line treatment of patients with fibromyalgia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18840008", "endSection": "abstract"}, {"offsetInBeginSection": 3926, "offsetInEndSection": 4099, "text": "Amitriptyline should continue to be used as part of the treatment of neuropathic pain or fibromyalgia, but only a minority of patients will achieve satisfactory pain relief. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23235657", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 171, "text": "Oral pregabalin, a calcium channel alpha(2)delta-subunit ligand with analgesic, anxiolytic and antiepileptic activity, has shown efficacy in the treatment of fibromyalgia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18840008", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 194, "text": "Amitriptyline is a tricyclic antidepressant that is widely used to treat chronic neuropathic pain (pain due to nerve damage) and fibromyalgia, and is recommended in many guidelines. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23235657", "endSection": "abstract"}, {"offsetInBeginSection": 152, "offsetInEndSection": 353, "text": "A multidisciplinary program was developed and implemented for patients with fibromyalgia in the primary care setting. The program included education (seven sessions) and physical therapy (25 sessions). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17653994", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 210, "text": "Valproic acid and its sodium salt (sodium valproate) are antiepileptic drugs that are sometimes used to treat chronic neuropathic pain and fibromyalgia, although they are not licensed for this use. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21975791", "endSection": "abstract"}]}, {"body": "What are the signatures of aggressive periodontitis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18980520", "http://www.ncbi.nlm.nih.gov/pubmed/15154918"], "triples": [], "ideal_answer": "A total of 35 microarrays, no significantly different gene expression profiles appeared to emerge between chronic and seven with aggressive periodontitis, were examined with respect to clinical periodontal status, composition of subgingival bacterial plaque assessed by checkerboard hybridizations, and levels of serum igg antibodies to periodontal bacteria assayed by checkerboard immunoblotting.This pilot study examined gene expression signatures in pathological gingival tissues of subjects with chronic and aggressive periodontitis.Gene ontology analysis identified 61 differentially expressed groups ( adjusted P < 0.05 ), including apoptosis, antimicrobial humoral response, antigen presentation, regulation of metabolic processes, signal transduction, and angiogenesis these two groups had similar clinical periodontal status and subgingival bacterial profiles, but differed significantly with respect to serum IgG levels against the important periodontal pathogens Porphyromonas gingivalis, Tannerella forsythensis and Campylobacter rectus.A total of 14 subjects into two fairly robust clusters was possible based on similarities in gene expression.These early data point to the usefulness of gene expression profiling techniques in the identification of subclasses of periodontitis with common pathobiology", "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:1474", "http://www.disease-ontology.org/api/metadata/DOID:824"], "type": "summary", "id": "5544da8f5beec11c10000004", "snippets": [{"offsetInBeginSection": 1546, "offsetInEndSection": 1782, "text": "Gene ontology analysis identified 61 differentially expressed groups (adjusted P <0.05), including apoptosis, antimicrobial humoral response, antigen presentation, regulation of metabolic processes, signal transduction, and angiogenesis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18980520", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 1486, "text": "This pilot study examined gene expression signatures in pathological gingival tissues of subjects with chronic or aggressive periodontitis, and explored whether new subclasses of periodontitis can be identified based on gene expression profiles. A total of 14 patients, seven with chronic and seven with aggressive periodontitis, were examined with respect to clinical periodontal status, composition of subgingival bacterial plaque assessed by checkerboard hybridizations, and levels of serum IgG antibodies to periodontal bacteria assayed by checkerboard immunoblotting. In addition, at least two pathological pockets/patient were biopsied, processed for RNA extraction, amplification and labeling, and used to study gene expression using Affymetrix U-133 A arrays. Based on a total of 35 microarrays, no significantly different gene expression profiles appeared to emerge between chronic and aggressive periodontitis. However, a de novo grouping of the 14 subjects into two fairly robust clusters was possible based on similarities in gene expression. These two groups had similar clinical periodontal status and subgingival bacterial profiles, but differed significantly with respect to serum IgG levels against the important periodontal pathogens Porphyromonas gingivalis, Tannerella forsythensis and Campylobacter rectus. These early data point to the usefulness of gene expression profiling techniques in the identification of subclasses of periodontitis with common pathobiology ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15154918", "endSection": "abstract"}]}, {"body": "With which complexes is the protein SUS1 associated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25526805", "http://www.ncbi.nlm.nih.gov/pubmed/24509845", "http://www.ncbi.nlm.nih.gov/pubmed/24705649", "http://www.ncbi.nlm.nih.gov/pubmed/23599000", "http://www.ncbi.nlm.nih.gov/pubmed/22771212", "http://www.ncbi.nlm.nih.gov/pubmed/22499857", "http://www.ncbi.nlm.nih.gov/pubmed/21749979", "http://www.ncbi.nlm.nih.gov/pubmed/20007317", "http://www.ncbi.nlm.nih.gov/pubmed/20395473", "http://www.ncbi.nlm.nih.gov/pubmed/20434206", "http://www.ncbi.nlm.nih.gov/pubmed/20230609"], "triples": [{"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/B4UN38", "o": "http://linkedlifedata.com/resource/#_4234554E3338005"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/B4UN38", "o": "http://linkedlifedata.com/resource/#_4234554E3338004"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_4234554E3338005", "o": "SUS1"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4234554E3338004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/B5RSM1", "o": "http://linkedlifedata.com/resource/#_423552534D31005"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_423552534D31005", "o": "SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/B5RSM1", "o": "http://linkedlifedata.com/resource/#_423552534D31004"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_423552534D31004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q5KHW5", "o": "http://linkedlifedata.com/resource/#_51354B485735007"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_51354B485735007", "o": "SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q5KHW5", "o": "http://linkedlifedata.com/resource/#_51354B485735006"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_51354B485735006", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q6BMU6", "o": "http://linkedlifedata.com/resource/#_5136424D5536005"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_5136424D5536005", "o": "SUS1"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_5136424D5536004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q6BMU6", "o": "http://linkedlifedata.com/resource/#_5136424D5536004"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q6CVU7", "o": "http://linkedlifedata.com/resource/#_513643565537005"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_513643565537005", "o": "SUS1"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513643565537004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q6CVU7", "o": "http://linkedlifedata.com/resource/#_513643565537004"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q75BB0", "o": "http://linkedlifedata.com/resource/#_513735424230005"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q75BB0", "o": "http://linkedlifedata.com/resource/#_513735424230004"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_513735424230005", "o": "SUS1"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513735424230004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/Q7LL15", "o": "true"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_51374C4C3135004", "o": "Protein sus1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q7LL15", "o": "http://linkedlifedata.com/resource/#_51374C4C3135004"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/A5DG59", "o": "true"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_413544473539004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/A5DG59", "o": "http://linkedlifedata.com/resource/#_413544473539004"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/A5E092", "o": "true"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_413545303932004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/A5E092", "o": "http://linkedlifedata.com/resource/#_413545303932004"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/A6ZL57", "o": "true"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_41365A4C3537004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/A6ZL57", "o": "http://linkedlifedata.com/resource/#_41365A4C3537004"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/B3LN41", "o": "true"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/B3LN41", "o": "http://linkedlifedata.com/resource/#_42334C4E3431005"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_42334C4E3431005", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/B4UN38", "o": "true"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/B4UN38", "o": "http://linkedlifedata.com/resource/#_4234554E3338004"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4234554E3338004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/B5RSM1", "o": "true"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/B5RSM1", "o": "http://linkedlifedata.com/resource/#_423552534D31004"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_423552534D31004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/Q5ADP6", "o": "true"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q5ADP6", "o": "http://linkedlifedata.com/resource/#_513541445036004"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513541445036004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/Q5KHW5", "o": "true"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q5KHW5", "o": "http://linkedlifedata.com/resource/#_51354B485735006"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_51354B485735006", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/Q6BMU6", "o": "true"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_5136424D5536004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q6BMU6", "o": "http://linkedlifedata.com/resource/#_5136424D5536004"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/Q6CVU7", "o": "true"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513643565537004", "o": "Protein SUS1"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q6CVU7", "o": "http://linkedlifedata.com/resource/#_513643565537004"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/Q75BB0", "o": "true"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q75BB0", "o": "http://linkedlifedata.com/resource/#_513735424230004"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513735424230004", "o": "Protein SUS1"}], "ideal_answer": "The conserved sac3 : thp1 : sem1 : sus1 is associated to the transcriptional co-activator saga and to the npc associated complex termed trex2 sus1, a component of the saga and trex-2 complexes ( npcs ) the yeast deubiquitinase ubp8 protein complexes : saga, a transcriptional co-activator; trex-2, which functions in mrna biogenesis and export.In the nucleus, sus1 : cdc31 ( trex2 ) complex binds to nuclear pore complexes, is involved in both transcription and mrna export sus1 ( heny2 ) participates in this coordination as part of two protein is recruited and activated by the saga complex and, together with sgf11, sus1, and sgf73, forms a dub module responsible for deubiquitinating histone h2b during gene expression.The yeast dubm comprises a catalytic subunit, ubp8, and three additional subunits, sgf11, sus1 and sgf73, all of which are required for dubm activity.Distinct subcomplex called the deubiquitinating module ( dubm ), which contains the ubiquitin-specific protease ubp8 protein is recruited and activated by the saga complex and, together with sgf11, sus1, and sgf73.", "exact_answer": [["SAGA complex"], ["TREX-2 complex"]], "concepts": [], "type": "list", "id": "56b773a96e3f8eaf4c000003", "snippets": [{"offsetInBeginSection": 316, "offsetInEndSection": 443, "text": "In the nucleus, Sus1 is associated to the transcriptional co-activator SAGA and to the NPC associated complex termed TREX2/THSC ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20230609", "endSection": "abstract"}, {"offsetInBeginSection": 87, "offsetInEndSection": 193, "text": "Sus1/ENY2, a component of the SAGA and TREX-2 complexes, is involved in both transcription and mRNA export ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21749979", "endSection": "abstract"}, {"offsetInBeginSection": 243, "offsetInEndSection": 337, "text": "the deubiquitination module (DUBm) of SAGA, which is composed of Ubp8, Sus1, Sgf11, and Sgf73. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24509845", "endSection": "abstract"}, {"offsetInBeginSection": 173, "offsetInEndSection": 307, "text": "Sus1 is a component of both the SAGA transcriptional co-activator complex and the TREX-2 complex that binds to nuclear pore complexes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20007317", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 94, "text": "The conserved Sac3:Thp1:Sem1:Sus1:Cdc31 (TREX2) complex binds to nuclear pore complexes (NPCs) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24705649", "endSection": "abstract"}, {"offsetInBeginSection": 239, "offsetInEndSection": 388, "text": " distinct subcomplex called the deubiquitinating module (DUBm), which contains the ubiquitin-specific protease Ubp8, bound to Sgf11, Sus1, and Sgf73. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20395473", "endSection": "abstract"}, {"offsetInBeginSection": 122, "offsetInEndSection": 295, "text": "Sus1 (hENY2) participates in this coordination as part of two protein complexes: SAGA, a transcriptional co-activator; TREX-2, which functions in mRNA biogenesis and export. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23599000", "endSection": "abstract"}, {"offsetInBeginSection": 223, "offsetInEndSection": 373, "text": "The yeast DUBm comprises a catalytic subunit, Ubp8, and three additional subunits, Sgf11, Sus1 and Sgf73, all of which are required for DUBm activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25526805", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 159, "text": "The deubiquitinating module (DUBm) of the SAGA coactivator contains the Ubp8 isopeptidase, Sgf11, Sus1, and Sgf73, which form a highly interconnected complex. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22771212", "endSection": "abstract"}, {"offsetInBeginSection": 215, "offsetInEndSection": 431, "text": "The yeast deubiquitinase Ubp8 protein is recruited and activated by the SAGA complex and, together with Sgf11, Sus1, and Sgf73, forms a DUB module responsible for deubiquitinating histone H2B during gene expression. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20434206", "endSection": "abstract"}]}, {"body": "Can Preimplantation Genetic Diagnosis (PGD) be used for gender selection?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20638568", "http://www.ncbi.nlm.nih.gov/pubmed/20102489", "http://www.ncbi.nlm.nih.gov/pubmed/19891844", "http://www.ncbi.nlm.nih.gov/pubmed/19294755", "http://www.ncbi.nlm.nih.gov/pubmed/19251775", "http://www.ncbi.nlm.nih.gov/pubmed/18829009", "http://www.ncbi.nlm.nih.gov/pubmed/18667646", "http://www.ncbi.nlm.nih.gov/pubmed/18222917", "http://www.ncbi.nlm.nih.gov/pubmed/12615807", "http://www.ncbi.nlm.nih.gov/pubmed/12470342", "http://www.ncbi.nlm.nih.gov/pubmed/9329835"], "triples": [], "ideal_answer": "This testing is used for identifying singlegene disorders, chromosomal abnormalities, mitochondrial disorders, gender selection for social reasons.Another concern is the use of this technology for nongenetic disorders such as gender.Although many clinics offer pgd for ha by gender selection in non-mendelian disorders with unequal gender distribution, aneuploidy screening, and other preconceptually identified genetic abnormalities in prospective parents.More specifically, i illustrate how the prescriptions of deliberative democracy can be applied to the issue of regulating non-medical uses of pgd have been reported in the past year for screening embryos for susceptibility to cancer, for late-onset diseases, for hla-matching for existing children, and for gender.Private clinics were more likely than other programs to be on either the east or west coast, list certain pgd risks ( e.g., diagnostic error ), note that pgd was new or controversial, reference source of pgd information, provide accuracy rates of genetic testing of embryos, and offer gender selection, an approach that detects the presence of the underlying f8 mutation has several advantages.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005783", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012743", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019836"], "type": "yesno", "id": "52b2ed144003448f55000004", "snippets": [{"offsetInBeginSection": 688, "offsetInEndSection": 785, "text": "Another concern is the use of this technology for nongenetic disorders such as gender selection. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9329835", "endSection": "abstract"}, {"offsetInBeginSection": 245, "offsetInEndSection": 455, "text": "More specifically, I illustrate how the prescriptions of deliberative democracy can be applied to the issue of regulating non-medical uses of pre-implantation genetic diagnosis (PGD), such as gender selection. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19251775", "endSection": "abstract"}, {"offsetInBeginSection": 136, "offsetInEndSection": 289, "text": " Although many clinics offer PGD for HA by gender selection, an approach that detects the presence of the underlying F8 mutation has several advantages. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20102489", "endSection": "abstract"}, {"offsetInBeginSection": 116, "offsetInEndSection": 301, "text": "New uses of PGD have been reported in the past year for screening embryos for susceptibility to cancer, for late-onset diseases, for HLA-matching for existing children, and for gender. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12615807", "endSection": "abstract"}, {"offsetInBeginSection": 928, "offsetInEndSection": 1111, "text": " In response to one specific question, one-third of the couples agreed to use the donor child as a lifetime organ donor and supported the use of PGD for non-medical gender selection. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19294755", "endSection": "abstract"}, {"offsetInBeginSection": 96, "offsetInEndSection": 390, "text": "This testing is used for identifying singlegene disorders, chromosomal abnormalities, mitochondrial disorders, gender selection in non-mendelian disorders with unequal gender distribution, aneuploidy screening, and other preconceptually identified genetic abnormalities in prospective parents. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20638568", "endSection": "abstract"}, {"offsetInBeginSection": 436, "offsetInEndSection": 708, "text": "This article describes current and likely future uses of PGD, and then analyses the ethical issues posed by new uses of PGD to screen embryos for susceptibility and late-onset conditions, for HLA-matching for tissue donation to an existing child, and for gender selection. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12615807", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 312, "text": "The use of PGD for sex selection arouses considerable debate, especially in countries like India that have a marked cultural preference for boys. It is argued that using PGD for sex selection is a treatment option that can be ethically offered to couples who desire to use this technology to plan their families. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12470342", "endSection": "abstract"}, {"offsetInBeginSection": 805, "offsetInEndSection": 1124, "text": "Private clinics were more likely than other programs to be on either the East or West Coast, list certain PGD risks (e.g., diagnostic error), note that PGD was new or controversial, reference source of PGD information, provide accuracy rates of genetic testing of embryos, and offer gender selection for social reasons. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18829009", "endSection": "abstract"}, {"offsetInBeginSection": 197, "offsetInEndSection": 653, "text": "One possible use of PGD is to perform gender selection for couples whose offspring are at increased risk of disorders that do not follow Mendelian inheritance, but which are substantially more common in one sex than another (unequal sex incidence). Here, we examine the clinical and ethical issues to be considered prior to offering PGD gender selection to reduce the risk of a child being affected by a non-Mendelian condition with unequal sex incidence. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18222917", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 552, "text": "The purpose of this article is to ascertain and appraise the ethical issues inherent to the utilisation of preimplantation genetic diagnosis for gender selection in infertile patients anticipating undergoing a medically indicated assisted reproductive technique procedure. Performance of preimplantation genetic diagnosis per request specifically for gender selection by an infertile couple undergoing medically indicated assisted reproductive technique may not breach the principles of ethics, and is unlikely to alter the population balance of sexes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18667646", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 719, "text": "Preimplantation genetic diagnosis (PGD) for gender selection for non-medical reasons has been considered an unethical procedure by several authors and agencies in the Western society on the basis that it could disrupt the sex ratio, that it discriminates against women and that it leads to disposal of normal embryos of the non-desired gender. In this study, the analysis of a large series of PGD procedures for gender selection from a wide geographical area in the USA shows that, in general, there is no deviation in preference towards any specific gender except for a preference of males in some ethnic populations of Chinese, Indian and Middle Eastern origin that represent a small percentage of the US population. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19891844", "endSection": "abstract"}]}, {"body": "What is the principle of ATAC (Assay for Transposase-Accessible Chromatin) technique?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25679813", "http://www.ncbi.nlm.nih.gov/pubmed/24097267"], "triples": [], "ideal_answer": "We describe an assay for transposase-accessible chromatin sites using sequencing ( atac-seq ), based on direct in vitro transposition of sequencing adaptors into native chromatin, as a rapid and sensitive method for integrative epigenomic analysis using atac-seq maps of human cd4 ( + ) t cells from a proband obtained on consecutive days, we demonstrated the feasibility of analyzing an individual's epigenome on a timescale compatible with clinical decision-making.We describe an assay for transposase-accessible chromatin using sequencing ( atac-seq ), to this end, we first compare two different approaches to detect open chromatin in vivo using the drosophila eye primordium as a model system : faire-seq, based on physical separation of open chromatin; and atac-seq, based on preferential integration of a transposon into open chromatin.Atac-seq captures open chromatin sites using a simple two-step protocol with 500-50,000 cells and reveals the interplay between genomic locations of open versus closed chromatin, dna-binding proteins, individual nucleosomes and chromatin compaction at nucleotide resolution.", "concepts": ["http://www.uniprot.org/uniprot/TRAT_AMIAI"], "type": "summary", "id": "56ebee26107309bc2f000002", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "We describe an assay for transposase-accessible chromatin using sequencing (ATAC-seq), ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24097267", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 239, "text": "We describe an assay for transposase-accessible chromatin using sequencing (ATAC-seq), based on direct in vitro transposition of sequencing adaptors into native chromatin, as a rapid and sensitive method for integrative epigenomic analysis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24097267", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 240, "text": "We describe an assay for transposase-accessible chromatin using sequencing (ATAC-seq), based on direct in vitro transposition of sequencing adaptors into native chromatin, as a rapid and sensitive method for integrative epigenomic analysis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24097267", "endSection": "abstract"}, {"offsetInBeginSection": 624, "offsetInEndSection": 840, "text": "Using ATAC-seq maps of human CD4(+) T cells from a proband obtained on consecutive days, we demonstrated the feasibility of analyzing an individual's epigenome on a timescale compatible with clinical decision-making. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24097267", "endSection": "abstract"}, {"offsetInBeginSection": 241, "offsetInEndSection": 502, "text": "ATAC-seq captures open chromatin sites using a simple two-step protocol with 500-50,000 cells and reveals the interplay between genomic locations of open chromatin, DNA-binding proteins, individual nucleosomes and chromatin compaction at nucleotide resolution. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24097267", "endSection": "abstract"}, {"offsetInBeginSection": 1892, "offsetInEndSection": 2173, "text": "In conclusion, we show that FAIRE-seq and ATAC-seq based open chromatin profiling, combined with motif discovery, is a straightforward approach to identify functional genomic regulatory regions, master regulators, and gene regulatory networks controlling complex in vivo processes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25679813", "endSection": "abstract"}, {"offsetInBeginSection": 539, "offsetInEndSection": 839, "text": "To this end, we first compare two different approaches to detect open chromatin in vivo using the Drosophila eye primordium as a model system: FAIRE-seq, based on physical separation of open versus closed chromatin; and ATAC-seq, based on preferential integration of a transposon into open chromatin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25679813", "endSection": "abstract"}]}, {"body": "Which are the main NMD factors in Saccharomyces cerevisiae?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20675403", "http://www.ncbi.nlm.nih.gov/pubmed/16043493", "http://www.ncbi.nlm.nih.gov/pubmed/11238889", "http://www.ncbi.nlm.nih.gov/pubmed/22227378", "http://www.ncbi.nlm.nih.gov/pubmed/18087042", "http://www.ncbi.nlm.nih.gov/pubmed/17705828", "http://www.ncbi.nlm.nih.gov/pubmed/16394582", "http://www.ncbi.nlm.nih.gov/pubmed/22065998", "http://www.ncbi.nlm.nih.gov/pubmed/11113196", "http://www.ncbi.nlm.nih.gov/pubmed/11073994", "http://www.ncbi.nlm.nih.gov/pubmed/22670525"], "triples": [], "ideal_answer": "This quality control pathway depends on the nmd-specific factors, upf1p, upf2p, and upf3p, as well as the two release factors, erf1 and erf3 ( respectively designated sup45p and sup35p in yeast ) interactions between upf1 and the decapping factors edc3 and pat1 in saccharomyces cerevisiae orthologue that functions in both translation termination and nmd, has been the only factor shown to be required for nmd in mammalian cells.Nmd activation is also enabled by the absence of the poly ( a ) -binding protein, pab1p, downstream of a termination event to date, human ( h ) upf1 protein ( p ) ( hupf1p ), a group 1 rna helicase named after its saccharomyces cerevisiae, three trans-acting factors ( upf1p to upf3p ) are required for nmd in mammalian cells.In addition, we show that these factors also regulate the same processes in the degradation of wild-type mrnas association of yeast upf1p with direct substrates of the nmd pathway in saccharomyces cerevisiae, three trans-acting factors ( upf1p to upf3p ) are required for nmd.", "exact_answer": [["Upf1p"], ["Nmd2p"], ["Upf3p"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012441", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000184"], "type": "list", "id": "5516757c46478f2f2c000008", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 94, "text": "Interactions between Upf1 and the decapping factors Edc3 and Pat1 in Saccharomyces cerevisiae. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22065998", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 68, "text": "Association of yeast Upf1p with direct substrates of the NMD pathway ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18087042", "endSection": "title"}, {"offsetInBeginSection": 422, "offsetInEndSection": 516, "text": "In Saccharomyces cerevisiae, three trans-acting factors (Upf1p to Upf3p) are required for NMD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11073994", "endSection": "abstract"}, {"offsetInBeginSection": 359, "offsetInEndSection": 477, "text": "NMD activation is also enabled by the absence of the poly(A)-binding protein, Pab1p, downstream of a termination event ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22227378", "endSection": "abstract"}, {"offsetInBeginSection": 143, "offsetInEndSection": 302, "text": "Of those, a group of weak and recessive suppressors, sup111, sup112 and sup113, is of particular interest because of their dependency on [PSI+], a yeast prion. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16394582", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 231, "text": "In Saccharomyces cerevisiae, rapid degradation of nonsense-containing mRNAs requires the decapping enzyme Dcp1p, the 5'-to-3' exoribonuclease Xrn1p, and the three nonsense-mediated mRNA decay (NMD) factors, Upf1p, Nmd2p, and Upf3p. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11238889", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 230, "text": "In Saccharomyces cerevisiae, rapid degradation of nonsense-containing mRNAs requires the decapping enzyme Dcp1p, the 5'-to-3' exoribonuclease Xrn1p, and the three nonsense-mediated mRNA decay (NMD) factors, Upf1p, Nmd2p, and Upf3p ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11238889", "endSection": "abstract"}, {"offsetInBeginSection": 163, "offsetInEndSection": 394, "text": "In yeast Saccharomyces cerevisiae, the activity of this pathway depends on the recognition of the PTC by the translational machinery and interaction of translation termination factors eRF1 and eRF3 with Upf1, Upf2 and Upf3 proteins ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22670525", "endSection": "abstract"}, {"offsetInBeginSection": 163, "offsetInEndSection": 395, "text": "In yeast Saccharomyces cerevisiae, the activity of this pathway depends on the recognition of the PTC by the translational machinery and interaction of translation termination factors eRF1 and eRF3 with Upf1, Upf2 and Upf3 proteins. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22670525", "endSection": "abstract"}, {"offsetInBeginSection": 158, "offsetInEndSection": 357, "text": "This quality control pathway depends on the NMD-specific factors, Upf1p, Upf2p/Nmd2p, and Upf3p, as well as the two release factors, eRF1 and eRF3 (respectively designated Sup45p and Sup35p in yeast) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22227378", "endSection": "abstract"}, {"offsetInBeginSection": 401, "offsetInEndSection": 641, "text": "Our results indicate that Upf1p, Nmd2p, and Upf3p regulate decapping and exonucleolytic degradation of nonsense-containing mRNAs. In addition, we show that these factors also regulate the same processes in the degradation of wild-type mRNAs ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11238889", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 229, "text": "In Saccharomyces cerevisiae, rapid degradation of nonsense-containing mRNAs requires the decapping enzyme Dcp1p, the 5-to-3 exoribonuclease Xrn1p, and the three nonsense-mediated mRNA decay (NMD) factors, Upf1p, Nmd2p, and Upf3p. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11238889", "endSection": "abstract"}, {"offsetInBeginSection": 904, "offsetInEndSection": 1145, "text": "From these results, we conclude that sup111, sup112 and sup113 are mutant alleles of UPF2, UPF3 and UPF1, respectively, and thus attribute suppressor activity of these mutations to defects in the NMD (nonsense-mediated mRNA decay) machinery. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16394582", "endSection": "abstract"}, {"offsetInBeginSection": 283, "offsetInEndSection": 525, "text": " Translation termination factors eRF1 (Sup45) and eRF3 (Sup35) participate not only in the last step of protein synthesis but also in mRNA degradation and translation initiation via interaction with such proteins as Pab1, Upf1, Upf2 and Upf3. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17705828", "endSection": "abstract"}, {"offsetInBeginSection": 448, "offsetInEndSection": 699, "text": "To date, human (h) Upf1 protein (p) (hUpf1p), a group 1 RNA helicase named after its Saccharomyces cerevisiae orthologue that functions in both translation termination and NMD, has been the only factor shown to be required for NMD in mammalian cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11113196", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 295, "text": "In addition to their well-documented roles in the promotion of nonsense-mediated mRNA decay (NMD), yeast Upf proteins (Upf1, Upf2/Nmd2, and Upf3) also manifest translational regulatory functions, at least in vitro, including roles in premature translation termination and subsequent reinitiation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20675403", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 297, "text": "In addition to their well-documented roles in the promotion of nonsense-mediated mRNA decay (NMD), yeast Upf proteins (Upf1, Upf2/Nmd2, and Upf3) also manifest translational regulatory functions, at least in vitro, including roles in premature translation termination and subsequent reinitiation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20675403", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 378, "text": "In Saccharomyces cerevisiae, nonsense-mediated mRNA decay (NMD) requires Upf1p, Upf2p, and Upf3p to accelerate the decay rate of two unique classes of transcripts: (1) nonsense mRNAs that arise through errors in gene expression, and (2) naturally occurring transcripts that lack coding errors but have built-in features that target them for accelerated decay (error-free mRNAs). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16043493", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 377, "text": "In Saccharomyces cerevisiae, nonsense-mediated mRNA decay (NMD) requires Upf1p, Upf2p, and Upf3p to accelerate the decay rate of two unique classes of transcripts: (1) nonsense mRNAs that arise through errors in gene expression, and (2) naturally occurring transcripts that lack coding errors but have built-in features that target them for accelerated decay (error-free mRNAs) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16043493", "endSection": "abstract"}]}, {"body": "Which histone marks are deposited by Set7?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21963854", "http://www.ncbi.nlm.nih.gov/pubmed/15200950", "http://www.ncbi.nlm.nih.gov/pubmed/12208845", "http://www.ncbi.nlm.nih.gov/pubmed/12086618"], "ideal_answer": "Indeed, upregulation of PR-Set7 expression upon loss of HCF-1 leads to improper mitotic H4-K20 methylation a human histone H4 lysine 20 methyltransferase and cloned the encoding gene, PR transcriptionally competent regions lack H4 lysine 20 methylation the loss of H4 lysine 20 methylation localization of PR-Set7 to mitotic chromosomes and subsequent increase in H4 Lys 20 methylation the H4-K20 methyltransferase PR-Set7.", "exact_answer": [["H4K20 monomethylation"], ["H3K4 monomethylation"]], "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0042393", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0016571", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0016570", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006657", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011495", "http://www.uniprot.org/uniprot/SETD7_HALRO"], "type": "list", "id": "5160412d298dcd4e5100003c", "snippets": [{"offsetInBeginSection": 190, "offsetInEndSection": 226, "text": "the loss of H4 lysine 20 methylation ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12086618", "endSection": "sections.0"}, {"offsetInBeginSection": 286, "offsetInEndSection": 351, "text": "Transcriptionally competent regions lack H4 lysine 20 methylation ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12086618", "endSection": "sections.0"}, {"offsetInBeginSection": 17, "offsetInEndSection": 102, "text": "a human histone H4 lysine 20 methyltransferase and cloned the encoding gene, PR/SET07 ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12086618", "endSection": "sections.0"}, {"offsetInBeginSection": 338, "offsetInEndSection": 433, "text": "Localization of PR-Set7 to mitotic chromosomes and subsequent increase in H4 Lys 20 methylation ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12208845", "endSection": "sections.0"}, {"offsetInBeginSection": 698, "offsetInEndSection": 842, "text": "the H4-K20 methyltransferase PR-Set7. Indeed, upregulation of PR-Set7 expression upon loss of HCF-1 leads to improper mitotic H4-K20 methylation ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15200950", "endSection": "sections.0"}]}, {"body": "Has proteomics been used in the study of the dry eye syndrome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24282230", "http://www.ncbi.nlm.nih.gov/pubmed/23272196", "http://www.ncbi.nlm.nih.gov/pubmed/21384922", "http://www.ncbi.nlm.nih.gov/pubmed/20882555", "http://www.ncbi.nlm.nih.gov/pubmed/19705875"], "triples": [], "ideal_answer": "Identification of tear fluid biomarkers in dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry.2d electrophoresis ( 2de ) and differential gel electrophoresis ( dige ) was done to identify differentially expressed proteins, and the findings could lead to identification of novel pathways for therapeutic targeting and new diagnostic markers.Dry eye syndrome in diabetic patients is associated with aberrant expression of tear proteins, and the findings could lead to identification of novel pathways for therapeutic targeting and new diagnostic markers.This study demonstrated that iTRAQ technology combined with 2D-nanoLC-nanoESI-MS quantitative proteomics is a powerful tool for biomarker discovery.Tear proteomic analysis of human tears : collection method in dry eye syndrome.Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome using itraq quantitative proteomics.Two dimensional electrophoretic analysis of human tears : collection method in dry eye syndrome.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015352", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D040901", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005123", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005136", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005128", "http://www.disease-ontology.org/api/metadata/DOID:10140", "http://www.disease-ontology.org/api/metadata/DOID:5614", "http://www.disease-ontology.org/api/metadata/DOID:225"], "type": "yesno", "id": "5322de919b2d7acc7e000012", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19705875", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "Two dimensional electrophoretic analysis of human tears: collection method in dry eye syndrome. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20882555", "endSection": "title"}, {"offsetInBeginSection": 1842, "offsetInEndSection": 1993, "text": "This study demonstrated that iTRAQ technology combined with 2D-nanoLC-nanoESI-MS/MS quantitative proteomics is a powerful tool for biomarker discovery. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19705875", "endSection": "abstract"}, {"offsetInBeginSection": 553, "offsetInEndSection": 679, "text": " 2D electrophoresis (2DE) and Differential gel electrophoresis (DIGE) was done to identify differentially expressed proteins. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23272196", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 162, "text": "Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24282230", "endSection": "title"}, {"offsetInBeginSection": 1424, "offsetInEndSection": 1636, "text": "Dry eye syndrome in diabetic patients is associated with aberrant expression of tear proteins, and the findings could lead to identification of novel pathways for therapeutic targeting and new diagnostic markers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24282230", "endSection": "abstract"}]}, {"body": "What is the indication for isradipine?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/7946181", "http://www.ncbi.nlm.nih.gov/pubmed/8466736", "http://www.ncbi.nlm.nih.gov/pubmed/2137344", "http://www.ncbi.nlm.nih.gov/pubmed/8205296", "http://www.ncbi.nlm.nih.gov/pubmed/15257873", "http://www.ncbi.nlm.nih.gov/pubmed/7921533", "http://www.ncbi.nlm.nih.gov/pubmed/10854683", "http://www.ncbi.nlm.nih.gov/pubmed/9544865", "http://www.ncbi.nlm.nih.gov/pubmed/12215829", "http://www.ncbi.nlm.nih.gov/pubmed/7789292", "http://www.ncbi.nlm.nih.gov/pubmed/2150641", "http://www.ncbi.nlm.nih.gov/pubmed/7738211", "http://www.ncbi.nlm.nih.gov/pubmed/1363224", "http://www.ncbi.nlm.nih.gov/pubmed/2949585", "http://www.ncbi.nlm.nih.gov/pubmed/7918132", "http://www.ncbi.nlm.nih.gov/pubmed/7848351", "http://www.ncbi.nlm.nih.gov/pubmed/7955262", "http://www.ncbi.nlm.nih.gov/pubmed/8963604", "http://www.ncbi.nlm.nih.gov/pubmed/2523644", "http://www.ncbi.nlm.nih.gov/pubmed/2523646", "http://www.ncbi.nlm.nih.gov/pubmed/10728516", "http://www.ncbi.nlm.nih.gov/pubmed/11172743", "http://www.ncbi.nlm.nih.gov/pubmed/14727944", "http://www.ncbi.nlm.nih.gov/pubmed/7621840", "http://www.ncbi.nlm.nih.gov/pubmed/8213473"], "triples": [], "ideal_answer": "It is concluded that isradipine is safe and effective when administered long-term in the treatment of hypertensive patients with either hyperlipidemia or NIDDM.Calcium channel antagonists ( CCAs ) may either be divided into the dihydropyridines ( e.g.It is advisable to be very careful in the use of isradipine as a therapy for hypertension and other indications.Isradipine monotherapy was an effective antihypertensive drug amlodipine, felodipine, isradipine, lacidipine, nilvadipine, nifedipine, nicardipine etc.", "exact_answer": [["Hypertension"]], "concepts": ["http://www.biosemantics.org/jochem#http://www.biosemantics.org/jochem#:4250298", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017275", "http://www.biosemantics.org/jochem#4250298", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006973"], "type": "factoid", "id": "56c3184050c68dd416000003", "snippets": [{"offsetInBeginSection": 48, "offsetInEndSection": 84, "text": "isradipine antihypertensive therapy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8466736", "endSection": "title"}, {"offsetInBeginSection": 775, "offsetInEndSection": 810, "text": "isradipine antihypertensive therapy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8466736", "endSection": "abstract"}, {"offsetInBeginSection": 1584, "offsetInEndSection": 1646, "text": "Isradipine monotherapy was an effective antihypertensive drug ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2137344", "endSection": "abstract"}, {"offsetInBeginSection": 1255, "offsetInEndSection": 1367, "text": "it is advisable to be very careful in the use of isradipine as a therapy for hypertension and other indications. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15257873", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 63, "text": "[Isradipine in arterial hypertension in motor vehicle drivers]. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8963604", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "Regression of left ventricular hypertrophy with isradipine antihypertensive therapy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8466736", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2523646", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 101, "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2523644", "endSection": "title"}, {"offsetInBeginSection": 977, "offsetInEndSection": 1138, "text": " It is concluded that isradipine is safe and effective when administered long-term in the treatment of hypertensive patients with either hyperlipidemia or NIDDM. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7946181", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 118, "text": "The new calcium antagonist isradipine. Effect on blood pressure and the left ventricle in black hypertensive patients. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2137344", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 155, "text": "[Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina]. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7848351", "endSection": "title"}, {"offsetInBeginSection": 195, "offsetInEndSection": 374, "text": "In the past few years, however, several dihydropyridine calcium channel antagonists, including nicardipine, isradipine, felodipine, nimodipine, and amlodipine, have been marketed. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8213473", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 182, "text": "Calcium channel antagonists (CCAs) may either be divided into the dihydropyridines (e.g. amlodipine, felodipine, isradipine, lacidipine, nilvadipine, nifedipine, nicardipine etc. ), t ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14727944", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 184, "text": "The antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8205296", "endSection": "abstract"}, {"offsetInBeginSection": 671, "offsetInEndSection": 912, "text": "Isradipine is cytoprotective after a stroke when used as an antihypertensive: at doses which normalise high blood pressure in spontaneously hypertensive rats, isradipine reduces by more than 60% the infarct size caused by a subsequent stroke ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2150641", "endSection": "abstract"}, {"offsetInBeginSection": 1584, "offsetInEndSection": 1827, "text": "Isradipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2137344", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 373, "text": "These are the preliminary data of an open multicenter trial of antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n = 11) or isradipine (7.5 +/- 0.63 mg twice daily) in combination with bopindolol (1.16 +/- 0.12 mg once daily; n = 30) administered for 3 years to patients with essential hypertension (WHO classification I or II). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7946181", "endSection": "abstract"}]}, {"body": "List non-surgical treatment modalities that are included in the Stupp protocol.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24111708", "http://www.ncbi.nlm.nih.gov/pubmed/23588276", "http://www.ncbi.nlm.nih.gov/pubmed/23535992", "http://www.ncbi.nlm.nih.gov/pubmed/23453151", "http://www.ncbi.nlm.nih.gov/pubmed/23254891", "http://www.ncbi.nlm.nih.gov/pubmed/25434389", "http://www.ncbi.nlm.nih.gov/pubmed/25201633", "http://www.ncbi.nlm.nih.gov/pubmed/24600235", "http://www.ncbi.nlm.nih.gov/pubmed/24518393", "http://www.ncbi.nlm.nih.gov/pubmed/24287680", "http://www.ncbi.nlm.nih.gov/pubmed/22464950", "http://www.ncbi.nlm.nih.gov/pubmed/22359215", "http://www.ncbi.nlm.nih.gov/pubmed/22141608", "http://www.ncbi.nlm.nih.gov/pubmed/21344976", "http://www.ncbi.nlm.nih.gov/pubmed/21156036", "http://www.ncbi.nlm.nih.gov/pubmed/20870254", "http://www.ncbi.nlm.nih.gov/pubmed/20428822", "http://www.ncbi.nlm.nih.gov/pubmed/20045159", "http://www.ncbi.nlm.nih.gov/pubmed/18808066"], "triples": [], "ideal_answer": "We analyzed mgmt methylation by methylation-specific pcr in 90 gbm patients from four portuguese hospitals, uniformly treated with radiotherapy combined with concomitant administration of temozolomide ( stupp protocol ).The standard treatment today is maximal surgical resection followed by concomitant chemo-radiation therapy followed by adjuvant temozolomide ( stupp protocol ).Objective : it is now accepted that the concomitant and adjuvant temozolomide with radiotherapy ( stupp regime ), in the treatment of patients with newly diagnosed glioblastoma multiforme ( gbm ), significantly improves survival and this practice has been adopted locally since 2004. the treatment of glioblastoma includes surgery followed by chemoradiation with the protocol of stupp et al.Standard chemoradiotherapy as per the stupp protocol, together with multimodal rehabilitation, resulted in substantial functional improvement within 6 weeks of initiation.The current care standards for newly diagnosed glioblastoma consist, when feasible, in surgical resection, radiotherapy, and chemotherapy, as described in the stupp protocol, together with multimodal rehabilitation, resulted in substantial functional improvement within 6 weeks of initiation.Afterward, patients received concomitant radiochemotherapy according to the stupp protocol.", "exact_answer": [["radiotherapy"], ["chemotherapy"]], "concepts": [], "type": "list", "id": "54df6ed91388e8454a000007", "snippets": [{"offsetInBeginSection": 137, "offsetInEndSection": 244, "text": "This is followed by concurrent radio-chemotherapy with temozolomide (TMZ) according to the Stupp protocol. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22464950", "endSection": "abstract"}, {"offsetInBeginSection": 843, "offsetInEndSection": 935, "text": "Afterward, patients received concomitant radiochemotherapy according to the Stupp protocol. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25434389", "endSection": "abstract"}, {"offsetInBeginSection": 120, "offsetInEndSection": 228, "text": "The treatment of glioblastoma includes surgery followed by chemoradiation with the protocol of Stupp et al. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25201633", "endSection": "abstract"}, {"offsetInBeginSection": 648, "offsetInEndSection": 777, "text": "Surprisingly, less than half the patients having surgery received concomitant radiochemotherapy according to the Stupp protocol. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20870254", "endSection": "abstract"}, {"offsetInBeginSection": 1485, "offsetInEndSection": 1641, "text": "CONCLUSIONS: FGS and radiochemotherapy according to the Stupp protocol have induced an impressive improvement in overall survival in glioblastoma patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23588276", "endSection": "abstract"}, {"offsetInBeginSection": 224, "offsetInEndSection": 400, "text": "Moreover, there are no data concerning the effect of concomitant radiochemotherapy according to the STUPP protocol on the course ofMS in patients with coexisting glioblastoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18808066", "endSection": "abstract"}, {"offsetInBeginSection": 121, "offsetInEndSection": 296, "text": "The current care standards for newly diagnosed glioblastoma consist, when feasible, in surgical resection, radiotherapy, and chemotherapy, as described in the Stupp protocol. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20045159", "endSection": "abstract"}, {"offsetInBeginSection": 184, "offsetInEndSection": 345, "text": "The standard treatment today is maximal surgical resection followed by concomitant chemo-radiation therapy followed by adjuvant TMZ according to Stupp protocol. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23453151", "endSection": "abstract"}, {"offsetInBeginSection": 172, "offsetInEndSection": 331, "text": "The standard treatment today is maximal surgical resection followed by concomitant chemo-radiation therapy followed by adjuvant TMZ according to Stupp protocol ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23453151", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 186, "text": "BACKGROUND: Patients with glioblastoma treated with BCNU wafer implantation for recurrence frequently receive frontline chemoradiotherapy with temozolomide as part of the Stupp protocol. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24287680", "endSection": "abstract"}, {"offsetInBeginSection": 568, "offsetInEndSection": 739, "text": "Standard chemoradiotherapy as per the Stupp protocol, together with multimodal rehabilitation, resulted in substantial functional improvement within 6 weeks of initiation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24518393", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 225, "text": "BACKGROUND: The introduction of ALA-Fluorescence-guided surgery (FGS) followed by concomitant radiochemotherapy according to the Stupp-protocol is representative of the major changes in glioblastoma therapy in the past years. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23588276", "endSection": "abstract"}, {"offsetInBeginSection": 365, "offsetInEndSection": 578, "text": "We analyzed MGMT methylation by methylation-specific PCR in 90 GBM patients from four Portuguese hospitals, uniformly treated with radiotherapy combined with concomitant and adjuvant temozolomide (Stupp protocol). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20428822", "endSection": "abstract"}, {"offsetInBeginSection": 478, "offsetInEndSection": 727, "text": "We also screened for associations between the level of methylation of CpG sites and overall survival in a cohort of 50 patients uniformly treated by surgery, radiotherapy and chemotherapy with concomitant and adjuvant temozolomide (STUPP protocol). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21156036", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 283, "text": "OBJECTIVE: It is now accepted that the concomitant administration of temozolomide with radiotherapy (Stupp regime), in the treatment of patients with newly diagnosed glioblastoma multiforme (GBM), significantly improves survival and this practice has been adopted locally since 2004. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24111708", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 280, "text": "In patients with glioblastoma multiforme (GBM), there is no consensus on the sequential use of two existing regimens: post-operative Gliadel implantation into the surgical cavity and concomitant temozolomide with radiotherapy followed by adjuvant temozolomide ('Stupp protocol'). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21344976", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 328, "text": "Current treatment strategies in patients with newly-diagnosed glioblastoma include surgical resection with post-operative radiotherapy and concomitant/adjuvant temozolomide (the \"Stupp protocol\") or resection with implantation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) wafers in the surgical cavity followed by radiotherapy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23535992", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 330, "text": "Current treatment strategies in patients with newly-diagnosed glioblastoma include surgical resection with post-operative radiotherapy and concomitant/adjuvant temozolomide (the \"Stupp protocol\") or resection with implantation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) wafers in the surgical cavity followed by radiotherapy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23535992", "endSection": "abstract"}, {"offsetInBeginSection": 273, "offsetInEndSection": 508, "text": "PATIENTS AND METHODS: A total of 191 patients with primary GBM were postoperatively treated with either radiation and concomitant TMZ, followed by adjuvant TMZ (Stupp protocol) (n = 154), or radiation followed by adjuvant TMZ (n = 37). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23254891", "endSection": "abstract"}, {"offsetInBeginSection": 1718, "offsetInEndSection": 2045, "text": "CONCLUSIONS: MGMT promoter methylation status and low MGMT expression both were identified as positive prognosticators in patients with newly diagnosed glioblastoma who underwent surgical resection and received Gliadel wafer implants followed by adjuvant radiotherapy and concomitant oral TMZ chemotherapy (the Stupp protocol). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22359215", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 345, "text": "INTRODUCTION: To evaluate the incidence and impact of early post-chemoradiation (cRT) 'pseudoprogression' (PsPD) amongst glioblastoma multiforme (GBM) patients treated with the current standard of care - 60 Gy conformal radiotherapy with concurrent low-dose temozolomide, followed by six cycles of high-dose temozolomide (the 'Stupp protocol'). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22141608", "endSection": "abstract"}, {"offsetInBeginSection": 595, "offsetInEndSection": 1043, "text": "Since the publication of a study by Stupp et al in 2005, which used a protocol of conventional fractionated irradiation with concomitant TMZ followed by standard TMZ for six cycles, many clinical studies in the People's Republic of China have demonstrated that such a treatment strategy has significantly improved efficacy with limited side effects for newly diagnosed glioblastoma after surgery as compared with strategies that do not contain TMZ. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24600235", "endSection": "abstract"}]}, {"body": "Which genes are associated with Ehlers-Danlos syndrome type I/II?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20847697", "http://www.ncbi.nlm.nih.gov/pubmed/12145749", "http://www.ncbi.nlm.nih.gov/pubmed/9425231", "http://www.ncbi.nlm.nih.gov/pubmed/8923000", "http://www.ncbi.nlm.nih.gov/pubmed/8752669", "http://www.ncbi.nlm.nih.gov/pubmed/9783710", "http://www.ncbi.nlm.nih.gov/pubmed/10796876", "http://www.ncbi.nlm.nih.gov/pubmed/8541855", "http://www.ncbi.nlm.nih.gov/pubmed/9499606"], "triples": [], "ideal_answer": "These studies indicate that heterozygous mutations in COL5A1 can result in EDS type I recently mutations have been found in the genes for type V collagen in a small number of people with the most common forms of EDS, types I and II order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1 ( V ) N-propeptides and Ehlers-Danlos syndrome type I null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome ( types I and II ).The gene encoding collagen alpha1 ( V ) ( COL5A1 ) is linked to mixed Ehlers-Danlos syndrome type I we report that genomic polymorphisms at the pro alpha 1 ( V ) gene ( COL5A1 ) locus cosegregated with the gravis form of Ehlers-Danlos syndrome ( EDS ) ( type I ) in a three generation family ehlers-Danlos syndrome ( EDS ) type I ( the classical variety ) is a dominantly inherited, genetically heterogeneous connective-tissue disorder.", "exact_answer": [["COL5A1"], ["COL5A2"]], "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:13359", "http://www.disease-ontology.org/api/metadata/DOID:14720"], "type": "list", "id": "54e22b62ae9738404b000011", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 97, "text": "The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", "endSection": "title"}, {"offsetInBeginSection": 967, "offsetInEndSection": 1052, "text": "These studies indicate that heterozygous mutations in COL5A1 can result in EDS type I ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8923000", "endSection": "abstract"}, {"offsetInBeginSection": 1082, "offsetInEndSection": 1183, "text": "Our findings show that heterozygous mutations of the COL5A2 gene can produce the EDS type I phenotype ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9425231", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", "endSection": "title"}, {"offsetInBeginSection": 85, "offsetInEndSection": 230, "text": "Recently mutations have been found in the genes for type V collagen in a small number of people with the most common forms of EDS, types I and II ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9783710", "endSection": "abstract"}, {"offsetInBeginSection": 368, "offsetInEndSection": 506, "text": "We identified a novel splice-acceptor mutation (IVS4-2A-->G) in the N-propeptide-encoding region of COL5A1, in one patient with EDS type I ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12145749", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9425231", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10796876", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II). ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8541855", "endSection": "title"}, {"offsetInBeginSection": 554, "offsetInEndSection": 707, "text": "Using a polymorphic intragenic simple sequence repeat at the COL5A1 locus, we now demonstrate tight linkage to EDS type I/II in a three-generation family ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", "endSection": "abstract"}, {"offsetInBeginSection": 1178, "offsetInEndSection": 1335, "text": "A smaller proportion of patients harbor a structural mutation in COL5A1 or COL5A2, causing the production of a functionally defective type V collagen protein ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20847697", "endSection": "abstract"}, {"offsetInBeginSection": 791, "offsetInEndSection": 974, "text": "The variation in expression in this family suggests that EDS types I and II are allelic, and the linkage data support the hypothesis that mutation in COL5A1 can cause both phenotypes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9499606", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 180, "text": "A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I) ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8923000", "endSection": "title"}, {"offsetInBeginSection": 954, "offsetInEndSection": 1176, "text": "In the majority of patients with molecularly characterized classic Ehlers-Danlos syndrome, the disease is caused by a mutation leading to a nonfunctional COL5A1 allele and resulting in haploinsufficiency of type V collagen ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20847697", "endSection": "abstract"}, {"offsetInBeginSection": 386, "offsetInEndSection": 552, "text": "Recently, genetic linkage has been demonstrated between the COL5A1 gene, which encodes the alphal chain of type V collagen, and EDS type II in a large British kindred ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", "endSection": "abstract"}, {"offsetInBeginSection": 169, "offsetInEndSection": 332, "text": "We have identified mutations of the COL5A2 gene, which encodes the alpha2(V) chain of type V collagen, in two unrelated patients with the severe type I form of EDS ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9425231", "endSection": "abstract"}, {"offsetInBeginSection": 267, "offsetInEndSection": 449, "text": "We report that genomic polymorphisms at the pro alpha 1(V) gene (COL5A1) locus cosegregated with the gravis form of Ehlers-Danlos syndrome (EDS) (type I) in a three generation family ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8923000", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 209, "text": "Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12145749", "endSection": "title"}, {"offsetInBeginSection": 437, "offsetInEndSection": 675, "text": "It is currently estimated that approximately 50% of patients with a clinical diagnosis of classic Ehlers-Danlos syndrome harbor mutations in the COL5A1 and the COL5A2 gene, encoding the \u03b11 and the \u03b12-chain of type V collagen, respectively ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20847697", "endSection": "abstract"}, {"offsetInBeginSection": 730, "offsetInEndSection": 965, "text": "Since exon 65 encodes 78 residues of the carboxyl propeptide, the expected result of this mutation is reduced efficiency in incorporating mutant pro alpha 1(V) chains into type V collagen molecules and reduced type V collagen synthesis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8923000", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 366, "text": "Ehlers-Danlos syndrome (EDS) type I (the classical variety) is a dominantly inherited, genetically heterogeneous connective-tissue disorder. Mutations in the COL5A1 and COL5A2 genes, which encode type V collagen, have been identified in several individuals. Most mutations affect either the triple-helical domain of the protein or the expression of one COL5A1 allele ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12145749", "endSection": "abstract"}]}, {"body": "Which factors are considered in the ABCD2 score?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23871489", "http://www.ncbi.nlm.nih.gov/pubmed/23683740", "http://www.ncbi.nlm.nih.gov/pubmed/22237056", "http://www.ncbi.nlm.nih.gov/pubmed/23983858", "http://www.ncbi.nlm.nih.gov/pubmed/21646462", "http://www.ncbi.nlm.nih.gov/pubmed/21554497", "http://www.ncbi.nlm.nih.gov/pubmed/21388829", "http://www.ncbi.nlm.nih.gov/pubmed/20582954", "http://www.ncbi.nlm.nih.gov/pubmed/20421579", "http://www.ncbi.nlm.nih.gov/pubmed/19803400", "http://www.ncbi.nlm.nih.gov/pubmed/19556026"], "triples": [], "ideal_answer": "Abcd2 ( age, blood pressure [ systolic > 140 mm hg or diastolic > 90 mm hg : 1 [; clinical features, duration, diabetes ) score and magnetic resonance imaging abnormalities help to identify patients hospitalized in 3 tertiary care neurology departments across 2 different racial populations ( white and asian ).Classification of low risk was based on an age, blood pressure, clinical features, duration and diabetes ( abcd ( 2 ) ) scoring by non-stroke specialists referring patients to a daily rapid access stroke prevention ( rasp ) service is unclear, as is the accuracy of abcd ( 2 ) scoring by trainee residents.", "exact_answer": [["Age"], ["Blood pressure"], ["Clinical features"], ["Duration of symptoms"], ["Diabetes"]], "concepts": [], "type": "list", "id": "551adceb622b194345000018", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 191, "text": "The risk of stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21554497", "endSection": "abstract"}, {"offsetInBeginSection": 155, "offsetInEndSection": 322, "text": "ABCD2 (Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities help to identify patients at high risk of stroke. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20582954", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 215, "text": "BACKGROUND AND PURPOSE: The risk of stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21554497", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 210, "text": "BACKGROUND: The ABCD2 score (Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used to identify patients having a transient ischemic attack who are at high risk for imminent stroke. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21646462", "endSection": "abstract"}, {"offsetInBeginSection": 162, "offsetInEndSection": 374, "text": "We examined the association of the age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model for stroke after TIA, and the presence of ICS or ECS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23983858", "endSection": "abstract"}, {"offsetInBeginSection": 448, "offsetInEndSection": 694, "text": " Classification of low risk was based on an age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score <4 and the absence of high risk features, including known carotid disease, crescendo TIA, or atrial fibrillation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23683740", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 272, "text": "The 'accuracy' of age, blood pressure, clinical features, duration and diabetes (ABCD(2)) scoring by non-stroke specialists referring patients to a daily Rapid Access Stroke Prevention (RASP) service is unclear, as is the accuracy of ABCD(2) scoring by trainee residents. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23871489", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 331, "text": "BACKGROUND: Modifications to the age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension and acute hyperglycemia in addition to acute blood pressure (BP) elevation and history of diabetes, have been proposed to increase the predictive value of the score. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21388829", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 311, "text": "STUDY OBJECTIVE: We evaluate, in admitted patients with transient ischemic attack, the accuracy of the ABCD(2) (age [A], blood pressure [B], clinical features [weakness/speech disturbance] [C], transient ischemic attack duration [D], and diabetes history [D]) score in predicting ischemic stroke within 7 days. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19556026", "endSection": "abstract"}, {"offsetInBeginSection": 150, "offsetInEndSection": 654, "text": "Our goal was to compare the very early predictive accuracy of the most relevant clinical scores [age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes (ABCD2) score, ABCD and brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within 1 week of the index event (ABCD3) score, California Risk Score, Essen Stroke Risk Score and Stroke Prognosis Instrument II] in consecutive transient ischemic attack (TIA) patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22237056", "endSection": "abstract"}, {"offsetInBeginSection": 334, "offsetInEndSection": 835, "text": "METHODS: We prospectively calculated the ABCD(2) score (age [> or = 60 years: 1 point]; blood pressure [systolic >140 mm Hg or diastolic >90 mm Hg: 1[; clinical features [unilateral weakness: 2, speech disturbance without weakness: 1, other symptom: 0]; duration of symptoms [ <10 minutes: 0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes mellitus [yes: 1]) in consecutive TIA patients hospitalized in 3 tertiary care neurology departments across 2 different racial populations (white and Asian). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20421579", "endSection": "abstract"}, {"offsetInBeginSection": 669, "offsetInEndSection": 1250, "text": "Early stroke risk is especially high in TIA patients with a high ABCD2 score of 4 or more (A age over 60 years [1 point]: B blood pressure > 140/90 mmHg [1 point]: C Clinical features, including unilateral weakness [2 points] and speech disturbance without weakness [1 point] D2: Diabetes [1 point] and Duration of symptoms [1 point for < 60 min and 2 points for > 60 min]), acute ischemic lesions on diffusion weighted image, > 50% carotid stenosis, severe intracranial artery stenosis, microembolic signals on transcranial Doppler, atrial fibrillation, or hypercoagulable states. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19803400", "endSection": "abstract"}]}, {"body": "Is Tuberous Sclerosis a genetic disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24310804", "http://www.ncbi.nlm.nih.gov/pubmed/24092520", "http://www.ncbi.nlm.nih.gov/pubmed/23966835", "http://www.ncbi.nlm.nih.gov/pubmed/23359422", "http://www.ncbi.nlm.nih.gov/pubmed/23035046", "http://www.ncbi.nlm.nih.gov/pubmed/22544534", "http://www.ncbi.nlm.nih.gov/pubmed/22497684", "http://www.ncbi.nlm.nih.gov/pubmed/22068806", "http://www.ncbi.nlm.nih.gov/pubmed/22125079", "http://www.ncbi.nlm.nih.gov/pubmed/22025691", "http://www.ncbi.nlm.nih.gov/pubmed/22021912", "http://www.ncbi.nlm.nih.gov/pubmed/21907282", "http://www.ncbi.nlm.nih.gov/pubmed/21309039", "http://www.ncbi.nlm.nih.gov/pubmed/21301339", "http://www.ncbi.nlm.nih.gov/pubmed/20087180", "http://www.ncbi.nlm.nih.gov/pubmed/20073603", "http://www.ncbi.nlm.nih.gov/pubmed/20041940", "http://www.ncbi.nlm.nih.gov/pubmed/19744185", "http://www.ncbi.nlm.nih.gov/pubmed/19624715", "http://www.ncbi.nlm.nih.gov/pubmed/21547713", "http://www.ncbi.nlm.nih.gov/pubmed/19297407", "http://www.ncbi.nlm.nih.gov/pubmed/18245941", "http://www.ncbi.nlm.nih.gov/pubmed/18080139", "http://www.ncbi.nlm.nih.gov/pubmed/16818174", "http://www.ncbi.nlm.nih.gov/pubmed/16757313", "http://www.ncbi.nlm.nih.gov/pubmed/15456557", "http://www.ncbi.nlm.nih.gov/pubmed/15340059", "http://www.ncbi.nlm.nih.gov/pubmed/12869586", "http://www.ncbi.nlm.nih.gov/pubmed/12582162", "http://www.ncbi.nlm.nih.gov/pubmed/12364343", "http://www.ncbi.nlm.nih.gov/pubmed/11288117", "http://www.ncbi.nlm.nih.gov/pubmed/9770187", "http://www.ncbi.nlm.nih.gov/pubmed/8129414", "http://www.ncbi.nlm.nih.gov/pubmed/1293183", "http://www.ncbi.nlm.nih.gov/pubmed/1479601", "http://www.ncbi.nlm.nih.gov/pubmed/2600265", "http://www.ncbi.nlm.nih.gov/pubmed/24226526"], "triples": [], "ideal_answer": "Tuberous sclerosis complex ( tsc ) is a genetic disease the size distribution of chromosome 9 linked families was similar to that of non-linked families.Tsc was recognized to be a genetic disease mutation in either the tsc1 or tsc2 tumor suppressor gene is responsible for the inherited genetic disease can complicate genetic counselling.Tsc was recognized to be a genetic disease with autosomal dominant inheritance tuberous sclerosis complex ( tsc ) is a genetic disease with prominent cutaneous and brain involvement the effects of missense changes and small in-frame deletions and insertions on protein function are not easy to predict, and the identification of such variants in individuals at risk of a genetic disease can complicate genetic counselling.", "exact_answer": "yes", "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:13515", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0033596", "http://www.uniprot.org/uniprot/TSC1_HUMAN", "http://www.uniprot.org/uniprot/TSC2_HUMAN", "http://www.uniprot.org/uniprot/TSC1_MOUSE", "http://www.uniprot.org/uniprot/TSC1_SCHPO", "http://www.uniprot.org/uniprot/TSC1_RAT", "http://www.uniprot.org/uniprot/TSC2_MOUSE", "http://www.uniprot.org/uniprot/TSC2_RAT", "http://www.uniprot.org/uniprot/TSC2_SCHPO", "http://www.biosemantics.org/jochem#4266396", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014402", "http://www.disease-ontology.org/api/metadata/DOID:630", "http://www.disease-ontology.org/api/metadata/DOID:0050739", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D030342", "http://www.disease-ontology.org/api/metadata/DOID:0050325"], "type": "yesno", "id": "52b06a68f828ad283c000005", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 53, "text": "Tuberous sclerosis complex (TSC) is a genetic disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15340059", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 44, "text": "Tuberous sclerosis is a rare genetic disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9770187", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 64, "text": "Tuberous sclerosis complex (TSC) is a multiorgan genetic disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16818174", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 51, "text": "Tuberous sclerosis is a dominant hereditary disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2600265", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 64, "text": "Tuberous Sclerosis Complex (TSC) is a multiorgan genetic disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21547713", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 65, "text": "Tuberous sclerosis (TSC) is an autosomal-dominant genetic disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22497684", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 53, "text": "Tuberous Sclerosis Complex (TSC) is a genetic disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22125079", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 76, "text": "Tuberous sclerosis is a genetic disease with autosomal dominant inheritance, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18245941", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 65, "text": "Tuberous sclerosis complex (TSC) is a multisystem genetic disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23966835", "endSection": "abstract"}, {"offsetInBeginSection": 122, "offsetInEndSection": 200, "text": "TSC was recognized to be a genetic disease with autosomal dominant inheritance ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1293183", "endSection": "abstract"}, {"offsetInBeginSection": 9, "offsetInEndSection": 101, "text": "Tuberous sclerosis (TS) is a genetic disease with prominent cutaneous and brain involvement ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8129414", "endSection": "abstract"}, {"offsetInBeginSection": 298, "offsetInEndSection": 411, "text": "In all these lesions, genetic alterations related to the tuberous sclerosis complex (TSC) have been demonstrated. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20073603", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 81, "text": "Tuberous sclerosis complex (TSC) is a relatively rare autosomal dominant disorder ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19297407", "endSection": "abstract"}, {"offsetInBeginSection": 181, "offsetInEndSection": 283, "text": "Many of these advances originated from studies of the genetic disease tuberous sclerosis complex (TSC) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24226526", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "Tuberous sclerosis complex (TSC) is a genetic disease caused by mutation in either TSC1 or TSC2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12869586", "endSection": "abstract"}, {"offsetInBeginSection": 297, "offsetInEndSection": 428, "text": "mTOR inhibitors have antiepileptogenic and antiseizure effects in animal models of the genetic disease, tuberous sclerosis complex. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22544534", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "The tuberous sclerosis gene 2 product tuberin is an important regulator of the mammalian target of rapamycin (mTOR). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19744185", "endSection": "abstract"}, {"offsetInBeginSection": 342, "offsetInEndSection": 464, "text": "The disease is caused by mutational inactivation of the tumor suppressor gene tuberous sclerosis complex 1 (TSC1) or TSC2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23035046", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Mutation in either the TSC1 or TSC2 tumor suppressor gene is responsible for the inherited genetic disease of tuberous sclerosis complex. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12364343", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "Tuberous sclerosis complex (TSC) is a genetic disease caused by mutations in either TSC1 or TSC2 tumor suppressor genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12582162", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 169, "text": "Although epilepsy affects most patients with tuberous sclerosis complex (TSC), little is known about the natural history of epilepsy in this genetic disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20041940", "endSection": "abstract"}, {"offsetInBeginSection": 632, "offsetInEndSection": 829, "text": "On average TSC families are very small; in most cases there are fewer than two informative meioses. The size distribution of chromosome 9 linked families was similar to that of non-linked families. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1479601", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 187, "text": "Tuberous sclerosis (TSC) is a frequent autosomal-dominant condition (affecting 1 in 6000 individuals) caused by various mutations in either the hamartin (TSC1) or the tuberin gene (TSC2). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11288117", "endSection": "abstract"}, {"offsetInBeginSection": 471, "offsetInEndSection": 722, "text": "PEComas are related to the genetic alterations of tuberous sclerosis complex (TSC), an autosomal dominant genetic disease due to losses of TSC1 (9q34) or TSC2 (16p13.3) genes which seem to have a role in the regulation of the Rheb/mTOR/p70S6K pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18080139", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 507, "text": "The effects of missense changes and small in-frame deletions and insertions on protein function are not easy to predict, and the identification of such variants in individuals at risk of a genetic disease can complicate genetic counselling. One option is to perform functional tests to assess whether the variants affect protein function. We have used this strategy to characterize variants identified in the TSC1 and TSC2 genes in individuals with, or suspected of having, Tuberous Sclerosis Complex (TSC). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21309039", "endSection": "abstract"}]}, {"body": "Does TRIM37 gene mutation causes Mulibrey nanism?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21865362", "http://www.ncbi.nlm.nih.gov/pubmed/19334051", "http://www.ncbi.nlm.nih.gov/pubmed/19329943", "http://www.ncbi.nlm.nih.gov/pubmed/11938494", "http://www.ncbi.nlm.nih.gov/pubmed/12754710", "http://www.ncbi.nlm.nih.gov/pubmed/14757854", "http://www.ncbi.nlm.nih.gov/pubmed/15108285", "http://www.ncbi.nlm.nih.gov/pubmed/17551331", "http://www.ncbi.nlm.nih.gov/pubmed/16514549", "http://www.ncbi.nlm.nih.gov/pubmed/16310976", "http://www.ncbi.nlm.nih.gov/pubmed/23385855"], "triples": [], "ideal_answer": "The pathogenetic mechanisms of mulibrey nanism are unknown.Few monogenic mutations causing human male infertility have been identified to date.Characterisation of the mulibrey nanism are unknown.A novel splice site mutation in the trim37 gene causes mulibrey nanism are unknown.Characterisation of the mulibrey nanism-associated TRIM37 gene : transcription initiation, promoter region and alternative splicing.Unlabelled : mulibrey nanism ( mul ) is a rare autosomal recessive disorder with severe primordial growth retardation and multiorgan involvement, caused by mutations in trim37 gene : transcription initiation, promoter region and alternative splicing.Unlabelled : mulibrey nanism in a turkish family with phenotypic heterogeneity novel mutations in the trim37 gene in mulibrey nanism the trim37 gene encodes a peroxisomal ring-b-box-coiled-coil protein : classification of mulibrey nanism as a new peroxisomal disorder.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050336", "http://www.disease-ontology.org/api/metadata/DOID:0050436", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009154"], "type": "yesno", "id": "56c1f03cef6e394741000054", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "A novel splice site mutation in the TRIM37 gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12754710", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 55, "text": "Novel mutations in the TRIM37 gene in Mulibrey Nanism. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15108285", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 79, "text": "A novel mutation in TRIM37 is associated with mulibrey nanism in a Turkish boy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17551331", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 53, "text": "Novel mutations in the TRIM37 gene in Mulibrey Nanism ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15108285", "endSection": "title"}, {"offsetInBeginSection": 247, "offsetInEndSection": 350, "text": "Five truncating mutations in the TRIM37 gene have previously been reported in Mulibrey nanism patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15108285", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Mulibrey nanism is an autosomal recessive growth disorder caused by mutations in the TRIM37 gene encoding a protein of unknown function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19329943", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 78, "text": "A novel mutation in TRIM37 is associated with mulibrey nanism in a Turkish boy ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17551331", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 148, "text": "Mulibrey nanism is a rare growth disorder of prenatal onset caused by mutations in the TRIM37 gene, which encodes a RING-B-box-coiled-coil protein. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11938494", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 156, "text": "Mulibrey nanism (MUL) is an autosomal recessive disease caused by mutations in the TRIM37 gene encoding the peroxisomal TRIM37 protein of unknown function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14757854", "endSection": "abstract"}, {"offsetInBeginSection": 168, "offsetInEndSection": 298, "text": "It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19334051", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 197, "text": "Mulibrey nanism (muscle-liver-brain-eye nanism; MUL) is an autosomal recessively transmitted disease characterized by severe growth delays of prenatal onset caused by mutations in the TRIM37 gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12754710", "endSection": "abstract"}, {"offsetInBeginSection": 246, "offsetInEndSection": 348, "text": "Five truncating mutations in the TRIM37 gene have previously been reported in Mulibrey nanism patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15108285", "endSection": "abstract"}, {"offsetInBeginSection": 86, "offsetInEndSection": 208, "text": "We studied pubertal development and fecundity in males with Mulibrey nanism (MUL) caused by mutations in the TRIM37 gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21865362", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Characterisation of the mulibrey nanism-associated TRIM37 gene: transcription initiation, promoter region and alternative splicing. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16310976", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "A novel splice site mutation in the TRIM37 gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12754710", "endSection": "title"}, {"offsetInBeginSection": 94, "offsetInEndSection": 227, "text": "OBJECTIVE: We studied pubertal development and fecundity in males with Mulibrey nanism (MUL) caused by mutations in the TRIM37 gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21865362", "endSection": "abstract"}, {"offsetInBeginSection": 1605, "offsetInEndSection": 1714, "text": "In MUL, mutations in TRIM37 lead to disturbance of sexual maturation, and fertility is severely compromised. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21865362", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11938494", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 125, "text": "Gynecological tumors in Mulibrey nanism and role for RING finger protein TRIM37 in the pathogenesis of ovarian fibrothecomas. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19329943", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 135, "text": "Mulibrey nanism is an autosomal recessive growth disorder caused by mutations in the TRIM37 gene encoding a protein of unknown function ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19329943", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 146, "text": "Mulibrey nanism is a rare growth disorder of prenatal onset caused by mutations in the TRIM37 gene, which encodes a RING-B-box-coiled-coil protein ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11938494", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 146, "text": "Refractory congestive heart failure following delayed pericardectomy in a 12-year-old child with Mulibrey nanism due to a novel mutation in TRIM37 ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23385855", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 174, "text": "UNLABELLED: Mulibrey nanism (MUL) is a rare autosomal recessive disorder with severe primordial growth retardation and multiorgan involvement, caused by mutations in TRIM37. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23385855", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 154, "text": "Mulibrey nanism (MUL) is an autosomal recessive disease caused by mutations in the TRIM37 gene encoding the peroxisomal TRIM37 protein of unknown function ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14757854", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "Mulibrey nanism (MUL) is a rare autosomal recessive disorder with severe primordial growth retardation and multiorgan involvement, caused by mutations in TRIM37 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23385855", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 162, "text": "Mulibrey nanism (MUL) is a rare autosomal recessive disorder with severe primordial growth retardation and multiorgan involvement, caused by mutations in TRIM37. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23385855", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 208, "text": " Mulibrey nanism is a rare growth disorder of prenatal onset caused by mutations in the TRIM37 gene, which encodes a RING-B-box-coiled-coil protein. The pathogenetic mechanisms of mulibrey nanism are unknown. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11938494", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 195, "text": "Mulibrey nanism (muscle-liver-brain-eye nanism; MUL) is an autosomal recessively transmitted disease characterized by severe growth delays of prenatal onset caused by mutations in the TRIM37 gene ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12754710", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 208, "text": " Few monogenic mutations causing human male infertility have been identified to date. We studied pubertal development and fecundity in males with Mulibrey nanism (MUL) caused by mutations in the TRIM37 gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21865362", "endSection": "abstract"}, {"offsetInBeginSection": 1684, "offsetInEndSection": 1918, "text": " In conclusion, inherited biallelic inactivation of TRIM37 (Mulibrey nanism) predisposes to both mesenchymal and epithelial ovarian tumors and dysregulation of TRIM37 may also be involved in the pathogenesis of sporadic fibrothecomas. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19329943", "endSection": "abstract"}, {"offsetInBeginSection": 67, "offsetInEndSection": 286, "text": "Mutations in TRIM37 underlie mulibrey nanism, a rare autosomal recessively inherited disorder with severe growth failure of prenatal onset, constrictive pericardium, hepatomegaly and characteristic dysmorphic features. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16310976", "endSection": "abstract"}, {"offsetInBeginSection": 602, "offsetInEndSection": 864, "text": "To investigate the possible involvement of TRIM37 alterations in the pathogenesis of sporadic fibrothecomas, we analyzed the TRIM37 cDNA for mutations and alternatively spliced transcripts and TRIM37 expression in fibrothecomas of women without Mulibrey nanism. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19329943", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 269, "text": "Mutations in the TRIM37 gene underlie mulibrey nanism (muscle-liver-brain-eye nanism), a rare monogenic developmental disorder characterized by severe growth failure, characteristic dysmorphic features, cardiopathy, failure of sexual maturation, and metabolic syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16514549", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 298, "text": "Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19334051", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 262, "text": " Mulibrey nanism is an autosomal recessive growth disorder caused by mutations in the TRIM37 gene encoding a protein of unknown function. More than half of female patients with Mulibrey nanism develop benign mesenchymal tumors of ovarian sex cord-stromal origin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19329943", "endSection": "abstract"}, {"offsetInBeginSection": 86, "offsetInEndSection": 386, "text": " We studied pubertal development and fecundity in males with Mulibrey nanism (MUL) caused by mutations in the TRIM37 gene. Twenty-eight male MUL patients of the Finnish national cohort aged 8.7 to 50.0 yr (median age, 28.8) at the end of observation were followed for 10 yr beginning from 2000-2001. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21865362", "endSection": "abstract"}]}, {"body": "Have thyronamines effects on fat tissue?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20880963"], "triples": [], "ideal_answer": "Intraperitoneal or central injection of 3-T ( 1 ) AM or T ( 0 ) AM into mice, rats, or Djungarian hamsters caused various prompt effects, such as metabolic depression, hypothermia, negative chronotropy, negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria, and reduction of fat mass.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000273", "http://www.biosemantics.org/jochem#4251308"], "type": "yesno", "id": "534bf050aeec6fbd07000015", "snippets": [{"offsetInBeginSection": 641, "offsetInEndSection": 947, "text": "Intraperitoneal or central injection of 3-T(1)AM or T(0)AM into mice, rats, or Djungarian hamsters caused various prompt effects, such as metabolic depression, hypothermia, negative chronotropy, negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria, and reduction of fat mass. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880963", "endSection": "abstract"}]}, {"body": "What is the genetic basis of progeria", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18796515", "http://www.ncbi.nlm.nih.gov/pubmed/16258283", "http://www.ncbi.nlm.nih.gov/pubmed/12714972", "http://www.ncbi.nlm.nih.gov/pubmed/21217880", "http://www.ncbi.nlm.nih.gov/pubmed/19875478", "http://www.ncbi.nlm.nih.gov/pubmed/19842191"], "triples": [], "ideal_answer": "Hutchinson-gilford progeria syndrome ( hgps ) and mandibuloacral dysplasia are well-recognized allelic autosomal dominant and recessive progeroid disorders, respectively, due to mutations in lamin a ( lmna ) gene mandibuloacral dysplasia ( mad ) is a rare autosomal recessive progeroid syndrome due to mutations in genes encoding nuclear lamina proteins, lamins a ( lmna ) or prelamin a processing enzyme, and zinc metalloproteinase ( zmpste24 ) the genetic basis in most cases is a mutation at the nucleotide position 1824 of the lamin a geneThe underlying defect is usually a homozygous mutation of lmna, or a combined defect of lmna and another gene, for example, zmpste-24 we present evidence of mutations in lamin a ( lmna ) as the cause of this disorder.Genetic defects in the nuclear envelope protein prelamin a or in the face-1 metalloprotease ( also called zmspte24 ) involved in prelamin a proteolytic maturation, cause the accumulation of an abnormal form of this protein and the subsequent disruption of nuclear envelope integrity.", "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:3911", "http://www.disease-ontology.org/api/metadata/DOID:0050325", "http://www.disease-ontology.org/api/metadata/DOID:630", "http://www.disease-ontology.org/api/metadata/DOID:0050739", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011371"], "type": "summary", "id": "52f7c91f2059c6d71c00002e", "snippets": [{"offsetInBeginSection": 399, "offsetInEndSection": 496, "text": "The genetic basis in most cases is a mutation at the nucleotide position 1824 of the lamin A gene ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21217880", "endSection": "abstract"}, {"offsetInBeginSection": 143, "offsetInEndSection": 224, "text": "we present evidence of mutations in lamin A (LMNA) as the cause of this disorder. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12714972", "endSection": "abstract"}, {"offsetInBeginSection": 363, "offsetInEndSection": 496, "text": "The underlying defect is usually a homozygous mutation of LMNA, or a combined defect of LMNA and another gene, for example, ZMPSTE-24 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19842191", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 222, "text": "Hutchinson-Gilford progeria syndrome (HGPS) and mandibuloacral dysplasia are well-recognized allelic autosomal dominant and recessive progeroid disorders, respectively, due to mutations in lamin A/C (LMNA) gene ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19875478", "endSection": "abstract"}, {"offsetInBeginSection": 336, "offsetInEndSection": 617, "text": "genetic defects in the nuclear envelope protein prelamin A or in the FACE-1 metalloprotease (also called Zmspte24) involved in prelamin A proteolytic maturation, cause the accumulation of an abnormal form of this protein and the subsequent disruption of nuclear envelope integrity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16258283", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 240, "text": "Mandibuloacral dysplasia (MAD) is a rare autosomal recessive progeroid syndrome due to mutations in genes encoding nuclear lamina proteins, lamins A/C (LMNA) or prelamin A processing enzyme, and zinc metalloproteinase (ZMPSTE24) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18796515", "endSection": "abstract"}]}, {"body": "What type of DNA repair pathways is initiated by AlkA glycosylase?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21491902", "http://www.ncbi.nlm.nih.gov/pubmed/18270439", "http://www.ncbi.nlm.nih.gov/pubmed/10375529", "http://www.ncbi.nlm.nih.gov/pubmed/8805338", "http://www.ncbi.nlm.nih.gov/pubmed/10455196", "http://www.ncbi.nlm.nih.gov/pubmed/10363024", "http://www.ncbi.nlm.nih.gov/pubmed/10455195", "http://www.ncbi.nlm.nih.gov/pubmed/9430628", "http://www.ncbi.nlm.nih.gov/pubmed/11266119", "http://www.ncbi.nlm.nih.gov/pubmed/9637245", "http://www.ncbi.nlm.nih.gov/pubmed/9895121", "http://www.ncbi.nlm.nih.gov/pubmed/24810496", "http://www.ncbi.nlm.nih.gov/pubmed/22683793", "http://www.ncbi.nlm.nih.gov/pubmed/12853604", "http://www.ncbi.nlm.nih.gov/pubmed/9535832", "http://www.ncbi.nlm.nih.gov/pubmed/12379112", "http://www.ncbi.nlm.nih.gov/pubmed/10946229", "http://www.ncbi.nlm.nih.gov/pubmed/10675345", "http://www.ncbi.nlm.nih.gov/pubmed/12832627"], "triples": [], "ideal_answer": "Alka, initiates repair by removal of the damaged base, whereas endonuclease v, endo v, hydrolyses the second phosphodiester bond 3' to the lesion the base excision repair pathway initiated by alka and the methyl-directed mismatch repair pathway initiated by muts.Base excision repair is initiated by dna glycosylases removing inappropriate bases from dna the alkylbase dna glycosylase, mag1p and mag2p, which share homology with escherichia coli alka.Schizosaccharomyces pombe has two paralogues of 3-methyladenine dna glycosylase, mag1p and mag2p, which share homology with escherichia coli alka.Alka, a monofunctional dna can be restored by two independent repair pathways, i.e.These results suggest that fu present in dna can be restored by two independent repair pathways, i.e.Enzymatic repair of 5-formyluracil.Base excision repair is initiated by dna glycosylases removing inappropriate bases, is structurally homologous to endo iii.AlkA, a monofunctional DNA glycosylase that acts on alkylated bases, is structurally homologous to endo III.These results suggest that fU present in DNA can be restored by two independent repair pathways, i.e.", "exact_answer": [["base excision repair (BER) pathway"]], "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006281", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0003905", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016798", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004260", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D045647", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0019104"], "type": "factoid", "id": "55421398ccca0ce74b000001", "snippets": [{"offsetInBeginSection": 1618, "offsetInEndSection": 1734, "text": "the base excision repair pathway initiated by AlkA and the methyl-directed mismatch repair pathway initiated by MutS ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10455196", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 91, "text": "Base excision repair is initiated by DNA glycosylases removing inappropriate bases from DNA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9430628", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "Base excision repair is initiated by DNA glycosylases removing inappropriate bases from DNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9430628", "endSection": "abstract"}, {"offsetInBeginSection": 776, "offsetInEndSection": 872, "text": "Escherichia coli alkA tagA double mutants, which are deficient in the repair of alkylated bases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10375529", "endSection": "abstract"}, {"offsetInBeginSection": 158, "offsetInEndSection": 269, "text": "Alkylation damage is removed by the action of DNA glycosylases, which initiate the base excision repair pathway ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10375529", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 123, "text": "The Escherichia coli AlkA protein is a base excision repair glycosylase that removes a variety of alkylated bases from DNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10675345", "endSection": "abstract"}, {"offsetInBeginSection": 158, "offsetInEndSection": 326, "text": "Alkylation damage is removed by the action of DNA glycosylases, which initiate the base excision repair pathway and protect the sequence information of the genome [3-5] ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10375529", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "3-Methyladenine DNA glycosylase II (AlkA) is a DNA-repair enzyme that removes alkylated bases in DNA via the base-excision repair (BER) pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22683793", "endSection": "abstract"}, {"offsetInBeginSection": 1516, "offsetInEndSection": 1735, "text": "These results suggest that fU present in DNA can be restored by two independent repair pathways, i.e. the base excision repair pathway initiated by AlkA and the methyl-directed mismatch repair pathway initiated by MutS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10455196", "endSection": "abstract"}, {"offsetInBeginSection": 40, "offsetInEndSection": 220, "text": "Mismatch formation between 5-formyluracil and guanine during dna replication and its recognition by two proteins involved in base excision repair (AlkA) and mismatch repair (MutS). ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10455196", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 199, "text": "Enzymatic repair of 5-formyluracil. I. Excision of 5-formyluracil site-specifically incorporated into oligonucleotide substrates by alka protein (Escherichia coli 3-methyladenine DNA glycosylase II). ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10455195", "endSection": "title"}, {"offsetInBeginSection": 200, "offsetInEndSection": 376, "text": "The alkylbase DNA glycosylase, AlkA, initiates repair by removal of the damaged base, whereas endonuclease V, Endo V, hydrolyses the second phosphodiester bond 3' to the lesion ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12853604", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 195, "text": "Human alkyladenine glycosylase (AAG) and Escherichia coli 3-methyladenine glycosylase (AlkA) are base excision repair glycosylases that recognize and excise a variety of alkylated bases from DNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10946229", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 233, "text": "The Escherichia coli 3-methyladenine DNA glycosylase II protein (AlkA) recognizes a broad range of oxidized and alkylated base lesions and catalyzes the hydrolysis of the N-glycosidic bond to initiate the base excision repair pathway ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21491902", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 234, "text": "The Escherichia coli 3-methyladenine DNA glycosylase II protein (AlkA) recognizes a broad range of oxidized and alkylated base lesions and catalyzes the hydrolysis of the N-glycosidic bond to initiate the base excision repair pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21491902", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 248, "text": "Schizosaccharomyces pombe has two paralogues of 3-methyladenine DNA glycosylase, Mag1p and Mag2p, which share homology with Escherichia coli AlkA. To clarify the function of these redundant enzymes in base excision repair (BER) of alkylation damage ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18270439", "endSection": "abstract"}, {"offsetInBeginSection": 1813, "offsetInEndSection": 2168, "text": "AlkA, a monofunctional DNA glycosylase that acts on alkylated bases, is structurally homologous to endo III. We have now identified a shared active site motif amongst these three proteins. Using this motif as a protein database searching tool, we find that it is present in a number of other base-excision DNA repair proteins that process diverse lesions. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8805338", "endSection": "abstract"}]}, {"body": "Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24141722", "http://www.ncbi.nlm.nih.gov/pubmed/22113972", "http://www.ncbi.nlm.nih.gov/pubmed/22045334", "http://www.ncbi.nlm.nih.gov/pubmed/20538595", "http://www.ncbi.nlm.nih.gov/pubmed/20453833", "http://www.ncbi.nlm.nih.gov/pubmed/20423330", "http://www.ncbi.nlm.nih.gov/pubmed/20351748", "http://www.ncbi.nlm.nih.gov/pubmed/20006583", "http://www.ncbi.nlm.nih.gov/pubmed/19176477", "http://www.ncbi.nlm.nih.gov/pubmed/18248624", "http://www.ncbi.nlm.nih.gov/pubmed/17963781", "http://www.ncbi.nlm.nih.gov/pubmed/17121848", "http://www.ncbi.nlm.nih.gov/pubmed/16154111", "http://www.ncbi.nlm.nih.gov/pubmed/12794086", "http://www.ncbi.nlm.nih.gov/pubmed/12127959", "http://www.ncbi.nlm.nih.gov/pubmed/11156945"], "triples": [{"p": "http://purl.uniprot.org/core/submittedName", "s": "http://purl.uniprot.org/uniprot/D7LBU2", "o": "http://linkedlifedata.com/resource/#_44374C42553200A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_44374C42553200A", "o": "Histone mono-ubiquitination 1"}], "ideal_answer": "Whereas poly-ubiquitination targets protein substrates for proteasomal degradation, mono-ubiquitination is known to regulate protein trafficking in the endosomal system and to target cargo proteins for lysosomal degradation.Our results indicate that Hsp70 facilitates CHIP-mediated poly-ubiquitination of Smad1 whereas it attenuates CHIP-meditated mono-ubiquitination of Smad1.We also found that Ro52 was conjugated with poly-ubiquitin chain in cells ( poly-ubiquitination ) the yeast G protein alpha subunit Gpa1 represents a rare example of a protein that undergoes both mono- and poly-ubiquitination.Ps1 ubiquitination after pi3k inhibition is represented by the multiple mono-ubiquitination, instead of poly-ubiquitination wild type smad4 is a relatively stable protein that undergoes both mono- and poly-ubiquitination, respectively, with ubiquitin-conjugating enzyme ( e2 ) -binding capabilities.Our results indicate that hsp70 facilitates chip-mediated poly-ubiquitination of smad1 whereas it attenuates chip-meditated mono-ubiquitination is known to regulate protein trafficking in the endosomal system and to target cargo proteins for lysosomal degradation.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054875", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D057149", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016567", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0031398", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0031396", "http://www.uniprot.org/uniprot/UBIQ_AVESA", "http://www.uniprot.org/uniprot/UBIQP_PHYIN"], "type": "yesno", "id": "530c7cfd970c65fa6b00000c", "snippets": [{"offsetInBeginSection": 883, "offsetInEndSection": 1006, "text": "PS1 ubiquitination after PI3K inhibition is represented by the multiple mono-ubiquitination, instead of poly-ubiquitination ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20006583", "endSection": "abstract"}, {"offsetInBeginSection": 419, "offsetInEndSection": 539, "text": " mono-ubiquitination of CIITA increases its transactivity, whereas poly-ubiquitination of CIITA leads to its degradation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20351748", "endSection": "abstract"}, {"offsetInBeginSection": 613, "offsetInEndSection": 738, "text": "mono-ubiquitination of CIITA dramatically increases its transactivity whereas poly-ubiquitination leads to CIITA degradation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20538595", "endSection": "abstract"}, {"offsetInBeginSection": 163, "offsetInEndSection": 292, "text": "The yeast G protein alpha subunit Gpa1 represents a rare example of a protein that undergoes both mono- and poly-ubiquitination. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19176477", "endSection": "abstract"}, {"offsetInBeginSection": 769, "offsetInEndSection": 910, "text": "wild type Smad4 is a relatively stable protein that undergoes mono- or oligo-ubiquitination, a modification not linked to protein degradation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12794086", "endSection": "abstract"}, {"offsetInBeginSection": 686, "offsetInEndSection": 827, "text": "Instead of promoting poly-ubiquitination and degradation, we show that Smurf2 actually induces multiple mono-ubiquitination of Smad3 in vivo. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22045334", "endSection": "abstract"}, {"offsetInBeginSection": 912, "offsetInEndSection": 1065, "text": "our results indicate that Hsp70 facilitates CHIP-mediated poly-ubiquitination of Smad1 whereas it attenuates CHIP-meditated mono-ubiquitination of Smad1. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17963781", "endSection": "abstract"}, {"offsetInBeginSection": 241, "offsetInEndSection": 400, "text": "These fingers possess E3 activities of mono-ubiquitination and poly-ubiquitination, respectively, with ubiquitin-conjugating enzyme (E2)-binding capabilities. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22113972", "endSection": "abstract"}, {"offsetInBeginSection": 829, "offsetInEndSection": 1008, "text": "This leads to a model in which Lys134 of LDB1 can be either mono-ubiquitinated, leading to stabilization, or poly-ubiquitinated, leading to degradation by the proteasome pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20423330", "endSection": "abstract"}, {"offsetInBeginSection": 1429, "offsetInEndSection": 1615, "text": "Our results suggest that oxidative stress induces not only poly-ubiquitination but also mono-ubiquitination of LDH-A, which may be involved in its lysosomal degradation during unloading. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16154111", "endSection": "abstract"}, {"offsetInBeginSection": 600, "offsetInEndSection": 748, "text": "Expression of p34 promotes PTEN poly-ubiquitination, leading to PTEN protein degradation, whereas p34 knockdown results in PTEN mono-ubiquitination. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24141722", "endSection": "abstract"}, {"offsetInBeginSection": 1626, "offsetInEndSection": 1813, "text": "These data suggest that oligo-ubiquitination positively regulates Smad4 function, whereas poly-ubiquitination primarily occurs in unstable cancer mutants and leads to protein degradation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12794086", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 224, "text": "Whereas poly-ubiquitination targets protein substrates for proteasomal degradation, mono-ubiquitination is known to regulate protein trafficking in the endosomal system and to target cargo proteins for lysosomal degradation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17121848", "endSection": "abstract"}, {"offsetInBeginSection": 348, "offsetInEndSection": 676, "text": "We found that Ro52 was strongly conjugated by a single molecule of ubiquitin in cells. Although the biological relevance of this mono-ubiquitination was not defined, the function of Ro52 might be modified by the mono-ubiquitination. We also found that Ro52 was conjugated with poly-ubiquitin chain in cells (poly-ubiquitination) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12127959", "endSection": "abstract"}, {"offsetInBeginSection": 1270, "offsetInEndSection": 1608, "text": "Our observations support a novel functional relationship between parkin and Hsc/Hsp70 and support the notion that parkin is a multi-purpose E3 ubiquitin ligase capable of modifying proteins either via attachment of alternatively linked poly-ubiquitin chains or through multiple mono-ubiquitination to achieve alternate biological outcomes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18248624", "endSection": "abstract"}]}, {"body": "Which are the musculoskeletal manifestations of Marfan syndrome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19726741", "http://www.ncbi.nlm.nih.gov/pubmed/17620463", "http://www.ncbi.nlm.nih.gov/pubmed/6481730", "http://www.ncbi.nlm.nih.gov/pubmed/21971724", "http://www.ncbi.nlm.nih.gov/pubmed/20686061"], "triples": [], "ideal_answer": "Patients with three to four physically evident features, or two highly specific features ( e.g., thumb and wrist signs, craniofacial features, dural ectasia, or protrusio ), should be carefully reexamined and possibly referred for an echocardiogram or a genetics consultation.Otto pelvis should be aware of the diagnostic features of marfan syndrome.Musculoskeletal abnormalities were found : pectus in 3 patients ( 11 % ), pectus and scoliosis, dural ectasia, protrusio acetabuli, and ligamentous laxity.Musculoskeletal manifestations include scoliosis, pectus excavatum and carinatum, arachnodactyly, and ligamentous laxity.Two cases are described in which protrusio acetabuli was a major problem.The following musculoskeletal abnormalities were found : pectus in 3 patients ( 11 % ), pectus excavatum and carinatum, arachnodactyly in 21 ( 80 % ).Musculoskeletal clinicians should be aware of the diagnostic features of marfan's syndrome.Scoliosis, dural ectasia, protrusio acetabuli, and acetabular protrusion are common musculoskeletal manifestations.Otto pelvis should be considered as one of the musculoskeletal manifestations of marfan syndrome.", "exact_answer": [["scoliosis"], ["dural ectasia"], ["pectus excavatum and carinatum"], ["arachnodactyly"], ["otto pelvis", "protrusio acetabuli"], ["dolichostenomelia"], ["ligamentous laxity"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008382", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009141"], "type": "list", "id": "532f0b2cd6d3ac6a3400002c", "snippets": [{"offsetInBeginSection": 220, "offsetInEndSection": 329, "text": "Musculoskeletal manifestations include scoliosis, dural ectasia, protrusio acetabuli, and ligamentous laxity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19726741", "endSection": "abstract"}, {"offsetInBeginSection": 460, "offsetInEndSection": 587, "text": "Scoliosis, pectus excavatum and carinatum, arachnodactyly, and acetabular protrusion are common musculoskeletal manifestations. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17620463", "endSection": "abstract"}, {"offsetInBeginSection": 135, "offsetInEndSection": 308, "text": "Two cases are described in which protrusio acetabuli was a major problem. Otto pelvis should be considered as one of the musculoskeletal manifestations of Marfan's syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6481730", "endSection": "abstract"}, {"offsetInBeginSection": 1415, "offsetInEndSection": 1594, "text": "The following musculoskeletal abnormalities were found: pectus in 3 patients (11%), pectus and scoliosis in 19 (73%), dolichostenomelia in 11 (42%) and arachnodactyly in 21 (80%). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21971724", "endSection": "abstract"}, {"offsetInBeginSection": 1815, "offsetInEndSection": 2179, "text": "Musculoskeletal clinicians should be aware of the diagnostic features of Marfan syndrome. Patients with three to four physically evident features, or two highly specific features (e.g., thumb and wrist signs, craniofacial features, dural ectasia, or protrusio), should be carefully reexamined and possibly referred for an echocardiogram or a genetics consultation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20686061", "endSection": "abstract"}]}, {"body": "What is the \"Proteomic ruler\"?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25225357"], "triples": [], "ideal_answer": "We show that the ms signal of histones can be used as a \"proteomic ruler\" because it is proportional to the amount of dna in the sample, which in turn depends on the number of cells.We show that the ms readout and allows estimation of the copy numbers of individual proteins per cell.A \"proteomic ruler approach adds an absolute scale to the ms readout and allows estimation without spike-in standards.As a result, our proteomic ruler approach adds an absolute scale to the MS readout and allows estimation of the copy numbers of individual proteins per cell.We show that the ms signal of histones can be used as a \"proteomic ruler\" for protein copy number and concentration estimation without spike-in standards.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020543", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D040901"], "type": "summary", "id": "54d7b457e19bba8909000004", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 100, "text": "A \"proteomic ruler\" for protein copy number and concentration estimation without spike-in standards. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25225357", "endSection": "title"}, {"offsetInBeginSection": 451, "offsetInEndSection": 791, "text": "We show that the MS signal of histones can be used as a \"proteomic ruler\" because it is proportional to the amount of DNA in the sample, which in turn depends on the number of cells. As a result, our proteomic ruler approach adds an absolute scale to the MS readout and allows estimation of the copy numbers of individual proteins per cell. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25225357", "endSection": "abstract"}]}, {"body": "What is the mechanism by which HIV-1-encoded Vif protein allows virus replication?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23707381", "http://www.ncbi.nlm.nih.gov/pubmed/23689841", "http://www.ncbi.nlm.nih.gov/pubmed/23316055", "http://www.ncbi.nlm.nih.gov/pubmed/22728817", "http://www.ncbi.nlm.nih.gov/pubmed/21725586", "http://www.ncbi.nlm.nih.gov/pubmed/20147392", "http://www.ncbi.nlm.nih.gov/pubmed/19887642", "http://www.ncbi.nlm.nih.gov/pubmed/24189052"], "triples": [], "ideal_answer": "A naturally occurring vif mutant ( i107t ) attenuates anti-apobec3g activity and hiv-1 protein vif, which contains distinct domains that specifically interact with these apobec3 proteins to ensure their proteasomal degradation, allowing virus replication to proceed abrogation of a3g function involves the hiv-1 vif protein, which binds a3g and serves as an adapter molecule to recruit a3g to a cullin5-based e3 ubiquitin ligase complex in addition, vif appears to be an active partner of the late steps of viral replication by participating in virus assembly and gag processing, thus regulating the final stage of virion formation notably genomic rna dimerization and by inhibiting the initiation of reverse transcription human apoplipoprotein b mrna-editing enzyme-catalytic polypeptide-like ( apobec ) 3g ( a3g ) is an antiviral protein that blocks hiv-1 replication.However, the antiviral activity of A3G is overcome by the HIV-1 protein Vif.A naturally occurring vif mutant ( i107t ) attenuates anti-apobec3g activity and hiv-1 replication hiv-1 counteracts apobec3 proteins by encoding the viral protein vif.Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif", "concepts": [], "type": "summary", "id": "54dfce9b1388e8454a00000b", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 76, "text": "Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20147392", "endSection": "title"}, {"offsetInBeginSection": 684, "offsetInEndSection": 798, "text": "These data suggest that polyubiquitination of APOBEC3G, not that of HIV-1 Vif, is crucial for APOBEC3G degradation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20147392", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23707381", "endSection": "title"}, {"offsetInBeginSection": 439, "offsetInEndSection": 589, "text": " Vif is thought to primarily overcome APOBEC3G through an interaction that mediates APOBEC3G ubiquitination and results in its proteasomal degradation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23316055", "endSection": "abstract"}, {"offsetInBeginSection": 591, "offsetInEndSection": 694, "text": "However, Vif may also inhibit APOBEC3G mRNA translation, virion encapsidation, and deamination activity ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23316055", "endSection": "abstract"}, {"offsetInBeginSection": 397, "offsetInEndSection": 632, "text": "HIV-1 counteracts APOBEC3 proteins by encoding the viral protein Vif, which contains distinct domains that specifically interact with these APOBEC3 proteins to ensure their proteasomal degradation, allowing virus replication to proceed ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24189052", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 199, "text": "The host protein APOBEC3G (A3G) can limit HIV-1 replication. Its protective effect is overcome by the HIV-1 'viral infectivity factor' (Vif), which targets A3G for proteosomal degradation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23689841", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 279, "text": "The human immunodeficiency virus type 1 (HIV-1) Vif protein counteracts the antiviral activity of the apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3) family of proteins by targeting the proteins for degradation through the ubiquitin-proteasome pathway ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23707381", "endSection": "abstract"}, {"offsetInBeginSection": 174, "offsetInEndSection": 470, "text": "Vif counteracts the packaging of two cellular cytidine deaminases named APOBEC3G (A3G) and A3F by diverse mechanisms including the recruitment of an E3 ubiquitin ligase complex and the proteasomal degradation of A3G/A3F, the inhibition of A3G mRNA translation or by a direct competition mechanism ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22728817", "endSection": "abstract"}, {"offsetInBeginSection": 472, "offsetInEndSection": 757, "text": "In addition, Vif appears to be an active partner of the late steps of viral replication by participating in virus assembly and Gag processing, thus regulating the final stage of virion formation notably genomic RNA dimerization and by inhibiting the initiation of reverse transcription ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22728817", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 311, "text": "Human apoplipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) 3G (A3G) is an antiviral protein that blocks HIV-1 replication. However, the antiviral activity of A3G is overcome by the HIV-1 protein Vif. This inhibitory function of Vif is related to its ability to degrade A3G in the proteasome ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21725586", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 412, "text": "During coevolution with the host, HIV-1 developed the ability to hijack the cellular ubiquitin/proteasome degradation pathway to counteract the antiviral activity of APOBEC3G (A3G), a host cytidine deaminase that can block HIV-1 replication. Abrogation of A3G function involves the HIV-1 Vif protein, which binds A3G and serves as an adapter molecule to recruit A3G to a Cullin5-based E3 ubiquitin ligase complex ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19887642", "endSection": "abstract"}]}, {"body": "Which proteins are the different isoforms of the p38 MAP kinase?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24107108", "http://www.ncbi.nlm.nih.gov/pubmed/22720195", "http://www.ncbi.nlm.nih.gov/pubmed/17855341", "http://www.ncbi.nlm.nih.gov/pubmed/17591882", "http://www.ncbi.nlm.nih.gov/pubmed/16022178", "http://www.ncbi.nlm.nih.gov/pubmed/9430721", "http://www.ncbi.nlm.nih.gov/pubmed/22175015", "http://www.ncbi.nlm.nih.gov/pubmed/18641461", "http://www.ncbi.nlm.nih.gov/pubmed/17241234", "http://www.ncbi.nlm.nih.gov/pubmed/23878395", "http://www.ncbi.nlm.nih.gov/pubmed/23722928", "http://www.ncbi.nlm.nih.gov/pubmed/19622861", "http://www.ncbi.nlm.nih.gov/pubmed/19251701", "http://www.ncbi.nlm.nih.gov/pubmed/18256287", "http://www.ncbi.nlm.nih.gov/pubmed/17088247", "http://www.ncbi.nlm.nih.gov/pubmed/14522818"], "triples": [], "ideal_answer": "The anomalous p38 inhibitor effect on il-1alpha induction is unclear.Involvement of the p38 isoforms p38 mapk isoforms are becoming increasingly important for a variety of cellular functions.We report the molecular cloning of a novel isoform of p38 map kinase isoforms and their differential uses by tnfalpha and il-1alpha in tm.We report the molecular cloning of a novel isoform of p38 delta suggests complex interactions between p38 map kinase, p38 beta 2. the p38 mitogen-activated protein ( map ) kinase, a serine kinase, is one of the best characterized kinases in the inflammatory process.Involvement of the p38 isoforms ( encoded by different genes ) to senescence induction is unclear.Involvement of the p38 inhibitor effect on il-1alpha induction of mmp-3 and phosphorylation of p38 delta suggests complex interactions between p38 map kinase isoforms and their differential uses by tnfalpha and il-1alpha in tm.The contribution of each of the four p38 mitogen-activated protein kinase alpha, beta, and gamma isoforms ( encoded by different genes ) to senescence induction is unclear.", "exact_answer": [["p38alpha", "p38\u03b1"], ["p38beta", "p38\u03b2"], ["p38gamma", "p38\u03b3"], ["p38delta", "p38\u03b4"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020033", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D048051", "http://www.uniprot.org/uniprot/CAPSD_CARMS", "http://www.uniprot.org/uniprot/NCAP_BDVV", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0004707"], "type": "list", "id": "5512c1ee6a8cde6b72000009", "snippets": [{"offsetInBeginSection": 275, "offsetInEndSection": 293, "text": "four p38 isoforms ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23878395", "endSection": "abstract"}, {"offsetInBeginSection": 154, "offsetInEndSection": 214, "text": " four identified p38 isoforms (p38\u03b1, p38\u03b2, p38\u03b3, and p38\u03b4), ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24107108", "endSection": "abstract"}, {"offsetInBeginSection": 267, "offsetInEndSection": 384, "text": "we showed here that p38alpha, beta, and gamma are expressed with distinct expression patterns during differentiation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18256287", "endSection": "abstract"}, {"offsetInBeginSection": 199, "offsetInEndSection": 317, "text": "p38alpha and -beta2 are ubiquitously expressed, whereas p38gamma and -delta appear to have more restricted expression. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14522818", "endSection": "abstract"}, {"offsetInBeginSection": 185, "offsetInEndSection": 266, "text": "We report the molecular cloning of a novel isoform of p38 MAP kinase, p38 beta 2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9430721", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "Involvement of the p38 mitogen-activated protein kinase alpha, beta, and gamma isoforms in myogenic differentiation. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18256287", "endSection": "title"}, {"offsetInBeginSection": 130, "offsetInEndSection": 257, "text": "Defining the roles of the various p38 family members, specifically p38alpha and p38beta, in these processes has been difficult. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17855341", "endSection": "abstract"}, {"offsetInBeginSection": 192, "offsetInEndSection": 340, "text": "Of the four p38 isoforms known to date, two (p38alpha and p38beta) have been identified as targets for cytokine-suppressive anti-inflammatory drugs. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19622861", "endSection": "abstract"}, {"offsetInBeginSection": 1352, "offsetInEndSection": 1497, "text": "Human and porcine TM cells expressed p38 alpha, beta, delta, and gamma isoforms, which migrate coincident with bands of specific phosphorylation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17591882", "endSection": "abstract"}, {"offsetInBeginSection": 144, "offsetInEndSection": 334, "text": "Among the four identified p38 isoforms (p38\u03b1, p38\u03b2, p38\u03b3, and p38\u03b4), the \u03b1-form is the most fully studied and plays a central role in the biosynthesis of the proinflammatory cytokines i ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24107108", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 204, "text": "The p38 family of kinases is a subgroup of the mitogen-activated protein kinase family. It is composed of four isoforms and is involved in critical biological processes as well as in inflammatory diseases ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17088247", "endSection": "abstract"}, {"offsetInBeginSection": 592, "offsetInEndSection": 772, "text": "Four p38 isoforms (p38alpha, p38beta, p38gamma and p38delta) exist in mammalian cells, being p38alpha and p38gamma the most abundantly expressed isoforms in adult skeletal muscle. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18641461", "endSection": "abstract"}, {"offsetInBeginSection": 279, "offsetInEndSection": 516, "text": "p38 MAPK isoforms are becoming increasingly important for a variety of cellular functions. The physiological functions of p38\u03b1 and -\u03b2 are now well documented in contrast to -\u03b3 and -\u03b4 which are comparatively under-studied and ill-defined. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23722928", "endSection": "abstract"}, {"offsetInBeginSection": 387, "offsetInEndSection": 646, "text": " the contribution of each of the four p38 isoforms (encoded by different genes) to senescence induction is unclear. In the current study, we demonstrated that p38alpha and p38gamma, but not p38beta, play an essential role in oncogenic ras-induced senescence. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19251701", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 212, "text": "The mammalian p38 mitogen-activated protein kinases (MAPKs) family is composed of four members (p38\u03b1, p38\u03b2, p38\u03b3, and p38\u03b4), which are very similar in amino acid sequence but differ in their expression patterns. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175015", "endSection": "abstract"}, {"offsetInBeginSection": 1841, "offsetInEndSection": 2070, "text": " The anomalous p38 inhibitor effect on IL-1alpha induction of MMP-3 and phosphorylation of p38 delta/gamma suggests complex interactions between p38 MAP kinase isoforms and their differential uses by TNFalpha and IL-1alpha in TM. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17591882", "endSection": "abstract"}, {"offsetInBeginSection": 359, "offsetInEndSection": 557, "text": "The p38 MAP kinase kinase MKK6 is identified as a common activator of p38 alpha, p38 beta 2, and p38 gamma MAP kinase isoforms, while MKK3 activates only p38 alpha and p38 gamma MAP kinase isoforms. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9430721", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 312, "text": "The p38 mitogen-activated protein kinases are activated in response to various extracellular signals in eukaryotic cells and play a critical role in the cellular responses to these signals. The four mammalian isoforms (p38alpha, p38beta, p38gamma, and p38delta) are coexpressed and coactivated in the same cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17241234", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 342, "text": "The mitogen-activated protein kinase (MAPK) p38 is a Ser/Thr kinase, originally isolated from lipopolysaccharide-stimulated monocytes. There are four isoforms of the enzyme (p38alpha, p38beta, p38gamma and p38delta), which differ in tissue distribution, regulation of kinase activation and subsequent phosphorylation of downstream substrates. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16022178", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 398, "text": "The p38 Mitogen-Activated Protein (MAP) kinase, a serine/threonine kinase, is one of the best characterized kinases in the inflammatory process. Among the four identified p38 isoforms (p38\u03b1, p38\u03b2, p38\u03b3, and p38\u03b4), the \u03b1-form is the most fully studied and plays a central role in the biosynthesis of the proinflammatory cytokines i.e. IL-1\u03b2 and TNF-\u03b1 at the translational and transcriptional levels. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24107108", "endSection": "abstract"}, {"offsetInBeginSection": 328, "offsetInEndSection": 692, "text": "The p38 mitogen-activated protein kinase (MAPK) is one of the kinase pathways that regulate the production of IL-1\u03b2 and TNF\u03b1. Importantly, small molecule inhibitors of the p38 MAPK family have been developed and show efficacy in blocking the production of IL-1\u03b2 and TNF\u03b1. The p38 family consists of at least four isoforms (p38\u03b1, \u03b2, \u03b3, \u03b4) encoded by separate genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22720195", "endSection": "abstract"}]}, {"body": "Are pseudogenes enriched with housekeeping protein families?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18957444"], "triples": [], "ideal_answer": "Housekeeping families tend to be enriched with a large number of pseudogenes", "exact_answer": "yes", "concepts": [], "type": "yesno", "id": "5709f212cf1c325851000020", "snippets": [{"offsetInBeginSection": 1370, "offsetInEndSection": 1446, "text": "housekeeping families tend to be enriched with a large number of pseudogenes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18957444", "endSection": "abstract"}]}, {"body": "What is the mechanism of cementogenesis in pulp regeneration?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23146645", "http://www.ncbi.nlm.nih.gov/pubmed/21854758", "http://www.ncbi.nlm.nih.gov/pubmed/21512722", "http://www.ncbi.nlm.nih.gov/pubmed/18636796"], "triples": [], "ideal_answer": "New vital tissues formed by df cells but little information is available about the regulation of df cell differentiation into either cementogenic or osteogenic cell lineages for the regeneration of diseased periodontal tissue.Hers cells played a role in the induction and maturation of cementum-like tissues can be regenerated in permanent canine teeth after pulpectomy and enlargement of the apical foramen therefore, regeneration of pulp is considered an ideal treatment to preserve teeth.", "concepts": [], "type": "summary", "id": "553ba7b7f321868558000006", "snippets": [{"offsetInBeginSection": 2015, "offsetInEndSection": 2139, "text": "Local modulation of Wnt/\u00df-catenin signaling has therapeutic potential to improve the regeneration of dentin and periodontium ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21854758", "endSection": "abstract"}, {"offsetInBeginSection": 969, "offsetInEndSection": 1062, "text": " implants of DF cells in the presence of pulp cells led to the formation of bone-like tissues ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21512722", "endSection": "abstract"}, {"offsetInBeginSection": 854, "offsetInEndSection": 955, "text": " HERS cells played a role in the induction and maturation of cementum-like tissues formed by DF cells ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21512722", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "Constitutive stabilization of \u00df-catenin in the dental mesenchyme leads to excessive dentin and cementum formation ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21854758", "endSection": "title"}, {"offsetInBeginSection": 1427, "offsetInEndSection": 1544, "text": "New vital tissues can be regenerated in permanent canine teeth after pulpectomy and enlargement of the apical foramen ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23146645", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "It is known that the dental follicle (DF) consists of progenitor cells that give rise to the cementum, periodontal ligament, and alveolar bone ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21512722", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 200, "text": "Wnt/\u00df-catenin signaling plays an important role in morphogenesis and cellular differentiation during development. Essential roles of Wnt/\u00df-catenin signaling in tooth morphogenesis have been well known ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21854758", "endSection": "abstract"}, {"offsetInBeginSection": 145, "offsetInEndSection": 298, "text": "Periodontal ligament (PDL) and cementum complex and dentin pulp complex have been tissue engineered using human dental pulp stem cells and PDL stem cells ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18636796", "endSection": "abstract"}, {"offsetInBeginSection": 14, "offsetInEndSection": 219, "text": "The loss of dental pulp may weaken teeth, rendering them susceptible to reinfection, fracture, and subsequent tooth loss. Therefore, regeneration of pulp is considered an ideal treatment to preserve teeth. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23146645", "endSection": "abstract"}, {"offsetInBeginSection": 778, "offsetInEndSection": 1048, "text": "Histological, immunohistochemical, and scanning electronic microscopy examinations results showed that bioengineered dentin could induce cementogenesis and PDL formation, and condense PDL arranged perpendicularly on the dentin surface via a layer of cementum-like tissue ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18636796", "endSection": "abstract"}, {"offsetInBeginSection": 1416, "offsetInEndSection": 1677, "text": "These results suggest that the combined use of DF, HERS, and pulp cells could direct DF cell differentiation into cementoblasts and/or osteoblasts in vivo, thus providing a novel strategy for the successful repair and regeneration of diseased periodontal tissue ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21512722", "endSection": "abstract"}, {"offsetInBeginSection": 143, "offsetInEndSection": 444, "text": " but little information is available about the regulation of DF cell differentiation into either cementogenic or osteogenic cell lineages for the regeneration of diseased periodontal tissue. Here, we investigated the roles of DF, Hertwig's epithelial root sheath (HERS), and pulp cells in the cementum ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21512722", "endSection": "abstract"}, {"offsetInBeginSection": 1064, "offsetInEndSection": 1414, "text": "Interestingly, in the presence of both HERS and pulp cells, DF cells formed both cementum-like and bone-like tissues. We demonstrated that while HERS cells are able to induce DF cell differentiation into cementoblasts and promote cementum formation, pulp cells could direct DF cell differentiation into osteoblasts and enhance alveolar bone formation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21512722", "endSection": "abstract"}, {"offsetInBeginSection": 1486, "offsetInEndSection": 2013, "text": "Our results indicate that persistent stabilization of \u00df-catenin in the dental mesenchyme leads to premature differentiation of odontoblasts and differentiation of cementoblasts, and induces excessive dentin and cementum formation in vivo. These results suggest that temporospatial regulation of Wnt/\u00df-catenin signaling plays critical roles in the differentiation of odontoblasts and cementoblasts, and that inhibition of Wnt/\u00df-catenin signaling may be important for the formation of dentin and cementum during tooth development ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21854758", "endSection": "abstract"}]}, {"body": "What are the reported adverse effects of gabapentin used in children?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23112238", "http://www.ncbi.nlm.nih.gov/pubmed/22134010", "http://www.ncbi.nlm.nih.gov/pubmed/19193587", "http://www.ncbi.nlm.nih.gov/pubmed/16490100", "http://www.ncbi.nlm.nih.gov/pubmed/15072101", "http://www.ncbi.nlm.nih.gov/pubmed/12199723", "http://www.ncbi.nlm.nih.gov/pubmed/12022084", "http://www.ncbi.nlm.nih.gov/pubmed/11361047", "http://www.ncbi.nlm.nih.gov/pubmed/11305405", "http://www.ncbi.nlm.nih.gov/pubmed/11274308", "http://www.ncbi.nlm.nih.gov/pubmed/10030434", "http://www.ncbi.nlm.nih.gov/pubmed/9120226", "http://www.ncbi.nlm.nih.gov/pubmed/8648543", "http://www.ncbi.nlm.nih.gov/pubmed/8617181", "http://www.ncbi.nlm.nih.gov/pubmed/8603631", "http://www.ncbi.nlm.nih.gov/pubmed/7489697"], "ideal_answer": "Adverse effects warranted discontinuation of the medication in only three patients.Only 8 children, adults and the elderly a postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash in 0.4 % of 3000 patients.Adverse effects, and the drug was discontinued in two.To determine the effectiveness of gabapentin as an add-on therapy in children ( 7 % ) reported adverse effects, and the drug was discontinued in two.We reviewed the reports in the literature on the safety, adverse effects were noted in 6 children, adults and the elderly a postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash in 0.4 % of 3000 patients.Behavioural adverse effects were noted in 6 children.We reviewed the reports in the literature on the safety, adverse effects and tolerance of gbp as treatment, used as monotherapy or associated with other drugs, in epilepsies in patients of all age groups, including children.", "exact_answer": [["Skin reactions"], ["Somnolence", "drowsiness", "sedation", "lassitude"], ["Dizziness"], ["hyperactivity"], ["defiance"], ["irritability"], ["agitation"], ["aggression"], ["explosive outbursts"], ["oppositional behavior"], ["malaise"]], "concepts": ["http://www.biosemantics.org/jochem#4258191", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002648", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004362"], "type": "list", "id": "515db70c298dcd4e51000017", "snippets": [{"offsetInBeginSection": 839, "offsetInEndSection": 880, "text": "Adverse effects were noted in 6 children. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23112238", "endSection": "sections.0"}, {"offsetInBeginSection": 206, "offsetInEndSection": 277, "text": "The charts of all children given gabapentin for seizures were reviewed. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15072101", "endSection": "sections.0"}, {"offsetInBeginSection": 880, "offsetInEndSection": 948, "text": "The cohort comprised 3,100 patients, of whom 136 (4%) were children. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12199723", "endSection": "sections.0"}, {"offsetInBeginSection": 906, "offsetInEndSection": 990, "text": "Only 8 children (7%) reported adverse effects, and the drug was discontinued in two. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15072101", "endSection": "sections.0"}, {"offsetInBeginSection": 655, "offsetInEndSection": 739, "text": "Thirteen patients (5%) withdrew during the 6-month period because of adverse events. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11305405", "endSection": "sections.0"}, {"offsetInBeginSection": 612, "offsetInEndSection": 689, "text": "Single doses of gabapentin were well tolerated by healthy pediatric subjects. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11361047", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 97, "text": "A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12199723", "endSection": "title"}, {"offsetInBeginSection": 651, "offsetInEndSection": 741, "text": "Data were analyzed in 30 patients as treatment was terminated in 1 due to adverse effects. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22134010", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 129, "text": "To determine the effectiveness of gabapentin as an add-on therapy in children presenting with overactive bladder (OAB) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22134010", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "Efficacy and safety of gabapentin monotherapy were evaluated in 33 children with newly diagnosed absence epilepsy ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9120226", "endSection": "sections.0"}, {"offsetInBeginSection": 156, "offsetInEndSection": 288, "text": "he purpose of our study was to review our experience with using gabapentin to treat insomnia in children. We identified 23 children, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23112238", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 159, "text": "To describe a child who developed a skin reaction during gabapentin therapy and discuss how we evaluated the probability of an adverse drug reaction ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19193587", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 147, "text": "Thirty-two children with refractory partial epilepsy received open-label gabapentin as an additional medication to their antiepileptic drug regimen ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8648543", "endSection": "sections.0"}, {"offsetInBeginSection": 1495, "offsetInEndSection": 1667, "text": "Neurologic-related events were the most frequently reported adverse events. They also were the commonest reasons for discontinuing treatment and reported as suspected ADRs. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12199723", "endSection": "sections.0"}, {"offsetInBeginSection": 614, "offsetInEndSection": 738, "text": "We noticed a rapid improvement, in 1 week, of our patients' VAS scores (from 9 or 10 to 4 or 3) with minimal adverse effects ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16490100", "endSection": "sections.0"}, {"offsetInBeginSection": 285, "offsetInEndSection": 425, "text": "Five patients treated in the Children's Hospital Pain Control Service for intractable neuropathic pain were included in gabapentin treatment ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16490100", "endSection": "sections.0"}, {"offsetInBeginSection": 1307, "offsetInEndSection": 1473, "text": "Gabapentin gives moderate results in children with OAB refractory to conventional anticholinergics. In general, the drug is well tolerated with fewer adverse effects. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22134010", "endSection": "sections.0"}, {"offsetInBeginSection": 757, "offsetInEndSection": 950, "text": "The major reported side effects were behavioral. These consisted of hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation with attention deficit. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8648543", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 161, "text": "The efficacy and safety of gabapentin as add-on therapy for refractory partial seizures in 237 children, aged 3 to 12 years were evaluated over a 6-month period. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11305405", "endSection": "sections.0"}, {"offsetInBeginSection": 457, "offsetInEndSection": 626, "text": "Male or female patients, at least 12 years old, with a recent history of partial seizures with or without secondary generalization, were randomized to receive gabapentin ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11274308", "endSection": "sections.0"}, {"offsetInBeginSection": 1527, "offsetInEndSection": 1703, "text": "However, children with intellectual disability who also are less than 10 years of age with baseline attention deficit appear to be at a higher risk of behavioural side-effects. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10030434", "endSection": "sections.0"}, {"offsetInBeginSection": 712, "offsetInEndSection": 928, "text": "Somnolence and dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important changes in laboratory assessments or other safety parameters were observed. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9120226", "endSection": "sections.0"}, {"offsetInBeginSection": 144, "offsetInEndSection": 391, "text": "We reviewed the reports in the literature on the safety, adverse effects and tolerance of GBP as treatment, used as monotherapy or associated with other drugs, in epilepsies in patients of all age groups, including children, adults and the elderly ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12022084", "endSection": "sections.0"}, {"offsetInBeginSection": 998, "offsetInEndSection": 1252, "text": "The most frequently reported adverse events reported during the first month of treatment, drowsiness/sedation, dizziness, and malaise/lassitude, also were the commonest reasons for discontinuing GBP and reported as suspected adverse drug reactions (ADRs) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12199723", "endSection": "sections.0"}, {"offsetInBeginSection": 829, "offsetInEndSection": 1049, "text": "GBP is a drug which is free of unwanted side effects. Its safety and tolerability profile is excellent for treatment of simple and complex partial crises, with or without generalization in epileptic patients of all ages. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12022084", "endSection": "sections.0"}, {"offsetInBeginSection": 1045, "offsetInEndSection": 1256, "text": "Of the four most common adverse events (somnolence, dizziness, ataxia, fatigue), only one, dizziness, occurred more often in the nontitrated (Rapid initiation) group than in the titrated (Slow initiation) group. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11274308", "endSection": "sections.0"}, {"offsetInBeginSection": 168, "offsetInEndSection": 378, "text": "Two studies were conducted to determine the single-dose pharmacokinetics of gabapentin in healthy subjects age 1 month to 12 years and to guide dose selection in safety and efficacy trials in pediatric patients ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11361047", "endSection": "sections.0"}, {"offsetInBeginSection": 1227, "offsetInEndSection": 1514, "text": "This case, and limited literature data, suggest that gabapentin may cause rash that is severe enough to necessitate discontinuation in a small percentage of children. Further research is needed to determine the actual incidence and severity of gabapentin-related rash in this population. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19193587", "endSection": "sections.0"}, {"offsetInBeginSection": 176, "offsetInEndSection": 454, "text": "We report 2 children who received GBP for intractable seizures and who developed intolerable aggressive behavior requiring dose reduction or drug discontinuation. Behavioral changes should be recognized as a possible side effect of GBP, especially in mentally retarded children. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8617181", "endSection": "sections.0"}, {"offsetInBeginSection": 437, "offsetInEndSection": 815, "text": "GBP is a well tolerated drug when used for monotherapy or associated with other antiepileptic drugs. The commonest adverse effects seen were somnolence, fainting, ataxia, nystagmus, tremor and headache. However, their incidence was low and intensity mild. There was no clear relationship between the dose given and appearance of side effects, except for fainting and somnolence. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12022084", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 276, "text": "Twenty-six children with intellectual disability and six normal children, all suffering from refractory partial seizures, received open-label gabapentin (range = 10-50 mg kg(-1) day(-1); mean = 26.7 mg kg(-1) day(-1) as an add-on medication to their antiepileptic drug regimen ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10030434", "endSection": "sections.0"}, {"offsetInBeginSection": 725, "offsetInEndSection": 1093, "text": "In contrast to other antiepileptic drugs, skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash in 0.4% of 3000 patients. The product monograph does not mention rash in children. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19193587", "endSection": "sections.0"}, {"offsetInBeginSection": 88, "offsetInEndSection": 511, "text": "We described 3 learning disabled children, 1 aged 7 and 2 aged 10 years, with intractable partial seizures who developed severe behavioral problems while receiving modest doses of GBP. The children became hyperactive and had explosive outburst consisting of aggressive and oppositional behavior. The behavioral problems were sufficiently severe to require discontinuation of GBP despite moderately improved seizure control. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7489697", "endSection": "sections.0"}, {"offsetInBeginSection": 768, "offsetInEndSection": 1371, "text": "In the present patient population, patients younger than 10 years of age, all of whom had intellectual disability, were more likely to have side-effects than those older than 10 years of age. Observed adverse effects, which were generally mild, occurred in patients with baseline intellectual disability, attention deficit disorder and behavioural problems. Behavioural adverse effects warranted discontinuation of the medication in only three patients. The severity of intellectual disability (mild versus moderate or severe) did not affect the extent of the response or the occurrence of side-effects. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10030434", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 564, "text": "We report 7 children who received gabapentin (GBP) as adjunctive medic ation and subsequently developed behavioral side effects. These behavioral changes consisted of intensification of baseline behaviors as well as new behavioral problems. Behaviors that parents considered most troublesome were tantrums, aggression directed toward others, hyperactivity, and defiance. All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention deficit hyperactivity disorder and developmental delays. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8603631", "endSection": "sections.0"}]}, {"body": "What is the effect of ranolazine in diastolic heart failure?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21538388", "http://www.ncbi.nlm.nih.gov/pubmed/22767404", "http://www.ncbi.nlm.nih.gov/pubmed/22343711", "http://www.ncbi.nlm.nih.gov/pubmed/19403851", "http://www.ncbi.nlm.nih.gov/pubmed/19333133", "http://www.ncbi.nlm.nih.gov/pubmed/23596505", "http://www.ncbi.nlm.nih.gov/pubmed/18439620", "http://www.ncbi.nlm.nih.gov/pubmed/17027025", "http://www.ncbi.nlm.nih.gov/pubmed/7873471", "http://www.ncbi.nlm.nih.gov/pubmed/19752362", "http://www.ncbi.nlm.nih.gov/pubmed/20924097", "http://www.ncbi.nlm.nih.gov/pubmed/24251065", "http://www.ncbi.nlm.nih.gov/pubmed/22465693"], "triples": [], "ideal_answer": "Ranolazine, probably resulting from a direct effect on myofilaments, indicating that cardiac oxidative stress may mediate diastolic dysfunction through altering the contractile apparatus.Data from in vitro and animal studies indicate that ranolazine is an innovative anti-ischemic and antianginal agent that inhibits the late na current, thereby reducing the na-dependent ca-overload, which improves diastolic tone and oxygen handling during myocardial ischemia.Diastolic dysfunction could be reversed by ranolazine ( 10 microm ) significantly reduced the pc-induced increase in lvedp by 72 + 6 % ( n = 6, p < 0.001 ), reduced left ventricular wall stiffness, and attenuated the pc-induced increase of cpp by 53 + 10 % ( n = 6-7, p < 0.05 ).New clinical and experimental studies even point to potential antiarrhythmic effects, beneficial effects in diastolic function by inhibiting the late sodium current.In addition, ranolazine seems to exert beneficial effects on diastolic cardiac function.In addition, ranolazine seems to exert beneficial effects on diastolic heart failure, and under hyperglycemic conditions.Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054144", "http://www.biosemantics.org/jochem#4202863"], "type": "summary", "id": "532f05a5d6d3ac6a34000025", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 103, "text": "Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22343711", "endSection": "title"}, {"offsetInBeginSection": 253, "offsetInEndSection": 383, "text": "Data from in vitro and animal studies indicate that ranolazine improves diastolic function by inhibiting the late sodium current. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21538388", "endSection": "abstract"}, {"offsetInBeginSection": 1120, "offsetInEndSection": 1288, "text": "New clinical and experimental studies even point to potential antiarrhythmic effects, beneficial effects in diastolic heart failure, and under hyperglycemic conditions. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19333133", "endSection": "abstract"}, {"offsetInBeginSection": 685, "offsetInEndSection": 804, "text": " Ranolazine, a specific inhibitor of late INa, reduces Na influx and hence ameliorates disturbed Na and Ca homeostasis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19333133", "endSection": "abstract"}, {"offsetInBeginSection": 1569, "offsetInEndSection": 1799, "text": "Diastolic dysfunction could be reversed by ranolazine, probably resulting from a direct effect on myofilaments, indicating that cardiac oxidative stress may mediate diastolic dysfunction through altering the contractile apparatus. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22343711", "endSection": "abstract"}, {"offsetInBeginSection": 71, "offsetInEndSection": 384, "text": "Ranolazine is an innovative anti-ischemic and antianginal agent that inhibits the late Na current, thereby reducing the Na-dependent Ca-overload, which improves diastolic tone and oxygen handling during myocardial ischemia. In addition, ranolazine seems to exert beneficial effects on diastolic cardiac function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22767404", "endSection": "abstract"}, {"offsetInBeginSection": 748, "offsetInEndSection": 981, "text": "Ranolazine (10 microM) significantly reduced the PC-induced increase in LVEDP by 72 +/- 6% (n = 6, p < 0.001), reduced left ventricular wall stiffness, and attenuated the PC-induced increase of CPP by 53 +/- 10% (n = 6-7, p < 0.05). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19403851", "endSection": "abstract"}]}, {"body": "Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24185383", "http://www.ncbi.nlm.nih.gov/pubmed/23927758", "http://www.ncbi.nlm.nih.gov/pubmed/23679284", "http://www.ncbi.nlm.nih.gov/pubmed/21211276", "http://www.ncbi.nlm.nih.gov/pubmed/19955917", "http://www.ncbi.nlm.nih.gov/pubmed/19901115", "http://www.ncbi.nlm.nih.gov/pubmed/19469626", "http://www.ncbi.nlm.nih.gov/pubmed/18463961", "http://www.ncbi.nlm.nih.gov/pubmed/18336401", "http://www.ncbi.nlm.nih.gov/pubmed/17938703", "http://www.ncbi.nlm.nih.gov/pubmed/16343176", "http://www.ncbi.nlm.nih.gov/pubmed/12449041", "http://www.ncbi.nlm.nih.gov/pubmed/12448655", "http://www.ncbi.nlm.nih.gov/pubmed/10964992", "http://www.ncbi.nlm.nih.gov/pubmed/16804928", "http://www.ncbi.nlm.nih.gov/pubmed/17966166", "http://www.ncbi.nlm.nih.gov/pubmed/16360545", "http://www.ncbi.nlm.nih.gov/pubmed/15839957", "http://www.ncbi.nlm.nih.gov/pubmed/22468744"], "triples": [], "ideal_answer": "Pertuzumab may add activity to gemcitabine for the treatment of platinum-resistant ovarian cancer to evaluate the efficacy and toxicities of gemcitabine combined with ifosfamide and anthracycline chemotherapy for recurrent platinum resistant ovarian epithelial cancer.The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant epithelial ovarian cancer patients.Pertuzumab may add activity to gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients.Pertuzumab may add activity to gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant ovarian cancer.A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer with response rates ranging from 11 % to 22 % in monotherapy in resistant or platinum refractory diseases, gemcitabine has quickly been shown to be an active agent in the treatment of patients with refractory recurrent ovarian cancer salvage therapy of gemcitabine plus endostar significantly improves progression-free survival ( pfs ) with platinum-resistant recurrent epithelial ovarian cancer.", "concepts": ["http://www.biosemantics.org/jochem#4260819", "http://www.biosemantics.org/jochem#4202605", "http://www.disease-ontology.org/api/metadata/DOID:2394"], "type": "summary", "id": "553c8fd1f32186855800000a", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 177, "text": "The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24185383", "endSection": "title"}, {"offsetInBeginSection": 1653, "offsetInEndSection": 1850, "text": "Gemcitabine combined with platinum chemotherapy appears to be an effective and well-tolerant treatment for recurrent epithelial ovarian cancer, including platinum-resistant or -refractory diseases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17966166", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19901115", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 127, "text": "[Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer]. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21211276", "endSection": "title"}, {"offsetInBeginSection": 1687, "offsetInEndSection": 1784, "text": "Pertuzumab may add activity to gemcitabine for the treatment of platinum-resistant ovarian cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19901115", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 101, "text": "Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23927758", "endSection": "title"}, {"offsetInBeginSection": 1604, "offsetInEndSection": 1729, "text": " the combination of gemcitabine and carboplatin is now approved for patients with platinum-sensitive recurrent ovarian cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19955917", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancer. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19469626", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "Salvage therapy of gemcitabine plus endostar significantly improves progression-free survival (PFS) with platinum-resistant recurrent epithelial ovarian cancer. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23679284", "endSection": "title"}, {"offsetInBeginSection": 147, "offsetInEndSection": 296, "text": " Gemcitabine and prolonged oral etoposide have shown reproducible single-agent activity in patients with platinum/paclitaxel-resistant ovarian cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12448655", "endSection": "abstract"}, {"offsetInBeginSection": 1535, "offsetInEndSection": 1749, "text": "Gemcitabine and carboplatin demonstrate moderate toxicity with similar efficacy in both platinum-sensitive and platinum-resistant epithelial ovarian cancer, suggesting reversal of platinum resistance by gemcitabine ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24185383", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 125, "text": "Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21211276", "endSection": "title"}, {"offsetInBeginSection": 12, "offsetInEndSection": 169, "text": "Both gemcitabine and pegylated liposomal doxorubicin (PLD) are antineoplastic drugs with clinical activity in patients with platinum-resistant ovarian cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18463961", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 176, "text": "The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24185383", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 190, "text": "The regimen of gemcitabine combined with ifosfamide and anthracycline is feasible, tolerable and effective in patients with recurrent platinum resistant/refractory epithelial ovarian cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21211276", "endSection": "abstract"}, {"offsetInBeginSection": 1506, "offsetInEndSection": 1722, "text": "Gemcitabine and carboplatin demonstrate moderate toxicity with similar efficacy in both platinum-sensitive and platinum-resistant epithelial ovarian cancer, suggesting reversal of platinum resistance by gemcitabine. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24185383", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 170, "text": "To evaluate the efficacy and toxicities of gemcitabine combined with ifosfamide and anthracycline chemotherapy for recurrent platinum resistant ovarian epithelial cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21211276", "endSection": "abstract"}, {"offsetInBeginSection": 1031, "offsetInEndSection": 1199, "text": "Gemcitabine plus endostar significantly improved the prognosis in patients with platinum-resistant recurrent ovarian cancer, especially in those with malignant effusion ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23679284", "endSection": "abstract"}, {"offsetInBeginSection": 2157, "offsetInEndSection": 2327, "text": "the combination of carboplatin and gemcitabine resulted in significantly higher response rates and improved progression-free survival when compared with carboplatin alone ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17938703", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 169, "text": "A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18463961", "endSection": "title"}, {"offsetInBeginSection": 106, "offsetInEndSection": 274, "text": "Gemcitabine is a novel agent that has shown consistent activity as a single agent in the treatment of platinum-resistant ovarian cancer and a favorable toxicity profile ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16343176", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 159, "text": "Salvage therapy of gemcitabine plus endostar significantly improves progression-free survival (PFS) with platinum-resistant recurrent epithelial ovarian cancer ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23679284", "endSection": "title"}, {"offsetInBeginSection": 1069, "offsetInEndSection": 1258, "text": "The regimen of gemcitabine combined with ifosfamide and anthracycline is feasible, tolerable and effective in patients with recurrent platinum resistant/refractory epithelial ovarian cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21211276", "endSection": "abstract"}, {"offsetInBeginSection": 1691, "offsetInEndSection": 1887, "text": "Gemcitabine combined with platinum chemotherapy appears to be an effective and well-tolerant treatment for recurrent epithelial ovarian cancer, including platinum-resistant or -refractory diseases ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17966166", "endSection": "abstract"}, {"offsetInBeginSection": 276, "offsetInEndSection": 493, "text": "Because of its clinical and preclinical synergism with platinum analogs, gemcitabine has been combined with carboplatin as a convincing approach in the treatment of platinum-sensitive recurrent ovarian cancer patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16343176", "endSection": "abstract"}, {"offsetInBeginSection": 1371, "offsetInEndSection": 1553, "text": "The combination of gemcitabine and PLD is an effective and tolerable treatment option, with 74.3 % disease control rate for patients with platinum resistant/refractory ovarian cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19469626", "endSection": "abstract"}, {"offsetInBeginSection": 1057, "offsetInEndSection": 1259, "text": "CONCLUSION: The regimen of gemcitabine combined with ifosfamide and anthracycline is feasible, tolerable and effective in patients with recurrent platinum resistant/refractory epithelial ovarian cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21211276", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 185, "text": "Gemcitabine combined with oxaliplatin (GEMOX) as salvage treatment in elderly patients with advanced ovarian cancer refractory or resistant to platinum: a single institution experience. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18073158", "endSection": "title"}, {"offsetInBeginSection": 732, "offsetInEndSection": 899, "text": "Though the endostar cohort also improved median OS by 2.1 months, there was no statistically significant difference compared with gemcitabine alone cohort in this case ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23679284", "endSection": "abstract"}, {"offsetInBeginSection": 1319, "offsetInEndSection": 1521, "text": "A biweekly schedule of gemcitabine combined with PLD is an active and safe chemotherapy regimen with acceptable and easily manageable toxicities in women with recurrent platinum-resistant ovarian cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18463961", "endSection": "abstract"}, {"offsetInBeginSection": 1542, "offsetInEndSection": 1764, "text": "GEMOX showed encouraging activity and manageable toxicity. Under circumstances requiring a rapid disease control, this combination regimen may offer a particularly viable option, particularly in heavily pretreated patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23927758", "endSection": "abstract"}, {"offsetInBeginSection": 211, "offsetInEndSection": 553, "text": "Gemcitabine is a new antimetabolite selected for clinical trials based on its activity in preclinical studies. With response rates ranging from 11% to 22% in monotherapy in resistant or platinum refractory diseases, gemcitabine has quickly been shown to be an active agent in the treatment of patients with refractory recurrent ovarian cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12449041", "endSection": "abstract"}]}, {"body": "Is olaparib effective for prostate cancer?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26510020", "http://www.ncbi.nlm.nih.gov/pubmed/25616434", "http://www.ncbi.nlm.nih.gov/pubmed/25583815", "http://www.ncbi.nlm.nih.gov/pubmed/25366685", "http://www.ncbi.nlm.nih.gov/pubmed/24789362", "http://www.ncbi.nlm.nih.gov/pubmed/24225019", "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "http://www.ncbi.nlm.nih.gov/pubmed/23847380"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0106149", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0090893", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0106148", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0091054", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0290426", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0290427", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0290428", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0290425", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A7786660", "o": "D011471"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A0667486", "o": "D011471"}], "ideal_answer": "We hypothesized that metastatic, castration-resistant prostate cancer cells to saha and olaparib.We hypothesized that metastatic, castration-resistant prostate cancers.We hypothesized that metastatic prostate cancer.The specificity of the biomarker suite was 94 %.Silencing rad51 sensitized prostate cancers with dna-repair defects would respond to poly ( adenosine diphosphate [ adp ] -ribose ) polymerase ( parp ) inhibition with olaparib alone.A phase ii study of the parp inhibitor olaparib ( astrazeneca ) for cancer patients with inherited brca1 and brca2 gene mutations confirmed earlier results showing clinical benefit for advanced breast and ovarian cancers, and demonstrated evidence of effectiveness against pancreatic and prostate cancers.Dna-repair defects and olaparib in metastatic prostate cancer is a heterogeneous disease, but current treatments are not based on molecular stratification.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011471", "http://www.disease-ontology.org/api/metadata/DOID:10283", "http://www.disease-ontology.org/api/metadata/DOID:10286"], "type": "yesno", "id": "56c1f01eef6e394741000046", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 62, "text": "DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "title"}, {"offsetInBeginSection": 512, "offsetInEndSection": 704, "text": "Olaparib, one of the most studied PARPis, has demonstrated activity in BRCA1/2(MUT+) and BRCA-like sporadic ovarian and breast cancers, and looks promising in prostate and pancreatic cancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24225019", "endSection": "abstract"}, {"offsetInBeginSection": 305, "offsetInEndSection": 501, "text": "We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 2035, "offsetInEndSection": 2243, "text": "CONCLUSIONS: Treatment with the PARP inhibitor olaparib in patients whose prostate cancers were no longer responding to standard treatments and who had defects in DNA-repair genes led to a high response rate. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 552, "offsetInEndSection": 829, "text": "Prostate cancer cells cotreated with the HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index<0.9), whereas normal prostatic cells did not. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 236, "text": "In a phase II study, researchers found that the PARP inhibitor olaparib led to stable disease or tumor regressions in patients with advanced breast, ovarian, pancreatic, and prostate cancers who had germline mutations in BRCA1 or BRCA2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25583815", "endSection": "abstract"}, {"offsetInBeginSection": 815, "offsetInEndSection": 1093, "text": "Prostate cancer cells cotreated with the HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index < 0.9), whereas normal prostatic cells did not. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "endSection": "abstract"}, {"offsetInBeginSection": 1398, "offsetInEndSection": 1646, "text": "Silencing RAD51 sensitized prostate cancer cells to SAHA and olaparib alone. Collectively, cotreatment with HDACi and PARPi downregulated HR-related protein expression and concomitantly increased DNA damage, resulting in prostate cancer cell death. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 307, "text": "Prostate cancer is a heterogeneous disease, but current treatments are not based on molecular stratification. We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 303, "text": "A phase II study of the PARP inhibitor olaparib (AstraZeneca) for cancer patients with inherited BRCA1 and BRCA2 gene mutations confirmed earlier results showing clinical benefit for advanced breast and ovarian cancers, and demonstrated evidence of effectiveness against pancreatic and prostate cancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23847380", "endSection": "abstract"}, {"offsetInBeginSection": 512, "offsetInEndSection": 768, "text": "In addition, phase III trials in breast, gastric and pancreatic cancer are underway/planned, and phase I/II investigation is being conducted in other malignancies, including prostate cancer, non-small cell lung cancer, Ewing's sarcoma and advanced cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25616434", "endSection": "abstract"}, {"offsetInBeginSection": 383, "offsetInEndSection": 647, "text": "Eligibility included ovarian cancer resistant to prior platinum; breast cancer with \u2265 three chemotherapy regimens for metastatic disease; pancreatic cancer with prior gemcitabine treatment; or prostate cancer with progression on hormonal and one systemic therapy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25366685", "endSection": "abstract"}, {"offsetInBeginSection": 511, "offsetInEndSection": 768, "text": " In addition, phase III trials in breast, gastric and pancreatic cancer are underway/planned, and phase I/II investigation is being conducted in other malignancies, including prostate cancer, non-small cell lung cancer, Ewing's sarcoma and advanced cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25616434", "endSection": "abstract"}, {"offsetInBeginSection": 541, "offsetInEndSection": 822, "text": "Prostate cancer cells cotreated with the HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index &lt; 0.9), whereas normal prostatic cells did not. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25127709", "endSection": "abstract"}, {"offsetInBeginSection": 122, "offsetInEndSection": 496, "text": "We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib.METHODS: We conducted a phase 2 trial in which patients with metastatic, castration-resistant prostate cancer were treated with olaparib tablets at a dose of 400 mg twice a day. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 496, "text": "BACKGROUND: Prostate cancer is a heterogeneous disease, but current treatments are not based on molecular stratification. We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib.METHODS: We conducted a phase 2 trial in which patients with metastatic, castration-resistant prostate cancer were treated with olaparib tablets at a dose of 400 mg twice a day. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 1809, "offsetInEndSection": 2244, "text": "The specificity of the biomarker suite was 94%. Anemia (in 10 of the 50 patients [20%]) and fatigue (in 6 [12%]) were the most common grade 3 or 4 adverse events, findings that are consistent with previous studies of olaparib.CONCLUSIONS: Treatment with the PARP inhibitor olaparib in patients whose prostate cancers were no longer responding to standard treatments and who had defects in DNA-repair genes led to a high response rate. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26510020", "endSection": "abstract"}, {"offsetInBeginSection": 698, "offsetInEndSection": 1301, "text": "It is increasingly clear that there are molecularly distinct subtypes of various common cancers, with different therapeutic approaches required for each subtype, for example, the use of the monoclonal antibodies (trastuzumab and cetuximab) in HER2-positive breast cancer and wild-type KRAS colorectal cancer; tyrosine kinase inhibitors (imatinib, gefitinib, erlotinib and crizotinib) in chronic myeloid leukaemia, gastrointestinal stromal tumours and non-small-cell lung cancer and intracellular agents (vemurafenib and olaparib) in metastatic malignant melanoma and ovarian, breast and prostate cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789362", "endSection": "abstract"}, {"offsetInBeginSection": 825, "offsetInEndSection": 1427, "text": "The tumor response rate was 26.2% (78 of 298; 95% CI, 21.3 to 31.6) overall and 31.1% (60 of 193; 95% CI, 24.6 to 38.1), 12.9% (eight of 62; 95% CI, 5.7 to 23.9), 21.7% (five of 23; 95% CI, 7.5 to 43.7), and 50.0% (four of eight; 95% CI, 15.7 to 84.3) in ovarian, breast, pancreatic, and prostate cancers, respectively. Stable disease \u2265 8 weeks was observed in 42% of patients (95% CI, 36.0 to 47.4), including 40% (95% CI, 33.4 to 47.7), 47% (95% CI, 34.0 to 59.9), 35% (95% CI, 16.4 to 57.3), and 25% (95% CI, 3.2 to 65.1) of those with ovarian, breast, pancreatic, or prostate cancer, respectively. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25366685", "endSection": "abstract"}]}, {"body": "How does Foxa transcription factor exhibits its pioneering function?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25436603", "http://www.ncbi.nlm.nih.gov/pubmed/21935353", "http://www.ncbi.nlm.nih.gov/pubmed/21502411", "http://www.ncbi.nlm.nih.gov/pubmed/20591647", "http://www.ncbi.nlm.nih.gov/pubmed/21404180", "http://www.ncbi.nlm.nih.gov/pubmed/19339686", "http://www.ncbi.nlm.nih.gov/pubmed/16909212", "http://www.ncbi.nlm.nih.gov/pubmed/22406422"], "triples": [], "ideal_answer": "The Fox DNA-binding domain structurally resembles linker histone and binds nucleosomes stably fOXO proteins represent a hybrid subclass having dual roles as pioneering factors and transcription factors.Insight into the unique molecular basis of foxa function has been obtained from recent genetic and genomic data, which identify the foxa proteins as 'pioneer factors' whose binding to promoters and enhancers enable chromatin access for other tissue-specific transcription factors.Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA in addition, EBNA1 and FoxA, when associated with mitotic chromatin may \"bookmark\" active genes and ensure their reactivation in postmitotic cells ( epigenetic memory ) we found one such target site at a cryptic \"shadow\" enhancer 7 kilobases ( kb ) downstream of the Cdx2 gene, where Rfx1 restricts transcriptional activation by FoxA about one-third of the FoxA bound sites are near silent genes, including genes without detectable RNA polymerase II.", "concepts": [], "type": "summary", "id": "57092f9bcf1c32585100001b", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 118, "text": "Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19339686", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 117, "text": "Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19339686", "endSection": "title"}, {"offsetInBeginSection": 132, "offsetInEndSection": 225, "text": "The Fox DNA-binding domain structurally resembles linker histone and binds nucleosomes stably ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19339686", "endSection": "abstract"}, {"offsetInBeginSection": 538, "offsetInEndSection": 650, "text": "Both EBNA1 and FoxA induce local DNA demethylation, nucleosome destabilization and bind to mitotic chromosomes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25436603", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 125, "text": "Nuclear mobility and mitotic chromosome binding: similarities between pioneer transcription factor FoxA and linker histone H1 ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21502411", "endSection": "title"}, {"offsetInBeginSection": 269, "offsetInEndSection": 385, "text": "about one-third of the FoxA bound sites are near silent genes, including genes without detectable RNA polymerase II. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21935353", "endSection": "abstract"}, {"offsetInBeginSection": 364, "offsetInEndSection": 537, "text": "In this overview we focus, however, on the epigenetic alterations elicited by EBNA1 by drawing a parallel between EBNA1 and the FoxA family of pioneer transcription factors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25436603", "endSection": "abstract"}, {"offsetInBeginSection": 215, "offsetInEndSection": 420, "text": "These discoveries followed the establishment of the conceptional framework of the mechanism of action of the FoxA proteins as 'pioneer factors' that can engage chromatin before other transcription factors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20591647", "endSection": "abstract"}, {"offsetInBeginSection": 740, "offsetInEndSection": 906, "text": "In addition, EBNA1 and FoxA, when associated with mitotic chromatin may \"bookmark\" active genes and ensure their reactivation in postmitotic cells (epigenetic memory) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25436603", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 190, "text": "Similarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a \"Bookmarking\" Oncoprotein that Alters the Host Cell Epigenotype? ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25436603", "endSection": "title"}, {"offsetInBeginSection": 617, "offsetInEndSection": 779, "text": "We found one such target site at a cryptic \"shadow\" enhancer 7 kilobases (kb) downstream of the Cdx2 gene, where Rfx1 restricts transcriptional activation by FoxA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21935353", "endSection": "abstract"}, {"offsetInBeginSection": 1101, "offsetInEndSection": 1327, "text": "The results indicate that the \"pioneer\" features of FoxA factors involve various chromatin-binding parameters seen in linker histones and that distinguish the factors with respect to their regulatory and mechanistic functions. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21502411", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 306, "text": "There exists a hierarchy by which transcription factors can engage their target sites in chromatin, in that a subset of factors can bind transcriptionally silent, nucleosomal DNA, whereas most factors cannot, and this hierarchy is reflected, at least in part, in the developmental function of the factors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21502411", "endSection": "abstract"}, {"offsetInBeginSection": 923, "offsetInEndSection": 1184, "text": "The purpose of this review is to critically examine the literature on three highly potent transcriptional activators: the herpes virus protein, VP16; the master regulator of skeletal muscle differentiation, MyoD and the \"pioneer\" factor for hepatogenesis, FoxA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404180", "endSection": "abstract"}, {"offsetInBeginSection": 970, "offsetInEndSection": 1263, "text": "FOXO proteins represent a hybrid subclass having dual roles as pioneering factors and transcription factors. A subset of FOX proteins interacts with condensed mitotic chromatin and may function as &apos;bookmarking&apos; agents to maintain transcriptional competence at specific genomic sites. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22406422", "endSection": "abstract"}, {"offsetInBeginSection": 954, "offsetInEndSection": 1233, "text": "Insight into the unique molecular basis of Foxa function has been obtained from recent genetic and genomic data, which identify the Foxa proteins as 'pioneer factors' whose binding to promoters and enhancers enable chromatin access for other tissue-specific transcription factors ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16909212", "endSection": "abstract"}, {"offsetInBeginSection": 420, "offsetInEndSection": 684, "text": "We find that slower nuclear mobility correlates with high nonspecific nucleosome binding, and point mutations that disrupt nonspecific binding markedly increase nuclear mobility. FoxA's distinct nuclear mobility is consistent with its pioneer activity in chromatin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19339686", "endSection": "abstract"}]}, {"body": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23861494", "http://www.ncbi.nlm.nih.gov/pubmed/23722259", "http://www.ncbi.nlm.nih.gov/pubmed/23704920", "http://www.ncbi.nlm.nih.gov/pubmed/23591016", "http://www.ncbi.nlm.nih.gov/pubmed/23487791", "http://www.ncbi.nlm.nih.gov/pubmed/23474887", "http://www.ncbi.nlm.nih.gov/pubmed/22581928", "http://www.ncbi.nlm.nih.gov/pubmed/22575762", "http://www.ncbi.nlm.nih.gov/pubmed/22522929", "http://www.ncbi.nlm.nih.gov/pubmed/20691899", "http://www.ncbi.nlm.nih.gov/pubmed/23050819", "http://www.ncbi.nlm.nih.gov/pubmed/21241459"], "triples": [], "ideal_answer": "Direct reprogramming of human cardiac transcriptional factors : gata4, mef2c, and tbx5 in addition, transplantation of gmt infected cfs into injured mouse hearts resulted in decreased cell survival with minimal induction of cardiomyocyte genes.Using calcium activity as our primary outcome measure, we compared several published combinations of transcription factors along with novel combinations in mouse embryonic fibroblasts.Srivastava's group reported the first direct reprogramming of mouse fibroblast cells into mesoderm lineage cells ( cardiomyocytes ) with the enforced expression of three cardiac transcriptional factors.Here we describe a detailed step-by-step protocol for in vitro cardiac fibroblasts ( hcfs ) into cardiomyocytes may hold great potential for this purpose.This combination is > 50-fold more efficient than GMT alone and produces iCMs with cardiomyocyte marker expression, robust calcium oscillation, and spontaneous beating that persist for weeks following inactivation of reprogramming factors.Here we describe a detailed step-by-step protocol for in vitro cardiac reprogramming using three cardiac transcription factors ( gata4 ) offers an alternative approach to regenerate heart muscle.", "exact_answer": [["Gata4"], ["Mef2c"], ["Tbx5"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D065150", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D032383", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014157"], "type": "list", "id": "54fb5c69d176fff445000003", "snippets": [{"offsetInBeginSection": 1116, "offsetInEndSection": 1233, "text": "Here we describe a detailed step-by-step protocol for in vitro cardiac reprogramming using retroviruses encoding GMT. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23722259", "endSection": "abstract"}, {"offsetInBeginSection": 192, "offsetInEndSection": 310, "text": "To assess the efficiency of direct fibroblast reprogramming via viral overexpression of GATA4, Mef2c, and Tbx5 (GMT). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22581928", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 180, "text": "Cardiac fibroblasts can be reprogrammed to cardiomyocyte-like cells by the introduction of three transcription factors: Gata4, Mef2c and Tbx5 (collectively referred to here as GMT) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23722259", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 181, "text": "Cardiac fibroblasts can be reprogrammed to cardiomyocyte-like cells by the introduction of three transcription factors: Gata4, Mef2c and Tbx5 (collectively referred to here as GMT). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23722259", "endSection": "abstract"}, {"offsetInBeginSection": 684, "offsetInEndSection": 842, "text": " In addition, transplantation of GMT infected CFs into injured mouse hearts resulted in decreased cell survival with minimal induction of cardiomyocyte genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22581928", "endSection": "abstract"}, {"offsetInBeginSection": 851, "offsetInEndSection": 1033, "text": "We found that functional cardiomyocytes can be directly induced from fibroblasts by a combination of three cardiac transcription factors, Gata4, Mef2c and Tbx5, in vitro and in vivo. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23474887", "endSection": "abstract"}, {"offsetInBeginSection": 574, "offsetInEndSection": 781, "text": "Overexpression of transcription factors MYOCD and SRF alone or in conjunction with Mesp1 and SMARCD3 enhanced the basal but necessary cardio-inducing effect of the previously reported GATA4, TBX5, and MEF2C. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23704920", "endSection": "abstract"}, {"offsetInBeginSection": 149, "offsetInEndSection": 372, "text": "We reported previously that cardiac fibroblasts,which represent 50%of the cells in the mammalian heart, can be directly reprogrammed to adult cardiomyocyte-like cells in vitro by the addition of Gata4, Mef2c and Tbx5 (GMT). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22522929", "endSection": "abstract"}, {"offsetInBeginSection": 370, "offsetInEndSection": 612, "text": "Here, we report that a combination of three developmental transcription factors (i.e., Gata4, Mef2c, and Tbx5) rapidly and efficiently reprogrammed postnatal cardiac or dermal fibroblasts directly into differentiated cardiomyocyte-like cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20691899", "endSection": "abstract"}, {"offsetInBeginSection": 558, "offsetInEndSection": 781, "text": "Srivastava's group reported the first direct reprogramming of mouse fibroblast cells into mesoderm lineage cells (cardiomyocytes) with the enforced expression of three cardiac transcriptional factors: Gata4, Mef2c, and Tbx5 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21241459", "endSection": "abstract"}, {"offsetInBeginSection": 558, "offsetInEndSection": 782, "text": "Srivastava's group reported the first direct reprogramming of mouse fibroblast cells into mesoderm lineage cells (cardiomyocytes) with the enforced expression of three cardiac transcriptional factors: Gata4, Mef2c, and Tbx5. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21241459", "endSection": "abstract"}, {"offsetInBeginSection": 254, "offsetInEndSection": 507, "text": "More recently, we showed that reprogramming of cardiac fibroblasts to cardiomyocyte-like cells in vivo after coronary artery ligation using three cardiac transcription factors (Gata4/Mef2c/Tbx5) offers an alternative approach to regenerate heart muscle. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23050819", "endSection": "abstract"}, {"offsetInBeginSection": 670, "offsetInEndSection": 909, "text": "Here we show that four human cardiac transcription factors, including GATA binding protein 4, Hand2, T-box5, and myocardin, and two microRNAs, miR-1 and miR-133, activated cardiac marker expression in neonatal and adult human fibroblasts. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23487791", "endSection": "abstract"}, {"offsetInBeginSection": 186, "offsetInEndSection": 545, "text": "Direct reprogramming of human cardiac fibroblasts (HCFs) into cardiomyocytes may hold great potential for this purpose. We reported previously that induced cardiomyocyte-like cells (iCMs) can be directly generated from mouse cardiac fibroblasts in vitro and vivo by transduction of three transcription factors: Gata4, Mef2c, and Tbx5, collectively termed GMT. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23861494", "endSection": "abstract"}, {"offsetInBeginSection": 370, "offsetInEndSection": 765, "text": "Here, we report that a combination of three developmental transcription factors (i.e., Gata4, Mef2c, and Tbx5) rapidly and efficiently reprogrammed postnatal cardiac or dermal fibroblasts directly into differentiated cardiomyocyte-like cells. Induced cardiomyocytes expressed cardiac-specific markers, had a global gene expression profile similar to cardiomyocytes, and contracted spontaneously. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20691899", "endSection": "abstract"}, {"offsetInBeginSection": 1063, "offsetInEndSection": 1578, "text": " Using calcium activity as our primary outcome measure, we compared several published combinations of transcription factors along with novel combinations in mouse embryonic fibroblasts. The most effective combination consisted of Hand2, Nkx2.5, Gata4, Mef2c, and Tbx5 (HNGMT). This combination is >50-fold more efficient than GMT alone and produces iCMs with cardiomyocyte marker expression, robust calcium oscillation, and spontaneous beating that persist for weeks following inactivation of reprogramming factors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23591016", "endSection": "abstract"}, {"offsetInBeginSection": 379, "offsetInEndSection": 933, "text": "Here, to identify a cardiac transcription factor combination facilitating mouse fibroblast reprogramming into cardiomyocytes, we directly screened all triplet combinations of 10 candidate factors combined with a Q-PCR assay reporting induction of multiple cardiac-specific genes. Through this screening method the combination of Tbx5, Mef2c, and Myocd was identified to upregulate a broader spectrum of cardiac genes compared to the combination of Tbx5, Mef2c, and Gata4 that was recently shown to induce reprogramming of fibroblasts into cardiomyocytes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22575762", "endSection": "abstract"}]}, {"body": "What is the name of Bruton's tyrosine kinase inhibitor that can be used for treatment of chronic lymphocytic leukemia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24311722", "http://www.ncbi.nlm.nih.gov/pubmed/24157582", "http://www.ncbi.nlm.nih.gov/pubmed/24085367", "http://www.ncbi.nlm.nih.gov/pubmed/24009233", "http://www.ncbi.nlm.nih.gov/pubmed/23782158", "http://www.ncbi.nlm.nih.gov/pubmed/23656200", "http://www.ncbi.nlm.nih.gov/pubmed/23619564", "http://www.ncbi.nlm.nih.gov/pubmed/23617325", "http://www.ncbi.nlm.nih.gov/pubmed/23617253", "http://www.ncbi.nlm.nih.gov/pubmed/23359016", "http://www.ncbi.nlm.nih.gov/pubmed/22960555", "http://www.ncbi.nlm.nih.gov/pubmed/22830347", "http://www.ncbi.nlm.nih.gov/pubmed/22300471"], "triples": [], "ideal_answer": "Next, we used this model to study ibrutinib, a Bruton's tyrosine kinase inhibitor in clinical development.Ibrutinib, an inhibitor of bruton's tyrosine kinase is showing impressive responses in heavily pre-treated high-risk cll, whether alone or in combination with moabs or chemotherapy.Ibrutinib : a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia.Next, we demonstrate that the bruton's tyrosine kinase inhibitor ibrutinib or the pi3k inhibitor idelalisib block b-cell receptor induced activation of lcp1.Ibrutinib in the tcl1 mouse significantly delays the development of cll, demonstrating that btk is a critical kinase for cll development and expansion and thus an important target of ibrutinib.Recent clinical data suggest remarkable activity through either targeted genetic inactivation or ibrutinib, the first-in-class covalent inhibitor of bruton's tyrosine kinase ( btk ), in chronic lymphocytic leukemia ( cll ), as well as excellent activity in other b cell malignancies, including in particular mantle cell lymphoma and waldenstrom macroglobulinemia.Recent clinical data suggest remarkable activity of ibrutinib.", "exact_answer": ["Ibrutinib"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015451", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011505", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007945", "http://www.uniprot.org/uniprot/IBTK_MOUSE", "http://www.uniprot.org/uniprot/IBTK_XENLA", "http://www.uniprot.org/uniprot/IBTK_HUMAN", "http://www.disease-ontology.org/api/metadata/DOID:1040", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013812", "http://www.uniprot.org/uniprot/BTK_MOUSE", "http://www.uniprot.org/uniprot/BTK_CHICK", "http://www.uniprot.org/uniprot/BTK_HUMAN", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0030292"], "type": "factoid", "id": "530cf4c54a5037880c000008", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 70, "text": "Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23782158", "endSection": "title"}, {"offsetInBeginSection": 890, "offsetInEndSection": 997, "text": "Next, we used this model to study ibrutinib, a Bruton's tyrosine kinase inhibitor in clinical development. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23619564", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 127, "text": "Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23617325", "endSection": "title"}, {"offsetInBeginSection": 1096, "offsetInEndSection": 1261, "text": "Furthermore, we demonstrate that the Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib block B-cell receptor induced activation of LCP1. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24009233", "endSection": "abstract"}, {"offsetInBeginSection": 931, "offsetInEndSection": 1113, "text": "Ibrutinib acts by inhibiting the Bruton's tyrosine kinase (BTK) while idelalisib represents a first-in-class specific inhibitor of the phosphoinositol-3 kinase (PI3K) delta isoform. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24085367", "endSection": "abstract"}, {"offsetInBeginSection": 292, "offsetInEndSection": 473, "text": "Ibrutinib, an inhibitor of Bruton's tyrosine kinase is showing impressive responses in heavily pre-treated high-risk CLL, whether alone or in combination with MoAbs or chemotherapy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24157582", "endSection": "abstract"}, {"offsetInBeginSection": 869, "offsetInEndSection": 1078, "text": "The compounds that are currently investigated in patients with CLL include ibrutinib -inhibitor of Btk, fostamatinib-inhibitor of Syk and idelalisib (GS-1101) -a specific isoform of the PI3K (PI3K) inhibitor. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23617253", "endSection": "abstract"}, {"offsetInBeginSection": 354, "offsetInEndSection": 600, "text": "Ibrutinib (PCI-32765), demonstrated that Btk inhibition sensitizes CLL cells to apoptosis and alters their migratory behavior, these studies however did not address whether Btk-mediated signaling is involved in the process of CLL leukemogenesis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23359016", "endSection": "abstract"}, {"offsetInBeginSection": 708, "offsetInEndSection": 938, "text": "More recently, several KIs have been developed to target the proximal B-cell receptor (BCR) signaling pathway including spleen tyrosine kinase inhibitor (Fostamatinib) and Bruton's tyrosine kinase inhibitors (Ibrutinib, AVL-263). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22830347", "endSection": "abstract"}, {"offsetInBeginSection": 1087, "offsetInEndSection": 1315, "text": "Small molecule inhibitors of BCR signaling kinases, Bruton's tyrosine kinase (Btk) inhibitor ibrutinib and the phosphoinositide 3'-kinase delta (PI3K\u03b4) inhibitor GS-1101, are currently transforming the landscape of CLL therapy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22960555", "endSection": "abstract"}, {"offsetInBeginSection": 368, "offsetInEndSection": 607, "text": "Ibrutinib, a Bruton's tyrosine kinase inhibitor, has shown highly encouraging results in phase I/II trials in patients with treatment-naive, relapsed and refractory CLL even in the presence of high risk disease or poor prognostic markers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23617325", "endSection": "abstract"}, {"offsetInBeginSection": 876, "offsetInEndSection": 1152, "text": "Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24311722", "endSection": "abstract"}, {"offsetInBeginSection": 319, "offsetInEndSection": 625, "text": "We conducted a phase 1b-2 multicenter study to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ibrutinib (PCI-32765), a first-in-class, oral covalent inhibitor of BTK designed for treatment of B-cell cancers, in patients with relapsed or refractory CLL or small lymphocytic lymphoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23782158", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 315, "text": "Recent clinical data suggest remarkable activity of ibrutinib, the first-in-class covalent inhibitor of Bruton's tyrosine kinase (BTK), in chronic lymphocytic leukemia (CLL), as well as excellent activity in other B cell malignancies, including in particular mantle cell lymphoma and Waldenstrom macroglobulinemia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23656200", "endSection": "abstract"}, {"offsetInBeginSection": 187, "offsetInEndSection": 620, "text": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL. Early clinical results in CLL with other reversible and irreversible BTK inhibitors have been less promising, however, raising the question of whether BTK kinase activity is an important target of ibrutinib and also in CLL. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24311722", "endSection": "abstract"}]}, {"body": "Is physical performance influenced by thyroid hormone metabolism?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21875391", "http://www.ncbi.nlm.nih.gov/pubmed/18523407", "http://www.ncbi.nlm.nih.gov/pubmed/16174720", "http://www.ncbi.nlm.nih.gov/pubmed/2704923", "http://www.ncbi.nlm.nih.gov/pubmed/17893267", "http://www.ncbi.nlm.nih.gov/pubmed/16621071", "http://www.ncbi.nlm.nih.gov/pubmed/19468264", "http://www.ncbi.nlm.nih.gov/pubmed/16910873"], "ideal_answer": "Oral l-thyroxine treatment was started and at a 1-month follow-up examination, mental status and physical performance were improved subclinical hyperthyroidism ( sh ) may be responsible for many cardiovascular changes, including an impaired exercise performance.She had generalised weakness of muscles, cold intolerance and a reduced physical performance were improved subclinical hyperthyroidism ( sh ) may be responsible for many cardiovascular changes, including an impaired exercise performance.Thr among patients with sch is beneficial not only by improvement in lipid profile, as well as by improvement in cognitive and functional status, replacement therapy by oral administration of l-thyroxin resulted in a gradual improvement of the patient's state even a modest thyroid hormone excess is associated with a reduced physical performance.She had generalised weakness of muscles, cold intolerance and a reduced physical function in elderly men.Multivariate analysis revealed that total T3 was an independent predictor of VO2max", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013963", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011988", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0070327", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0070324", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0042403", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0004887", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013974", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D037021", "http://www.biosemantics.org/jochem#4275389", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D037042", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014284", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0010861", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0006590", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0046966", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=2000609", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0004996", "http://www.uniprot.org/uniprot/THB_CHICK", "http://www.uniprot.org/uniprot/THB_PAROL", "http://www.uniprot.org/uniprot/THBA_XENLA", "http://www.uniprot.org/uniprot/THB_RAT", "http://www.uniprot.org/uniprot/THB_CAIMO", "http://www.uniprot.org/uniprot/THB_SHEEP", "http://www.uniprot.org/uniprot/THB_LITCT", "http://www.uniprot.org/uniprot/THB_HUMAN", "http://www.uniprot.org/uniprot/THB_MOUSE", "http://www.uniprot.org/uniprot/THB_DANRE", "http://www.uniprot.org/uniprot/THA_SHEEP", "http://www.uniprot.org/uniprot/THAA_PAROL", "http://www.uniprot.org/uniprot/THAA_XENLA", "http://www.uniprot.org/uniprot/THAA_DANRE", "http://www.uniprot.org/uniprot/THA_APTPA", "http://www.uniprot.org/uniprot/THA_MOUSE", "http://www.uniprot.org/uniprot/THA_PYGAD", "http://www.uniprot.org/uniprot/THA_HIPHI", "http://www.uniprot.org/uniprot/THA_SALSA", "http://www.uniprot.org/uniprot/THA_RAT", "http://www.uniprot.org/uniprot/THA_PIG", "http://www.uniprot.org/uniprot/THA_CAIMO", "http://www.uniprot.org/uniprot/THA_NECMA", "http://www.uniprot.org/uniprot/THA_ONCMY", "http://www.uniprot.org/uniprot/THA_ELECQ", "http://www.uniprot.org/uniprot/THA_CHICK", "http://www.uniprot.org/uniprot/THA_SPAAU", "http://www.uniprot.org/uniprot/THA_HUMAN", "http://www.uniprot.org/uniprot/THA_LITCT", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0015349", "http://www.uniprot.org/uniprot/NCOA6_MOUSE", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003918", "http://www.uniprot.org/uniprot/NCOA6_RAT", "http://www.uniprot.org/uniprot/NCOA6_HUMAN", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D056892", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0002154"], "type": "yesno", "id": "5151b8efd24251bc0500007a", "snippets": [{"offsetInBeginSection": 84, "offsetInEndSection": 177, "text": "She had generalised weakness of muscles, cold intolerance and a reduced physical performance. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2704923", "endSection": "sections.0"}, {"offsetInBeginSection": 730, "offsetInEndSection": 813, "text": "multivariate analysis revealed that total T3 was an independent predictor of VO2max ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17893267", "endSection": "sections.0"}, {"offsetInBeginSection": 1238, "offsetInEndSection": 1337, "text": "Even a modest thyroid hormone excess is associated with a reduced physical function in elderly men. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21875391", "endSection": "sections.0"}, {"offsetInBeginSection": 1028, "offsetInEndSection": 1142, "text": "changes in thyroid hormone were closely correlated to myocardial functional status in patients with heart failure. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17893267", "endSection": "sections.0"}, {"offsetInBeginSection": 1225, "offsetInEndSection": 1337, "text": "CONCLUSIONS: Even a modest thyroid hormone excess is associated with a reduced physical function in elderly men. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21875391", "endSection": "sections.0"}, {"offsetInBeginSection": 696, "offsetInEndSection": 827, "text": "Oral L-thyroxine treatment was started and at a 1-month follow-up examination, mental status and physical performance were improved ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18523407", "endSection": "sections.0"}, {"offsetInBeginSection": 528, "offsetInEndSection": 641, "text": "Replacement therapy by oral administration of L-thyroxin resulted in a gradual improvement of the patient's state ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2704923", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 128, "text": "Subclinical hyperthyroidism (SH) may be responsible for many cardiovascular changes, including an impaired exercise performance. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16910873", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "BACKGROUND: Physiological changes in thyroid hormone concentrations might be related to changes in the overall physical function in the elderly. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16174720", "endSection": "sections.0"}, {"offsetInBeginSection": 1572, "offsetInEndSection": 1704, "text": "In a population of independently living elderly men, higher FT4 and rT3 concentrations are associated with a lower physical function ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16174720", "endSection": "sections.0"}, {"offsetInBeginSection": 1848, "offsetInEndSection": 1993, "text": "THR among patients with SCH is beneficial not only by improvement in lipid profile, as well as by improvement in cognitive and functional status, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16621071", "endSection": "sections.0"}, {"offsetInBeginSection": 1073, "offsetInEndSection": 1223, "text": "Longitudinal analysis showed that in Eut men higher baseline FT4 was significantly (p = 0.02) predictive of a lower SPPB score at the 3-year follow-up ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21875391", "endSection": "sections.0"}]}, {"body": "Do plant genomes contain CpG islands?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21548945", "http://www.ncbi.nlm.nih.gov/pubmed/16283384", "http://www.ncbi.nlm.nih.gov/pubmed/15733327", "http://www.ncbi.nlm.nih.gov/pubmed/12857799", "http://www.ncbi.nlm.nih.gov/pubmed/12054347", "http://www.ncbi.nlm.nih.gov/pubmed/11489175", "http://www.ncbi.nlm.nih.gov/pubmed/16453856"], "triples": [], "ideal_answer": "In plant genomes, there exist discrete regions rich in cpg dinucleotides, namely cpg clusters may be regarded as plant cpg islandsSegmental distribution of genes harboring a cpg island-like region on rice chromosomes preliminary analysis shows that promoter location based on the detection of potential cpg islands in the arabidopsis genome is not straightforward.These plant cpg-rich clusters satisfied the criteria used for identifying human cpg islands, which suggests that these cpg clusters may be regarded as plant cpg dinucleotides within these sequences in addition, gc-skew is a good candidate index for tss prediction in plant genomes, where there is a lack of correlation among cpg islands and genes unmethylated cpg islands associated with genes in higher plant dna.We screened plant genome sequences, primarily from rice and arabidopsis thaliana, for cpg islands, and identified dna segments rich in cpg dinucleotides, namely cpg clusters.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018899", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D044404", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018745"], "type": "yesno", "id": "553d0005f321868558000011", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 67, "text": "Unmethylated CpG islands associated with genes in higher plant DNA. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16453856", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 86, "text": "Segmental distribution of genes harboring a CpG island-like region on rice chromosomes ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16283384", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 94, "text": "In plant genomes, there exist discrete regions rich in CpG dinucleotides, namely CpG clusters. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16283384", "endSection": "abstract"}, {"offsetInBeginSection": 657, "offsetInEndSection": 826, "text": "These plant CpG-rich clusters satisfied the criteria used for identifying human CpG islands, which suggests that these CpG clusters may be regarded as plant CpG islands. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11489175", "endSection": "abstract"}, {"offsetInBeginSection": 657, "offsetInEndSection": 825, "text": "These plant CpG-rich clusters satisfied the criteria used for identifying human CpG islands, which suggests that these CpG clusters may be regarded as plant CpG islands ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11489175", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 175, "text": "We screened plant genome sequences, primarily from rice and Arabidopsis thaliana, for CpG islands, and identified DNA segments rich in CpG dinucleotides within these sequences ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11489175", "endSection": "abstract"}, {"offsetInBeginSection": 1679, "offsetInEndSection": 2039, "text": "This study represents the first systematic genome-scale analysis of DNA curvature, CpG islands and tandem repeats at the DNA sequence level in plant genomes, and finds that not all of the chromosomes in plants follow the same rules common to other eukaryote organisms, suggesting that some of these genomic properties might be considered as specific to plants. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21548945", "endSection": "abstract"}, {"offsetInBeginSection": 1711, "offsetInEndSection": 2070, "text": "This study represents the first systematic genome-scale analysis of DNA curvature, CpG islands and tandem repeats at the DNA sequence level in plant genomes, and finds that not all of the chromosomes in plants follow the same rules common to other eukaryote organisms, suggesting that some of these genomic properties might be considered as specific to plants ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21548945", "endSection": "abstract"}, {"offsetInBeginSection": 1698, "offsetInEndSection": 2071, "text": "CONCLUSIONS: This study represents the first systematic genome-scale analysis of DNA curvature, CpG islands and tandem repeats at the DNA sequence level in plant genomes, and finds that not all of the chromosomes in plants follow the same rules common to other eukaryote organisms, suggesting that some of these genomic properties might be considered as specific to plants. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21548945", "endSection": "abstract"}, {"offsetInBeginSection": 1610, "offsetInEndSection": 2066, "text": "Preliminary analysis shows that promoter location based on the detection of potential CpG/CpNpG islands in the Arabidopsis genome is not straightforward. Nevertheless, because the landscape of CpG/CpNpG islands differs considerably between promoters and introns on the one side and exons (whether coding or not) on the other, more sophisticated approaches can probably be developed for the successful detection of \"putative\" CpG and CpNpG islands in plants ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12857799", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 394, "text": "In plant genomes, there exist discrete regions rich in CpG dinucleotides, namely CpG clusters. In rice, most of these CpG clusters are associated with genes. Rice genes are grouped into one of the five classes according to the position of an associated CpG cluster. Among them, class 1 genes, which harbor a CpG cluster at the 5'-terminus, share similarities with human genes having CpG islands ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16283384", "endSection": "abstract"}, {"offsetInBeginSection": 1986, "offsetInEndSection": 2516, "text": "Highly-expressed Arabidopsis genes had overall a more marked GC-skew in the TSS compared to genes with low expression levels. We therefore propose that the GC-skew around the TSS in some plants and fungi is related to transcription. It might be caused by mutations during transcription initiation or the frequent use of transcription factor-biding sites having a strand preference. In addition, GC-skew is a good candidate index for TSS prediction in plant genomes, where there is a lack of correlation among CpG islands and genes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15733327", "endSection": "abstract"}]}, {"body": "Describe the isolation of transcription factor complexes by in vivo biotinylation tagging and direct binding to streptavidin beads, as applied for the case of the essential hematopoietic transcription factor GATA-1.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19196479", "http://www.ncbi.nlm.nih.gov/pubmed/16339652", "http://www.ncbi.nlm.nih.gov/pubmed/16888367", "http://www.ncbi.nlm.nih.gov/pubmed/15920471"], "triples": [], "ideal_answer": "Using a biotinylation tagging approach in erythroid cells, as was demonstrated by the tagging of the essential hematopoietic transcription factor gata-1.Owing to the very high affinity of biotin for avidin and streptavidin, biotinylation tagging approach in erythroid cells, we describe distinct gata-1 interactions with the essential hematopoietic factor gfi-1b, the repressive mecp1 complex and the chromatin remodeling acf complex, in addition to the known gata-1 and gata-1 complexes.A short sequence tag fused n-terminally to the transcription factor of interest is very efficiently biotinylated by bira coexpressed in the same cells, as was demonstrated by the tagging offers an attractive approach for the efficient purification of protein complexes.Isolation and characterization of hematopoietic transcription factor gata-1 as example, we describe several optimization steps for the application of the high affinity biotin streptavidin system in chip the direct binding to streptavidin of biotinylated gata-1 in nuclear extracts resulted in the single-step capture of the tagged factor and associated proteins, which were eluted and identified by mass spectrometry.Using the biotin tagged erythroid transcription factor complexes by in vivo biotinylation tagging and mass spectrometry.", "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0005488", "http://www.uniprot.org/uniprot/SAV_STRAV", "http://www.biosemantics.org/jochem#4250381", "http://www.uniprot.org/uniprot/GATA1_RAT", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0008134", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0005667", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0033613", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000989"], "type": "summary", "id": "553a761cf321868558000001", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "Isolation and characterization of hematopoietic transcription factor complexes by in vivo biotinylation tagging and mass spectrometry. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16339652", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "Isolation and characterization of hematopoietic transcription factor complexes by in vivo biotinylation tagging and mass spectrometry ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16339652", "endSection": "title"}, {"offsetInBeginSection": 375, "offsetInEndSection": 557, "text": "Epitope tags have often been used as more reliable alternatives. In addition, we have employed protein in vivo biotinylation tagging as a very high affinity alternative to antibodies ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19196479", "endSection": "abstract"}, {"offsetInBeginSection": 970, "offsetInEndSection": 1184, "text": "The direct binding to streptavidin of biotinylated GATA-1 in nuclear extracts resulted in the single-step capture of the tagged factor and associated proteins, which were eluted and identified by mass spectrometry. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16888367", "endSection": "abstract"}, {"offsetInBeginSection": 723, "offsetInEndSection": 968, "text": "A short sequence tag fused N-terminally to the transcription factor of interest is very efficiently biotinylated by BirA coexpressed in the same cells, as was demonstrated by the tagging of the essential hematopoietic transcription factor GATA-1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16888367", "endSection": "abstract"}, {"offsetInBeginSection": 723, "offsetInEndSection": 969, "text": "A short sequence tag fused N-terminally to the transcription factor of interest is very efficiently biotinylated by BirA coexpressed in the same cells, as was demonstrated by the tagging of the essential hematopoietic transcription factor GATA-1. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16888367", "endSection": "abstract"}, {"offsetInBeginSection": 750, "offsetInEndSection": 938, "text": "Using the biotin tagged erythroid transcription factor GATA-1 as example, we describe several optimization steps for the application of the high affinity biotin streptavidin system in ChIP ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19196479", "endSection": "abstract"}, {"offsetInBeginSection": 365, "offsetInEndSection": 664, "text": "Using a biotinylation tagging/proteomics approach in erythroid cells, we describe distinct GATA-1 interactions with the essential hematopoietic factor Gfi-1b, the repressive MeCP1 complex and the chromatin remodeling ACF/WCRF complex, in addition to the known GATA-1/FOG-1 and GATA-1/TAL-1 complexes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15920471", "endSection": "abstract"}, {"offsetInBeginSection": 365, "offsetInEndSection": 665, "text": "Using a biotinylation tagging/proteomics approach in erythroid cells, we describe distinct GATA-1 interactions with the essential hematopoietic factor Gfi-1b, the repressive MeCP1 complex and the chromatin remodeling ACF/WCRF complex, in addition to the known GATA-1/FOG-1 and GATA-1/TAL-1 complexes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15920471", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 472, "text": "We have described the application of a simple biotinylation tagging approach for the direct purification of tagged transcription factor complexes, based on the use of artificial short peptide tags that are specifically and efficiently biotinylated by the bacterial BirA biotin ligase, which is co-expressed in cells with the tagged factor. We used this approach to initially characterize complexes formed by the hematopoietic transcription factor GATA-1 in erythroid cells ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16339652", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 1519, "text": "Efficient tagging methodologies are an integral aspect of protein complex characterization by proteomic approaches. Owing to the very high affinity of biotin for avidin and streptavidin, biotinylation tagging offers an attractive approach for the efficient purification of protein complexes. The very high affinity of the biotin/(strept)avidin system also offers the potential for the single-step capture of lower abundance protein complexes, such as transcription factor complexes. The identification of short peptide tags that are efficiently biotinylated by the bacterial BirA biotin ligase led to an approach for the single-step purification of transcription factor complexes by specific in vivo biotinylation tagging. A short sequence tag fused N-terminally to the transcription factor of interest is very efficiently biotinylated by BirA coexpressed in the same cells, as was demonstrated by the tagging of the essential hematopoietic transcription factor GATA-1. The direct binding to streptavidin of biotinylated GATA-1 in nuclear extracts resulted in the single-step capture of the tagged factor and associated proteins, which were eluted and identified by mass spectrometry. This led to the characterization of several distinct GATA-1 complexes with other transcription factors and chromatin remodeling cofactors, which are involved in activation and repression of gene targets. Thus, BirA-mediated tagging is an efficient approach for the direct capture and characterization of transcription factor complexes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16888367", "endSection": "abstract"}]}, {"body": "Are high-flow nasal cannulae effective for treatment of preterm infants?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24106935", "http://www.ncbi.nlm.nih.gov/pubmed/23947111", "http://www.ncbi.nlm.nih.gov/pubmed/23782410", "http://www.ncbi.nlm.nih.gov/pubmed/23260098", "http://www.ncbi.nlm.nih.gov/pubmed/23143331", "http://www.ncbi.nlm.nih.gov/pubmed/23114244", "http://www.ncbi.nlm.nih.gov/pubmed/22958022", "http://www.ncbi.nlm.nih.gov/pubmed/22964658", "http://www.ncbi.nlm.nih.gov/pubmed/22173399", "http://www.ncbi.nlm.nih.gov/pubmed/21682982", "http://www.ncbi.nlm.nih.gov/pubmed/21563154", "http://www.ncbi.nlm.nih.gov/pubmed/21276671", "http://www.ncbi.nlm.nih.gov/pubmed/19762171", "http://www.ncbi.nlm.nih.gov/pubmed/17989697", "http://www.ncbi.nlm.nih.gov/pubmed/11331690", "http://www.ncbi.nlm.nih.gov/pubmed/22518179", "http://www.ncbi.nlm.nih.gov/pubmed/24225220", "http://www.ncbi.nlm.nih.gov/pubmed/23955516", "http://www.ncbi.nlm.nih.gov/pubmed/23903677"], "triples": [], "ideal_answer": "There is growing evidence of the feasibility of hfnc as an alternative to other forms of non-invasive ventilation in preterm infants ( 34.2 % ) in the nasal-cannulae group and in 39 of 151 infants ( 25.8 % ) in the cpap group ( risk difference, 8.4 percentage points; 95 % confidence interval, -1.9 to 18.7 ).High-flow nasal cannula ( hfnc ) are gaining in popularity as a form of non-invasive respiratory support for preterm infants in neonatal intensive care units around the world.Heated, humidified, high-flow nasal cannulae was similar to that of cpap as respiratory support for very preterm infants after extubation.A number of centers use high-flow nasal cannula oxygen therapy ( hhhfnc ) has been used to improve ventilation in preterm infants.Although the result for the primary outcome was close to the margin of noninferiority, the efficacy of high-flow nasal cannulae was noninferior to the use of nasal cpap, with treatment failure occurring in 52 of 152 infants after extubation.Hfnc is as effective as ncpap in the management of aop.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007234", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D057785", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000281"], "type": "yesno", "id": "530cf4c54a5037880c000002", "snippets": [{"offsetInBeginSection": 1645, "offsetInEndSection": 1700, "text": "HFNC is as effective as NCPAP in the management of AOP. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11331690", "endSection": "abstract"}, {"offsetInBeginSection": 1042, "offsetInEndSection": 1104, "text": "HHHFNC and NCPAP produced similar rates of extubation failure. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23260098", "endSection": "abstract"}, {"offsetInBeginSection": 1078, "offsetInEndSection": 1179, "text": "In conclusion, there is a growing evidence of the feasibility of HFNC as an alternative mode of NIV. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23947111", "endSection": "abstract"}, {"offsetInBeginSection": 1191, "offsetInEndSection": 1325, "text": "There is growing evidence of the feasibility of HFNC as an alternative to other forms of non-invasive ventilation in preterm infants. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22964658", "endSection": "abstract"}, {"offsetInBeginSection": 1948, "offsetInEndSection": 2055, "text": "When used following extubation, HFNC may be associated with a higher rate of reintubation than nasal CPAP. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21563154", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 137, "text": "Heated, humidified, high-flow nasal cannula oxygen therapy (HHHFNC) has been used to improve ventilation in preterm infants. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114244", "endSection": "abstract"}, {"offsetInBeginSection": 1412, "offsetInEndSection": 1532, "text": "Increasing flow rates of HHHFNC therapy are associated with linear increases in NP pressures in bronchiolitis patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114244", "endSection": "abstract"}, {"offsetInBeginSection": 1385, "offsetInEndSection": 1517, "text": "Weaning preterm infants from NCPAP to NC is associated with increased exposure to oxygen and longer duration of respiratory support. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21276671", "endSection": "abstract"}, {"offsetInBeginSection": 1292, "offsetInEndSection": 1452, "text": "Current evidence suggests that HFNC is well tolerated and may be feasible in a subset of patients who require ventilatory support with non-invasive ventilation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23143331", "endSection": "abstract"}, {"offsetInBeginSection": 111, "offsetInEndSection": 287, "text": "The use of HFNC as a respiratory support modality is increasing in the infant, pediatric, and adult populations as an alternative to non-invasive positive pressure ventilation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23143331", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21276671", "endSection": "title"}, {"offsetInBeginSection": 203, "offsetInEndSection": 350, "text": "A number of centers use high-flow nasal cannula (HFNC) in the management of AOP without measuring the positive distending pressure (PDP) generated. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11331690", "endSection": "abstract"}, {"offsetInBeginSection": 922, "offsetInEndSection": 1102, "text": "HFNC may be as effective as NCPAP at improving respiratory parameters such as tidal volume and work of breathing in preterm infants, but probably only at flow rates >2 litres/min. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22964658", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 186, "text": "High-flow nasal cannulae (HFNC) are gaining in popularity as a form of non-invasive respiratory support for preterm infants in neonatal intensive care units around the world. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22964658", "endSection": "abstract"}, {"offsetInBeginSection": 1610, "offsetInEndSection": 1832, "text": "Although the result for the primary outcome was close to the margin of noninferiority, the efficacy of high-flow nasal cannulae was similar to that of CPAP as respiratory support for very preterm infants after extubation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24106935", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 245, "text": "The use of high-flow nasal cannulae is an increasingly popular alternative to nasal continuous positive airway pressure (CPAP) for noninvasive respiratory support of very preterm infants (gestational age, <32 weeks) after extubation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24106935", "endSection": "abstract"}, {"offsetInBeginSection": 438, "offsetInEndSection": 627, "text": "Recently high flow nasal cannula (HFNC) is emerging as an efficient, better tolerated form of NIV, allowing better access to the baby's face, which may improve nursing, feeding and bonding. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23947111", "endSection": "abstract"}, {"offsetInBeginSection": 944, "offsetInEndSection": 1244, "text": "The use of high-flow nasal cannulae was noninferior to the use of nasal CPAP, with treatment failure occurring in 52 of 152 infants (34.2%) in the nasal-cannulae group and in 39 of 151 infants (25.8%) in the CPAP group (risk difference, 8.4 percentage points; 95% confidence interval, -1.9 to 18.7). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24106935", "endSection": "abstract"}, {"offsetInBeginSection": 1068, "offsetInEndSection": 1372, "text": "After randomization, the no-NC group had fewer days on oxygen [median (interquartile range): 5 (1-8) vs 14 (7.5-19.25) days, p<0.001] and shorter duration of respiratory support [10.5 (4-21) vs 18 (11.5-29) days, p=0.03]. There were no differences between groups regarding success of weaning from NCPAP. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21276671", "endSection": "abstract"}, {"offsetInBeginSection": 76, "offsetInEndSection": 534, "text": "An alternative to the use of nasal continuous positive airway pressure (NCPAP) as a non-invasive modality to support respiratory distress in premature infants has been the recent introduction of high flow nasal cannula (HFNC) devices in many neonatal units. There has been increased use of HFNC presumably because of anecdotal reports and experience that it is easy to use, and well tolerated by the infants, while experiencing decreased nasal septumerosion. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22958022", "endSection": "abstract"}, {"offsetInBeginSection": 1284, "offsetInEndSection": 1793, "text": "When used as primary respiratory support after birth, one trial found similar rates of treatment failure in infants treated with HFNC and nasal CPAP. Following extubation, one trial found that infants treated with HFNC had a significantly higher rate of reintubation than those treated with nasal CPAP. Another trial found similar rates of reintubation for humidified and non-humidified HFNC, and the fourth trial found no difference between two different models of equipment used to deliver humidified HFNC. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21563154", "endSection": "abstract"}]}, {"body": "What are the molecular characteristics of the FAA (FANCA) cDNA?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/8896563"], "triples": [], "ideal_answer": "In contrast to the 63-kd cytosolic protein encoded by the fac gene, the predicted faa protein ( m ( r ) 162, 752 ) contains two overlapping bipartite nuclear localization signals and a partial leucine zipper consensus, which are suggestive of a nuclear localization the 5.5-kb cdna has an open reading frame of 4,368 nucleotides.Here we report the isolation of a cdna representing the faa gene, following an expression cloning method similar to the one used to clone the fac gene.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018076", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D052217"], "type": "summary", "id": "54edf1ee94afd6150400000f", "snippets": [{"offsetInBeginSection": 789, "offsetInEndSection": 1265, "text": "Here we report the isolation of a cDNA representing the FAA gene, following an expression cloning method similar to the one used to clone the FAC gene. The 5.5-kb cDNA has an open reading frame of 4,368 nucleotides. In contrast to the 63-kD cytosolic protein encoded by the FAC gene, the predicted FAA protein (M(r) 162, 752) contains two overlapping bipartite nuclear localization signals and a partial leucine zipper consensus, which are suggestive of a nuclear localization ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8896563", "endSection": "abstract"}]}, {"body": "What are the skeletal muscle satellite cells?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26074812", "http://www.ncbi.nlm.nih.gov/pubmed/25732238", "http://www.ncbi.nlm.nih.gov/pubmed/26341996", "http://www.ncbi.nlm.nih.gov/pubmed/26248268", "http://www.ncbi.nlm.nih.gov/pubmed/24747722", "http://www.ncbi.nlm.nih.gov/pubmed/22233500", "http://www.ncbi.nlm.nih.gov/pubmed/12757751", "http://www.ncbi.nlm.nih.gov/pubmed/21339173", "http://www.ncbi.nlm.nih.gov/pubmed/26055324", "http://www.ncbi.nlm.nih.gov/pubmed/24439806", "http://www.ncbi.nlm.nih.gov/pubmed/17996437", "http://www.ncbi.nlm.nih.gov/pubmed/17600112", "http://www.ncbi.nlm.nih.gov/pubmed/19265661", "http://www.ncbi.nlm.nih.gov/pubmed/21727135"], "triples": [], "ideal_answer": "Satellite cells are essential for skeletal muscle satellite cells, located between the basal lamina and plasma membrane of myofibers, are required for skeletal muscle regeneration.In adult muscle, satellite cells have a greater similarity to human satellite cells with regard to metabolism, life span, proliferation and differentiation, than satellite cells of the rat and mouse.Research focusing on the canonical adult myogenic precursors that rebuild damaged muscle tissue skeletal muscle satellite cells, located between the basal lamina and plasma membrane of myofibers, are required for skeletal muscle regeneration.Skeletal muscle satellite cells are normally mitotically quiescent.Skeletal muscle regeneration as they ultimately provide the myogenic precursors that rebuild damaged muscle tissue skeletal muscle satellite cells are adult muscle-derived stem cells receiving increasing attention.Sheep satellite cells are committed to myogenesis and do not spontaneously adopt nonmyogenic fates.Skeletal muscle satellite cell, is still an ever-growing field 46 years from their initial description.Skeletal muscle satellite cells are adult muscle-derived stem cells receiving increasing attention.", "concepts": [], "type": "summary", "id": "571f356f0fd6f91b68000006", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 100, "text": "Skeletal muscle satellite cells are adult muscle-derived stem cells receiving increasing attention. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22233500", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "Skeletal muscle satellite cells are committed to myogenesis and do not spontaneously adopt nonmyogenic fates. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21339173", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "Skeletal muscle satellite cells play key roles in postnatal muscle growth and regeneration. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17600112", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 173, "text": "Skeletal muscle satellite cells are quiescent mononucleated myogenic cells, located between the sarcolemma and basement membrane of terminally-differentiated muscle fibres. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12757751", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 93, "text": "Satellite cells (SC) are quiescent adult muscle stem cells critical for postnatal development ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25732238", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 178, "text": "Muscle satellite cells are a stem cell population required for postnatal skeletal muscle development and regeneration, accounting for 2-5% of sublaminal nuclei in muscle fibers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24747722", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 147, "text": "Skeletal muscle satellite cells, located between the basal lamina and plasma membrane of myofibers, are required for skeletal muscle regeneration. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19265661", "endSection": "abstract"}, {"offsetInBeginSection": 127, "offsetInEndSection": 275, "text": "Satellite cells are essential for skeletal muscle regeneration as they ultimately provide the myogenic precursors that rebuild damaged muscle tissue ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24439806", "endSection": "abstract"}, {"offsetInBeginSection": 694, "offsetInEndSection": 853, "text": "Satellite cell-derived muscle precursor cells may be used to repair and regenerate damaged or myopathic skeletal muscle, or to act as vectors for gene therapy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12757751", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 169, "text": "Research focusing on the canonical adult myogenic progenitor, the skeletal muscle satellite cell, is still an ever-growing field 46 years from their initial description. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17996437", "endSection": "abstract"}, {"offsetInBeginSection": 173, "offsetInEndSection": 367, "text": "These are normally quiescent in adult muscle, but act as a reserve population of cells, able to proliferate in response to injury and give rise to regenerated muscle and to more satellite cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12757751", "endSection": "abstract"}, {"offsetInBeginSection": 173, "offsetInEndSection": 377, "text": "Skeletal muscle is formed during embryogenesis from a subset of muscle precursor cells, which generate both differentiated muscle fibres and specialized muscle-forming stem cells known as satellite cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21727135", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 175, "text": "Satellite cells are multipotential stem cells that mediate postnatal muscle growth and respond differently to temperature based upon aerobic versus anaerobic fiber-type origin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26341996", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 246, "text": "The acquisition of a proliferating-cell status from a quiescent state as well as the shift between proliferation and differentiation are key developmental steps in skeletal-muscle stem cells (satellite cells) to provide proper muscle regeneration ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26055324", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 247, "text": " Muscle satellite cells are a stem cell population required for postnatal skeletal muscle development and regeneration, accounting for 2-5% of sublaminal nuclei in muscle fibers. In adult muscle, satellite cells are normally mitotically quiescent. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24747722", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 289, "text": " Skeletal muscle satellite cells are adult muscle-derived stem cells receiving increasing attention. Sheep satellite cells have a greater similarity to human satellite cells with regard to metabolism, life span, proliferation and differentiation, than satellite cells of the rat and mouse. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22233500", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 377, "text": " Skeletal muscle is a highly specialized tissue composed of non-dividing, multi-nucleated muscle fibres that contract to generate force in a controlled and directed manner. Skeletal muscle is formed during embryogenesis from a subset of muscle precursor cells, which generate both differentiated muscle fibres and specialized muscle-forming stem cells known as satellite cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21727135", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 390, "text": " Skeletal muscle satellite cells, located between the basal lamina and plasma membrane of myofibers, are required for skeletal muscle regeneration. The capacity of satellite cells as well as other cell lineages including mesoangioblasts, mesenchymal stem cells, and side population (SP) cells to contribute to muscle regeneration has complicated the identification of a satellite stem cell. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19265661", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 454, "text": "Skeletal muscle satellite cells (SCs) are Pax7(+) myogenic stem cells that reside between the basal lamina and the plasmalemma of the myofiber. In mature muscles, SCs are typically quiescent, but can be activated in response to muscle injury. Depending on the magnitude of tissue trauma, SCs may divide minimally to repair subtle damage within individual myofibers or produce a larger progeny pool that forms new myofibers in cases of overt muscle injury ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26074812", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 493, "text": "Skeletal muscle mass, function, and repair capacity all progressively decline with aging, restricting mobility, voluntary function, and quality of life. Skeletal muscle repair is facilitated by a population of dedicated muscle stem cells (MuSCs), also known as satellite cells, that reside in anatomically defined niches within muscle tissues. In adult tissues, MuSCs are retained in a quiescent state until they are primed to regenerate damaged muscle through cycles of self-renewal divisions ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26248268", "endSection": "abstract"}]}, {"body": "What is the role of neurogranin in Alzheimer's disease patients?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26136856", "http://www.ncbi.nlm.nih.gov/pubmed/20875798", "http://www.ncbi.nlm.nih.gov/pubmed/15851848"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A8417448", "o": "D051579"}], "ideal_answer": "We recently showed that the dendritic protein neurogranin ( Ng ), including the endogenous Ng peptide 48 to 76 ( Ng48-76 ), is markedly increased in cerebrospinal fluid ( CSF ) in AD and that Ng48-76 is the dominant peptide in human brain tissue.The elevated neurogranin levels in the mci and ad patients, we studied 3 presynaptic vesicle proteins ( synaptotagmin, synaptophysin, and rab 3a ), 2 synaptic degeneration.The elevated neurogranin levels in the mci and ad biomarkers in the early diagnosis of ad and warrants further studies to determine the diagnostic value of neurogranin.These results together suggest that cerebrospinal fluid neurogranin might be valuable together with the established ad group compared with controls, while the mci group was not statistically different from either controls or the ad group.Relative quantification revealed a significant increase of neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in alzheimer's disease.", "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:10652", "http://www.biosemantics.org/jochem#4250477", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051579", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012380", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000544", "http://www.uniprot.org/uniprot/NEUG_BOVIN", "http://www.uniprot.org/uniprot/NEUG_CAPHI", "http://www.uniprot.org/uniprot/NEUG_SERCA", "http://www.uniprot.org/uniprot/NEUG_MOUSE"], "type": "summary", "id": "56bce51cd36b5da37800000a", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20875798", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer&apos;s disease ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20875798", "endSection": "title"}, {"offsetInBeginSection": 1791, "offsetInEndSection": 1915, "text": "In agreement with previous studies, we show that CSF Ng is significantly increased in AD as compared with healthy controls. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26136856", "endSection": "abstract"}, {"offsetInBeginSection": 1452, "offsetInEndSection": 1609, "text": "Our study suggests that postsynaptic proteins and presynaptic proteins are important for synaptic function and may be related to cognitive impairments in AD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15851848", "endSection": "abstract"}, {"offsetInBeginSection": 520, "offsetInEndSection": 721, "text": "Relative quantification revealed a significant increase of neurogranin in the AD group compared with controls, while the MCI group was not statistically different from either controls or the AD group. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20875798", "endSection": "abstract"}, {"offsetInBeginSection": 2011, "offsetInEndSection": 2224, "text": "The results suggest that CSF Ng, in particular Ng48-76, might reflect the neurodegenerative processes within the brain, indicating a role for Ng as a potential novel clinical biomarker for synaptic function in AD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26136856", "endSection": "abstract"}, {"offsetInBeginSection": 1462, "offsetInEndSection": 1699, "text": "These results together suggest that cerebrospinal fluid neurogranin might be valuable together with the established AD biomarkers in the early diagnosis of AD and warrants further studies to determine the diagnostic value of neurogranin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20875798", "endSection": "abstract"}, {"offsetInBeginSection": 816, "offsetInEndSection": 1091, "text": " These modifications were associated with impaired spatial memory and reduced hippocampal expression of signaling molecules important for synaptic plasticity and memory, including neurogranin, CaMKII, ERK, GSK3\u03b2, CREB, and expression of the transcription factor EGR1/Zif268. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24978200", "endSection": "abstract"}, {"offsetInBeginSection": 265, "offsetInEndSection": 505, "text": "We recently showed that the dendritic protein neurogranin (Ng), including the endogenous Ng peptide 48 to 76 (Ng48-76), is markedly increased in cerebrospinal fluid (CSF) in AD and that Ng48-76 is the dominant peptide in human brain tissue. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26136856", "endSection": "abstract"}, {"offsetInBeginSection": 1138, "offsetInEndSection": 1469, "text": "The elevated neurogranin levels in the MCI and AD groups might reflect synaptic degeneration. These results together suggest that cerebrospinal fluid neurogranin might be valuable together with the established AD biomarkers in the early diagnosis of AD and warrants further studies to determine the diagnostic value of neurogranin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20875798", "endSection": "abstract"}, {"offsetInBeginSection": 141, "offsetInEndSection": 522, "text": "Further, to determine whether presynaptic or postsynaptic compartments of neurons are preferentially affected in AD patients, we studied 3 presynaptic vesicle proteins (synaptotagmin, synaptophysin, and Rab 3A), 2 synaptic membrane proteins (Gap 43 and synaptobrevin), and 2 postsynaptic proteins (neurogranin and synaptopodin) in specimens from AD and age-matched control brains. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15851848", "endSection": "abstract"}]}, {"body": "Does triiodothyronine play a regulatory role in insulin secretion from pancreas?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21914860", "http://www.ncbi.nlm.nih.gov/pubmed/21099301", "http://www.ncbi.nlm.nih.gov/pubmed/20730704", "http://www.ncbi.nlm.nih.gov/pubmed/19021014", "http://www.ncbi.nlm.nih.gov/pubmed/17408701", "http://www.ncbi.nlm.nih.gov/pubmed/1357067", "http://www.ncbi.nlm.nih.gov/pubmed/1537314", "http://www.ncbi.nlm.nih.gov/pubmed/2242013", "http://www.ncbi.nlm.nih.gov/pubmed/3310493", "http://www.ncbi.nlm.nih.gov/pubmed/619228"], "ideal_answer": "Both t3 and t4 inhibited insulin secretion hyroid hormones modulate the immune system and metabolism, influence insulin secretion the administration of thyroxine ( 10 micrograms ) or 3,5,3'-triiodothyronine ( 150 ng ) to 30 + 7 microunits the p43 (- ) mice had a major defect in insulin secretion both in vivo and in isolated pancreatic islets and a loss of glucose-stimulated insulin secretion.All these hormones increased the release of insulin secretion.In the perfused rat pancreas, the addition of thyroxine ( 40 micrograms, s.c. ) in vivo increased the plasma insulin level from 11 + 2 microunits ( mean + sd ) to the perfusing medium did not affect insulin secretion.Islets preincubated with glucose ( 3.3 mmol ) and glucagon ( 1.4 mumol ) plus theophylline ( 10 mmol ), ACTH ( 0.11 nmol ), bovine GH ( 0.46 mumol ), prolactin ( 0.2 mumol ) or tri-iodothyronine ( 1.0 nmol ) have significantly lower Ca ( 2+ ) -ATPase activity than those preincubated with only 3.3 mmol glucose.", "exact_answer": "yes", "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0030073", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050417", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0032024", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0050796", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0046676", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014284", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010179", "http://www.biosemantics.org/jochem#4275389", "http://www.biosemantics.org/jochem#4249447", "http://www.biosemantics.org/jochem#4054676", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007328", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D061385", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011988", "http://www.uniprot.org/uniprot/INS_LOPAM", "http://www.uniprot.org/uniprot/INS_MYOSC", "http://www.uniprot.org/uniprot/INS_GADMC", "http://www.uniprot.org/uniprot/INS_DANRE", "http://www.uniprot.org/uniprot/INS_VERMO", "http://www.uniprot.org/uniprot/INS_LOPPI", "http://www.uniprot.org/uniprot/INS_APLCA", "http://www.uniprot.org/uniprot/INS_RODSP", "http://www.uniprot.org/uniprot/INS_HORSE", "http://www.uniprot.org/uniprot/INS_HYSCR", "http://www.uniprot.org/uniprot/INS_ATRSP", "http://www.uniprot.org/uniprot/INS_CAVPO", "http://www.uniprot.org/uniprot/INS_ORENI", "http://www.uniprot.org/uniprot/INS_CALMI", "http://www.uniprot.org/uniprot/INS_CANFA", "http://www.uniprot.org/uniprot/INS_CAMDR", "http://www.uniprot.org/uniprot/INS_ORNAN", "http://www.uniprot.org/uniprot/INS_CAPHI", "http://www.uniprot.org/uniprot/INS_CAIMO", "http://www.uniprot.org/uniprot/INS_CHICK", "http://www.uniprot.org/uniprot/INS_CHICH", "http://www.uniprot.org/uniprot/INS_PHYMC", "http://www.uniprot.org/uniprot/INS_LAMFL", "http://www.uniprot.org/uniprot/INS_PIAME", "http://www.uniprot.org/uniprot/INS_SHEEP", "http://www.uniprot.org/uniprot/INS_OCTDE", "http://www.uniprot.org/uniprot/INS_SQUAC", "http://www.uniprot.org/uniprot/INS_PANBU", "http://www.uniprot.org/uniprot/INS_AOTTR"], "type": "yesno", "id": "51682382298dcd4e51000066", "snippets": [{"offsetInBeginSection": 588, "offsetInEndSection": 630, "text": "Both T3 and T4 inhibited insulin secretion ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/619228", "endSection": "sections.0"}, {"offsetInBeginSection": 1266, "offsetInEndSection": 1344, "text": "Nonetheless, the insulin secretion is sensibly augmented after T3 stimulation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21099301", "endSection": "sections.0"}, {"offsetInBeginSection": 1, "offsetInEndSection": 87, "text": "hyroid hormones modulate the immune system and metabolism, influence insulin secretion ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19021014", "endSection": "sections.0"}, {"offsetInBeginSection": 202, "offsetInEndSection": 373, "text": "In the perfused rat pancreas, the addition of thyroxine (10 micrograms/dL) or 3,5,3'-triiodothyronine (150 ng/dL) to the perfusing medium did not affect insulin secretion. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2242013", "endSection": "sections.0"}, {"offsetInBeginSection": 1326, "offsetInEndSection": 1476, "text": "T3 (0.2 nM) did not affect insulin secretion in the absence or presence of glucose or in the presence of secretagogues (potassium and glyceraldehyde). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1537314", "endSection": "sections.0"}, {"offsetInBeginSection": 492, "offsetInEndSection": 648, "text": "The p43(-/-) mice had a major defect in insulin secretion both in vivo and in isolated pancreatic islets and a loss of glucose-stimulated insulin secretion. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21914860", "endSection": "sections.0"}, {"offsetInBeginSection": 1182, "offsetInEndSection": 1340, "text": "Although adult offspring born from hypothyroid mothers were euthyroid, their glucose tolerance and glucose stimulated insulin secretion of islets were altered ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20730704", "endSection": "sections.0"}, {"offsetInBeginSection": 914, "offsetInEndSection": 1083, "text": "We demonstrated that treatment of primary cultures of rat pancreatic islets with T3 results in augmented \u03b2-cell vitality with an increase of their functional properties. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21099301", "endSection": "sections.0"}, {"offsetInBeginSection": 1105, "offsetInEndSection": 1320, "text": "Our findings establish that p43 is an important regulator of glucose homeostasis and pancreatic \u03b2-cell function and provide evidence for the first time of a physiological role for a mitochondrial endocrine receptor. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21914860", "endSection": "sections.0"}, {"offsetInBeginSection": 999, "offsetInEndSection": 1190, "text": "Only T(3) concentrations higher than 250 microM were able to decrease cell viability and proliferation rate, to increase the rate of apoptosis and to reduce glucose-induced insulin secretion. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17408701", "endSection": "sections.0"}, {"offsetInBeginSection": 374, "offsetInEndSection": 541, "text": "The administration of thyroxine (40 micrograms/kg, s.c.) in vivo increased the plasma insulin level from 11 +/- 2 microUnits/mL (mean +/- SD) to 30 +/- 7 microUnits/mL ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2242013", "endSection": "sections.0"}, {"offsetInBeginSection": 681, "offsetInEndSection": 946, "text": "Plasma glucose concentration of the fetal hypothyroid group during intravenous glucose tolerance test was significantly higher (p=0.003) at 5-20 min as compared to the control group, whereas plasma insulin concentration was significantly lower (p=0.012) at 5-20 min ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20730704", "endSection": "sections.0"}, {"offsetInBeginSection": 626, "offsetInEndSection": 1003, "text": "Addition of T3 to the incubation medium, significantly modified the insulin release, but its effect varied according to the glucose concentration in the medium, i.e. it enhanced the insulin release at a glucose concentration between 2 to 8 mmol/l; it has no effect at 12 mmol/glucose, and significantly inhibited the secretion of insulin in the presence of 16.6 mmol/l glucose. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3310493", "endSection": "sections.0"}, {"offsetInBeginSection": 359, "offsetInEndSection": 735, "text": "Islets preincubated with glucose (3.3 mmol/l) and glucagon (1.4 mumol/l) plus theophylline (10 mmol/l), ACTH (0.11 nmol/l), bovine GH (0.46 mumol/l), prolactin (0.2 mumol/l) or tri-iodothyronine (1.0 nmol/l) have significantly lower Ca(2+)-ATPase activity than those preincubated with only 3.3 mmol glucose/l. All these hormones increased the release of insulin significantly. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1357067", "endSection": "sections.0"}]}, {"body": "How many disulfide bridges has the protein hepcidin got?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24018861", "http://www.ncbi.nlm.nih.gov/pubmed/22967859", "http://www.ncbi.nlm.nih.gov/pubmed/22705624", "http://www.ncbi.nlm.nih.gov/pubmed/21838701", "http://www.ncbi.nlm.nih.gov/pubmed/11985602", "http://www.ncbi.nlm.nih.gov/pubmed/21073997"], "triples": [], "ideal_answer": "Cshepc has eight cysteines formed four intramolecular disulfide bridges, similarly to that of human's hepcidin, a 25 amino acid peptide hormone containing a complex network of four disulfide bonds is the hormone regulator of iron homeostasis hepcidin contains eight cysteine residues that form four disulfide bridges, which stabilize a hairpin-shaped structure with two beta sheets.Hepcidin, containing four disulfide bridges molecular mass measurements of the native peptide and the reduced and alkylated peptide confirmed the sequence with four intramolecular disulfide bridges.", "exact_answer": [["Hepcidin contains eight cysteine residues that form four disulfide bridges"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D064451", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004220", "http://www.uniprot.org/uniprot/HEPC_RAT"], "type": "factoid", "id": "54f2210164850a5854000001", "snippets": [{"offsetInBeginSection": 356, "offsetInEndSection": 400, "text": " hepcidin, containing four disulfide bridges ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24018861", "endSection": "abstract"}, {"offsetInBeginSection": 533, "offsetInEndSection": 629, "text": "Cshepc has eight cysteines formed four conserved disulfide bridges, similarly to that of human's ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22967859", "endSection": "abstract"}, {"offsetInBeginSection": 203, "offsetInEndSection": 313, "text": "The native peptide of 25 amino acids (Hepc25) contains four disulfide bridges that maintain a \u03b2-hairpin motif. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22705624", "endSection": "abstract"}, {"offsetInBeginSection": 467, "offsetInEndSection": 622, "text": "Molecular mass measurements of the native peptide and the reduced and alkylated peptide confirmed the sequence with four intramolecular disulfide bridges. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11985602", "endSection": "abstract"}, {"offsetInBeginSection": 435, "offsetInEndSection": 575, "text": "Hepcidin contains eight cysteine residues that form four disulfide bridges, which stabilize a hairpin-shaped structure with two beta sheets. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21073997", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "Hepcidin, a 25 amino acid peptide hormone containing a complex network of four disulfide bonds is the hormone regulator of iron homeostasis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21838701", "endSection": "abstract"}]}, {"body": "What is the association between GERD and gluten ?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23567359", "http://www.ncbi.nlm.nih.gov/pubmed/21438963", "http://www.ncbi.nlm.nih.gov/pubmed/20601132", "http://www.ncbi.nlm.nih.gov/pubmed/18853995", "http://www.ncbi.nlm.nih.gov/pubmed/15316418"], "triples": [], "ideal_answer": "Food intolerance is a common complaint amongst patients with functional gastrointestinal ( gi ) disorders ( fgids ), including those with irritable bowel syndrome ( ibs ), functional dyspepsia, as well as gastroesophageal reflux disease.The association between these two conditions is, at most, weak, but a gluten-free diet may still bring symptomatic relief for reflux symptoms in coeliac disease since the participation of gluten in the esophageal symptoms of CD seems clear, its intimate mechanisms have yet to be elucidated, and several hypothesis have been proposed, including the specific immune alterations characterizing CD, the reduction in nutrient absorption determining the arrival of intact gluten to distal gastrointestinal segments, and various dysregulations in the function of gastrointestinal hormones and peptides.The gfd is associated with a rapid and persistent improvement in reflux symptoms we aimed to assess the prevalence of gerd symptoms at diagnosis and to determine the impact of the gluten-free diet ( gfd ).There is a great interest in the role of a major dietary protein, gluten, in the production of symptoms that resembles the healthy population.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005764", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005983", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002446", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D055050"], "type": "summary", "id": "5324d12b9b2d7acc7e000024", "snippets": [{"offsetInBeginSection": 895, "offsetInEndSection": 998, "text": "There is a great interest in the role of a major dietary protein, gluten, in the production of symptoms ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23567359", "endSection": "abstract"}, {"offsetInBeginSection": 1472, "offsetInEndSection": 1578, "text": "In coeliac patients, the reflux symptoms were mild but nevertheless were alleviated on a gluten-free diet. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15316418", "endSection": "abstract"}, {"offsetInBeginSection": 1068, "offsetInEndSection": 1187, "text": "Altogether, 0.9% of patients with oesophagitis and 0.6% of those with oesophageal reflux symptoms had coeliac disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15316418", "endSection": "abstract"}, {"offsetInBeginSection": 836, "offsetInEndSection": 949, "text": "Moderate to severe symptoms were significantly associated with the classical clinical presentation of CD (35.0%) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20601132", "endSection": "abstract"}, {"offsetInBeginSection": 1297, "offsetInEndSection": 1399, "text": "The prevalence of oesophagitis was 5.2% in untreated coeliac disease, 5.6% in treated coeliac disease, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15316418", "endSection": "abstract"}, {"offsetInBeginSection": 1725, "offsetInEndSection": 1885, "text": "The association between these two conditions is, at most, weak, but a gluten-free diet may still bring symptomatic relief for reflux symptoms in coeliac disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15316418", "endSection": "abstract"}, {"offsetInBeginSection": 602, "offsetInEndSection": 720, "text": ": At diagnosis, celiac patients had a significantly higher reflux symptom mean score than healthy controls (P < .001). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20601132", "endSection": "abstract"}, {"offsetInBeginSection": 424, "offsetInEndSection": 586, "text": "several published studies have consistently shown the efficacy of a gluten-free diet in rapidly controlling esophageal symptoms and in preventing their recurrence ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21438963", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "Effect of gluten-free diet on preventing recurrence of gastroesophageal reflux disease-related symptoms in adult celiac patients with nonerosive reflux disease. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18853995", "endSection": "title"}, {"offsetInBeginSection": 1188, "offsetInEndSection": 1382, "text": "GERD symptoms are common in classically symptomatic untreated CD patients. The GFD is associated with a rapid and persistent improvement in reflux symptoms that resembles the healthy population. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20601132", "endSection": "abstract"}, {"offsetInBeginSection": 19, "offsetInEndSection": 253, "text": "Celiac disease (CD) patients often complain of symptoms consistent with gastroesophageal reflux disease (GERD). We aimed to assess the prevalence of GERD symptoms at diagnosis and to determine the impact of the gluten-free diet (GFD). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20601132", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 231, "text": "Food intolerance is a common complaint amongst patients with functional gastrointestinal (GI) disorders (FGIDs), including those with irritable bowel syndrome (IBS), functional dyspepsia, as well as gastroesophageal reflux disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23567359", "endSection": "abstract"}, {"offsetInBeginSection": 1083, "offsetInEndSection": 1350, "text": "The present study is the first to have evaluated the effect of a GFD in the nonerosive form of GERD in CD patients, by means of clinical long-term follow-up, suggesting that GFD could be a useful approach in reducing GERD symptoms and in the prevention of recurrence. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18853995", "endSection": "abstract"}, {"offsetInBeginSection": 588, "offsetInEndSection": 1023, "text": "Since the participation of gluten in the esophageal symptoms of CD seems clear, its intimate mechanisms have yet to be elucidated, and several hypothesis have been proposed, including the specific immune alterations characterizing CD, the reduction in nutrient absorption determining the arrival of intact gluten to distal gastrointestinal segments, and various dysregulations in the function of gastrointestinal hormones and peptides. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21438963", "endSection": "abstract"}]}, {"body": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18812180"], "triples": [], "ideal_answer": "Upon DNA damage, phosphorylation of additional Chk2 sites was observed ( S19, S33 ) transfection of HEK293 cells with Chk2 wildtype and Chk2 mutants in the absence or presence of DNA damage showed significant T68 phosphorylation already in the absence of DNA damaging reagents despite distinct time-dependent autophosphorylation kinetics by monitoring the phosphorylation of amino acid residues T68, S19, S33, T432, in Chk2 wildtype and Chk2 mutants ( T68A, T68D and Q69E ) they gave identical specific activities", "exact_answer": [["T68"], ["S19"], ["S33/35"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010766", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D064447", "http://www.uniprot.org/uniprot/CHK2_HUMAN", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016310", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0042325", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006468", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0001932"], "type": "list", "id": "5357b9bcf1005d6b58000008", "snippets": [{"offsetInBeginSection": 890, "offsetInEndSection": 974, "text": "Upon DNA damage, phosphorylation of additional Chk2 sites was observed (S19, S33/35) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18812180", "endSection": "abstract"}, {"offsetInBeginSection": 696, "offsetInEndSection": 888, "text": "Transfection of HEK293 cells with Chk2 wildtype and Chk2 mutants in the absence or presence of DNA damage showed significant T68 phosphorylation already in the absence of DNA damaging reagents ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18812180", "endSection": "abstract"}, {"offsetInBeginSection": 263, "offsetInEndSection": 500, "text": "Despite distinct time-dependent autophosphorylation kinetics by monitoring the phosphorylation of amino acid residues T68, S19, S33/35, T432, in Chk2 wildtype and Chk2 mutants (T68A, T68D and Q69E) they gave identical specific activities ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18812180", "endSection": "abstract"}]}, {"body": "Is the Histidine-Rich Calcium Binding protein (HRC) related to arrhythmias and cardiac disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24125847", "http://www.ncbi.nlm.nih.gov/pubmed/21742996", "http://www.ncbi.nlm.nih.gov/pubmed/20807542", "http://www.ncbi.nlm.nih.gov/pubmed/19403607", "http://www.ncbi.nlm.nih.gov/pubmed/18617481", "http://www.ncbi.nlm.nih.gov/pubmed/22952658", "http://www.ncbi.nlm.nih.gov/pubmed/22040806", "http://www.ncbi.nlm.nih.gov/pubmed/17030629", "http://www.ncbi.nlm.nih.gov/pubmed/15191886"], "triples": [], "ideal_answer": "We observed that the levels of hrc were reduced in animal models and human heart failure.Chronic overexpression of hrc that may disrupt intracellular ca ( 2+ ) binding protein, specifically expressed in striated muscles of mammals.Hrc plays an important role in myocyte differentiation and in antiapoptotic cardioprotection against ischemia induced cardiac injury.Chronic overexpression of hrc that may disrupt intracellular ca ( 2+ ) homeostasis is implicated in pathogenesis of cardiac fibrosis compared with control.However, aav9-mediated hrc-kd in tac-fh was associated with decreased fractional shortening and increased cardiac muscles, hrc binds to sarcoplasmic reticulum ( sr ) membranes via triadin, a junctional sr protein.In rabbit skeletal and cardiac muscles, hrc binds to sarcoplasmic reticulum ( sr ) membranes via triadin, a junctional sr protein.However, aav9-mediated hrc-kd in tac-fh was associated with decreased fractional shortening and increased cardiac hypertrophy the histidine-rich calcium binding protein ( hrc ) ser96ala polymorphism was shown to correlate with ventricular arrhythmias and sudden death only in dilated cardiomyopathy patients but not in healthy human carriers.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006331", "http://www.biosemantics.org/jochem#4263030"], "type": "yesno", "id": "54f482d264850a5854000009", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "AAV-mediated knock-down of HRC exacerbates transverse aorta constriction-induced heart failure. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22952658", "endSection": "title"}, {"offsetInBeginSection": 288, "offsetInEndSection": 377, "text": "We observed that the levels of HRC were reduced in animal models and human heart failure. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15191886", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18617481", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding protein. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24125847", "endSection": "title"}, {"offsetInBeginSection": 191, "offsetInEndSection": 323, "text": "Chronic overexpression of HRC that may disrupt intracellular Ca(2+) homeostasis is implicated in pathogenesis of cardiac hypertrophy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22952658", "endSection": "abstract"}, {"offsetInBeginSection": 1296, "offsetInEndSection": 1441, "text": "However, AAV9-mediated HRC-KD in TAC-FH was associated with decreased fractional shortening and increased cardiac fibrosis compared with control. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22952658", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 214, "text": "The histidine-rich calcium binding protein (HRC) Ser96Ala polymorphism was shown to correlate with ventricular arrhythmias and sudden death only in dilated cardiomyopathy patients but not in healthy human carriers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21742996", "endSection": "abstract"}, {"offsetInBeginSection": 1297, "offsetInEndSection": 1456, "text": "Collectively, these data indicate that alterations in expression levels of HRC are associated with impaired cardiac SR Ca homeostasis and contractile function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15191886", "endSection": "abstract"}, {"offsetInBeginSection": 1404, "offsetInEndSection": 1575, "text": "This review summarizes studies, which have established the critical role of HRC in Ca(2+)-homeostasis, suggesting its importance in cardiac physiology and pathophysiology. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20807542", "endSection": "abstract"}, {"offsetInBeginSection": 325, "offsetInEndSection": 499, "text": "Ablation of HRC showed relatively normal phenotypes under basal condition, but exhibited a significantly increased susceptibility to isoproterenol-induced cardiac hypertrophy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22952658", "endSection": "abstract"}, {"offsetInBeginSection": 1949, "offsetInEndSection": 2095, "text": "Our results present evidence that down-regulation of HRC could deteriorate cardiac function in TAC-FH through perturbed SR-mediated Ca(2+) cycling ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22952658", "endSection": "abstract"}, {"offsetInBeginSection": 1186, "offsetInEndSection": 1402, "text": "Interestingly, HRC has been linked with familiar cardiac conduction disease and an HRC polymorphism was shown to associate with malignant ventricular arrhythmias in the background of idiopathic dilated cardiomyopathy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20807542", "endSection": "abstract"}, {"offsetInBeginSection": 1207, "offsetInEndSection": 1423, "text": "The Ser96Ala genetic variant of HRC is associated with life-threatening ventricular arrhythmias in idiopathic DCM and may serve as an independent predictor of susceptibility to arrhythmogenesis in the setting of DCM. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18617481", "endSection": "abstract"}, {"offsetInBeginSection": 1817, "offsetInEndSection": 1998, "text": "These findings suggest that aberrant SR Ca2+ release and increased susceptibility to delayed afterdepolarizations underlie triggered arrhythmic activity in human Ala96 HRC carriers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24125847", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 212, "text": "A human genetic variant (Ser96Ala) in the sarcoplasmic reticulum (SR) histidine-rich Ca(2+)-binding (HRC) protein has been linked to ventricular arrhythmia and sudden death in dilated cardiomyopathy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24125847", "endSection": "abstract"}, {"offsetInBeginSection": 1274, "offsetInEndSection": 1525, "text": "These findings indicate that the HRC Ser96Ala variant increases the propensity of arrhythmogenic Ca(2+) waves in the stressed failing heart, suggesting a link between this genetic variant and life-threatening ventricular arrhythmias in human carriers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21742996", "endSection": "abstract"}, {"offsetInBeginSection": 1040, "offsetInEndSection": 1403, "text": "HRC plays an important role in myocyte differentiation and in antiapoptotic cardioprotection against ischemia/reperfusion induced cardiac injury. Interestingly, HRC has been linked with familiar cardiac conduction disease and an HRC polymorphism was shown to associate with malignant ventricular arrhythmias in the background of idiopathic dilated cardiomyopathy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20807542", "endSection": "abstract"}, {"offsetInBeginSection": 996, "offsetInEndSection": 1488, "text": "In addition, HRC null mice displayed a significantly exaggerated response to the induction of cardiac hypertrophy by isoproterenol compared to their wild-type littermates. The exaggerated response of HRC knockout mice to the induction of cardiac hypertrophy is consistent with a regulatory role for HRCBP in calcium handling in vivo and suggests that mutations in HRC, in combination with other genetic or environmental factors, might contribute to pathological hypertrophy and heart failure. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17030629", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 448, "text": "Histidine-rich calcium binding protein (HRC) is a high capacity, low affinity Ca(2+) binding protein, specifically expressed in striated muscles of mammals. In rabbit skeletal and cardiac muscles, HRC binds to sarcoplasmic reticulum (SR) membranes via triadin, a junctional SR protein. Recently, a potential role in heart failure and arrhythmogenesis has been assigned to HRC due to its activity as regulator of SR Ca(2+) uptake and Ca(2+) release. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22040806", "endSection": "abstract"}, {"offsetInBeginSection": 634, "offsetInEndSection": 1193, "text": "HRC is a SR luminal Ca(2+) binding protein known to associate with both triadin and the sarcoplasmic reticulum Ca(2+)-ATPase, and may thus mediate the crosstalk between SR Ca(2+) uptake and release. Indeed, evidence from genetic models of JCN and HRC indicate that they are important in cardiophysiology as alterations in these proteins affect SR Ca(2+) handling and cardiac function. In addition, downregulation of JCN and HRC may contribute to Ca(2+) cycling perturbations manifest in the failing heart, where their protein levels are significantly reduced. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19403607", "endSection": "abstract"}]}, {"body": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23093601", "http://www.ncbi.nlm.nih.gov/pubmed/21364800", "http://www.ncbi.nlm.nih.gov/pubmed/17584494", "http://www.ncbi.nlm.nih.gov/pubmed/21945744", "http://www.ncbi.nlm.nih.gov/pubmed/18582175", "http://www.ncbi.nlm.nih.gov/pubmed/14643658", "http://www.ncbi.nlm.nih.gov/pubmed/12218031", "http://www.ncbi.nlm.nih.gov/pubmed/24822028", "http://www.ncbi.nlm.nih.gov/pubmed/25309521", "http://www.ncbi.nlm.nih.gov/pubmed/24808892", "http://www.ncbi.nlm.nih.gov/pubmed/18237442", "http://www.ncbi.nlm.nih.gov/pubmed/12732098", "http://www.ncbi.nlm.nih.gov/pubmed/17188685", "http://www.ncbi.nlm.nih.gov/pubmed/19332823"], "triples": [], "ideal_answer": "Here, we summarize the recent advances of in silico prediction of oriCs in bacterial and archaeal genomes using the Z-curve based method dNA base composition asymmetry is the basis of numerous in silico methods used to detect the origin and terminus of replication in prokaryotes it increases the prediction accuracy of the replication termini compared with previously documented methods based on genomic base composition.The sequences of the ori regions were identified in silico for wolbachia strains and eleven other related bacteria while fundamental characteristics like presence of dnaa and ihf binding sites as well as the boundary genes are more widely conserved.", "exact_answer": [["GC skew analysis"], ["Z curve analysis"], ["comparative genomics"], ["dnaA gene location"], ["localization of dnaA binding sites (DnaA boxes)"], ["localization of CtrA binding sites"], ["localization of IHF binding sites"], ["localization of cell division cycle (cdc6) gene"], ["localization of other boundary genes"], ["localization of other consensus origin recognition box (ORB) sequences"], ["the gene order around the ori"], ["gene distribution in leading versus lagging strand"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018741", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0003688", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000808", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004261"], "type": "list", "id": "5542644fed966d112c000004", "snippets": [{"offsetInBeginSection": 450, "offsetInEndSection": 491, "text": "DnaA binds a single DnaA box as a monomer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14643658", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "Recent Advances in the Identification of Replication Origins Based on the Z-curve Method. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24822028", "endSection": "title"}, {"offsetInBeginSection": 983, "offsetInEndSection": 1119, "text": "Here, we summarize the recent advances of in silico prediction of oriCs in bacterial and archaeal genomes using the Z-curve based method ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24822028", "endSection": "abstract"}, {"offsetInBeginSection": 272, "offsetInEndSection": 415, "text": "DNA base composition asymmetry is the basis of numerous in silico methods used to detect the origin and terminus of replication in prokaryotes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18582175", "endSection": "abstract"}, {"offsetInBeginSection": 272, "offsetInEndSection": 414, "text": "DNA base composition asymmetry is the basis of numerous in silico methods used to detect the origin and terminus of replication in prokaryotes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18582175", "endSection": "abstract"}, {"offsetInBeginSection": 595, "offsetInEndSection": 737, "text": "It increases the prediction accuracy of the replication termini compared with previously documented methods based on genomic base composition. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17188685", "endSection": "abstract"}, {"offsetInBeginSection": 128, "offsetInEndSection": 264, "text": "Using compositional skews such as the GC skew, replication origin and terminus can be predicted in silico by observing the shift points. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17188685", "endSection": "abstract"}, {"offsetInBeginSection": 1127, "offsetInEndSection": 1357, "text": "The sequences of the ori regions described here are only similar among closely related bacteria while fundamental characteristics like presence of DnaA and IHF binding sites as well as the boundary genes are more widely conserved. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17584494", "endSection": "abstract"}, {"offsetInBeginSection": 522, "offsetInEndSection": 715, "text": "Based on the Z-curve theory, we have developed a web-based system Ori-Finder to predict oriCs in bacterial genomes with high accuracy and reliability by taking advantage of comparative genomics ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23093601", "endSection": "abstract"}, {"offsetInBeginSection": 714, "offsetInEndSection": 935, "text": "we have applied a combination of multiple in silico approaches - Z curve, the cell division cycle (cdc6) gene location and location of consensus origin recognition box (ORB) sequences for location of origin of replication ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21364800", "endSection": "abstract"}, {"offsetInBeginSection": 300, "offsetInEndSection": 613, "text": "In silico comparative analysis of sequenced mollicute genomes indicated the lack of conservation of gene order in the region containing the predicted origin of replication (oriC) and the existence, in most of the mollicute genomes examined, of putative DnaA boxes lying upstream and downstream from the dnaA gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12218031", "endSection": "abstract"}, {"offsetInBeginSection": 862, "offsetInEndSection": 1153, "text": "These analyses include finding the dnaA gene and its binding sites; making BLAST analyses of the intergenic sequences compared to related species; studying the gene order around the origin sequence; and studying the distribution of the genes encoded in the leading versus the lagging strand. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18582175", "endSection": "abstract"}, {"offsetInBeginSection": 481, "offsetInEndSection": 888, "text": "Using features that have been previously experimentally verified in the alpha-Proteobacterium Caulobacter crescentus, the origin of DNA replication (ori) regions were identified in silico for Wolbachia strains and eleven other related bacteria belonging to Ehrlichia, Anaplasma, and Rickettsia genera. These features include DnaA-, CtrA- and IHF-binding sites as well as the flanking genes in C. crescentus. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17584494", "endSection": "abstract"}, {"offsetInBeginSection": 692, "offsetInEndSection": 1090, "text": "In this paper we have applied a combination of multiple in silico approaches - Z curve, the cell division cycle (cdc6) gene location and location of consensus origin recognition box (ORB) sequences for location of origin of replication in Thermococcus onnurineus, Thermococcus gammatolerans and other Themococcales and compared the results to that of the well-documented case of Pyrococcus abyssi. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21364800", "endSection": "abstract"}, {"offsetInBeginSection": 452, "offsetInEndSection": 783, "text": "We present a web-based tool Ori-Finder 2 to predict oriCs in the archaeal genomes automatically, based on the integrated method comprising the analysis of base composition asymmetry using the Z-curve method, the distribution of origin recognition boxes identified by FIMO tool, and the occurrence of genes frequently close to oriCs ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25309521", "endSection": "abstract"}, {"offsetInBeginSection": 340, "offsetInEndSection": 724, "text": "We propose a correlation measure and show that it is correctly able to predict the origin of replication in most of the bacterial genomes. When applied to Methanocaldococcus jannaschii, Plasmodium falciparum apicoplast and Nicotiana tabacum plastid, this correlation based method is able to correctly predict the origin of replication whereas the generally used GC skew measure fails. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21945744", "endSection": "abstract"}]}, {"body": "What is the use of emulsion PCR in Next Generation Sequencing?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23900195", "http://www.ncbi.nlm.nih.gov/pubmed/23744319", "http://www.ncbi.nlm.nih.gov/pubmed/23665194", "http://www.ncbi.nlm.nih.gov/pubmed/23546785", "http://www.ncbi.nlm.nih.gov/pubmed/23398507", "http://www.ncbi.nlm.nih.gov/pubmed/23148498", "http://www.ncbi.nlm.nih.gov/pubmed/22668416", "http://www.ncbi.nlm.nih.gov/pubmed/22355625", "http://www.ncbi.nlm.nih.gov/pubmed/21543404", "http://www.ncbi.nlm.nih.gov/pubmed/21513157"], "triples": [], "ideal_answer": "We present a unified strategy in which emulsion pcr is coupled with target enrichment followed by next-generation sequencing.During genomic pcr, in this 4-primer system, the outer set of primers containing the mid and the 454 adaptor sequences are enriched by raindance emulsion pcr.Based on the mechanism of emulsion pcr, a unique dna template would only generate a unique sequence tag at the 5' end of the forward and reverse primers.Here, we describe a novel approach for normalization of multiplex next generation sequencing libraries after emulsion PCR.In our ngs approach, the 16,569-bp mtdna is enriched by long-range pcr and the 108 nuclear genes ( which represent 1301 amplicons and 680 kb ) are incorporated into an amplicon generated by the inner hla target-specific primers each containing a common sequence tag at the 5' end of the forward and reverse primers.Sequencing is performed on Illumina HiSeq 2000 or MiSeq platforms, and bioinformatics analysis is performed using commercial and in-house developed bioinformatics pipelines.Template would only generate a unique sequence read after being amplified and sequenced on gs flx.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004655", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016133", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017422", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017421"], "type": "summary", "id": "5319a83bb166e2b80600002c", "snippets": [{"offsetInBeginSection": 281, "offsetInEndSection": 403, "text": "Here, we describe a novel approach for normalization of multiplex next generation sequencing libraries after emulsion PCR. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22355625", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "Emulsion PCR-coupled target enrichment: an effective fishing method for high-throughput sequencing of poorly preserved ancient DNA ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23900195", "endSection": "title"}, {"offsetInBeginSection": 156, "offsetInEndSection": 307, "text": "Based on the mechanism of emulsion PCR, a unique DNA template would only generate a unique sequence read after being amplified and sequenced on GS FLX. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21543404", "endSection": "abstract"}, {"offsetInBeginSection": 872, "offsetInEndSection": 1073, "text": "We show the efficacy by comparing the method to a commercial kit and further demonstrate that emulsion PCR can be used for bias free amplification and virtual immortalization of DNA template libraries. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22668416", "endSection": "abstract"}, {"offsetInBeginSection": 404, "offsetInEndSection": 607, "text": "Briefly, amplified libraries carrying unique barcodes are prepared by fluorescent tagging of complementary sequences and then resolved by high-speed flow cytometric sorting of labeled emulsion PCR beads. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22355625", "endSection": "abstract"}, {"offsetInBeginSection": 461, "offsetInEndSection": 684, "text": "However, pyrosequencing of emulsion PCR reactions, amplifying from only one molecule at a time, can generate megabases of clonally amplified loci at high coverage, thereby greatly simplifying allelic sequence determination. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23546785", "endSection": "abstract"}, {"offsetInBeginSection": 763, "offsetInEndSection": 1015, "text": "Prior to SOLiD sequencing reaction, the libraries were amplified with emulsion PCR and enriched with the P2 enrichment beads. The library samples were loaded to sequencing Chip for Work Flow Analysis (WFA) or sequencing running with default parameters. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21513157", "endSection": "abstract"}, {"offsetInBeginSection": 428, "offsetInEndSection": 724, "text": "The purpose of our study was to compare NGS enrichment methods for a clinical assay targeting the nine genes known to be associated with aortopathy. RainDance emulsion PCR and SureSelect RNA-bait hybridization capture enrichment methods were directly compared by enriching DNA from eight samples. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148498", "endSection": "abstract"}, {"offsetInBeginSection": 325, "offsetInEndSection": 680, "text": "We present a unified strategy in which emulsion PCR is coupled with target enrichment followed by next-generation sequencing. The method made it possible to obtain efficiently non-duplicated reads mapped to target sequences of interest, and this can achieve deep and reliable sequencing of ancient DNA from typical materials, even though poorly preserved. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23900195", "endSection": "abstract"}, {"offsetInBeginSection": 802, "offsetInEndSection": 1156, "text": "In our NGS approach, the 16,569-bp mtDNA is enriched by long-range PCR and the 108 nuclear genes (which represent 1301 amplicons and 680 kb) are enriched by RainDance emulsion PCR. Sequencing is performed on Illumina HiSeq 2000 or MiSeq platforms, and bioinformatics analysis is performed using commercial and in-house developed bioinformatics pipelines. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23665194", "endSection": "abstract"}, {"offsetInBeginSection": 608, "offsetInEndSection": 959, "text": "The protocol is simple and provides an even sequence distribution of multiplex libraries when sequencing the flow-sorted beads. Moreover, since many empty and mixed emulsion PCR beads are removed, the approach gives rise to a substantial increase in sequence quality and mean read length, as compared to that obtained by standard enrichment protocols. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22355625", "endSection": "abstract"}, {"offsetInBeginSection": 492, "offsetInEndSection": 900, "text": "Three multiplex PCR reactions were carried out to amplify the coding exons of 328 genes including FBN1, TGFBR1 and TGFBR2. DNA fragments from different samples were ligated with barcoded sequencing adaptors. Template preparation and emulsion PCR, and Ion Sphere Particles enrichment were carried out using an Ion One Touch system. The ion sphere particles were sequenced on a 318 chip using the PGM platform. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23744319", "endSection": "abstract"}, {"offsetInBeginSection": 861, "offsetInEndSection": 1319, "text": "During genomic PCR, in this 4-primer system, the outer set of primers containing the MID and the 454 adaptor sequences are incorporated into an amplicon generated by the inner HLA target-specific primers each containing a common sequence tag at the 5' end of the forward and reverse primers. Pools of the resulting amplicons are used for emulsion PCR and clonal sequencing on the 454 Life Sciences GS FLX System, followed by genotyping with Conexio software. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23398507", "endSection": "abstract"}]}, {"body": "Can adult humans be induced to produce fetal hemoglobin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18379999", "http://www.ncbi.nlm.nih.gov/pubmed/17456718", "http://www.ncbi.nlm.nih.gov/pubmed/17486495", "http://www.ncbi.nlm.nih.gov/pubmed/20201948", "http://www.ncbi.nlm.nih.gov/pubmed/20305142", "http://www.ncbi.nlm.nih.gov/pubmed/17041717", "http://www.ncbi.nlm.nih.gov/pubmed/16735596", "http://www.ncbi.nlm.nih.gov/pubmed/14594506", "http://www.ncbi.nlm.nih.gov/pubmed/11929793", "http://www.ncbi.nlm.nih.gov/pubmed/11144280", "http://www.ncbi.nlm.nih.gov/pubmed/10908330", "http://www.ncbi.nlm.nih.gov/pubmed/7541126", "http://www.ncbi.nlm.nih.gov/pubmed/10575541", "http://www.ncbi.nlm.nih.gov/pubmed/21415990", "http://www.ncbi.nlm.nih.gov/pubmed/23997901", "http://www.ncbi.nlm.nih.gov/pubmed/22460946", "http://www.ncbi.nlm.nih.gov/pubmed/16939628", "http://www.ncbi.nlm.nih.gov/pubmed/24222332"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A15585362", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C2350438", "o": "http://linkedlifedata.com/resource/umls/label/A15585362"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A15585362", "o": "G gamma-Globin"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C2350438", "o": "http://linkedlifedata.com/resource/umls/label/A15591265"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A15591265", "o": "G gamma Globin"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C2350438", "o": "http://linkedlifedata.com/resource/umls/label/A15585362"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A15591265", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C2350438", "o": "http://linkedlifedata.com/resource/umls/label/A15585362"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A15585362", "o": "G gamma-Globin"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C2350438", "o": "http://linkedlifedata.com/resource/umls/label/A15591265"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A15591265", "o": "G gamma Globin"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C2350438", "o": "http://linkedlifedata.com/resource/umls/label/A15585362"}, {"p": "http://purl.uniprot.org/core/citation", "s": "http://purl.uniprot.org/uniprot/P68078", "o": "http://purl.uniprot.org/citations/2420747"}, {"p": "http://purl.uniprot.org/core/name", "s": "http://purl.uniprot.org/pubmed/2420747", "o": "Hemoglobin"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/2420747", "o": "http://purl.uniprot.org/pubmed/2420747"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68078", "o": "http://linkedlifedata.com/resource/#_503638303738009"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68078", "o": "http://linkedlifedata.com/resource/#_503638303738008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303738008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303738007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68078", "o": "http://linkedlifedata.com/resource/#_503638303738007"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/2420747", "o": "http://purl.uniprot.org/medline/86167516"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303738009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/citation", "s": "http://purl.uniprot.org/uniprot/P68079", "o": "http://purl.uniprot.org/citations/511581"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68079", "o": "http://linkedlifedata.com/resource/#_503638303739007"}, {"p": "http://purl.uniprot.org/core/name", "s": "http://purl.uniprot.org/pubmed/511581", "o": "Hemoglobin"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303739008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68079", "o": "http://linkedlifedata.com/resource/#_503638303739008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303739009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303739007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68079", "o": "http://linkedlifedata.com/resource/#_503638303739009"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/511581", "o": "http://purl.uniprot.org/medline/80071586"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/511581", "o": "http://purl.uniprot.org/pubmed/511581"}, {"p": "http://purl.uniprot.org/core/citation", "s": "http://purl.uniprot.org/uniprot/P02097", "o": "http://purl.uniprot.org/citations/105752"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/105752", "o": "http://purl.uniprot.org/medline/79124683"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P02097", "o": "http://linkedlifedata.com/resource/#_503032303937007"}, {"p": "http://purl.uniprot.org/core/name", "s": "http://purl.uniprot.org/pubmed/105752", "o": "Biochemistry"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P02097", "o": "http://linkedlifedata.com/resource/#_503032303937009"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P02097", "o": "http://linkedlifedata.com/resource/#_503032303937008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503032303937007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503032303937009", "o": "Hemoglobin gamma chain"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/105752", "o": "http://purl.uniprot.org/pubmed/105752"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503032303937008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/citation", "s": "http://purl.uniprot.org/uniprot/P68077", "o": "http://purl.uniprot.org/citations/6157408"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68077", "o": "http://linkedlifedata.com/resource/#_503638303737008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303737009", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/name", "s": "http://purl.uniprot.org/pubmed/6157408", "o": "Biochemistry"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/6157408", "o": "http://purl.uniprot.org/pubmed/6157408"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68077", "o": "http://linkedlifedata.com/resource/#_503638303737009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303737008", "o": "Hemoglobin subunit gamma"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/6157408", "o": "http://purl.uniprot.org/medline/81000303"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68077", "o": "http://linkedlifedata.com/resource/#_50363830373700A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50363830373700A", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P08225", "o": "http://linkedlifedata.com/resource/#_50303832323500A"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P08225", "o": "http://linkedlifedata.com/resource/#_503038323235007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503038323235007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P08225", "o": "http://linkedlifedata.com/resource/#_503038323235008"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P08225", "o": "http://linkedlifedata.com/resource/#_503038323235009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503038323235009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503038323235008", "o": "Gamma-globin"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50303832323500A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P56285", "o": "http://linkedlifedata.com/resource/#_50353632383500A"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P56285", "o": "http://linkedlifedata.com/resource/#_503536323835007"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P56285", "o": "http://linkedlifedata.com/resource/#_503536323835008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503536323835008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503536323835009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P56285", "o": "http://linkedlifedata.com/resource/#_503536323835009"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50353632383500A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503536323835007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68071", "o": "http://linkedlifedata.com/resource/#_50363830373100A"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68071", "o": "http://linkedlifedata.com/resource/#_503638303731009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303731009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303731007", "o": "Hemoglobin subunit gamma"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830373100A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68071", "o": "http://linkedlifedata.com/resource/#_503638303731008"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68071", "o": "http://linkedlifedata.com/resource/#_503638303731007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303731008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68078", "o": "http://linkedlifedata.com/resource/#_50363830373800A"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830373800A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68078", "o": "http://linkedlifedata.com/resource/#_503638303738009"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68078", "o": "http://linkedlifedata.com/resource/#_503638303738008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303738008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303738007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68078", "o": "http://linkedlifedata.com/resource/#_503638303738007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303738009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68079", "o": "http://linkedlifedata.com/resource/#_50363830373900A"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68079", "o": "http://linkedlifedata.com/resource/#_503638303739007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303739008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68079", "o": "http://linkedlifedata.com/resource/#_503638303739008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303739009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303739007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68079", "o": "http://linkedlifedata.com/resource/#_503638303739009"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830373900A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q27940", "o": "http://linkedlifedata.com/resource/#_51323739343000A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513237393430009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513237393430008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q27940", "o": "http://linkedlifedata.com/resource/#_513237393430007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513237393430007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q27940", "o": "http://linkedlifedata.com/resource/#_513237393430008"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_51323739343000A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q27940", "o": "http://linkedlifedata.com/resource/#_513237393430009"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q45XH6", "o": "http://linkedlifedata.com/resource/#_51343558483600B"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_51343558483600B", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q45XH6", "o": "http://linkedlifedata.com/resource/#_513435584836008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584836008", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH6", "o": "http://linkedlifedata.com/resource/#_513435584836009"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH6", "o": "http://linkedlifedata.com/resource/#_51343558483600A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584836009", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_51343558483600A", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q45XH7", "o": "http://linkedlifedata.com/resource/#_51343558483700B"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584837009", "o": "Gamma-globin"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_51343558483700B", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH7", "o": "http://linkedlifedata.com/resource/#_51343558483700A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_51343558483700A", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q45XH7", "o": "http://linkedlifedata.com/resource/#_513435584837008"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH7", "o": "http://linkedlifedata.com/resource/#_513435584837009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584837008", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q45XH8", "o": "http://linkedlifedata.com/resource/#_51343558483800B"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_51343558483800A", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH8", "o": "http://linkedlifedata.com/resource/#_51343558483800A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584838009", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584838008", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q45XH8", "o": "http://linkedlifedata.com/resource/#_513435584838008"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH8", "o": "http://linkedlifedata.com/resource/#_513435584838009"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_51343558483800B", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/O77655", "o": "http://linkedlifedata.com/resource/#_4F373736353500B"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/O77655", "o": "http://linkedlifedata.com/resource/#_4F3737363535008"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/O77655", "o": "http://linkedlifedata.com/resource/#_4F3737363535009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F3737363535009", "o": "Gamma-globin"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_4F373736353500B", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F373736353500A", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/O77655", "o": "http://linkedlifedata.com/resource/#_4F373736353500A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F3737363535008", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P02097", "o": "http://linkedlifedata.com/resource/#_50303230393700A"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P02097", "o": "http://linkedlifedata.com/resource/#_503032303937007"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50303230393700A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P02097", "o": "http://linkedlifedata.com/resource/#_503032303937009"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P02097", "o": "http://linkedlifedata.com/resource/#_503032303937008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503032303937007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503032303937009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503032303937008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P08224", "o": "http://linkedlifedata.com/resource/#_50303832323400A"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50303832323400A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503038323234009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P08224", "o": "http://linkedlifedata.com/resource/#_503038323234007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503038323234008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P08224", "o": "http://linkedlifedata.com/resource/#_503038323234008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503038323234007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P08224", "o": "http://linkedlifedata.com/resource/#_503038323234009"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P18436", "o": "http://linkedlifedata.com/resource/#_50313834333600A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503138343336009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503138343336007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P18436", "o": "http://linkedlifedata.com/resource/#_503138343336007"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50313834333600A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503138343336008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P18436", "o": "http://linkedlifedata.com/resource/#_503138343336008"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P18436", "o": "http://linkedlifedata.com/resource/#_503138343336009"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P19760", "o": "http://linkedlifedata.com/resource/#_50313937363000F"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50313937363000C", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P19760", "o": "http://linkedlifedata.com/resource/#_50313937363000C"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P19760", "o": "http://linkedlifedata.com/resource/#_50313937363000D"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50313937363000F", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P19760", "o": "http://linkedlifedata.com/resource/#_50313937363000B"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50313937363000B", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50313937363000D", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68030", "o": "http://linkedlifedata.com/resource/#_50363830333000A"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68030", "o": "http://linkedlifedata.com/resource/#_503638303330008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303330008", "o": "Gamma-globin"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830333000A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303330007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303330009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68030", "o": "http://linkedlifedata.com/resource/#_503638303330007"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68030", "o": "http://linkedlifedata.com/resource/#_503638303330009"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68031", "o": "http://linkedlifedata.com/resource/#_50363830333100A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303331007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303331009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68031", "o": "http://linkedlifedata.com/resource/#_503638303331009"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68031", "o": "http://linkedlifedata.com/resource/#_503638303331007"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68031", "o": "http://linkedlifedata.com/resource/#_503638303331008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303331008", "o": "Gamma-globin"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830333100A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68068", "o": "http://linkedlifedata.com/resource/#_50363830363800C"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68068", "o": "http://linkedlifedata.com/resource/#_50363830363800A"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830363800C", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68068", "o": "http://linkedlifedata.com/resource/#_503638303638009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303638009", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50363830363800A", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68068", "o": "http://linkedlifedata.com/resource/#_50363830363800B"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50363830363800B", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68069", "o": "http://linkedlifedata.com/resource/#_50363830363900A"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68069", "o": "http://linkedlifedata.com/resource/#_503638303639008"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830363900A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68069", "o": "http://linkedlifedata.com/resource/#_503638303639007"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68069", "o": "http://linkedlifedata.com/resource/#_503638303639009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303639009", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303639007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303639008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68070", "o": "http://linkedlifedata.com/resource/#_50363830373000A"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68070", "o": "http://linkedlifedata.com/resource/#_503638303730009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303730007", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303730009", "o": "Hemoglobin gamma chain"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830373000A", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68070", "o": "http://linkedlifedata.com/resource/#_503638303730007"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68070", "o": "http://linkedlifedata.com/resource/#_503638303730008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303730008", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/P68077", "o": "http://linkedlifedata.com/resource/#_50363830373700B"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P68077", "o": "http://linkedlifedata.com/resource/#_503638303737008"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_50363830373700B", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303737009", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68077", "o": "http://linkedlifedata.com/resource/#_503638303737009"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_503638303737008", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P68077", "o": "http://linkedlifedata.com/resource/#_50363830373700A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50363830373700A", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q45XH5", "o": "http://linkedlifedata.com/resource/#_51343558483500B"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584835009", "o": "Gamma-globin"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_51343558483500B", "o": "HBG"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH5", "o": "http://linkedlifedata.com/resource/#_513435584835009"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH5", "o": "http://linkedlifedata.com/resource/#_51343558483500A"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q45XH5", "o": "http://linkedlifedata.com/resource/#_513435584835008"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_51343558483500A", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584835008", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/mnemonic", "s": "http://purl.uniprot.org/uniprot/Q45XH8", "o": "HBG_LOXAF"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_51343558483800A", "o": "Hemoglobin gamma chain"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH8", "o": "http://linkedlifedata.com/resource/#_51343558483800A"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584838009", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513435584838008", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q45XH8", "o": "http://linkedlifedata.com/resource/#_513435584838008"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q45XH8", "o": "http://linkedlifedata.com/resource/#_513435584838009"}, {"p": "http://purl.uniprot.org/core/citation", "s": "http://purl.uniprot.org/uniprot/P19760", "o": "http://purl.uniprot.org/citations/1639402"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/1639402", "o": "http://purl.uniprot.org/medline/92347874"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50313937363000C", "o": "Gamma-globin"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P19760", "o": "http://linkedlifedata.com/resource/#_50313937363000C"}, {"p": "http://purl.uniprot.org/core/name", "s": "http://purl.uniprot.org/pubmed/1639402", "o": "Genomics"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/P19760", "o": "http://linkedlifedata.com/resource/#_50313937363000D"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/P19760", "o": "http://linkedlifedata.com/resource/#_50313937363000B"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/1639402", "o": "http://purl.uniprot.org/pubmed/1639402"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50313937363000B", "o": "Hemoglobin subunit gamma"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_50313937363000D", "o": "Hemoglobin gamma chain"}], "ideal_answer": "The data suggest that tgf-beta reactivates gamma-globin expression, combined with a sequential stimulation and suppression of erythropoiesis.With the increased understanding and discovery of molecular regulators of haemoglobin switching, such as bcl11a, new avenues of research may lead ultimately to novel therapeutic, mechanism-based approaches to fetal haemoglobin reactivation in patients.Whereas in the trace amounts of HbF that is found in the adult it reverses to 40:60 because of a gamma- to beta-globin gene switchAt the time of birth, HbF accounts for approximately 70 % of the total Hb.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D055545", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005914", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002648", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D055544", "http://www.uniprot.org/uniprot/HBG_BRAAR", "http://www.uniprot.org/uniprot/GLB_APLLI", "http://www.biosemantics.org/jochem#4249367", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0005344", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006454", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005319", "http://www.biosemantics.org/jochem#4249310"], "type": "yesno", "id": "531481ade3eabad021000016", "snippets": [{"offsetInBeginSection": 243, "offsetInEndSection": 318, "text": " At the time of birth, HbF accounts for approximately 70% of the total Hb. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18379999", "endSection": "abstract"}, {"offsetInBeginSection": 1050, "offsetInEndSection": 1192, "text": "The data suggest that TGF-beta reactivates gamma-globin expression, combined with a sequential stimulation and suppression of erythropoiesis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14594506", "endSection": "abstract"}, {"offsetInBeginSection": 390, "offsetInEndSection": 521, "text": " whereas in the trace amounts of HbF that is found in the adult it reverses to 40:60 because of a gamma- to beta-globin gene switch ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18379999", "endSection": "abstract"}, {"offsetInBeginSection": 734, "offsetInEndSection": 986, "text": "With the increased understanding and discovery of molecular regulators of haemoglobin switching, such as BCL11A, new avenues of research may lead ultimately to novel therapeutic, mechanism-based approaches to fetal haemoglobin reactivation in patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20201948", "endSection": "abstract"}]}, {"body": "Which receptors can be evaluated with the [18F]altanserin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23456885", "http://www.ncbi.nlm.nih.gov/pubmed/23390031", "http://www.ncbi.nlm.nih.gov/pubmed/23137806", "http://www.ncbi.nlm.nih.gov/pubmed/21996132", "http://www.ncbi.nlm.nih.gov/pubmed/21750562", "http://www.ncbi.nlm.nih.gov/pubmed/21473029", "http://www.ncbi.nlm.nih.gov/pubmed/21473027", "http://www.ncbi.nlm.nih.gov/pubmed/21098981", "http://www.ncbi.nlm.nih.gov/pubmed/20641567", "http://www.ncbi.nlm.nih.gov/pubmed/19959344", "http://www.ncbi.nlm.nih.gov/pubmed/19353726", "http://www.ncbi.nlm.nih.gov/pubmed/19162492", "http://www.ncbi.nlm.nih.gov/pubmed/19007894", "http://www.ncbi.nlm.nih.gov/pubmed/18828013", "http://www.ncbi.nlm.nih.gov/pubmed/17541696", "http://www.ncbi.nlm.nih.gov/pubmed/17241616", "http://www.ncbi.nlm.nih.gov/pubmed/9826230", "http://www.ncbi.nlm.nih.gov/pubmed/7673371", "http://www.ncbi.nlm.nih.gov/pubmed/9027929", "http://www.ncbi.nlm.nih.gov/pubmed/9257335", "http://www.ncbi.nlm.nih.gov/pubmed/10587097", "http://www.ncbi.nlm.nih.gov/pubmed/10688105", "http://www.ncbi.nlm.nih.gov/pubmed/12902843", "http://www.ncbi.nlm.nih.gov/pubmed/17195073", "http://www.ncbi.nlm.nih.gov/pubmed/15356424", "http://www.ncbi.nlm.nih.gov/pubmed/12224404", "http://www.ncbi.nlm.nih.gov/pubmed/1428914", "http://www.ncbi.nlm.nih.gov/pubmed/12642173", "http://www.ncbi.nlm.nih.gov/pubmed/9824691", "http://www.ncbi.nlm.nih.gov/pubmed/10588399", "http://www.ncbi.nlm.nih.gov/pubmed/20956470", "http://www.ncbi.nlm.nih.gov/pubmed/19015089", "http://www.ncbi.nlm.nih.gov/pubmed/22940693", "http://www.ncbi.nlm.nih.gov/pubmed/16206185", "http://www.ncbi.nlm.nih.gov/pubmed/17185512", "http://www.ncbi.nlm.nih.gov/pubmed/24120220", "http://www.ncbi.nlm.nih.gov/pubmed/7995287", "http://www.ncbi.nlm.nih.gov/pubmed/21722741", "http://www.ncbi.nlm.nih.gov/pubmed/23824248", "http://www.ncbi.nlm.nih.gov/pubmed/23303045", "http://www.ncbi.nlm.nih.gov/pubmed/21359565"], "triples": [], "ideal_answer": "Influence of synaptic serotonin level on [ 18F ] altanserin binding to 5HT2 receptors in man.Our data confirmed that [ 18f ] altanserin binding to human 5ht2a receptors binding studies.[ 18f ] altanserin, a fluorobenzoyl derivative related to ketanserin, was reported to be a potent inhibitor of 5-ht2a receptors is unaltered after citalopram and pindolol challenge.PET quantification of 5-HT2A receptors in the human brain : a constant infusion paradigm with [ 18F ] altanserin.Altanserin dv values using both of these methods were significantly correlated with literature-based values of the regional concentrations of 5-ht2a receptors determined by postmortem autoradiographic studies ( r2 = 0.95, p < 0.001 for the 4c model and r2 = 0.96, p < 0.001 for the logan method ).We, therefore, studied the binding potential of the serotonin 2A ( 5-HT ( 2A ) ) receptor ligand [ 18F ] altanserin in 8 patients with clinically probable PSP and 13 healthy controls using positron emission tomography.", "exact_answer": [["5-HT2A"]], "concepts": ["http://www.biosemantics.org/jochem#4263650"], "type": "factoid", "id": "55242d512c8b63434a000006", "snippets": [{"offsetInBeginSection": 659, "offsetInEndSection": 752, "text": "Our data confirmed that [18F]altanserin is a valid tracer for 5HT2 receptors binding studies. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9257335", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 259, "text": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23456885", "endSection": "abstract"}, {"offsetInBeginSection": 2652, "offsetInEndSection": 2762, "text": "These findings support the usefulness of [18F]altanserin as a radioligand for PET studies of 5-HT2A receptors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9826230", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 112, "text": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12902843", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "[18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15356424", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10688105", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "We used [18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A receptors in humans. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9027929", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9257335", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12642173", "endSection": "title"}, {"offsetInBeginSection": 1, "offsetInEndSection": 102, "text": "18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15356424", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10587097", "endSection": "title"}, {"offsetInBeginSection": 697, "offsetInEndSection": 788, "text": "[(18)F]altanserin is suitable for quantification of 5-HT(2A) receptor availability in rats. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21750562", "endSection": "abstract"}, {"offsetInBeginSection": 1021, "offsetInEndSection": 1138, "text": "CONCLUSION: [18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23456885", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 136, "text": "PURPOSE: To determine the reproducibility of measurements of brain 5-HT2A receptors with an [18F]altanserin PET bolus/infusion approach. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17195073", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "We used [18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A receptors in humans ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9027929", "endSection": "abstract"}, {"offsetInBeginSection": 349, "offsetInEndSection": 448, "text": "Twenty-one healthy subjects underwent PET scanning with the 5-HT(2A) antagonist, [(18)F]altanserin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19007894", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9824691", "endSection": "title"}, {"offsetInBeginSection": 1220, "offsetInEndSection": 1346, "text": "MZ and [(18) F]altanserin was blocked by ketanserin supporting that both radioligands bind to 5-HT2A receptors in the pig brain ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23390031", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9027929", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "[(18)F]altanserin is the preferred radiotracer for in-vivo labeling of serotonin 2A receptors by positron emission tomography (PET). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19162492", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 215, "text": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10587097", "endSection": "abstract"}, {"offsetInBeginSection": 312, "offsetInEndSection": 447, "text": "[(18)F]altanserin showed sufficient brain uptake in a distribution pattern consistent with the known distribution of 5-HT(2A) receptors ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21750562", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 216, "text": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10587097", "endSection": "abstract"}, {"offsetInBeginSection": 1185, "offsetInEndSection": 1348, "text": "The cortical binding of [(18) F]MH.MZ and [(18) F]altanserin was blocked by ketanserin supporting that both radioligands bind to 5-HT2A receptors in the pig brain. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23390031", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 268, "text": "PURPOSE: While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23456885", "endSection": "abstract"}, {"offsetInBeginSection": 634, "offsetInEndSection": 802, "text": "Two hours after placebo/drug administration, 250 MBq of the 5-HT(2A) receptor selective PET-radiotracer [(18)F]altanserin was administered intravenously as a 30s bolus. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21996132", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 170, "text": "Imaging the cerebral serotonin 2A (5-HT2A ) receptors with positron emission tomography (PET) has been carried out in humans with [(11) C]MDL 100907 and [(18) F]altanserin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23390031", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 172, "text": "Imaging the cerebral serotonin 2A (5-HT2A ) receptors with positron emission tomography (PET) has been carried out in humans with [(11) C]MDL 100907 and [(18) F]altanserin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23390031", "endSection": "abstract"}, {"offsetInBeginSection": 2351, "offsetInEndSection": 2650, "text": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9826230", "endSection": "abstract"}, {"offsetInBeginSection": 2351, "offsetInEndSection": 2651, "text": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9826230", "endSection": "abstract"}, {"offsetInBeginSection": 196, "offsetInEndSection": 381, "text": "We investigated the relationships of gender, mood, impulsivity, aggression and temperament to 5HT(2A) receptor binding in 21 healthy subjects using [18F]altanserin and PET neuroimaging. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19959344", "endSection": "abstract"}, {"offsetInBeginSection": 383, "offsetInEndSection": 553, "text": "This controlled cross-over PET study aimed to identify brain regions with WM-induced changes in the binding potential (BP(nd)) of the 5-HT2aR antagonist [(18)F]altanserin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21722741", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 183, "text": "The 5-hydroxytryptamine type 2a (5-HT(2A)) selective radiotracer [(18)F]altanserin has been subjected to a quantitative micro-positron emission tomography study in Lister Hooded rats. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21750562", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 227, "text": "The aim of the present study is to describe and validate a method for accurate quantification of 5-hydroxytryptamine (5-HT)(2A) receptors using [18F]altanserin-positron emission tomography (PET) and the bolus/infusion approach. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12902843", "endSection": "abstract"}, {"offsetInBeginSection": 246, "offsetInEndSection": 535, "text": "To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9826230", "endSection": "abstract"}, {"offsetInBeginSection": 364, "offsetInEndSection": 525, "text": "METHODS: [(18)F]-Altanserin PET was used to quantify 5-HT(2A) receptors in 12 healthy elderly individuals at baseline and at 2 years in six volumes of interest. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18828013", "endSection": "abstract"}, {"offsetInBeginSection": 253, "offsetInEndSection": 478, "text": "Baseline and follow-up partial volume corrected levels of 5-HT2A in four neocortical lobes and the posterior cingulate gyrus were investigated using [18F]altanserin positron emission tomography with a bolus-infusion approach. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21098981", "endSection": "abstract"}, {"offsetInBeginSection": 247, "offsetInEndSection": 458, "text": "We, therefore, studied the binding potential of the serotonin 2A (5-HT(2A)) receptor ligand [18F]altanserin in 8 patients with clinically probable PSP and 13 healthy controls using positron emission tomography. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19353726", "endSection": "abstract"}, {"offsetInBeginSection": 1679, "offsetInEndSection": 1921, "text": "These data suggest that the combination of a dexfenfluramine-induced 5-HT release and subsequent assessment of 5-HT(2A) receptor availability with [(18)F]altanserin PET is suitable to measure cortical 5-HT release capacity in the human brain. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21996132", "endSection": "abstract"}, {"offsetInBeginSection": 357, "offsetInEndSection": 583, "text": "The aim of this feasibility study was to examine whether acute ketamine-induced 5-HT release interferes with the binding of the 5-HT(2A) receptor (5-HT(2A)R) radioligand [(18)F]altanserin and positron emission tomography (PET) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17541696", "endSection": "abstract"}, {"offsetInBeginSection": 246, "offsetInEndSection": 494, "text": "We investigated 94 healthy individuals (60 men, mean age 47.0\u00b118.7, range 23-86) to determine if trait aggression and trait impulsivity were related to frontal cortex 5-HT2A receptor binding (5-HT2AR) as measured with [18F]-altanserin PET imaging. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23137806", "endSection": "abstract"}, {"offsetInBeginSection": 302, "offsetInEndSection": 557, "text": "METHODS: Fifteen women ill with AN (ILL AN) were compared with 29 healthy control women (CW); PET and [11C]WAY100635 were used to assess binding potential (BP) of the 5-HT1A receptor, and [18F]altanserin was used to assess postsynaptic 5-HT2A receptor BP. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17241616", "endSection": "abstract"}, {"offsetInBeginSection": 1506, "offsetInEndSection": 1819, "text": "The regional [18F]altanserin DV values using both of these methods were significantly correlated with literature-based values of the regional concentrations of 5-HT2A receptors determined by postmortem autoradiographic studies (r2 = 0.95, P < 0.001 for the 4C model and r2 = 0.96, P < 0.001 for the Logan method). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9826230", "endSection": "abstract"}, {"offsetInBeginSection": 2262, "offsetInEndSection": 2662, "text": "Altanserin, a fluorobenzoyl derivative related to ketanserin, was reported to be a potent antagonist of 5-HT2A receptors with >100-fold selectivity over D2/3 receptors, 5-HT1A, 5-HT6, and 5-HT7 (9, 10). This led to the development of 3-{2-[4-(4-[(18)F]fluorobenzoyl)-1-piperidyl]ethyl}-2-sulfanyl-3H-quinazolin-4-one ([(18)F]altanserin) as a useful tool for 5-HT2A receptor PET imaging in vivo (11). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21473029", "endSection": "abstract"}, {"offsetInBeginSection": 2240, "offsetInEndSection": 2637, "text": "Altanserin, a fluorobenzoyl derivative related to ketanserin, was reported to be a potent inhibitor of 5-HT2A receptors with >100-fold selectivity over D2/3 receptors, 5-HT1A, 5-HT6, and 5-HT7 (8, 9). This led to the development of 3-[2-[4-(4-[(18)F]fluorobenzoyl)-1-piperidyl]ethyl]-2-sulfanyl-3H-quinazolin-4-one ([(18)F]altanserin) as a useful tool for 5-HT2A receptor PET imaging in vivo (10). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20641567", "endSection": "abstract"}, {"offsetInBeginSection": 279, "offsetInEndSection": 680, "text": "PET was performed by using [18F]altanserin to evaluate 5-HT2A receptor binding in 11 elderly patients with depression (four men, seven women; mean age = 65.0 years, SD = 5.5); nine Alzheimer's disease patients, including three with concurrent depression (two men, seven women; mean age = 69.7 years, SD = 5.0); and 10 age-matched healthy subjects (four men, six women; mean age = 69.8 years, SD = 5.0) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10588399", "endSection": "abstract"}, {"offsetInBeginSection": 2262, "offsetInEndSection": 2936, "text": "Altanserin, a fluorobenzoyl derivative related to ketanserin, was reported to be a potent antagonist of 5-HT2A receptors with >100-fold selectivity over D2/3 receptors, 5-HT1A, 5-HT6, and 5-HT7 (9, 10). This led to the development of 3-{2-[4-(4-[(18)F]fluorobenzoyl)-1-piperidyl]ethyl}-2-sulfanyl-3H-quinazolin-4-one ([(18)F]altanserin) as a useful tool for 5-HT2A receptor PET imaging in vivo (11). 5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A agonists bind only to the high-affinity functional state of the receptor but may be more important in disease states because the high affinity sites are the ones that transmit the intracellular signals. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21473027", "endSection": "abstract"}]}, {"body": "Which diseases have been associated with the PTPN22 620W allele?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22237046", "http://www.ncbi.nlm.nih.gov/pubmed/16320352", "http://www.ncbi.nlm.nih.gov/pubmed/16277672", "http://www.ncbi.nlm.nih.gov/pubmed/15790351", "http://www.ncbi.nlm.nih.gov/pubmed/15719322", "http://www.ncbi.nlm.nih.gov/pubmed/16464986", "http://www.ncbi.nlm.nih.gov/pubmed/16391555", "http://www.ncbi.nlm.nih.gov/pubmed/19248096"], "triples": [], "ideal_answer": "The ptpn22 620w allele associates with multiple autoimmune phenotypes the ptpn22 620w allele is a risk factor for wegener's granulomatosis the risk of developing ra later in life in patients with type 1 dm may be attributed, in part, to the presence of the 620w ptpn22 allele, suggesting that this risk factor may represent a common pathway for the pathogenesis of these 2 diseases.An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive ( RF+ ) rheumatoid arthritis ( RA ), among other autoimmune diseases the PTPN22 620W allele associates with multiple autoimmune phenotypes the PTPN22 620W allele frequency was significantly increased in antineutrophil cytoplasmic antibody ( ANCA ) -positive WG patients compared with healthy controlsThe ptpn22 620w allele appears to be involved in the pathogenesis of wg, and anca positivity seems to be the hallmark the ptpn22 620w allele is a risk factor for wegener's granulomatosis the risk of developing ra later in life in patients compared with healthy controls", "exact_answer": [["type 1 diabetes"], ["seropositive rheumatoid arthritis"], ["systemic lupus erythematosus"], ["Hashimoto thyroiditis"], ["Wegener's granulomatosis (granulomatosis with polyangiitis)"]], "concepts": [], "type": "list", "id": "550316a6e9bde69634000029", "snippets": [{"offsetInBeginSection": 96, "offsetInEndSection": 165, "text": "the PTPN22 620W allele associates with multiple autoimmune phenotypes ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15719322", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 68, "text": "The PTPN22 620W allele is a risk factor for Wegener's granulomatosis ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16320352", "endSection": "title"}, {"offsetInBeginSection": 1129, "offsetInEndSection": 1246, "text": "The PTPN22 620W allele appears to be involved in the pathogenesis of WG, and ANCA positivity seems to be the hallmark ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16320352", "endSection": "abstract"}, {"offsetInBeginSection": 178, "offsetInEndSection": 357, "text": "An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16277672", "endSection": "abstract"}, {"offsetInBeginSection": 850, "offsetInEndSection": 963, "text": "PTPN22 620W risk allele was associated with ACPA production [odds ratio (OR)\u2009=\u20092.21, 95% CI 1.4, 3.4, P\u2009<\u20090.0001] ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21752868", "endSection": "abstract"}, {"offsetInBeginSection": 1302, "offsetInEndSection": 1443, "text": "The PTPN22 620W allele confers susceptibility to the development of GPA (but not of MPA or CSS), and particularly of its ANCA-positive subset ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22237046", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 132, "text": "Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16277672", "endSection": "title"}, {"offsetInBeginSection": 790, "offsetInEndSection": 948, "text": "The PTPN22 620W allele frequency was significantly increased in antineutrophil cytoplasmic antibody (ANCA)-positive WG patients compared with healthy controls ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16320352", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 254, "text": "The 620W allele of PTPN22 has been associated with susceptibility to several different forms of chronic inflammatory disease, including Type 1 diabetes (T1D), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and autoimmune thyroiditis (AIT) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16391555", "endSection": "abstract"}, {"offsetInBeginSection": 439, "offsetInEndSection": 666, "text": "A functional variant (R620W) of the intracellular protein tyrosine phosphatase N22 (PTPN22) has now been conclusively shown to confer approximately two-fold risk for seropositive RA as well as several other autoimmune disorders ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15790351", "endSection": "abstract"}, {"offsetInBeginSection": 1629, "offsetInEndSection": 1872, "text": "The risk of developing RA later in life in patients with type 1 DM may be attributed, in part, to the presence of the 620W PTPN22 allele, suggesting that this risk factor may represent a common pathway for the pathogenesis of these 2 diseases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19248096", "endSection": "abstract"}, {"offsetInBeginSection": 964, "offsetInEndSection": 1231, "text": "We report that a recently described functional single-nucleotide polymorphism (rs2476601, encoding R620W) in the intracellular tyrosine phosphatase (PTPN22) confers risk of four separate autoimmune phenotypes in these families: T1D, RA, SLE, and Hashimoto thyroiditis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15719322", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 255, "text": "The 620W allele of PTPN22 has been associated with susceptibility to several different forms of chronic inflammatory disease, including Type 1 diabetes (T1D), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and autoimmune thyroiditis (AIT). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16391555", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 357, "text": "The protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene encodes for lymphoid tyrosine phosphatase LYP, involved in the negative regulation of early T-cell activation. An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16277672", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 367, "text": "The minor allele of the R620W missense single-nucleotide polymorphism (SNP; rs2476601) in the PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been reported to be associated with multiple autoimmune diseases, including type 1 diabetes, systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, autoimmune thyroiditis and vitiligo ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16464986", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 369, "text": "The minor allele of the R620W missense single-nucleotide polymorphism (SNP; rs2476601) in the PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been reported to be associated with multiple autoimmune diseases, including type 1 diabetes, systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, autoimmune thyroiditis and vitiligo. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16464986", "endSection": "abstract"}, {"offsetInBeginSection": 11, "offsetInEndSection": 415, "text": "Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16320352", "endSection": "abstract"}, {"offsetInBeginSection": 667, "offsetInEndSection": 1045, "text": "The frequency of the minor allele (620W) was significantly higher in GPA patients than in controls [P\u2009=\u20090.005, \u03c7(2\u2009)=\u20097.858, odds ratio (OR)\u2009=\u20091.91], while no statistically significant association was found with MPA or CSS. Among GPA patients, the 620W allele was particularly enriched in ANCA-positive patients as compared with controls (P\u2009=\u20090.00012, \u03c7(2\u2009)=\ufffd\ufffd\ufffd14.73, OR\u2009=\u20092.31) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22237046", "endSection": "abstract"}]}, {"body": "Which extra thyroid tissues have thyrotropin (TSH) receptors?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22517745", "http://www.ncbi.nlm.nih.gov/pubmed/22496347", "http://www.ncbi.nlm.nih.gov/pubmed/22399514", "http://www.ncbi.nlm.nih.gov/pubmed/22289392", "http://www.ncbi.nlm.nih.gov/pubmed/21956421"], "ideal_answer": "Tshr, infiltrate the orbit, and comprise a large subset of orbital fibroblasts in tao.Tshr levels are higher than those in orbital fibroblasts.Gd orbital fibroblasts, which comprise a mixture of cd34 ( + ) and cd34 (- ) cells, express much lower levels of tg and tshr these fibrocytes infiltrate orbital connective tissues in thyroid-associated ophthalmopathy and express functional tsh receptor ( tshr ).Tsh induced lipolysis in adipose tissues.Tsh worked as a lipolytic factor in white adipose tissues, previously, we found that cd34 ( + ) progenitor cells, known as fibrocytes, express functional tshr, infiltrate the orbit, and comprise a large subset of orbital fibroblasts.", "exact_answer": [["adipose tissue"], ["fibrotic tissue"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011989", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0004996", "http://www.biosemantics.org/jochem#4250044"], "type": "list", "id": "513f45abbee46bd34c000013", "snippets": [{"offsetInBeginSection": 882, "offsetInEndSection": 923, "text": "TSH induced lipolysis in adipose tissues. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22496347", "endSection": "sections.0"}, {"offsetInBeginSection": 1047, "offsetInEndSection": 1104, "text": "TSHR levels are higher than those in orbital fibroblasts. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21956421", "endSection": "sections.0"}, {"offsetInBeginSection": 1376, "offsetInEndSection": 1434, "text": "TSH worked as a lipolytic factor in white adipose tissues, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22496347", "endSection": "sections.0"}, {"offsetInBeginSection": 303, "offsetInEndSection": 439, "text": "These fibrocytes infiltrate orbital connective tissues in thyroid-associated ophthalmopathy and express functional TSH receptor (TSHR). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21956421", "endSection": "sections.0"}, {"offsetInBeginSection": 1217, "offsetInEndSection": 1336, "text": "GD orbital fibroblasts, which comprise a mixture of CD34(+) and CD34(-) cells, express much lower levels of Tg and TSHR ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22517745", "endSection": "sections.0"}, {"offsetInBeginSection": 552, "offsetInEndSection": 731, "text": "Previously, we found that CD34(+) progenitor cells, known as fibrocytes, express functional TSHR, infiltrate the orbit, and comprise a large subset of orbital fibroblasts in TAO. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22517745", "endSection": "sections.0"}]}, {"body": "Which histone modifications distinguish between promoters and enhancers?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23547170", "http://www.ncbi.nlm.nih.gov/pubmed/22421546", "http://www.ncbi.nlm.nih.gov/pubmed/21937433", "http://www.ncbi.nlm.nih.gov/pubmed/19295514", "http://www.ncbi.nlm.nih.gov/pubmed/20008934", "http://www.ncbi.nlm.nih.gov/pubmed/19094206", "http://www.ncbi.nlm.nih.gov/pubmed/12461564", "http://www.ncbi.nlm.nih.gov/pubmed/18441229", "http://www.ncbi.nlm.nih.gov/pubmed/24038352", "http://www.ncbi.nlm.nih.gov/pubmed/21106759"], "triples": [], "ideal_answer": "Using h3k27ac profiles, we identified 28,377 putative enhancers.We also find that some developmental enhancers, many of which are likely to be limb specific based on strong enrichment near genes highly expressed in the limb and comparisons with tissue-specific ep300 sites and known enhancers.At some locations, h3k27 monomethylation was also found to be associated with chromatin states and enhancers in mouse embryonic forelimb and hindlimb.Although certain chromatin features, such as the histone acetyltransferase p300 and the histone modification h3k4me1, indicate the presence of enhancers, only a fraction of enhancers are functionally active.We also found to be associated with chromatin signatures of gene enhancers exhibit components of this signature, including hypersensitivity, h3k27ac enrichment, and h3k27me3 depletion, at lower levels in tissues in which they are not active.Here we use whole-transcriptome analysis coupled with genome-wide profiling of h3k27ac and h3k27me3 to map chromatin signatures of gene enhancers.Individual chromatin marks, such as H3K27ac and H3K27me3, have been identified to distinguish active from inactive enhancers.", "exact_answer": [["H3K27ac enrichment"], ["H3K27me3 depletion"]], "concepts": [], "type": "list", "id": "56ddbbaf51531f7e33000009", "snippets": [{"offsetInBeginSection": 287, "offsetInEndSection": 413, "text": "Individual chromatin marks, such as H3K27ac and H3K27me3, have been identified to distinguish active from inactive enhancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24038352", "endSection": "abstract"}, {"offsetInBeginSection": 1355, "offsetInEndSection": 1472, "text": "At some locations, H3K27 monomethylation was also found to be associated with chromatin signatures of gene enhancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21937433", "endSection": "abstract"}, {"offsetInBeginSection": 719, "offsetInEndSection": 843, "text": "We find that histone H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1 alone. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21106759", "endSection": "abstract"}, {"offsetInBeginSection": 365, "offsetInEndSection": 544, "text": "Here we use whole-transcriptome analysis coupled with genome-wide profiling of H3K27ac and H3K27me3 to map chromatin states and enhancers in mouse embryonic forelimb and hindlimb. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22421546", "endSection": "abstract"}, {"offsetInBeginSection": 1221, "offsetInEndSection": 1434, "text": "We also find that some developmental enhancers exhibit components of this signature, including hypersensitivity, H3K27ac enrichment, and H3K27me3 depletion, at lower levels in tissues in which they are not active. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22421546", "endSection": "abstract"}, {"offsetInBeginSection": 1011, "offsetInEndSection": 1219, "text": "a chromatin state signature associated with active developmental enhancers, defined by high levels of H3K27ac marking, nucleosome displacement, hypersensitivity to sonication, and strong depletion of H3K27me3 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22421546", "endSection": "abstract"}, {"offsetInBeginSection": 80, "offsetInEndSection": 413, "text": "Although certain chromatin features, such as the histone acetyltransferase P300 and the histone modification H3K4me1, indicate the presence of enhancers, only a fraction of enhancers are functionally active. Individual chromatin marks, such as H3K27ac and H3K27me3, have been identified to distinguish active from inactive enhancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24038352", "endSection": "abstract"}, {"offsetInBeginSection": 752, "offsetInEndSection": 999, "text": "Using H3K27ac profiles, we identified 28,377 putative enhancers, many of which are likely to be limb specific based on strong enrichment near genes highly expressed in the limb and comparisons with tissue-specific EP300 sites and known enhancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22421546", "endSection": "abstract"}, {"offsetInBeginSection": 464, "offsetInEndSection": 744, "text": "Here, we used chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) to measure genome-wide changes in histone H3 acetylation at lysine 27 (H3K27ac), a marker of active enhancers, in unstimulated HUVECs and HUVECs stimulated with VEGFA for 1, 4, and 12 h. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23547170", "endSection": "abstract"}]}, {"body": "Where is the metaxin complex localized?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19552401", "http://www.ncbi.nlm.nih.gov/pubmed/17981999", "http://www.ncbi.nlm.nih.gov/pubmed/17624330", "http://www.ncbi.nlm.nih.gov/pubmed/17510655", "http://www.ncbi.nlm.nih.gov/pubmed/11027586", "http://www.ncbi.nlm.nih.gov/pubmed/10381257", "http://www.ncbi.nlm.nih.gov/pubmed/9705320", "http://www.ncbi.nlm.nih.gov/pubmed/9045676"], "triples": [], "ideal_answer": "Final integration of tspo into the omm occurs via its interaction with metaxin 1. the mitochondrial inner membrane protein mitofilin exists as a complex with sam50, metaxins 1 and 2, coiled-coil-helix coiled-coil-helix domain-containing protein 3 and 6 and dnajc11.We conclude that the pathway of vdac biogenesis in human mitochondria involves the tom complex in the outer membrane of the mammalian mitochondrion.Functional analysis of human metaxin is a component of a preprotein import complex in the outer membrane of the mammalian mitochondrion.We conclude that the pathway of vdac biogenesis in human metaxin in mitochondrial protein import in cultured cells and its relationship with the tom complex, sam50 and metaxins, and that it is evolutionarily conserved.Functional role of this new complex is uncertain.The functional analysis of human metaxin in mitochondrial protein import in cultured cells and its relationship with the tom complex is uncertain.", "exact_answer": [["To the outer mitochondrial membrane."]], "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0043234", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0032991", "http://www.uniprot.org/uniprot/MTX1_HUMAN"], "type": "factoid", "id": "54e0ba781388e8454a000011", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 107, "text": "Metaxin is a component of a preprotein import complex in the outer membrane of the mammalian mitochondrion. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9045676", "endSection": "title"}, {"offsetInBeginSection": 204, "offsetInEndSection": 285, "text": "metaxin gene (Mtx), which encodes an outer mitochondrial membrane import protein. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9705320", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "Metaxin is an outer membrane protein of mammalian mitochondria which is suggested to be involved in protein import into the organelle. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11027586", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Functional analysis of human metaxin in mitochondrial protein import in cultured cells and its relationship with the Tom complex. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11027586", "endSection": "title"}, {"offsetInBeginSection": 1097, "offsetInEndSection": 1253, "text": "We conclude that the pathway of VDAC biogenesis in human mitochondria involves the TOM complex, Sam50 and metaxins, and that it is evolutionarily conserved. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17510655", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 119, "text": "Metaxin 1 interacts with metaxin 2, a novel related protein associated with the mammalian mitochondrial outer membrane. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10381257", "endSection": "title"}, {"offsetInBeginSection": 316, "offsetInEndSection": 443, "text": " TOM20 (translocase of the outer mitochondrial membrane), METAXIN, and mtOM64 (outer mitochondrial membrane protein of 64 kD). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17981999", "endSection": "abstract"}, {"offsetInBeginSection": 1135, "offsetInEndSection": 1313, "text": ". Metaxin 2 in intact mitochondria was susceptible to digestion with proteinase K, indicating that metaxin 2 is located on the cytosolic face of the mitochondrial outer membrane. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10381257", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 183, "text": "The mitochondrial inner membrane protein mitofilin exists as a complex with SAM50, metaxins 1 and 2, coiled-coil-helix coiled-coil-helix domain-containing protein 3 and 6 and DnaJC11. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17624330", "endSection": "title"}, {"offsetInBeginSection": 837, "offsetInEndSection": 1021, "text": "In subcellular fractions of mouse liver, a 29 kD immunoreactive protein, consistent in size with the predicted translation product of metaxin 2 cDNA, was found solely in mitochondria. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10381257", "endSection": "abstract"}, {"offsetInBeginSection": 862, "offsetInEndSection": 1068, "text": "The outer membrane protein METAXIN was characterized to play a role in the import of mitochondrial precursor proteins and likely plays a role in the assembly of beta-barrel proteins into the outer membrane. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17981999", "endSection": "abstract"}, {"offsetInBeginSection": 1554, "offsetInEndSection": 1797, "text": " The C-terminus plays an important role in targeting TSPO to mitochondria, whereas its import into the OMM is dependent upon the presence of the Schellman motif. Final integration of TSPO into the OMM occurs via its interaction with Metaxin 1. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19552401", "endSection": "abstract"}, {"offsetInBeginSection": 440, "offsetInEndSection": 838, "text": " The functional role of this new complex is uncertain. However, a role in protein import related to maintenance of mitochondrial structure is suggested as mitofilin helps regulate mitochondrial morphology and at least four of the associated proteins (metaxins 1 and 2, SAM50 and CHCHD3) have been implicated in protein import, while DnaJC11 is a chaperone-like protein that may have a similar role. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17624330", "endSection": "abstract"}]}, {"body": "What are the major classes of retrotransposons active in the human genome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23282240", "http://www.ncbi.nlm.nih.gov/pubmed/22923465", "http://www.ncbi.nlm.nih.gov/pubmed/22093876", "http://www.ncbi.nlm.nih.gov/pubmed/22528351", "http://www.ncbi.nlm.nih.gov/pubmed/17431169", "http://www.ncbi.nlm.nih.gov/pubmed/16511833", "http://www.ncbi.nlm.nih.gov/pubmed/16399224", "http://www.ncbi.nlm.nih.gov/pubmed/15867427", "http://www.ncbi.nlm.nih.gov/pubmed/12213770", "http://www.ncbi.nlm.nih.gov/pubmed/12167372", "http://www.ncbi.nlm.nih.gov/pubmed/11343131", "http://www.ncbi.nlm.nih.gov/pubmed/10677855", "http://www.ncbi.nlm.nih.gov/pubmed/2165587"], "ideal_answer": "Since certain types of retrotransposons, particularly members of the alu, l1, and the factors determining their retroposition capacity are poorly understood.Half of the human genome is composed of repeated dna, and the factors determining their retroposition capacity are poorly understood.Alu elements are the most successful sines ( short interspersed elements ) in primate genomes and have reached more than 1,000,000 copies in the human genome despite their abundance, only a small fraction of them are currently active in our genome ( long interspersed element-1 ( line-1 ), alu, l1, and sva elements ).Half of the human genome is composed of repeated dna, and sva families, are mobile within our genome ( transposons and retrotransposons ).Alu elements are able to retropose, and the factors determining their retroposition capacity are poorly understood.Only a few alu elements are still active, their recent and ongoing propagation generates a unique and important class of human genomic diversity 1 and alu represent the most prolific human line and sine families, respectively.", "exact_answer": [["LINE-1", "L1"], ["Alu"], ["SVA"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018626"], "type": "list", "id": "517843638ed59a060a000036", "snippets": [{"offsetInBeginSection": 120, "offsetInEndSection": 201, "text": "1 and Alu represent the most prolific human LINE and SINE families, respectively. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12213770", "endSection": "sections.0"}, {"offsetInBeginSection": 202, "offsetInEndSection": 328, "text": "Only a few Alu elements are able to retropose, and the factors determining their retroposition capacity are poorly understood. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12213770", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 155, "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have reached more than 1,000,000 copies in the human genome ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15867427", "endSection": "sections.0"}, {"offsetInBeginSection": 114, "offsetInEndSection": 343, "text": "Since certain types of retrotransposons, particularly members of the Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates a unique and important class of human genomic diversity/polymorphism ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16511833", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 286, "text": "Half of the human genome is composed of repeated DNA, and some types are mobile within our genome (transposons and retrotransposons). Despite their abundance, only a small fraction of them are currently active in our genome (Long Interspersed Element-1 (LINE-1), Alu, and SVA elements). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22528351", "endSection": "sections.0"}]}, {"body": "Which are the clinical characteristics of Diamond-Blackfan anemia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22739174", "http://www.ncbi.nlm.nih.gov/pubmed/20603584", "http://www.ncbi.nlm.nih.gov/pubmed/20960466", "http://www.ncbi.nlm.nih.gov/pubmed/23795277", "http://www.ncbi.nlm.nih.gov/pubmed/12679976"], "triples": [], "ideal_answer": "The results indicated that out of 45 children diagnosed as DBA, 14 cases ( 31.1 % ) had short stature and physical malformation.Diamond-blackfan anemia ( dba ) is characterized by a defect of erythroid progenitors and, clinically, by anemia and malformations.Diamond Blackfan anemia is characterized by a severe hypoplastic anemia and a heterogeneous collection of other clinical features bone marrow examination showed a marked erythroid hypoplasia in all patients all patients had anemia with reticulocytopenia.Diamond-blackfan anemia is a rare congenital erythroid hypoplastic anemia that usually presents as a chronic, normochromic macrocytosis due to red cell lineage bone marrow failureDiamond-blackfan anemia ( dba ) is characterized by a defect of erythroid hypoplastic anemia that usually presents early in infancy and is inherited in up to 45 % of cases.Diamond-Blackfan anemia is a rare, inherited disease that characteristically presents as a chronic, normochromic macrocytosis due to red cell lineage bone marrow failure", "exact_answer": [["Red cell aplasia"], ["Congenital anomalies"], ["Predisposition to cancer"]], "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:1339", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D029503"], "type": "list", "id": "55031286e9bde6963400001b", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Diamond Blackfan anemia is characterized by a severe hypoplastic anemia and a heterogeneous collection of other clinical features ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16239073", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Diamond-Blackfan Anemia (DBA) is characterized by a defect of erythroid progenitors and, clinically, by anemia and malformations. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20960466", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "Diamond Blackfan anemia is characterized by a severe hypoplastic anemia and a heterogeneous collection of other clinical features. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16239073", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Diamond Blackfan Anemia (DBA) is a rare hypoplastic anemia that presents in infancy with macrocytic anemia and reticulocytopenia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23795277", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 169, "text": "Diamond-Blackfan anemia is a rare, inherited disease that characteristically presents as a chronic, normochromic macrocytosis due to red cell lineage bone marrow failure ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24662257", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 225, "text": "Diamond-Blackfan anaemia (congenital hypoplastic anaemia) is a rare hereditary disease with isolated congenital hypoplasia of red blood cells precursors in bone marrow, and its important characteristic is successful treatment ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12679976", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 252, "text": "Diamond-Blackfan anemia (DBA) is a rare congenital erythroid hypoplastic anemia that usually presents early in infancy and is inherited in up to 45% of cases. It is characterized by red cell aplasia, congenital anomalies, and a predisposition to cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20603584", "endSection": "abstract"}, {"offsetInBeginSection": 331, "offsetInEndSection": 686, "text": "The results indicated that out of 45 children diagnosed as DBA, 14 cases (31.1%) had short stature and physical malformation. All patients had anemia with reticulocytopenia. Thirty-four patients (75.6%) had mean corpuscular volume. Eleven patients (24.4%) had macrocytic anemia. Bone marrow examination showed a marked erythroid hypoplasia in all patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22739174", "endSection": "abstract"}]}, {"body": "How can the expression of SerH3 immobilization antigen be regulated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/3336362", "http://www.ncbi.nlm.nih.gov/pubmed/3537733", "http://www.ncbi.nlm.nih.gov/pubmed/4054606", "http://www.ncbi.nlm.nih.gov/pubmed/3915784", "http://www.ncbi.nlm.nih.gov/pubmed/11973302", "http://www.ncbi.nlm.nih.gov/pubmed/7731807", "http://www.ncbi.nlm.nih.gov/pubmed/7828814", "http://www.ncbi.nlm.nih.gov/pubmed/8414992", "http://www.ncbi.nlm.nih.gov/pubmed/1522546", "http://www.ncbi.nlm.nih.gov/pubmed/2233735", "http://www.ncbi.nlm.nih.gov/pubmed/2854007", "http://www.ncbi.nlm.nih.gov/pubmed/3211135"], "triples": [{"p": "http://purl.uniprot.org/core/submittedName", "s": "http://purl.uniprot.org/uniprot/Q9U697", "o": "http://linkedlifedata.com/resource/#_513955363937005"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513955363937005", "o": "SerH3 immobilization antigen"}, {"p": "http://purl.uniprot.org/core/submittedName", "s": "http://purl.uniprot.org/uniprot/Q22YJ5", "o": "http://linkedlifedata.com/resource/#_513232594A35007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513232594A35007", "o": "SerH3 immobilization antigen, putative"}, {"p": "http://purl.uniprot.org/core/submittedName", "s": "http://purl.uniprot.org/uniprot/Q23VE7", "o": "http://linkedlifedata.com/resource/#_513233564537007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513233564537007", "o": "SerH3 immobilization antigen, putative"}, {"p": "http://purl.uniprot.org/core/submittedName", "s": "http://purl.uniprot.org/uniprot/Q22TF4", "o": "http://linkedlifedata.com/resource/#_513232544634007"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_513232544634007", "o": "SerH3 immobilization antigen, putative"}, {"p": "http://purl.uniprot.org/core/encodedBy", "s": "http://purl.uniprot.org/uniprot/Q9U697", "o": "http://linkedlifedata.com/resource/#_513955363937008"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/#_513955363937008", "o": "SerH3"}], "ideal_answer": "We studied serh3-ts1, a temperature-sensitive allele of the temperature-regulated serh3 gene normally expressed when cells are incubated between the temperatures of 20 and 35 degrees.Serh3 gene normally expressed from 20-36 degrees c, while sert is expressed when cells are grown at temperatures above 35 degrees c. serh3, a temperature-sensitive allele of the temperature-regulated surface antigen.Expression of the temperature-specific surface protein serh3 is controlled primarily by a temperature-dependent change in the stability.Serh3 is expressed when cells are incubated between the temperatures of 20 and 35 degrees c rapidly induced expression of a specific immobilization antigen at the cell surface in tetrahymena thermophila.In tetrahymena thermophila gene encoding a temperature-regulated surface protein serh3 is controlled primarily by a temperature-dependent change in the stability of its mrna.Serh3 ) and serotype t ( sert is expressed when cells are grown at temperatures above 35 degrees c. serh3, a tetrahymena surface antigen.The expression of each allele is regulated by temperature-sensitive mrna stability.", "exact_answer": ["Temperature regulation"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015870", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005786", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010468", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010467", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010628", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010629", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012703", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000941", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007103"], "type": "factoid", "id": "5335f053d6d3ac6a34000055", "snippets": [{"offsetInBeginSection": 30, "offsetInEndSection": 117, "text": "SerH3, a Tetrahymena thermophila gene encoding a temperature-regulated surface antigen. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2233735", "endSection": "title"}, {"offsetInBeginSection": 318, "offsetInEndSection": 450, "text": "we studied SerH3-ts1, a temperature-sensitive allele of the temperature-regulated SerH3 gene normally expressed from 20-36 degrees. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7828814", "endSection": "abstract"}, {"offsetInBeginSection": 1016, "offsetInEndSection": 1163, "text": "Expression of each allele is regulated by temperature-sensitive mRNA stability. H mRNAs are stable at <36 degrees but are unstable at >36 degrees. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11973302", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "mRNA stability plays a major role in regulating the temperature-specific expression of a Tetrahymena thermophila surface protein. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336362", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 181, "text": "In Tetrahymena thermophila, the expression of the temperature-specific surface protein SerH3 is controlled primarily by a temperature-dependent change in the stability of its mRNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7731807", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 168, "text": "The presence of specific proteins (known as immobilization antigens) on the surface of the ciliated protozoan Tetrahymena thermophila is under environmental regulation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3537733", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 156, "text": "A temperature shift from 40 to 28 degrees C rapidly induced expression of a specific immobilization antigen at the cell surface in Tetrahymena thermophila. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3915784", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "The surfaces of Tetrahymena thermophila cells grown between 20 and 35 degrees C are covered by one or more variants of H antigens. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2854007", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 214, "text": "In Tetrahymena thermophila, the expression of a temperature-specific surface protein known as SerH3 is primarily controlled by a temperature-dependent change in the stability of the mRNA that encodes this protein. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8414992", "endSection": "abstract"}, {"offsetInBeginSection": 274, "offsetInEndSection": 473, "text": "In the holotrich Tetrahymena thermophila five alternative cell surface immobilization proteins (i-antigens) are expressed under different conditions of temperature (L, H, T) and culture media (I, S). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1522546", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 298, "text": "The expression of Tetrahymena surface proteins serotype H3 (SerH3) and serotype T (SerT) is under environmental regulation. SerH3 is expressed when cells are incubated between the temperatures of 20 and 35 degrees C, while SerT is expressed when cells are grown at temperatures above 35 degrees C. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3211135", "endSection": "abstract"}]}, {"body": "Which factors play a role in promoter proximal pausing of RNA polymerase II?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24050178", "http://www.ncbi.nlm.nih.gov/pubmed/23699410", "http://www.ncbi.nlm.nih.gov/pubmed/23589332", "http://www.ncbi.nlm.nih.gov/pubmed/22549956", "http://www.ncbi.nlm.nih.gov/pubmed/22244331", "http://www.ncbi.nlm.nih.gov/pubmed/21670248", "http://www.ncbi.nlm.nih.gov/pubmed/17942706", "http://www.ncbi.nlm.nih.gov/pubmed/20534440", "http://www.ncbi.nlm.nih.gov/pubmed/20170405", "http://www.ncbi.nlm.nih.gov/pubmed/20028984", "http://www.ncbi.nlm.nih.gov/pubmed/19860741", "http://www.ncbi.nlm.nih.gov/pubmed/19245807", "http://www.ncbi.nlm.nih.gov/pubmed/18373978", "http://www.ncbi.nlm.nih.gov/pubmed/18332113", "http://www.ncbi.nlm.nih.gov/pubmed/17567605", "http://www.ncbi.nlm.nih.gov/pubmed/16880520", "http://www.ncbi.nlm.nih.gov/pubmed/12782658"], "triples": [], "ideal_answer": "Dsif plays also a role in transcriptional activation, and in concert with the negative elongation factor nelf causes promoter proximal pausing of rna polymerase ii.Pausing factors NELF and DSIF nELF-mediated stalling of RNAPII ( DSIF ), is involved in regulating the processivity of RNA polymerase II.Pausing of rna polymerase ii nelf causes pol ii to pause in the promoter-proximal region ( nelf ) and 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole sensitivity-inducing factor ( dsif ) are involved in pausing rna polymerase ii ( pol ii ) in the promoter-proximal region pausing and resumption of the elongation of transcripts is under the control of transcription elongation factors.", "exact_answer": [["NELF"], ["DSIF"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012319", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006366"], "type": "list", "id": "533ec7abc45e133714000015", "snippets": [{"offsetInBeginSection": 810, "offsetInEndSection": 839, "text": "pausing factors NELF and DSIF ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21670248", "endSection": "abstract"}, {"offsetInBeginSection": 68, "offsetInEndSection": 93, "text": "pausing complex NELF/DSIF ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23589332", "endSection": "title"}, {"offsetInBeginSection": 16, "offsetInEndSection": 39, "text": "pausing caused by NELF ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16880520", "endSection": "title"}, {"offsetInBeginSection": 174, "offsetInEndSection": 207, "text": "NELF-mediated stalling of RNAPII ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20028984", "endSection": "abstract"}, {"offsetInBeginSection": 683, "offsetInEndSection": 720, "text": "The presence of DSIF reduced pausing, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17567605", "endSection": "abstract"}, {"offsetInBeginSection": 25, "offsetInEndSection": 70, "text": "negative transcription elongation factor NELF ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19245807", "endSection": "title"}, {"offsetInBeginSection": 708, "offsetInEndSection": 761, "text": "pausing factor DSIF (DRB sensitivity-inducing factor) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17942706", "endSection": "abstract"}, {"offsetInBeginSection": 135, "offsetInEndSection": 194, "text": "NELF causes Pol II to pause in the promoter-proximal region ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18332113", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 69, "text": "ELF and DSIF collaborate to inhibit elongation by RNA polymerase IIa ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12782658", "endSection": "abstract"}, {"offsetInBeginSection": 919, "offsetInEndSection": 1013, "text": "knockdown of the pause-inducing factor NELF leads to broadly attenuated immune gene activation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22549956", "endSection": "abstract"}, {"offsetInBeginSection": 927, "offsetInEndSection": 1023, "text": "BMP target gene expression requires the pause-inducing negative elongation factor (NELF) complex ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23699410", "endSection": "abstract"}, {"offsetInBeginSection": 589, "offsetInEndSection": 720, "text": "Among the factors we describe are the pausing factors--NELF (negative elongation factor) and DSIF (DRB sensitivity-inducing factor) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24050178", "endSection": "abstract"}, {"offsetInBeginSection": 27, "offsetInEndSection": 204, "text": "(NELF) and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole sensitivity-inducing factor (DSIF) are involved in pausing RNA Polymerase II (Pol II) in the promoter-proximal region ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20534440", "endSection": "abstract"}, {"offsetInBeginSection": 83, "offsetInEndSection": 212, "text": "(DSIF) and negative elongation factor (NELF) negatively regulate transcription elongation by RNA polymerase II (RNAPII) in vitro. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16880520", "endSection": "abstract"}, {"offsetInBeginSection": 381, "offsetInEndSection": 562, "text": "Pausing and resumption of the elongation of transcripts is under the control of transcription elongation factors. Three of them, P-TEFb, DSIF, and NELF have been well characterized ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20170405", "endSection": "abstract"}, {"offsetInBeginSection": 382, "offsetInEndSection": 525, "text": "At several eukaryotic promoters, DSIF, together with NELF (negative elongation factor), leads to promoter-proximal pausing of RNA polymerase II ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19860741", "endSection": "abstract"}, {"offsetInBeginSection": 119, "offsetInEndSection": 275, "text": "(DSIF) regulates RNA polymerase II (RNAPII) processivity by promoting, in concert with negative elongation factor (NELF), promoter-proximal pausing of RNAPI ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17567605", "endSection": "abstract"}, {"offsetInBeginSection": 130, "offsetInEndSection": 366, "text": "(DSIF), is involved in regulating the processivity of RNA polymerase II. DSIF plays also a role in transcriptional activation, and in concert with the negative elongation factor NELF causes promoter proximal pausing of RNA polymerase II ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18373978", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 151, "text": "NA polymerase II (Pol II) and the pausing complex, NELF and DSIF, are detected near the transcription start site (TSS) of many active and silent genes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23589332", "endSection": "abstract"}]}, {"body": "Which are the main clinical features of Fanconi anemia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24773018", "http://www.ncbi.nlm.nih.gov/pubmed/24604962", "http://www.ncbi.nlm.nih.gov/pubmed/21956823", "http://www.ncbi.nlm.nih.gov/pubmed/21131752", "http://www.ncbi.nlm.nih.gov/pubmed/12525534", "http://www.ncbi.nlm.nih.gov/pubmed/23585528", "http://www.ncbi.nlm.nih.gov/pubmed/16675878", "http://www.ncbi.nlm.nih.gov/pubmed/23444773", "http://www.ncbi.nlm.nih.gov/pubmed/9389754", "http://www.ncbi.nlm.nih.gov/pubmed/8058745", "http://www.ncbi.nlm.nih.gov/pubmed/10915769"], "triples": [], "ideal_answer": "Bone marrow failure resulting in pancytopenia is the main cause of death of fa patients fanconi anaemia ( fa ) is an autosomal recessive disease characterised by congenital abnormalities, defective haemopoiesis, and predisposition to malignancy have suggested a fundamental anomaly of dna repair in fanconi anemia.Features of chromosomal aberrations, hypersensitivity to dna crosslinking agents, and a high risk of developing acute myeloid leukaemia and certain solid tumours progressive bone marrow failure starting in the first decade of life is one of the main characteristics of fanconi anemia.Fanconi anemia patients with fa exhibit a heterogeneous spectrum of clinical symptoms, such as progressive bone marrow failure, hypersensitivity to dna cross-linking agents, chromosomal instability and susceptibility to cancer.Fanconi anemia ( fa ), a recessive syndrome with both autosomal and x-linked inheritance, features diverse clinical symptoms, such as progressive bone marrow failure, hypersensitivity to dna crosslinking agents, chromosomal instability and susceptibility to cancer.The clinical features of cytopenia, developmental defects, and tumor predisposition are similar in each group, suggesting that the gene products participate in a common pathway.", "exact_answer": [["congenital abnormalities"], ["defective haemopoiesis"], ["increased risk of malignancies"], ["cellular hypersensitivity to DNA crosslinking agents"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005199", "http://www.disease-ontology.org/api/metadata/DOID:13636", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051856", "http://www.disease-ontology.org/api/metadata/DOID:1062"], "type": "list", "id": "54ecb640445c3b5a5f000001", "snippets": [{"offsetInBeginSection": 97, "offsetInEndSection": 184, "text": "Bone marrow failure resulting in pancytopenia is the main cause of death of FA patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10915769", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 121, "text": "Progressive bone marrow failure starting in the first decade of life is one of the main characteristics of Fanconi anemia ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23585528", "endSection": "abstract"}, {"offsetInBeginSection": 160, "offsetInEndSection": 337, "text": "The clinical features of cytopenia, developmental defects, and tumor predisposition are similar in each group, suggesting that the gene products participate in a common pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24773018", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 184, "text": "Features of chromosomal aberrations, hypersensitivity to DNA crosslinking agents, and predisposition to malignancy have suggested a fundamental anomaly of DNA repair in Fanconi anemia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8058745", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 233, "text": "Fanconi anemia (FA) is a genetically and phenotypically heterogeneous recessive disorder characterized by diverse congenital malformations, progressive pancytopenia and predisposition to both hematologic malignancies and solid tumors ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24604962", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 201, "text": "Fanconi anaemia (FA) is an autosomal recessive disease characterised by congenital abnormalities, defective haemopoiesis, and a high risk of developing acute myeloid leukaemia and certain solid tumours ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12525534", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 264, "text": "Fanconi anemia (FA), a recessive syndrome with both autosomal and X-linked inheritance, features diverse clinical symptoms, such as progressive bone marrow failure, hypersensitivity to DNA cross-linking agents, chromosomal instability and susceptibility to cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675878", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 261, "text": "Fanconi anemia (FA) is an autosomal recessive, cancer susceptibility disorder characterized by diverse clinical features, such as short stature, skeletal or skin abnormalities, progressive bone marrow (BM) failure, and increased risk of malignancies ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21131752", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 274, "text": "Fanconi anemia (FA) consists of a group of at least five autosomal recessive disorders that share both clinical (e.g., birth defects and hematopoietic failure) and cellular (e.g., sensitivity to cross-linking agents and predisposition to apoptosis) features with each other. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9389754", "endSection": "abstract"}, {"offsetInBeginSection": 113, "offsetInEndSection": 401, "text": "Patients with FA exhibit a heterogeneous spectrum of clinical features. The most significant and consistent phenotypic characteristics are stem cell loss, causing progressive bone marrow failure and sterility, diverse developmental abnormalities and a profound predisposition to neoplasia ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21956823", "endSection": "abstract"}, {"offsetInBeginSection": 194, "offsetInEndSection": 506, "text": "FA is an autosomal recessive disease with three main features: chromosome instability, hypersensitivity to DNA cross-linking agents such as mitomycin C (MMC), cisplatin and so on, and susceptible to a number of cancer types, mainly leukemia and squamous cell carcinomas of the head and neck or gynecologic system ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23444773", "endSection": "abstract"}]}, {"body": "Which is the receptor for the immunosuppressive drug cyclosporin A (CsA)?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25707381", "http://www.ncbi.nlm.nih.gov/pubmed/2477715", "http://www.ncbi.nlm.nih.gov/pubmed/3043797"], "triples": [], "ideal_answer": "Hemical modification of csa has led to analogs with distinct biological activities associated with its protein receptor family, cyclophilins the csa receptor, cyclophilinThese results would support cyclophilin as the major, if not only, intracellular receptor protein for csa.", "exact_answer": [["cyclophilin"]], "concepts": [], "type": "factoid", "id": "56f6c11109dd18d46b00000e", "snippets": [{"offsetInBeginSection": 549, "offsetInEndSection": 579, "text": " the CsA receptor, cyclophilin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2477715", "endSection": "abstract"}, {"offsetInBeginSection": 1164, "offsetInEndSection": 1271, "text": "These results would support cyclophilin as the major, if not only, intracellular receptor protein for CsA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3043797", "endSection": "abstract"}, {"offsetInBeginSection": 220, "offsetInEndSection": 360, "text": "hemical modification of CsA has led to analogs with distinct biological activities associated with its protein receptor family, cyclophilins ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25707381", "endSection": "abstract"}]}, {"body": "Why are insulators necessary in gene therapy vectors?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23786330", "http://www.ncbi.nlm.nih.gov/pubmed/21205311", "http://www.ncbi.nlm.nih.gov/pubmed/21562592", "http://www.ncbi.nlm.nih.gov/pubmed/15638709", "http://www.ncbi.nlm.nih.gov/pubmed/14683449", "http://www.ncbi.nlm.nih.gov/pubmed/24312663", "http://www.ncbi.nlm.nih.gov/pubmed/19536296", "http://www.ncbi.nlm.nih.gov/pubmed/24098520", "http://www.ncbi.nlm.nih.gov/pubmed/21247248", "http://www.ncbi.nlm.nih.gov/pubmed/21475904", "http://www.ncbi.nlm.nih.gov/pubmed/19352322", "http://www.ncbi.nlm.nih.gov/pubmed/9368350", "http://www.ncbi.nlm.nih.gov/pubmed/12200360"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A11616828", "o": "GO:0043035"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1156211", "o": "http://linkedlifedata.com/resource/umls/label/A11616828"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11616828", "o": "chromatin insulator sequence binding"}], "ideal_answer": "This study demonstrates that mar sequences not necessarily increase transgene expression and that the effect of these sequences is probably context dependent and vector dependent.This study demonstrates that mar sequences not necessarily increase transgene expression and that the effect of these sequences is probably context dependent and chromosomal insulators is, therefore, warranted to further enhance the safety features of onco-retroviral vectors.In the mean time, the use of chromatin insulators can reduce chances for retrovirus-mediated oncogenesis by inhibiting non-specific activation of nearby cellular proto-oncogenes.The use of suicide genes, self-inactivating vectors gamma-retroviral vectors enclosing these insulator elements were produced at titers similar to their non-insulated counterparts and proved to be less genotoxic in an in vitro immortalization assay, yielding lower activation of evi1 oncogene expression and reduced clonal expansion of bone marrow cells.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015316", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D038101", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005822", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005796", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0044009", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0043035", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016458", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0044008", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010467", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010468", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002273", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009857", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015513"], "type": "summary", "id": "52d2b75403868f1b06000035", "snippets": [{"offsetInBeginSection": 1854, "offsetInEndSection": 2027, "text": "The use of suicide genes, self-inactivating vectors and/or chromosomal insulators is, therefore, warranted to further enhance the safety features of onco-retroviral vectors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14683449", "endSection": "abstract"}, {"offsetInBeginSection": 476, "offsetInEndSection": 627, "text": "Compared with the EF1\u03b1 and the WASp promoters, expression from the MND promoter in mouse transplant recipients was much higher in all lineages examined ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23786330", "endSection": "abstract"}, {"offsetInBeginSection": 894, "offsetInEndSection": 1072, "text": "In the mean time, the use of chromatin insulators can reduce chances for retrovirus-mediated oncogenesis by inhibiting non-specific activation of nearby cellular proto-oncogenes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15638709", "endSection": "abstract"}, {"offsetInBeginSection": 1747, "offsetInEndSection": 1929, "text": "This study demonstrates that MAR sequences not necessarily increase transgene expression and that the effect of these sequences is probably context dependent and/or vector dependent. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21205311", "endSection": "abstract"}, {"offsetInBeginSection": 1085, "offsetInEndSection": 1279, "text": "Our results demonstrate that the Ig-\u03ba MAR in the context of LV slightly increases transduction efficiency only in Hela, NIH-3T3 and Jurkat cells. In the context of double-copy lentiviral vectors ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21205311", "endSection": "abstract"}, {"offsetInBeginSection": 1104, "offsetInEndSection": 1320, "text": "We conclude that the use of engineered piggyBac transposase mRNA and insulated transposons offer promising ways of improving the quality of the integration process and sustaining the expression of transposon vectors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24312663", "endSection": "abstract"}, {"offsetInBeginSection": 788, "offsetInEndSection": 1028, "text": "Analysis of WAS protein expression in transduced human EBV-immortalized B-cells and transduced patient peripheral blood mononuclear cells also demonstrated stronger expression per copy from the MND promoter compared with the other promoters ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23786330", "endSection": "abstract"}, {"offsetInBeginSection": 1046, "offsetInEndSection": 1348, "text": "Gamma-retroviral vectors enclosing these insulator elements were produced at titers similar to their non-insulated counterparts and proved to be less genotoxic in an in vitro immortalization assay, yielding lower activation of Evi1 oncogene expression and reduced clonal expansion of bone marrow cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21562592", "endSection": "abstract"}]}, {"body": "Which drugs may interfere thyroxine absorption?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22908106", "http://www.ncbi.nlm.nih.gov/pubmed/19942153", "http://www.ncbi.nlm.nih.gov/pubmed/19789374", "http://www.ncbi.nlm.nih.gov/pubmed/18466075", "http://www.ncbi.nlm.nih.gov/pubmed/19119983", "http://www.ncbi.nlm.nih.gov/pubmed/17725434", "http://www.ncbi.nlm.nih.gov/pubmed/12796075", "http://www.ncbi.nlm.nih.gov/pubmed/1728914", "http://www.ncbi.nlm.nih.gov/pubmed/23154888", "http://www.ncbi.nlm.nih.gov/pubmed/23264396", "http://www.ncbi.nlm.nih.gov/pubmed/21748540", "http://www.ncbi.nlm.nih.gov/pubmed/21516059", "http://www.ncbi.nlm.nih.gov/pubmed/20012189", "http://www.ncbi.nlm.nih.gov/pubmed/19191742", "http://www.ncbi.nlm.nih.gov/pubmed/18996189", "http://www.ncbi.nlm.nih.gov/pubmed/16641395", "http://www.ncbi.nlm.nih.gov/pubmed/16898074", "http://www.ncbi.nlm.nih.gov/pubmed/22374714", "http://www.ncbi.nlm.nih.gov/pubmed/19108789", "http://www.ncbi.nlm.nih.gov/pubmed/15301044", "http://www.ncbi.nlm.nih.gov/pubmed/15142360", "http://www.ncbi.nlm.nih.gov/pubmed/22238404", "http://www.ncbi.nlm.nih.gov/pubmed/21633823", "http://www.ncbi.nlm.nih.gov/pubmed/21468525", "http://www.ncbi.nlm.nih.gov/pubmed/21435090", "http://www.ncbi.nlm.nih.gov/pubmed/19733399", "http://www.ncbi.nlm.nih.gov/pubmed/19226259", "http://www.ncbi.nlm.nih.gov/pubmed/17093176", "http://www.ncbi.nlm.nih.gov/pubmed/22099156", "http://www.ncbi.nlm.nih.gov/pubmed/15927726", "http://www.ncbi.nlm.nih.gov/pubmed/14751040", "http://www.ncbi.nlm.nih.gov/pubmed/18511320", "http://www.ncbi.nlm.nih.gov/pubmed/11668059", "http://www.ncbi.nlm.nih.gov/pubmed/21933675", "http://www.ncbi.nlm.nih.gov/pubmed/21595516", "http://www.ncbi.nlm.nih.gov/pubmed/17446037", "http://www.ncbi.nlm.nih.gov/pubmed/10838651", "http://www.ncbi.nlm.nih.gov/pubmed/18845642", "http://www.ncbi.nlm.nih.gov/pubmed/17931806", "http://www.ncbi.nlm.nih.gov/pubmed/17711927"], "ideal_answer": "Hypothyroid patients taking sevelamer hydrochloride or chromium picolinate should be advised to separate the time of ingestion of these drugs from their thyroid hormone preparation by several hours.Ommonly used drugs, such as bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine", "exact_answer": [["bile acide sequestrant"], ["ferrous sulphate"], ["sucralfate"], ["Calcium carbonate"], ["aluminium-containing antacids"], ["raloxifene"], ["proton pump inhibithors"], ["sevelamer"], ["chromium picolinate"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013974", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000042", "http://www.biosemantics.org/jochem#4250045"], "type": "list", "id": "513f3d1fbee46bd34c000010", "snippets": [{"offsetInBeginSection": 1074, "offsetInEndSection": 1272, "text": "Hypothyroid patients taking sevelamer hydrochloride or chromium picolinate should be advised to separate the time of ingestion of these drugs from their thyroid hormone preparation by several hours. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17725434", "endSection": "sections.0"}, {"offsetInBeginSection": 319, "offsetInEndSection": 579, "text": "ommonly used drugs, such as bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942153", "endSection": "sections.0"}]}, {"body": "Is Turcot syndrome associated with glioblastoma?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23729388", "http://www.ncbi.nlm.nih.gov/pubmed/23320220", "http://www.ncbi.nlm.nih.gov/pubmed/23119205", "http://www.ncbi.nlm.nih.gov/pubmed/22676959", "http://www.ncbi.nlm.nih.gov/pubmed/19156169", "http://www.ncbi.nlm.nih.gov/pubmed/20657316", "http://www.ncbi.nlm.nih.gov/pubmed/17138070", "http://www.ncbi.nlm.nih.gov/pubmed/16960645", "http://www.ncbi.nlm.nih.gov/pubmed/16144131", "http://www.ncbi.nlm.nih.gov/pubmed/16000562", "http://www.ncbi.nlm.nih.gov/pubmed/15701281", "http://www.ncbi.nlm.nih.gov/pubmed/11975096", "http://www.ncbi.nlm.nih.gov/pubmed/11907360", "http://www.ncbi.nlm.nih.gov/pubmed/10921328", "http://www.ncbi.nlm.nih.gov/pubmed/10223463", "http://www.ncbi.nlm.nih.gov/pubmed/9695069", "http://www.ncbi.nlm.nih.gov/pubmed/9508118", "http://www.ncbi.nlm.nih.gov/pubmed/9505220", "http://www.ncbi.nlm.nih.gov/pubmed/9343324", "http://www.ncbi.nlm.nih.gov/pubmed/7515658", "http://www.ncbi.nlm.nih.gov/pubmed/8025896", "http://www.ncbi.nlm.nih.gov/pubmed/8387650", "http://www.ncbi.nlm.nih.gov/pubmed/8127448", "http://www.ncbi.nlm.nih.gov/pubmed/2165772", "http://www.ncbi.nlm.nih.gov/pubmed/2540108", "http://www.ncbi.nlm.nih.gov/pubmed/3032534", "http://www.ncbi.nlm.nih.gov/pubmed/6307612", "http://www.ncbi.nlm.nih.gov/pubmed/6274254", "http://www.ncbi.nlm.nih.gov/pubmed/11339660", "http://www.ncbi.nlm.nih.gov/pubmed/19822006", "http://www.ncbi.nlm.nih.gov/pubmed/24310308"], "triples": [{"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PMSL2"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PMSL2", "o": "PMSL2"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/COCA2"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/COCA2", "o": "COCA2"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/MLH1"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/MLH1", "o": "MLH1"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/MLH1", "o": "http://www.dbpedia.org/resource/MLH1"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/HNPCC4"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/HNPCC4", "o": "HNPCC4"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/HNPCC2"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/HNPCC2", "o": "HNPCC2"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PMS2"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PMS2", "o": "PMS2"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PMS2", "o": "http://www.dbpedia.org/resource/PMS2"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/diseaseSubtypeOf", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/1156"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/1156", "o": "http://www.dbpedia.org/resource/Turcot_syndrome"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/1156", "o": "Turcot_syndrome"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/diseaseSubtypeOf", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/1156"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/1156", "o": "http://www.dbpedia.org/resource/Turcot_syndrome"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/1156", "o": "Turcot_syndrome"}, {"p": "http://linkedlifedata.com/resource/relationontology/treat", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "DB03431"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "Adenosine-5'-Diphosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/secondaryAccessionNumber", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "expt00436"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "DB03431"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "Adenosine-5'-Diphosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/secondaryAccessionNumber", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "expt00436"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/possibleDiseaseTarget", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "DB03431"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "Adenosine-5'-Diphosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/secondaryAccessionNumber", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "expt00436"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB03431", "o": "[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (dihydroxyphosphinothioyloxy-hydroxyphosphoryl) hydrogen phosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "DB02930"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "Phosphothiophosphoric Acid-Adenylate Ester"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/secondaryAccessionNumber", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "expt00458"}, {"p": "http://linkedlifedata.com/resource/relationontology/treat", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (dihydroxyphosphinothioyloxy-hydroxyphosphoryl) hydrogen phosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "DB02930"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/secondaryAccessionNumber", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "expt00458"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "Phosphothiophosphoric Acid-Adenylate Ester"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/possibleDiseaseTarget", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (dihydroxyphosphinothioyloxy-hydroxyphosphoryl) hydrogen phosphate"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "DB02930"}, {"p": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/secondaryAccessionNumber", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "expt00458"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB02930", "o": "Phosphothiophosphoric Acid-Adenylate Ester"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "C3938"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "C536928"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "C536928"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "276300"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "NCI Thesaurus"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Metathesaurus Names"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#definition", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "NCI: The syndrome of polyposis coli, colon cancer and brain tumors."}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520870"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R69865242", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108937798"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/omim", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "http://bio2rdf.org/omim:120436"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R119892539", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54264357", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108527990"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520871"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108533303", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108535497", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54326923"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108512677", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108527985", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108535496", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/chromosomalLocation", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/chromosomalLocation/3p21.3"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54292285"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108508498", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108533841", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/omim", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://bio2rdf.org/omim:600259"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108535497"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108533304"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54292286"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108513938", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520859"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108507257", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/omimPage", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600259"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108527988", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54292287"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108527984", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108533841"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R69798948", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108537658"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54292288"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108513096", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108533302"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54226085", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R69830643"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520857"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54226396", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108514384", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108535496"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108507331", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108533303"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54292289"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54393456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108514872"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54226673", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108541476", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520869"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108527986", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520858"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54263586", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108527985"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108512676", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108527989", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520868"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R119807587"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108533302", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108513097", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R120073491", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108527986"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520867"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54226105", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108512678", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108508077", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108537658", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108506793", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520856"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R119807589"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520866"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108527987"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54438032"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108541476"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108512226", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108510291", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520865"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R69877248", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108536636", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108527984"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520855"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R119807588"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108527988"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54226224", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54438031"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108527990", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520864"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520854"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113837386", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108527987", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108508424", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108527989"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108536636"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108508968", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www.w3.org/2004/02/skos/core#inScheme", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R69826314"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520863"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520874"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R113845414"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520862"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54226336", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108533304", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108507918", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R119979672", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54166689", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/chromosomalLocation", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/chromosomalLocation/7p22"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520861"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108507347", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108508425", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108937799", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520872"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R54292290"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R69817576"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/class", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseaseClass/Cancer"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4101", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/class", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseaseClass/Cancer"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4102", "o": "Turcot syndrome with glioblastoma, 276300"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R54228336", "o": "http://linkedlifedata.com/resource/umls/id/C0265325"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520860"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/relation/R108520873"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608078", "o": "MMRCS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615647", "o": "BRAIN TUMOR-POLYPOSIS SYNDROME 1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608079"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18467817", "o": "Turcot syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608080", "o": "BTPS1"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608080"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615647"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608078"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16608081"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16749653"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A7628038"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7628038", "o": "Turcot Syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608079", "o": "MMR DEFICIENCY"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16615646", "o": "CHILDHOOD CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16609958", "o": "BTP1 SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18458641"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16749653", "o": "Turcot syndrome (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18458641", "o": "CNS tumors with Familial polyposis of the colon"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16615646"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A18467817"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16611904", "o": "MISMATCH REPAIR CANCER SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16619491"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16609958"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16608081", "o": "TURCOT SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0265325", "o": "http://linkedlifedata.com/resource/umls/label/A16611904"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16619491", "o": "MISMATCH REPAIR DEFICIENCY"}], "ideal_answer": "[ glioblastoma multiforme as a manifestation of turcot syndrome ( ts ) are predisposed to colon tumors and primary brain tumors, typically glioblastomas or medulloblastomas.Familial glioblastoma multiforme is a rather uncommon entity, being in most cases associated to known genetic disorders ( as Turcot syndrome, Li-Fraumeni syndrome, neurofibromatosis, etc.Turcot syndrome represents the unique and discrete occurrence of polyposis coli with glioblastoma.Turcot syndrome caused by apc gene develops medulloblastoma, or both.Malignant transformation of high-grade astrocytoma associated with neurocysticercosis in a patient with turcot syndrome caused by apc gene develops medulloblastoma and turcot syndrome caused by mismatch repair gene develops glioblastoma.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005909", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013577", "http://www.disease-ontology.org/api/metadata/DOID:3068", "http://www.disease-ontology.org/api/metadata/DOID:3073", "http://www.disease-ontology.org/api/metadata/DOID:225"], "type": "yesno", "id": "533581f5d6d3ac6a3400004d", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 64, "text": "[Glioblastoma multiforme as a manifestation of Turcot syndrome]. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11975096", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "Malignant transformation of high-grade astrocytoma associated with neurocysticercosis in a patient with Turcot syndrome. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17138070", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "Type A microsatellite instability in pediatric gliomas as an indicator of Turcot syndrome. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19156169", "endSection": "title"}, {"offsetInBeginSection": 178, "offsetInEndSection": 271, "text": "It is characterized by central nervous system (CNS) neoplasms and gastrointestinal polyposis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9508118", "endSection": "abstract"}, {"offsetInBeginSection": 156, "offsetInEndSection": 291, "text": "Turcot syndrome represents the unique and discrete occurrence of polyposis coli with glioblastoma multiforme, medulloblastoma, or both. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6274254", "endSection": "abstract"}, {"offsetInBeginSection": 152, "offsetInEndSection": 242, "text": "We report the clinicopathological and genetic features of 3 gliomas in TS type 1 patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20657316", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "The Turcot syndrome has been defined as the simultaneous presence of multiple polyposis of the colon and a malignant brain tumor. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9505220", "endSection": "abstract"}, {"offsetInBeginSection": 2254, "offsetInEndSection": 2381, "text": " Two of 13 showed microsatellite instability, one of which in a patient with Turcot syndrome, the other in gliomatosis cerebri. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9343324", "endSection": "abstract"}, {"offsetInBeginSection": 771, "offsetInEndSection": 879, "text": "Brain tumor is mainly diagnosed as glioblastoma or astrocytoma and mismatch repair genes might be involved. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10921328", "endSection": "abstract"}, {"offsetInBeginSection": 397, "offsetInEndSection": 541, "text": "We present the case of a 20-year-old male with a clinical presentation of both glioblastoma multiforme and multiple adenomatous colonic polyps. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23320220", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 167, "text": "Turcot syndrome is the association of colorectal polyposis with primary neuroepithelial tumors of the central nervous system such as glioblastoma and medulloblastoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10921328", "endSection": "abstract"}, {"offsetInBeginSection": 567, "offsetInEndSection": 696, "text": " Biallelic mutations of MMR genes are associated with pediatric cancers, including glial tumors, in Turcot syndrome type 1 (TS1). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19156169", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 127, "text": "The authors describe two patients with the association of polyposis-coli and central nervous system tumor (Turcot's syndrome). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2165772", "endSection": "abstract"}, {"offsetInBeginSection": 427, "offsetInEndSection": 563, "text": "Seven months after resection of this Dukes' C2 adenocarcinoma, she presented with a second primary CNS tumor, a glioblastoma multiforme. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9508118", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "We report a case of Turcot's syndrome in a 20-year old man with multiple adenomatous polyps of the colon and glioblastoma multiforme. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2540108", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 189, "text": "Familial glioblastoma multiforme is a rather uncommon entity, being in most cases associated to known genetic disorders (as Turcot syndrome, Li-Fraumeni syndrome, neurofibromatosis, etc. ). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16960645", "endSection": "abstract"}, {"offsetInBeginSection": 273, "offsetInEndSection": 407, "text": "Turcot Syndrome caused by APC gene develops medulloblastoma and Turcot Syndrome caused by mismatch repair gene develops glioblastoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9695069", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 135, "text": "Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20657316", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 200, "text": "A 45-year-old woman with anaplastic astrocytoma was clinically diagnosed with Turcot syndrome, and subsequently developed simultaneous neurocysticercosis and malignant transformation to glioblastoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17138070", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 141, "text": "Turcot syndrome (TS) is a rare genetic disorder of DNA mismatch repair predisposing to glioblastoma (GBM) in the type 1 variant. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20657316", "endSection": "abstract"}, {"offsetInBeginSection": 273, "offsetInEndSection": 451, "text": "In the present case, a 60-year-old patient with glioblastoma multiforme and a history of hereditary malignomas is described as an example of a HNPCC-associated Turcot's syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11975096", "endSection": "abstract"}, {"offsetInBeginSection": 668, "offsetInEndSection": 857, "text": "However, no somatic mutations in APC were found among 91 neuroepithelial tumors (medulloblastoma, glioblastoma, astrocytoma, and oligodendroglioma), whether sporadic or associated with TS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7515658", "endSection": "abstract"}, {"offsetInBeginSection": 76, "offsetInEndSection": 242, "text": "This patient's case deals with the association between a glioblastoma, anaplastic glioma (WHO Grade III) and colonic adenocarcinoma based on familial polyposis coli. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8127448", "endSection": "abstract"}, {"offsetInBeginSection": 494, "offsetInEndSection": 681, "text": "Based on this case study, the synchronous presentation of glioblastoma multiforme and adenocarcinoma of the colon might suggest a shorter survival rate for patients with Turcot syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23119205", "endSection": "abstract"}, {"offsetInBeginSection": 124, "offsetInEndSection": 331, "text": "Turcot syndrome (MIM276300) has been described as the association of central nervous system malignant tumors and familial colorectal cancer and has been reported to be both a dominant and recessive disorder. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16000562", "endSection": "abstract"}, {"offsetInBeginSection": 1380, "offsetInEndSection": 1568, "text": "We report here the first identification of a homozygous mutation in MSH6 in a family with childhood-onset brain tumor, lymphoma, colorectal cancer, and neurofibromatosis type 1 phenotype. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16000562", "endSection": "abstract"}, {"offsetInBeginSection": 202, "offsetInEndSection": 378, "text": "Such syndromes include neurofibromatosis type 2, neurofibromatosis type 1, Li-Fraumeni syndrome, as well as von Hippel-Lindau disease, tuberous sclerosis, and Turcot syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8025896", "endSection": "abstract"}, {"offsetInBeginSection": 602, "offsetInEndSection": 831, "text": "Because this patient had an unusual underlying condition and his tumor had a unique histological appearance for TS, it was hypothesized that this genetic defect may predispose to malignant gliomas with oligodendroglial features. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10223463", "endSection": "abstract"}, {"offsetInBeginSection": 283, "offsetInEndSection": 485, "text": "The case of a 47-year-old man submitted to a right hemicolectomy for cancer and polyposis, following a series of endoscopic polypectomies and, finally, removal of left temporal glioma is here presented. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9505220", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 209, "text": "Another unusual autopsy case of the Turcot syndrome is reported in a 23-year-old woman with polyposis coli, who developed primary carcinoma of the jejunum and glioblastoma multiforme of the left frontal lobe. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6307612", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 218, "text": "The Turcot syndrome (TS) is a rare, probably autosomal recessive, disorder characterized by development of primary neuroepithelial tumors of the central nervous system (CNS) and numerous adenomatous colorectal polyps. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7515658", "endSection": "abstract"}, {"offsetInBeginSection": 1527, "offsetInEndSection": 1739, "text": "We conclude that 1) the giant cell variant of GBM is overrepresented in TS; 2) gliosarcomas may also be encountered; and 3) survival is often favorable, despite histological anaplasia and exuberant proliferation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20657316", "endSection": "abstract"}, {"offsetInBeginSection": 177, "offsetInEndSection": 426, "text": "Computed tomography brain scan and computed tomography-guided biopsy revealed a left frontoparietal glioblastoma multiforme. This case illustrates the rare presentation of Turcot syndrome-a hereditary colorectal polyposis syndrome-in an older adult. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11907360", "endSection": "abstract"}, {"offsetInBeginSection": 1141, "offsetInEndSection": 1388, "text": "Of the 21 patients, 12 have died (10 after relapse, with a median time to progression for the whole series of 14 months; one with intratumoral bleeding at 40 months after diagnosis; and one affected by Turcot syndrome for duodenal cancer relapse). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15701281", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 316, "text": "Turcot syndrome (TS) is a rare hereditary disorder clinically characterized by the occurrence of primary tumors of the colon and the central nervous system (CNS). Here we present the case of an 11-year-old boy with a synchronous clinical presentation of both glioblastoma multiforme (GBM) and colonic adenocarcinoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23119205", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 330, "text": "Turcot syndrome is an autosomal recessive disorder clinically characterized by the occurrence of primary tumors of the central nervous system and adenomatous colonic polyps during the first or second decades of life, with a spectrum of clinical features such as \"caf\u00e9-au-lait\" spots, axillary freckling, and hyperpigmented spots. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23320220", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 348, "text": "Patients with Turcot syndrome (TS) are predisposed to colon tumors and primary brain tumors, typically glioblastomas or medulloblastomas. The authors describe a patient with TS featuring a known germline mutation of exon 5 of the hPMS2 mismatch repair gene who developed two metachronous glioblastomas, both with distinct oligodendroglial features. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10223463", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 526, "text": "A 15-year-old boy was admitted with the diagnosis of colonic polyposis, and during a 2-year follow-up, he underwent operation for right parieto-occipital anaplastic astrocytoma, left-side colonic non-Hodgkin lymphoma (NHL) and cerebella glioblastoma which were all confirmed by histology. Although cases of Turcot's syndrome (TS) (colonic polyposis and primary brain tumour occurring in the same patient) have been previously described, association with haematological malignancy is rare. We hereby report such a case with TS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22676959", "endSection": "abstract"}]}, {"body": "Which is the gene most commonly mutated in Tay-Sachs disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/14648242", "http://www.ncbi.nlm.nih.gov/pubmed/9401008", "http://www.ncbi.nlm.nih.gov/pubmed/7858168", "http://www.ncbi.nlm.nih.gov/pubmed/8411703", "http://www.ncbi.nlm.nih.gov/pubmed/8490625", "http://www.ncbi.nlm.nih.gov/pubmed/3375249", "http://www.ncbi.nlm.nih.gov/pubmed/3362213", "http://www.ncbi.nlm.nih.gov/pubmed/2967444"], "triples": [{"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4016", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/HEXA"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/HEXA", "o": "HEXA"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/HEXA", "o": "http://www.dbpedia.org/resource/HEXA"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/4016", "o": "Tay-Sachs disease, 272800"}], "ideal_answer": "Mutated hexa alleles in a druze patient with late-infantile tay-sachs disease ( infantile form ), mrna of beta-hexosaminidase alpha subunit is not produced or is unstable ay-sachs disease is an inherited disorder in which the alpha chain of the lysosomal enzyme beta-n-acetylhexosaminidase a bears the mutation.Mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease molecular analysis of HEXA gene in Argentinean patients affected with Tay-Sachs disease : possible common origin of the prevalent c.459+5A > G mutation.In the severest phenotype of Tay-Sachs disease ( infantile form ), mRNA of beta-hexosaminidase alpha subunit is not produced or is unstable ay-Sachs disease is an inherited disorder in which the alpha chain of the lysosomal enzyme beta-N-acetylhexosaminidase A bears the mutation tay-Sachs disease ( TSD ) is a recessively inherited disorder caused by the deficient activity of hexosaminidase A due to mutations in the HEXA gene.Mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers identification of novel mutations in HEXA gene in children affected with Tay Sachs disease from India.", "exact_answer": [["HEXA"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013661", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005678", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D049290", "http://www.disease-ontology.org/api/metadata/DOID:3320"], "type": "factoid", "id": "536e46f27d100faa09000012", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 82, "text": "Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9401008", "endSection": "title"}, {"offsetInBeginSection": 4, "offsetInEndSection": 81, "text": "mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9401008", "endSection": "title"}, {"offsetInBeginSection": 4, "offsetInEndSection": 69, "text": "novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8490625", "endSection": "title"}, {"offsetInBeginSection": 9, "offsetInEndSection": 81, "text": "mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14648242", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Identification of novel mutations in HEXA gene in children affected with Tay Sachs disease from India. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22723944", "endSection": "title"}, {"offsetInBeginSection": 4, "offsetInEndSection": 101, "text": "affected HEXA alleles were found in an Israeli Druze Tay-Sachs child born to first-cousin parents ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9401008", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 140, "text": "ay-Sachs disease is an inherited disorder in which the alpha chain of the lysosomal enzyme beta-N-acetylhexosaminidase A bears the mutation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3375249", "endSection": "abstract"}, {"offsetInBeginSection": 667, "offsetInEndSection": 804, "text": "In the severest phenotype of Tay-Sachs disease (infantile form), mRNA of beta-hexosaminidase alpha subunit is not produced or is unstable ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8411703", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14648242", "endSection": "title"}, {"offsetInBeginSection": 4, "offsetInEndSection": 141, "text": "abnormalities in the gene coding for the beta-hexosaminidase alpha subunit were analysed from fibroblast's RNAs of 42 Tay-Sachs patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7858168", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 147, "text": "Tay-Sachs disease (TSD) is a recessively inherited disorder caused by the deficient activity of hexosaminidase A due to mutations in the HEXA gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22441121", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 183, "text": "ay-Sachs disease is an autosomal recessive genetic disorder resulting from mutation of the HEXA gene encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3362213", "endSection": "abstract"}, {"offsetInBeginSection": 203, "offsetInEndSection": 370, "text": "Tay-Sachs disease lack detectable alpha-chain message when analyzed by Northern blotting with complementary DNA encoding the alpha-chain of human beta-hexosaminidase A ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2967444", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 169, "text": "We have identified three mutations in the beta-hexoseaminidase A (HEXA) gene in a juvenile Tay-Sachs disease (TSD) patient, which exhibited a reduced level of HEXA mRNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20363167", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "Molecular analysis of HEXA gene in Argentinean patients affected with Tay-Sachs disease: possible common origin of the prevalent c.459+5A>G mutation. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22441121", "endSection": "title"}]}, {"body": "In which types of DNA repair is the UvrAB complex involved?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22749141", "http://www.ncbi.nlm.nih.gov/pubmed/17630776", "http://www.ncbi.nlm.nih.gov/pubmed/10913608", "http://www.ncbi.nlm.nih.gov/pubmed/10811888", "http://www.ncbi.nlm.nih.gov/pubmed/9049317", "http://www.ncbi.nlm.nih.gov/pubmed/8702928", "http://www.ncbi.nlm.nih.gov/pubmed/11551204", "http://www.ncbi.nlm.nih.gov/pubmed/20227373", "http://www.ncbi.nlm.nih.gov/pubmed/12145219", "http://www.ncbi.nlm.nih.gov/pubmed/2665605", "http://www.ncbi.nlm.nih.gov/pubmed/11101153", "http://www.ncbi.nlm.nih.gov/pubmed/9049316", "http://www.ncbi.nlm.nih.gov/pubmed/8969181"], "triples": [], "ideal_answer": "Uvrab complex suppresses illegitimate recombination uvra binds uvrb, and the assembled uvrab* complex initiates repair in prokaryotes.The activity of the uvrab complex which can induce dna conformational change is employed in ner transcription-coupled dna repair coupling factor, mfd.The recognition by escherichia coli uvr nucleotide excision repair proteins of a variety of lesions with diverse chemical structures and the presence of helicase activity in the uvrab complex which can displace short oligonucleotides annealed to single-stranded dna led to a model in which this activity moves uvrab along undamaged dna to damaged sites where the lesion blocks further translocation and the protein-dna pre-incision complex is formed.The transcription repair ( ner ) is responsible for removing bulky dna adducts by dual incisions of the uvrabc endonuclease.", "exact_answer": [["nucleotide excision repair (NER)"], ["transcription-coupled repair (TCR)"], ["suppression of illegitimate recombination"]], "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006281", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004260"], "type": "list", "id": "553f7a71ab98a37113000009", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 48, "text": "Transcription-coupled DNA repair in prokaryotes. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22749141", "endSection": "title"}, {"offsetInBeginSection": 1140, "offsetInEndSection": 1191, "text": "UvrAB complex suppresses illegitimate recombination ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10811888", "endSection": "abstract"}, {"offsetInBeginSection": 763, "offsetInEndSection": 828, "text": "illegitimate recombination is mostly suppressed by UvrA and UvrB. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10811888", "endSection": "abstract"}, {"offsetInBeginSection": 410, "offsetInEndSection": 478, "text": "UvrB subunits bind to UvrA, most likely as part of a UvrA2B2 complex ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17630776", "endSection": "abstract"}, {"offsetInBeginSection": 151, "offsetInEndSection": 246, "text": "the activity of the UvrAB complex which can induce DNA conformational change is employed in NER ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10913608", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "Transcription when coupled to nucleotide excision repair specifies the location in active genes where preferential DNA repair is to take place ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8702928", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 143, "text": "Transcription when coupled to nucleotide excision repair specifies the location in active genes where preferential DNA repair is to take place. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8702928", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "UvrB plays a key role in bacterial nucleotide excision repair. It is the ultimate damage-binding protein that interacts with both UvrA and UvrC. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17630776", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 141, "text": "Escherichia coli nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrABC endonuclease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10913608", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 166, "text": "Transcription-coupled repair (TCR) is a subpathway of nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of expressed genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22749141", "endSection": "abstract"}, {"offsetInBeginSection": 320, "offsetInEndSection": 531, "text": "the transcription repair coupling factor, Mfd. This protein recruits the NER lesion-recognition factor UvrA, and then dissociates from the DNA. UvrA binds UvrB, and the assembled UvrAB* complex initiates repair. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22749141", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 450, "text": "The recognition by Escherichia coli Uvr nucleotide excision repair proteins of a variety of lesions with diverse chemical structures and the presence of helicase activity in the UvrAB complex which can displace short oligonucleotides annealed to single-stranded DNA led to a model in which this activity moves UvrAB along undamaged DNA to damaged sites where the lesion blocks further translocation and the protein-DNA pre-incision complex is formed. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9049317", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 449, "text": "The recognition by Escherichia coli Uvr nucleotide excision repair proteins of a variety of lesions with diverse chemical structures and the presence of helicase activity in the UvrAB complex which can displace short oligonucleotides annealed to single-stranded DNA led to a model in which this activity moves UvrAB along undamaged DNA to damaged sites where the lesion blocks further translocation and the protein-DNA pre-incision complex is formed ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9049317", "endSection": "abstract"}]}, {"body": "What is the localization of the protein encoded by the gene DNAJC11?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17624330"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "25570"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "25570"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17738715", "o": "25570"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "25570"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "HUGO"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "HUGO"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A17738715", "o": "HUGO"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "HUGO"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "Metathesaurus Names"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11695815"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17746647", "o": "DNAJC11"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11695815", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A11657583"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17738715"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A17746647"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11657583", "o": "FLJ10737"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1539296", "o": "http://linkedlifedata.com/resource/umls/label/A8264562"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8264562", "o": "DNAJC11 gene"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A12988852", "o": "C487553"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988853", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988853"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988852"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12996051", "o": "FLJ10737 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988852", "o": "DNAJC11 protein, human"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12996051"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A12988853", "o": "C487553"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988853", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988853"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988852"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12996051", "o": "FLJ10737 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988852", "o": "DNAJC11 protein, human"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12996051"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A12996051", "o": "C487553"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988853", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988853"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988852"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12996051", "o": "FLJ10737 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988852", "o": "DNAJC11 protein, human"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12996051"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A12988852", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988853", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988853"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988852"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12996051", "o": "FLJ10737 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988852", "o": "DNAJC11 protein, human"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12996051"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A12988853", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988853", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988853"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988852"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12996051", "o": "FLJ10737 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988852", "o": "DNAJC11 protein, human"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12996051"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A12996051", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988853", "o": "DnaJ (Hsp40) homolog, subfamily C, member 11 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988853"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12988852"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12996051", "o": "FLJ10737 protein, human"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12988852", "o": "DNAJC11 protein, human"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1453469", "o": "http://linkedlifedata.com/resource/umls/label/A12996051"}], "ideal_answer": "The first three are outer membrane proteins, chchd3 has been assigned to the matrix space, and the other two proteins have not been described in mitochondria previously.", "exact_answer": ["mitochondrial inner membrane"], "concepts": ["http://www.uniprot.org/uniprot/DJC11_BOVIN", "http://www.uniprot.org/uniprot/DJC11_MOUSE", "http://www.uniprot.org/uniprot/DJC11_HUMAN", "http://www.uniprot.org/uniprot/DJC11_DICDI", "http://www.uniprot.org/uniprot/DJC11_PONAB"], "type": "factoid", "id": "531e2695267d7dd05300000f", "snippets": [{"offsetInBeginSection": 247, "offsetInEndSection": 440, "text": " DnaJC11, respectively. The first three are outer membrane proteins, CHCHD3 has been assigned to the matrix space, and the other two proteins have not been described in mitochondria previously. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17624330", "endSection": "abstract"}]}, {"body": "Is Calcium/Calmodulin dependent protein kinase II (CaMKII) involved in cardiac arrhythmias and heart failure?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23877259", "http://www.ncbi.nlm.nih.gov/pubmed/24077098", "http://www.ncbi.nlm.nih.gov/pubmed/23862619", "http://www.ncbi.nlm.nih.gov/pubmed/23789646", "http://www.ncbi.nlm.nih.gov/pubmed/23781262", "http://www.ncbi.nlm.nih.gov/pubmed/23613689", "http://www.ncbi.nlm.nih.gov/pubmed/23279377", "http://www.ncbi.nlm.nih.gov/pubmed/23159442", "http://www.ncbi.nlm.nih.gov/pubmed/22514276", "http://www.ncbi.nlm.nih.gov/pubmed/22453965", "http://www.ncbi.nlm.nih.gov/pubmed/21742790", "http://www.ncbi.nlm.nih.gov/pubmed/21276796", "http://www.ncbi.nlm.nih.gov/pubmed/22578240", "http://www.ncbi.nlm.nih.gov/pubmed/21174213", "http://www.ncbi.nlm.nih.gov/pubmed/21098440", "http://www.ncbi.nlm.nih.gov/pubmed/20194790", "http://www.ncbi.nlm.nih.gov/pubmed/19919992", "http://www.ncbi.nlm.nih.gov/pubmed/19482609", "http://www.ncbi.nlm.nih.gov/pubmed/19333131", "http://www.ncbi.nlm.nih.gov/pubmed/18556468", "http://www.ncbi.nlm.nih.gov/pubmed/17704163", "http://www.ncbi.nlm.nih.gov/pubmed/17124532", "http://www.ncbi.nlm.nih.gov/pubmed/16610345"], "triples": [], "ideal_answer": "Calcium-calmodulin-dependent protein kinase ii ( camkii ) has emerged as a central mediator of cardiac arrhythmias camkii is upregulated in heart failure where arrhythmias are common, and camkii inhibition can reduce arrhythmias.Ca2+ dependent kinase ii ( camkii ) seems to be involved in the development of heart failure and arrhythmias and may therefore be a promising target for the development of antiarrhythmic therapies overexpression of ca ( 2+ ) protein kinase ii ( camkii ) in transgenic mice results in heart failure and arrhythmias.Calcium protein kinase ii contributes to cardiac arrhythmogenesis in heart failure.The ca-calmodulin dependent protein kinase ii ( camkii ) in transgenic mice results in heart failure and arrhythmias.Calcium-calmodulin-dependent protein kinase ii ( camkii ) has emerged as a central mediator of cardiac stress responses which may serve several critical roles in the regulation of cardiac rhythm, cardiac contractility and growth.Calcium-calmodulin-dependent protein kinase ii ( camkii ) can phosphorylate ryr2 and modulate its activity.", "exact_answer": "yes", "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0004683", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0005954", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054737", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017871", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054734", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054729", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054732"], "type": "yesno", "id": "5502abd1e9bde69634000008", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 68, "text": "Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22009705", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 104, "text": "Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19919992", "endSection": "title"}, {"offsetInBeginSection": 12, "offsetInEndSection": 94, "text": "CaMKII activation is proarrhythmic in heart failure where myocardium is stretched. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23279377", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22578240", "endSection": "title"}, {"offsetInBeginSection": 1649, "offsetInEndSection": 1750, "text": "Thus, CaMKII-dependent regulation of Na(+) channel function may contribute to arrhythmogenesis in HF. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17124532", "endSection": "abstract"}, {"offsetInBeginSection": 405, "offsetInEndSection": 612, "text": "The Ca-calmodulin dependent kinase II (CaMKII) seems to be involved in the development of heart failure and arrhythmias and may therefore be a promising target for the development of antiarrhythmic therapies ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23159442", "endSection": "abstract"}, {"offsetInBeginSection": 985, "offsetInEndSection": 1117, "text": " In contrast, inhibiting the CaMKII pathway appears to reduce arrhythmias and improve myocardial responses to pathological stimuli. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21276796", "endSection": "abstract"}, {"offsetInBeginSection": 336, "offsetInEndSection": 469, "text": "Overexpression of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in transgenic mice results in heart failure and arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23781262", "endSection": "abstract"}, {"offsetInBeginSection": 405, "offsetInEndSection": 613, "text": "The Ca-calmodulin dependent kinase II (CaMKII) seems to be involved in the development of heart failure and arrhythmias and may therefore be a promising target for the development of antiarrhythmic therapies. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23159442", "endSection": "abstract"}, {"offsetInBeginSection": 333, "offsetInEndSection": 467, "text": " Overexpression of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in transgenic mice results in heart failure and arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23781262", "endSection": "abstract"}, {"offsetInBeginSection": 1641, "offsetInEndSection": 1788, "text": "Thus, late I(Na) inhibition appears to be a promising option for diastolic dysfunction and arrhythmias in HF where CaMKII is found to be increased. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21174213", "endSection": "abstract"}, {"offsetInBeginSection": 128, "offsetInEndSection": 313, "text": "CaMKII targets numerous proteins involved in excitation-contraction coupling and excitability, and its activation may simultaneously contribute to heart failure and cardiac arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19333131", "endSection": "abstract"}, {"offsetInBeginSection": 128, "offsetInEndSection": 312, "text": "CaMKII targets numerous proteins involved in excitation-contraction coupling and excitability, and its activation may simultaneously contribute to heart failure and cardiac arrhythmias ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19333131", "endSection": "abstract"}, {"offsetInBeginSection": 246, "offsetInEndSection": 392, "text": "Under stress conditions, excessive CaMKII activity promotes heart failure and arrhythmias, in part through actions at Ca(2+) homeostatic proteins. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18556468", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "Transgenic (TG) Ca/calmodulin-dependent protein kinase II (CaMKII)delta(C) mice have heart failure and isoproterenol (ISO)-inducible arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19919992", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "Transgenic (TG) Ca/calmodulin-dependent protein kinase II (CaMKII)delta(C) mice have heart failure and isoproterenol (ISO)-inducible arrhythmias ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19919992", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 157, "text": "BACKGROUND: Transgenic (TG) Ca/calmodulin-dependent protein kinase II (CaMKII)delta(C) mice have heart failure and isoproterenol (ISO)-inducible arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19919992", "endSection": "abstract"}, {"offsetInBeginSection": 337, "offsetInEndSection": 522, "text": "We tested the hypothesis that increased RyR2 phosphorylation by Ca(2+)/calmodulin-dependent protein kinase II is both necessary and sufficient to promote lethal ventricular arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21098440", "endSection": "abstract"}, {"offsetInBeginSection": 267, "offsetInEndSection": 479, "text": "Because CaMKII expression and activity are increased in cardiac hypertrophy, heart failure, and during arrhythmias both in animal models as well as in the human heart a clinical significance of CaMKII is implied. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22453965", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 228, "text": "In the recent years, Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) was suggested to be associated with cardiac hypertrophy and heart failure but also with arrhythmias both in animal models as well as in the human heart. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23862619", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 239, "text": "Excessive activation of calmodulin kinase II (CaMKII) causes arrhythmias and heart failure, but the cellular mechanisms for CaMKII-targeted proteins causing disordered cell membrane excitability and myocardial dysfunction remain uncertain. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20194790", "endSection": "abstract"}, {"offsetInBeginSection": 806, "offsetInEndSection": 1050, "text": "Recent findings that CaMKII expression in the heart changes during hypertrophy, heart failure, myocardial ischemia, and infarction suggest that CaMKII may be a viable therapeutic target for patients suffering from common forms of heart disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16610345", "endSection": "abstract"}, {"offsetInBeginSection": 1492, "offsetInEndSection": 1735, "text": "CaMKII-dependent phosphorylation of Na(V)1.5 at multiple sites (including Thr-594 and Ser-516) appears to be required to evoke loss-of-function changes in gating that could contribute to acquired Brugada syndrome-like effects in heart failure. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22514276", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 313, "text": "Calcium/calmodulin-dependent kinase II (CaMKII) is a multifunctional serine/threonine kinase expressed abundantly in the heart. CaMKII targets numerous proteins involved in excitation-contraction coupling and excitability, and its activation may simultaneously contribute to heart failure and cardiac arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19333131", "endSection": "abstract"}, {"offsetInBeginSection": 1548, "offsetInEndSection": 1785, "text": "CONCLUSIONS: our results suggest that Ca(2+)/calmodulin-dependent protein kinase II phosphorylation of RyR2 Ca(2+) release channels at S2814 plays an important role in arrhythmogenesis and sudden cardiac death in mice with heart failure. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21098440", "endSection": "abstract"}, {"offsetInBeginSection": 170, "offsetInEndSection": 425, "text": "Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is up-regulated in heart failure and has been shown to cause I(Na) gating changes that mimic those induced by a point mutation in humans that is associated with combined long QT and Brugada syndromes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22514276", "endSection": "abstract"}, {"offsetInBeginSection": 436, "offsetInEndSection": 760, "text": "Ca2+/calmodulin dependent protein kinase II (CaMKII) can phosphorylate RyR2 and modulate its activity. This phosphorylation positively modulates cardiac inotropic function but in extreme situations such as heart failure, elevated CaMKII activity can adversely increase Ca2+ release from the SR and lead to arrhythmogenesis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19482609", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 328, "text": "Transgenic (TG) Ca/calmodulin-dependent protein kinase II (CaMKII)delta(C) mice have heart failure and isoproterenol (ISO)-inducible arrhythmias. We hypothesized that CaMKII contributes to arrhythmias and underlying cellular events and that inhibition of CaMKII reduces cardiac arrhythmogenesis in vitro and in vivo. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19919992", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 255, "text": "In heart failure (HF), Ca(2+)/calmodulin kinase II (CaMKII) expression is increased. Altered Na(+) channel gating is linked to and may promote ventricular tachyarrhythmias (VTs) in HF. Calmodulin regulates Na(+) channel gating, in part perhaps via CaMKII. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17124532", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 321, "text": "Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is an enzyme with important regulatory functions in the heart and brain, and its chronic activation can be pathological. CaMKII activation is seen in heart failure, and can directly induce pathological changes in ion channels, Ca(2+) handling and gene transcription. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24077098", "endSection": "abstract"}, {"offsetInBeginSection": 355, "offsetInEndSection": 668, "text": "From recent studies, it appears evident that Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) plays a central role in the arrhythmogenic processes in heart failure by sensing intracellular Ca(2+) and redox stress, affecting individual ion channels and thereby leading to electrical instability in the heart. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613689", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 391, "text": "The multifunctional Ca(2+)- and calmodulin-dependent protein kinase II (CaMKII) is now recognized to play a central role in pathological events in the cardiovascular system. CaMKII has diverse downstream targets that promote vascular disease, heart failure, and arrhythmias, so improved understanding of CaMKII signaling has the potential to lead to new therapies for cardiovascular disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21742790", "endSection": "abstract"}, {"offsetInBeginSection": 1786, "offsetInEndSection": 2145, "text": "We conclude that CaMKII contributes to cardiac arrhythmogenesis in TG CaMKIIdelta(C) mice having heart failure and suggest the increased SR Ca leak as an important mechanism. Moreover, CaMKII inhibition reduces cardiac arrhythmias in vitro and in vivo and may therefore indicate a potential role for future antiarrhythmic therapies warranting further studies. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19919992", "endSection": "abstract"}, {"offsetInBeginSection": 14, "offsetInEndSection": 455, "text": "Calcium-calmodulin-dependent protein kinase II (CaMKII) has emerged as a central mediator of cardiac stress responses which may serve several critical roles in the regulation of cardiac rhythm, cardiac contractility and growth. Sustained and excessive activation of CaMKII during cardiac disease has, however, been linked to arrhythmias, and maladaptive cardiac remodeling, eventually leading to heart failure (HF) and sudden cardiac death. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23789646", "endSection": "abstract"}, {"offsetInBeginSection": 168, "offsetInEndSection": 625, "text": "In this review, we discuss the important role of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in the regulation of RyR2-mediated Ca(2+) release. In particular, we examine how pathological activation of CaMKII can lead to an increased risk of sudden arrhythmic death. Finally, we discuss how reduction of CaMKII-mediated RyR2 hyperactivity might reduce the risk of arrhythmias and may serve as a rationale for future pharmacotherapeutic approaches. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22578240", "endSection": "abstract"}, {"offsetInBeginSection": 1307, "offsetInEndSection": 1740, "text": "In human hypertrophy, both CaMKII and PKA functionally regulate RyR2 and may induce SR Ca(2+) leak. In the transition from hypertrophy to HF, the diastolic Ca(2+) leak increases and disturbed Ca(2+) cycling occurs. This is associated with an increase in CaMKII- but not PKA-dependent RyR2 phosphorylation. CaMKII inhibition may thus reflect a promising therapeutic target for the treatment of arrhythmias and contractile dysfunction. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23877259", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 388, "text": "Transgenic (TG) Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) \u03b4(C) mice develop systolic heart failure (HF). CaMKII regulates intracellular Ca(2+) handling proteins as well as sarcolemmal Na(+) channels. We hypothesized that CaMKII also contributes to diastolic dysfunction and arrhythmias via augmentation of the late Na(+) current (late I(Na)) in early HF (8-week-old TG mice). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21174213", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 482, "text": "Ca-calmodulin-dependent protein kinase II (CaMKII) was recently shown to alter Na(+) channel gating and recapitulate a human Na(+) channel genetic mutation that causes an unusual combined arrhythmogenic phenotype in patients: simultaneous long QT syndrome and Brugada syndrome. CaMKII is upregulated in heart failure where arrhythmias are common, and CaMKII inhibition can reduce arrhythmias. Thus, CaMKII-dependent channel modulation may contribute to acquired arrhythmic disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17704163", "endSection": "abstract"}, {"offsetInBeginSection": 130, "offsetInEndSection": 791, "text": "In our opinion, the multifunctional Ca and calmodulin-dependent protein kinase II (CaMKII) has emerged as a molecule to watch, in part because a solid body of accumulated data essentially satisfy Koch's postulates, showing that the CaMKII pathway is a core mechanism for promoting myocardial hypertrophy and heart failure. Multiple groups have now confirmed the following: (1) that CaMKII activity is increased in hypertrophied and failing myocardium from animal models and patients; (2) CaMKII overexpression causes myocardial hypertrophy and HF and (3) CaMKII inhibition (by drugs, inhibitory peptides and gene deletion) improves myocardial hypertrophy and HF ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21276796", "endSection": "abstract"}]}, {"body": "What is the lay name of the treatment for CCSVI (chronic cerebro-spinal venous insufficiency)  in multiple sclerosis.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23523158", "http://www.ncbi.nlm.nih.gov/pubmed/23402260", "http://www.ncbi.nlm.nih.gov/pubmed/23380649", "http://www.ncbi.nlm.nih.gov/pubmed/23354606", "http://www.ncbi.nlm.nih.gov/pubmed/23301864", "http://www.ncbi.nlm.nih.gov/pubmed/23202144", "http://www.ncbi.nlm.nih.gov/pubmed/23034121", "http://www.ncbi.nlm.nih.gov/pubmed/22951366", "http://www.ncbi.nlm.nih.gov/pubmed/22687168", "http://www.ncbi.nlm.nih.gov/pubmed/22648477", "http://www.ncbi.nlm.nih.gov/pubmed/22640501", "http://www.ncbi.nlm.nih.gov/pubmed/22155803", "http://www.ncbi.nlm.nih.gov/pubmed/22088659", "http://www.ncbi.nlm.nih.gov/pubmed/21876515", "http://www.ncbi.nlm.nih.gov/pubmed/21856578", "http://www.ncbi.nlm.nih.gov/pubmed/21839654", "http://www.ncbi.nlm.nih.gov/pubmed/21838669", "http://www.ncbi.nlm.nih.gov/pubmed/21808631", "http://www.ncbi.nlm.nih.gov/pubmed/21803799", "http://www.ncbi.nlm.nih.gov/pubmed/21755134", "http://www.ncbi.nlm.nih.gov/pubmed/21679067", "http://www.ncbi.nlm.nih.gov/pubmed/21136256", "http://www.ncbi.nlm.nih.gov/pubmed/21107001", "http://www.ncbi.nlm.nih.gov/pubmed/20373339", "http://www.ncbi.nlm.nih.gov/pubmed/20351675", "http://www.ncbi.nlm.nih.gov/pubmed/21687341", "http://www.ncbi.nlm.nih.gov/pubmed/19958985"], "ideal_answer": "The treatment based on the CCSVI theory has appealingly been called \"liberation treatment\" the European Society of Neurosonology and Cerebral Hemodynamics ( ESNCH ) has considerable concerns regarding the accuracy of the proposed criteria for CCSVI in MS. stent implantation into the jugular vein, the aim of this report is to assess the safety of endovascular treatment for chronic cerebrospinal venous insufficiency ( CCSVI ) although it is debated whether chronic cerebro-spinal venous insufficiency ( CCSVI ) plays a role in multiple sclerosis ( MS ) development, many patients undergo endovascular treatment ( ET ) of CCSVIAn endovascular treatment of Chronic Cerebro-Spinal Venous Insufficiency in multiple sclerosis patients chronic cerebrospinal venous insufficiency ( CCSVI ) is associated with multiple sclerosis ( MS ).", "exact_answer": ["LIberation therapy"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009103", "http://www.disease-ontology.org/api/metadata/DOID:2377"], "type": "factoid", "id": "515df199298dcd4e5100002a", "snippets": [{"offsetInBeginSection": 1004, "offsetInEndSection": 1045, "text": "stent implantation into the jugular vein, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21876515", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 67, "text": "Endovascular treatment of CCSVI in patients with multiple sclerosis ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23354606", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 72, "text": "Clinical improvement after extracranial venoplasty in multiple sclerosis ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22951366", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 79, "text": "Safety of endovascular treatment of chronic cerebrospinal venous insufficiency: ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22088659", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 93, "text": "Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22640501", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Endovascular treatment of patients with chronic cerebrospinal venous insufficiency and multiple sclerosis ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22155803", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 103, "text": "An endovascular treatment of Chronic Cerebro-Spinal Venous Insufficiency in multiple sclerosis patients ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21876515", "endSection": "title"}, {"offsetInBeginSection": 900, "offsetInEndSection": 990, "text": "The treatment based on the CCSVI theory has appealingly been called \"liberation treatment\" ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21755134", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19958985", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 91, "text": "Internal jugular thrombosis post venoplasty for chronic cerebrospinal venous insufficiency. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21803799", "endSection": "title"}, {"offsetInBeginSection": 323, "offsetInEndSection": 422, "text": "A total of 564 endovascular procedures (balloon angioplasty or, if this procedure failed, stenting) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21107001", "endSection": "sections.0"}, {"offsetInBeginSection": 730, "offsetInEndSection": 845, "text": "She underwent percutaneous balloon angioplasty of the associated chronic cerebrospinal venous insufficiency (CCSVI) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20351675", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 138, "text": "The aim of this report is to assess the safety of endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21107001", "endSection": "sections.0"}, {"offsetInBeginSection": 360, "offsetInEndSection": 495, "text": "While balloon angioplasty was preferred, 98 stents were implanted in 76 patients for lesion recoil, restenosis, or suboptimal dilation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21679067", "endSection": "sections.0"}, {"offsetInBeginSection": 478, "offsetInEndSection": 639, "text": "Endovascular treatment (percutaneous transluminal angioplasty (PTA) with or without stenting) of CCSVI was reported to be feasible with a minor complication rate ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22155803", "endSection": "sections.0"}, {"offsetInBeginSection": 204, "offsetInEndSection": 359, "text": "Twenty-nine patients with clinically definite relapsing-remitting MS underwent percutaneous transluminal angioplasty for CCSVI, outside a clinical relapse. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22687168", "endSection": "sections.0"}, {"offsetInBeginSection": 1161, "offsetInEndSection": 1351, "text": "As the debate about CCSVI and its relationship to MS continues, the complications and risks associated with venous stenting and angioplasty in jugular and azygous veins are becoming clearer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21856578", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 179, "text": "Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23202144", "endSection": "title"}, {"offsetInBeginSection": 434, "offsetInEndSection": 602, "text": "CCSVI theory has generated a scientific and mass media debate with a great hope for the miracle of a new possible endovascular treatment of MS (\"liberation procedure\"). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21838669", "endSection": "sections.0"}, {"offsetInBeginSection": 233, "offsetInEndSection": 407, "text": "Thirty-six patients with confirmed MS and CCSVI underwent endovascular treatment by the means of the uni- or bilateral jugular vein angioplasty with optional stent placement. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21876515", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 218, "text": "This study proposed to prospectively evaluate safety and clinical changes in outpatient endovascular treatment in patients with multiple sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22951366", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 223, "text": "In this study, the mid-term results (6 month follow-up) of the endovascular treatment in patients with Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) and multiple sclerosis (MS) were prospectively evaluated. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21876515", "endSection": "sections.0"}, {"offsetInBeginSection": 341, "offsetInEndSection": 522, "text": "A potential shift in the treatment paradigm of MS involving endovascular balloon angioplasty or venous stent placement has been proposed as well as conducted in small patient series ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20373339", "endSection": "sections.0"}, {"offsetInBeginSection": 184, "offsetInEndSection": 330, "text": "MS patients (261 women; mean age 45.4 years, range 21-79) with CCSVI underwent endovascular treatment of 1012 venous lesions during 495 procedures ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21679067", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 194, "text": "Although it is debated whether chronic cerebro-spinal venous insufficiency (CCSVI) plays a role in multiple sclerosis (MS) development, many patients undergo endovascular treatment (ET) of CCSVI ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23380649", "endSection": "sections.0"}, {"offsetInBeginSection": 130, "offsetInEndSection": 366, "text": "patients with relapsing-remitting (RR) multiple sclerosis (MS) receiving standard medical treatment who had been diagnosed with chronic cerebrospinal venous insufficiency (CCSVI) and underwent percutaneous transluminal angioplasty (PTA) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23523158", "endSection": "sections.0"}, {"offsetInBeginSection": 243, "offsetInEndSection": 434, "text": "Our open-label study included 94 MS patients who fulfilled ultrasound sonographic criteria required for CCSVI. The internal jugular and/or azygous veins by a catheter venography were dilated. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23202144", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 203, "text": "Although it is still debated whether chronic cerebro-spinal venous insufficiency (CCSVI) plays a role in multiple sclerosis (MS) development, many patients underwent endovascular treatment (ET) of CCSVI. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23354606", "endSection": "sections.0"}, {"offsetInBeginSection": 898, "offsetInEndSection": 1103, "text": "The work of Dr. Zamboni, et al, who reported that treating the venous stenoses causing CCSVI with angioplasty resulting in significant improvement in the symptoms and quality of life of patients with MS (2 ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22640501", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 274, "text": "Chronic cerebrospinal venous insufficiency (CCSVI) is associated with multiple sclerosis (MS). The objective of the study was to see if percutaneous transluminal angioplasty (PTA) of duplex-detected lesions, of the internal jugular and/or azygous veins, was safe, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21839654", "endSection": "sections.0"}, {"offsetInBeginSection": 21, "offsetInEndSection": 282, "text": "Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) has been proposed to be associated with Multiple Sclerosis (MS). Zamboni et\u00a0al reported significant improvement in neurological outcomes in MS patients who underwent Percutaneous Transluminal Angioplasty (PTA) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23301864", "endSection": "sections.0"}, {"offsetInBeginSection": 1192, "offsetInEndSection": 1495, "text": "The European Society of Neurosonology and Cerebral Hemodynamics (ESNCH) has considerable concerns regarding the accuracy of the proposed criteria for CCSVI in MS. Therefore, any potentially harmful interventional treatment such as transluminal angioplasty and/or stenting should be strongly discouraged. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22648477", "endSection": "sections.0"}, {"offsetInBeginSection": 584, "offsetInEndSection": 830, "text": "Sixty-five consecutive patients with CCSVI, subdivided by MS clinical course into 35 with relapsing remitting (RR), 20 with secondary progressive (SP), and 10 with primary progressive (PP) MS, underwent percutaneous transluminal angioplasty (PTA) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19958985", "endSection": "sections.0"}, {"offsetInBeginSection": 699, "offsetInEndSection": 933, "text": "For patients treated primarily, 87% (208 of 239) had angioplasty, and 11% (26 of 239) had stent placement; 5 patients were not treated. Of patients with restenosis, 50% (9 of 18) had angioplasty, and 50% (9 of 18) had stent placement. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22088659", "endSection": "sections.0"}]}, {"body": "Which hormone abnormalities are characteristic to Pendred syndrome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23235354", "http://www.ncbi.nlm.nih.gov/pubmed/22116361", "http://www.ncbi.nlm.nih.gov/pubmed/22109890", "http://www.ncbi.nlm.nih.gov/pubmed/21511235", "http://www.ncbi.nlm.nih.gov/pubmed/20834201", "http://www.ncbi.nlm.nih.gov/pubmed/20822748", "http://www.ncbi.nlm.nih.gov/pubmed/20583162", "http://www.ncbi.nlm.nih.gov/pubmed/20501687", "http://www.ncbi.nlm.nih.gov/pubmed/20298745", "http://www.ncbi.nlm.nih.gov/pubmed/19692489", "http://www.ncbi.nlm.nih.gov/pubmed/19318451", "http://www.ncbi.nlm.nih.gov/pubmed/19205523", "http://www.ncbi.nlm.nih.gov/pubmed/19196800", "http://www.ncbi.nlm.nih.gov/pubmed/19189692", "http://www.ncbi.nlm.nih.gov/pubmed/18692402", "http://www.ncbi.nlm.nih.gov/pubmed/17697873", "http://www.ncbi.nlm.nih.gov/pubmed/17365057", "http://www.ncbi.nlm.nih.gov/pubmed/17120770", "http://www.ncbi.nlm.nih.gov/pubmed/16263499", "http://www.ncbi.nlm.nih.gov/pubmed/15863666", "http://www.ncbi.nlm.nih.gov/pubmed/15807875", "http://www.ncbi.nlm.nih.gov/pubmed/15279074", "http://www.ncbi.nlm.nih.gov/pubmed/11375792", "http://www.ncbi.nlm.nih.gov/pubmed/10650967", "http://www.ncbi.nlm.nih.gov/pubmed/9618167", "http://www.ncbi.nlm.nih.gov/pubmed/8706311", "http://www.ncbi.nlm.nih.gov/pubmed/7852510", "http://www.ncbi.nlm.nih.gov/pubmed/21745434", "http://www.ncbi.nlm.nih.gov/pubmed/8630497", "http://www.ncbi.nlm.nih.gov/pubmed/10700480", "http://www.ncbi.nlm.nih.gov/pubmed/7492068", "http://www.ncbi.nlm.nih.gov/pubmed/17322586", "http://www.ncbi.nlm.nih.gov/pubmed/18538122", "http://www.ncbi.nlm.nih.gov/pubmed/1159063", "http://www.ncbi.nlm.nih.gov/pubmed/10571950", "http://www.ncbi.nlm.nih.gov/pubmed/15355436", "http://www.ncbi.nlm.nih.gov/pubmed/10637573"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17838014", "o": "E07.1"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "274600"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "274600"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "274600"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "274600"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "274600"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "274600"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "274600"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "274600"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "C536648"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "C536648"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "C536648"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "OMIM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "MeSH"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A17838014", "o": "ICD-10-CM"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Metathesaurus Names"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/relationontology/hasInclusionCriteria", "s": "http://data.linkedct.org/resource/trials/NCT00216255", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00216255", "o": "Trial NCT00216255"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/relationontology/hasInclusionCriteria", "s": "http://data.linkedct.org/resource/trials/NCT00630370", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00630370", "o": "Trial NCT00630370"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#narrower", "s": "http://linkedlifedata.com/resource/umls/id/C0018023", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0064393", "o": "Goiters, Nodular"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0415707", "o": "GOITER NODULAR"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0064385", "o": "Goiter, Nodular"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17969523", "o": "Goiter, Nodular [Disease/Finding]"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8395403", "o": "Nodular Goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0092674", "o": "Nodular Goiters"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8375698", "o": "Nodular goiter NOS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12019521", "o": "Nodular goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#broader", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/id/C0018023"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0064393", "o": "Goiters, Nodular"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0415707", "o": "GOITER NODULAR"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0064385", "o": "Goiter, Nodular"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8395403", "o": "Nodular Goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17969523", "o": "Goiter, Nodular [Disease/Finding]"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0092674", "o": "Nodular Goiters"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8375698", "o": "Nodular goiter NOS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12019521", "o": "Nodular goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/relationontology/hasInclusionCriteria", "s": "http://data.linkedct.org/resource/trials/NCT00239915", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/trials/NCT00239915", "o": "Trial NCT00239915"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#broader", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/id/C0018784"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7577188", "o": "Sensorineural Hearing Loss"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8363138", "o": "Sensorineural hearing loss, unspecified"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18016059", "o": "Hearing Loss, Sensorineural [Disease/Finding]"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0488964", "o": "sensorineural hearing loss"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12009292", "o": "Sensorineural hearing loss"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0066355", "o": "Hearing Loss, Sensorineural"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17826267", "o": "Unspecified sensorineural hearing loss"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0913473", "o": "Deafness Sensorineural"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0418108", "o": "HEARING DISORDER, NEURAL"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11966484", "o": "Deafness, sensorineural"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0418105", "o": "HEARING DISORDER RETROCOCHLEAR"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7573621", "o": "Sensorineural Deafness"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17800546", "o": "Perceptive hearing loss NOS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11994439", "o": "Sensorineural deafness"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8373970", "o": "Perceptive hearing loss or deafness"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17467506", "o": "Hearing loss, perceptive"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11922573", "o": "Hearing loss, sensorineural"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17851703", "o": "Sensorineural deafness NOS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0245849", "o": "HEARING DISORDER, SENSORINEURAL"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12023235", "o": "Deafness, neurosensory"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16784526", "o": "Sensorineural Hearing Loss (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0404241", "o": "DEAFNESS, PERCEPTIVE"}, {"p": "http://www.w3.org/2004/02/skos/core#narrower", "s": "http://linkedlifedata.com/resource/umls/id/C0018784", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7577188", "o": "Sensorineural Hearing Loss"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8363138", "o": "Sensorineural hearing loss, unspecified"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18016059", "o": "Hearing Loss, Sensorineural [Disease/Finding]"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0488964", "o": "sensorineural hearing loss"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12009292", "o": "Sensorineural hearing loss"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0066355", "o": "Hearing Loss, Sensorineural"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17826267", "o": "Unspecified sensorineural hearing loss"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0913473", "o": "Deafness Sensorineural"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0418108", "o": "HEARING DISORDER, NEURAL"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11966484", "o": "Deafness, sensorineural"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0418105", "o": "HEARING DISORDER RETROCOCHLEAR"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7573621", "o": "Sensorineural Deafness"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17800546", "o": "Perceptive hearing loss NOS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11994439", "o": "Sensorineural deafness"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8373970", "o": "Perceptive hearing loss or deafness"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17467506", "o": "Hearing loss, perceptive"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A11922573", "o": "Hearing loss, sensorineural"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17851703", "o": "Sensorineural deafness NOS"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0245849", "o": "HEARING DISORDER, SENSORINEURAL"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12023235", "o": "Deafness, neurosensory"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A16784526", "o": "Sensorineural Hearing Loss (disorder)"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0404241", "o": "DEAFNESS, PERCEPTIVE"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113857879", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844388"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R119946067", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R03275989", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844387"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R60705962"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R60618697", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113836345", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113841830", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R71684698"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113842412", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113850402"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R60488385", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113850401", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113838723", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113850403"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844384"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R115219063", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R03348218"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R115213380"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113839841", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113842118", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113840203", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113840188", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R119806980"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113858879", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R57732439", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844386"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R119806981"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113857554", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113857879"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844385"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113856198", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113856198"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R60618697"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R57732440"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113840915", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113842413", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113857554"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R60575809", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R71684699", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R60705962", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844392"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R60488385"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://www.w3.org/2004/02/skos/core#inScheme", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R60560481", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844393"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113850403", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R03685854", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113860871"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R108937811", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844394"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R03690859"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R60575809"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R60575808", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113858879"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R60575808"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113860871", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R108937810"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113842729", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113850402", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R60560481"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relation", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/relation/R113844390"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R113840607", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}, {"p": "http://linkedlifedata.com/resource/umls/relatedConcept", "s": "http://linkedlifedata.com/resource/umls/relation/R119944384", "o": "http://linkedlifedata.com/resource/umls/id/C0271829"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17463293", "o": "TDH2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18464677", "o": "Pendred syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17462098"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016629"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17466910"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016630", "o": "DEAFNESS WITH GOITER"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016631"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17468130"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17463293"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18452359"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016629", "o": "PDS"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016630"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18455456"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17466910", "o": "THYROID DYSHORMONOGENESIS 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A18464677"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17468130", "o": "THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18452359", "o": "Goiter-deafness syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A17838014"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016628", "o": "PENDRED SYNDROME"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12060170"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12016631", "o": "GOITER-DEAFNESS SYNDROME"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A18455456", "o": "Deafness with goiter"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17462098", "o": "HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12060170", "o": "Pendred's syndrome"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0271829", "o": "http://linkedlifedata.com/resource/umls/label/A12016628"}], "ideal_answer": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in eva thyroid function seems to be preserved individuals were assigned affected status based on the characteristic clinical features of pendred's syndrome, namely the presence of congenital sensorineural hearing loss and the appearance in early life of a goitre.We report a young woman with genetically confirmed pendred syndrome and discuss the current therapeutic strategies of dyshormonogenetic goitre pendred syndrome ( ps ) and resistance to thyroid hormone ( rth ).Mutations of slc26a4 cause an enlarged vestibular aqueduct, nonsyndromic deafness, and deafness can be associated in some genetic syndromes, e.g.Two patients were hypothyroid, two individuals were euthyroid.Mutations of SLC26A4 cause an enlarged vestibular aqueduct, nonsyndromic deafness, and deafness as part of Pendred syndrome.We report a young woman with genetically confirmed pendred syndrome.", "exact_answer": [["thyroid"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006728", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013577", "http://www.disease-ontology.org/api/metadata/DOID:225"], "type": "factoid", "id": "53148a07dae131f847000002", "snippets": [{"offsetInBeginSection": 790, "offsetInEndSection": 833, "text": "Thyroid goiter was found in 46.5% of cases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20822748", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 181, "text": "Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10571950", "endSection": "abstract"}, {"offsetInBeginSection": 979, "offsetInEndSection": 1041, "text": "Two patients were hypothyroid, two individuals were euthyroid. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11375792", "endSection": "abstract"}, {"offsetInBeginSection": 924, "offsetInEndSection": 1140, "text": "Individuals were assigned affected status based on the characteristic clinical features of Pendred's syndrome, namely the presence of congenital sensorineural hearing loss and the appearance in early life of a goitre ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8706311", "endSection": "abstract"}, {"offsetInBeginSection": 600, "offsetInEndSection": 709, "text": "Management of a patient with Pendred syndrome requires careful follow-up and regular imaging of the thyroid. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19189692", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "Pendred syndrome is an autosomal recessive disorder characterized by congenital deafness and thyroid goiter. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10650967", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the Pendred thyroid. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20501687", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome confirmed by mutations in the PDS/SLC26A4 gene. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19189692", "endSection": "title"}, {"offsetInBeginSection": 164, "offsetInEndSection": 315, "text": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15279074", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 151, "text": "Genetic causes of goiter and deafness: Pendred syndrome in a girl and cooccurrence of Pendred syndrome and resistance to thyroid hormone in her sister. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19318451", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 143, "text": "We report a young woman with genetically confirmed Pendred syndrome and discuss the current therapeutic strategies of dyshormonogenetic goitre. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19189692", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 141, "text": "Pendred syndrome is an autosomal recessive disorder defined by sensorineural deafness, goiter and a partial organification defect of iodide. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22116361", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 148, "text": "The autosomal recessive Pendred's syndrome is defined by congenital sensorineural deafness, goiter, and impaired iodide organification. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11375792", "endSection": "abstract"}, {"offsetInBeginSection": 1611, "offsetInEndSection": 1769, "text": "This is the first report of the cooccurrence, in the same individual, of PS and RTH, two genetic syndromes both associated with goiter and hearing impairment. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19318451", "endSection": "abstract"}, {"offsetInBeginSection": 618, "offsetInEndSection": 752, "text": "Goiter development and hypothyroidism vary among affected individuals and seem to be partially dependent on nutritional iodide intake. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21511235", "endSection": "abstract"}, {"offsetInBeginSection": 163, "offsetInEndSection": 313, "text": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15279074", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "Biallelic mutations of SLC26A4 (encoding pendrin) cause Pendred syndrome (PS), an autosomal recessive genetic disorder with deafness and goiter. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20583162", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "Biallelic mutations of SLC26A4 (encoding pendrin) cause Pendred syndrome (PS), an autosomal recessive genetic disorder with deafness and goiter ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20583162", "endSection": "abstract"}, {"offsetInBeginSection": 1312, "offsetInEndSection": 1465, "text": "All patients harbouring mutations in the SLC26A4 gene had goiter and a positive perchlorate discharge test: 3 were slightly hypothyroid and 2 euthyroid. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15279074", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 172, "text": "Pendred syndrome (PS) is an autosomal recessive disease that is characterized by congenital sensorineural hearing loss, goiter, and a partial iodine organification defect. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17697873", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 202, "text": "Mutations in the SLC26A4 gene, coding for the anion transporter pendrin, are responsible for Pendred syndrome, characterized by congenital sensorineural deafness and dyshormonogenic goiter. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20834201", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 169, "text": "Pendred syndrome (PS) is an autosomal recessive disease that is characterized by congenital sensorineural hearing loss, goiter, and a partial iodine organification defect ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17697873", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 177, "text": "For over 100 years after the first description of the disorder, the molecular pathology underlying the deafness and thyroid pathology in Pendred syndrome (PS) remained unknown. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17120770", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 179, "text": "Pendred syndrome, defined as the constellation of goiter, sensori-neural hearing loss, and positive perchlorate discharge test, is the most frequent cause of congenital deafness. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17365057", "endSection": "abstract"}, {"offsetInBeginSection": 1166, "offsetInEndSection": 1360, "text": "These results demonstrate that pendrin translocates to the membrane in response to TSH and suggest that it may have a physiological role in apical iodide transport and thyroid hormone synthesis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22109890", "endSection": "abstract"}, {"offsetInBeginSection": 468, "offsetInEndSection": 620, "text": "From age 15 years, her thyroid gland showed progressive enlargement accompanied by elevation of serum thyroglobulin reaching 10-fold the normal amount. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20583162", "endSection": "abstract"}, {"offsetInBeginSection": 1115, "offsetInEndSection": 1298, "text": "Biallelic mutations in the SLC26A4 gene lead to Pendred syndrome, an autosomal recessive disorder characterized by sensorineural deafness, goiter, and impaired iodide organification. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19196800", "endSection": "abstract"}, {"offsetInBeginSection": 1598, "offsetInEndSection": 1741, "text": "Endocrine examination showed hypothyroidism in 5, its subclinical form in 1, diffuse thyroid goitre in 4 and nodular thyroid goiter in 2 cases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19205523", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 215, "text": "Pendred syndrome is an autosomal recessive disorder characterized by the association between sensorineural hearing loss and thyroid swelling or goitre and is likely to be the most common form of syndromic deafness. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9618167", "endSection": "abstract"}, {"offsetInBeginSection": 154, "offsetInEndSection": 363, "text": "Loss or reduction of function mutations of SLC26A4 underlie Pendred syndrome, a disorder invariably leading to hearing loss with enlarged vestibular aqueducts and in some patients to hypothyroidism and goiter. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23235354", "endSection": "abstract"}, {"offsetInBeginSection": 370, "offsetInEndSection": 570, "text": "Pendrin is mainly expressed in the thyroid, the inner ear, and the kidney. In the thyroid, pendrin localizes to the apical membrane of thyrocytes, where it may be involved in mediating iodide efflux. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20298745", "endSection": "abstract"}, {"offsetInBeginSection": 823, "offsetInEndSection": 1063, "text": "Elucidation of the molecular basis of Pendred syndrome and the function of pendrin has provided unexpected novel insights into the pathophysiology of the inner ear, thyroid hormone synthesis, and chloride/bicarbonate exchange in the kidney. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21511235", "endSection": "abstract"}, {"offsetInBeginSection": 402, "offsetInEndSection": 589, "text": "Presuming the classic triad as the gold standard, we compared MRI findings in six such defined patients with six cases having goiter, hearing loss, and normal perchlorate discharge test. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17365057", "endSection": "abstract"}, {"offsetInBeginSection": 602, "offsetInEndSection": 813, "text": "Results of immunoblot and immunofluorescence experiments reveal that TSH and forskolin rapidly increase pendrin abundance at the plasma membrane through the protein kinase A pathway in PCCL-3 rat thyroid cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22109890", "endSection": "abstract"}, {"offsetInBeginSection": 89, "offsetInEndSection": 314, "text": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19205523", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 214, "text": "Mutations of SLC26A4 cause an enlarged vestibular aqueduct, nonsyndromic deafness, and deafness as part of Pendred syndrome. SLC26A4 encodes pendrin, an anion exchanger located in the cochlea, thyroid, and kidney. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19692489", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 241, "text": "Pendred syndrome is an autosomal recessive disorder characterized by sensorineural deafness, goiter and a partial defect in iodide organification. Goiter development and hypothyroidism vary and appear to depend on nutritional iodide intake. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20298745", "endSection": "abstract"}, {"offsetInBeginSection": 795, "offsetInEndSection": 1024, "text": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15863666", "endSection": "abstract"}, {"offsetInBeginSection": 754, "offsetInEndSection": 1011, "text": "The elder sister had an elevated TSH level at newborn screening followed by subclinical hypothyroidism, childhood-onset goiter, and bilateral progressive sensorineural hearing impairment with enlarged vestibular aqueducts, consistent with a diagnosis of PS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19318451", "endSection": "abstract"}, {"offsetInBeginSection": 1240, "offsetInEndSection": 1457, "text": "In summary, a molecularly confirmed PS patient showed goiter progression accompanied by elevated serum thyroglobulin and increased thyroidal iodine uptake, but normal serum TSH levels and normal iodine organification. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20583162", "endSection": "abstract"}, {"offsetInBeginSection": 1763, "offsetInEndSection": 1987, "text": "Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15279074", "endSection": "abstract"}, {"offsetInBeginSection": 568, "offsetInEndSection": 803, "text": "Levels of thyroid hormones were essentially normal in all patients: 2 patients had goiters and/or elevated serum thyroglobulin levels, whereas 2 other patients had positive thyroid antibodies and a positive perchlorate discharge test. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17697873", "endSection": "abstract"}, {"offsetInBeginSection": 9, "offsetInEndSection": 290, "text": "Goiter and deafness can be associated in some genetic syndromes, e.g. Pendred syndrome (PS) and resistance to thyroid hormone (RTH). PS is an autosomal recessive disorder characterized by goiter and sensorineural hearing impairment with an enlarged vestibular aqueduct bilaterally. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19318451", "endSection": "abstract"}, {"offsetInBeginSection": 333, "offsetInEndSection": 611, "text": "The clinical phenotype of patients with Pendred syndrome and the fact that pendrin can mediate iodide efflux in transfected cells suggest that this anion exchanger may be involved in mediating iodide efflux into the follicular lumen, a key step in thyroid hormone biosynthesis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22116361", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 345, "text": "Pendred syndrome is an autosomal recessive disorder characterized by sensorineural hearing impairment, presence of goiter, and a partial defect in iodide organification, which may be associated with insufficient thyroid hormone synthesis. Goiter development and development of hypothyroidism are variable and depend on nutritional iodide intake. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18692402", "endSection": "abstract"}, {"offsetInBeginSection": 809, "offsetInEndSection": 1143, "text": "We review the literature to identify genetic defects involved in the iodination process of the thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid cell, defects in iodide transport from the thyroid cell to the follicular lumen (Pendred syndrome), and defects of iodide organification. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16263499", "endSection": "abstract"}, {"offsetInBeginSection": 1692, "offsetInEndSection": 1967, "text": "Among permanent CH cases, those with a goitre (n = 27) had an iodine organification defect (n = 10), Pendred syndrome (n = 1), a defect of thyroglobulin synthesis (n = 8), or a defect of sodium iodine symporter (n = 1), and in seven patients no aetiology could be determined. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15807875", "endSection": "abstract"}]}, {"body": "What is the mode of inheritance of  long QT  Jervell and Lange-Nielsen syndrome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23392653", "http://www.ncbi.nlm.nih.gov/pubmed/15950200", "http://www.ncbi.nlm.nih.gov/pubmed/12051962", "http://www.ncbi.nlm.nih.gov/pubmed/11140949", "http://www.ncbi.nlm.nih.gov/pubmed/10704188", "http://www.ncbi.nlm.nih.gov/pubmed/9302275", "http://www.ncbi.nlm.nih.gov/pubmed/10593671", "http://www.ncbi.nlm.nih.gov/pubmed/7721491", "http://www.ncbi.nlm.nih.gov/pubmed/10654932", "http://www.ncbi.nlm.nih.gov/pubmed/10077519", "http://www.ncbi.nlm.nih.gov/pubmed/18595190", "http://www.ncbi.nlm.nih.gov/pubmed/12132284", "http://www.ncbi.nlm.nih.gov/pubmed/1917338", "http://www.ncbi.nlm.nih.gov/pubmed/9341873", "http://www.ncbi.nlm.nih.gov/pubmed/11140992", "http://www.ncbi.nlm.nih.gov/pubmed/1721555", "http://www.ncbi.nlm.nih.gov/pubmed/23400408"], "triples": [], "ideal_answer": "Jervell and lange-nielsen syndrome ( mim 220400; jlns ), is a rare form of profound congenital deafness combined with syncopal attacks and sudden death due to prolonged qtc; it is an autosomal recessive trait.Homozygous or compound heterozygous mutations in KCNQ1 cause Jervell and Lange-Nielsen syndrome, a rare, autosomal-recessive form of long-QT syndrome characterized by deafness, marked QT prolongation, and a high risk of sudden death.Different mutations in kvlqt1 cause the dominant romano-ward ( rw ) syndrome and the recessive jervell and lange-nielsen ( jln ) syndrome, which, in addition to cardiac abnormalities, includes congenital deafness and prolongation of the qt interval on the electrocardiogram, representing abnormal ventricular repolarisation.KCNQ1 is associated with two different entities of LQTS, the autosomal-dominant Romano-Ward syndrome ( RWS ), and the autosomal-recessive Jervell and Lange-Nielsen syndrome ( JLNS ) characterized by bilateral deafness jervell and Lange-Nielsen syndrome ( JLNS ) is characterized by sensorineural deafness, QT prolongation, abnormal T waves, ventricular tachyarrhythmias, and autosomal recessive inheritance.", "exact_answer": ["autosomal recessive"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D029593", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008133", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D040582"], "type": "factoid", "id": "52eea4dcc8da89891000000c", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 187, "text": "Jervell and Lange-Nielsen syndrome (JLNS) is characterized by sensorineural deafness, QT prolongation, abnormal T waves, ventricular tachyarrhythmias, and autosomal recessive inheritance. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12051962", "endSection": "abstract"}, {"offsetInBeginSection": 301, "offsetInEndSection": 514, "text": "KCNQ1 is associated with two different entities of LQTS, the autosomal-dominant Romano-Ward syndrome (RWS), and the autosomal-recessive Jervell and Lange-Nielsen syndrome (JLNS) characterized by bilateral deafness ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15950200", "endSection": "abstract"}, {"offsetInBeginSection": 180, "offsetInEndSection": 449, "text": "The Jervell and Lange-Nielsen syndrome (JLNS) is characterized by prolongation of the QT interval, deafness, and autosomal-recessive inheritance, and the Romano-Ward syndrome is characterized by a prolonged QT interval, autosomal-dominant inheritance, and no deafness. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10593671", "endSection": "abstract"}, {"offsetInBeginSection": 402, "offsetInEndSection": 612, "text": "Different mutations in KVLQT1 cause the dominant Romano-Ward (RW) syndrome and the recessive Jervell and Lange-Nielsen (JLN) syndrome, which, in addition to cardiac abnormalities, includes congenital deafness. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302275", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 248, "text": "Jervell and Lange-Nielsen syndrome (JLNS) is an autosomal recessive syndrome characterised by profound congenital sensorineural deafness and prolongation of the QT interval on the electrocardiogram, representing abnormal ventricular repolarisation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11140949", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 208, "text": "Jervell and Lange-Nielsen syndrome (MIM 220400; JLNS), is a rare form of profound congenital deafness combined with syncopal attacks and sudden death due to prolonged QTc; it is an autosomal recessive trait. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10704188", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 245, "text": "Homozygous or compound heterozygous mutations in KCNQ1 cause Jervell and Lange-Nielsen syndrome, a rare, autosomal-recessive form of long-QT syndrome characterized by deafness, marked QT prolongation, and a high risk of sudden death. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23392653", "endSection": "abstract"}]}, {"body": "List programs suitable for protein docking", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24266324", "http://www.ncbi.nlm.nih.gov/pubmed/24187131", "http://www.ncbi.nlm.nih.gov/pubmed/24123140", "http://www.ncbi.nlm.nih.gov/pubmed/24108416", "http://www.ncbi.nlm.nih.gov/pubmed/24063890", "http://www.ncbi.nlm.nih.gov/pubmed/24050689", "http://www.ncbi.nlm.nih.gov/pubmed/23873600", "http://www.ncbi.nlm.nih.gov/pubmed/23862697", "http://www.ncbi.nlm.nih.gov/pubmed/23836482", "http://www.ncbi.nlm.nih.gov/pubmed/23829357", "http://www.ncbi.nlm.nih.gov/pubmed/23818491", "http://www.ncbi.nlm.nih.gov/pubmed/23813626", "http://www.ncbi.nlm.nih.gov/pubmed/23812908", "http://www.ncbi.nlm.nih.gov/pubmed/23808933", "http://www.ncbi.nlm.nih.gov/pubmed/23775700", "http://www.ncbi.nlm.nih.gov/pubmed/23712937", "http://www.ncbi.nlm.nih.gov/pubmed/23647909", "http://www.ncbi.nlm.nih.gov/pubmed/23633577", "http://www.ncbi.nlm.nih.gov/pubmed/23590204", "http://www.ncbi.nlm.nih.gov/pubmed/23451944", "http://www.ncbi.nlm.nih.gov/pubmed/23436713", "http://www.ncbi.nlm.nih.gov/pubmed/23351099", "http://www.ncbi.nlm.nih.gov/pubmed/23198780", "http://www.ncbi.nlm.nih.gov/pubmed/15215358", "http://www.ncbi.nlm.nih.gov/pubmed/16933295", "http://www.ncbi.nlm.nih.gov/pubmed/11841293", "http://www.ncbi.nlm.nih.gov/pubmed/17444519"], "triples": [], "ideal_answer": "The pose prediction success rate of each docking program alone was found in this trial to be 55 % for Autodock, 58 % for DOCK, and 64 % for Vina.We report the performance of our approaches for protein-protein docking and interface analysis in capri rounds 20-26. at the core of our pipeline was the zdock program alone was found in this trial to be 55 % for autodock, 58 % for dock, and 64 % for vina.We report the performance of our approaches for protein-protein docking and interface analysis in capri rounds 20-26. at the core of our pipeline was the zdock program for rigid-body protein-protein docking is a free and open source application that unifies a suite of software programs within a user-friendly graphical user interface ( gui ) to facilitate molecular docking experiments sol and discore programs are described.GalaxyDock protein-ligand docking program is introduced.This article presents docktrina, a novel protein docking method for modeling the 3d structures of nonsymmetrical triangular trimers", "exact_answer": [["CSBB-ConeExclusion"], ["HADDOCK"], ["ZDOCK"], ["GalaxyDock"], ["PHASE"], ["DockRank"], ["HotLig"], ["SOL"], ["AutodockVina"], ["DockoMatic"], ["DockTrina"], ["CAVITY"], ["LiGenDock"], ["DOCK"], ["DISCORE"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019542", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012984", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016560", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0048278", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0022406", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0022614", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000059", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0022615", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0005785", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0005047"], "type": "list", "id": "53355befd6d3ac6a34000046", "snippets": [{"offsetInBeginSection": 824, "offsetInEndSection": 955, "text": "This article presents DockTrina, a novel protein docking method for modeling the 3D structures of nonsymmetrical triangular trimers ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23775700", "endSection": "abstract"}, {"offsetInBeginSection": 786, "offsetInEndSection": 935, "text": "We present CSBB-ConeExclusion, a methodology and computer program which provides a measure of the applicability of solution dockings to solid support ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24266324", "endSection": "abstract"}, {"offsetInBeginSection": 215, "offsetInEndSection": 379, "text": "we present the functionalities of LiGenDock and its accompanying module LiGenPocket, aimed at the binding site analysis and structure-based pharmacophore definition ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23590204", "endSection": "abstract"}, {"offsetInBeginSection": 597, "offsetInEndSection": 739, "text": "The pose prediction success rate of each docking program alone was found in this trial to be 55% for Autodock, 58% for DOCK, and 64% for Vina. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23351099", "endSection": "abstract"}, {"offsetInBeginSection": 423, "offsetInEndSection": 564, "text": "Four possible binding pockets (Pocket A, B, C, and D) at the stalk region of hemagglutinin were detected and defined using the CAVITY program ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23647909", "endSection": "abstract"}, {"offsetInBeginSection": 10, "offsetInEndSection": 188, "text": " is a free and open source application that unifies a suite of software programs within a user-friendly graphical user interface (GUI) to facilitate molecular docking experiments ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23808933", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 218, "text": "We report the performance of our approaches for protein-protein docking and interface analysis in CAPRI rounds 20-26. At the core of our pipeline was the ZDOCK program for rigid-body protein-protein docking ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24123140", "endSection": "abstract"}, {"offsetInBeginSection": 13, "offsetInEndSection": 182, "text": "a method called residue contact frequency (RCF), which uses the complex structures generated by the protein-protein docking algorithm ZDOCK to predict interface residues ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23836482", "endSection": "abstract"}, {"offsetInBeginSection": 579, "offsetInEndSection": 747, "text": "improves the binding energy scoring by the local energy optimization of the ligand docked pose and a simple linear regression on the base of available experimental data ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23829357", "endSection": "abstract"}, {"offsetInBeginSection": 791, "offsetInEndSection": 978, "text": "Prime and the binding energy function in YASARA suggested it could be possible to evaluate the quality of the orthosteric binding site based on the prediction of relative binding energies ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23812908", "endSection": "abstract"}, {"offsetInBeginSection": 16, "offsetInEndSection": 199, "text": "a novel de novo design program, called LiGen, we developed a docking program, LiGenDock, based on pharmacophore models of binding sites, including a non-enumerative docking algorithm. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23590204", "endSection": "abstract"}, {"offsetInBeginSection": 782, "offsetInEndSection": 989, "text": " the method yields improved success over the standard DOCK energy function for pose identification across a large test set of experimental co-crystal structures, for crossdocking, and for database enrichment ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23436713", "endSection": "abstract"}, {"offsetInBeginSection": 291, "offsetInEndSection": 527, "text": "Within this context, low-resolution shape data obtained from either ion-mobility mass spectrometry (IM-MS) or SAXS experiments have been integrated into the conventional scoring function of the information-driven docking program HADDOCK ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23633577", "endSection": "abstract"}, {"offsetInBeginSection": 630, "offsetInEndSection": 858, "text": "Utilizing NMR titration data, we generated the structural models of S100B-FGF2 complex from the computational docking program, HADDOCK which were further proved stable during 15ns unrestrained molecular dynamics (MD) simulations ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24063890", "endSection": "abstract"}, {"offsetInBeginSection": 296, "offsetInEndSection": 567, "text": "The template-based methods showed similar performance to a docking method (ZDOCK) when the latter was allowed one prediction for each complex, but when the same number of predictions was allowed for each method, the docking approach outperformed template-based approaches ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23818491", "endSection": "abstract"}, {"offsetInBeginSection": 40, "offsetInEndSection": 281, "text": "GalaxyDock protein-ligand docking program is introduced. GalaxyDock performs conformational space annealing (CSA) global optimization to find the optimal binding pose of a ligand both in the rigid-receptor mode and the flexible-receptor mode ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24108416", "endSection": "abstract"}, {"offsetInBeginSection": 207, "offsetInEndSection": 441, "text": "VinaMPI is a massively parallel Message Passing Interface (MPI) program based on the multithreaded virtual docking program AutodockVina, and is used to distribute tasks while multithreading is used to speed-up individual docking tasks ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23813626", "endSection": "abstract"}, {"offsetInBeginSection": 470, "offsetInEndSection": 720, "text": "Thereafter, all molecules were docked into the newly generated active site environment of the selected protein using glide docking program, and the 3D-QSAR analysis was performed in PHASE program utilizing the docking based alignment of the molecules ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24050689", "endSection": "abstract"}, {"offsetInBeginSection": 171, "offsetInEndSection": 443, "text": "Here we describe the application of the program AutoDock to the design of a focused library that was used in the \"click chemistry in-situ\" generation of the most potent noncovalent inhibitor of the native enzyme acetylcholinesterase (AChE) yet developed (K(d) = ~100 fM). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23451944", "endSection": "abstract"}, {"offsetInBeginSection": 110, "offsetInEndSection": 409, "text": "The structure of the \u03b11I-peptide complex was investigated using data from NMR, small angle x-ray scattering, and size exclusion chromatography that were used to generate and validate a model of the complex using the data-driven docking program, HADDOCK (High Ambiguity Driven Biomolecular Docking). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24187131", "endSection": "abstract"}, {"offsetInBeginSection": 175, "offsetInEndSection": 520, "text": "In this study, we developed a novel scoring program, HotLig, which applies the Connolly surface of a protein to calculate hydrophobic interaction and paired pharmacophore interactions with ligands. In addition to molecular surface distance, ligand-contacting areas and hydrogen-bond angles were also introduced to the scoring functions in HotLig ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23862697", "endSection": "abstract"}, {"offsetInBeginSection": 279, "offsetInEndSection": 606, "text": "To account for the important docking interactions between the UBSAs ligand and hCA II enzyme, a molecular docking program AutoDock Vina is used. The molecular docking results obtained by AutoDock Vina revealed that the docked conformer has root mean square deviation value less than 1.50 \u00c5 compared to X-ray crystal structures. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23712937", "endSection": "abstract"}, {"offsetInBeginSection": 14, "offsetInEndSection": 470, "text": "devoted to results obtained by the docking program SOL and the post-processing program DISCORE at the CSAR benchmark. SOL and DISCORE programs are described. SOL is the original docking program developed on the basis of the genetic algorithm, MMFF94 force field, rigid protein, precalculated energy grid including desolvation in the frame of simplified GB model, vdW, and electrostatic interactions and taking into account the ligand internal strain energy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23829357", "endSection": "abstract"}, {"offsetInBeginSection": 351, "offsetInEndSection": 908, "text": "DockRank uses interface residues predicted by partner-specific sequence homology-based protein-protein interface predictor (PS-HomPPI), which predicts the interface residues of a query protein with a specific interaction partner. We compared the performance of DockRank with several state-of-the-art docking scoring functions using Success Rate (the percentage of cases that have at least one near-native conformation among the top m conformations) and Hit Rate (the percentage of near-native conformations that are included among the top m conformations). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23873600", "endSection": "abstract"}]}, {"body": "Which genes have been found mutated in Gray platelet syndrome patients?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24325358", "http://www.ncbi.nlm.nih.gov/pubmed/23100277", "http://www.ncbi.nlm.nih.gov/pubmed/21765412", "http://www.ncbi.nlm.nih.gov/pubmed/17209061"], "triples": [], "ideal_answer": "The genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the nbeal2 gene.Sequencing of gata1 revealed a g-to-a mutation at position 759 corresponding to amino acid change arg216gln.Here we show that mutations in nbeal2 ( neurobeachin-like 2 ), which segregated with the platelet phenotype and included the gata1 gene.Here we show that mutations in nbeal2 ( neurobeachin-like 2 ), which encodes a beach domain protein, cause gps and that megakaryocytes and platelets from individuals with gps express a unique combination of nbeal2 transcripts.We identified a family with gray platelet syndrome ( gps ) segregating as a sex-linked trait.We identified a family with gray platelet syndrome due to a gata1 arg216gln mutationX-linked gray platelet syndrome due to a gata1 revealed a g-to-a mutation at position 759 corresponding to amino acid change arg216gln.We detected a nonsense mutation in the gene encoding the transcription factor GFI1B ( growth factor independent 1B ) that causes autosomal dominant gray platelet syndrome.", "exact_answer": [["NBEAL2"], ["GFI1B"], ["GATA1"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D055652", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009154"], "type": "list", "id": "52f89f4f2059c6d71c00004e", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 65, "text": "X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17209061", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "We identified a family with gray platelet syndrome (GPS) segregating as a sex-linked trait. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17209061", "endSection": "abstract"}, {"offsetInBeginSection": 155, "offsetInEndSection": 279, "text": "The genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the NBEAL2 gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23100277", "endSection": "abstract"}, {"offsetInBeginSection": 145, "offsetInEndSection": 315, "text": "We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24325358", "endSection": "abstract"}, {"offsetInBeginSection": 136, "offsetInEndSection": 370, "text": "Here we show that mutations in NBEAL2 (neurobeachin-like 2), which encodes a BEACH/ARM/WD40 domain protein, cause GPS and that megakaryocytes and platelets from individuals with GPS express a unique combination of NBEAL2 transcripts. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21765412", "endSection": "abstract"}, {"offsetInBeginSection": 385, "offsetInEndSection": 665, "text": "Linkage analysis revealed a 63 cM region on the X chromosome between markers G10578 and DXS6797, which segregated with the platelet phenotype and included the GATA1 gene. Sequencing of GATA1 revealed a G-to-A mutation at position 759 corresponding to amino acid change Arg216Gln. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17209061", "endSection": "abstract"}]}, {"body": "Does dasatinib promote or inhibit T-cell proliferation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19056158", "http://www.ncbi.nlm.nih.gov/pubmed/17962511", "http://www.ncbi.nlm.nih.gov/pubmed/18413841", "http://www.ncbi.nlm.nih.gov/pubmed/18619726", "http://www.ncbi.nlm.nih.gov/pubmed/19016717", "http://www.ncbi.nlm.nih.gov/pubmed/18395492", "http://www.ncbi.nlm.nih.gov/pubmed/19066329"], "triples": [], "ideal_answer": "We also demonstrated inhibition of TCR signalling through Src-family kinase LCK, and predicted that inhibition of LCK and other kinases involved in T-cell signalling by dasatinib is responsible for the suppression of T-cell function.T-cell functions including proliferation, activation and cytokine production were all uniformly inhibited in the presence of dasatinib.Dasatinib inhibited antigen-specific proliferation of murine cd4 ( + ) and cd8 ( + ) transgenic t cells in vitro and in vivo dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits t-cell activation and proliferation dasatinib inhibits the proliferation and function of cd4+cd25+ regulatory t cells.Herein, we show that dasatinib inhibits tcr-mediated signal transduction, cellular proliferation, cytokine production, and in vivo t-cell responses both dasatinib and staurosporine inhibited t-cell activation and proliferation dasatinib inhibits the proliferation and function of cd4+cd25+ regulatory t cells.", "exact_answer": [["inhibits"]], "concepts": ["http://www.biosemantics.org/jochem#http://www.biosemantics.org/jochem#:4274027", "http://amigo.geneontology.org/amigo/term/GO:0042098", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000069439", "http://www.biosemantics.org/jochem#4244012", "http://www.biosemantics.org/jochem#4274027", "http://amigo.geneontology.org/amigo/term/GO:0042130", "http://amigo.geneontology.org/amigo/term/GO:0042102"], "type": "factoid", "id": "56c85ed65795f9a73e000012", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 82, "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19016717", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17962511", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 107, "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17962511", "endSection": "title"}, {"offsetInBeginSection": 1046, "offsetInEndSection": 1190, "text": "Both dasatinib and staurosporine inhibited T-cell activation, proliferation, cytokine production, and degranulation in a dose-dependent manner. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18413841", "endSection": "abstract"}, {"offsetInBeginSection": 1020, "offsetInEndSection": 1138, "text": "Dasatinib inhibited antigen-specific proliferation of murine CD4(+) and CD8(+) transgenic T cells in vitro and in vivo ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19056158", "endSection": "abstract"}, {"offsetInBeginSection": 417, "offsetInEndSection": 566, "text": "Herein, we show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17962511", "endSection": "abstract"}, {"offsetInBeginSection": 417, "offsetInEndSection": 564, "text": "Herein, we show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17962511", "endSection": "abstract"}, {"offsetInBeginSection": 501, "offsetInEndSection": 871, "text": "T-cell functions including proliferation, activation and cytokine production were all uniformly inhibited in the presence of dasatinib. We also demonstrated inhibition of TCR signalling through Src-family kinase LCK, and predicted that inhibition of LCK and other kinases involved in T-cell signalling by dasatinib is responsible for the suppression of T-cell function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18395492", "endSection": "abstract"}]}, {"body": "Does SCRIB deregulation promote cancer?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/14767561", "http://www.ncbi.nlm.nih.gov/pubmed/21549346", "http://www.ncbi.nlm.nih.gov/pubmed/21643016", "http://www.ncbi.nlm.nih.gov/pubmed/24276238", "http://www.ncbi.nlm.nih.gov/pubmed/23730214", "http://www.ncbi.nlm.nih.gov/pubmed/22169974", "http://www.ncbi.nlm.nih.gov/pubmed/21965329", "http://www.ncbi.nlm.nih.gov/pubmed/19041750", "http://www.ncbi.nlm.nih.gov/pubmed/18641685"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A7659777", "o": "C36345"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1514542", "o": "http://linkedlifedata.com/resource/umls/label/A7659777"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7659777", "o": "Protein Deregulation"}], "ideal_answer": "Loss of human homologs of drosophila dlg, scrib, and lgl are cancer-associated genes.Scrib heterozygosity predisposes to lung cancer human scribble cooperates with h-ras to promote cell invasion through deregulation of mapk signalling.Loss of human scribble inhibits breast cancer formation and that deregulation of mapk signalling.Scrib levels predict tumor relapse in hepatocellular carcinoma patients.Scribble ( SCRIB ) complexes ) is intricately related to advanced stages of tumour progression and invasiveness.We demonstrate that scribble inhibits breast cancer formation and that deregulation of polarity pathways promotes dysplastic and neoplastic growth in mammals by disrupting morphogenesis and inhibiting cell death.Scrib expression is deregulated in human prostate cancer,", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009369", "http://www.disease-ontology.org/api/metadata/DOID:162", "http://www.uniprot.org/uniprot/SCRIB_DANRE", "http://www.uniprot.org/uniprot/LAP4_DROME"], "type": "yesno", "id": "53314c98d6d3ac6a3400003b", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 47, "text": "Scrib heterozygosity predisposes to lung cancer ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24276238", "endSection": "title"}, {"offsetInBeginSection": 531, "offsetInEndSection": 582, "text": "Scrib heterozygosity initiated prostate hyperplasia ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21965329", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 57, "text": "SCRIB expression is deregulated in human prostate cancer, ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21965329", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18641685", "endSection": "title"}, {"offsetInBeginSection": 406, "offsetInEndSection": 463, "text": "Scribble, a product of a well-known tumor suppressor gene ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23730214", "endSection": "abstract"}, {"offsetInBeginSection": 1131, "offsetInEndSection": 1195, "text": "Scribble expression is decreased in many invasive human cancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18641685", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 77, "text": "Aberrant overexpression of the cell polarity module scribble in human cancer. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21549346", "endSection": "title"}, {"offsetInBeginSection": 832, "offsetInEndSection": 904, "text": "Scrib levels predict tumor relapse in hepatocellular carcinoma patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21643016", "endSection": "abstract"}, {"offsetInBeginSection": 134, "offsetInEndSection": 211, "text": "human homologs of Drosophila dlg, scrib, and lgl are cancer-associated genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14767561", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "CD74-dependent deregulation of the tumor suppressor scribble in human epithelial and breast cancer cells. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23730214", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 106, "text": "Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19041750", "endSection": "title"}, {"offsetInBeginSection": 247, "offsetInEndSection": 358, "text": " scribble (SCRIB) complexes) is intricately related to advanced stages of tumour progression and invasiveness. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22169974", "endSection": "abstract"}, {"offsetInBeginSection": 637, "offsetInEndSection": 743, "text": "loss of Scribble promotes invasion of cells through extracellular matrix in an organotypic culture system. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18641685", "endSection": "abstract"}, {"offsetInBeginSection": 754, "offsetInEndSection": 859, "text": "loss of Scrib and activated oncogenic KRas cooperate in vivo, resulting in more aggressive lung tumors, l ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24276238", "endSection": "abstract"}, {"offsetInBeginSection": 984, "offsetInEndSection": 1153, "text": "The clinical significance of the work in mice was highlighted by our observation that SCRIB deregulation strongly correlated with poor survival in human prostate cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21965329", "endSection": "abstract"}, {"offsetInBeginSection": 762, "offsetInEndSection": 939, "text": "These data uncover a previously unrecognized exploitation of Scrib for aberrant tumor cell motility and invasion, thus potentially contributing to disease progression in humans. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21549346", "endSection": "abstract"}, {"offsetInBeginSection": 578, "offsetInEndSection": 737, "text": "oss of miR-296 causes aberrantly increased and mislocalized Scrib in human tumors, resulting in exaggerated random cell migration and tumor cell invasiveness. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21643016", "endSection": "abstract"}, {"offsetInBeginSection": 839, "offsetInEndSection": 1051, "text": "we demonstrate that scribble inhibits breast cancer formation and that deregulation of polarity pathways promotes dysplastic and neoplastic growth in mammals by disrupting morphogenesis and inhibiting cell death. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19041750", "endSection": "abstract"}, {"offsetInBeginSection": 140, "offsetInEndSection": 318, "text": "we show that Scrib is nearly universally overexpressed in cultured tumor cell lines and genetically disparate cancer patient series compared with matched normal tissues in vivo. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21549346", "endSection": "abstract"}]}, {"body": "Is cardiac magnetic resonance imaging indicated in the pre-participation screening of athletes?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24029371", "http://www.ncbi.nlm.nih.gov/pubmed/23097483", "http://www.ncbi.nlm.nih.gov/pubmed/22375228", "http://www.ncbi.nlm.nih.gov/pubmed/18208827", "http://www.ncbi.nlm.nih.gov/pubmed/22853772", "http://www.ncbi.nlm.nih.gov/pubmed/15689345", "http://www.ncbi.nlm.nih.gov/pubmed/21118665", "http://www.ncbi.nlm.nih.gov/pubmed/21567995", "http://www.ncbi.nlm.nih.gov/pubmed/20833588", "http://www.ncbi.nlm.nih.gov/pubmed/16831826", "http://www.ncbi.nlm.nih.gov/pubmed/21486912", "http://www.ncbi.nlm.nih.gov/pubmed/20048491", "http://www.ncbi.nlm.nih.gov/pubmed/22457200", "http://www.ncbi.nlm.nih.gov/pubmed/16004915", "http://www.ncbi.nlm.nih.gov/pubmed/19055989", "http://www.ncbi.nlm.nih.gov/pubmed/20599016", "http://www.ncbi.nlm.nih.gov/pubmed/22375189", "http://www.ncbi.nlm.nih.gov/pubmed/21791458", "http://www.ncbi.nlm.nih.gov/pubmed/19734502", "http://www.ncbi.nlm.nih.gov/pubmed/16914373", "http://www.ncbi.nlm.nih.gov/pubmed/21278396", "http://www.ncbi.nlm.nih.gov/pubmed/22983606", "http://www.ncbi.nlm.nih.gov/pubmed/21782775", "http://www.ncbi.nlm.nih.gov/pubmed/10663764", "http://www.ncbi.nlm.nih.gov/pubmed/12446071", "http://www.ncbi.nlm.nih.gov/pubmed/15166900", "http://www.ncbi.nlm.nih.gov/pubmed/18325444", "http://www.ncbi.nlm.nih.gov/pubmed/20705486", "http://www.ncbi.nlm.nih.gov/pubmed/22653640", "http://www.ncbi.nlm.nih.gov/pubmed/23897528"], "triples": [], "ideal_answer": "As modern imaging further enhances our understanding of the spectrum of athlete's heart, its role may expand from the assessment of athletes with suspected disease to being part of comprehensive pre-participation screening.As modern imaging further enhances our understanding of the spectrum of athlete's heart, its role of cmr in pre-participation screening.Finally we will address the role may expand from the assessment of athletes with suspected disease to being part of comprehensive pre-participation screening in apparently healthy athletes.Finally we will address the role of CMR in pre-participation screening.", "exact_answer": "no", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008279", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D056352", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013177", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019028", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054874"], "type": "yesno", "id": "531d3dc0267d7dd053000005", "snippets": [{"offsetInBeginSection": 801, "offsetInEndSection": 872, "text": "Finally we will address the role of CMR in pre-participation screening. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23097483", "endSection": "abstract"}, {"offsetInBeginSection": 1858, "offsetInEndSection": 2112, "text": "As modern imaging further enhances our understanding of the spectrum of athlete's heart, its role may expand from the assessment of athletes with suspected disease to being part of comprehensive pre-participation screening in apparently healthy athletes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24029371", "endSection": "abstract"}]}, {"body": "Is imatinib an antidepressant drug?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22678007", "http://www.ncbi.nlm.nih.gov/pubmed/22593820", "http://www.ncbi.nlm.nih.gov/pubmed/22484890", "http://www.ncbi.nlm.nih.gov/pubmed/22460758", "http://www.ncbi.nlm.nih.gov/pubmed/22135725", "http://www.ncbi.nlm.nih.gov/pubmed/22110503", "http://www.ncbi.nlm.nih.gov/pubmed/22035758", "http://www.ncbi.nlm.nih.gov/pubmed/21938530", "http://www.ncbi.nlm.nih.gov/pubmed/21087500", "http://www.ncbi.nlm.nih.gov/pubmed/21073206", "http://www.ncbi.nlm.nih.gov/pubmed/20726677", "http://www.ncbi.nlm.nih.gov/pubmed/20676553", "http://www.ncbi.nlm.nih.gov/pubmed/20442314", "http://www.ncbi.nlm.nih.gov/pubmed/20407930", "http://www.ncbi.nlm.nih.gov/pubmed/19628568", "http://www.ncbi.nlm.nih.gov/pubmed/19110398", "http://www.ncbi.nlm.nih.gov/pubmed/18506179", "http://www.ncbi.nlm.nih.gov/pubmed/17554495", "http://www.ncbi.nlm.nih.gov/pubmed/16566359", "http://www.ncbi.nlm.nih.gov/pubmed/16403813", "http://www.ncbi.nlm.nih.gov/pubmed/15966213", "http://www.ncbi.nlm.nih.gov/pubmed/23394826", "http://www.ncbi.nlm.nih.gov/pubmed/21607924", "http://www.ncbi.nlm.nih.gov/pubmed/22831984", "http://www.ncbi.nlm.nih.gov/pubmed/22487918"], "triples": [{"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/724", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3066", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/541", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/2610", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/513", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/612", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/441", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/251", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/795", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3277", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/782", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/possibleDrug", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/2806", "o": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12798671", "o": "Imatinib"}, {"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A17885052", "o": "http://www.w3.org/2008/05/skos-xl#Label"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A12790183", "o": "IMATINIB"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A1989038", "o": "MeSH"}, {"p": "http://linkedlifedata.com/resource/relationontology/hasSideEffect", "s": "http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00619", "o": "http://linkedlifedata.com/resource/pubmed/mesh/Anxiety"}], "ideal_answer": "Bcr-abl-expressing cells showed resistance to death activated by spindle defects, reversed by imatinib.On clinical suspicion of recurrence 5 months later, magnetic resonance imaging ( mri ) revealed a lesion at the site of preceded surgery, which was treated by imatinib mesylate for cml we analysed imatinib, dasatinib and nilotinib.Results : bevacizumab, capecitabine, cetuximab, erlotinib, rituximab, imatinib, and temozolomide significant pharmacokinetic interactions have already been shown between st. john's wort ( sjw ) and the anticancer drugs imatinib and irinotecan.Imatinib plus hydroxyurea is well tolerated among patients with meningioma but has modest anti-tumor activity for this indication.Treatment is not recommended in an imatinib-insensitive D842V-mutated GIST", "exact_answer": "no", "concepts": ["http://www.biosemantics.org/jochem#4275840", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007202"], "type": "yesno", "id": "51542e84d24251bc05000083", "snippets": [{"offsetInBeginSection": 540, "offsetInEndSection": 580, "text": "Bcr-Abl, an oncogene responsible for CML ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20442314", "endSection": "sections.0"}, {"offsetInBeginSection": 1386, "offsetInEndSection": 1440, "text": "for CML we analysed imatinib, dasatinib and nilotinib. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21073206", "endSection": "sections.0"}, {"offsetInBeginSection": 1931, "offsetInEndSection": 2005, "text": "Treatment is not recommended in an imatinib-insensitive D842V-mutated GIST ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22831984", "endSection": "sections.0"}, {"offsetInBeginSection": 1596, "offsetInEndSection": 1686, "text": "imatinib mesylate could be a therapeutic target of strategies against osteosarcoma tumors. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22135725", "endSection": "sections.0"}, {"offsetInBeginSection": 1496, "offsetInEndSection": 1585, "text": "R1 surgery (versus R0) alone is not an indication for adjuvant imatinib in low-risk GIST. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22831984", "endSection": "sections.0"}, {"offsetInBeginSection": 1442, "offsetInEndSection": 1545, "text": "Bcr-Abl-expressing cells showed resistance to death activated by spindle defects, reversed by imatinib. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20442314", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 130, "text": "Surgical indication for metastatic gastrointestinal stromal tumor (GIST) treated with imatinib is not yet established. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19628568", "endSection": "sections.0"}, {"offsetInBeginSection": 275, "offsetInEndSection": 399, "text": "Imatinib, an oral tyrosine kinase inhibitor (TKI), is first-line treatment in patients with metastatic or unresectable GIST. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20407930", "endSection": "sections.0"}, {"offsetInBeginSection": 1089, "offsetInEndSection": 1219, "text": "Imatinib plus hydroxyurea is well tolerated among patients with meningioma but has modest anti-tumor activity for this indication. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21938530", "endSection": "sections.0"}, {"offsetInBeginSection": 410, "offsetInEndSection": 554, "text": "Significant pharmacokinetic interactions have already been shown between St. John's Wort (SJW) and the anticancer drugs imatinib and irinotecan. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23394826", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 167, "text": "To explore the effect of preoperative imatinib mesylate (IM) in patients with unresectable or locally advanced primary gastrointestinal stromal tumor (GIST) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19110398", "endSection": "sections.0"}, {"offsetInBeginSection": 1512, "offsetInEndSection": 1678, "text": "Radical surgery remains the most effective method of GIST treatment. In inoperable/metastatic lesion the treatment of choice is tyrosinase kinase inhibitor--imatinib. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16566359", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 154, "text": "Imatinib mesylate is the sole BCR-ABL tyrosine kinase inhibitor approved as first-line treatment of accelerated-phase (AP) chronic myeloid leukemia (CML). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22460758", "endSection": "sections.0"}, {"offsetInBeginSection": 1206, "offsetInEndSection": 1368, "text": "Adjuvant imatinib 400 mg/day for 3 years duration is a standard treatment in all patients with significant risk of recurrence following resection of primary GISTs ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22831984", "endSection": "sections.0"}, {"offsetInBeginSection": 1206, "offsetInEndSection": 1369, "text": "Adjuvant imatinib 400 mg/day for 3 years duration is a standard treatment in all patients with significant risk of recurrence following resection of primary GISTs. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22831984", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 162, "text": "Imatinib mesylate (STI571), a specific Bcr-Abl inhibitor, has shown a potent antileukemic activity in clinical studies of chronic myeloid leukemia (CML) patients. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16403813", "endSection": "sections.0"}, {"offsetInBeginSection": 1272, "offsetInEndSection": 1440, "text": "Ki67 correlated with time to recurrence (p=0.022). Ki67 >11% was taken as the indication to start imatinib chemotherapy (sensitivity 61.5%, specificity 92.0%, p=0.022). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21607924", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 195, "text": "Imatinib, an inhibitor of the tyrosine kinase activity of c-kit, was used as an adjuvant chemotherapy in two patients who underwent curative surgery for recurrent gastrointestinal stromal tumors. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15966213", "endSection": "sections.0"}, {"offsetInBeginSection": 1097, "offsetInEndSection": 1285, "text": "Surgery of residual disease upon best clinical response seems associated with survival benefit compared with historical controls in similar patient collectives treated with imatinib alone. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19628568", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 253, "text": "Imatinib mesylate, an orally administered kinase inhibitor that targets the Kit (CD117) protein, currently has 10 approved indications including treatment of chronic myelogenous leukemia and metastatic gastrointestinal stromal tumors (GIST). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20726677", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 300, "text": "Allogeneic hematopoietic stem cell transplantation (HSCT) is well-established as a potentially curative treatment for patients who have chronic myeloid leukemia. The success of imatinib and other tyrosine kinase inhibitors (TKI) as initial therapy has changed the treatment paradigm for this disease. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22035758", "endSection": "sections.0"}, {"offsetInBeginSection": 11, "offsetInEndSection": 325, "text": "Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Surgery remains the elective treatment. We retrospectively compared two group of patients, who underwent surgery for GIST before and after Imatinib advent in order to analyze the recurrence and survival rate. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22487918", "endSection": "sections.0"}, {"offsetInBeginSection": 725, "offsetInEndSection": 1054, "text": "The patient had been diagnosed 14 months earlier and had been submitted to surgery, followed by adjuvant radiotherapy and temozolomide-based chemotherapy. On clinical suspicion of recurrence 5 months later, magnetic resonance imaging (MRI) revealed a lesion at the site of preceded surgery, which was treated by imatinib mesylate ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17554495", "endSection": "sections.0"}, {"offsetInBeginSection": 539, "offsetInEndSection": 903, "text": "The drugs were assessed according to clinical evidence on efficacy and safety, based on Micromedex categorization, on systematic reviews and meta-analyses. Indications present in the legal documentation were compared to the indications approved by regulatory agencies. RESULTS: Bevacizumab, capecitabine, cetuximab, erlotinib, rituximab, imatinib, and temozolomide ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20676553", "endSection": "sections.0"}, {"offsetInBeginSection": 310, "offsetInEndSection": 701, "text": "Prognostic factors such as tumor size, mitotic rate and presence of metastases may provide an indication for adjuvant imatinib mesylate (IM) treatment. Here we present a young patient with a large GIST with high-risk features who is in complete remission after surgical excision and adjuvant IM treatment. This patient is the only colon-located CD117-positive case where IM was administered. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22678007", "endSection": "sections.0"}]}, {"body": "Are defects in recombination repair involved in carcinogenesis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23721719", "http://www.ncbi.nlm.nih.gov/pubmed/23541693", "http://www.ncbi.nlm.nih.gov/pubmed/22665067", "http://www.ncbi.nlm.nih.gov/pubmed/21427292", "http://www.ncbi.nlm.nih.gov/pubmed/21404276", "http://www.ncbi.nlm.nih.gov/pubmed/21267443", "http://www.ncbi.nlm.nih.gov/pubmed/20298636", "http://www.ncbi.nlm.nih.gov/pubmed/19083132", "http://www.ncbi.nlm.nih.gov/pubmed/17363343", "http://www.ncbi.nlm.nih.gov/pubmed/15660524", "http://www.ncbi.nlm.nih.gov/pubmed/12592385", "http://www.ncbi.nlm.nih.gov/pubmed/12427531", "http://www.ncbi.nlm.nih.gov/pubmed/12191483", "http://www.ncbi.nlm.nih.gov/pubmed/12016139", "http://www.ncbi.nlm.nih.gov/pubmed/11395777", "http://www.ncbi.nlm.nih.gov/pubmed/11178982", "http://www.ncbi.nlm.nih.gov/pubmed/10753787"], "triples": [], "ideal_answer": "Breast carcinogenesis, particularly in familial cases, has been linked with a defect in the homologous recombination.Both mechanisms may contribute to carcinogenesis in hr-deficient cells.Breast carcinogenesis, particularly in familial cases, has been linked with a defect in the homologous recombination ( HR ) pathway, defects in components of DSB repair pathways are associated with a predisposition to cancer.Palb2 interacts with brca1 and brca2 in supercomplexes involved in dna repair via homologous recombination.Furthermore, activation of akt1 was involved in brca1-deficiency-mediated tumorigenesis in mice.This resulted in dna damage disrepair, inherited mutations in genes involved in hr are associated with gene rearrangement and may be a prerequisite for tumor development in some cancer-prone hereditary diseases like bloom, werner and rothmund-thomson syndromes.Both mechanisms may contribute to carcinogenesis in HR-deficient cells.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D059767", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051721", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D059765", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005785", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000725", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000724", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0036298", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D063646", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011995"], "type": "yesno", "id": "52f118aa2059c6d71c000003", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "Brca1 deficiency leads to the development of breast cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22665067", "endSection": "abstract"}, {"offsetInBeginSection": 1250, "offsetInEndSection": 1334, "text": "The breast cancer-associated BRCA1 and BRCA2 proteins are strongly implicated in HRR ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12427531", "endSection": "abstract"}, {"offsetInBeginSection": 869, "offsetInEndSection": 999, "text": "Breast carcinogenesis, particularly in familial cases, has been linked with a defect in the homologous recombination (HR) pathway, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23541693", "endSection": "abstract"}, {"offsetInBeginSection": 1272, "offsetInEndSection": 1355, "text": "human tumor viruses may manipulate cellular DNA-damage responses to promote cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21427292", "endSection": "abstract"}, {"offsetInBeginSection": 1112, "offsetInEndSection": 1229, "text": "HTLV-1 p30 may facilitate the accumulation of mutations in the host genome and the cumulative risk of transformation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21427292", "endSection": "abstract"}, {"offsetInBeginSection": 1127, "offsetInEndSection": 1267, "text": "enhanced telomeric recombination in human cells with mismatch-repair defects may contribute to cell immortalization and hence tumorigenesis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11395777", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 164, "text": "A DNA double-strand break (DSB) has long been recognized as a severe cellular lesion, potentially representing an initiating event for carcinogenesis or cell death. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23721719", "endSection": "abstract"}, {"offsetInBeginSection": 250, "offsetInEndSection": 461, "text": "Furthermore, activation of Akt1 was involved in Brca1-deficiency-mediated tumorigenesis in mice. Defective homologous recombination (HR) is thought to be a major contributor to tumorigenesis in Brca1 deficiency. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22665067", "endSection": "abstract"}, {"offsetInBeginSection": 74, "offsetInEndSection": 222, "text": "defective DNA double-strand break repair can lead to toxicity and large scale sequence rearrangements that cause cancer and promote premature aging. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17363343", "endSection": "abstract"}, {"offsetInBeginSection": 1209, "offsetInEndSection": 1389, "text": "WRN depletion in HL60 cells led to the hyper-activation of homologous recombination repair via up-regulation of RAD51 and BLM protein levels. This resulted in DNA damage disrepair, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21267443", "endSection": "abstract"}, {"offsetInBeginSection": 295, "offsetInEndSection": 517, "text": "Inherited mutations in genes involved in HR are associated with gene rearrangement and may be a prerequisite for tumor development in some cancer-prone hereditary diseases like Bloom, Werner and Rothmund-Thomson syndromes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22276468", "endSection": "abstract"}, {"offsetInBeginSection": 1583, "offsetInEndSection": 1794, "text": "the effects of WRN silencing on cell proliferation and genomic instability are modulated probably by other genetic factors, including p53, which might play a role in the carcinogenesis induced by WRN deficiency. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21267443", "endSection": "abstract"}, {"offsetInBeginSection": 402, "offsetInEndSection": 631, "text": "Inaccurate repair or lack of repair of a DSB can lead to mutations or to larger-scale genomic instability through the generation of dicentric or acentric chromosomal fragments. Such genome changes may have tumourigenic potential. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12016139", "endSection": "abstract"}, {"offsetInBeginSection": 1512, "offsetInEndSection": 1724, "text": "Detection of pathway-specific error-prone DSB repair activities by functional testing was proposed to serve as biomarker for hereditary breast cancer risk and responsiveness to therapies targeting HR dysfunction. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23541693", "endSection": "abstract"}, {"offsetInBeginSection": 1050, "offsetInEndSection": 1293, "text": "This review mainly focuses on various roles of human RecQ helicases in the process of recombination-based DNA repair to maintain genome stability and physiological consequences of their defects in the development of cancer and premature aging. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19083132", "endSection": "abstract"}, {"offsetInBeginSection": 902, "offsetInEndSection": 1165, "text": "Here, I provide an overview of these systems, with particular emphasis on the two major pathways of DSB repair: non-homologous end-joining and homologous recombination. Inherited or acquired defects in these pathways may lead to cancer or to other human diseases, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12016139", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 289, "text": "We review the genes and proteins related to the homologous recombinational repair (HRR) pathway that are implicated in cancer through either genetic disorders that predispose to cancer through chromosome instability or the occurrence of somatic mutations that contribute to carcinogenesis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12427531", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 253, "text": "The breast- and ovarian-specific tumor suppressor, BRCA1, has been implicated to function in many nuclear processes, including DNA damage repair, recombination, transcription, ubiquitination, cell cycle checkpoint enforcement, and centrosome regulation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12592385", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 259, "text": "DNA-repair pathways recognise and repair DNA damaged by exogenous and endogenous agents to maintain genomic integrity. Defects in these pathways lead to replication errors, loss or rearrangement of genomic material and eventually cell death or carcinogenesis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20298636", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 305, "text": "The link between loss or defect in functional BRCA1 and predisposition for development of ovarian and breast cancer is well established. Germ-line mutations in BRCA1 are responsible for both hereditary breast and ovarian cancer, which is around 5-10% for all breast and 10-15% of all ovarian cancer cases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21887486", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 356, "text": "Human cells can process DNA double-strand breaks (DSBs) by either homology directed or non-homologous repair pathways. Defects in components of DSB repair pathways are associated with a predisposition to cancer. The products of the BRCA1 and BRCA2 genes, which normally confer protection against breast cancer, are involved in homology-directed DSB repair. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10753787", "endSection": "abstract"}, {"offsetInBeginSection": 555, "offsetInEndSection": 897, "text": "Aberrant RAD9 expression has been linked to breast, lung, thyroid, skin and prostate tumorigenesis, and a cause-effect relationship has been demonstrated for the latter two. Interestingly, human RAD9 overproduction correlates with prostate cancer whereas deletion of Mrad9, the corresponding mouse gene, in keratinocytes leads to skin cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21278450", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 351, "text": "PALB2 interacts with BRCA1 and BRCA2 in supercomplexes involved in DNA repair via homologous recombination. Heterozygous germline mutations in PALB2 confer a moderate risk of breast cancer, while biallelic PALB2 mutations are linked to a severe form of Fanconi anaemia characterized by early childhood solid tumours and severe chromosomal instability. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404276", "endSection": "abstract"}, {"offsetInBeginSection": 95, "offsetInEndSection": 485, "text": "Homologous recombination repair plays an important role in DSB repair and impairment of this repair mechanism may lead to loss of genomic integrity, which is one of the hallmarks of cancer. Recent research has shown that the tumor suppressor genes p53 and BRCA1 and -2 are involved in the proper control of homologous recombination, suggesting a role of this type of repair in human cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11178982", "endSection": "abstract"}, {"offsetInBeginSection": 429, "offsetInEndSection": 879, "text": "XRCC3 function is not limited to HR initiation, but extends to later stages in formation and resolution of HR intermediates, possibly by stabilizing heteroduplex DNA. The results further demonstrate that HR defects can promote genomic instability not only through failure to initiate HR (leading to nonhomologous repair) but also through aberrant processing of HR intermediates. Both mechanisms may contribute to carcinogenesis in HR-deficient cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12191483", "endSection": "abstract"}, {"offsetInBeginSection": 718, "offsetInEndSection": 1193, "text": "The specific DNA repair systems for which there are data regarding the impact of repair defects on stem cell function include O(6)-alkylguanine DNA alkyltransferase, nucleotide excision repair, base excision repair, mismatch repair, non-homologous DNA end-joining Fanconi's anemia protein complex, and homologous recombination. It has recently become clear that deficiencies of these processes are associated not only with cancer and/or aging but also with stem cell defects. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15660524", "endSection": "abstract"}]}, {"body": "What is the function of the MTH1 enzyme in cancer cells?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24277933", "http://www.ncbi.nlm.nih.gov/pubmed/23295485", "http://www.ncbi.nlm.nih.gov/pubmed/22790201", "http://www.ncbi.nlm.nih.gov/pubmed/22757673", "http://www.ncbi.nlm.nih.gov/pubmed/22556419", "http://www.ncbi.nlm.nih.gov/pubmed/21787772", "http://www.ncbi.nlm.nih.gov/pubmed/21389046", "http://www.ncbi.nlm.nih.gov/pubmed/21195604", "http://www.ncbi.nlm.nih.gov/pubmed/20542142", "http://www.ncbi.nlm.nih.gov/pubmed/20144704", "http://www.ncbi.nlm.nih.gov/pubmed/17917452", "http://www.ncbi.nlm.nih.gov/pubmed/17425590", "http://www.ncbi.nlm.nih.gov/pubmed/17207658", "http://www.ncbi.nlm.nih.gov/pubmed/17071637", "http://www.ncbi.nlm.nih.gov/pubmed/16716086", "http://www.ncbi.nlm.nih.gov/pubmed/16607562", "http://www.ncbi.nlm.nih.gov/pubmed/16621731"], "triples": [], "ideal_answer": "To counteract such deleterious effects of nucleotide pool damage, mammalian cells, mth1 and nudt5 proteins degrade 8-oxogtp and 8-oxogdp to 8-oxogmp, which is an unusable form for rna synthesis.T mTH1 cleaves 8-oxo-dGTP in mammalian cells, MTH1 and NUDT5 proteins degrade 8-oxoGTP and 8-oxoGDP to 8-oxoGMP, which is an unusable form for RNA synthesis.The MTH1 protein catalyzes hydrolysis of oxidatively damaged purine nucleotides including 8-hydroxy-dGTP to the monophosphates.To counteract such deleterious effects of nucleotide pool damage, mammalian cells possess mutt homolog-1 ( mth1 ) with oxidized purine nucleoside triphosphatase and related enzymes, thus minimizing the accumulation of oxidized bases in cellular dna the glucose-responsive transcription factor mth1 human mut t homolog 1 ( mth1 ) : a roadblock for the tumor-suppressive effects of oncogenic ras-induced ros.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004798", "http://www.uniprot.org/uniprot/MTH1_YEAST", "http://www.uniprot.org/uniprot/8ODP_MOUSE", "http://www.uniprot.org/uniprot/8ODP_HUMAN", "http://www.uniprot.org/uniprot/8ODP_RAT"], "type": "summary", "id": "551af9106b348bb82c000002", "snippets": [{"offsetInBeginSection": 780, "offsetInEndSection": 803, "text": "MTH1 cleaves 8-oxo-dGTP ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22556419", "endSection": "abstract"}, {"offsetInBeginSection": 220, "offsetInEndSection": 268, "text": "the glucose-responsive transcription factor Mth1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23468525", "endSection": "abstract"}, {"offsetInBeginSection": 602, "offsetInEndSection": 667, "text": "MutT homolog 1 (oxidized purine nucleoside triphosphatase, MTH1), ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22757673", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "MTH1 hydrolyzes oxidized nucleotide triphosphates, thereby preventing them from being incorporated into DNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21787772", "endSection": "abstract"}, {"offsetInBeginSection": 221, "offsetInEndSection": 325, "text": "MTH1 (or NUDT1) are also involved in the repair of 7,8-dihydro-8-oxoguanine (8-oxo-G), previous studies, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21195604", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "Human MTH1 (hMTH1) is an enzyme that hydrolyses several oxidized purine nucleoside triphosphates to their corresponding nucleoside monophosphates ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23295485", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Human Mut T Homolog 1 (MTH1): a roadblock for the tumor-suppressive effects of oncogenic RAS-induced ROS. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22790201", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "Human MTH1, an oxidized purine nucleoside triphosphatase, hydrolyzes 8-oxo-dGTP thereby preventing its misincorporation into DNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17917452", "endSection": "abstract"}, {"offsetInBeginSection": 780, "offsetInEndSection": 928, "text": "These results indicate that all three of the human MTH1, MTH2, and NUDT5 proteins act as a defense against the mutagenesis induced by oxidized dGTP. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20144704", "endSection": "abstract"}, {"offsetInBeginSection": 722, "offsetInEndSection": 922, "text": "MTH1 is a mammalian ortholog of Escherichia coli MutT, which hydrolyzes 8-oxo-dGTP to its monophosphate form in nucleotide pools, thereby preventing incorporation of the mutagenic substrate into DNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17425590", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 257, "text": "Human MTH1 protein hydrolyzes oxidized purine nucleotides 8-oxo-2'-deoxyguanosine triphosphate (8-oxo-dGTP), 2-OH-dATP or their ribo-forms to their monophosphates, thus minimizing replicational and transcriptional errors both in the nuclei and mitochondria. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16607562", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 250, "text": "MutT-related proteins, including Escherichia coli MutT and the human MTH1 (NUDT1), degrade 8-oxo-7, 8-dihydrodeoxyguanosine triphosphate (8-oxo-dGTP) to 8-oxo-dGMP and thereby prevent mutations caused by the misincorporation of 8-oxoguanine into DNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21389046", "endSection": "abstract"}, {"offsetInBeginSection": 193, "offsetInEndSection": 419, "text": "Several pathways are involved in the repair of DNA lesions caused by oxidative stress, such as the base excision repair system (BER), which repairs mutation involving 8-oxoguanine and comprises the MUTYH, OGG1 and MTH1 genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17207658", "endSection": "abstract"}, {"offsetInBeginSection": 193, "offsetInEndSection": 428, "text": " We have recently shown that oncogenic RAS-induced DNA damage and attendant premature senescence can be prevented by overexpressing human MutT Homolog 1 (MTH1), the major mammalian detoxifier of the oxidized DNA precursor, 8-oxo-dGTP. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22790201", "endSection": "abstract"}, {"offsetInBeginSection": 399, "offsetInEndSection": 645, "text": "To counteract such deleterious effects of nucleotide pool damage, mammalian cells possess MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase and related enzymes, thus minimizing the accumulation of oxidized bases in cellular DNA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20542142", "endSection": "abstract"}, {"offsetInBeginSection": 466, "offsetInEndSection": 756, "text": "In mammalian cells, MTH1 and NUDT5 proteins degrade 8-oxoGTP and 8-oxoGDP to 8-oxoGMP, which is an unusable form for RNA synthesis. In a search for proteins functioning at the RNA level, polynucleotide phosphorylase (PNP) protein has been suggested to be a good candidate for such a role. T ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16716086", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 281, "text": "The MTH1 protein catalyzes hydrolysis of oxidatively damaged purine nucleotides including 8-hydroxy-dGTP to the monophosphates. The MTH1 protein seems to act as an important defense system against mutagenesis, carcinogenesis, and cell death induced by oxidized purine nucleotides. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17071637", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 321, "text": "In human and rodent cells, MTH1, an oxidized purine nucleoside triphosphatase, efficiently hydrolyzes oxidized dGTP, GTP, dATP and ATP such as 2'-deoxy-8-oxoguanosine triphosphate (8-oxo-dGTP) and 2'-deoxy-2-hydroxyadenosine triphosphate (2-OH-dATP) in nucleotide pools, thus avoiding their incorporation into DNA or RNA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16621731", "endSection": "abstract"}]}, {"body": "Are ultraconserved elements depleted among copy number variants (CNVs)?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21092253", "http://www.ncbi.nlm.nih.gov/pubmed/18957701", "http://www.ncbi.nlm.nih.gov/pubmed/25340765", "http://www.ncbi.nlm.nih.gov/pubmed/16998490", "http://www.ncbi.nlm.nih.gov/pubmed/18174240"], "triples": [], "ideal_answer": "We propose that these elements are strongly depleted among segmental duplications and copy number variants.Here, we report that nonexonic uces are also depleted among 10 of 11 recent genomewide data sets of human cnvs, including 3 obtained with strategies permitting greater precision in determining the extents of cnvs we have demonstrated that nonexonic uces are depleted among segmental duplications ( sds ) and copy number variants ( cnvs ) and proposed that their ultraconservation may be interpreted as hallmarks for dose-sensitive genes, particularly for those genes whose gain or loss may be directly implied in neurodevelopmental disorders.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D056915"], "type": "yesno", "id": "55413142182542114d000002", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "Mammalian ultraconserved elements are strongly depleted among segmental duplications and copy number variants. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16998490", "endSection": "title"}, {"offsetInBeginSection": 612, "offsetInEndSection": 716, "text": "Here, we show that UCEs are significantly depleted among segmental duplications and copy number variants ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16998490", "endSection": "abstract"}, {"offsetInBeginSection": 430, "offsetInEndSection": 566, "text": "Interestingly, human UCEs have been reported to be strongly depleted among segmental duplications and benign copy number variants (CNVs) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21092253", "endSection": "abstract"}, {"offsetInBeginSection": 442, "offsetInEndSection": 579, "text": "Interestingly, human UCEs have been reported to be strongly depleted among segmental duplications and benign copy number variants (CNVs). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21092253", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 226, "text": "Ultraconserved elements (UCEs) are strongly depleted from segmental duplications and copy number variations (CNVs) in the human genome, suggesting that deletion or duplication of a UCE can be deleterious to the mammalian cell. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25340765", "endSection": "abstract"}, {"offsetInBeginSection": 362, "offsetInEndSection": 580, "text": "We have demonstrated that nonexonic UCEs are depleted among segmental duplications (SDs) and copy number variants (CNVs) and proposed that their ultraconservation may reflect a mechanism of copy counting via comparison ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18957701", "endSection": "abstract"}, {"offsetInBeginSection": 362, "offsetInEndSection": 581, "text": "We have demonstrated that nonexonic UCEs are depleted among segmental duplications (SDs) and copy number variants (CNVs) and proposed that their ultraconservation may reflect a mechanism of copy counting via comparison. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18957701", "endSection": "abstract"}, {"offsetInBeginSection": 364, "offsetInEndSection": 639, "text": "The depletion of UCEs among copy number variation as well as the significant under-representation of single-nucleotide polymorphisms (SNPs) within UCEs have also revealed their evolutional and functional importance indicating their potential impact on disease, such as cancer ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18174240", "endSection": "abstract"}, {"offsetInBeginSection": 1449, "offsetInEndSection": 1763, "text": "We propose that these elements may be interpreted as hallmarks for dose-sensitive genes, particularly for those genes whose gain or loss may be directly implied in neurodevelopmental disorders. Therefore, their presence in genomic imbalances of unknown effect might be suggestive of a clinically relevant condition ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21092253", "endSection": "abstract"}, {"offsetInBeginSection": 362, "offsetInEndSection": 794, "text": "We have demonstrated that nonexonic UCEs are depleted among segmental duplications (SDs) and copy number variants (CNVs) and proposed that their ultraconservation may reflect a mechanism of copy counting via comparison. Here, we report that nonexonic UCEs are also depleted among 10 of 11 recent genomewide data sets of human CNVs, including 3 obtained with strategies permitting greater precision in determining the extents of CNVs ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18957701", "endSection": "abstract"}]}, {"body": "Is the microRNA 132 (miR-132) involved in brain pathologies?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23144617", "http://www.ncbi.nlm.nih.gov/pubmed/23001356", "http://www.ncbi.nlm.nih.gov/pubmed/22315408", "http://www.ncbi.nlm.nih.gov/pubmed/21945804", "http://www.ncbi.nlm.nih.gov/pubmed/21813326", "http://www.ncbi.nlm.nih.gov/pubmed/21807765", "http://www.ncbi.nlm.nih.gov/pubmed/21035445", "http://www.ncbi.nlm.nih.gov/pubmed/20010955", "http://www.ncbi.nlm.nih.gov/pubmed/19557767", "http://www.ncbi.nlm.nih.gov/pubmed/19458943", "http://www.ncbi.nlm.nih.gov/pubmed/21136867", "http://www.ncbi.nlm.nih.gov/pubmed/17314675"], "triples": [{"p": "http://purl.uniprot.org/core/name", "s": "http://purl.uniprot.org/citations/10071047", "o": "Brain"}, {"p": "http://purl.uniprot.org/core/name", "s": "http://purl.uniprot.org/pubmed/10430839", "o": "Brain"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/citations/12566285", "o": "http://purl.uniprot.org/pubmed/12566285"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C2745360", "o": "http://linkedlifedata.com/resource/umls/label/A17397784"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17397784", "o": "mmu-mir-132"}], "ideal_answer": "Levels of several microRNA ( miR-10a, -10b, -212, -132, -495 ) were significantly altered.To determine if production of mir-132 is regulated by neuronal activity its expression in mouse brain development at the time when 4r-tau becomes expressed.Finally, we provide evidence that mir-132 is inversely correlated with ptbp2 during post-natal brain was monitored by quantitative rt-pcr ( rt-qpcr ) mir-132 dysregulation and subsequent abnormal expression of mir-132 target genes contribute to the neurodevelopmental and neuromorphological pathologies present in schizophrenia.This information should aid in future studies on therapeutic application of miRNAs in HD.To determine if production of mir-132 directly targets the neuronal splicing factor polypyrimidine tract-binding protein 2 ( ptbp2 ), which protein levels were increased in psp patients.Nine mirnas ( mir-22, mir-29c, mir-128, mir-132, mir-138, mir-218, mir-222, mir-344, and mir-674* ) were commonly down-regulated in both the 12-month-old yac128 and 10-week-old r6 mice.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001927", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010336", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001921", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0007420", "http://www.disease-ontology.org/api/metadata/DOID:936", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002545", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002534", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001928"], "type": "yesno", "id": "5156be5ed24251bc05000087", "snippets": [{"offsetInBeginSection": 1562, "offsetInEndSection": 1740, "text": "miR-132 dysregulation and subsequent abnormal expression of miR-132 target genes contribute to the neurodevelopmental and neuromorphological pathologies present in schizophrenia. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22315408", "endSection": "sections.0"}, {"offsetInBeginSection": 224, "offsetInEndSection": 372, "text": "To determine if production of miR-132 is regulated by neuronal activity its expression in mouse brain was monitored by quantitative RT-PCR (RT-qPCR) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19557767", "endSection": "sections.0"}, {"offsetInBeginSection": 1459, "offsetInEndSection": 1599, "text": "transgenic HD mice have abnormal miRNA biogenesis. This information should aid in future studies on therapeutic application of miRNAs in HD. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21035445", "endSection": "sections.0"}, {"offsetInBeginSection": 627, "offsetInEndSection": 769, "text": "Expression of key neuronal microRNAs-including mir-9/9*, mir-124 and mir-132-is repressed in the brains of human HD patients and mouse models. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19458943", "endSection": "sections.0"}, {"offsetInBeginSection": 384, "offsetInEndSection": 529, "text": "We investigated how prior seizure preconditioning affects the miRNA response to status epilepticus evoked by intra-amygdalar kainic acid in mice. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21945804", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 204, "text": "Preconditioning describes the ischemic stimulus that triggers an endogenous, neuroprotective response that protects the brain during a subsequent severe ischemic injury, a phenomenon known as 'tolerance'. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20010955", "endSection": "sections.0"}, {"offsetInBeginSection": 1117, "offsetInEndSection": 1302, "text": "Nine miRNAs (miR-22, miR-29c, miR-128, miR-132, miR-138, miR-218, miR-222, miR-344, and miR-674*) were commonly down-regulated in both the 12-month-old YAC128 and 10-week-old R6/2 mice. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21035445", "endSection": "sections.0"}, {"offsetInBeginSection": 923, "offsetInEndSection": 1208, "text": "Expression levels of primary and mature-miR-132 increased significantly between postnatal Days 10 and 24. We conclude that miR-132 is an activity-dependent microRNA in vivo, and may contribute to the long-lasting proteomic changes required for experience-dependent neuronal plasticity. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19557767", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 227, "text": "Huntington's disease (HD) is a genetic neurodegenerative disease caused by abnormal CAG expansion. MicroRNAs (miRNAs) are short RNA molecules regulating gene expression, and are implicated in a variety of diseases including HD. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21035445", "endSection": "sections.0"}, {"offsetInBeginSection": 1135, "offsetInEndSection": 1542, "text": "Downregulation of miR-132 is consistent with our finding that preconditioning ischemia induces a rapid increase in MeCP2 protein, but not mRNA, in mouse cortex. These studies reveal that ischemic preconditioning regulates expression of miRNAs and their predicted targets in mouse brain cortex, and further suggest that miRNAs and MeCP2 could serve as effectors of ischemic preconditioning-induced tolerance. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20010955", "endSection": "sections.0"}, {"offsetInBeginSection": 1097, "offsetInEndSection": 1576, "text": "Levels of several microRNA (miR-10a, -10b, -212, -132, -495) were significantly altered. One of them (miR-132) has been reported to be highly inducible by growth factors and to be a key regulator of neurite outgrowth. Moreover, miR-132-recognition sequences were detected in the mRNA transcripts of two differentially expressed proteins. MicroRNA may thus represent novel biomarkers for neuronal malfunction and potential therapeutic targets for human neurodegenerative diseases. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21136867", "endSection": "sections.0"}, {"offsetInBeginSection": 430, "offsetInEndSection": 889, "text": "micro-RNAs encoding miR-9, miR-124a, miR-125b, miR-128, miR-132 and miR-219 are abundantly represented in fetal hippocampus, are differentially regulated in aged brain, and an alteration in specific micro-RNA complexity occurs in Alzheimer hippocampus. These data are consistent with the idea that altered micro-RNA-mediated processing of messenger RNA populations may contribute to atypical mRNA abundance and neural dysfunction in Alzheimer's disease brain. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17314675", "endSection": "sections.0"}, {"offsetInBeginSection": 7, "offsetInEndSection": 545, "text": "reports of microRNA (miR) modulators of both neuronal and immune processes (here termed NeurimmiRs) predict therapeutic potential for manipulating NeurimmiR levels in diseases affecting both the immune system and higher brain functions, such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS) and anxiety-related disorders. In our opinion, NeurimmiRs that function within both the nervous and the immune systems, such as miR-132 and miR-124, may act as 'negotiators' between these two interacting compartments. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21813326", "endSection": "sections.0"}, {"offsetInBeginSection": 955, "offsetInEndSection": 1553, "text": "Increased miR-132 levels were matched with increased binding to Argonaute-2, a constituent of the RNA-induced silencing complex. In tolerant animals, expression responses of >40% of the injury-group-detected miRNAs differed, being either unchanged relative to control or down-regulated, and this included miR-132. In vivo microinjection of locked nucleic acid-modified oligonucleotides (antagomirs) against miR-132 depleted hippocampal miR-132 levels and reduced seizure-induced neuronal death. Thus, our data strongly suggest that miRNAs are important regulators of seizure-induced neuronal death. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21945804", "endSection": "sections.0"}, {"offsetInBeginSection": 976, "offsetInEndSection": 1630, "text": "miR-132 directly targets the neuronal splicing factor polypyrimidine tract-binding protein 2 (PTBP2), which protein levels were increased in PSP patients. miR-132 overexpression or PTBP2 knockdown similarly affected endogenous 4R:3R-tau ratios in neuronal cells. Finally, we provide evidence that miR-132 is inversely correlated with PTBP2 during post-natal brain development at the time when 4R-tau becomes expressed. Taken together, these results suggest that changes in the miR-132/PTBP2 pathway could contribute to the abnormal splicing of tau exon 10 in the brain, and sheds light into the potential role played by miRNAs in a subset of tauopathies. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21807765", "endSection": "sections.0"}]}, {"body": "What is an approximate number of CTCF binding sites in the human genome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23707059", "http://www.ncbi.nlm.nih.gov/pubmed/22955980", "http://www.ncbi.nlm.nih.gov/pubmed/22829947", "http://www.ncbi.nlm.nih.gov/pubmed/22709888", "http://www.ncbi.nlm.nih.gov/pubmed/15670593", "http://www.ncbi.nlm.nih.gov/pubmed/15229244", "http://www.ncbi.nlm.nih.gov/pubmed/11854173", "http://www.ncbi.nlm.nih.gov/pubmed/11076856", "http://www.ncbi.nlm.nih.gov/pubmed/8034708"], "triples": [], "ideal_answer": "However, only ~3,700 out of the ~5,700 CTCFL- and ~31,000 CTCF-binding sites overlap.", "exact_answer": [["30,000-50,000"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001665", "http://www.uniprot.org/uniprot/CTCF_HUMAN", "http://www.uniprot.org/uniprot/CTCF_MOUSE", "http://www.uniprot.org/uniprot/CTCF_CHICK", "http://www.uniprot.org/uniprot/CTCF_RAT"], "type": "factoid", "id": "533c38b3c45e133714000009", "snippets": [{"offsetInBeginSection": 1436, "offsetInEndSection": 1521, "text": "However, only ~3,700 out of the ~5,700 CTCFL- and ~31,000 CTCF-binding sites overlap. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22709888", "endSection": "abstract"}, {"offsetInBeginSection": 265, "offsetInEndSection": 384, "text": "To study CTCF multivalency in\u00a0vivo, we define ZF binding requirements at \u223c50,000 genomic sites in primary lymphocytes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23707059", "endSection": "abstract"}]}, {"body": "Does cucumber lower blood sugar in diabetics?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/2620957", "http://www.ncbi.nlm.nih.gov/pubmed/937227", "http://www.ncbi.nlm.nih.gov/pubmed/22897583", "http://www.ncbi.nlm.nih.gov/pubmed/22419465", "http://www.ncbi.nlm.nih.gov/pubmed/21264099", "http://www.ncbi.nlm.nih.gov/pubmed/20614191", "http://www.ncbi.nlm.nih.gov/pubmed/19854256", "http://www.ncbi.nlm.nih.gov/pubmed/19276533", "http://www.ncbi.nlm.nih.gov/pubmed/17650589", "http://www.ncbi.nlm.nih.gov/pubmed/16179750", "http://www.ncbi.nlm.nih.gov/pubmed/11451723", "http://www.ncbi.nlm.nih.gov/pubmed/8569244", "http://www.ncbi.nlm.nih.gov/pubmed/22416705"], "ideal_answer": "The amount of sucrose in ordinary marinated foods, such as herring, cucumber cerebroside and its long-chain base can improve the glucose and lipid metabolism in obese mice.In streptozotocin-induced-diabetic rats.Cucumis trigonus Roxb.Ethanolic extract of Tricosanthes dioica Roxb plant caused a significant lowering of blood sugar in fasted rats and depressed the peak value in glucose loaded single and longterm fed groups of rats.Therefore, sea cucumber fatty acids can potentially be developed as a novel natural nutraceutical for the management of type-2 diabetes.Therefore, sea cucumber, and common beet was negligibleConclusions : sea cucumber cerebroside and its long-chain base can improve the glucose and insulin levels, lower homeostatic model assessment for insulin resistance index, and area under the blood glucose curve, suggesting that insulin sensitivity is enhanced by dietary ssc.Mice administrated with 0.1 % ssc had significantly decreased serum glucose and insulin levels, lower homeostatic model assessment for insulin resistance index, and area under the blood glucose curve, suggesting that insulin sensitivity is enhanced by dietary ssc.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001786", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018553", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003920"], "type": "yesno", "id": "516c220e298dcd4e51000071", "snippets": [{"offsetInBeginSection": 979, "offsetInEndSection": 1087, "text": "The amount of sucrose in ordinary marinated foods, such as herring, cucumber, and common beet was negligible ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/937227", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "Antidiabetic activity of aqueous fruit extract of Cucumis trigonus Roxb. in streptozotocin-induced-diabetic rats. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19854256", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "[Effects of sea cucumber cerebroside and its long-chain base on lipid and glucose metabolism in obese mice]. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22419465", "endSection": "title"}, {"offsetInBeginSection": 786, "offsetInEndSection": 907, "text": "CONCLUSIONS: Sea cucumber cerebroside and its long-chain base can improve the glucose and lipid metabolism in obese mice. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22419465", "endSection": "sections.0"}, {"offsetInBeginSection": 490, "offsetInEndSection": 632, "text": "The antidiabetic activity of aqueous extract of Cucumis trigonus fruit was evaluated by using normal and streptozotocin-induced-diabetic rats. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19854256", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Dietary saponins of sea cucumber ameliorate obesity, hepatic steatosis, and glucose intolerance in high-fat diet-fed mice. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22897583", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 136, "text": "Role of pectin from cucumber (Cucumis sativus) in modulation of protein kinase C activity and regulation of glycogen metabolism in rats. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17650589", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 140, "text": "Two unsaturated fatty acids with potent \u03b1-glucosidase inhibitory activity purified from the body wall of sea cucumber (Stichopus japonicus). ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22416705", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "OBJECTIVE: To investigate the effect of sea cucumber cerebroside(SCC) and its long-chain base(LCB) on lipid and glucose metabolism in obese mice. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22419465", "endSection": "sections.0"}, {"offsetInBeginSection": 116, "offsetInEndSection": 271, "text": "In this study, we investigated the effects of saponins of sea cucumber (SSC) on high-fat diet-induced obesity, insulin resistance, and fatty liver in mice. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22897583", "endSection": "sections.0"}, {"offsetInBeginSection": 1347, "offsetInEndSection": 1512, "text": "The aqueous fruit extract of Cucumis trigonus has had beneficial effects in reducing the elevated blood glucose level and lipid profile of STZ-induced-diabetic rats. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19854256", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 190, "text": "Possible amelioration of atherogenic diet induced dyslipidemia, hypothyroidism and hyperglycemia by the peel extracts of Mangifera indica, Cucumis melo and Citrullus vulgaris fruits in rats. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19276533", "endSection": "title"}, {"offsetInBeginSection": 900, "offsetInEndSection": 1086, "text": "All the three peel extracts nearly reversed most of these changes induced by alloxan suggesting their possible role in ameliorating diabetes mellitus and related changes in serum lipids. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20614191", "endSection": "sections.0"}, {"offsetInBeginSection": 236, "offsetInEndSection": 461, "text": "Tolbutamide, Cucurbita ficifolia, Phaseolus vulgaris, Opuntia streptacantha, Spinacea oleracea, Cucumis sativus and Cuminum cyminum decrease significantly the area under the glucose tolerance curve and the hyperglycemic peak. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8569244", "endSection": "sections.0"}, {"offsetInBeginSection": 616, "offsetInEndSection": 879, "text": "Mice administrated with 0.1% SSC had significantly decreased serum glucose and insulin levels, lower homeostatic model assessment for insulin resistance index, and area under the blood glucose curve, suggesting that insulin sensitivity is enhanced by dietary SSC. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22897583", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 261, "text": "Hitherto unknown efficacy of the peel extracts of Mangifera indica (MI), Cucumis melo (CM) and Citrullus vulgaris (CV) fruits in ameliorating the diet-induced alterations in dyslipidemia, thyroid dysfunction and diabetes mellitus have been investigated in rats. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19276533", "endSection": "sections.0"}, {"offsetInBeginSection": 1386, "offsetInEndSection": 1693, "text": "Addition of fermented milk (yogurt) and pickled cucumber to a breakfast with a high-glycemic index bread significantly lowered postprandial glycemia and insulinemia compared with the reference meal. In contrast, addition of regular milk and fresh cucumber had no favorable effect on the metabolic responses. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11451723", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 347, "text": "Cucumis trigonus Roxb. (Cucurbitaceae) fruit is used in the Indian traditional medicine for the treatment of diabetes. Based on a number of reports on the blood glucose level reduction and the other complications of diabetes associated with some Cucurbitaceae plants, the antidiabetic effect of Cucumis trigonus fruit was investigated. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19854256", "endSection": "sections.0"}, {"offsetInBeginSection": 125, "offsetInEndSection": 411, "text": "The ethanolic extract of Cucumis sativus Linn, Cucumis melo utilissimum Roxb, Cucumis melo Linn, Benincasa hispida Thunb Cogn and Tricosanthes anguina Nees, when administered in 250 mg/kg dose, orally to rats failed to lower blood sugar or to depress the peak value, after glucose load. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2620957", "endSection": "sections.0"}, {"offsetInBeginSection": 1041, "offsetInEndSection": 1361, "text": "In this study, 2 fatty acids with strong \u03b1-glucosidase-inhibitory activity, 7(Z)-octadecenoic acid and 7(Z),10(Z)-octadecadienoic acid, were purified and identified from sea cucumber. Therefore, sea cucumber fatty acids can potentially be developed as a novel natural nutraceutical for the management of type-2 diabetes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22416705", "endSection": "sections.0"}, {"offsetInBeginSection": 615, "offsetInEndSection": 952, "text": "Ethanolic extract of Tricosanthes dioica Roxb plant caused a significant lowering of blood sugar in fasted rats and depressed the peak value in glucose loaded single and longterm fed groups of rats. The ethanolic extract of the aerial part of T. dioica also induced significant depression in the peak values in the glucose loaded models. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2620957", "endSection": "sections.0"}, {"offsetInBeginSection": 919, "offsetInEndSection": 1296, "text": "Rats, treated simultaneously with either of the peel extracts reversed the CCT-diet induced increase in the levels of tissue LPO, serum lipids, glucose, creatinine kinase-MB and decrease in the levels of thyroid hormones and insulin indicating their potential to ameliorate the diet induced alterations in serum lipids, thyroid dysfunctions and hyperglycemia/diabetes mellitus. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19276533", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 380, "text": "The hitherto unknown glucose regulating role of three vegetable peels from cucurbitaceae family was evaluated. In a preliminary study, effects of ethanolic extracts of Cucurbita pepo, Cucumis sativus and Praecitrullus fistulosus peels were studied at 250 and 500\u00a0mg\u00a0kg(-1)\u00a0d(-1) for 15\u00a0days in the alterations in serum glucose and in hepatic lipid peroxidation (LPO) in male mice. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20614191", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 518, "text": "The regulatory role of protein kinase C (PKC) in glycogen metabolism in pectin fed rats was investigated. Administration of pectin (5 g/kg body wt/day) from cucumber (Cucumis sativius L.) led to inhibitory effects on PKC activity in the liver of rats. In the brain and pancreas, PKC activity was significantly higher in pectin-treated rats as compared to the control group. Level of blood glucose was significantly lowered and the level of glycogen in the liver was significantly increased in pectin-administered rats. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17650589", "endSection": "sections.0"}]}, {"body": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23746327", "http://www.ncbi.nlm.nih.gov/pubmed/23498838", "http://www.ncbi.nlm.nih.gov/pubmed/23152493", "http://www.ncbi.nlm.nih.gov/pubmed/22828895", "http://www.ncbi.nlm.nih.gov/pubmed/21659649", "http://www.ncbi.nlm.nih.gov/pubmed/20676041", "http://www.ncbi.nlm.nih.gov/pubmed/18483626", "http://www.ncbi.nlm.nih.gov/pubmed/15890976", "http://www.ncbi.nlm.nih.gov/pubmed/14571276", "http://www.ncbi.nlm.nih.gov/pubmed/12919952"], "triples": [], "ideal_answer": "These data provide the first experimental demonstration that the r4496c ryr2 mutation predisposes the murine heart to vt and vf in response caffeine and adrenergic stimulation.We found that mice heterozygous for the r2474s mutation in ryr2 mutations to explore the role of diastolic sr ca2+ leak in af.Recently, a novel cpvt ryr2 mutations suggested to cause defective ca2+ sensitivity of single ryr2 channels in lipid bilayers.Ryr2 mutation, g230c, was found to increase the cytosolic, but not the luminal, ca2+ channel function have recently been identified in catecholaminergic polymorphic ventricular tachycardia ( cpvt ) and arrhythmogenic right ventricular dysplasia ( arvd ) affected individuals.We report expression of three cpvt-linked human ryr2 mutations ( s2246l, n4104k, and r4497c ) in hl-1 cardiomyocytes displaying correct targeting to the endoplasmic reticulum.The mutation has been functionally characterized via store-overload-induced Ca ( 2+ ) release ( SOICR ) and tritium-labelled ryanodine ( [ ( 3 ) H ] ryanodine ) binding assays.", "exact_answer": [["RyR2-G230C"], ["RyR2-S4153R"], ["RyR2-V2475F"], ["RyR2-R2474S"], ["RyR2-N2386I"], ["RyR2-L433P"], ["RyR2-E189D"], ["RyR2-R4497C (RyR2-R4496C in the mouse)"], ["RyR2-V2306I,"], ["RyR2-P4902L"], ["RyR2-R4959Q"], ["RyR2-S2246L"], ["RyR2-N4104K"]], "concepts": ["http://www.uniprot.org/uniprot/RYR2_HUMAN"], "type": "list", "id": "550712739d0faaa527000008", "snippets": [{"offsetInBeginSection": 1752, "offsetInEndSection": 1888, "text": "The mutation RyR2-V2475F is phenotypically strong among other CPVT mutations and produces heterogeneous mechanisms of RyR2 dysfunction. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23152493", "endSection": "abstract"}, {"offsetInBeginSection": 952, "offsetInEndSection": 1085, "text": " Thus, CPVT-associated mutant leaky Ryr2-R2474S channels in the brain can cause seizures in mice, independent of cardiac arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18483626", "endSection": "abstract"}, {"offsetInBeginSection": 575, "offsetInEndSection": 737, "text": "Recently, a novel CPVT RyR2 mutation, G230C, was found to increase the cytosolic, but not the luminal, Ca2+ sensitivity of single RyR2 channels in lipid bilayers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23746327", "endSection": "abstract"}, {"offsetInBeginSection": 1466, "offsetInEndSection": 1645, "text": "These data provide the first experimental demonstration that the R4496C RyR2 mutation predisposes the murine heart to VT and VF in response caffeine and/or adrenergic stimulation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15890976", "endSection": "abstract"}, {"offsetInBeginSection": 313, "offsetInEndSection": 503, "text": "We screened 12 Finnish CPVT probands for mutations in these genes and identified three novel RYR2 mutations (V2306I, P4902L, R4959Q), which were absent in unaffected and control individuals. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14571276", "endSection": "abstract"}, {"offsetInBeginSection": 345, "offsetInEndSection": 535, "text": "To determine the molecular and cellular mechanisms by which a novel RyR2-V2475F mutation associated with CPVT in humans triggers Ca(2+)-dependent arrhythmias in whole hearts and intact mice. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23152493", "endSection": "abstract"}, {"offsetInBeginSection": 1513, "offsetInEndSection": 1743, "text": "These data suggest that the G230C mutation enhances the propensity for SOICR by sensitizing the channel to luminal and cytosolic Ca2+ activation, and that G230C has an intrinsic structural impact on the N-terminal domains of RyR2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23746327", "endSection": "abstract"}, {"offsetInBeginSection": 468, "offsetInEndSection": 731, "text": "We found that mice heterozygous for the R2474S mutation in Ryr2 (Ryr2-R2474S mice) exhibited spontaneous generalized tonic-clonic seizures (which occurred in the absence of cardiac arrhythmias), exercise-induced ventricular arrhythmias, and sudden cardiac death. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18483626", "endSection": "abstract"}, {"offsetInBeginSection": 682, "offsetInEndSection": 940, "text": "We developed a conditional knock-in mouse model carrier of the R4496C mutation, the mouse equivalent to the R4497C mutations identified in CPVT families, to evaluate if the animals would develop a CPVT phenotype and if beta blockers would prevent arrhythmias ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15890976", "endSection": "abstract"}, {"offsetInBeginSection": 683, "offsetInEndSection": 942, "text": "We developed a conditional knock-in mouse model carrier of the R4496C mutation, the mouse equivalent to the R4497C mutations identified in CPVT families, to evaluate if the animals would develop a CPVT phenotype and if beta blockers would prevent arrhythmias. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15890976", "endSection": "abstract"}, {"offsetInBeginSection": 149, "offsetInEndSection": 567, "text": "RyR2 mutations suggested to cause defective Ca2+ channel function have recently been identified in catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia (ARVD) affected individuals. We report expression of three CPVT-linked human RyR2 (hRyR2) mutations (S2246L, N4104K, and R4497C) in HL-1 cardiomyocytes displaying correct targeting to the endoplasmic reticulum. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12919952", "endSection": "abstract"}, {"offsetInBeginSection": 1058, "offsetInEndSection": 1527, "text": "A novel CPVT mutation, E189D, was identified. The E189D mutation does not alter the affinity of the channel for FKBP12.6, but it increases the propensity for store-overload-induced Ca(2+) release (SOICR). Furthermore, the E189D mutation enhances the basal channel activity of RyR2 and its sensitivity to activation by caffeine. The E189D RyR2 mutation is causative for CPVT and functionally increases the propensity for SOICR without altering the affinity for FKBP12.6. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20676041", "endSection": "abstract"}, {"offsetInBeginSection": 546, "offsetInEndSection": 1117, "text": "We generated 3 knock-in mice with mutations introduced into RyR2 that result in leaky channels and cause exercise induced polymorphic ventricular tachycardia in humans [catecholaminergic polymorphic ventricular tachycardia (CPVT)]. We examined AF susceptibility in these three CPVT mouse models harboring RyR2 mutations to explore the role of diastolic SR Ca2+ leak in AF. AF was stimulated with an intra-esophageal burst pacing protocol in the 3 CPVT mouse models (RyR2-R2474S+/-, 70%; RyR2-N2386I+/-, 60%; RyR2-L433P+/-, 35.71%) but not in wild-type (WT) mice (P<0.05). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22828895", "endSection": "abstract"}, {"offsetInBeginSection": 118, "offsetInEndSection": 765, "text": "The novel RYR2-S4153R mutation has been implicated as a cause of CPVT and atrial fibrillation. The mutation has been functionally characterized via store-overload-induced Ca(2+) release (SOICR) and tritium-labelled ryanodine ([(3)H]ryanodine) binding assays. The S4153R mutation enhanced propensity for spontaneous Ca(2+) release and reduced SOICR threshold but did not alter Ca(2+) activation of [(3)H]ryanodine binding, a common feature of other CPVT gain-of-function RYR2 mutations. We conclude that the S4153R mutation is a gain-of-function RYR2 mutation associated with a clinical phenotype characterized by both CPVT and atrial fibrillation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23498838", "endSection": "abstract"}, {"offsetInBeginSection": 1300, "offsetInEndSection": 1917, "text": "The RyR2-G230C mutant exhibits similar biophysical defects compared with previously characterized CPVT mutations: decreased binding of the stabilizing subunit calstabin2 and a leftward shift in the Ca(2+) dependence for activation under conditions that simulate exercise, consistent with a \"leaky\" channel. Both RyR2-G230C and RyR2-P2328S channels exhibit normal luminal Ca(2+) activation. Thus, diastolic sarcoplasmic reticulum Ca(2+) leak caused by reduced calstabin2 binding and a leftward shift in the Ca(2+) dependence for activation by diastolic levels of cytosolic Ca(2+) is a common mechanism underlying CPVT. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21659649", "endSection": "abstract"}]}, {"body": "Which population has a high frequency of the HLA-B*1502 allele?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22211527", "http://www.ncbi.nlm.nih.gov/pubmed/21424386", "http://www.ncbi.nlm.nih.gov/pubmed/21306565", "http://www.ncbi.nlm.nih.gov/pubmed/21169036", "http://www.ncbi.nlm.nih.gov/pubmed/20345939", "http://www.ncbi.nlm.nih.gov/pubmed/19915237", "http://www.ncbi.nlm.nih.gov/pubmed/19694795", "http://www.ncbi.nlm.nih.gov/pubmed/18855540", "http://www.ncbi.nlm.nih.gov/pubmed/18637831", "http://www.ncbi.nlm.nih.gov/pubmed/16415921", "http://www.ncbi.nlm.nih.gov/pubmed/15057820"], "triples": [{"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A18289792", "o": "http://www.w3.org/2008/05/skos-xl#Label"}, {"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A7573122", "o": "http://www.w3.org/2008/05/skos-xl#Label"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1257890", "o": "http://linkedlifedata.com/resource/umls/label/A7573122"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0103552", "o": "Population"}, {"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A0103553", "o": "http://www.w3.org/2008/05/skos-xl#Label"}, {"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A0103554", "o": "http://www.w3.org/2008/05/skos-xl#Label"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://linkedlifedata.com/resource/pubmed/keyword/POPULATIONS", "o": "POPULATIONS"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://linkedlifedata.com/resource/pubmed/mesh/Population", "o": "Population"}], "ideal_answer": "European studies suggested that hla-b*1502 is not a universal marker but is ethnicity-specific for asians.Found a strong association between HLA-B*1502 and CBZ-induced SJS in the Han Chinese population from central and northern China.Observed an increased frequency of hla-b*1502 allele in patients ( 44.44 % ) compared with tolerant controls ( 11.11 % ), although it failed to reach statistical significance ( p=0.294 ).The hla allele in chinese han chinese, this allele is seen in high frequency in many asian populations other than han chinese, but there are few data on whether the allele is a marker for this severe outcome in anyone other than han chinese.Results from this study suggest that hla-b*1502 may be a useful pharmacogenetic test for screening thai individuals who may be at risk for cbz-induced sjs and ten.In the present study, we conducted a pilot study to detect a possible association of oxcarbazepine ( oxc ) -induced mpe with hla-b*1502 allele b*1502 as a marker for carbamazepine-induced stevens-johnson syndrome and toxic epidermal necrolysis in han population.", "exact_answer": ["Han Chinese and other Asian populations, except Japanese"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011153", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005787", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D044382", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005828", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D044469", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005805"], "type": "factoid", "id": "51542e6fd24251bc05000082", "snippets": [{"offsetInBeginSection": 274, "offsetInEndSection": 388, "text": "A strong association between HLA-B*1502 and carbamazepine-induced SJS/TEN has been identified in Chinese and Thai. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21306565", "endSection": "sections.0"}, {"offsetInBeginSection": 234, "offsetInEndSection": 363, "text": "A very strong association of carbamazepine-induced SJS with HLA-B*1502 has recently been described in the Han Chinese population. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16415921", "endSection": "sections.0"}, {"offsetInBeginSection": 134, "offsetInEndSection": 265, "text": "the HLA allele B*1502 as a marker for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese, ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18855540", "endSection": "sections.0"}, {"offsetInBeginSection": 189, "offsetInEndSection": 308, "text": "the human leukocyte antigen HLA-B*1502 is associated with Stevens-Johnson syndrome (SJS) induced by CBZ in Han Chinese. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19694795", "endSection": "sections.0"}, {"offsetInBeginSection": 34, "offsetInEndSection": 186, "text": "a strong association between HLA-B*1502 and carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS) in Han Chinese, but not in Caucasian populations. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637831", "endSection": "sections.0"}, {"offsetInBeginSection": 323, "offsetInEndSection": 525, "text": "This allele is seen in high frequency in many Asian populations other than Han Chinese, but there are few data on whether the allele is a marker for this severe outcome in anyone other than Han Chinese. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18855540", "endSection": "sections.0"}, {"offsetInBeginSection": 1120, "offsetInEndSection": 1283, "text": "Results from this study suggest that HLA-B*1502 may be a useful pharmacogenetic test for screening Thai individuals who may be at risk for CBZ-induced SJS and TEN. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20345939", "endSection": "sections.0"}, {"offsetInBeginSection": 321, "offsetInEndSection": 487, "text": "In the present study, we conducted a pilot study to detect a possible association of oxcarbazepine (OXC)-induced MPE with HLA-B*1502 allele in Chinese Han population. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169036", "endSection": "sections.0"}, {"offsetInBeginSection": 172, "offsetInEndSection": 394, "text": "there is a strong association in Han Chinese between a genetic marker, the human leukocyte antigen HLA-B*1502, and Stevens-Johnson syndrome induced by carbamazepine, a drug commonly prescribed for the treatment of seizures ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15057820", "endSection": "sections.0"}, {"offsetInBeginSection": 229, "offsetInEndSection": 438, "text": "A strong association between human leukocyte antigen (HLA)-B*1502 and CBZ-induced SJS/TEN has been reported in Han Chinese, Thai, Malaysian and Indian populations, but not in Caucasian or Japanese populations. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22211527", "endSection": "sections.0"}, {"offsetInBeginSection": 169, "offsetInEndSection": 414, "text": "A strong association has been reported between human leucocyte antigen (HLA)-B*1502 and carbamazepine-induced SJS in Han Chinese patients. European studies suggested that HLA-B*1502 is not a universal marker but is ethnicity-specific for Asians. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19915237", "endSection": "sections.0"}, {"offsetInBeginSection": 189, "offsetInEndSection": 479, "text": "A strong association between HLA-B*1502 and CBZ-induced SJS/TEN has been reported in Han Chinese but not in Caucasian and Japanese populations. A case-control study was conducted to determine whether HLA-B*1502 is a valid pharmacogenetic test for SJS/TEN caused by CBZ in a Thai population. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20345939", "endSection": "sections.0"}, {"offsetInBeginSection": 1263, "offsetInEndSection": 1591, "text": "observed an increased frequency of HLA-B*1502 allele in patients (44.44%) compared with tolerant controls (11.11%), although it failed to reach statistical significance (P=0.294). CONCLUSIONS: Our findings indicate that HLA-B*1502 allele may contribute to the genetic susceptibility to OXC-induced MPE in Chinese Han population. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169036", "endSection": "sections.0"}, {"offsetInBeginSection": 802, "offsetInEndSection": 1129, "text": "found a strong association between HLA-B*1502 and CBZ-induced SJS/TEN in the Han Chinese population from central and northern China. Combined with previous studies of the southern Han Chinese subpopulation, our results suggest that HLA-B*1502 is strongly associated with CBZ-induced SJS/TEN in the whole Han Chinese population. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21424386", "endSection": "sections.0"}]}, {"body": "What are the observations regarding telomere integrity and function in Fanconi anemia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23571757", "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "http://www.ncbi.nlm.nih.gov/pubmed/19129235", "http://www.ncbi.nlm.nih.gov/pubmed/11591364"], "triples": [], "ideal_answer": "Our observations indicate that accelerated telomere shortening in patients with fa is not due to a role of fancg at telomeres but instead may be secondary to the disease thus, the fa pathway has a novel function in alt telomere maintenance related to dna repair.Our observations indicate that accelerated shortening of telomeres in fa, we have studied several markers of telomere integrity and function in fa patients and age-matched controls to get insights into the mechanisms and consequences of telomere erosion in fa breaks at telomeres and trf2-independent end fusions in fanconi anemia.Since previous works suggested an accelerated telomere integrity and function in fa patients and age-matched controls to get insights into the mechanisms and consequences of telomere erosion in fa breaks at telomeres and trf2-independent end fusions in fanconi anemia fibroblasts -- a longitudinal study.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005199", "http://www.disease-ontology.org/api/metadata/DOID:13636", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051856", "http://www.disease-ontology.org/api/metadata/DOID:1062", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010833", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010834"], "type": "summary", "id": "54edeb4394afd6150400000b", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 71, "text": "Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "Accelerated telomere shortening in Fanconi anemia fibroblasts--a longitudinal study. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11591364", "endSection": "title"}, {"offsetInBeginSection": 281, "offsetInEndSection": 350, "text": "previous works suggested an accelerated shortening of telomeres in FA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "endSection": "abstract"}, {"offsetInBeginSection": 897, "offsetInEndSection": 976, "text": "Restoration of \u03b1IISp levels to normal in FA-A cells corrects these deficiencies ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23571757", "endSection": "abstract"}, {"offsetInBeginSection": 1055, "offsetInEndSection": 1147, "text": "Thus, the FA pathway has a novel function in ALT telomere maintenance related to DNA repair. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19129235", "endSection": "abstract"}, {"offsetInBeginSection": 1121, "offsetInEndSection": 1290, "text": "Our observations indicate that accelerated telomere shortening in patients with FA is not due to a role of FANCG at telomeres but instead may be secondary to the disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15319283", "endSection": "abstract"}, {"offsetInBeginSection": 1316, "offsetInEndSection": 1458, "text": "Consistent with impaired telomeres in FA patients, we observed a >10-fold increase in chromosome end fusions in FA compared to normal controls ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "endSection": "abstract"}, {"offsetInBeginSection": 892, "offsetInEndSection": 1087, "text": "Consistent with previous reports, quantitative FISH analysis showed an accelerated telomere shortening of 0.68 kb in FA, which occurred concurrently in both chromosome arms in a similar magnitude ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "endSection": "abstract"}, {"offsetInBeginSection": 275, "offsetInEndSection": 537, "text": "Since previous works suggested an accelerated shortening of telomeres in FA, we have studied several markers of telomere integrity and function in FA patients and age-matched controls to get insights into the mechanisms and consequences of telomere erosion in FA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "endSection": "abstract"}, {"offsetInBeginSection": 1089, "offsetInEndSection": 1314, "text": "Our data therefore suggest that the telomere erosion in FA is caused by a higher rate of breakage at TTAGGG sequences in vivo in differentiated cells, in addition to mere replicative shortening during lymphocyte proliferation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "endSection": "abstract"}, {"offsetInBeginSection": 275, "offsetInEndSection": 538, "text": "Since previous works suggested an accelerated shortening of telomeres in FA, we have studied several markers of telomere integrity and function in FA patients and age-matched controls to get insights into the mechanisms and consequences of telomere erosion in FA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "endSection": "abstract"}, {"offsetInBeginSection": 539, "offsetInEndSection": 890, "text": "A higher frequency of extra-chromosomic TTAGGG signals and of chromosome ends with undetectable TTAGGG repeats was observed in FA cells by fluorescence in situ hybridization (FISH), suggesting intensive breakage at telomeric sequences. This was proven by measuring the frequency of excess of telomeric signals per cell, which was 2.8-fold higher in FA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11854176", "endSection": "abstract"}, {"offsetInBeginSection": 273, "offsetInEndSection": 895, "text": "We now demonstrate that \u03b1IISp is also important for telomere maintenance after ICL damage. It localizes to telomeres in S phase after ICL damage where it has enhanced association with TRF1 and TRF2 and is required for recruitment of the ICL repair protein, XPF, to damage-induced foci at telomeres. In telomerase-positive normal cells depleted of \u03b1IISp by siRNA or in Fanconi anemia, complementation group A (FA-A) cells, where \u03b1IISp levels are 35-40% of normal, ICL damage results in failure of XPF to localize to telomeres, markedly increased telomere dysfunction-induced foci, followed by catastrophic loss of telomeres ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23571757", "endSection": "abstract"}]}, {"body": "Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20967796", "http://www.ncbi.nlm.nih.gov/pubmed/18184405", "http://www.ncbi.nlm.nih.gov/pubmed/24252593", "http://www.ncbi.nlm.nih.gov/pubmed/24140475", "http://www.ncbi.nlm.nih.gov/pubmed/24068942", "http://www.ncbi.nlm.nih.gov/pubmed/23730497", "http://www.ncbi.nlm.nih.gov/pubmed/23022380", "http://www.ncbi.nlm.nih.gov/pubmed/18056171", "http://www.ncbi.nlm.nih.gov/pubmed/21302811", "http://www.ncbi.nlm.nih.gov/pubmed/25493453", "http://www.ncbi.nlm.nih.gov/pubmed/16707600", "http://www.ncbi.nlm.nih.gov/pubmed/17575125", "http://www.ncbi.nlm.nih.gov/pubmed/20015880", "http://www.ncbi.nlm.nih.gov/pubmed/21263446", "http://www.ncbi.nlm.nih.gov/pubmed/20008221", "http://www.ncbi.nlm.nih.gov/pubmed/23033986", "http://www.ncbi.nlm.nih.gov/pubmed/21463127", "http://www.ncbi.nlm.nih.gov/pubmed/24401270", "http://www.ncbi.nlm.nih.gov/pubmed/24301524"], "triples": [], "ideal_answer": "Gain-of-function mutations in notch-1 have been reported in more than 50 % of human t-cell acute lymphoblastic leukemia ( t-all ) the notch signaling pathway has been recognized as a key factor for the pathogenesis of t-cell acute lymphoblastic leukemia ( t-all ), because of the high incidence of activating mutations of notch1Notch1 is a transmembrane receptor that is frequently mutated in human t-cell acute lymphoblastic leukemia ( t-all ) is characterized as a high-risk stratified disease associated with frequent relapse, chemotherapy resistance, and a poorer prognostic outlook than b-precursor all.T-cell acute lymphoblastic leukemia ( T-ALL ) patients frequently display NOTCH1 activating mutations and Notch can transcriptionally down-regulate the tumor suppressor PTEN.Notch signaling is of crucial importance in normal t-cell development and notch 1 is frequently mutated in t-cell acute lymphoblastic leukemia ( t-all ), leading to aberrantly high notch signaling mutations in notch1 activate notch signaling and are of prognostic outlook than b-precursor all.", "exact_answer": "yes", "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:5603"], "type": "yesno", "id": "5522fadb7b523f2123000001", "snippets": [{"offsetInBeginSection": 81, "offsetInEndSection": 207, "text": "Gain-of-function mutations in Notch-1 have been reported in more than 50% of human T-cell acute lymphoblastic leukemia (T-ALL) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21302811", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 119, "text": "Activating Notch-1 mutations are frequent in T-cell acute lymphoblastic leukemia (T-ALL), occurring in >50% of patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18056171", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "Activating Notch-1 mutations are frequent in T-cell acute lymphoblastic leukemia (T-ALL), occurring in >50% of patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18056171", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "NOTCH signaling pathway is essential in T-cell development and NOTCH1 mutations are frequently present in T-cell acute lymphoblastic leukemia (T-ALL) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16707600", "endSection": "abstract"}, {"offsetInBeginSection": 79, "offsetInEndSection": 207, "text": "Gain-of-function mutations in Notch-1 have been reported in more than 50% of human T-cell acute lymphoblastic leukemia (T-ALL). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21302811", "endSection": "abstract"}, {"offsetInBeginSection": 180, "offsetInEndSection": 296, "text": "Notch1 is a transmembrane receptor that is frequently mutated in human T-cell acute lymphoblastic leukemia (T-ALL). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24068942", "endSection": "abstract"}, {"offsetInBeginSection": 194, "offsetInEndSection": 342, "text": "Mutations in NOTCH1/FBXW7 activate NOTCH signaling and are of prognostic significance in patients with T-cell acute lymphoblastic leukemia (T-ALL). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25493453", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 127, "text": "Activating mutations in NOTCH1 consitute the most prominent genetic abnormality in T-cell acute lymphoblastic leukemia (T-ALL). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21463127", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 157, "text": "T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer that is frequently associated with activating mutations in NOTCH1 and dysregulation of MYC ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24401270", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 150, "text": "NOTCH signaling pathway is essential in T-cell development and NOTCH1 mutations are frequently present in T-cell acute lymphoblastic leukemia (T-ALL). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16707600", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 153, "text": "Activating mutations in NOTCH1, an essential regulator of T cell development, are frequently found in human T cell acute lymphoblastic leukemia (T-ALL). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23022380", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 198, "text": "Activation of the Notch pathway occurs commonly in T acute lymphoblastic leukemia (T-ALL) because of mutations in Notch1 or Fbw7 and is involved in the regulation of cell proliferation and survival. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21263446", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 172, "text": "T-cell acute lymphoblastic leukemia (T-ALL) patients frequently display NOTCH1 activating mutations and Notch can transcriptionally down-regulate the tumor suppressor PTEN. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20015880", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 195, "text": "The Notch signaling pathway has been recognized as a key factor for the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL), because of the high incidence of activating mutations of Notch1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24301524", "endSection": "abstract"}, {"offsetInBeginSection": 1126, "offsetInEndSection": 1300, "text": "Our data indicate that NOTCH1 is mutated in T-ALL, but not in other common human cancers, and that NOTCH2, NOTCH3 and NOTH4 genes are rarely mutated in common human cancers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18184405", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 195, "text": "Notch signaling is of crucial importance in normal T-cell development and Notch 1 is frequently mutated in T-cell acute lymphoblastic leukemias (T-ALL), leading to aberrantly high Notch signaling ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17575125", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 196, "text": "Notch signaling is of crucial importance in normal T-cell development and Notch 1 is frequently mutated in T-cell acute lymphoblastic leukemias (T-ALL), leading to aberrantly high Notch signaling. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17575125", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 295, "text": "The identification of activating mutations in NOTCH1 in over 50% of T-cell acute lymphoblastic leukemias (T-ALL) has generated major interest in the elucidation of the mechanisms of transformation downstream of oncogenic NOTCH and in the targeting of the NOTCH signaling pathway in this disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20008221", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 263, "text": "BACKGROUND: In T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL), activating mutations of NOTCH1 are observed in more than 50% of cases, whereas the t(7;9)(q34;q34) involving NOTCH1 at 9q34 and TRB@ at 7q34 is an extremely rare but recurrent translocation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23033986", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 364, "text": "T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) is characterized by aberrant activation of NOTCH1 in over 60% of T-ALL cases. The high prevalence of activating NOTCH1 mutations highlights the critical role of NOTCH signaling in the pathogenesis of this disease and has prompted the development of therapeutic approaches targeting the NOTCH signaling pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23730497", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 351, "text": "NOTCH proteins (NOTCH1, NOTCH2, NOTCH3 and NOTCH4) play crucial roles in embryonic development. Also, mounting evidence indicates that NOTCH contributes to the pathogenesis of hematopoietic and solid malignancies. Recent studies reported a high incidence of gain-of-function mutations of the NOTCH1 gene in T-cell acute lymphoblastic leukemias (ALL). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18184405", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 467, "text": "Notch receptors participate in a highly conserved signalling pathway that regulates normal development and tissue homeostasis in a context- and dose-dependent manner. Deregulated Notch signalling has been implicated in many diseases, but the clearest example of a pathogenic role is found in T-cell lymphoblastic leukaemia/lymphoma (T-LL), in which the majority of human and murine tumours have acquired mutations that lead to aberrant increases in Notch1 signalling. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20967796", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 521, "text": "T-cell acute lymphoblastic leukemia (T-ALL) is characterized as a high-risk stratified disease associated with frequent relapse, chemotherapy resistance, and a poorer prognostic outlook than B-precursor ALL. Many of the challenges in treating T-ALL reflect the lack of prognostic cytogenetic or molecular abnormalities on which to base therapy, including targeted therapy. Notch1 activating mutations were identified in more than 50% of T-ALL cases and can be therapeutically targeted with \u03b3-secretase inhibitors (GSIs). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24140475", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 602, "text": "The Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner. Dysregulation of Notch signaling has been suggested to be key events in a variety of hematological malignancies. Notch1 signaling appears to be the central oncogenic trigger in T cell acute lymphoblastic leukemia (T-ALL), in which the majority of human malignancies have acquired mutations that lead to constitutive activation of Notch1 signaling. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24252593", "endSection": "abstract"}]}, {"body": "What is the role of the Tsix gene during X chromosome inactivation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21826206", "http://www.ncbi.nlm.nih.gov/pubmed/19013827", "http://www.ncbi.nlm.nih.gov/pubmed/17333538", "http://www.ncbi.nlm.nih.gov/pubmed/16648248", "http://www.ncbi.nlm.nih.gov/pubmed/12023758"], "triples": [], "ideal_answer": "Antisense transcript, encoded by the tsix transcription negatively regulates xist and protects one x-chromosome in cis from inactivation by xist.In the mouse placenta, where x inactivation is imprinted ( the paternal x chromosome is always inactive ), the maternal xist allele is repressed by a cis-acting antisense transcript, encoded by the tsix gene within the human x-inactivation center.The tsix gene ( antisense counterpart of xist ) xist works as a functional rna molecule that recruits repressive chromatin factors towards one of the two x chromosomes in female mammalian cells is subject to inactivation.Transcriptional silencing of the human inactive x chromosome is induced by the xist works as a functional rna molecule that recruits repressive chromatin factors towards one of the female xs for inactivation.Our results identify a function for DXPas34 in murine XCI and demonstrate the critical role of Tsix transcription in preventing XCI in differentiating male ES cells and in normal functioning of the counting pathway.Antisense tsix transcription negatively regulates xist and protects one x-chromosome in cis from inactivation ( xci ) initiated by the xist gene.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D049951", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0009048", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:1900097", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:1900095", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:1900096", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0060816", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050172", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0060821", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020868", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0060817", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0060820", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014960", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000805", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0060819", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0060818", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D041321", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016458"], "type": "summary", "id": "52f1287d2059c6d71c000008", "snippets": [{"offsetInBeginSection": 225, "offsetInEndSection": 270, "text": "the Tsix gene (antisense counterpart of Xist) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21826206", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "One of the two X chromosomes in female mammalian cells is subject to inactivation (XCI) initiated by the Xist gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21826206", "endSection": "abstract"}, {"offsetInBeginSection": 697, "offsetInEndSection": 858, "text": "A conservation of Tsix expression pattern in voles, rat and mice suggests a crucial role of the antisense transcription in regulation of Xist and XIC in rodents. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21826206", "endSection": "abstract"}, {"offsetInBeginSection": 1357, "offsetInEndSection": 1572, "text": "Our results identify a function for DXPas34 in murine XCI and demonstrate the critical role of Tsix transcription in preventing XCI in differentiating male ES cells and in normal functioning of the counting pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16648248", "endSection": "abstract"}, {"offsetInBeginSection": 133, "offsetInEndSection": 350, "text": "In eutherian mammals, random XCI of the soma requires a master regulatory locus known as the 'X-inactivation center' (XIC/Xic), wherein lies the noncoding XIST/Xist silencer RNA and its regulatory antisense Tsix gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17333538", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 439, "text": "Transcriptional silencing of the human inactive X chromosome is induced by the XIST gene within the human X-inactivation center. The XIST allele must be turned off on one X chromosome to maintain its activity in cells of both sexes. In the mouse placenta, where X inactivation is imprinted (the paternal X chromosome is always inactive), the maternal Xist allele is repressed by a cis-acting antisense transcript, encoded by the Tsix gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12023758", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 613, "text": "A counting process senses the X chromosome/autosome ratio and ensures that X chromosome inactivation (XCI) initiates in the early female (XX) embryo and in differentiating female ES cells but not in their male (XY) counterparts. Counting depends on the X inactivation center (Xic), which contains the Xist gene encoding a nuclear RNA, which coats the inactive X chromosome and induces gene silencing. A 37-kb sequence lying 3' to the Xist gene is known to prevent initiation of XCI in male differentiating ES cells. This region contains the major and minor promoters of the Tsix gene, which runs antisense to Xist ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16648248", "endSection": "abstract"}, {"offsetInBeginSection": 295, "offsetInEndSection": 1032, "text": "One example for antisense regulation is the Xist (X-inactive specific transcript) and Tsix gene pair, which is pivotal in X-inactivation. Xist works as a functional RNA molecule that recruits repressive chromatin factors towards one of the female Xs for inactivation. Antisense Tsix transcription negatively regulates Xist and protects one X-chromosome in cis from inactivation by Xist. Albeit, the precise molecular mechanism is still obscure it has been shown that Tsix transcription regulates the chromatin structure by altering histone tail modifications and DNA methylation at the Xist promoter. In addition, Xist and Tsix RNA form an RNA duplexes in vivo and are processed to small RNAs, which have a potential regulatory function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19013827", "endSection": "abstract"}]}, {"body": "Is the protein FAK (Focal Adhesion Kinase) phosphorylated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24058594", "http://www.ncbi.nlm.nih.gov/pubmed/24164869", "http://www.ncbi.nlm.nih.gov/pubmed/24157923", "http://www.ncbi.nlm.nih.gov/pubmed/24217647", "http://www.ncbi.nlm.nih.gov/pubmed/24311785", "http://www.ncbi.nlm.nih.gov/pubmed/24121272", "http://www.ncbi.nlm.nih.gov/pubmed/24115647", "http://www.ncbi.nlm.nih.gov/pubmed/24091658", "http://www.ncbi.nlm.nih.gov/pubmed/24006257", "http://www.ncbi.nlm.nih.gov/pubmed/23990393", "http://www.ncbi.nlm.nih.gov/pubmed/23970932", "http://www.ncbi.nlm.nih.gov/pubmed/23906871", "http://www.ncbi.nlm.nih.gov/pubmed/23817042"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A14256646", "o": "Gene Ontology"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1150610", "o": "http://linkedlifedata.com/resource/umls/label/A2497986"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A14256646", "o": "focal adhesion kinase activity"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1150610", "o": "http://linkedlifedata.com/resource/umls/label/A14256646"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A2497986", "o": "FAK activity"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1150610", "o": "http://linkedlifedata.com/resource/umls/label/A2497986"}], "ideal_answer": "E first time, that the EGF-dependent EGFR activation led to increased P-FAKSer732 uppressed both the phosphorylation of FAK yrosine phosphorylated FAK the protein expression of PTPN13, focal adhesion kinase ( FAK ) and phosphorylated FAK ( P-FAK ) was evaluated using immunohistochemical staining and western blotting.", "exact_answer": "yes", "concepts": ["http://www.uniprot.org/uniprot/FAK1_CHICK", "http://www.uniprot.org/uniprot/FAK1_HUMAN", "http://www.uniprot.org/uniprot/FAK1_RAT", "http://www.uniprot.org/uniprot/FAK1_MOUSE"], "type": "yesno", "id": "54f4c382d0d681a040000006", "snippets": [{"offsetInBeginSection": 104, "offsetInEndSection": 130, "text": "yrosine phosphorylated FAK ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24058594", "endSection": "title"}, {"offsetInBeginSection": 886, "offsetInEndSection": 928, "text": "uppressed both the phosphorylation of FAK ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990393", "endSection": "abstract"}, {"offsetInBeginSection": 574, "offsetInEndSection": 607, "text": "Western blots were used for P-FAK ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24115647", "endSection": "abstract"}, {"offsetInBeginSection": 991, "offsetInEndSection": 1053, "text": " A GEF-inactive Rgnef mutant rescues FAK-Y397 phosphorylation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24006257", "endSection": "abstract"}, {"offsetInBeginSection": 360, "offsetInEndSection": 437, "text": "ownregulation of G3BP significantly inhibited the phosphorylation of Src, FAK ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24157923", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "TNF\u03b1 contributes for attenuating both Y397FAK and Y416Src phosphorylations in osteoblasts. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24164869", "endSection": "title"}, {"offsetInBeginSection": 707, "offsetInEndSection": 792, "text": "Overexpression of NEDD9 led to tyrosine phosphorylation of FAK and SRC oncoproteins, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24058594", "endSection": "abstract"}, {"offsetInBeginSection": 563, "offsetInEndSection": 662, "text": " It was possible to show that TNF\u03b1 provokes attenuation at Y-phosphorylation of both FAK (at Y397 ) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24164869", "endSection": "abstract"}, {"offsetInBeginSection": 402, "offsetInEndSection": 566, "text": " The protein expression of PTPN13, focal adhesion kinase (FAK) and phosphorylated FAK (P-FAK) was evaluated using immunohistochemical staining and western blotting. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23906871", "endSection": "abstract"}, {"offsetInBeginSection": 1236, "offsetInEndSection": 1317, "text": "e first time, that the EGF-dependent EGFR activation led to increased P-FAKSer732 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24091658", "endSection": "abstract"}, {"offsetInBeginSection": 478, "offsetInEndSection": 590, "text": "Periodic mechanical stress significantly induced sustained phosphorylation of FAK at Tyr(397) and Tyr(576/577). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24217647", "endSection": "abstract"}, {"offsetInBeginSection": 444, "offsetInEndSection": 592, "text": "functional characterization of many of today's best-known Src substrates (for example, p85-Cortactin, p110-AFAP1, p130Cas, p125FAK and p120-catenin) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24121272", "endSection": "abstract"}, {"offsetInBeginSection": 712, "offsetInEndSection": 897, "text": "oss of \u03b1SNAP impaired Golgi-dependent glycosylation and trafficking of \u03b21 integrin and decreased phosphorylation of focal adhesion kinase (FAK) and paxillin resulting in FA disassembly. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24311785", "endSection": "abstract"}, {"offsetInBeginSection": 743, "offsetInEndSection": 932, "text": "Curcumin inhibits focal adhesion kinase (FAK) phosphorylation and enhances the expressions of several extracellular matrix components which play a critical role in invasion and metastasis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23970932", "endSection": "abstract"}, {"offsetInBeginSection": 734, "offsetInEndSection": 909, "text": "specially, phosphorylation of Tyr925-FAK that is required for full activation of FAK was nearly completely suppressed even with 1nM of methyl violet 2B in A375P cancer cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23817042", "endSection": "abstract"}, {"offsetInBeginSection": 731, "offsetInEndSection": 1026, "text": ". P-FAKSer732 presence was crucial for the maintenance of the proliferation rate and its levels were inversely related to the levels of acetylated \u03b1-tubulin. P-FAKSer732 localized at the microtubules (MTs) of the spindle, biochemically associated with MTs and contributed to MT depolymerization. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24091658", "endSection": "abstract"}]}, {"body": "Which is the substrate of the haspin kinase during mitosis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21658950", "http://www.ncbi.nlm.nih.gov/pubmed/21514157", "http://www.ncbi.nlm.nih.gov/pubmed/19997740", "http://www.ncbi.nlm.nih.gov/pubmed/19918057", "http://www.ncbi.nlm.nih.gov/pubmed/18978305", "http://www.ncbi.nlm.nih.gov/pubmed/24184212", "http://www.ncbi.nlm.nih.gov/pubmed/23973165", "http://www.ncbi.nlm.nih.gov/pubmed/23746640", "http://www.ncbi.nlm.nih.gov/pubmed/23071153", "http://www.ncbi.nlm.nih.gov/pubmed/23071152", "http://www.ncbi.nlm.nih.gov/pubmed/22732840", "http://www.ncbi.nlm.nih.gov/pubmed/22335895", "http://www.ncbi.nlm.nih.gov/pubmed/21804608", "http://www.ncbi.nlm.nih.gov/pubmed/21749502", "http://www.ncbi.nlm.nih.gov/pubmed/21527018", "http://www.ncbi.nlm.nih.gov/pubmed/21447816", "http://www.ncbi.nlm.nih.gov/pubmed/21401527", "http://www.ncbi.nlm.nih.gov/pubmed/20953165", "http://www.ncbi.nlm.nih.gov/pubmed/20929775", "http://www.ncbi.nlm.nih.gov/pubmed/20705815", "http://www.ncbi.nlm.nih.gov/pubmed/20705812", "http://www.ncbi.nlm.nih.gov/pubmed/17084365", "http://www.ncbi.nlm.nih.gov/pubmed/15846065", "http://www.ncbi.nlm.nih.gov/pubmed/15681610"], "triples": [], "ideal_answer": "Haspin is a protein kinase the only known target of which is phosphorylation of histone h3 at thr3 residue ( h3t3ph ) haspin, a member of a distinctive group of protein kinases present in diverse eukaryotes, phosphorylates h3 at thr 3 haspin is a histone h3 thr3 kinase that has important roles in chromosome cohesion during mitosis.Phosphorylating Thr3 of histone H3, Haspin promotes centromeric recruitment of the chromosome passenger complex ( CPC ) during mitosis.Phosphorylating thr3 residue ( h3t3ph ) haspin, a member of a distinctive group of protein kinases present in diverse eukaryotes, phosphorylates h3 at thr 3 haspin is a histone h3 thr3 kinase that has important roles in chromosome passenger complex ( cpc ) during mitosis h3t3 kinase haspin during mitosis haspin is phosphorylated, associates with the chromosomes, centrosomes and spindle, and is responsible for phosphorylation of histone h3 at threonine-3 protein kinase haspin-mediated spreading of h3t3ph", "exact_answer": ["Histone 3 at Thr3"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008938", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0007067", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0007088", "http://www.uniprot.org/uniprot/HASP_DROME", "http://www.uniprot.org/uniprot/HASP_HUMAN"], "type": "factoid", "id": "53442023aeec6fbd07000007", "snippets": [{"offsetInBeginSection": 620, "offsetInEndSection": 638, "text": "H3T3 kinase haspin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20953165", "endSection": "abstract"}, {"offsetInBeginSection": 142, "offsetInEndSection": 185, "text": "H3T3 phosphorylation is catalyzed by Haspin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24184212", "endSection": "abstract"}, {"offsetInBeginSection": 122, "offsetInEndSection": 164, "text": "Haspin-dependent histone H3 phosphorylatio ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22732840", "endSection": "abstract"}, {"offsetInBeginSection": 526, "offsetInEndSection": 579, "text": "kinase activity of Haspin, which phosphorylates H3T3, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20705815", "endSection": "abstract"}, {"offsetInBeginSection": 395, "offsetInEndSection": 441, "text": "Haspin/Gsg2 is a histone H3 threonine-3 kinase ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17084365", "endSection": "abstract"}, {"offsetInBeginSection": 691, "offsetInEndSection": 742, "text": "protein kinase Haspin-mediated spreading of H3T3ph ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21514157", "endSection": "abstract"}, {"offsetInBeginSection": 1429, "offsetInEndSection": 1475, "text": "Haspin kinase is a histone H3 threonine kinase ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21527018", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 42, "text": "istone H3 Thr-3 phosphorylation by Haspin ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20705812", "endSection": "title"}, {"offsetInBeginSection": 1, "offsetInEndSection": 57, "text": "aspin phosphorylates histone H3 at threonine-3 (H3T3ph), ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071152", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 64, "text": "aspin phosphorylates histone H3 at Thr3 (H3T3ph) during mitosis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21658950", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 86, "text": "aspin is a serine/threonine kinase that phosphorylates Thr-3 of histone H3 in mitosis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22335895", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 88, "text": "aspin/Gsg2 is a kinase that phosphorylates histone H3 at Thr-3 (H3T3ph) during mitosis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18978305", "endSection": "abstract"}, {"offsetInBeginSection": 269, "offsetInEndSection": 329, "text": "phosphorylation of histone H3 threonine 3 (H3T3ph) by Haspin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20705812", "endSection": "abstract"}, {"offsetInBeginSection": 341, "offsetInEndSection": 410, "text": "phosphorylation of histone H3-threonine 3 (H3-pT3) mediated by Haspin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20929775", "endSection": "abstract"}, {"offsetInBeginSection": 707, "offsetInEndSection": 772, "text": "Haspin phosphorylated histone H3 at both Thr3 and Thr11 in vitro. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21527018", "endSection": "abstract"}, {"offsetInBeginSection": 362, "offsetInEndSection": 418, "text": "Haspin in vitro phosphorylates histone H3 at threonine 3 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21749502", "endSection": "abstract"}, {"offsetInBeginSection": 1494, "offsetInEndSection": 1558, "text": "Haspin phosphorylated histone H3 at both Thr3 and Thr11 in vitro ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21527018", "endSection": "abstract"}, {"offsetInBeginSection": 840, "offsetInEndSection": 909, "text": "phosphorylation of histone H3 threonine 3 (H3-pT3) mediated by Haspin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21447816", "endSection": "abstract"}, {"offsetInBeginSection": 324, "offsetInEndSection": 403, "text": "histone H3 that is phosphorylated at T3 (H3T3ph) by Aurora B-stimulated Haspin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23746640", "endSection": "abstract"}, {"offsetInBeginSection": 373, "offsetInEndSection": 478, "text": "Haspin localizes predominantly to chromosomes and phosphorylates histone H3 at threonine-3 during mitosis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19997740", "endSection": "abstract"}, {"offsetInBeginSection": 98, "offsetInEndSection": 195, "text": "Haspin is a histone H3 Thr3 kinase that has important roles in chromosome cohesion during mitosis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21527018", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 92, "text": "aspin is an atypical protein kinase that in several organisms phosphorylates histone H3Thr3 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23973165", "endSection": "abstract"}, {"offsetInBeginSection": 420, "offsetInEndSection": 537, "text": "histone H3 specifically when it is phosphorylated at threonine 3, a mark that is placed by the mitotic kinase, haspin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21401527", "endSection": "abstract"}, {"offsetInBeginSection": 246, "offsetInEndSection": 361, "text": "Haspin is a protein kinase the only known target of which is phosphorylation of histone H3 at Thr3 residue (H3T3ph) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21804608", "endSection": "abstract"}, {"offsetInBeginSection": 19, "offsetInEndSection": 129, "text": "haspin/Gsg2 plays an important role in mitosis, where it specifically phosphorylates Thr-3 in histone H3 (H3T3 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19918057", "endSection": "abstract"}, {"offsetInBeginSection": 407, "offsetInEndSection": 573, "text": "During mitosis haspin is phosphorylated, associates with the chromosomes, centrosomes and spindle, and is responsible for phosphorylation of histone H3 at threonine-3 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15846065", "endSection": "abstract"}, {"offsetInBeginSection": 3, "offsetInEndSection": 136, "text": "phosphorylating Thr3 of histone H3, Haspin promotes centromeric recruitment of the chromosome passenger complex (CPC) during mitosis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071153", "endSection": "abstract"}, {"offsetInBeginSection": 471, "offsetInEndSection": 587, "text": "haspin, a member of a distinctive group of protein kinases present in diverse eukaryotes, phosphorylates H3 at Thr 3 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15681610", "endSection": "abstract"}]}, {"body": "Which are the most widely reported side-effects in the treatment of Crohn's disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21453886", "http://www.ncbi.nlm.nih.gov/pubmed/21317611", "http://www.ncbi.nlm.nih.gov/pubmed/21254868", "http://www.ncbi.nlm.nih.gov/pubmed/20919963", "http://www.ncbi.nlm.nih.gov/pubmed/20458240", "http://www.ncbi.nlm.nih.gov/pubmed/19420815", "http://www.ncbi.nlm.nih.gov/pubmed/18989561", "http://www.ncbi.nlm.nih.gov/pubmed/18788068", "http://www.ncbi.nlm.nih.gov/pubmed/17628557", "http://www.ncbi.nlm.nih.gov/pubmed/17667053", "http://www.ncbi.nlm.nih.gov/pubmed/18469440", "http://www.ncbi.nlm.nih.gov/pubmed/12603508", "http://www.ncbi.nlm.nih.gov/pubmed/11205659", "http://www.ncbi.nlm.nih.gov/pubmed/10981226", "http://www.ncbi.nlm.nih.gov/pubmed/9399771", "http://www.ncbi.nlm.nih.gov/pubmed/9097825", "http://www.ncbi.nlm.nih.gov/pubmed/9005529", "http://www.ncbi.nlm.nih.gov/pubmed/3069176", "http://www.ncbi.nlm.nih.gov/pubmed/6139796", "http://www.ncbi.nlm.nih.gov/pubmed/7084615", "http://www.ncbi.nlm.nih.gov/pubmed/30666"], "ideal_answer": "Persistent corneal endothelial deposits associated with rifabutin therapy for Crohn's disease leucopoenia was the more frequent side effect observed, occurring in 36 ( 34 % ) eosionophilia was present and the lymphocyte stimulation test with mesalazine was positive these occurred in 50 % of the patients and developed in the patients at a mean of 6.5 mo after the onset of treatment.The only troublesome side effect is paresthesia, which apparently is dose-related and not progressive nodular regenerative hyperplasia as a side effect of azathioprine in a patient with crohn's disease immune thrombocytopenic purpura is rarely reported in association with inflammatory bowel disease.", "exact_answer": [["Leukopenia"], ["paresthesia"], ["psoriasis"], ["alopecia"], ["hemolysis"], ["pancreatitis"], ["liver toxicity"], ["pericarditis"]], "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:8778", "http://www.disease-ontology.org/api/metadata/DOID:8577"], "type": "list", "id": "511a20f3df1ebcce7d00000c", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 61, "text": "Recurrent myopericarditis in association with Crohn's disease ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12603508", "endSection": "title"}, {"offsetInBeginSection": 305, "offsetInEndSection": 403, "text": "Immune thrombocytopenic purpura is rarely reported in association with inflammatory bowel disease. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9399771", "endSection": "sections.0"}, {"offsetInBeginSection": 432, "offsetInEndSection": 471, "text": "3 patients who developed scalp alopecia ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21317611", "endSection": "sections.0"}, {"offsetInBeginSection": 690, "offsetInEndSection": 750, "text": "Hemolysis is not a rare side-effect of sulfasalazine therapy ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/30666", "endSection": "sections.0"}, {"offsetInBeginSection": 500, "offsetInEndSection": 546, "text": "resulted to watery stools, vomiting, and fever ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9097825", "endSection": "sections.0"}, {"offsetInBeginSection": 1, "offsetInEndSection": 86, "text": "Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10981226", "endSection": "title"}, {"offsetInBeginSection": 149, "offsetInEndSection": 228, "text": "Pericarditis as a side effect induced by sulfasalazine or 5-aminosalicylic acid ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9005529", "endSection": "sections.0"}, {"offsetInBeginSection": 336, "offsetInEndSection": 437, "text": "The only troublesome side effect is paresthesia, which apparently is dose-related and not progressive ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6139796", "endSection": "sections.0"}, {"offsetInBeginSection": 766, "offsetInEndSection": 820, "text": "Nausea, vomit, although slight, occurred in 29 (27.4%) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18989561", "endSection": "sections.0"}, {"offsetInBeginSection": 640, "offsetInEndSection": 730, "text": "Eosionophilia was present and the lymphocyte stimulation test with mesalazine was positive ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9097825", "endSection": "sections.0"}, {"offsetInBeginSection": 81, "offsetInEndSection": 162, "text": "A severe side effect is acute pancreatitis, which is specific for Crohn's disease ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18469440", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17667053", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11205659", "endSection": "title"}, {"offsetInBeginSection": 965, "offsetInEndSection": 1042, "text": "Leucopoenia was the more frequent side effect observed, occurring in 36 (34%) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18989561", "endSection": "sections.0"}, {"offsetInBeginSection": 173, "offsetInEndSection": 266, "text": "Different cutaneous side effects have been described for anti-TNF-\u03b1 therapy such as psoriasis ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21453886", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 98, "text": "Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21254868", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 93, "text": "Persistent corneal endothelial deposits associated with rifabutin therapy for Crohn's disease ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20458240", "endSection": "title"}, {"offsetInBeginSection": 1, "offsetInEndSection": 100, "text": "Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18788068", "endSection": "title"}, {"offsetInBeginSection": 220, "offsetInEndSection": 322, "text": "side effects appearing in about a fifth of the patients, including myelosuppression and liver toxicity ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20919963", "endSection": "sections.0"}, {"offsetInBeginSection": 165, "offsetInEndSection": 252, "text": "Anti-TNF drug-induced alopecia is a less well-known side effect of this class of drugs. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21317611", "endSection": "sections.0"}, {"offsetInBeginSection": 465, "offsetInEndSection": 579, "text": "Analysis of the liver histology was highly suggestive of an azathioprine-related, nodular regenerative hyperplasia ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18788068", "endSection": "sections.0"}, {"offsetInBeginSection": 152, "offsetInEndSection": 253, "text": "The whole blood count revealed a pancytopenia, hyperbilirubinemia and slightly elevated transaminases ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18788068", "endSection": "sections.0"}, {"offsetInBeginSection": 483, "offsetInEndSection": 602, "text": "The commonest side-effect was hyperaesthesia, but one patient developed nephrotoxicity and one developed hepatotoxicity ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3069176", "endSection": "sections.0"}, {"offsetInBeginSection": 93, "offsetInEndSection": 204, "text": "complained of alopecia 3 days after starting 6-mercaptopurine (6-MP) and then developed severe myelosuppression ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19420815", "endSection": "sections.0"}, {"offsetInBeginSection": 174, "offsetInEndSection": 303, "text": "Leukopenia and thrombocytopenia are observed mostly as a side effect of therapy, particularly with use of immunosuppressive drugs ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9399771", "endSection": "sections.0"}, {"offsetInBeginSection": 1052, "offsetInEndSection": 1223, "text": "The only major side effect observed was paresthesias. These occurred in 50% of the patients and developed in the patients at a mean of 6.5 mo after the onset of treatment. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7084615", "endSection": "sections.0"}, {"offsetInBeginSection": 79, "offsetInEndSection": 226, "text": "17 of 40 (43%) patients with inflammatory bowel disease receiving sulfasalazine had evidence of hemolysis as detected by starch gel electrophoresis ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/30666", "endSection": "sections.0"}, {"offsetInBeginSection": 725, "offsetInEndSection": 882, "text": "3 serious adverse events (SAEs) known to be associated with CD treatment (progressive multifocal leukoencephalopathy (PML), serious infections, and lymphoma) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17628557", "endSection": "sections.0"}]}, {"body": "Are most driver gene mutations synonymous or non-synonymous?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24147068", "http://www.ncbi.nlm.nih.gov/pubmed/23935863", "http://www.ncbi.nlm.nih.gov/pubmed/23819581", "http://www.ncbi.nlm.nih.gov/pubmed/23799614", "http://www.ncbi.nlm.nih.gov/pubmed/23704925", "http://www.ncbi.nlm.nih.gov/pubmed/23694700", "http://www.ncbi.nlm.nih.gov/pubmed/23450047", "http://www.ncbi.nlm.nih.gov/pubmed/23015295", "http://www.ncbi.nlm.nih.gov/pubmed/22893128", "http://www.ncbi.nlm.nih.gov/pubmed/22649506", "http://www.ncbi.nlm.nih.gov/pubmed/22072984", "http://www.ncbi.nlm.nih.gov/pubmed/19633228", "http://www.ncbi.nlm.nih.gov/pubmed/15946860"], "triples": [], "ideal_answer": "Moreover, we find that a large fraction of the driver mutations are neither located in conserved functional sites, nor responsible for structural stability, but rather regulate protein activity through allosteric transitions, protein-protein interactions, or protein-nucleic acid interactions.We identified 101 single-nucleotide variants ( snvs ) including 77 non-synonymous somatic mutations in squamous cell lung cancer.This is accomplished by choosing genes whose mutations are selected for during tumor development.In addition, we show that netdiseasesnp discriminates cancer driver and passenger mutations satisfactorily.Whole genome sequencing of the index liver metastasis identified 44 non-synonymous somatic mutations in 42 genes ( 0.85 mutation ) and a large hemizygous deletion in the atrx gene which has been recently reported in neuroblastoma.We used whole-exome sequencing to identify novel non-synonymous snvs ( 67 missense and 10 nonsense mutations ) and 11 indels causing frameshifts.Whole genome sequencing of the index liver metastasis identified 101 single-nucleotide variants ( snvs ) including 77 non-synonymous snvs ( 67 missense and 10 nonsense mutations ) and 11 indels causing frameshifts.", "exact_answer": [["non-synonymous"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009154", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009369", "http://www.disease-ontology.org/api/metadata/DOID:162"], "type": "factoid", "id": "534427f8aeec6fbd07000009", "snippets": [{"offsetInBeginSection": 543, "offsetInEndSection": 650, "text": "In addition, we show that NetDiseaseSNP discriminates cancer driver and passenger mutations satisfactorily. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23935863", "endSection": "abstract"}, {"offsetInBeginSection": 128, "offsetInEndSection": 239, "text": "We used whole-exome sequencing to identify novel non-synonymous somatic mutations in squamous cell lung cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23799614", "endSection": "abstract"}, {"offsetInBeginSection": 240, "offsetInEndSection": 399, "text": "We identified 101 single-nucleotide variants (SNVs) including 77 non-synonymous SNVs (67 missense and 10 nonsense mutations) and 11 INDELs causing frameshifts. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23799614", "endSection": "abstract"}, {"offsetInBeginSection": 1649, "offsetInEndSection": 1869, "text": "Therefore, this study highlights the need for multiple biopsies and sequencing during progression of a cancer and combinatorial DNA and RNA sequencing approach for systematic identification of expressed driver mutations. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24147068", "endSection": "abstract"}, {"offsetInBeginSection": 703, "offsetInEndSection": 934, "text": "Whole genome sequencing of the index liver metastasis identified 44 non-synonymous somatic mutations in 42 genes (0.85 mutation/MB) and a large hemizygous deletion in the ATRX gene which has been recently reported in neuroblastoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24147068", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 260, "text": "A common goal of tumor sequencing projects is finding genes whose mutations are selected for during tumor development. This is accomplished by choosing genes that have more non-synonymous mutations than expected from an estimated background mutation frequency. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23694700", "endSection": "abstract"}, {"offsetInBeginSection": 651, "offsetInEndSection": 913, "text": "Our method outperforms other state-of-the-art methods on several disease/neutral datasets as well as on cancer driver/passenger mutation datasets and can thus be used to pinpoint and prioritize plausible disease candidates among nsSNPs for further investigation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23935863", "endSection": "abstract"}, {"offsetInBeginSection": 1411, "offsetInEndSection": 1704, "text": "Moreover, we find that a large fraction of the driver mutations are neither located in conserved functional sites, nor responsible for structural stability, but rather regulate protein activity through allosteric transitions, protein-protein interactions, or protein-nucleic acid interactions. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23819581", "endSection": "abstract"}, {"offsetInBeginSection": 781, "offsetInEndSection": 1066, "text": "Besides confirming the presence of known melanoma driver mutations (BRAF(V600E), NRAS(Q61R) ), we identified novel mutated genes involved in signalling pathways crucial for melanoma pathogenesis and already addressed by current targeted therapies (such as MAPK and glutamate pathways). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23704925", "endSection": "abstract"}]}, {"body": "What is the advantage of neutral loss detection in phosphoproteomics?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23918812", "http://www.ncbi.nlm.nih.gov/pubmed/22844594", "http://www.ncbi.nlm.nih.gov/pubmed/21526838", "http://www.ncbi.nlm.nih.gov/pubmed/21033674", "http://www.ncbi.nlm.nih.gov/pubmed/21455477", "http://www.ncbi.nlm.nih.gov/pubmed/19504542", "http://www.ncbi.nlm.nih.gov/pubmed/19241031", "http://www.ncbi.nlm.nih.gov/pubmed/19056867", "http://www.ncbi.nlm.nih.gov/pubmed/18785766", "http://www.ncbi.nlm.nih.gov/pubmed/16641100", "http://www.ncbi.nlm.nih.gov/pubmed/15665377"], "triples": [], "ideal_answer": "The intense neutral loss scanning, and this yielded multiple serine and tyrosine residues are limiting factors for objectively scoring site patterns across thousands of peptides.The localization of phosphorylation sites in peptide sequences is a challenging problem in large-scale phosphoproteomics analysis.We extended the proteomic analysis to phosphoproteomic profiling using neutral loss scanning, and this yielded multiple novel phosphorylation sites, including serine-811 in the thiazide-sensitive na-cl co-transporter, ncc.We identified a novel fragmentation mechanism that generates a phosphorylation site identification by liquid chromatography-mass spectrometry ( n ) neutral loss scanning.We extended the proteomic analysis to phosphoproteomic profiling using neutral loss peaks and the coexistence of multiple serine and tyrosine residues are limiting factors for objectively scoring site patterns across thousands of peptides.In this procedure we use a combination of tools to assign b-, y-, neutral loss, and internal fragment ions, with the goal of assigning all significant ions in the MS spectrum.", "concepts": [], "type": "summary", "id": "550889db098a1b487b000005", "snippets": [{"offsetInBeginSection": 520, "offsetInEndSection": 624, "text": "CID of phosphopeptides typically results in spectra dominated by a neutral loss of the phosphate group. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19504542", "endSection": "abstract"}, {"offsetInBeginSection": 462, "offsetInEndSection": 566, "text": "phosphorylation site identification by liquid chromatography-mass spectrometry(n) neutral loss scanning. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16641100", "endSection": "abstract"}, {"offsetInBeginSection": 1356, "offsetInEndSection": 1500, "text": "MS/MS and neutral loss-directed MS/MS/MS analysis allowed detection and sequencing of phosphopeptides with exceptional accuracy and specificity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15665377", "endSection": "abstract"}, {"offsetInBeginSection": 809, "offsetInEndSection": 927, "text": "The higher-order fragmentations of neutral loss ions enhance the fragment ion mass spectra of phosphorylated peptides. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22844594", "endSection": "abstract"}, {"offsetInBeginSection": 1256, "offsetInEndSection": 1428, "text": "we identified a novel fragmentation mechanism that generates a phosphorylation site-specific neutral loss derived x-ion, which directly pinpoints the phosphorylated residue ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21526838", "endSection": "abstract"}, {"offsetInBeginSection": 867, "offsetInEndSection": 1025, "text": "LC separation and MS/MS are followed by neutral loss-dependent MS/MS/MS for phosphopeptide identification using a linear ion trap (LTQ)-FT mass spectrometer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18785766", "endSection": "abstract"}, {"offsetInBeginSection": 964, "offsetInEndSection": 1143, "text": "In this procedure we use a combination of tools to assign b-, y-, neutral loss, and internal fragment ions, with the goal of assigning all significant ions in the MS/MS spectrum. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19241031", "endSection": "abstract"}, {"offsetInBeginSection": 555, "offsetInEndSection": 777, "text": "We extended the proteomic analysis to phosphoproteomic profiling using neutral loss scanning, and this yielded multiple novel phosphorylation sites, including serine-811 in the thiazide-sensitive Na-Cl co-transporter, NCC. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19056867", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 325, "text": "The localization of phosphorylation sites in peptide sequences is a challenging problem in large-scale phosphoproteomics analysis. The intense neutral loss peaks and the coexistence of multiple serine/threonine and/or tyrosine residues are limiting factors for objectively scoring site patterns across thousands of peptides. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23918812", "endSection": "abstract"}]}, {"body": "Does ghrelin play a role in ischemic stroke?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23576609", "http://www.ncbi.nlm.nih.gov/pubmed/22190447", "http://www.ncbi.nlm.nih.gov/pubmed/22167137", "http://www.ncbi.nlm.nih.gov/pubmed/20720512", "http://www.ncbi.nlm.nih.gov/pubmed/19352052", "http://www.ncbi.nlm.nih.gov/pubmed/15613277", "http://www.ncbi.nlm.nih.gov/pubmed/24961317", "http://www.ncbi.nlm.nih.gov/pubmed/24768795"], "triples": [], "ideal_answer": "Human ghrelin treatment in vagus nerve-intact rats significantly decreased the above measurements.In this review we discuss pre-clinical evidence suggesting ghrelin may be a useful therapeutic in protecting the brain against injury after ischemic stroke.In this review we discuss pre-clinical evidence suggesting ghrelin may be a useful therapeutic in protecting the brain against injury after ischemic stroke both ghrelin and des-acyl ghrelin protected cortical neurons from ischemic injury adipokines and ghrelin play an important role in ischemic stroke, but their function in stroke subtypes seems to be different and sex influenced the serum ghrelin level was higher in the mcao group when compared with the control group ( p < 0.05 ).Leptin, adiponectin and ghrelin is thus a neuroprotective agent that inhibits inflammation, nnos activity, and apoptosis in focal cerebral ischemia through a vagal pathwayLeptin, adiponectin and ghrelin play an important role in ischemic stroke, but their function in stroke subtypes seems to be different and sex influenced the serum ghrelin level was higher in the mcao group when compared with the control group ( p < 0.05 ).", "exact_answer": "yes", "concepts": ["http://www.uniprot.org/uniprot/GHRL_LITCT", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054439"], "type": "yesno", "id": "551c2c276b348bb82c00000c", "snippets": [{"offsetInBeginSection": 1106, "offsetInEndSection": 1250, "text": "Adipokines and ghrelin play an important role in ischemic stroke, but their function in stroke subtypes seems to be different and sex influenced ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22167137", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "Adipokines and ghrelin play an important role in ischemic stroke, but their function in stroke subtypes seems to be different and sex influenced. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22167137", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 76, "text": "Leptin, adiponectin and ghrelin, new potential mediators of ischemic stroke. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22167137", "endSection": "title"}, {"offsetInBeginSection": 367, "offsetInEndSection": 450, "text": "Both ghrelin and des-acyl ghrelin protected cortical neurons from ischemic injury. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19352052", "endSection": "abstract"}, {"offsetInBeginSection": 369, "offsetInEndSection": 450, "text": "Both ghrelin and des-acyl ghrelin protected cortical neurons from ischemic injury ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19352052", "endSection": "abstract"}, {"offsetInBeginSection": 873, "offsetInEndSection": 983, "text": "Ghrelin levels correlated mildly with triglyceride levels, and were dominant in men with cardioembolic stroke. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22167137", "endSection": "abstract"}, {"offsetInBeginSection": 958, "offsetInEndSection": 1083, "text": "In conclusion, it is considered that ghrelin as well as S-100B can be a useful marker for the prediction of stoke after CPB. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15613277", "endSection": "abstract"}, {"offsetInBeginSection": 1133, "offsetInEndSection": 1291, "text": "CONCLUSIONS: Adipokines and ghrelin play an important role in ischemic stroke, but their function in stroke subtypes seems to be different and sex influenced. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22167137", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 117, "text": "Ghrelin is known to promote neuronal defense and survival against ischemic injury by inhibiting apoptotic processes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19352052", "endSection": "abstract"}, {"offsetInBeginSection": 981, "offsetInEndSection": 1084, "text": " The serum ghrelin level was higher in the MCAO group when compared with the control group (P < 0.05). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22190447", "endSection": "abstract"}, {"offsetInBeginSection": 154, "offsetInEndSection": 311, "text": "In this review we discuss pre-clinical evidence suggesting ghrelin may be a useful therapeutic in protecting the brain against injury after ischemic stroke. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24961317", "endSection": "abstract"}, {"offsetInBeginSection": 597, "offsetInEndSection": 723, "text": "RESULTS: Significantly higher levels of leptin and lower levels of adiponectin and ghrelin were confirmed in the stroke group. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22167137", "endSection": "abstract"}, {"offsetInBeginSection": 96, "offsetInEndSection": 213, "text": "Recent evidence suggests that ghrelin may also be neuroprotective after injury in animal models of cerebral ischemia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23576609", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20720512", "endSection": "title"}, {"offsetInBeginSection": 155, "offsetInEndSection": 310, "text": "In this review we discuss pre-clinical evidence suggesting ghrelin may be a useful therapeutic in protecting the brain against injury after ischemic stroke ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24961317", "endSection": "abstract"}, {"offsetInBeginSection": 1435, "offsetInEndSection": 1587, "text": "Our results showed that higher level of serum ghrelin decreased gastrointestinal motility and damage to the intestinal mucosa existed in rats with MCAO. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22190447", "endSection": "abstract"}, {"offsetInBeginSection": 1672, "offsetInEndSection": 1825, "text": "Human ghrelin is thus a neuroprotective agent that inhibits inflammation, nNOS activity, and apoptosis in focal cerebral ischemia through a vagal pathway ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20720512", "endSection": "abstract"}, {"offsetInBeginSection": 1671, "offsetInEndSection": 1825, "text": "Human ghrelin is thus a neuroprotective agent that inhibits inflammation, nNOS activity, and apoptosis in focal cerebral ischemia through a vagal pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20720512", "endSection": "abstract"}, {"offsetInBeginSection": 895, "offsetInEndSection": 1098, "text": "Our data indicate that des-acyl ghrelin, as well as ghrelin, protect cortical neurons against ischemic injury through the inhibition of Par-4 expression and apoptotic molecules in mitochondrial pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19352052", "endSection": "abstract"}, {"offsetInBeginSection": 851, "offsetInEndSection": 1026, "text": "Compared with vehicle treatment, human ghrelin treatment in vagus nerve-intact rats after MCAO showed marked reduction in neurological deficit by 57% and infarct size by 25%. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20720512", "endSection": "abstract"}, {"offsetInBeginSection": 1573, "offsetInEndSection": 1840, "text": "Overall, these experiments point to a neurodegenerative but antiapoptotic effect of endogenous ghrelin in this model of global ischemia, highlighting that further research is essential before we can apply ghrelin treatments to neurodegenerative insults in the clinic. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23576609", "endSection": "abstract"}, {"offsetInBeginSection": 1572, "offsetInEndSection": 1838, "text": "Overall, these experiments point to a neurodegenerative but antiapoptotic effect of endogenous ghrelin in this model of global ischemia, highlighting that further research is essential before we can apply ghrelin treatments to neurodegenerative insults in the clinic ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23576609", "endSection": "abstract"}, {"offsetInBeginSection": 116, "offsetInEndSection": 367, "text": "In the present study, we investigated the role of prostate apoptosis response-4 (Par-4), a proapoptotic gene the expression of which is increased after ischemic injury, in ghrelin-mediated neuroprotection during middle cerebral artery occlusion (MCAO) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19352052", "endSection": "abstract"}, {"offsetInBeginSection": 1213, "offsetInEndSection": 1498, "text": "Human ghrelin treatment in vagus nerve-intact rats significantly decreased the above measurements. Human ghrelin treatment also improved 7-day survival and significantly decreased neurological deficit over the entire 7 days after MCAO in vagus nerve-intact rats compared with vehicle. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20720512", "endSection": "abstract"}]}, {"body": "What is the mechanism of drug-induced gingival overgrowth?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23878564", "http://www.ncbi.nlm.nih.gov/pubmed/16712728", "http://www.ncbi.nlm.nih.gov/pubmed/16006738", "http://www.ncbi.nlm.nih.gov/pubmed/15221438", "http://www.ncbi.nlm.nih.gov/pubmed/12466121", "http://www.ncbi.nlm.nih.gov/pubmed/11453236", "http://www.ncbi.nlm.nih.gov/pubmed/8233439"], "triples": [], "ideal_answer": "The mechanism of pht-induced gingival overgrowth, however, is not well understood.Drug-induced gingival overgrowth is a frequent adverse effect associated principally with administration of the immunosuppressive drug cyclosporin a and also certain antiepileptic and antihypertensive drugs although the precise mechanism is not yet known, the enhanced proliferation of gingival fibroblasts observed in this disease could be caused at least partly by the effects of the drugs on the cell cycle and cyclin expression in these cells in addition, reduced cathepsin-l activity may play an important role in inducing drug-induced gingival overgrowth it is well-known that the anticonvulsant drug, phenytoin ( pht ), induces gingival overgrowth as a side effect.Cathepsin-l, a key molecule in the pathogenesis of drug-induced and i-cell disease-mediated gingival overgrowth thus, the increase in cell growth that occurs in drug-induced gingival overgrowth may be mediated by over-expression of cyclin b1The mechanism of pht-induced gingival overgrowth thus, the increase in cell growth that occurs in drug-induced gingival overgrowth may be mediated by over-expression of cyclin b1Drug-induced gingival overgrowth, however, is not well understood.", "concepts": ["http://www.disease-ontology.org/api/metadata/DOID:3086", "http://www.disease-ontology.org/api/metadata/DOID:3087"], "type": "summary", "id": "554500065beec11c1000000b", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 111, "text": "Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12466121", "endSection": "title"}, {"offsetInBeginSection": 1886, "offsetInEndSection": 1984, "text": "The results indicated that CsA stimulated cell proliferation in the pediatric fibroblast cell line ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23878564", "endSection": "abstract"}, {"offsetInBeginSection": 787, "offsetInEndSection": 916, "text": "Thus, the increase in cell growth that occurs in drug-induced gingival overgrowth may be mediated by over-expression of cyclin B1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15221438", "endSection": "abstract"}, {"offsetInBeginSection": 566, "offsetInEndSection": 726, "text": "A calcium antagonist, nifedipine, specifically suppressed cathepsin-L activity and mRNA expression, but not that of cathepsin-B in cultured gingival fibroblasts ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12466121", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 153, "text": "The immunosuppressant and hyperplasia-inducing drug cyclosporin A regulates the cell cycle and cyclin B1 gene expression in gingival fibroblasts in vitro ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15221438", "endSection": "title"}, {"offsetInBeginSection": 1211, "offsetInEndSection": 1393, "text": "The results suggest that the increased epithelial thickness observed in Cyclosporin A-induced gingival overgrowth is associated with increased proliferative activity in keratinocytes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16712728", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 192, "text": "It is well-known that the anticonvulsant drug, phenytoin (PHT), induces gingival overgrowth as a side effect. The mechanism of PHT-induced gingival overgrowth, however, is not well understood. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16006738", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 218, "text": "Drug-induced gingival overgrowth is a frequent adverse effect associated principally with administration of the immunosuppressive drug cyclosporin A and also certain antiepileptic and antihypertensive drugs ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16712728", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 199, "text": "Certain anticonvulsants, cyclosporine, and a variety of calcium channel blockers have been shown to produce clinically and histologically similar gingival enlargements in certain susceptible patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8233439", "endSection": "abstract"}, {"offsetInBeginSection": 1447, "offsetInEndSection": 1637, "text": "This study has shown, for the first time, that the level of KGF is elevated in GO and suggests that KGF may have an important role in the enhanced epithelial proliferation associated with GO ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11453236", "endSection": "abstract"}, {"offsetInBeginSection": 2341, "offsetInEndSection": 2552, "text": "The mechanism of a CsA-induced fibroblast overgrowth may converge on the steps involving fibroblast proliferation and cytokine network including IL-6, IL-8, IL-1\u03b2, TGF-\u03b21, and PGE2, in both adults and pediatrics ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23878564", "endSection": "abstract"}, {"offsetInBeginSection": 392, "offsetInEndSection": 701, "text": "Although the mechanism by which the drugs cause GO is not yet understood, keratinocyte growth factor (KGF), which is a potent epithelial cell mitogen, has been implicated in other hyperplastic conditions, including mammary and prostatic hyperplasia, and could also be involved in the molecular pathology of GO ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11453236", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 390, "text": "Drug-induced gingival overgrowth (GO) is a frequent and adverse side-effect associated principally with the administration of the immunosuppressive drug cyclosporin A (CsA) and also certain anti-epileptic and anti-hypertensive drugs. It is characterized by a marked increase in the thickness of the epithelial layer and the accumulation of excessive amounts of connective tissue ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11453236", "endSection": "abstract"}, {"offsetInBeginSection": 1985, "offsetInEndSection": 2326, "text": " Comparison between the results in the adult and pediatric groups demonstrated that the levels of IL-1\u03b2, IL-6, IL-8, and PGE2 were significantly higher in the pediatric group than in the adult group; however, statistics showed no significant difference in the levels of TNF-\u03b1 and TGF-\u03b21 and CsA-induced proliferation between these two groups ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23878564", "endSection": "abstract"}, {"offsetInBeginSection": 1257, "offsetInEndSection": 1588, "text": "Since cathepsin-L deficiency was reported to be associated with thickening of the skin, impaired cathepsin-L activity may play a key role in the establishment of skin and gingival abnormalities seen in I-cell disease. In addition, reduced cathepsin-L activity may play an important role in inducing drug-induced gingival overgrowth ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12466121", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 386, "text": "Gingival overgrowth is a frequent and adverse side-effect caused by certain immunosuppressant, anti-convulsant and calcium channel-blocking drugs. Although the precise mechanism is not yet known, the enhanced proliferation of gingival fibroblasts observed in this disease could be caused at least partly by the effects of the drugs on the cell cycle and cyclin expression in these cells ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15221438", "endSection": "abstract"}]}, {"body": "Is LPS a microbial product?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18406367", "http://www.ncbi.nlm.nih.gov/pubmed/25259707", "http://www.ncbi.nlm.nih.gov/pubmed/26029695", "http://www.ncbi.nlm.nih.gov/pubmed/25957290"], "triples": [], "ideal_answer": "Sterile bacterial wall lipopolysaccharide ( LPS ) to investigate the changes in innate lung microbiota bacterial lipopolysaccharide ( LPS ) and microbial translocation [ lipopolysaccaride ( LPS ), microbial 16S rDNA and sCD14 ] lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections", "exact_answer": "yes", "concepts": [], "type": "yesno", "id": "56e6f419a12c1fc13b000002", "snippets": [{"offsetInBeginSection": 793, "offsetInEndSection": 827, "text": "bacterial lipopolysaccharide (LPS) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26029695", "endSection": "abstract"}, {"offsetInBeginSection": 237, "offsetInEndSection": 321, "text": "and microbial translocation [lipopolysaccaride (LPS), microbial 16S rDNA and sCD14] ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25259707", "endSection": "abstract"}, {"offsetInBeginSection": 227, "offsetInEndSection": 327, "text": "sterile bacterial wall lipopolysaccharide (LPS) to investigate the changes in innate lung microbiota ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25957290", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18406367", "endSection": "title"}]}, {"body": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20661663", "http://www.ncbi.nlm.nih.gov/pubmed/20591222", "http://www.ncbi.nlm.nih.gov/pubmed/20551323", "http://www.ncbi.nlm.nih.gov/pubmed/19321450", "http://www.ncbi.nlm.nih.gov/pubmed/18371338", "http://www.ncbi.nlm.nih.gov/pubmed/18371328", "http://www.ncbi.nlm.nih.gov/pubmed/18275833", "http://www.ncbi.nlm.nih.gov/pubmed/17989730", "http://www.ncbi.nlm.nih.gov/pubmed/17651940", "http://www.ncbi.nlm.nih.gov/pubmed/17145810", "http://www.ncbi.nlm.nih.gov/pubmed/17102614", "http://www.ncbi.nlm.nih.gov/pubmed/16537449", "http://www.ncbi.nlm.nih.gov/pubmed/16157028", "http://www.ncbi.nlm.nih.gov/pubmed/16155021", "http://www.ncbi.nlm.nih.gov/pubmed/14982841", "http://www.ncbi.nlm.nih.gov/pubmed/14574365", "http://www.ncbi.nlm.nih.gov/pubmed/12714971", "http://www.ncbi.nlm.nih.gov/pubmed/12482990", "http://www.ncbi.nlm.nih.gov/pubmed/9923679", "http://www.ncbi.nlm.nih.gov/pubmed/21928107", "http://www.ncbi.nlm.nih.gov/pubmed/18346113", "http://www.ncbi.nlm.nih.gov/pubmed/21496667", "http://www.ncbi.nlm.nih.gov/pubmed/21164364", "http://www.ncbi.nlm.nih.gov/pubmed/19907431", "http://www.ncbi.nlm.nih.gov/pubmed/19390085", "http://www.ncbi.nlm.nih.gov/pubmed/19389366", "http://www.ncbi.nlm.nih.gov/pubmed/17597110", "http://www.ncbi.nlm.nih.gov/pubmed/17233832", "http://www.ncbi.nlm.nih.gov/pubmed/16869752", "http://www.ncbi.nlm.nih.gov/pubmed/16778197", "http://www.ncbi.nlm.nih.gov/pubmed/15964994", "http://www.ncbi.nlm.nih.gov/pubmed/15892997", "http://www.ncbi.nlm.nih.gov/pubmed/14732230", "http://www.ncbi.nlm.nih.gov/pubmed/14536079", "http://www.ncbi.nlm.nih.gov/pubmed/11355949"], "triples": [], "ideal_answer": "Bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression our data therefore implicate p21 as an important Bmi-1 target in NSCs one important pathway regulated by Bmi-1 is that involving two cyclin-dependent kinase inhibitors, p16 ( Ink4a ) and p19 ( Arf ) bmi-1-mediated repression of Cdkn2A in the absence of Bmi-1, the cyclin-dependent kinase inhibitor gene p16Ink4a is upregulated in neural stem cells, reducing the rate of proliferationP16 ( INK4a ) expression was regulated by the Polycomb group repressor Bmi-1 increased frequency to a telomere-independent senescent state mediated by the cyclin-dependent kinase inhibitor p16 ( INK4a ).", "exact_answer": ["p16INK4"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050756", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019941", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0004861", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0045736", "http://www.uniprot.org/uniprot/CD2A1_MONDO"], "type": "factoid", "id": "533abc76d6d3ac6a34000064", "snippets": [{"offsetInBeginSection": 628, "offsetInEndSection": 663, "text": "Bmi-1-mediated repression of Cdkn2A ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18275833", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 29, "text": "mi-1 regulation of INK4A-ARF ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14536079", "endSection": "title"}, {"offsetInBeginSection": 1493, "offsetInEndSection": 1526, "text": "BMI-1-mediated INK4a/ARF pathway ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21928107", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 35, "text": "mi-1 regulates the Ink4a/Arf locus ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19390085", "endSection": "title"}, {"offsetInBeginSection": 1, "offsetInEndSection": 52, "text": "16Ink4a suppression of lung adenocarcinoma by Bmi-1 ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21164364", "endSection": "title"}, {"offsetInBeginSection": 1386, "offsetInEndSection": 1460, "text": "The suppression of p16Ink4a occurred in parallel with an increase in Bmi-1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21164364", "endSection": "abstract"}, {"offsetInBeginSection": 387, "offsetInEndSection": 442, "text": "introduction of Bmi-1 can inhibit p16(INK4a) expression ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17233832", "endSection": "abstract"}, {"offsetInBeginSection": 395, "offsetInEndSection": 492, "text": "involving the polycomb group repressor Bmi-1 and the cyclin-dependent kinase inhibitor p16(INK4a) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17102614", "endSection": "abstract"}, {"offsetInBeginSection": 912, "offsetInEndSection": 989, "text": "overexpression of BMI-1, a transcriptional repressor of the p16(INK4a) locus, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16155021", "endSection": "abstract"}, {"offsetInBeginSection": 419, "offsetInEndSection": 495, "text": "bmi-1 overexpression induces immortalization due to repression of p16/p19ARF ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11355949", "endSection": "abstract"}, {"offsetInBeginSection": 1224, "offsetInEndSection": 1282, "text": "Bmi-1 overexpression reduced p16(INK4a) promoter activity ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19907431", "endSection": "abstract"}, {"offsetInBeginSection": 212, "offsetInEndSection": 291, "text": "derepression of the Ink4a/Arf locus is associated with decreased Bmi-1 binding, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19390085", "endSection": "abstract"}, {"offsetInBeginSection": 241, "offsetInEndSection": 320, "text": " expression of the polycomb protein BMI-1 and its downstream targets p16(Ink4a) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18346113", "endSection": "abstract"}, {"offsetInBeginSection": 823, "offsetInEndSection": 892, "text": "Our data therefore implicate p21 as an important Bmi-1 target in NSCs ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18371338", "endSection": "abstract"}, {"offsetInBeginSection": 1621, "offsetInEndSection": 1694, "text": "In EC9706 cells transfected by Bmi-1 siRNA, the expression levels of p16 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20591222", "endSection": "abstract"}, {"offsetInBeginSection": 364, "offsetInEndSection": 443, "text": "BMI-1 is a transcriptional repressor of the Ink4a/Arf locus encoding p16(ink4a) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17597110", "endSection": "abstract"}, {"offsetInBeginSection": 663, "offsetInEndSection": 748, "text": "the knockdown of BMI-1 expression could lead to significant up-regulation of p16INK4a ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20661663", "endSection": "abstract"}, {"offsetInBeginSection": 800, "offsetInEndSection": 874, "text": "experimental model systems indicate that p16 is a downstream target of Bmi ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14982841", "endSection": "abstract"}, {"offsetInBeginSection": 270, "offsetInEndSection": 392, "text": "One important pathway regulated by Bmi-1 is that involving two cyclin-dependent kinase inhibitors, p16(Ink4a) and p19(Arf) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20551323", "endSection": "abstract"}, {"offsetInBeginSection": 635, "offsetInEndSection": 718, "text": "Bmi-1 promotes stem cell self-renewal partly by repressing the expression of Ink4a ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16869752", "endSection": "abstract"}, {"offsetInBeginSection": 4, "offsetInEndSection": 113, "text": "Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14732230", "endSection": "title"}, {"offsetInBeginSection": 17, "offsetInEndSection": 110, "text": "Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9923679", "endSection": "title"}, {"offsetInBeginSection": 355, "offsetInEndSection": 442, "text": "overexpression of the polycomb-group gene BMI-1 might also down-regulate p16 expression ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15892997", "endSection": "abstract"}, {"offsetInBeginSection": 798, "offsetInEndSection": 894, "text": "decreased expression of proliferating cell nuclear antigen and Bmi-1; upregulation of p16(INK4a) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17989730", "endSection": "abstract"}, {"offsetInBeginSection": 657, "offsetInEndSection": 742, "text": "Bmi-1 thus prevents the premature senescence of neural stem cells by repressing Ink4a ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15964994", "endSection": "abstract"}, {"offsetInBeginSection": 180, "offsetInEndSection": 307, "text": "Bmi-1 function in stem cells during development that, surprisingly, seems to involve regulation of the cell-cycle inhibitor p21 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18371328", "endSection": "abstract"}, {"offsetInBeginSection": 629, "offsetInEndSection": 777, "text": "In the absence of Bmi-1, the cyclin-dependent kinase inhibitor gene p16Ink4a is upregulated in neural stem cells, reducing the rate of proliferation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574365", "endSection": "abstract"}, {"offsetInBeginSection": 1029, "offsetInEndSection": 1152, "text": "pronounced effects of Bmi-1 over-expression in culture were largely attributable to the attenuated induction of p16(Ink4a) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19389366", "endSection": "abstract"}, {"offsetInBeginSection": 809, "offsetInEndSection": 925, "text": "modulation of Bmi-1 protein might be involved in human colorectal carcinogenesis by repressing the INK4a/ARF protein ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14732230", "endSection": "abstract"}, {"offsetInBeginSection": 777, "offsetInEndSection": 912, "text": "in bmi-1-deficient lymphocytes, the expression of the tumour suppressors p16 and p19Arf, which are encoded by ink4a, is raised markedly ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9923679", "endSection": "abstract"}, {"offsetInBeginSection": 399, "offsetInEndSection": 596, "text": "increased frequency to a telomere-independent senescent state mediated by the cyclin-dependent kinase inhibitor p16(INK4a). p16(INK4a) expression was regulated by the Polycomb group repressor Bmi-1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16537449", "endSection": "abstract"}, {"offsetInBeginSection": 1445, "offsetInEndSection": 1549, "text": "The antisense Bmi-1 gene can inhibit the growth of K562 cell and upgrade expression of p16 in K562 cells ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16157028", "endSection": "abstract"}, {"offsetInBeginSection": 4, "offsetInEndSection": 126, "text": "bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11355949", "endSection": "title"}, {"offsetInBeginSection": 4, "offsetInEndSection": 106, "text": "polycomb protein Bmi-1 represses the INK4a locus, which encodes the tumor suppressors p16 and p14(ARF) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12482990", "endSection": "abstract"}, {"offsetInBeginSection": 294, "offsetInEndSection": 428, "text": "expression of BMI-1, a lymphoid oncogene whose product functions as a transcriptional repressor of the INK4A-ARF tumor suppressor locu ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14536079", "endSection": "abstract"}, {"offsetInBeginSection": 643, "offsetInEndSection": 814, "text": "We also observe that ROS-induced up-regulation of p16(Ink4a) occurs correlatively with ERK1/2-dependent down-regulation and subsequent dissociation from chromatin of Bmi-1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321450", "endSection": "abstract"}, {"offsetInBeginSection": 917, "offsetInEndSection": 1060, "text": "Overexpression of Bmi-1 in NPECs led to the induction of human telomerase reverse transcriptase activity and reduction of p16(INK4a) expression ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16778197", "endSection": "abstract"}, {"offsetInBeginSection": 573, "offsetInEndSection": 701, "text": "BMI-1 promotes self-renewal of stem cells largely by interfering with two central cellular tumor suppressor pathways, p16(Ink4a) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17651940", "endSection": "abstract"}, {"offsetInBeginSection": 905, "offsetInEndSection": 1029, "text": "reduced expression of Bmi-1, OC, DSP, and BSP compared with rapidly proliferating cells, whereas p16(INK4A) level increased. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21496667", "endSection": "abstract"}, {"offsetInBeginSection": 51, "offsetInEndSection": 214, "text": "Bmi-1 is important for postnatal, but not embryonic, neural stem cell (NSC) self-renewal and have identified the cell-cycle inhibitors p16/p19 as molecular targets ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18371338", "endSection": "abstract"}, {"offsetInBeginSection": 104, "offsetInEndSection": 327, "text": "p16INK4a and p14ARF tumor suppressors, human telomerase reverse transcriptase (h-TERT), and oncoprotein c-Myc have been implicated in the regulation of the cell cycle and proliferation mediated by PcG proteins, mainly Bmi-1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17145810", "endSection": "abstract"}, {"offsetInBeginSection": 686, "offsetInEndSection": 935, "text": "A gene expression analysis revealed that the expression of stem cell associated genes, cell survival genes, transcription factors, and genes modulating proliferation including p16Ink4a and p19Arf was altered in bone marrow cells of the Bmi-1-/- mice ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12714971", "endSection": "abstract"}]}, {"body": "Which microRNAs are involved in exercise adaptation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23242657", "http://www.ncbi.nlm.nih.gov/pubmed/23047984", "http://www.ncbi.nlm.nih.gov/pubmed/21690193", "http://www.ncbi.nlm.nih.gov/pubmed/21311168", "http://www.ncbi.nlm.nih.gov/pubmed/20724368", "http://www.ncbi.nlm.nih.gov/pubmed/19440340"], "ideal_answer": "The mir-494 content significantly decreased basal expression of all four myomirs ( p < 0.05 ) some mirnas as mir-1, mir-133 and mir-208a are highly expressed in the heart and strongly associated with the development of cardiac hypertrophy.In resting biopsies, endurance training for 12 weeks decreased basal expression of mttfa and foxj3 proteins.These results suggest that miR-494 regulates mitochondrial biogenesis by downregulating mtTFA and Foxj3 during myocyte differentiation and skeletal muscle adaptation to physical exercise.The mir-494 content significantly decreased after endurance exercise in c57bl mice, accompanied by an increase in expression of mttfa and foxj3 proteins.Recent data indicate that these mirnas as well as mir-206 change their expression quickly in response to physical activity.", "exact_answer": [["miR-1"], ["miR-133"], ["miR-208a"], ["miR-206"], ["miR-494"], ["miR-146a"], ["miR-222"], ["miR-21"], ["miR-221"], ["miR-20a"], ["miR-133a"], ["miR-133b"], ["miR-23"], ["miR-107"], ["miR-181"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D035683", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015444", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005081", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000222", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000220"], "type": "list", "id": "518cca6f310faafe0800000a", "snippets": [{"offsetInBeginSection": 824, "offsetInEndSection": 934, "text": "In resting biopsies, endurance training for 12 weeks decreased basal expression of all four myomiRs (P < 0.05) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20724368", "endSection": "sections.0"}, {"offsetInBeginSection": 1255, "offsetInEndSection": 1416, "text": "MicroRNA 1 expression was decreased independent of the training modality, and was paralleled by an increased expression of IGF-1 representing a potential target. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21311168", "endSection": "sections.0"}, {"offsetInBeginSection": 1066, "offsetInEndSection": 1253, "text": "These results suggest that miR-494 regulates mitochondrial biogenesis by downregulating mtTFA and Foxj3 during myocyte differentiation and skeletal muscle adaptation to physical exercise. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23047984", "endSection": "sections.0"}, {"offsetInBeginSection": 1003, "offsetInEndSection": 1268, "text": "1) c-miRNA up-regulated by acute exercise before and after sustained training (miR-146a and miR-222), (2) c-miRNA responsive to acute exercise before but not after sustained training (miR-21 and miR-221), (3) c-miRNA responsive only to sustained training (miR-20a), ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21690193", "endSection": "sections.0"}, {"offsetInBeginSection": 345, "offsetInEndSection": 614, "text": "Some miRNAs as miR-1, miR-133 and miR-208a are highly expressed in the heart and strongly associated with the development of cardiac hypertrophy. Recent data indicate that these miRNAs as well as miR-206 change their expression quickly in response to physical activity. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23242657", "endSection": "sections.0"}, {"offsetInBeginSection": 169, "offsetInEndSection": 476, "text": "we investigated the expression of these myomiRs, including miR-1, miR-133a, miR-133b and miR-206 in muscle biopsies from vastus lateralis of healthy young males (n = 10) in relation to a hyperinsulinaemic\u2013euglycaemic clamp as well as acute endurance exercise before and after 12 weeks of endurance training. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20724368", "endSection": "sections.0"}, {"offsetInBeginSection": 909, "offsetInEndSection": 1253, "text": "the miR-494 content significantly decreased after endurance exercise in C57BL/6J mice, accompanied by an increase in expression of mtTFA and Foxj3 proteins. These results suggest that miR-494 regulates mitochondrial biogenesis by downregulating mtTFA and Foxj3 during myocyte differentiation and skeletal muscle adaptation to physical exercise. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23047984", "endSection": "sections.0"}]}, {"body": "Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22151470", "http://www.ncbi.nlm.nih.gov/pubmed/21724593", "http://www.ncbi.nlm.nih.gov/pubmed/19492068", "http://www.ncbi.nlm.nih.gov/pubmed/19273034", "http://www.ncbi.nlm.nih.gov/pubmed/18412963", "http://www.ncbi.nlm.nih.gov/pubmed/18048180", "http://www.ncbi.nlm.nih.gov/pubmed/17946720", "http://www.ncbi.nlm.nih.gov/pubmed/17555593", "http://www.ncbi.nlm.nih.gov/pubmed/16342039", "http://www.ncbi.nlm.nih.gov/pubmed/15919726", "http://www.ncbi.nlm.nih.gov/pubmed/8481828", "http://www.ncbi.nlm.nih.gov/pubmed/19208138", "http://www.ncbi.nlm.nih.gov/pubmed/18798993"], "triples": [{"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A0021572", "o": "Alignments, Sequence"}], "ideal_answer": "The accelerator implements a version of the needleman-wunsch algorithm for nucleotide sequence alignment, approximate string matching and longest common subsequence.We have constructed a linear systolic array to perform pairwise sequence alignment.We present a reconfigurable systolic architecture that can be applied for the efficient treatment of several dynamic programming methods for resolving well-known problems, such as global and local sequence alignment.We describe how this technique leads to significant runtime savings for hmm database scanning on a standard off-the-shelf field-programmable gate array to perform pairwise sequence distance computations using dynamic programming.Sequence lengths are constrained only by available memory; the product of sequence lengths in the current implementation can be up to 2 ( 22 ).The accelerator implements a version of the needleman-wunsch algorithm for nucleotide sequence lengths are constrained only by available memory; the product of sequence lengths in the current implementation can be up to 2 ( 22 ).The machine is implemented as two NuBus boards connected to a Mac IIf, using a mixture of TTL and FPGA technology clocked at 10 MHz.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016415", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003201", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020539", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017423", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017422", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017421", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017385", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017386", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012689"], "type": "yesno", "id": "51be1750047fa84d1d000005", "snippets": [{"offsetInBeginSection": 256, "offsetInEndSection": 368, "text": "This results in an implementation of ClustalW with significant runtime savings on a standard off-the-shelf FPGA. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15919726", "endSection": "sections.0"}, {"offsetInBeginSection": 284, "offsetInEndSection": 459, "text": "in this paper, we focused on accelerating the Smith-Waterman algorithm by modifying the computationally repeated portion of the algorithm by FPGA hardware custom instructions. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17946720", "endSection": "sections.0"}, {"offsetInBeginSection": 442, "offsetInEndSection": 650, "text": "We have constructed a linear systolic array to perform pairwise sequence distance computations using dynamic programming. This results in an implementation with significant runtime savings on a standard FPGA. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18048180", "endSection": "sections.0"}, {"offsetInBeginSection": 576, "offsetInEndSection": 889, "text": "This paper shows how reconfigurable architectures can be used to derive an efficient fine-grained parallelization of the dynamic programming calculation. We describe how this technique leads to significant runtime savings for HMM database scanning on a standard off-the-shelf field-programmable gate array (FPGA). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19273034", "endSection": "sections.0"}, {"offsetInBeginSection": 383, "offsetInEndSection": 800, "text": "we have designed and built a high-performance FPGA-accelerated version of BLASTP, Mercury BLASTP. In this paper, we describe the architecture of the portions of the application that are accelerated in the FPGA, and we also describe the integration of these FPGA-accelerated portions with the existing BLASTP software. We have implemented Mercury BLASTP on a commodity workstation with two Xilinx Virtex-II 6000 FPGAs. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19492068", "endSection": "sections.0"}, {"offsetInBeginSection": 597, "offsetInEndSection": 978, "text": "The accelerator implements a version of the Needleman-Wunsch algorithm for nucleotide sequence alignment. Sequence lengths are constrained only by available memory; the product of sequence lengths in the current implementation can be up to 2(22). The machine is implemented as two NuBus boards connected to a Mac IIf/x, using a mixture of TTL and FPGA technology clocked at 10 MHz. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8481828", "endSection": "sections.0"}, {"offsetInBeginSection": 868, "offsetInEndSection": 1262, "text": "A linear error model for the raw intensity data and Burrows-Wheeler transform (BWT) based alignment are combined utilizing a Bayesian score function, which is then globally optimized over all possible genomic locations using an efficient branch-and-bound approach. The algorithm has been implemented in soft- and hardware [field-programmable gate array (FPGA)] to achieve real-time performance. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21724593", "endSection": "sections.0"}, {"offsetInBeginSection": 286, "offsetInEndSection": 839, "text": "We present a reconfigurable systolic architecture that can be applied for the efficient treatment of several dynamic programming methods for resolving well-known problems, such as global and local sequence alignment, approximate string matching and longest common subsequence. The dynamicity of the reconfigurability was found to be useful for practical applications in the construction of sequence alignments. A VHDL (VHSIC hardware description language) version of this new architecture was implemented on an APEX FPGA (Field programmable gate array). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16342039", "endSection": "sections.0"}]}, {"body": "List inhibtors targeting the mitochondrial permeability transition pore.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25793558", "http://www.ncbi.nlm.nih.gov/pubmed/24657357", "http://www.ncbi.nlm.nih.gov/pubmed/25351957", "http://www.ncbi.nlm.nih.gov/pubmed/24675465", "http://www.ncbi.nlm.nih.gov/pubmed/24968303", "http://www.ncbi.nlm.nih.gov/pubmed/24615518", "http://www.ncbi.nlm.nih.gov/pubmed/25502879", "http://www.ncbi.nlm.nih.gov/pubmed/24801220", "http://www.ncbi.nlm.nih.gov/pubmed/24627421", "http://www.ncbi.nlm.nih.gov/pubmed/24273204", "http://www.ncbi.nlm.nih.gov/pubmed/24885907", "http://www.ncbi.nlm.nih.gov/pubmed/23423267", "http://www.ncbi.nlm.nih.gov/pubmed/23536162", "http://www.ncbi.nlm.nih.gov/pubmed/24349464", "http://www.ncbi.nlm.nih.gov/pubmed/22197697", "http://www.ncbi.nlm.nih.gov/pubmed/22198507", "http://www.ncbi.nlm.nih.gov/pubmed/22745676", "http://www.ncbi.nlm.nih.gov/pubmed/20966765", "http://www.ncbi.nlm.nih.gov/pubmed/21542787", "http://www.ncbi.nlm.nih.gov/pubmed/21294074", "http://www.ncbi.nlm.nih.gov/pubmed/21372381", "http://www.ncbi.nlm.nih.gov/pubmed/20937730", "http://www.ncbi.nlm.nih.gov/pubmed/21669242", "http://www.ncbi.nlm.nih.gov/pubmed/20960209", "http://www.ncbi.nlm.nih.gov/pubmed/20668412", "http://www.ncbi.nlm.nih.gov/pubmed/19819119", "http://www.ncbi.nlm.nih.gov/pubmed/24434143", "http://www.ncbi.nlm.nih.gov/pubmed/24297180", "http://www.ncbi.nlm.nih.gov/pubmed/24951958", "http://www.ncbi.nlm.nih.gov/pubmed/10413027", "http://www.ncbi.nlm.nih.gov/pubmed/21297983", "http://www.ncbi.nlm.nih.gov/pubmed/25767484", "http://www.ncbi.nlm.nih.gov/pubmed/14627909", "http://www.ncbi.nlm.nih.gov/pubmed/18660440", "http://www.ncbi.nlm.nih.gov/pubmed/16516918", "http://www.ncbi.nlm.nih.gov/pubmed/12952973", "http://www.ncbi.nlm.nih.gov/pubmed/25063991", "http://www.ncbi.nlm.nih.gov/pubmed/15961375", "http://www.ncbi.nlm.nih.gov/pubmed/24998301"], "triples": [], "ideal_answer": "Postconditioning with cyclosporine a reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.Here we show that antamanide inhibits the mitochondrial permeability pore, a central effector of cell death induction, by targeting the pore regulator cyclophilin d. rather, we find that kb-r7943 inhibits opening of the mitochondrial permeability transition pore in permeabilized cells and isolated liver mitochondria.Mitochondrial permeability transition pore inhibitor ( Cyclosporine A ).Mitochondrially targeted gallic acid was found more effective in reducing oxidative stress and mitochondrial permeability pore.Postconditioning with cyclosporine a reduces early renal dysfunction by inhibiting mitochondrial permeability transition.Our data reveal another mechanism through which kb-r7943 may protect against calcium-induced injury, as well as a novel means to inhibit the mitochondrial permeability pore transition than gallic acid.", "exact_answer": [["Cyclosporine A"], ["Atractyloside"], ["N-metyl-4-isoleucine-cyclosporine", "NIM811"], ["Sanglifehrin A"], ["TRO-19622"]], "concepts": ["http://amigo.geneontology.org/amigo/term/GO:0005757", "http://amigo.geneontology.org/amigo/term/GO:0046902"], "type": "list", "id": "5717cdd2070aa3d072000001", "snippets": [{"offsetInBeginSection": 706, "offsetInEndSection": 734, "text": "MPTP inhibitor cyclosporin A ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22197697", "endSection": "abstract"}, {"offsetInBeginSection": 1242, "offsetInEndSection": 1277, "text": " cyclosporine A, an MPTP inhibitor, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675465", "endSection": "abstract"}, {"offsetInBeginSection": 1124, "offsetInEndSection": 1158, "text": " the mPTP inhibitor cyclosporine A ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20668412", "endSection": "abstract"}, {"offsetInBeginSection": 739, "offsetInEndSection": 767, "text": "A mPTP inhibitor (TRO-19622) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24273204", "endSection": "abstract"}, {"offsetInBeginSection": 1476, "offsetInEndSection": 1506, "text": " mPTP inhibitor cyclosporin A ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22198507", "endSection": "abstract"}, {"offsetInBeginSection": 710, "offsetInEndSection": 736, "text": "The mPTP inhibitor NIM811, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24627421", "endSection": "abstract"}, {"offsetInBeginSection": 1125, "offsetInEndSection": 1160, "text": "MPTP inhibitor cyclosporine A (CsA) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20960209", "endSection": "abstract"}, {"offsetInBeginSection": 1235, "offsetInEndSection": 1283, "text": " treatment with the MPTP inhibitor atractyloside ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25351957", "endSection": "abstract"}, {"offsetInBeginSection": 539, "offsetInEndSection": 580, "text": " The mPTP inhibitor sanglifehrin A (SfA) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24615518", "endSection": "abstract"}, {"offsetInBeginSection": 504, "offsetInEndSection": 539, "text": "mPTP inhibitor cyclosporin A (CsA) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23536162", "endSection": "abstract"}, {"offsetInBeginSection": 668, "offsetInEndSection": 708, "text": "cyclosporine A (CsA), a MPTP inhibitor, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24801220", "endSection": "abstract"}, {"offsetInBeginSection": 741, "offsetInEndSection": 780, "text": "The mPTP inhibitor cyclosporine A (CsA) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19819119", "endSection": "abstract"}, {"offsetInBeginSection": 1618, "offsetInEndSection": 1654, "text": "mPTP inhibitor, cyclosporin A (CsA), ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25502879", "endSection": "abstract"}, {"offsetInBeginSection": 599, "offsetInEndSection": 668, "text": " and N-methyl-4-isoleucine cyclosporine (NIM811), an mPTP inhibitor, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23423267", "endSection": "abstract"}, {"offsetInBeginSection": 767, "offsetInEndSection": 837, "text": "mitochondrial permeability transition pore inhibitor (Cyclosporine A). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24657357", "endSection": "abstract"}, {"offsetInBeginSection": 954, "offsetInEndSection": 1038, "text": "Cyclosporine A (CsA), a mitochondria permeability transition pore (MPTP) inhibitor, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885907", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25063991", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 121, "text": "Postconditioning with cyclosporine a reduces early renal dysfunction by inhibiting mitochondrial permeability transition. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25793558", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16516918", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "ADP is not only a key substrate for ATP generation, but also a potent inhibitor of mitochondrial permeability transition pore (mPTP). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24349464", "endSection": "abstract"}, {"offsetInBeginSection": 518, "offsetInEndSection": 671, "text": "Rather, we find that KB-R7943 inhibits opening of the mitochondrial permeability transition pore in permeabilized cells and isolated liver mitochondria. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24434143", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 127, "text": "KB-R7943, a plasma membrane Na(+)/Ca(2+) exchanger inhibitor, blocks opening of the mitochondrial permeability transition pore. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24434143", "endSection": "title"}, {"offsetInBeginSection": 80, "offsetInEndSection": 256, "text": "Here we show that antamanide inhibits the mitochondrial permeability transition pore, a central effector of cell death induction, by targeting the pore regulator cyclophilin D. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21297983", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 173, "text": "Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18660440", "endSection": "title"}, {"offsetInBeginSection": 956, "offsetInEndSection": 1111, "text": "Mitochondrially targeted gallic acid was found more effective in reducing oxidative stress and mitochondrial permeability pore transition than gallic acid. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24998301", "endSection": "abstract"}, {"offsetInBeginSection": 188, "offsetInEndSection": 382, "text": "NIM-811 (N-metyl-4-isoleucine-cyclosporine) is a mitochondria specific drug, which can prevent ischemic-reperfusion (IR) injury, by inhibiting mitochondrial permeability transition pores (mPTP). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24968303", "endSection": "abstract"}, {"offsetInBeginSection": 959, "offsetInEndSection": 1143, "text": "Our data reveal another mechanism through which KB-R7943 may protect against calcium-induced injury, as well as a novel means to inhibit the mitochondrial permeability transition pore. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24434143", "endSection": "abstract"}, {"offsetInBeginSection": 687, "offsetInEndSection": 917, "text": "The involvement of mitochondrial permeability transition pore was determined with a mitochondrial permeability transition pore opener atractyloside and a specific mitochondrial permeability transition pore inhibitor cyclosporin A. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22732280", "endSection": "abstract"}, {"offsetInBeginSection": 1016, "offsetInEndSection": 1229, "text": "Unlike pyrrophenone, the diacylglycerol analog 1-oleoyl-2-acetyl-sn-glycerol and CsA blocked cell death and arachidonic acid release not by preventing mitochondrial calcium uptake but by inhibiting MPTP formation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24297180", "endSection": "abstract"}, {"offsetInBeginSection": 568, "offsetInEndSection": 816, "text": "Furthermore, in wild-type (non-transfected) SHSY5Y cells, the effects of lactacystin on mitochondrial function and cell viability are also prevented by cyclosporin A (1\u00a0\u03bcM) which blocks the activity of the mitochondrial permeability transition pore ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25319443", "endSection": "abstract"}, {"offsetInBeginSection": 691, "offsetInEndSection": 890, "text": "Inhibitors of calcium/calmodulin-dependent protein kinase II, a mitochondrial Ca(2+) uniporter (MCU) regulator, also prevented MPTP formation and arachidonic acid release induced by A23187 and H2O2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24297180", "endSection": "abstract"}, {"offsetInBeginSection": 698, "offsetInEndSection": 955, "text": "Pre\u2014treatment of gallic acid and mitochondrially targeted gallic acid to sodium nitroprusside treated mitochondria not only significantly reduced the oxidative stress but also prevented mitochondrial permeability pore transition to a significant difference. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24998301", "endSection": "abstract"}, {"offsetInBeginSection": 956, "offsetInEndSection": 1245, "text": "Mitochondrially targeted gallic acid was found more effective in reducing oxidative stress and mitochondrial permeability pore transition than gallic acid. We conclude that mitochondrially targeted gallic acid can be used for preventing mitochondrial impairment caused by oxidative stress. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24998301", "endSection": "abstract"}, {"offsetInBeginSection": 839, "offsetInEndSection": 1159, "text": "Incubation with \u03b23AR agonist (BRL37344, 7\u00a0\u03bcmol/L) significantly reduced cell death in isolated adult mouse cardiomyocytes during hypoxia/reoxygenation and decreased susceptibility to deleterious opening of the mitochondrial permeability transition pore (mPTP), via a mechanism dependent on the Akt-NO signaling pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24951958", "endSection": "abstract"}, {"offsetInBeginSection": 698, "offsetInEndSection": 1111, "text": "Pre\u2014treatment of gallic acid and mitochondrially targeted gallic acid to sodium nitroprusside treated mitochondria not only significantly reduced the oxidative stress but also prevented mitochondrial permeability pore transition to a significant difference. Mitochondrially targeted gallic acid was found more effective in reducing oxidative stress and mitochondrial permeability pore transition than gallic acid. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24998301", "endSection": "abstract"}, {"offsetInBeginSection": 668, "offsetInEndSection": 1258, "text": "Here we show that antamanide inhibits the mitochondrial permeability transition pore, a central effector of cell death induction, by targeting the pore regulator cyclophilin D. Indeed, (i) permeability transition pore inhibition by antamanide is not additive with the cyclophilin D-binding drug cyclosporin A, (ii) the inhibitory action of antamanide on the pore requires phosphate, as previously shown for cyclosporin A; (iii) antamanide is ineffective in mitochondria or cells derived from cyclophilin D null animals, and (iv) abolishes CyP-D peptidyl-prolyl cis-trans isomerase activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21297983", "endSection": "abstract"}]}, {"body": "What is ceritinib?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25228534", "http://www.ncbi.nlm.nih.gov/pubmed/25381900", "http://www.ncbi.nlm.nih.gov/pubmed/25101329", "http://www.ncbi.nlm.nih.gov/pubmed/24675041", "http://www.ncbi.nlm.nih.gov/pubmed/24670165", "http://www.ncbi.nlm.nih.gov/pubmed/25258420", "http://www.ncbi.nlm.nih.gov/pubmed/24980964", "http://www.ncbi.nlm.nih.gov/pubmed/25458559", "http://www.ncbi.nlm.nih.gov/pubmed/25258279", "http://www.ncbi.nlm.nih.gov/pubmed/24891360", "http://www.ncbi.nlm.nih.gov/pubmed/26018086", "http://www.ncbi.nlm.nih.gov/pubmed/25170107", "http://www.ncbi.nlm.nih.gov/pubmed/25733882"], "triples": [], "ideal_answer": "The ability of ceritinib bound to alk provides structural bases for this increased potency.Ceritinib to overcome alectinib-resistance mutations suggests a potential role for sequential therapy with multiple next-generation alk-tkis.Treatment of the patient with ceritinib is effective and approved for alk-positive nsclc in the acquired resistance setting.Preclinical data showed impressive antitumor activity against crizotinib-resistant clones, and based on available data, ceritinib is effective and approved for alk-positive nsclc.Ceritinib overcomes crizotinib resistance in non-small cell lung cancer.In particular, ceritinib effectively inhibits alk harboring l1196m, g1269a, i1171t, and s1206y mutations, and a cocrystal structure of ceritinib led to a marked response.The alk inhibitor ceritinib is effective and approved for alk-positive nsclc in the acquired resistance setting.Preclinical data showed impressive antitumor activity against crizotinib-resistant clones, and s1206y mutations, and a cocrystal structure of ceritinib could represent a suitable option in crizotinib-resistant nsclc.Ceritinib is an oral, potent, second-generation alk inhibitor recently approved by the u.s. food and drug administrationIn particular, ceritinib effectively inhibits alk inhibitor recently approved by the u.s. food and drug administration", "concepts": [], "type": "summary", "id": "56d03a4d3975bb303a00000c", "snippets": [{"offsetInBeginSection": 1156, "offsetInEndSection": 1251, "text": "Ceritinib is effective and approved for ALK-positive NSCLC in the acquired resistance setting. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25381900", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675041", "endSection": "title"}, {"offsetInBeginSection": 802, "offsetInEndSection": 930, "text": "We tested the antitumor activity of the next-generation ALK-TKI ceritinib in the patient with acquired resistance to alectinib. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228534", "endSection": "abstract"}, {"offsetInBeginSection": 687, "offsetInEndSection": 807, "text": "Ceritinib is an oral, potent, second-generation ALK inhibitor recently approved by the U.S. Food and Drug Administration ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25101329", "endSection": "abstract"}, {"offsetInBeginSection": 1735, "offsetInEndSection": 1891, "text": "The ability of ceritinib to overcome alectinib-resistance mutations suggests a potential role for sequential therapy with multiple next-generation ALK-TKIs. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228534", "endSection": "abstract"}, {"offsetInBeginSection": 9, "offsetInEndSection": 167, "text": "The first-generation ALK tyrosine kinase inhibitor (TKI) crizotinib is a standard therapy for patients with ALK-rearranged non-small cell lung cancer (NSCLC). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228534", "endSection": "abstract"}, {"offsetInBeginSection": 1234, "offsetInEndSection": 1446, "text": "Both ALK mutations conferred resistance to alectinib as well as to crizotinib, but were sensitive to ceritinib and other next-generation ALK-TKIs. Treatment of the patient with ceritinib led to a marked response. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228534", "endSection": "abstract"}, {"offsetInBeginSection": 809, "offsetInEndSection": 1003, "text": "Preclinical data showed impressive antitumor activity against crizotinib-resistant clones, and based on available data, ceritinib could represent a suitable option in crizotinib-resistant NSCLC. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25101329", "endSection": "abstract"}, {"offsetInBeginSection": 1021, "offsetInEndSection": 1427, "text": "Altogether, our results demonstrate that ceritinib can overcome crizotinib resistance, consistent with clinical data showing marked efficacy of ceritinib in patients with crizotinib-resistant disease. The second-generation ALK inhibitor ceritinib can overcome several crizotinib-resistant mutations and is potent against several in vitro and in vivo laboratory models of acquired resistance to crizotinib. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675041", "endSection": "abstract"}, {"offsetInBeginSection": 1312, "offsetInEndSection": 1985, "text": "In this review, we aim to present the current knowledge on acquired resistance of crizotinib known as a first-in-class ALK inhibitor and potential solutions to improve the cost-effectiveness, and to review the difference between ceritinib and crizotinib; preclinical data and results of the elegant early clinical trial of ceritinib which promoted its accelerated approval, pharmacokinetics, safety profile, and tolerability, the updated results (eg, efficacy on brain metastases), and robust design of ongoing phase II/III trials, and future directions of ceritinib to be a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancer are also presented. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25458559", "endSection": "abstract"}, {"offsetInBeginSection": 593, "offsetInEndSection": 1451, "text": "In particular, ceritinib effectively inhibits ALK harboring L1196M, G1269A, I1171T, and S1206Y mutations, and a cocrystal structure of ceritinib bound to ALK provides structural bases for this increased potency. However, we observed that ceritinib did not overcome two crizotinib-resistant ALK mutations, G1202R and F1174C, and one of these mutations was identified in 5 of 11 biopsies from patients with acquired resistance to ceritinib. Altogether, our results demonstrate that ceritinib can overcome crizotinib resistance, consistent with clinical data showing marked efficacy of ceritinib in patients with crizotinib-resistant disease.SIGNIFICANCE: The second-generation ALK inhibitor ceritinib can overcome several crizotinib-resistant mutations and is potent against several in vitro and in vivo laboratory models of acquired resistance to crizotinib. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675041", "endSection": "abstract"}, {"offsetInBeginSection": 330, "offsetInEndSection": 1316, "text": "The accelerated approval of potent ALK inhibitors, such as crizotinib and more recently ceritinib (LDK378), based on the well designed phase I/II trials has been a landmark success in clinical cancer research and contributes a new era of oncogenic targeted therapy characterized by elegant clinical trial design. In this review, we aim to present the current knowledge on acquired resistance of crizotinib known as a first-in-class ALK inhibitor and potential solutions to improve the cost-effectiveness, and to review the difference between ceritinib and crizotinib; preclinical data and results of the elegant early clinical trial of ceritinib which promoted its accelerated approval, pharmacokinetics, safety profile, and tolerability, the updated results (eg, efficacy on brain metastases), and robust design of ongoing phase II/III trials, and future directions of ceritinib to be a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancer are also presented. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25458559", "endSection": "abstract"}]}, {"body": "Which protein is found to be mutated in Friedreich's ataxia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25929520", "http://www.ncbi.nlm.nih.gov/pubmed/25597503", "http://www.ncbi.nlm.nih.gov/pubmed/25430730", "http://www.ncbi.nlm.nih.gov/pubmed/12194387", "http://www.ncbi.nlm.nih.gov/pubmed/16510442", "http://www.ncbi.nlm.nih.gov/pubmed/18463734", "http://www.ncbi.nlm.nih.gov/pubmed/18206656", "http://www.ncbi.nlm.nih.gov/pubmed/23247094", "http://www.ncbi.nlm.nih.gov/pubmed/12140189", "http://www.ncbi.nlm.nih.gov/pubmed/24242291", "http://www.ncbi.nlm.nih.gov/pubmed/18537827", "http://www.ncbi.nlm.nih.gov/pubmed/11823441", "http://www.ncbi.nlm.nih.gov/pubmed/12393810", "http://www.ncbi.nlm.nih.gov/pubmed/9700204", "http://www.ncbi.nlm.nih.gov/pubmed/16787388", "http://www.ncbi.nlm.nih.gov/pubmed/12174969", "http://www.ncbi.nlm.nih.gov/pubmed/20819074", "http://www.ncbi.nlm.nih.gov/pubmed/20674094"], "triples": [], "ideal_answer": "Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia.The friedreich ataxia ( frda ) and which is associated with abnormal intramitochondrial iron handling friedreich's ataxia protein frataxin, which carries single point mutations in some patients.Frataxin is a mitochondrial protein deficient in friedreich's ataxia results from a deficiency in the mitochondrial protein frataxin, which carries single point mutations in some patients.Frataxin is a mitochondrial protein deficient in friedreich ataxia patients might be more susceptible to al toxicity.The DNA abnormality found in 98 % of Friedreich's ataxia chromosomes is the unstable hyperexpansion of a GAA triplet repeat in the first intron of the frataxin gene.Interestingly, drosophila frataxin ( dfh ), which causes friedreich's ataxia protein frataxin modulates dna base excision repair in prokaryotes and mammals.Friedreich ataxia, an autosomal recessive neurodegenerative and cardiac disease, is caused by abnormally low levels of frataxin, an essential mitochondrial protein.Friedreich ataxia if mutated in humans, displayed an interacting effect with al, suggesting friedreich's ataxia patients might be more susceptible to al toxicity.", "exact_answer": [["Frataxin"]], "concepts": [], "type": "factoid", "id": "571f5c150fd6f91b68000009", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11823441", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "Friedreich ataxia (FRDA) is a neurodegenerative disease characterized by a decreased expression of the mitochondrial protein frataxin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24242291", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 103, "text": "The Friedreich's ataxia protein frataxin modulates DNA base excision repair in prokaryotes and mammals. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20819074", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "Frataxin is a mitochondrial protein deficient in Friedreich ataxia (FRDA) and which is associated with abnormal intramitochondrial iron handling ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9700204", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "Friedreich ataxia is a human neurodegenerative and myocardial disease caused by decreased expression of the mitochondrial protein frataxin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16510442", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "Friedreich's ataxia results from a deficiency in the mitochondrial protein frataxin, which carries single point mutations in some patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18537827", "endSection": "abstract"}, {"offsetInBeginSection": 184, "offsetInEndSection": 348, "text": "The DNA abnormality found in 98% of Friedreich's ataxia chromosomes is the unstable hyperexpansion of a GAA triplet repeat in the first intron of the frataxin gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12194387", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 162, "text": "Friedreich ataxia (FRDA) is an autosomal recessive degenerative disease caused by a deficiency of frataxin, a conserved mitochondrial protein of unknown function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11823441", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 164, "text": "Friedreich ataxia, an autosomal recessive neurodegenerative and cardiac disease, is caused by abnormally low levels of frataxin, an essential mitochondrial protein. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18463734", "endSection": "abstract"}, {"offsetInBeginSection": 552, "offsetInEndSection": 771, "text": "Interestingly, Drosophila frataxin (dfh), which causes Friedreich's ataxia if mutated in humans, displayed an interacting effect with Al, suggesting Friedreich's ataxia patients might be more susceptible to Al toxicity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20674094", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 183, "text": "Friedreich's ataxia is a severe neurodegenerative disease caused by the decreased expression of frataxin, a mitochondrial protein that stimulates iron-sulfur (Fe-S) cluster biogenesis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25597503", "endSection": "abstract"}, {"offsetInBeginSection": 425, "offsetInEndSection": 625, "text": "Although the Friedreich's ataxia phenotype results from decreased expression of a mitochondrially targeted protein, frataxin, mitochondrial myopathy has not been described as a feature of the disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12174969", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 185, "text": "Friedreich's ataxia (FRDA), an autosomal recessive cardio- and neurodegenerative disease, is caused by low expression of frataxin, a small mitochondrial protein, encoded in the nucleus. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12140189", "endSection": "abstract"}, {"offsetInBeginSection": 1042, "offsetInEndSection": 1234, "text": "This review will focus on the progress of potential treatment strategies for Friedreich ataxia that target the GAA expanded gene and seek to increase the level of frataxin message and protein. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18206656", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 197, "text": "The severe reduction in mRNA and protein levels of the mitochondrial protein frataxin, encoded by the X25 gene, causes Friedreich ataxia (FRDA), the most common form of recessive hereditary ataxia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12393810", "endSection": "abstract"}, {"offsetInBeginSection": 598, "offsetInEndSection": 806, "text": "Complete absence of frataxin, the mitochondrial protein defective in patients with Friedreich's ataxia, is lethal in C. elegans, while its partial deficiency extends animal lifespan in a p53 dependent manner. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23247094", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 226, "text": "In eukaryotes, frataxin deficiency (FXN) causes severe phenotypes including loss of iron-sulfur (Fe-S) cluster protein activity, accumulation of mitochondrial iron and leads to the neurodegenerative disease Friedreich's ataxia ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25430730", "endSection": "abstract"}, {"offsetInBeginSection": 74, "offsetInEndSection": 348, "text": "It is caused by deficiency of frataxin, a highly conserved nuclear-encoded protein localized in mitochondria. The DNA abnormality found in 98% of Friedreich's ataxia chromosomes is the unstable hyperexpansion of a GAA triplet repeat in the first intron of the frataxin gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12194387", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 279, "text": "The neurodegenerative disorder FRDA (Friedreich&apos;s ataxia) results from a deficiency in frataxin, a putative iron chaperone, and is due to the presence of a high number of GAA repeats in the coding regions of both alleles of the frataxin gene, which impair protein expression ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16787388", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 272, "text": "It is generally accepted that Friedreich's ataxia (FRDA) is caused by a deficiency in frataxin expression, a mitochondrial protein involved in iron homeostasis, which mainly affects the brain, dorsal root ganglia of the spinal cord, heart and in certain cases the pancreas ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25929520", "endSection": "abstract"}]}, {"body": "Which is the process that Conserved noncoding elements mostly regulate?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23042552", "http://www.ncbi.nlm.nih.gov/pubmed/21731768", "http://www.ncbi.nlm.nih.gov/pubmed/21629789", "http://www.ncbi.nlm.nih.gov/pubmed/21478460", "http://www.ncbi.nlm.nih.gov/pubmed/21175683", "http://www.ncbi.nlm.nih.gov/pubmed/19704032", "http://www.ncbi.nlm.nih.gov/pubmed/19492354", "http://www.ncbi.nlm.nih.gov/pubmed/19073165", "http://www.ncbi.nlm.nih.gov/pubmed/18334644", "http://www.ncbi.nlm.nih.gov/pubmed/18282512", "http://www.ncbi.nlm.nih.gov/pubmed/18279518", "http://www.ncbi.nlm.nih.gov/pubmed/18056681", "http://www.ncbi.nlm.nih.gov/pubmed/17442748", "http://www.ncbi.nlm.nih.gov/pubmed/16533910", "http://www.ncbi.nlm.nih.gov/pubmed/19698106", "http://www.ncbi.nlm.nih.gov/pubmed/16630819", "http://www.ncbi.nlm.nih.gov/pubmed/17096848"], "ideal_answer": "In 74 % of cases, we were able to assign a specific set of paralogous genes with annotation relating to transcriptional regulation.Animal genomes possess highly conserved cis-regulatory sequences that are often found near genes that regulate transcription and development.This result suggests that there is widespread adaptation in mammalian conserved noncoding dna elements ( cnes ) in the genome demonstrates that they cluster around genes involved in developmental regulation of crucially important processes, including development.Hcnes from the same area often drive overlapping patterns, suggesting that multiple regulatory inputs are required to achieve robust and precise complex expression patterns exhibited by developmental regulation.Animal genomes possess highly conserved cis-regulatory sequences that are required to achieve robust and precise complex expression patterns exhibited by developmental genes.Further positional analysis of these conserved noncoding elements ( cnes ) in the genome demonstrates that they cluster around genes.This result suggests that there is widespread adaptation in mammalian conserved noncoding dna elements, some of which have been implicated in the regulation and development to each family hcnes of both human and zebrafish function as specific developmental enhancers in zebrafish.", "exact_answer": ["Development"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017124"], "type": "factoid", "id": "51387022bee46bd34c000002", "snippets": [{"offsetInBeginSection": 585, "offsetInEndSection": 677, "text": "HCNEs of both human and zebrafish function as specific developmental enhancers in zebrafish. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19073165", "endSection": "sections.0"}, {"offsetInBeginSection": 1277, "offsetInEndSection": 1412, "text": "The majority of tetrapod-specific UCEs are noncoding and associated with genes involved in regulation of transcription and development. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18056681", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 141, "text": "Animal genomes possess highly conserved cis-regulatory sequences that are often found near genes that regulate transcription and development. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19704032", "endSection": "sections.0"}, {"offsetInBeginSection": 480, "offsetInEndSection": 648, "text": "Further positional analysis of these conserved noncoding elements (CNEs) in the genome demonstrates that they cluster around genes involved in developmental regulation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18282512", "endSection": "sections.0"}, {"offsetInBeginSection": 507, "offsetInEndSection": 681, "text": "Much evidence suggests that CNEs are selectively constrained and not mutational cold-spots, and there is evidence that some CNEs play a role in the regulation of development. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21478460", "endSection": "sections.0"}, {"offsetInBeginSection": 1463, "offsetInEndSection": 1676, "text": "This result suggests that there is widespread adaptation in mammalian conserved noncoding DNA elements, some of which have been implicated in the regulation of crucially important processes, including development. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21478460", "endSection": "sections.0"}, {"offsetInBeginSection": 792, "offsetInEndSection": 955, "text": "In 74% of cases, we were able to assign a specific set of paralogous genes with annotation relating to transcriptional regulation and/or development to each family ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16533910", "endSection": "sections.0"}, {"offsetInBeginSection": 1401, "offsetInEndSection": 1596, "text": "These results suggest important roles for SINEs in the development of the mammalian neuronal network, a part of which was initiated with the exaptation of AmnSINE1 in a common mammalian ancestor. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18334644", "endSection": "sections.0"}, {"offsetInBeginSection": 143, "offsetInEndSection": 345, "text": "Some characteristics of CNEs include their high frequency in mammalian genomes, their potential regulatory role in gene expression, and their enrichment in gene deserts nearby master developmental genes ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21175683", "endSection": "sections.0"}, {"offsetInBeginSection": 1185, "offsetInEndSection": 1391, "text": "HCNEs from the same area often drive overlapping patterns, suggesting that multiple regulatory inputs are required to achieve robust and precise complex expression patterns exhibited by developmental genes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19073165", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 304, "text": "Fish-mammal genomic comparisons have proved powerful in identifying conserved noncoding elements likely to be cis-regulatory in nature, and the majority of those tested in vivo have been shown to act as tissue-specific enhancers associated with genes involved in transcriptional regulation of development ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16533910", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 276, "text": "The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16630819", "endSection": "sections.0"}]}, {"body": "What is the main mechanism by which human papillomavirus proteins E6 and E7 contribute to cell transformation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21980285", "http://www.ncbi.nlm.nih.gov/pubmed/21643539", "http://www.ncbi.nlm.nih.gov/pubmed/9537653", "http://www.ncbi.nlm.nih.gov/pubmed/9223480", "http://www.ncbi.nlm.nih.gov/pubmed/17768080", "http://www.ncbi.nlm.nih.gov/pubmed/17332339", "http://www.ncbi.nlm.nih.gov/pubmed/10809724", "http://www.ncbi.nlm.nih.gov/pubmed/9817205", "http://www.ncbi.nlm.nih.gov/pubmed/8207801", "http://www.ncbi.nlm.nih.gov/pubmed/8397367", "http://www.ncbi.nlm.nih.gov/pubmed/20088881", "http://www.ncbi.nlm.nih.gov/pubmed/16249186", "http://www.ncbi.nlm.nih.gov/pubmed/1331501", "http://www.ncbi.nlm.nih.gov/pubmed/10698500"], "ideal_answer": "The ability of high-risk HPV E6 and E7 protein to promote the degradation of p53 and pRb, respectively, has been suggested as a mechanism by which HPV oncogenes induce cellular transformation.E6 and e7 abrogate cell cycle checkpoints and induce genomic instability that leads to malignant conversion the e7 protein of human papillomavirus type 16 contains an element that binds to prb and appears to be functionally homologous to the e1a sequencesFirst, we found that human papillomavirus E6 and E7 oncogenes, which block the function of the p53 and Rb tumor suppressors, respectively, and SV40 small t antigen were required to allow mutant K-Ras ( 12D ) growth transformation the recognition of a causal relationship between human papillomaviruses and cancer almost 30 years ago led to a rapid expansion of knowledge in the field, resulting in the description of the main mediators of HPV-induced carcinogenesis, the viral proteins E6 and E7.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050725", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0019087"], "type": "summary", "id": "5178444e8ed59a060a000037", "snippets": [{"offsetInBeginSection": 966, "offsetInEndSection": 1053, "text": "Based on these studies we present a mechanistic model for how E7 displaces E2F from pRb ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16249186", "endSection": "sections.0"}, {"offsetInBeginSection": 364, "offsetInEndSection": 498, "text": "a general requirement for oncoproteins such as human papillomavirus E6 and E7 has suggested that the p53 and Rb pathways are targeted. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9817205", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "Transformation by the human papillomavirus (HPV) early gene products, E6 and E7, involves their interaction with cellular proteins p53 and Rb. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8207801", "endSection": "sections.0"}, {"offsetInBeginSection": 185, "offsetInEndSection": 327, "text": "Several of the biological activities of HPV16 E7 are mediated by inactivation of the members of the pocket protein family, pRb, p107 and p130. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10698500", "endSection": "sections.0"}, {"offsetInBeginSection": 614, "offsetInEndSection": 761, "text": "The E7 protein of human papillomavirus type 16 contains an element that binds to pRB and appears to be functionally homologous to the E1A sequences ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1331501", "endSection": "sections.0"}, {"offsetInBeginSection": 1191, "offsetInEndSection": 1331, "text": "the E7-RbAB interaction involves multiple motifs within the N-terminal domain of E7 and at least two conserved interaction surfaces in RbAB. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20088881", "endSection": "sections.0"}, {"offsetInBeginSection": 686, "offsetInEndSection": 891, "text": "The results showed that tumorigenicity and decreased serum requirement were associated with the ability of E6 to bind to p53, although the subsequent degradation of p53 was not required for these functions ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9537653", "endSection": "sections.0"}, {"offsetInBeginSection": 427, "offsetInEndSection": 618, "text": "In recent years, it has become clear that in addition to E6-induced degradation of p53 tumor suppressor protein, other targets of E6 are required for mammary epithelial cells immortalization. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10809724", "endSection": "sections.0"}, {"offsetInBeginSection": 567, "offsetInEndSection": 793, "text": "First, we found that human papillomavirus E6 and E7 oncogenes, which block the function of the p53 and Rb tumor suppressors, respectively, and SV40 small t antigen were required to allow mutant K-Ras(12D) growth transformation ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332339", "endSection": "sections.0"}, {"offsetInBeginSection": 583, "offsetInEndSection": 828, "text": "The E7 mutants chosen had either an in-frame deletion in the conserved region 2 (CR2) domain, which is required for binding of the retinoblastoma tumor suppressor protein (pRb) and pRb-like proteins, or an in-frame deletion in the E7 CR1 domain. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9223480", "endSection": "sections.0"}, {"offsetInBeginSection": 816, "offsetInEndSection": 1116, "text": "The ability of high-risk HPV E6 and E7 protein to promote the degradation of p53 and pRb, respectively, has been suggested as a mechanism by which HPV oncogenes induce cellular transformation. E6 and E7 abrogate cell cycle checkpoints and induce genomic instability that leads to malignant conversion ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21643539", "endSection": "sections.0"}, {"offsetInBeginSection": 1610, "offsetInEndSection": 1939, "text": "The results from this study support the theory that p53 protein binds HPV-16/18 E6 protein in the cell cytoplasm, thus preventing p53 from exerting its tumor-suppressor function in the nucleus. Hence, inactivation of wild-type p53 by p53-E6 complex formation in cervical cancer may be a critical step in malignant transformation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8397367", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 416, "text": "The recognition of a causal relationship between human papillomaviruses and cancer almost 30 years ago led to a rapid expansion of knowledge in the field, resulting in the description of the main mediators of HPV-induced carcinogenesis, the viral proteins E6 and E7. These oncoproteins show a remarkable pleiotropism in binding host-cell proteins, with the tumour suppressor genes p53 and pRb as their major targets. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17768080", "endSection": "sections.0"}]}, {"body": "List bacterial species identified in the iceman tissues.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24941044", "http://www.ncbi.nlm.nih.gov/pubmed/10861348", "http://www.ncbi.nlm.nih.gov/pubmed/10640948"], "triples": [], "ideal_answer": "While the untreated skin still bears the remains of large numbers of bacteria belonging to the genera sphingomonas, afipia, curtobacterium, microbacterium, agromyces, and bacteroides sp.The colon, however, was found to contain, rather unexpectedly, also some members of the fecal flora of humans, such as clostridium perfringens, c. ghonii, c. sordellii, eubacterium tenue, and bacteroides sp.Here, we report the molecular detection of the oral spirochete Treponema denticola in ancient human tissue biopsies of the Iceman, a 5,300-year-old Copper Age natural ice mummy.The iceman's colon, on the other hand, contains several members of the fecal flora of humans, such as clostridium perfringens, c. ghonii, c. sordellii, eubacterium tenue, and bacteroides sp.Here, we report the molecular detection of the oral spirochete treponema denticola in ancient human tissue biopsies of the iceman's colon, however, was found to contain, rather unexpectedly, also some members of the genus vibrio.", "exact_answer": [["Spirochete Treponema denticola"], ["Clostridium perfringens"], ["Clostridium ghonii"], ["Clostridium sordellii"], ["Eubacterium tenue"], ["Bacteroides sp"], ["Vibrio"], ["Sphingomonas"], ["Afipia"], ["Curtobacterium"], ["Microbacterium"], ["Agromyces"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001419", "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004755", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016045"], "type": "list", "id": "56d1fd67f22319765a000002", "snippets": [{"offsetInBeginSection": 643, "offsetInEndSection": 822, "text": " while the untreated skin still bears the remains of large numbers of bacteria belonging to the genera Sphingomonas, Afipia, Curtobacterium, Microbacterium, Agromyces, and others. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10640948", "endSection": "abstract"}, {"offsetInBeginSection": 177, "offsetInEndSection": 355, "text": "Here, we report the molecular detection of the oral spirochete Treponema denticola in ancient human tissue biopsies of the Iceman, a 5,300-year-old Copper Age natural ice mummy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941044", "endSection": "abstract"}, {"offsetInBeginSection": 1207, "offsetInEndSection": 1500, "text": "The colon, on the other hand, contains several members of the fecal flora of humans, such as Clostridium perfringens, C. ghonii, C. sordellii, Eubacterium tenue, and Bacteroides sp. The Iceman's colon, however, was found to contain, rather unexpectedly, also some members of the genus Vibrio. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10861348", "endSection": "abstract"}]}, {"body": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26121403", "http://www.ncbi.nlm.nih.gov/pubmed/25569111", "http://www.ncbi.nlm.nih.gov/pubmed/25475057", "http://www.ncbi.nlm.nih.gov/pubmed/25452335", "http://www.ncbi.nlm.nih.gov/pubmed/25430002", "http://www.ncbi.nlm.nih.gov/pubmed/24981863", "http://www.ncbi.nlm.nih.gov/pubmed/22575960", "http://www.ncbi.nlm.nih.gov/pubmed/19180239", "http://www.ncbi.nlm.nih.gov/pubmed/6318439", "http://www.ncbi.nlm.nih.gov/pubmed/6592581", "http://www.ncbi.nlm.nih.gov/pubmed/3029112", "http://www.ncbi.nlm.nih.gov/pubmed/25412662", "http://www.ncbi.nlm.nih.gov/pubmed/9409616"], "triples": [], "ideal_answer": "Previous studies suggested that m6a affects the efficiency of mrna processing or transport, although the mechanism by which this occurs is not known.The role of fat mass and obesity-associated protein ( fto ) and its substrate n6-methyladenosine ( m6a ) in pre-mrna are important for formation of late simian virus 40 mrnasThe data argues for a role of internal m6a moieties in modulating the processing-linked transport of mrna with potential roles in fine-tuning the rna life cycle.Methylations of adenosine residues ( m6a ) in pre-mrna are important for formation of late simian virus 40 mrnasThe role of fat mass and obesity-associated protein ( fto ) and its substrate n6-methyladenosine ( m6a ) is a common modification of mrna processing and adipogenesis remains largely unknown.Methylations of adenosine residues ( m6a ) in mrna processing and adipogenesis remains largely unknown.Previous studies suggested that m6a affects the efficiency of mrna and has been linked to diverse effects on mrna fate.N ( 6 ) -methyladenosine ( m6a ) is the most abundant modified base in eukaryotic mrna from the nucleus to the cytoplasm of nontransformed cells.", "exact_answer": [["mRNA stability"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012333", "http://www.biosemantics.org/jochem#4252558"], "type": "factoid", "id": "56df03c751531f7e3300000a", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "N6-methyladenosine (m6A) is a common modification of mRNA with potential roles in fine-tuning the RNA life cycle. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24981863", "endSection": "abstract"}, {"offsetInBeginSection": 601, "offsetInEndSection": 722, "text": "m(6)A predominantly and directly reduces mRNA stability, including that of key na\u00efve pluripotency-promoting transcripts. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25569111", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "Methylations of adenosine residues (m6A) in pre-mRNA are important for formation of late simian virus 40 mRNAs ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6318439", "endSection": "title"}, {"offsetInBeginSection": 109, "offsetInEndSection": 248, "text": "The results of that study and of experiments using inhibitors of methylation suggest that m6A might be involved in mRNA processing events. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3029112", "endSection": "abstract"}, {"offsetInBeginSection": 150, "offsetInEndSection": 300, "text": "Previous studies suggested that m6A affects the efficiency of mRNA processing or transport, although the mechanism by which this occurs is not known. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9409616", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 161, "text": "The role of Fat Mass and Obesity-associated protein (FTO) and its substrate N6-methyladenosine (m6A) in mRNA processing and adipogenesis remains largely unknown. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25412662", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "N(6)-methyladenosine (m6A) is the most abundant modified base in eukaryotic mRNA and has been linked to diverse effects on mRNA fate. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26121403", "endSection": "abstract"}, {"offsetInBeginSection": 1328, "offsetInEndSection": 1493, "text": "The data argues for a role of internal m6A moieties in modulating the processing-linked transport of mRNA from the nucleus to the cytoplasm of nontransformed cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6318439", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 206, "text": "N6-Methyladenosine (m6A) residues, which are found internally in viral and cellular mRNA populations at the sequences Apm6ApC and Gpm6ApC, have been proposed to play a role in mRNA processing and transport. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6592581", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 220, "text": "Recent discoveries of reversible N(6)-methyladenosine (m(6)A) methylation on messenger RNA (mRNA) and mapping of m(6)A methylomes in mammals and yeast have revealed potential regulatory functions of this RNA modification ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25430002", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 300, "text": " The methylation of internal adenosine residues in eukaryotic mRNA, forming N6-methyladenosine (m6A), is catalyzed by a complex multicomponent enzyme. Previous studies suggested that m6A affects the efficiency of mRNA processing or transport, although the mechanism by which this occurs is not known. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9409616", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 300, "text": "The methylation of internal adenosine residues in eukaryotic mRNA, forming N6-methyladenosine (m6A), is catalyzed by a complex multicomponent enzyme. Previous studies suggested that m6A affects the efficiency of mRNA processing or transport, although the mechanism by which this occurs is not known. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9409616", "endSection": "abstract"}, {"offsetInBeginSection": 319, "offsetInEndSection": 764, "text": "Monitoring m6A levels upon WTAP depletion allowed the definition of accurate and near single-nucleotide resolution methylation maps and their classification into WTAP-dependent and -independent sites. WTAP-dependent sites are located at internal positions in transcripts, topologically static across a variety of systems we surveyed, and inversely correlated with mRNA stability, consistent with a role in establishing \"basal\" degradation rates. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24981863", "endSection": "abstract"}, {"offsetInBeginSection": 151, "offsetInEndSection": 615, "text": "Previous studies suggested that m6A affects the efficiency of mRNA processing or transport, although the mechanism by which this occurs is not known. As a step toward better understanding the mechanism and function of this ubiquitous posttranscriptional modification, we have shown that HeLa mRNA (N6-adenosine)-methyltransferase requires at least two separate protein factors, MT-A and MT-B, and MT-A contains the AdoMet binding site on a 70-kDa subunit (MT-A70). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9409616", "endSection": "abstract"}]}, {"body": "What is the implication of histone lysine methylation in medulloblastoma?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23184418", "http://www.ncbi.nlm.nih.gov/pubmed/19270706", "http://www.ncbi.nlm.nih.gov/pubmed/23179372"], "triples": [], "ideal_answer": "Consistent with our genetic data, restoration of expression of genes controlling h3k9 methylation greatly diminishes proliferation of medulloblastoma.We identified previously unknown amplifications and homozygous deletions, including recurrent, mutually exclusive, highly focal genetic events in genes targeting histone lysine methylation, particularly that of histone 3, lysine 9 ( H3K9 ).Post-translational modification of histone proteins is critical for regulation of gene expression, can participate in determination of stem cell fates and has been implicated in carcinogenesis.Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.Notably, we also report mutations in histone h3 lysine 27 ( h3k27 ) demethylases in medulloblastomas of group 3 and group 4 % ( 7 ) of tumors.Consistent with our genetic events in genes controlling h3k9 methylation greatly diminishes proliferation of medulloblastoma in vitro copy number aberrations of genes with critical roles in writing, reading, removing and blocking the state of histone lysine methylation, particularly at h3k9, suggest that defective control of the histone code contributes to the pathogenesis of medulloblastoma.", "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0034968", "http://www.disease-ontology.org/api/metadata/DOID:3858", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016571", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0031060", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0051567", "http://www.disease-ontology.org/api/metadata/DOID:3873"], "type": "summary", "id": "5539062dbc4f83e828000013", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23184418", "endSection": "title"}, {"offsetInBeginSection": 925, "offsetInEndSection": 1186, "text": "Copy number aberrations of genes with critical roles in writing, reading, removing and blocking the state of histone lysine methylation, particularly at H3K9, suggest that defective control of the histone code contributes to the pathogenesis of medulloblastoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19270706", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 186, "text": "Recent studies showed frequent mutations in histone H3 lysine 27 (H3K27) demethylases in medulloblastomas of Group 3 and Group 4, suggesting a role for H3K27 methylation in these tumors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23179372", "endSection": "abstract"}, {"offsetInBeginSection": 332, "offsetInEndSection": 923, "text": "we identified previously unknown amplifications and homozygous deletions, including recurrent, mutually exclusive, highly focal genetic events in genes targeting histone lysine methylation, particularly that of histone 3, lysine 9 (H3K9). Post-translational modification of histone proteins is critical for regulation of gene expression, can participate in determination of stem cell fates and has been implicated in carcinogenesis. Consistent with our genetic data, restoration of expression of genes controlling H3K9 methylation greatly diminishes proliferation of medulloblastoma in vitro ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19270706", "endSection": "abstract"}, {"offsetInBeginSection": 280, "offsetInEndSection": 1148, "text": "Through targeted re-sequencing, we identified mutations of MLL2 in 8 % (14/175) of MBs, the majority of which were loss of function. Notably, we also report mutations affecting the MLL2-binding partner KDM6A, in 4 % (7/175) of tumors. While MLL2 mutations were independent of age, gender, histological subtype, M-stage or molecular subgroup, KDM6A mutations were most commonly identified in Group 4 MBs, and were mutually exclusive with MLL2 mutations. Immunohistochemical staining for H3K4me3 and H3K27me3, the chromatin effectors of MLL2 and KDM6A activity, respectively, demonstrated alterations of the histone code in 24 % (53/220) of MBs across all subgroups. Correlating these MLL2- and KDM6A-driven histone marks with prognosis, we identified populations of MB with improved (K4+/K27-) and dismal (K4-/K27-) outcomes, observed primarily within Group 3 and 4 MBs ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23184418", "endSection": "abstract"}]}, {"body": "What is the Orco protein in mosquitos?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23894621", "http://www.ncbi.nlm.nih.gov/pubmed/23719379", "http://www.ncbi.nlm.nih.gov/pubmed/23352695", "http://www.ncbi.nlm.nih.gov/pubmed/23292750", "http://www.ncbi.nlm.nih.gov/pubmed/22272331", "http://www.ncbi.nlm.nih.gov/pubmed/22269900", "http://www.ncbi.nlm.nih.gov/pubmed/21555561", "http://www.ncbi.nlm.nih.gov/pubmed/22174894"], "triples": [], "ideal_answer": "A functional or complex consists of both a conventional odorant-binding or and the orco coreceptor ( orco ) that is highly conserved across insect taxa.A novel or co-receptor ( orco ) that is highly conserved across insect odorant receptors ( ors ) function as odorant-gated ion channels consisting of a conventional odorant-binding or and a nonconventional coreceptor.Surprisingly, mutation of the obligate olfactory coreceptor ( orco ) does not abolish co ( 2 ) aversion during walking yet eliminates co ( 2 ) tracking in flight.A novel or co-receptor ( orco ) insect odorant receptors ( ors ), membrane proteins that form heteromeric odour-gated ion channels consisting of a conventional, odorant-binding or and the orco coreceptor.Orco functions as a non-selective cation channel and is expressed in the majority of olfactory receptor neurons ( orns ).Insects sense odours via several chemosensory receptor families, including the odorant receptors ( ors ) function as odorant-gated ion channels comprising a variable ligand-selective subunit and an obligate co-receptor called orco in insects, odor cues are discriminated through a divergent family of odorant receptors ( ors ).", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009033", "http://www.uniprot.org/uniprot/OR83B_DROME"], "type": "summary", "id": "54f616cd5f206a0c0600000c", "snippets": [{"offsetInBeginSection": 292, "offsetInEndSection": 321, "text": "a novel OR co-receptor (Orco) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22269900", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 156, "text": "Insect odorant receptors (ORs) function as odorant-gated ion channels consisting of a conventional, odorant-binding OR and the Orco coreceptor. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22174894", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 174, "text": "Insect odorant receptors function as heteromeric odorant-gated cation channels comprising a conventional odorant-sensitive tuning receptor, and a conserved co-receptor (Orco) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23894621", "endSection": "abstract"}, {"offsetInBeginSection": 649, "offsetInEndSection": 804, "text": "Surprisingly, mutation of the obligate olfactory coreceptor (Orco) does not abolish CO(2) aversion during walking yet eliminates CO(2) tracking in flight. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23352695", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 255, "text": "In insects, odor cues are discriminated through a divergent family of odorant receptors (ORs). A functional OR complex consists of both a conventional odorant-binding OR and a nonconventional coreceptor (Orco) that is highly conserved across insect taxa. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21555561", "endSection": "abstract"}, {"offsetInBeginSection": 498, "offsetInEndSection": 753, "text": "Insects sense odours via several chemosensory receptor families, including the odorant receptors (ORs), membrane proteins that form heteromeric odour-gated ion channels comprising a variable ligand-selective subunit and an obligate co-receptor called Orco ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23719379", "endSection": "abstract"}, {"offsetInBeginSection": 183, "offsetInEndSection": 547, "text": " Most odors are detected via a family of odorant receptors (ORs), which form heteromeric complexes consisting of a well-conserved OR co-receptor (Orco) ion channel and a non-conserved tuning OR that provides coding specificity to each complex. Orco functions as a non-selective cation channel and is expressed in the majority of olfactory receptor neurons (ORNs). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22272331", "endSection": "abstract"}]}, {"body": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20471717", "http://www.ncbi.nlm.nih.gov/pubmed/18755209", "http://www.ncbi.nlm.nih.gov/pubmed/16806196", "http://www.ncbi.nlm.nih.gov/pubmed/16687499", "http://www.ncbi.nlm.nih.gov/pubmed/12212772"], "ideal_answer": "Involvement of i2pp2a in the abnormal hyperphosphorylation were dramatically reduced in hucb-msc transplanted app mice administration of 7-nitroindazole to cms-exposed old rats significantly ( p=0.002 ) increased gad activity, decreased glutamate levels ( 7.19+ vs. 763.9+ micromol tissue protein; p=0.0005 ), and decreased phosphorylation of tau proteins compared to cms exposed rats.Here, we show that transgene shutdown in symptomatic mice leads to normal gsk-3 activity, normal phospho-tau levels, diminished neuronal death, and suppression of the cognitive deficit, thus further supporting the potential of gsk-3 inhibitors for ad therapeutics.", "exact_answer": [["Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) transplantation"], ["Administration of 7-nitroindazole  (neuronal nitric oxide synthase inhibitor)"], ["Administration of Memantine  (un-competitive inhibitor of N-methyl-D-aspartate receptors)"], ["Administration glycogen synthase kinase-3  (GSK-3) inhibitors"], ["Administration of M1 muscarinic agonists such as AF150(S) and AF267B"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016875", "http://www.uniprot.org/uniprot/TAU_HUMAN", "http://www.uniprot.org/uniprot/TAU_MOUSE", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0016310", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010766", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0042327"], "type": "list", "id": "517775c78ed59a060a000033", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16806196", "endSection": "title"}, {"offsetInBeginSection": 529, "offsetInEndSection": 617, "text": "tau hyperphosphorylation were dramatically reduced in hUCB-MSC transplanted APP/PS1 mice ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20471717", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16687499", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 221, "text": "Changes in glutamate decarboxylase enzyme activity and tau-protein phosphorylation in the hippocampus of old rats exposed to chronic mild stress: reversal with the neuronal nitric oxide synthase inhibitor 7-nitroindazole. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18755209", "endSection": "title"}, {"offsetInBeginSection": 524, "offsetInEndSection": 795, "text": "These effects can be combined with the beneficial effects of these compounds on some other major hallmarks of Alzheimer's disease (AD) (e.g. tau hyperphosphorylation and paired helical filaments [PHF]; and loss of cholinergic function conducive to cognitive impairments.) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12212772", "endSection": "sections.0"}, {"offsetInBeginSection": 1590, "offsetInEndSection": 1854, "text": "Here, we show that transgene shutdown in symptomatic mice leads to normal GSK-3 activity, normal phospho-tau levels, diminished neuronal death, and suppression of the cognitive deficit, thus further supporting the potential of GSK-3 inhibitors for AD therapeutics. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16687499", "endSection": "sections.0"}, {"offsetInBeginSection": 1110, "offsetInEndSection": 1384, "text": "Administration of 7-nitroindazole to CMS-exposed old rats significantly (p=0.002) increased GAD activity, decreased glutamate levels (7.19+/-3.19 vs. 763.9+/-91 micromol/g tissue protein; p=0.0005), and decreased phosphorylation of tau proteins compared to CMS exposed rats. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18755209", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 522, "text": "The M1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren's Syndrome), AF150(S) and AF267B--1) are neurotrophic and synergistic with neurotrophins such as nerve growth factor and epidermal growth factor; 2) elevate the non-amyloidogenic amyloid precursor protein (alpha-APPs) in vitro and decrease beta-amyloid (A beta) levels in vitro and in vivo; and 3) inhibit A beta- and oxidative-stress-induced cell death and apoptosis in PC12 cells transfected with the M1 muscarinic receptor ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12212772", "endSection": "sections.0"}]}, {"body": "What is the role of 5hmC (5 hydroxy-methyl-Cytocine) in differentiation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22722204", "http://www.ncbi.nlm.nih.gov/pubmed/22234893", "http://www.ncbi.nlm.nih.gov/pubmed/21514197", "http://www.ncbi.nlm.nih.gov/pubmed/26275994", "http://www.ncbi.nlm.nih.gov/pubmed/24838624", "http://www.ncbi.nlm.nih.gov/pubmed/25263596", "http://www.ncbi.nlm.nih.gov/pubmed/24735881", "http://www.ncbi.nlm.nih.gov/pubmed/25071199", "http://www.ncbi.nlm.nih.gov/pubmed/22730288", "http://www.ncbi.nlm.nih.gov/pubmed/21460836", "http://www.ncbi.nlm.nih.gov/pubmed/21873190"], "triples": [], "ideal_answer": "5-hydroxymethylcytosine ( 5hmc ), converted from 5-methylcytocine ( 5mc ) by tet family of dioxygenases ( tet1, tet2, and tet3 ), is enriched in the embryonic stem cells ( escs ) and in the brain however, the role of 5hmc and tet family in the process of esc differentiation especially neuronal differentiation remains elusive in this study, we show by genome-wide mapping that the newly discovered deoxyribonucleic acid ( dna ) modification 5-hydroxymethylcytosine ( 5hmc ) is dynamically associated with transcription factor binding to distal regulatory sites during neural differentiation of mouse p19 cells and during adipocyte differentiation of mouse 3t3-l1 cells the modification of dna by 5-methylcytosine ( 5mc ) has essential roles in cell differentiation and development through epigenetic gene regulation.5-hydroxy methyl cytosine ( 5hmC ) is a modification identified in vertebrates several decades ago.We show that 5hmc is enriched in the gene body of highly expressed genes at all developmental stages and that its presence correlates positively with gene expression.Dynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers", "concepts": [], "type": "summary", "id": "56c5ade15795f9a73e000003", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 117, "text": "5-Methylcytosine (5 mC) in genomic DNA has important epigenetic functions in embryonic development and tumor biology. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22234893", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 94, "text": "Dynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22730288", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 78, "text": "Loss of Tet enzymes compromises proper differentiation of embryonic stem cells ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24735881", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25263596", "endSection": "title"}, {"offsetInBeginSection": 457, "offsetInEndSection": 586, "text": "We found that Tet3 expression is basically undetectable in ESCs, but its level increases rapidly during neuronal differentiation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24838624", "endSection": "abstract"}, {"offsetInBeginSection": 786, "offsetInEndSection": 926, "text": "Our data constitute a valuable resource that will facilitate detailed analysis of the role of 5hmC in T-cell development and differentiation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25071199", "endSection": "abstract"}, {"offsetInBeginSection": 288, "offsetInEndSection": 434, "text": "Notably, the balance between 5hmC and 5mC in the genome is linked with cell-differentiation processes such as pluripotency and lineage commitment. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22722204", "endSection": "abstract"}, {"offsetInBeginSection": 189, "offsetInEndSection": 319, "text": "However, the role of 5hmC and Tet family in the process of ESC differentiation especially neuronal differentiation remains elusive ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24838624", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "The modification of DNA by 5-methylcytosine (5mC) has essential roles in cell differentiation and development through epigenetic gene regulation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22722204", "endSection": "abstract"}, {"offsetInBeginSection": 967, "offsetInEndSection": 1132, "text": "These findings suggest a requirement for Tet- and 5hmC-mediated DNA demethylation in proper regulation of gene expression during ESC differentiation and development. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24735881", "endSection": "abstract"}, {"offsetInBeginSection": 768, "offsetInEndSection": 908, "text": "Consequently, Tet1 and Tet2 deletion led to Foxp3 hypermethylation, impaired Treg cell differentiation and function, and autoimmune disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275994", "endSection": "abstract"}, {"offsetInBeginSection": 320, "offsetInEndSection": 486, "text": "We show that 5hmC is enriched in the gene body of highly expressed genes at all developmental stages and that its presence correlates positively with gene expression. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25071199", "endSection": "abstract"}, {"offsetInBeginSection": 293, "offsetInEndSection": 496, "text": "Recent experiments have demonstrated that enhancers are enriched for 5-hydroxymethylcytosine (5hmC), an oxidization product of the Tet family of 5mC dioxygenases and an intermediate of DNA demethylation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25263596", "endSection": "abstract"}, {"offsetInBeginSection": 577, "offsetInEndSection": 766, "text": "Tet1 and Tet2 catalyzed conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in Foxp3 to establish a Treg-cell-specific hypomethylation pattern and stable Foxp3 expression ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275994", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 187, "text": "5-Hydroxymethylcytosine (5hmC), converted from 5-methylcytocine (5mC) by Tet family of dioxygenases (Tet1, Tet2, and Tet3), is enriched in the embryonic stem cells (ESCs) and in the brain ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24838624", "endSection": "abstract"}, {"offsetInBeginSection": 623, "offsetInEndSection": 828, "text": "We find that 5hmC is mostly associated with euchromatin and that whereas 5mC is under-represented at gene promoters and CpG islands, 5hmC is enriched and is associated with increased transcriptional levels ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21460836", "endSection": "abstract"}, {"offsetInBeginSection": 842, "offsetInEndSection": 1054, "text": "This Tet1-mediated antagonism of CpG methylation imparts differential maintenance of DNA methylation status at Tet1 targets, ultimately contributing to mESC differentiation and the onset of embryonic development. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21514197", "endSection": "abstract"}, {"offsetInBeginSection": 1352, "offsetInEndSection": 1562, "text": "Hence, acquisition of 5hmC in cell-specific distal regulatory regions may represent a major event of enhancer progression toward an active state and participate in selective activation of tissue-specific genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22730288", "endSection": "abstract"}, {"offsetInBeginSection": 610, "offsetInEndSection": 892, "text": "By mapping DNA methylation and hydroxymethylation at base resolution, we find that deletion of Tet2 causes extensive loss of 5hmC at enhancers, accompanied by enhancer hypermethylation, reduction of enhancer activity, and delayed gene induction in the early steps of differentiation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25263596", "endSection": "abstract"}, {"offsetInBeginSection": 981, "offsetInEndSection": 1300, "text": "Knockdown of Tet1 and Tet2 causes downregulation of a group of genes that includes pluripotency-related genes (including Esrrb, Prdm14, Dppa3, Klf2, Tcl1 and Zfp42) and a concomitant increase in methylation of their promoters, together with an increased propensity of ES cells for extraembryonic lineage differentiation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21460836", "endSection": "abstract"}, {"offsetInBeginSection": 98, "offsetInEndSection": 367, "text": "More recently, a possible role of 5hmC as an epigenetic modifier and/or transcriptional regulator has started to emerge, with altered levels in early embryonic development, embryonic stem (ES) cell differentiation and tumours (Tahiliani et al, 2009; Yang et al, 2012). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23403924", "endSection": "abstract"}, {"offsetInBeginSection": 168, "offsetInEndSection": 506, "text": "In this study, we show by genome-wide mapping that the newly discovered deoxyribonucleic acid (DNA) modification 5-hydroxymethylcytosine (5hmC) is dynamically associated with transcription factor binding to distal regulatory sites during neural differentiation of mouse P19 cells and during adipocyte differentiation of mouse 3T3-L1 cells ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22730288", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 367, "text": "5-hydroxy methyl cytosine (5hmC) is a modification identified in vertebrates several decades ago. More recently, a possible role of 5hmC as an epigenetic modifier and/or transcriptional regulator has started to emerge, with altered levels in early embryonic development, embryonic stem (ES) cell differentiation and tumours (Tahiliani et al, 2009; Yang et al, 2012). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23403924", "endSection": "abstract"}, {"offsetInBeginSection": 597, "offsetInEndSection": 991, "text": " Tet2 deficiency led to decreased genomic levels of 5hmC and augmented the size of the hematopoietic stem/progenitor cell pool in a cell-autonomous manner. In competitive transplantation assays, Tet2-deficient HSCs were capable of multilineage reconstitution and possessed a competitive advantage over wild-type HSCs, resulting in enhanced hematopoiesis into both lymphoid and myeloid lineages. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21873190", "endSection": "abstract"}, {"offsetInBeginSection": 300, "offsetInEndSection": 896, "text": "Here we report a method that combines TET-assisted bisulfite conversion with Illumina 450K DNA methylation arrays for a low-cost high-throughput approach that distinguishes 5hmC and 5mC signals at base resolution. Implementing this approach, termed \"TAB-array\", we assessed DNA methylation dynamics in the differentiation of human pluripotent stem cells into cardiovascular progenitors and neural precursor cells. With the ability to discriminate 5mC and 5hmC, we identified a large number of novel dynamically methylated genomic regions that are implicated in the development of these lineages. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25179373", "endSection": "abstract"}]}, {"body": "Which is the histone residue methylated by MLL1?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23399917", "http://www.ncbi.nlm.nih.gov/pubmed/23038103", "http://www.ncbi.nlm.nih.gov/pubmed/22666422", "http://www.ncbi.nlm.nih.gov/pubmed/22488473", "http://www.ncbi.nlm.nih.gov/pubmed/22046413", "http://www.ncbi.nlm.nih.gov/pubmed/21875999", "http://www.ncbi.nlm.nih.gov/pubmed/21124902", "http://www.ncbi.nlm.nih.gov/pubmed/21113167", "http://www.ncbi.nlm.nih.gov/pubmed/20861184", "http://www.ncbi.nlm.nih.gov/pubmed/19855399", "http://www.ncbi.nlm.nih.gov/pubmed/19818711", "http://www.ncbi.nlm.nih.gov/pubmed/19481096", "http://www.ncbi.nlm.nih.gov/pubmed/19219072", "http://www.ncbi.nlm.nih.gov/pubmed/19187761", "http://www.ncbi.nlm.nih.gov/pubmed/18838538", "http://www.ncbi.nlm.nih.gov/pubmed/18562676", "http://www.ncbi.nlm.nih.gov/pubmed/17942719", "http://www.ncbi.nlm.nih.gov/pubmed/17168535", "http://www.ncbi.nlm.nih.gov/pubmed/16651450", "http://www.ncbi.nlm.nih.gov/pubmed/15960975", "http://www.ncbi.nlm.nih.gov/pubmed/15941828"], "triples": [], "ideal_answer": "All of these histone methyltransferases regulate methylation of lysine 4 of histone h3, which is a signature of actively transcribed genes mutations in the mll1 set domain that fail to support overall h3 k4 methylation the biological function of mll1 is mediated by the histone h3k4 methyltransferase activity of the carboxyl-terminal set domain.Trimethylated H3K4 histones and histone methyltransferase MLL1 h3K4 ) in Saccharomyces cerevisiae is implemented by Set1, which was originally purified based on the similarity of yeast Set1 to human MLL1 and Drosophila melanogaster Trithorax ( Trx ) histone H3K4me3 methylase MLL1 complex in the human MLL1 ( mixed-lineage leukemia-1 ) HMT complex, DPY-30L binds to the BRE2 homolog ASH2L in order to regulate histone 3-lysine 4 trimethylation.", "exact_answer": ["H3K4"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011495", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0042054", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0018024", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0042800", "http://www.uniprot.org/uniprot/MLL1_MOUSE", "http://www.uniprot.org/uniprot/MLL1_HUMAN", "http://www.uniprot.org/uniprot/SETMR_HUMAN"], "type": "factoid", "id": "533be71dfd9a95ea0d000009", "snippets": [{"offsetInBeginSection": 52, "offsetInEndSection": 80, "text": "H3 K4 methyltransferase MLL1 ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960975", "endSection": "title"}, {"offsetInBeginSection": 216, "offsetInEndSection": 264, "text": "MLL1 histone methyltransferase (H3K4me3) complex ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19818711", "endSection": "abstract"}, {"offsetInBeginSection": 1408, "offsetInEndSection": 1446, "text": "histone H3K4me3 methylase MLL1 complex ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23038103", "endSection": "abstract"}, {"offsetInBeginSection": 1478, "offsetInEndSection": 1541, "text": " trimethylated H3K4 histones and histone methyltransferase MLL1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18562676", "endSection": "abstract"}, {"offsetInBeginSection": 998, "offsetInEndSection": 1046, "text": "MLL1 histone H3 Lys4 methyltransferase complexes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19855399", "endSection": "abstract"}, {"offsetInBeginSection": 105, "offsetInEndSection": 169, "text": "effectors of H3K4 methylation is mixed-lineage leukemia 1 (MLL1) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17168535", "endSection": "abstract"}, {"offsetInBeginSection": 120, "offsetInEndSection": 204, "text": "MLL1/MLL2 histone methyltransferase complexes specific for Lys4 of histone H3 (H3K4) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16651450", "endSection": "abstract"}, {"offsetInBeginSection": 807, "offsetInEndSection": 897, "text": "MLL1 (Mixed Lineage Leukemia 1), a histone methyltransferase that methylates H3K4 residues ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22046413", "endSection": "abstract"}, {"offsetInBeginSection": 436, "offsetInEndSection": 562, "text": "MLL1, a mammalian homolog of Drosophila trithorax, is an H3K4-specific methyltransferase implicated in transcriptional control ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21113167", "endSection": "abstract"}, {"offsetInBeginSection": 928, "offsetInEndSection": 1007, "text": "Mutations in the MLL1 SET domain that fail to support overall H3 K4 methylation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21124902", "endSection": "abstract"}, {"offsetInBeginSection": 771, "offsetInEndSection": 894, "text": "lack of interaction with the histone methyltransferase, MLL1, resulting in decreased histone H3K4me3 and gene transcription ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23399917", "endSection": "abstract"}, {"offsetInBeginSection": 134, "offsetInEndSection": 261, "text": "The biological function of MLL1 is mediated by the histone H3K4 methyltransferase activity of the carboxyl-terminal SET domain. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19187761", "endSection": "abstract"}, {"offsetInBeginSection": 724, "offsetInEndSection": 827, "text": "We show that the mixed lineage leukemia 1 (MLL1) protein, a histone methyltransferase specific for H3K4 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20861184", "endSection": "abstract"}, {"offsetInBeginSection": 374, "offsetInEndSection": 508, "text": "purified complex has a robust MLL1-mediated histone methyltransferase activity that can effect mono-, di-, and trimethylation of H3 K4 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960975", "endSection": "abstract"}, {"offsetInBeginSection": 165, "offsetInEndSection": 304, "text": "MEN1 encodes menin, a subunit of MLL1/MLL2-containing histone methyltransferase complexes that trimethylate histone H3 at lysine 4 (H3K4me3 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22666422", "endSection": "abstract"}, {"offsetInBeginSection": 936, "offsetInEndSection": 1097, "text": "MLL1 and MLL2 H3K4 methyltransferase complexes are tethered by p52 on the MMP9 but not on the IkappaBalpha promoter, and the H3K4 trimethyltransferase activity r ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19219072", "endSection": "abstract"}, {"offsetInBeginSection": 315, "offsetInEndSection": 468, "text": "In the human MLL1 (mixed-lineage leukemia-1) HMT complex, DPY-30L binds to the BRE2 homolog ASH2L in order to regulate histone 3-lysine 4 trimethylation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19481096", "endSection": "abstract"}, {"offsetInBeginSection": 640, "offsetInEndSection": 815, "text": " lacZ knock-in allele of mixed-lineage leukemia 1 (Mll1), a histone methyltransferase expressed in GABAergic and other cortical neurons, resulted in decreased H3K4 methylation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17942719", "endSection": "abstract"}, {"offsetInBeginSection": 36, "offsetInEndSection": 227, "text": "H3K4) in Saccharomyces cerevisiae is implemented by Set1/COMPASS, which was originally purified based on the similarity of yeast Set1 to human MLL1 and Drosophila melanogaster Trithorax (Trx) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21875999", "endSection": "abstract"}, {"offsetInBeginSection": 1, "offsetInEndSection": 170, "text": "istone H3 lysine 4 (K4) methylation is a prevalent mark associated with transcription activation and is mainly catalyzed by the MLL/SET1 family histone methyltransferase ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21124902", "endSection": "abstract"}, {"offsetInBeginSection": 362, "offsetInEndSection": 501, "text": "MLL1 localizes with RNA polymerase II (Pol II) to the 5' end of actively transcribed genes, where histone H3 lysine 4 trimethylation occurs ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15941828", "endSection": "abstract"}, {"offsetInBeginSection": 610, "offsetInEndSection": 837, "text": "MLL1, MLL5, Set1 and ASH1 to be highly up-regulated during transdifferentiation of HSCs. All of these histone methyltransferases regulate methylation of lysine 4 of histone H3, which is a signature of actively transcribed genes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22488473", "endSection": "abstract"}, {"offsetInBeginSection": 37, "offsetInEndSection": 313, "text": "Set1/COMPASS is capable of methylating H3K4, a posttranslational modification associated with actively transcribed genes. There is only one Set1 in yeast; yet in mammalian cells there are multiple H3K4 methylases, including Set1A/B, forming human COMPASS complexes, and MLL1-4 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18838538", "endSection": "abstract"}]}, {"body": "What is CRISPRi?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25566532", "http://www.ncbi.nlm.nih.gov/pubmed/24136345", "http://www.ncbi.nlm.nih.gov/pubmed/26080438", "http://www.ncbi.nlm.nih.gov/pubmed/23452860", "http://www.ncbi.nlm.nih.gov/pubmed/23849981", "http://www.ncbi.nlm.nih.gov/pubmed/26047700", "http://www.ncbi.nlm.nih.gov/pubmed/26098216", "http://www.ncbi.nlm.nih.gov/pubmed/25409531"], "triples": [], "ideal_answer": "( CRISPRi ), for targeted silencing of transcription in bacteria and human cells.CRISPRi can be used to repress multiple target genes simultaneously, and its effects are reversible.Crispr interference ( crispri ) the crispri system is derived from the streptococcus pyogenes crispr ( clustered regularly interspaced palindromic repeats ) pathway, requiring only the coexpression of a catalytically inactive cas9 protein and a customizable single guide rna ( sgrna ).Crispri provides a simplified approach for rapid gene repression within 1-2 weeks.Genetic screening based on loss-of-function phenotypes is a powerful discovery tool in biology e2f8, were most highly upregulated in miR-142-deficient cells.", "concepts": [], "type": "summary", "id": "56f157a52ac5ed1459000011", "snippets": [{"offsetInBeginSection": 1052, "offsetInEndSection": 1081, "text": "CRISPR interference (CRISPRi) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26080438", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 79, "text": "CRISPR interference (CRISPRi) for sequence-specific control of gene expression. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24136345", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 78, "text": "CRISPR interference (CRISPRi) for sequence-specific control of gene expression ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24136345", "endSection": "title"}, {"offsetInBeginSection": 1276, "offsetInEndSection": 1350, "text": "Clustered regularly interspaced palindromic repeats interference (CRISPRi) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26047700", "endSection": "abstract"}, {"offsetInBeginSection": 222, "offsetInEndSection": 322, "text": "CRISPR interference (CRISPRi), for targeted silencing of transcription in bacteria and human cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24136345", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 94, "text": "Genetic screening based on loss-of-function phenotypes is a powerful discovery tool in biology ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26080438", "endSection": "abstract"}, {"offsetInBeginSection": 756, "offsetInEndSection": 873, "text": "RNA-seq analysis indicates that CRISPR interference (CRISPRi)-mediated transcriptional repression is highly specific. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23849981", "endSection": "abstract"}, {"offsetInBeginSection": 946, "offsetInEndSection": 1117, "text": "E2f8, were most highly upregulated in miR-142-deficient cells. Clustered regularly interspaced short palindromic repeat interference-mediated (CRISPRi-mediated) silencing ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26098216", "endSection": "abstract"}, {"offsetInBeginSection": 540, "offsetInEndSection": 678, "text": " a new system for genome engineering based on the bacterial CRISPR-Cas9 system (Clustered Regularly Interspaced Short Palindromic Repeats) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566532", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 173, "text": "Sequence-specific control of gene expression on a genome-wide scale is an important approach for understanding gene functions and for engineering genetic regulatory systems. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24136345", "endSection": "abstract"}, {"offsetInBeginSection": 95, "offsetInEndSection": 251, "text": " Although the recent development of clustered regularly interspaced short palindromic repeats (CRISPR)-based screening approaches in mammalian cell culture ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26080438", "endSection": "abstract"}, {"offsetInBeginSection": 534, "offsetInEndSection": 805, "text": "This system, which we call CRISPR interference (CRISPRi), can efficiently repress expression of targeted genes in Escherichia coli, with no detectable off-target effects. CRISPRi can be used to repress multiple target genes simultaneously, and its effects are reversible. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23452860", "endSection": "abstract"}, {"offsetInBeginSection": 462, "offsetInEndSection": 709, "text": "We show that delivery of the CRISPRi system is successful and can specifically repress a reporter gene in recipient cells, thereby establishing a new tool for gene regulation across bacterial cells and potentially for bacterial population control. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25409531", "endSection": "abstract"}, {"offsetInBeginSection": 761, "offsetInEndSection": 1041, "text": "Our results establish that the CRISPR system can be used as a modular and flexible DNA-binding platform for the recruitment of proteins to a target DNA sequence, revealing the potential of CRISPRi as a general tool for the precise regulation of gene expression in eukaryotic cells ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23849981", "endSection": "abstract"}, {"offsetInBeginSection": 526, "offsetInEndSection": 823, "text": "More recently, a new system for genome engineering based on the bacterial CRISPR-Cas9 system (Clustered Regularly Interspaced Short Palindromic Repeats), was shown to have the potential to also regulate gene expression at both transcriptional and post-transcriptional level in a more specific way. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566532", "endSection": "abstract"}, {"offsetInBeginSection": 175, "offsetInEndSection": 572, "text": "We have recently described an RNA-based method, CRISPR interference (CRISPRi), for targeted silencing of transcription in bacteria and human cells. The CRISPRi system is derived from the Streptococcus pyogenes CRISPR (clustered regularly interspaced palindromic repeats) pathway, requiring only the coexpression of a catalytically inactive Cas9 protein and a customizable single guide RNA (sgRNA). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24136345", "endSection": "abstract"}, {"offsetInBeginSection": 1073, "offsetInEndSection": 1388, "text": "CRISPRi provides a simplified approach for rapid gene repression within 1-2 weeks. The method can also be adapted for high-throughput interrogation of genome-wide gene functions and genetic interactions, thus providing a complementary approach to RNA interference, which can be used in a wider variety of organisms. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24136345", "endSection": "abstract"}, {"offsetInBeginSection": 242, "offsetInEndSection": 770, "text": "(CRISPRi), for targeted silencing of transcription in bacteria and human cells. The CRISPRi system is derived from the Streptococcus pyogenes CRISPR (clustered regularly interspaced palindromic repeats) pathway, requiring only the coexpression of a catalytically inactive Cas9 protein and a customizable single guide RNA (sgRNA). The Cas9-sgRNA complex binds to DNA elements complementary to the sgRNA and causes a steric block that halts transcript elongation by RNA polymerase, resulting in the repression of the target gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24136345", "endSection": "abstract"}]}, {"body": "Which type of cells is affected in Amyotrophic Lateral Sclerosis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24269728", "http://www.ncbi.nlm.nih.gov/pubmed/24971881", "http://www.ncbi.nlm.nih.gov/pubmed/22797053", "http://www.ncbi.nlm.nih.gov/pubmed/22900096", "http://www.ncbi.nlm.nih.gov/pubmed/23197818", "http://www.ncbi.nlm.nih.gov/pubmed/23114367", "http://www.ncbi.nlm.nih.gov/pubmed/25384799", "http://www.ncbi.nlm.nih.gov/pubmed/20846186"], "triples": [], "ideal_answer": "Early muscle abnormalities that precede motor neuron loss in als.Amyotrophic lateral sclerosis is the most common adult-onset motor neuron loss in als may destabilize neuromuscular junctions, and we have previously demonstrated alterations in myogenic regulatory factor ( mrf ) expression in vivo and in the activation of myofiber-associated skeletal muscle satellite cells influence disease progression in amyotrophic lateral sclerosis, spasticity is traditionally thought to be the result of degeneration of the upper motor neurons in the cerebral cortex, although degeneration of other neuronal types, in particular serotonergic neurons, might also represent a cause of spasticity.Amyotrophic lateral sclerosis ( als ), affecting the motoneurones of the central nervous system ( cns ), stem cell-based therapy aims to replace dying host motoneurones by transplantation of cells in disease-affected regions we report that both small ubiquitin-like modifier ( sumo ) 1 and sumo2 modify als-linked sod1 mutant proteins at lysine 75 in a motoneuronal cell line, the cell type affected in als.Stem cell research raises hopes for incurable neurodegenerative diseases.", "exact_answer": [["Motor neurons"]], "concepts": [], "type": "factoid", "id": "56c8274f5795f9a73e00000d", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor neurons. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22900096", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 172, "text": "Activation of microglia, CNS resident immune cells, is a pathological hallmark of amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder affecting motor neurons. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24269728", "endSection": "abstract"}, {"offsetInBeginSection": 194, "offsetInEndSection": 376, "text": "We report that both small ubiquitin-like modifier (SUMO) 1 and SUMO2/3 modify ALS-linked SOD1 mutant proteins at lysine 75 in a motoneuronal cell line, the cell type affected in ALS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24971881", "endSection": "abstract"}, {"offsetInBeginSection": 74, "offsetInEndSection": 297, "text": "In amyotrophic lateral sclerosis (ALS), affecting the motoneurones of the central nervous system (CNS), stem cell-based therapy aims to replace dying host motoneurones by transplantation of cells in disease-affected regions ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846186", "endSection": "abstract"}, {"offsetInBeginSection": 123, "offsetInEndSection": 348, "text": "In the ALS motor neurons, TAR DNA-binding protein of 43 kDa (TDP-43) is dislocated from the nucleus to cytoplasm and forms inclusions, suggesting that loss of a nuclear function of TDP-43 may underlie the pathogenesis of ALS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22900096", "endSection": "abstract"}, {"offsetInBeginSection": 201, "offsetInEndSection": 482, "text": "In amyotrophic lateral sclerosis, spasticity is traditionally thought to be the result of degeneration of the upper motor neurons in the cerebral cortex, although degeneration of other neuronal types, in particular serotonergic neurons, might also represent a cause of spasticity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114367", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 285, "text": "Amyotrophic lateral sclerosis is the most common adult-onset motor neuron disease and evidence from mice expressing amyotrophic lateral sclerosis-causing SOD1 mutations suggest that neurodegeneration is a non-cell autonomous process where microglial cells influence disease progression ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25384799", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 299, "text": "Stem cell research raises hopes for incurable neurodegenerative diseases. In amyotrophic lateral sclerosis (ALS), affecting the motoneurones of the central nervous system (CNS), stem cell-based therapy aims to replace dying host motoneurones by transplantation of cells in disease-affected regions. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846186", "endSection": "abstract"}, {"offsetInBeginSection": 541, "offsetInEndSection": 979, "text": "Development of an in vitro model system for ALS is expected to help in obtaining novel insights into disease mechanisms and discovery of therapeutics. We report the establishment of an in vitro FALS model from human embryonic stem cells overexpressing either a wild-type (WT) or a mutant SOD1 (G93A) gene and the evaluation of the phenotypes and survival of the spinal motor neurons (sMNs), which are the neurons affected in ALS patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23197818", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 504, "text": "Amyotrophic lateral sclerosis (ALS) is the most common adult-onset neurodegenerative disease characterized by ascending muscle weakness, atrophy and paralysis. Early muscle abnormalities that precede motor neuron loss in ALS may destabilize neuromuscular junctions, and we have previously demonstrated alterations in myogenic regulatory factor (MRF) expression in vivo and in the activation of myofiber-associated skeletal muscle satellite cells (SMSCs) in the mouse model of ALS (SOD1-G93A). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22797053", "endSection": "abstract"}]}, {"body": "Is Achondroplasia associated with hearing loss?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22628261", "http://www.ncbi.nlm.nih.gov/pubmed/22183904", "http://www.ncbi.nlm.nih.gov/pubmed/18328977", "http://www.ncbi.nlm.nih.gov/pubmed/9733026", "http://www.ncbi.nlm.nih.gov/pubmed/8267016", "http://www.ncbi.nlm.nih.gov/pubmed/8456822", "http://www.ncbi.nlm.nih.gov/pubmed/3143244", "http://www.ncbi.nlm.nih.gov/pubmed/3240244"], "triples": [], "ideal_answer": "Fourteen children with achondroplasia had normal tympanograms ( 42 % ); 11 had bilateral abnormal tympanograms ( 33 % ); and 8 had unilateral abnormal tympanograms ( 24 % ).The phenotype is characterized by rhizomelic disproportionate short stature, enlarged head, midface hypoplasia, short hands and lordotic lumbar spine, associated with normal cognitive development.This partial deficiency is probably related to frequent middle ear infections and resulting conductive hearing loss in achondroplasia is not due to sequelae of otitis media as some authors have suggested.This partial deficiency is probably related to frequent middle ear infections and resulting conductive hearing loss.We believe that the persistent hearing loss.Achondroplasia ( mim 100800 ) is the most common non-lethal skeletal dysplasia.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D034381", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000130", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006313", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006315", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D054062", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D046089", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006309", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006311", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0007605", "http://www.disease-ontology.org/api/metadata/DOID:4480", "http://www.disease-ontology.org/api/metadata/DOID:10003"], "type": "yesno", "id": "52b2efcb4003448f55000005", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 165, "text": "The AA report a clinical and radiological study performed in 18 achondroplastic patients in order to achieve a nosological settlement of the otological impairments. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3240244", "endSection": "abstract"}, {"offsetInBeginSection": 316, "offsetInEndSection": 512, "text": "In order to determine whether these morphologic changes are the cause of the hearing deficit in achondroplasia, audiometric studies and ENT evaluation were performed in eight of the nine patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8456822", "endSection": "abstract"}, {"offsetInBeginSection": 1270, "offsetInEndSection": 1483, "text": "We conclude that verbal comprehension is significantly impaired in children with achondroplasia. This partial deficiency is probably related to frequent middle ear infections and resulting conductive hearing loss. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8267016", "endSection": "abstract"}, {"offsetInBeginSection": 953, "offsetInEndSection": 1213, "text": "The report includes information on otitis media, ventilation tubes, hearing loss, tonsillectomy, speech problems, tibial bowing and osteotomy, ventricular shunting, apnoea, cervicomedullary decompression, and neurological signs attributable to spinal stenosis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9733026", "endSection": "abstract"}, {"offsetInBeginSection": 965, "offsetInEndSection": 1316, "text": "Audiograms were obtained in six of the nine achondroplastic subjects (two adults and four children). There was evidence of mixed hearing loss in the four children, but only of sensorineural hearing loss in the adults. We believe that the persistent hearing loss in achondroplasia is not due to sequelae of otitis media as some authors have suggested. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3143244", "endSection": "abstract"}, {"offsetInBeginSection": 865, "offsetInEndSection": 1520, "text": "Forty-four children had achondroplasia, and 31 had normal hearing in both ears (71%); 8 failed hearing screening in 1 ear (18%), and 3 in both ears (7%). Tympanometry was performed in 45 children, with normal tympanograms found in 21 (47%), bilateral abnormal tympanograms in 15 (33%), and unilateral abnormal tympanograms in 9 (20%). Fourteen children with achondroplasia had normal tympanograms (42%); 11 had bilateral abnormal tympanograms (33%); and 8 had unilateral abnormal tympanograms (24%). For those children without functioning tympanostomy tubes, there was a 9.5 times greater odds of hearing loss if there was abnormal tympanometry (P\u00a0=\u00a0.03). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22183904", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 837, "text": "Achondroplasia (MIM 100800) is the most common non-lethal skeletal dysplasia. Its incidence is between one in 10,000 and one in 30,000. The phenotype is characterized by rhizomelic disproportionate short stature, enlarged head, midface hypoplasia, short hands and lordotic lumbar spine, associated with normal cognitive development. This autosomal-dominant disorder is caused by a gain-of-function mutation in the gene encoding the type 3 receptor for fibroblast growth factor (FGFR3); in more than 95% of cases, the mutation is G380R. The diagnosis is suspected on physical examination and confirmed by different age-related radiological features. Anticipatory and management care by a multidisciplinary team will prevent and treat complications, including cervical cord compression, conductive hearing loss and thoracolumbar gibbosity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18328977", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 800, "text": "A hearing screening program was performed to determine the prevalence of hearing loss and abnormal tympanometry in individuals with short-stature skeletal dysplasias attending a national meeting. Behavioral audiometry, otoacoustic emission testing, and tympanometry were used to assess hearing. Failed hearing screen was defined as hearing \u2265 35 dB at one or more frequencies or by \"fail\" on otoacoustic emissions. One hundred ten of 112 subjects completed the screening. 58 (51.8%) were children. Seventy-three (65.2%) had achondroplasia, 34 (30.4%) had one of 11 other diagnoses, and 5(4.4%) were undiagnosed. 25.8% of children failed hearing screening in one or both ears, while 46.3% of adults failed in one or both ears. 55.1% of adults and 25.0% of children with achondroplasia failed screening. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22628261", "endSection": "abstract"}]}, {"body": "Is the JNK pathway activated during liver regeneration?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23035542", "http://www.ncbi.nlm.nih.gov/pubmed/21354444", "http://www.ncbi.nlm.nih.gov/pubmed/21338344", "http://www.ncbi.nlm.nih.gov/pubmed/20578144", "http://www.ncbi.nlm.nih.gov/pubmed/20207439", "http://www.ncbi.nlm.nih.gov/pubmed/18671679", "http://www.ncbi.nlm.nih.gov/pubmed/18382767", "http://www.ncbi.nlm.nih.gov/pubmed/17762881", "http://www.ncbi.nlm.nih.gov/pubmed/16797887", "http://www.ncbi.nlm.nih.gov/pubmed/16242670", "http://www.ncbi.nlm.nih.gov/pubmed/15970430", "http://www.ncbi.nlm.nih.gov/pubmed/12668975", "http://www.ncbi.nlm.nih.gov/pubmed/11709497"], "triples": [], "ideal_answer": "Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration initial activity of the JNK pathway growth factors and cytokines are involved in liver regeneration genetic inactivation of the JNK pathway results in impaired proliferation of fetal hepatoblasts in vitro and defective adult liver regeneration in vivo stress induced during intermittent selective clamping accelerates rat liver regeneration through JNK pathway add45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling mice lacking c-jun in the liver display impaired regeneration after partial hepatectomy ( PH )", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020935", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008115", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012038", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D048670", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0031098", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0004705", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0031099", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0007254", "http://www.uniprot.org/uniprot/JNK_DROME", "http://www.uniprot.org/uniprot/JNK_SUBDO"], "type": "yesno", "id": "53455e0caeec6fbd0700000f", "snippets": [{"offsetInBeginSection": 967, "offsetInEndSection": 1002, "text": "initial activity of the JNK pathway ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21338344", "endSection": "abstract"}, {"offsetInBeginSection": 558, "offsetInEndSection": 606, "text": "use of Drosophila for the study of regeneration ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21338344", "endSection": "abstract"}, {"offsetInBeginSection": 14, "offsetInEndSection": 72, "text": "c-jun is not mandatory for mouse hepatocyte proliferation ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21354444", "endSection": "title"}, {"offsetInBeginSection": 5, "offsetInEndSection": 68, "text": "growth factors and cytokines are involved in liver regeneration ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11709497", "endSection": "abstract"}, {"offsetInBeginSection": 4, "offsetInEndSection": 94, "text": "c-Jun-N-terminal kinase (JNK) pathway is strongly activated after partial hepatectomy (PH) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12668975", "endSection": "abstract"}, {"offsetInBeginSection": 1139, "offsetInEndSection": 1186, "text": "JNK2 promotes injury after mouse LT via the MPT ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18671679", "endSection": "abstract"}, {"offsetInBeginSection": 586, "offsetInEndSection": 647, "text": "Jun N-terminal kinase and p38 MAPK, but not Akt, was altered. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16242670", "endSection": "abstract"}, {"offsetInBeginSection": 1336, "offsetInEndSection": 1419, "text": "paths of JNK signaling pathway regulate cell proliferation and apoptosis in both LR ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23035542", "endSection": "abstract"}, {"offsetInBeginSection": 2, "offsetInEndSection": 95, "text": "Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12668975", "endSection": "title"}, {"offsetInBeginSection": 1, "offsetInEndSection": 101, "text": "add45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18382767", "endSection": "title"}, {"offsetInBeginSection": 19, "offsetInEndSection": 111, "text": "Mice lacking c-jun in the liver display impaired regeneration after partial hepatectomy (PH) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21354444", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 120, "text": "stress induced during intermittent selective clamping accelerates rat liver regeneration through JNK pathway ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20207439", "endSection": "title"}, {"offsetInBeginSection": 12, "offsetInEndSection": 130, "text": "analysis of the role of JNK signaling pathway in regulating cell proliferation and apoptosis of rat liver regeneration ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23035542", "endSection": "title"}, {"offsetInBeginSection": 1354, "offsetInEndSection": 1481, "text": "basis for JNK suppression during liver regeneration and identify Gadd45beta as a potential therapeutic target in liver diseases ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18382767", "endSection": "abstract"}, {"offsetInBeginSection": 1356, "offsetInEndSection": 1471, "text": " JNK, ERK and JAK2 inhibitors partially abrogated apoptosis and when used in combination reduced it to basal levels ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15970430", "endSection": "abstract"}, {"offsetInBeginSection": 53, "offsetInEndSection": 178, "text": "enhancement of the activation of Jun N-terminal kinase and p38 mitogen-activated protein kinase caused by partial hepatectomy ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16797887", "endSection": "title"}, {"offsetInBeginSection": 1268, "offsetInEndSection": 1415, "text": " arsenite induced apoptosis in the hepatocytes in vivo, through the enhancement of the activation of JNK and p38 MAPK caused by partial hepatectomy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16797887", "endSection": "abstract"}, {"offsetInBeginSection": 1488, "offsetInEndSection": 1633, "text": "induction of CD40-mediated cholangiocyte apoptosis requires JAK2-mediated phosphorylation of STAT3 as well as sustained JNK1/2, ERK1/2 activation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15970430", "endSection": "abstract"}, {"offsetInBeginSection": 820, "offsetInEndSection": 950, "text": "Loss of macroautophagy led to overactivation of the c-Jun N-terminal kinase (JNK)/c-Jun signaling pathway that induced cell death. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20578144", "endSection": "abstract"}, {"offsetInBeginSection": 717, "offsetInEndSection": 869, "text": " genetic inactivation of the JNK pathway results in impaired proliferation of fetal hepatoblasts in vitro and defective adult liver regeneration in vivo ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17762881", "endSection": "abstract"}, {"offsetInBeginSection": 2, "offsetInEndSection": 127, "text": "Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18671679", "endSection": "title"}, {"offsetInBeginSection": 484, "offsetInEndSection": 644, "text": "JAB1 (Jun activation domain-binding protein 1), a co-activator of AP-1, which is essential for liver regeneration, specifically interacts with intracellular HPO ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11709497", "endSection": "abstract"}, {"offsetInBeginSection": 119, "offsetInEndSection": 352, "text": "Although mechanical stress has been implicated in hepatic cirrhosis and liver regeneration following hepatectomy, the signaling pathway(s) that may be activated in hepatocytes in response to mechanical stress have not been determined ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16242670", "endSection": "abstract"}]}, {"body": "Is STAT3 transcription factor regulated by mTORC1?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26026060", "http://www.ncbi.nlm.nih.gov/pubmed/24931163", "http://www.ncbi.nlm.nih.gov/pubmed/24302004", "http://www.ncbi.nlm.nih.gov/pubmed/23641065", "http://www.ncbi.nlm.nih.gov/pubmed/22055460"], "triples": [], "ideal_answer": "Suppression of the mTORC1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids.Here we present evidence for the involvement of stat3, a known mtorc1 regulated transcription factor, in this process tsc1 inactivation inhibits akt through mtorc1-dependent up-regulation of stat3-pten cascade.Therefore, mTORC1 signaling critically protects against inflammatory bowel disease through modulation of inflammation-induced Stat3 activity.", "exact_answer": "yes", "concepts": [], "type": "yesno", "id": "56caf71b5795f9a73e00002d", "snippets": [{"offsetInBeginSection": 249, "offsetInEndSection": 366, "text": "Here we present evidence for the involvement of STAT3, a known mTORC1 regulated transcription factor, in this process ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22055460", "endSection": "abstract"}, {"offsetInBeginSection": 249, "offsetInEndSection": 368, "text": "Here we present evidence for the involvement of STAT3, a known mTORC1 regulated transcription factor, in this process. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22055460", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 97, "text": "TSC1/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22055460", "endSection": "title"}, {"offsetInBeginSection": 827, "offsetInEndSection": 952, "text": "we demonstrated that STAT3 is directly phosphorylated by mTORC1 on Ser727 during hypoxia, promoting HIF-1\u03b1 mRNA transcription ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931163", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24302004", "endSection": "title"}, {"offsetInBeginSection": 861, "offsetInEndSection": 1072, "text": "Mechanistically, mTORC1 signaling was activated by excess amino acids, which then positively regulated Notch1 expression through the activation of the signal transducer and activator of transcription 3 (STAT3). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24302004", "endSection": "abstract"}, {"offsetInBeginSection": 907, "offsetInEndSection": 1250, "text": "Mechanistically, mTORC1 mediated IL-6-induced Stat3 activation in intestinal epithelial cells to stimulate the expression of downstream targets essential for cell proliferation and tissue regeneration. Therefore, mTORC1 signaling critically protects against inflammatory bowel disease through modulation of inflammation-induced Stat3 activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26026060", "endSection": "abstract"}, {"offsetInBeginSection": 958, "offsetInEndSection": 1363, "text": "Here, we review the connections between mTORC1 and gene transcription by focusing on its impact in regulating the activation of specific transcription factors including including STAT3, SREBPs, PPAR\u03b3, PPAR\u03b1, HIF1\u03b1, YY1\u2013PGC1\u03b1 and TFEB. We also discuss the importance of these transcription factors in mediating the effects of mTORC1 on various cellular processes in physiological and pathological contexts. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23641065", "endSection": "abstract"}, {"offsetInBeginSection": 814, "offsetInEndSection": 1189, "text": "Furthermore, we demonstrated that STAT3 is directly phosphorylated by mTORC1 on Ser727 during hypoxia, promoting HIF-1\u03b1 mRNA transcription. mTORC1 also regulates HIF-1\u03b1 synthesis on a translational level via co-operative regulation of both initiation factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase-1 (S6K1), whereas\u00a0HIF-1\u03b1 degradation remains unaffected ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931163", "endSection": "abstract"}]}, {"body": "How is mTORC1 involved in the regulation of heat stress?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21177857"], "triples": [], "ideal_answer": "Our findings imply a plausible mechanism for how persistent pi3k-mtorc1 signaling favors the development of age-related pathologies by attenuating stress conditions.Conversely, hsp70 synthesis is enhanced under the reduced pi3k-mtorc1 signaling one prominent example is the selective translation of heat shock proteins ( hsps ) under stress conditions.Our findings imply a plausible mechanism for how persistent pi3k-mtorc1 signaling here we show that the stress-induced preferential translation of hsp70 mrna is negatively regulated by pi3k-mtorc1 signaling.Although the transcriptional regulation of Hsp genes has been well established, neither the specific translation-promoting features nor the regulatory mechanism of the translation machinery have been clearly defined.Our findings imply a plausible mechanism for how persistent pi3k-mtorc1 signaling favors the development of age-related pathologies by attenuating stress resistance pi3k-mtorc1 attenuates stress response by inhibiting cap-independent hsp70 translation", "concepts": [], "type": "summary", "id": "56cafca85795f9a73e000030", "snippets": [{"offsetInBeginSection": 837, "offsetInEndSection": 916, "text": "Conversely, Hsp70 synthesis is enhanced under the reduced PI3K-mTORC1 signaling ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21177857", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "PI3K-mTORC1 attenuates stress response by inhibiting cap-independent Hsp70 translation. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21177857", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 86, "text": "PI3K-mTORC1 attenuates stress response by inhibiting cap-independent Hsp70 translation ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21177857", "endSection": "title"}, {"offsetInBeginSection": 600, "offsetInEndSection": 702, "text": "stress-induced preferential translation of Hsp70 mRNA is negatively regulated by PI3K-mTORC1 signaling ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21177857", "endSection": "abstract"}, {"offsetInBeginSection": 1069, "offsetInEndSection": 1233, "text": "Our findings imply a plausible mechanism for how persistent PI3K-mTORC1 signaling favors the development of age-related pathologies by attenuating stress resistance ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21177857", "endSection": "abstract"}, {"offsetInBeginSection": 255, "offsetInEndSection": 704, "text": "One prominent example is the selective translation of heat shock proteins (Hsps) under stress conditions. Although the transcriptional regulation of Hsp genes has been well established, neither the specific translation-promoting features nor the regulatory mechanism of the translation machinery have been clearly defined. Here we show that the stress-induced preferential translation of Hsp70 mRNA is negatively regulated by PI3K-mTORC1 signaling. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21177857", "endSection": "abstract"}]}, {"body": "List components of the CRSP/Med complex.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24820420", "http://www.ncbi.nlm.nih.gov/pubmed/19571180", "http://www.ncbi.nlm.nih.gov/pubmed/15195149", "http://www.ncbi.nlm.nih.gov/pubmed/15175162", "http://www.ncbi.nlm.nih.gov/pubmed/14759369", "http://www.ncbi.nlm.nih.gov/pubmed/12509459", "http://www.ncbi.nlm.nih.gov/pubmed/12050112", "http://www.ncbi.nlm.nih.gov/pubmed/11834832", "http://www.ncbi.nlm.nih.gov/pubmed/10377381", "http://www.ncbi.nlm.nih.gov/pubmed/9989412"], "triples": [], "ideal_answer": "CRSPs 34, 77 and 130 are new proteins, but the amino terminus of CRSP70 is homologous to elongation factor TFIIS.Interestingly, different activators are known to bind distinct subunits reveals that crsp33 is a homologue of the yeast mediator subunit med7, whereas crsp150 contains a domain conserved in yeast mediator subunit rgr1.Crsp contains unique subunits within the crsp complex.Cloning of genes encoding crsp contains unique subunits as well as polypeptides that are shared with other cofactor complexes.Interestingly, different activators are new proteins, but the amino terminus of crsp70 is homologous to elongation factor tfiis.Purification of crsp identifies a complex ( crsp ) that specifically lacks both the med220 and the med70 subunits with m ( r ) values ranging from 33k to 200k.CRSP p200 is identical to the nuclear hormone-receptor co-activator subunit TRIP2.We have isolated a stable, endogenous crsp complex.Cloning of genes encoding crsp identifies a complex of approximate relative molecular mass 700,000 ( m ( r ) approximately 700k ) that contains nine subunits with m ( r ) values ranging from 33k to 200k.", "exact_answer": [["Mediator of RNA polymerase II transcription subunit 7"], ["Mediator of RNA polymerase II transcription subunit 14"], ["Mediator of RNA polymerase II transcription subunit 17"], ["Mediator of RNA polymerase II transcription subunit 23"], ["Mediator of RNA polymerase II transcription subunit 26"], ["Mediator of RNA polymerase II transcription subunit 27"], ["Mediator of RNA polymerase II transcription subunit 24"]], "concepts": ["http://www.uniprot.org/uniprot/MED14_MOUSE", "http://www.uniprot.org/uniprot/MED14_HUMAN", "http://www.uniprot.org/uniprot/MED23_DANRE", "http://www.uniprot.org/uniprot/MED23_RAT", "http://www.uniprot.org/uniprot/MED23_MOUSE", "http://www.uniprot.org/uniprot/MED23_HUMAN", "http://www.uniprot.org/uniprot/MED24_HUMAN", "http://www.uniprot.org/uniprot/MED17_HUMAN", "http://www.uniprot.org/uniprot/MED17_BOVIN", "http://www.uniprot.org/uniprot/MED17_CHICK", "http://www.uniprot.org/uniprot/MED17_DANRE", "http://www.uniprot.org/uniprot/MED17_MOUSE", "http://www.uniprot.org/uniprot/MED17_XENTR", "http://www.uniprot.org/uniprot/MED26_DANRE", "http://www.uniprot.org/uniprot/MED26_XENLA", "http://www.uniprot.org/uniprot/MED26_HUMAN", "http://www.uniprot.org/uniprot/MED26_BOVIN", "http://www.uniprot.org/uniprot/MED26_MOUSE", "http://www.uniprot.org/uniprot/MED27_PONAB", "http://www.uniprot.org/uniprot/MED27_DANRE", "http://www.uniprot.org/uniprot/MD27A_XENLA", "http://www.uniprot.org/uniprot/MED27_PIG", "http://www.uniprot.org/uniprot/MED27_MOUSE", "http://www.uniprot.org/uniprot/MED27_BOVIN", "http://www.uniprot.org/uniprot/MED27_XENTR", "http://www.uniprot.org/uniprot/MED27_HUMAN", "http://www.uniprot.org/uniprot/MED7_PIG", "http://www.uniprot.org/uniprot/MED7_DANRE", "http://www.uniprot.org/uniprot/MED7_XENTR", "http://www.uniprot.org/uniprot/MED7_MOUSE", "http://www.uniprot.org/uniprot/MED7A_XENLA", "http://www.uniprot.org/uniprot/MED7_BOVIN", "http://www.uniprot.org/uniprot/MED7_HUMAN", "http://www.uniprot.org/uniprot/MD27B_XENLA", "http://www.uniprot.org/uniprot/MED7B_XENLA", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003067", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016329"], "type": "list", "id": "54e0dfa91388e8454a000018", "snippets": [{"offsetInBeginSection": 805, "offsetInEndSection": 905, "text": "CRSP contains unique subunits as well as polypeptides that are shared with other cofactor complexes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10377381", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 432, "text": "The multi-subunit, human CRSP coactivator-also known as Mediator (Med)-regulates transcription by mediating signals between enhancer-bound factors (activators) and the core transcriptional machinery. Interestingly, different activators are known to bind distinct subunits within the CRSP/Med complex. We have isolated a stable, endogenous CRSP/Med complex (CRSP/Med2) that specifically lacks both the Med220 and the Med70 subunits. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15175162", "endSection": "abstract"}, {"offsetInBeginSection": 622, "offsetInEndSection": 1322, "text": " Here we describe a new human factor, CRSP, that is required together with the TAF(II)s for transcriptional activation by Sp1. Purification of CRSP identifies a complex of approximate relative molecular mass 700,000 (M(r) approximately 700K) that contains nine subunits with M(r) values ranging from 33K to 200K. Cloning of genes encoding CRSP subunits reveals that CRSP33 is a homologue of the yeast mediator subunit Med7, whereas CRSP150 contains a domain conserved in yeast mediator subunit Rgr1. CRSP p200 is identical to the nuclear hormone-receptor co-activator subunit TRIP2/PBP. CRSPs 34, 77 and 130 are new proteins, but the amino terminus of CRSP70 is homologous to elongation factor TFIIS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9989412", "endSection": "abstract"}]}, {"body": "Patients of which disease could be treated by utilizing knowledge obtained from experiments suppressing TDP-43 toxicity in yeast?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23104007"], "triples": [], "ideal_answer": "Mutations in the gene encoding tdp-43 cause some forms of the disease, and cytoplasmic tdp-43 aggregates may be effective the strongest suppressor of tdp-43 toxicity was deletion of dbr1, which encodes an rna lariat debranching enzyme.Amyotrophic lateral sclerosis ( als ) is a devastating neurodegenerative disease primarily affecting motor neurons.Amyotrophic lateral sclerosis ( als ) is a devastating neurodegenerative disease, and cytoplasmic tdp-43 aggregates accumulate in degenerating neurons of most individuals with als.Thus, strategies aimed at targeting the toxicity of cytoplasmic TDP-43 aggregates may be effective the strongest suppressor of TDP-43 toxicity was deletion of DBR1, which encodes an RNA lariat debranching enzyme.Our findings provide insight into TDP-43-mediated cytotoxicity and suggest that decreasing Dbr1 activity could be a potential therapeutic approach for ALS knockdown of Dbr1 in a human neuronal cell line or in primary rat neurons is also sufficient to rescue TDP-43 toxicity.We show that, in the absence of dbr1 enzymatic activity, intronic lariats accumulate in the cytoplasm and likely act as decoys to sequester tdp-43, preventing it from interfering with essential cellular rnas and rna-binding proteins.", "exact_answer": [["Amyotrophic lateral sclerosis (ALS)"]], "concepts": [], "type": "factoid", "id": "5545e65bd355485447000001", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 382, "text": "Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease primarily affecting motor neurons. Mutations in the gene encoding TDP-43 cause some forms of the disease, and cytoplasmic TDP-43 aggregates accumulate in degenerating neurons of most individuals with ALS. Thus, strategies aimed at targeting the toxicity of cytoplasmic TDP-43 aggregates may be effective ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23104007", "endSection": "abstract"}, {"offsetInBeginSection": 491, "offsetInEndSection": 1113, "text": "The strongest suppressor of TDP-43 toxicity was deletion of DBR1, which encodes an RNA lariat debranching enzyme. We show that, in the absence of Dbr1 enzymatic activity, intronic lariats accumulate in the cytoplasm and likely act as decoys to sequester TDP-43, preventing it from interfering with essential cellular RNAs and RNA-binding proteins. Knockdown of Dbr1 in a human neuronal cell line or in primary rat neurons is also sufficient to rescue TDP-43 toxicity. Our findings provide insight into TDP-43-mediated cytotoxicity and suggest that decreasing Dbr1 activity could be a potential therapeutic approach for ALS ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23104007", "endSection": "abstract"}]}, {"body": "Is calcium overload involved in the development of diabetic cardiomyopathy?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22402252", "http://www.ncbi.nlm.nih.gov/pubmed/8761317", "http://www.ncbi.nlm.nih.gov/pubmed/3850773", "http://www.ncbi.nlm.nih.gov/pubmed/10359740", "http://www.ncbi.nlm.nih.gov/pubmed/8864644", "http://www.ncbi.nlm.nih.gov/pubmed/3384188"], "ideal_answer": "Background : it has been suggested that intracellular calcium overload is intimately involved in the development of diabetic cardiomyopathy; these events led to mitochondrial dysfunction and apoptosis.Background : it has been suggested that intracellular ca2+ overload and the development of diabetic cardiomyopathy.It seems that intracellular calcium overload within individual myocytes.The results from the alloxan-rat model of diabetes support the view that membrane abnormalities with respect to ca2+ handling may lead to the occurrence of intracellular ca2+ overload in cardiac myocytes leads to the development of diabetic cardiomyopathy.The novel findings of the study reveal that high glucose induces apoptosis by both mitochondria-dependent and independent pathways via concomitant rise in intracellular calcium ( [ ca2+ ] m ) increase resulted in enhanced reactive oxygen and nitrogen species generation.Diabetes-induced myocardial dysfunction has been attributed, in part, to calcium overload in cardiac myocytes leads to the development of diabetic cardiomyopathy.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D058065", "http://www.disease-ontology.org/api/metadata/DOID:9351", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002118", "http://www.biosemantics.org/jochem#4071295"], "type": "yesno", "id": "517139098ed59a060a000004", "snippets": [{"offsetInBeginSection": 1136, "offsetInEndSection": 1250, "text": "It seems that intracellular calcium overload is intimately involved in the development of diabetic cardiomyopathy; ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3850773", "endSection": "sections.0"}, {"offsetInBeginSection": 107, "offsetInEndSection": 224, "text": "Diabetes-induced myocardial dysfunction has been attributed, in part, to calcium overload within individual myocytes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8761317", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "BACKGROUND: It has been suggested that intracellular Ca2+ overload in cardiac myocytes leads to the development of diabetic cardiomyopathy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10359740", "endSection": "sections.0"}, {"offsetInBeginSection": 1788, "offsetInEndSection": 1965, "text": "The novel findings of the study reveal that high glucose induces apoptosis by both mitochondria-dependent and independent pathways via concomitant rise in intracellular calcium. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22402252", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 261, "text": "It has been suggested that the occurrence of an intracellular Ca2+ overload may result in the development of diabetic cardiomyopathy, which is associated with depletion of high-energy phosphate stores and a derangement of ultrastructure and cardiac dysfunction. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3384188", "endSection": "sections.0"}, {"offsetInBeginSection": 858, "offsetInEndSection": 1089, "text": "The results from the alloxan-rat model of diabetes support the view that membrane abnormalities with respect to Ca2+ handling may lead to the occurrence of intracellular Ca2+ overload and the development of diabetic cardiomyopathy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8864644", "endSection": "sections.0"}, {"offsetInBeginSection": 1136, "offsetInEndSection": 1403, "text": "It seems that intracellular calcium overload is intimately involved in the development of diabetic cardiomyopathy; however, a concentrated research effort is required to understand the primary biochemical lesion in the pathogenesis of cardiac dysfunction in diabetes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3850773", "endSection": "sections.0"}, {"offsetInBeginSection": 800, "offsetInEndSection": 1107, "text": "High-glucose treatment resulted in increased intracellular calcium ([Ca2+]i) which was mobilized to the mitochondria. Concomitant intra-mitochondrial calcium ([Ca2+]m) increase resulted in enhanced reactive oxygen and nitrogen species generation. These events led to mitochondrial dysfunction and apoptosis. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22402252", "endSection": "sections.0"}]}, {"body": "What is the mechanism of viroid replication?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25287502", "http://www.ncbi.nlm.nih.gov/pubmed/21994552", "http://www.ncbi.nlm.nih.gov/pubmed/18370255", "http://www.ncbi.nlm.nih.gov/pubmed/18190946", "http://www.ncbi.nlm.nih.gov/pubmed/15448723", "http://www.ncbi.nlm.nih.gov/pubmed/9601006", "http://www.ncbi.nlm.nih.gov/pubmed/7747427", "http://www.ncbi.nlm.nih.gov/pubmed/3860809", "http://www.ncbi.nlm.nih.gov/pubmed/6760914", "http://www.ncbi.nlm.nih.gov/pubmed/7231549", "http://www.ncbi.nlm.nih.gov/pubmed/1717335", "http://www.ncbi.nlm.nih.gov/pubmed/9356244", "http://www.ncbi.nlm.nih.gov/pubmed/17438124", "http://www.ncbi.nlm.nih.gov/pubmed/11907231"], "triples": [], "ideal_answer": "Viroid replication for hdv rna silencing-a host defense mechanism that targets the viroid itself.In this study, we initially revisited the determination of the replication initiation sites of peach latent mosaic viroid ( plmvd ).In this study, we initially revisited the determination of the replication of many viral and subviral pathogens as well as the amplification of certain cellular genes proceeds via a rolling circle mechanism.However, the exact mechanism of rolling circle replication is entirely dependent on host transcription machinery, and their replication in the infected cells can activate rna and viroids is not clear.However, the exact mechanism of rolling circle replication for hdv rna and viroids is not clear.In this study, we initially revisited the determination of the replication.In vitro synthesis of complementary rna produces distinct transcripts larger than unit length thus reflecting the in vivo mechanism that targets the viroid itself.", "exact_answer": [["rolling cycle"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014772"], "type": "factoid", "id": "56f3faed09dd18d46b000002", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "Viroid replication: rolling-circles, enzymes and ribozymes. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21994552", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "Viroids replicate through a rolling circle mechanism that is exclusively RNA dependent. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18190946", "endSection": "abstract"}, {"offsetInBeginSection": 505, "offsetInEndSection": 615, "text": "Subsequently, an in vitro selection procedure based on a model rolling circle replication assay was developed. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18190946", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 148, "text": "Viroids replicate via a rolling circle mechanism, and cleavage/ligation requires extensive rearrangement of the highly base-paired native structure. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17438124", "endSection": "abstract"}, {"offsetInBeginSection": 1447, "offsetInEndSection": 1610, "text": "Viroid replication occurs via a rolling circle mechanism using either a symmetric or asymmetric pathway in three steps, RNA transcription, processing and ligation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15448723", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 148, "text": "The replication of many viral and subviral pathogens as well as the amplification of certain cellular genes proceeds via a rolling circle mechanism. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9601006", "endSection": "abstract"}, {"offsetInBeginSection": 199, "offsetInEndSection": 353, "text": "In vitro synthesis of complementary RNA produces distinct transcripts larger than unit length thus reflecting the in vivo mechanism of viroid replication. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6760914", "endSection": "abstract"}, {"offsetInBeginSection": 118, "offsetInEndSection": 333, "text": "Viroid replication is entirely dependent on host transcription machinery, and their replication/accumulation in the infected cells can activate RNA silencing-a host defense mechanism that targets the viroid itself. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25287502", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 219, "text": " Viroids replicate through a rolling circle mechanism that is exclusively RNA dependent. In this study, we initially revisited the determination of the replication initiation sites of peach latent mosaic viroid (PLMVd). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18190946", "endSection": "abstract"}, {"offsetInBeginSection": 805, "offsetInEndSection": 975, "text": "Viroids are not translated; they are replicated by a host enzyme (or enzymes) (probably RNA polymerase II) via oligomeric RNA intermediates by a rolling circle mechanism. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1717335", "endSection": "abstract"}, {"offsetInBeginSection": 1295, "offsetInEndSection": 1457, "text": "Viroid replication occurs via a rolling circle mechanism using either a symmetric or asymmetric pathway in three steps, RNA transcription, processing and ligation ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15448723", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 173, "text": "Hepatitis delta virus (HDV) contains a viroid-like circular RNA that is presumed to replicate via a rolling circle replication mechanism mediated by cellular RNA polymerases ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11907231", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 219, "text": "Viroids replicate through a rolling circle mechanism that is exclusively RNA dependent. In this study, we initially revisited the determination of the replication initiation sites of peach latent mosaic viroid (PLMVd). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18190946", "endSection": "abstract"}, {"offsetInBeginSection": 777, "offsetInEndSection": 979, "text": "This mechanism could account for the origin of viroids and also RNA viruses, whereby modules of genetic information may have undergone repeated exchange between RNA pathogens and the RNA of their hosts. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3860809", "endSection": "abstract"}, {"offsetInBeginSection": 1720, "offsetInEndSection": 2023, "text": "We hypothesize that the intramolecular self-ligation which produces circular conformers may contribute to the circularization step of the rolling circle replication, while the intermolecular non-enzymatic ligation is a potential mechanism for the sequence reassortment of viroids and viroid-like species ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9356244", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 272, "text": " Hepatitis delta virus (HDV) contains a viroid-like circular RNA that is presumed to replicate via a rolling circle replication mechanism mediated by cellular RNA polymerases. However, the exact mechanism of rolling circle replication for HDV RNA and viroids is not clear. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11907231", "endSection": "abstract"}, {"offsetInBeginSection": 178, "offsetInEndSection": 505, "text": "Together with the specific alpha-amanitin sensitivity of viroid replication observed in vivo, these findings suggest that viroids replicate by an entirely novel mechanism in which infecting viroid RNA molecules are copied by the host enzyme which is normally responsible for the synthesis of nuclear precursors to messenger RNA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7231549", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 272, "text": "Hepatitis delta virus (HDV) contains a viroid-like circular RNA that is presumed to replicate via a rolling circle replication mechanism mediated by cellular RNA polymerases. However, the exact mechanism of rolling circle replication for HDV RNA and viroids is not clear. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11907231", "endSection": "abstract"}, {"offsetInBeginSection": 95, "offsetInEndSection": 643, "text": "Replication of these minimal genomes, composed exclusively by a circular RNA of 246-401 nt, occurs in the nucleus (family Pospiviroidae) or in the chloroplast (family Avsunviroidae) by an RNA-based rolling-circle mechanism with three steps: (1) synthesis of longer-than-unit strands catalyzed by host DNA-dependent RNA polymerases recruited and redirected to transcribe RNA templates, (2) cleavage to unit-length, which in family Avsunviroidae is mediated by hammerhead ribozymes, and (3) circularization through an RNA ligase or autocatalytically. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18370255", "endSection": "abstract"}, {"offsetInBeginSection": 290, "offsetInEndSection": 920, "text": "Viroid replication proceeds through an RNA-based rolling-circle mechanism with three steps that, with some variations, operate in both polarity strands: i) synthesis of longer-than-unit strands catalyzed by either the nuclear RNA polymerase II or a nuclear-encoded chloroplastic RNA polymerase, in both instances redirected to transcribe RNA templates, ii) cleavage to unit-length, which in the family Avsunviroidae is mediated by hammerhead ribozymes embedded in both polarity strands, while in the family Pospiviroidae the oligomeric RNAs provide the proper conformation but not the catalytic activity, and iii) circularization. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21994552", "endSection": "abstract"}]}, {"body": "Which mitochondrial genes are regulated by thyroid hormone?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12225634", "http://www.ncbi.nlm.nih.gov/pubmed/1331777", "http://www.ncbi.nlm.nih.gov/pubmed/7763274"], "ideal_answer": "Following this procedure, we now report the identification of the mitochondrial gene as target of thyroid hormone.Tissue levels of these mrnas were generally decreased in hypothyroid animals and were up-regulated again after thyroid hormone receptor ( tr ) specific binding site in the mitochondrial nd3 gene.We studied the coordination of the two genomes by measuring transcript levels for nuclear ( iv, va, and vic ) and mitochondrial nadh dehydrogenase subunit 3 ( nd3 ) gene as target of thyroid hormone.We used a polymerase chain reaction ( pcr ) -based mrna differential display ( dd ) analysis to obtain a profile of thyroid hormone.Sequencing and electrophoretic mobility shift assays confirmed the presence of a thyroid hormone-responsive genes in osteoblast-like cells at the 2-hour time point, 1 true-positive novel clone was identified and shown to be the mitochondrial gene, subunit 6 of atp synthase ( atpase-6 ).", "exact_answer": [["subunit 6 of ATP synthase", "ATPase-6"], ["mitochondrial II and III subunits of cytochrome-c oxidase"], ["NADH dehydrogenase subunit 3", "ND3"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013963", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050259", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011988", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013974"], "type": "list", "id": "517539e68ed59a060a000028", "snippets": [{"offsetInBeginSection": 186, "offsetInEndSection": 335, "text": "Following this procedure, we now report the identification of the mitochondrial NADH dehydrogenase subunit 3 (ND3) gene as target of thyroid hormone. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7763274", "endSection": "sections.0"}, {"offsetInBeginSection": 503, "offsetInEndSection": 649, "text": "At the 2-hour time point, 1 true-positive novel clone was identified and shown to be the mitochondrial gene, subunit 6 of ATP synthase (ATPase-6). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12225634", "endSection": "sections.0"}, {"offsetInBeginSection": 76, "offsetInEndSection": 244, "text": "We used a polymerase chain reaction (PCR)-based mRNA differential display (DD) analysis to obtain a profile of thyroid hormone-responsive genes in osteoblast-like cells ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12225634", "endSection": "sections.0"}, {"offsetInBeginSection": 412, "offsetInEndSection": 582, "text": "Sequencing and electrophoretic mobility shift assays confirmed the presence of a thyroid hormone receptor (TR)/c-erbA specific binding site in the mitochondrial ND3 gene. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7763274", "endSection": "sections.0"}, {"offsetInBeginSection": 124, "offsetInEndSection": 549, "text": "We studied the coordination of the two genomes by measuring transcript levels for nuclear (IV, Va, and VIc) and mitochondrial (II and III) subunits of cytochrome-c oxidase after altering the mitochondrial content of rat muscle and liver by altering the thyroid state of the animals. Tissue levels of these mRNAs were generally decreased in hypothyroid animals and were up-regulated again after thyroid hormone (T3) treatment. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1331777", "endSection": "sections.0"}]}, {"body": "Mutation of which gene is associated with McLeod syndrome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23943810", "http://www.ncbi.nlm.nih.gov/pubmed/21145924", "http://www.ncbi.nlm.nih.gov/pubmed/19909712", "http://www.ncbi.nlm.nih.gov/pubmed/19040496", "http://www.ncbi.nlm.nih.gov/pubmed/18167163", "http://www.ncbi.nlm.nih.gov/pubmed/17870653", "http://www.ncbi.nlm.nih.gov/pubmed/17469188", "http://www.ncbi.nlm.nih.gov/pubmed/17302777", "http://www.ncbi.nlm.nih.gov/pubmed/17300882", "http://www.ncbi.nlm.nih.gov/pubmed/17277857", "http://www.ncbi.nlm.nih.gov/pubmed/16344536", "http://www.ncbi.nlm.nih.gov/pubmed/16314760", "http://www.ncbi.nlm.nih.gov/pubmed/12899725", "http://www.ncbi.nlm.nih.gov/pubmed/12823753", "http://www.ncbi.nlm.nih.gov/pubmed/12243006", "http://www.ncbi.nlm.nih.gov/pubmed/11761473", "http://www.ncbi.nlm.nih.gov/pubmed/11746618", "http://www.ncbi.nlm.nih.gov/pubmed/11703337", "http://www.ncbi.nlm.nih.gov/pubmed/11562915", "http://www.ncbi.nlm.nih.gov/pubmed/11261514", "http://www.ncbi.nlm.nih.gov/pubmed/11099667", "http://www.ncbi.nlm.nih.gov/pubmed/10930599", "http://www.ncbi.nlm.nih.gov/pubmed/10882128", "http://www.ncbi.nlm.nih.gov/pubmed/10846875", "http://www.ncbi.nlm.nih.gov/pubmed/10651848", "http://www.ncbi.nlm.nih.gov/pubmed/10426139", "http://www.ncbi.nlm.nih.gov/pubmed/8619554", "http://www.ncbi.nlm.nih.gov/pubmed/8004674", "http://www.ncbi.nlm.nih.gov/pubmed/1734714", "http://www.ncbi.nlm.nih.gov/pubmed/3334897", "http://www.ncbi.nlm.nih.gov/pubmed/22383943", "http://www.ncbi.nlm.nih.gov/pubmed/24179763", "http://www.ncbi.nlm.nih.gov/pubmed/24098554"], "triples": [{"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3073", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/XK"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3073", "o": "http://www.dbpedia.org/resource/McLeod_syndrome"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/XK", "o": "XK"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3073", "o": "McLeod syndrome"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3074", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/XK"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/XK", "o": "XK"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3074", "o": "McLeod syndrome with neuroacanthosis"}], "ideal_answer": "Although the e327k missense mutation was associated with the immunohematologic characteristics of mcleod syndrome, the mutated xk, an x-chromosomal gene of unknown function.A spontaneous novel XK gene mutation in a patient with McLeod syndrome.The gene mutation in a patient who also suffers from chronic granulomatous disease and mcleod syndrome.We present six males ( aged 29 to 60 years ), with proven xk mutations, to discuss the chorea associated with mcleod phenotype and characterization of two novel cases.The gene termed srpx ( sushi-repeat-containing protein, x chromosome ) is deleted in an rp patient with mcleod syndrome.Insights into extensive deletions around the xk locus associated with mcleod syndrome, which results from inherited xk mutations.Although the e327k missense mutation was associated with the immunohematologic characteristics of mcleod syndrome, which results from inherited xk mutations.Although the e327k missense mutation was associated with the immunohematologic characteristics of mcleod syndrome is caused by mutations of xk protein seemed to be largely functional.", "exact_answer": ["XK"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009154", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005796", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013577", "http://www.disease-ontology.org/api/metadata/DOID:225"], "type": "factoid", "id": "531464a6e3eabad021000014", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 51, "text": "McLeod syndrome resulting from a novel XK mutation. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12899725", "endSection": "title"}, {"offsetInBeginSection": 308, "offsetInEndSection": 368, "text": "MLS is caused by hemizygosity for mutations in the XK gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12899725", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 71, "text": "A spontaneous novel XK gene mutation in a patient with McLeod syndrome. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11703337", "endSection": "title"}, {"offsetInBeginSection": 208, "offsetInEndSection": 286, "text": "Linkage analysis and sequencing revealed a XK gene mutation (McLeod syndrome). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16344536", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 69, "text": "Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1734714", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 88, "text": "McLeod syndrome is caused by mutations of XK, an X-chromosomal gene of unknown function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11761473", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12823753", "endSection": "title"}, {"offsetInBeginSection": 326, "offsetInEndSection": 412, "text": "Genetic test revealed a R133X mutation of the XK gene, confirming the McLeod syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17870653", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "McLeod syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK gene. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16314760", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 91, "text": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10426139", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Identification and characterization of a novel XK splice site mutation in a patient with McLeod syndrome. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040496", "endSection": "title"}, {"offsetInBeginSection": 247, "offsetInEndSection": 343, "text": "The diagnosis of MLS was confirmed by genetic testing showing a hemizygous mutation of XK gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23943810", "endSection": "abstract"}, {"offsetInBeginSection": 374, "offsetInEndSection": 480, "text": " The mRNA expression pattern of one of them, designated as XK, correlates closely to the McLeod phenotype. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8004674", "endSection": "abstract"}, {"offsetInBeginSection": 136, "offsetInEndSection": 220, "text": "It is caused by XK gene defects and may include large deletions in the Xp21 region. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10651848", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 103, "text": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK protein. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11261514", "endSection": "abstract"}, {"offsetInBeginSection": 1185, "offsetInEndSection": 1261, "text": "he XK gene had a point mutation in the donor splice site of intron 1 (G>C). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11099667", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 127, "text": "Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17300882", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 117, "text": "Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3334897", "endSection": "title"}, {"offsetInBeginSection": 337, "offsetInEndSection": 454, "text": "Fifteen different XK mutations were found, nine of which were novel, including the one of the eponymous case McLeod. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11761473", "endSection": "abstract"}, {"offsetInBeginSection": 368, "offsetInEndSection": 492, "text": "We present six males (aged 29 to 60 years), with proven XK mutations, to discuss the chorea associated with McLeod syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11746618", "endSection": "abstract"}, {"offsetInBeginSection": 105, "offsetInEndSection": 234, "text": "It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11562915", "endSection": "abstract"}, {"offsetInBeginSection": 245, "offsetInEndSection": 352, "text": "Investigation of the patient's XK gene revealed a novel TGG- to-TAG transition at position 1023 in exon 3. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11703337", "endSection": "abstract"}, {"offsetInBeginSection": 903, "offsetInEndSection": 1007, "text": "Case 1 has greater than 1.12 million base-pairs (mb) deletion around the XK locus with 7 genes affected. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17300882", "endSection": "abstract"}, {"offsetInBeginSection": 818, "offsetInEndSection": 930, "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K). WBC XK RNA levels were not decreased. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12823753", "endSection": "abstract"}, {"offsetInBeginSection": 1457, "offsetInEndSection": 1584, "text": "The different XK mutations may have different effects upon the XK gene product and thus may account for the variable phenotype. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17302777", "endSection": "abstract"}, {"offsetInBeginSection": 227, "offsetInEndSection": 399, "text": "The expression level of all the Kell antigens in erythrocyte was decreased and molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10426139", "endSection": "abstract"}, {"offsetInBeginSection": 599, "offsetInEndSection": 745, "text": "Nucleotide sequence analysis of XK from two unrelated McLeod patients has identified point mutations at conserved splice donor and acceptor sites. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8004674", "endSection": "abstract"}, {"offsetInBeginSection": 1281, "offsetInEndSection": 1444, "text": "Despite documented McLeod phenotype on RBCs, and identified mutations of XK, neurologic and other clinical findings were minimal at ages expected to manifest MLS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17302777", "endSection": "abstract"}, {"offsetInBeginSection": 549, "offsetInEndSection": 719, "text": "The gene termed SRPX (sushi-repeat-containing protein, x chromosome) is deleted in an RP patient who also suffers from chronic granulomatous disease and McLeod syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8634708", "endSection": "abstract"}, {"offsetInBeginSection": 364, "offsetInEndSection": 520, "text": "We describe a family with a novel point mutation in the XK gene consisting of a C to T base transition at nucleotide position 977, introducing a stop codon. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11261514", "endSection": "abstract"}, {"offsetInBeginSection": 135, "offsetInEndSection": 292, "text": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040496", "endSection": "abstract"}, {"offsetInBeginSection": 304, "offsetInEndSection": 486, "text": "Direct sequencing of the PCR-amplified genomic DNA revealed the mutation was a single C-nucleotide insertion at codon 151 in exon 2 of the XK gene, which resulted in a 3'-frameshift. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10930599", "endSection": "abstract"}, {"offsetInBeginSection": 820, "offsetInEndSection": 1016, "text": "The responsible XK mutation was characterized at the mRNA level by reverse transcription-polymerase chain reaction (PCR), identified by genomic DNA sequencing, and verified by allele-specific PCR. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040496", "endSection": "abstract"}, {"offsetInBeginSection": 1432, "offsetInEndSection": 1686, "text": "The detailed characterization at the molecular biology level of this novel XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype correlation in the McLeod syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040496", "endSection": "abstract"}, {"offsetInBeginSection": 89, "offsetInEndSection": 296, "text": "We hypothesized that because the XK gene is X-linked, it would be easy to identify spontaneously arising red cells with a phenotype resembling the McLeod syndrome, which results from inherited XK mutations. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19909712", "endSection": "abstract"}, {"offsetInBeginSection": 314, "offsetInEndSection": 521, "text": "Here, we present an immunohistochemical study in skeletal muscle of normal controls and a McLeod patient with a XK gene point mutation (C977T) using affinity-purified antibodies against XK and Kell proteins. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11562915", "endSection": "abstract"}, {"offsetInBeginSection": 493, "offsetInEndSection": 647, "text": "DNA studies demonstrated a single-base deletion at position 172 in exon 1 of the XK gene, giving rise to a premature stop codon at position 129 in exon 2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16314760", "endSection": "abstract"}, {"offsetInBeginSection": 193, "offsetInEndSection": 416, "text": "A variety of mutations have been found in the responsible gene (XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK, and different deletion mutations. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17302777", "endSection": "abstract"}, {"offsetInBeginSection": 215, "offsetInEndSection": 489, "text": "With the discovery of their molecular bases, mutations of the X-linked gene XK and autosomal recessive mutations of the gene coding for chorein, respectively, the two phenotypes can now be differentiated and extend the diagnostic spectrum in patients presenting with chorea. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12243006", "endSection": "abstract"}, {"offsetInBeginSection": 249, "offsetInEndSection": 517, "text": "The McLeod Syndrome, one of the core neuroacanthocytosis syndromes, is a rare X-linked disorder caused by mutations of the XK gene, an X-chromosomal gene of unknown function characterized by haemopoietic abnormalities and late-onset neurological and muscular defects. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17277857", "endSection": "abstract"}, {"offsetInBeginSection": 378, "offsetInEndSection": 616, "text": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21145924", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 237, "text": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17300882", "endSection": "abstract"}, {"offsetInBeginSection": 312, "offsetInEndSection": 593, "text": "Molecular genetic analysis revealed a small deletion in the XK gene (938-942delCTCTA), which has been already described in a North American patient of Anglo-Saxon descent and a Japanese family, presenting with seizures, muscle atrophy or chorea yet absence of psychiatric features. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17469188", "endSection": "abstract"}, {"offsetInBeginSection": 866, "offsetInEndSection": 1182, "text": "The first case had been authenticated as a genuine McLeod both by serology and by genotyping (R222G missense mutation) and the second case had a mutation in XK (IVS2+5G>A) and by serology exhibited very weak Kx antigen and no detectable Kell antigens, except extremely low k antigen by adsorption-elution technique. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17302777", "endSection": "abstract"}, {"offsetInBeginSection": 366, "offsetInEndSection": 667, "text": "MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17300882", "endSection": "abstract"}, {"offsetInBeginSection": 924, "offsetInEndSection": 1321, "text": "The patient's daughters had two populations of red cells, consistent with them being heterozygous for an XK0 allele. The molecular basis of MLS in this family is a novel mutation consisting of a 7453-bp deletion that includes exon 2 of the XK gene. This confirms that the patient's 7-year-old grandson, who is currently asymptomatic, also has the XK0 allele and is therefore likely to develop MLS. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12899725", "endSection": "abstract"}, {"offsetInBeginSection": 1026, "offsetInEndSection": 1419, "text": "A novel XK splice site mutation (IVS1-1G>A) has been identified in a McLeod patient who has developed hematologic, neuromuscular, and neurologic symptoms. This is the first reported example of a XK point mutation affecting the 3' acceptor splice site of Intron 1, and it was demonstrated that this mutation indeed induces aberrant splicing of XK RNA and lack of XK protein at the RBC membrane. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040496", "endSection": "abstract"}, {"offsetInBeginSection": 1197, "offsetInEndSection": 1748, "text": "Known disease-causing XK gene mutations comprised deletions, nonsense, or splice-site mutations predicting absent or truncated XK protein devoid of the Kell-protein binding site. Although the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK protein seemed to be largely functional. These findings contribute to the understanding of the physiology of XK and Kell proteins, and the pathogenetic mechanisms of acanthocytosis, myopathy, and striatal neurodegeneration in McLeod syndrome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12823753", "endSection": "abstract"}]}, {"body": "Is RIP1 (RIP-1) part of the necrosome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22033613", "http://www.ncbi.nlm.nih.gov/pubmed/22016814", "http://www.ncbi.nlm.nih.gov/pubmed/21749897", "http://www.ncbi.nlm.nih.gov/pubmed/24098568", "http://www.ncbi.nlm.nih.gov/pubmed/24059293", "http://www.ncbi.nlm.nih.gov/pubmed/23898178", "http://www.ncbi.nlm.nih.gov/pubmed/23612963", "http://www.ncbi.nlm.nih.gov/pubmed/23162759", "http://www.ncbi.nlm.nih.gov/pubmed/22817896", "http://www.ncbi.nlm.nih.gov/pubmed/22576661", "http://www.ncbi.nlm.nih.gov/pubmed/22421439", "http://www.ncbi.nlm.nih.gov/pubmed/22666585", "http://www.ncbi.nlm.nih.gov/pubmed/21890409"], "triples": [], "ideal_answer": "Rip-1 kinase activity triggers formation of the necrosome ( in complex with rip-3 ) leading to the formation of amyloid-like signaling complexes.Receptor interacting protein kinase activity triggers formation of the necrosome ( in complex with rip-3 ) leading to programmed necrosis.The rip1 necrosome formation of the rip1 complex ( called necrosome ) the phosphorylation of rip1 and rip3 are key components of the necrosome.He 'necrosome ', that includes receptor-interacting protein ( RIP ) 1, RIP3 and caspase-8.He 'necrosome ', that includes receptor-interacting protein ( rip ) 1, rip3 is critical for assembly of the necrosome, rip1 and rip3 mediate necrosome aggregation leading to the formation of amyloid-like signaling complexes.The rip1 necrosome formation of the rip1 complex ( called necrosome ) the phosphorylation of rip1 and rip3 are key components of the necrosome, rip1 and rip3 mediate necrosome aggregation leading to the formation of amyloid-like signaling complexes.Rip-1 kinase 1 ( ripk1 ) and rip3 are key components of the necrosome.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009336", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0001906", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0008219", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0070265", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0097300", "http://www.uniprot.org/uniprot/RIPK1_MOUSE", "http://www.uniprot.org/uniprot/RIPK1_HUMAN", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D053422"], "type": "yesno", "id": "532bfd15d6d3ac6a34000017", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 24, "text": "The RIP1/RIP3 necrosome ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22817896", "endSection": "title"}, {"offsetInBeginSection": 497, "offsetInEndSection": 527, "text": "RIP1-RIP3 \"necrosome\" complex ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23898178", "endSection": "abstract"}, {"offsetInBeginSection": 966, "offsetInEndSection": 1001, "text": "Rip1-Rip3 death complex (necrosome) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22576661", "endSection": "abstract"}, {"offsetInBeginSection": 189, "offsetInEndSection": 268, "text": "The phosphorylation of RIP1 and RIP3 is critical for assembly of the necrosome, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24059293", "endSection": "abstract"}, {"offsetInBeginSection": 840, "offsetInEndSection": 894, "text": "Formation of the RIP1/RIP3 complex (called necrosome) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23162759", "endSection": "abstract"}, {"offsetInBeginSection": 902, "offsetInEndSection": 975, "text": "necrosome complex consisting of RIP1, RIP3, FADD, caspase-8 and cFLIP(L). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22016814", "endSection": "abstract"}, {"offsetInBeginSection": 576, "offsetInEndSection": 663, "text": "he 'necrosome', that includes receptor-interacting protein (RIP)1, RIP3 and caspase-8. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21890409", "endSection": "abstract"}, {"offsetInBeginSection": 295, "offsetInEndSection": 400, "text": "RIP1 and RIP3 mediate necrosome aggregation leading to the formation of amyloid-like signaling complexes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23612963", "endSection": "abstract"}, {"offsetInBeginSection": 1179, "offsetInEndSection": 1272, "text": "formation of a different necrosome whose components, besides RIP1 and RIP3, are still unknown ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22033613", "endSection": "abstract"}, {"offsetInBeginSection": 884, "offsetInEndSection": 998, "text": "RIP-1 kinase activity triggers formation of the necrosome (in complex with RIP-3) leading to programmed necrosis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22666585", "endSection": "abstract"}, {"offsetInBeginSection": 116, "offsetInEndSection": 213, "text": "Receptor interacting protein kinase 1 (RIPK1/RIP1) and RIP3 are key components of the necrosome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24098568", "endSection": "abstract"}, {"offsetInBeginSection": 477, "offsetInEndSection": 673, "text": "assembly of a supramolecular complex containing the receptor-interacting protein kinases 1 and 3 (RIP1 and RIP3) that delivers a pronecrotic signal. Such complex has recently been dubbed necrosome ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21749897", "endSection": "abstract"}]}, {"body": "Which is the molecular target of the immunosuppressant drug Rapamycin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23994756", "http://www.ncbi.nlm.nih.gov/pubmed/23301832", "http://www.ncbi.nlm.nih.gov/pubmed/23261661", "http://www.ncbi.nlm.nih.gov/pubmed/22442756", "http://www.ncbi.nlm.nih.gov/pubmed/18980246", "http://www.ncbi.nlm.nih.gov/pubmed/18451231", "http://www.ncbi.nlm.nih.gov/pubmed/17728765", "http://www.ncbi.nlm.nih.gov/pubmed/17041625", "http://www.ncbi.nlm.nih.gov/pubmed/15901852", "http://www.ncbi.nlm.nih.gov/pubmed/15627018", "http://www.ncbi.nlm.nih.gov/pubmed/15163844", "http://www.ncbi.nlm.nih.gov/pubmed/14508096"], "triples": [], "ideal_answer": "Molecular target of rapamycin ( mTOR ), the molecular Target Of Rapamycin, TOR molecular target of rapamycin ( mTOR molecular target of rapamycin ( mTOR )", "exact_answer": ["mTOR"], "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0031929", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0032006", "http://www.biosemantics.org/jochem#4274961", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020123", "http://www.uniprot.org/uniprot/TOR_ORYSJ", "http://www.uniprot.org/uniprot/TOR_ARATH", "http://www.uniprot.org/uniprot/TOR_DROME", "http://www.uniprot.org/uniprot/TOR_DICDI"], "type": "factoid", "id": "53124bdae3eabad02100000b", "snippets": [{"offsetInBeginSection": 1930, "offsetInEndSection": 1967, "text": "molecular target of rapamycin (mTOR) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15163844", "endSection": "abstract"}, {"offsetInBeginSection": 14, "offsetInEndSection": 49, "text": "molecular target of rapamycin (mTOR ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15627018", "endSection": "title"}, {"offsetInBeginSection": 325, "offsetInEndSection": 363, "text": "the molecular Target Of Rapamycin, TOR ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17041625", "endSection": "abstract"}, {"offsetInBeginSection": 4, "offsetInEndSection": 41, "text": "molecular target of rapamycin (mTOR), ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14508096", "endSection": "abstract"}]}, {"body": "Is the protein KCNQ2 associated with idiopathic epilepsy?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23182620", "http://www.ncbi.nlm.nih.gov/pubmed/19464834", "http://www.ncbi.nlm.nih.gov/pubmed/18640800", "http://www.ncbi.nlm.nih.gov/pubmed/18625963", "http://www.ncbi.nlm.nih.gov/pubmed/17044971", "http://www.ncbi.nlm.nih.gov/pubmed/18246739", "http://www.ncbi.nlm.nih.gov/pubmed/21937445", "http://www.ncbi.nlm.nih.gov/pubmed/10716662", "http://www.ncbi.nlm.nih.gov/pubmed/9677360", "http://www.ncbi.nlm.nih.gov/pubmed/10363917", "http://www.ncbi.nlm.nih.gov/pubmed/16260777", "http://www.ncbi.nlm.nih.gov/pubmed/14640909", "http://www.ncbi.nlm.nih.gov/pubmed/19818940", "http://www.ncbi.nlm.nih.gov/pubmed/16302872", "http://www.ncbi.nlm.nih.gov/pubmed/10323247", "http://www.ncbi.nlm.nih.gov/pubmed/10446744", "http://www.ncbi.nlm.nih.gov/pubmed/12458027", "http://www.ncbi.nlm.nih.gov/pubmed/10472660"], "triples": [], "ideal_answer": "KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes mutations in KCNQ2 or KCNQ3 that reduce the M-current are responsible for benign familial neonatal seizures, a rare autosomal dominant idiopathic epilepsy of the newborn this paper summarizes recent findings concerning sodium ( SCN1A ) and potassium channel ( KCNQ2 and KCNQ3 ) dysfunctions in the pathogenesis of rare and common idiopathic epilepsies ( IE ).The functional interaction between KCNQ2 and KCNQ3 provides a framework for understanding how mutations in either channel can cause a form of idiopathic generalized epilepsy role of KCNQ2 and KCNQ3 genes in juvenile idiopathic epilepsy in Arabian foals.These include benign familial neonatal convulsions due to mutations in KCNQ2 or KCNQ3, generalized epilepsy with febrile seizures plus due to mutations in SCN1A, SCN2A, SCN1B, and GABRG2, autosomal-dominant juvenile myoclonic epilepsy ( JME ) due to a mutation in GABRA1 and mutations in CLCN2 associated with several IGE sub-types the underlying genetic abnormalities of rare familial idiopathic epilepsy have been identified, such as mutation in KCNQ2, a K ( + ) channel gene.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051658", "http://www.uniprot.org/uniprot/KCNQ2_MOUSE", "http://www.uniprot.org/uniprot/KCNQ2_RAT"], "type": "yesno", "id": "56c30ce99d3e5f1412000002", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 80, "text": "KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18625963", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 79, "text": "KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18625963", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 79, "text": "Role of KCNQ2 and KCNQ3 genes in juvenile idiopathic epilepsy in Arabian foals. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23182620", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 78, "text": "Role of KCNQ2 and KCNQ3 genes in juvenile idiopathic epilepsy in Arabian foals ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23182620", "endSection": "title"}, {"offsetInBeginSection": 1591, "offsetInEndSection": 1711, "text": "Sequence variations of the KCNQ2 and KCNQ3 genes may contribute to the etiology of common idiopathic epilepsy syndromes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18625963", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 155, "text": "The underlying genetic abnormalities of rare familial idiopathic epilepsy have been identified, such as mutation in KCNQ2, a K(+) channel gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18640800", "endSection": "abstract"}, {"offsetInBeginSection": 1521, "offsetInEndSection": 1651, "text": "They also demonstrate that sequence variations of the KCNQ2 and KCNQ3 genes may contribute to the etiology of common IE syndromes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19464834", "endSection": "abstract"}, {"offsetInBeginSection": 1367, "offsetInEndSection": 1540, "text": "The functional interaction between KCNQ2 and KCNQ3 provides a framework for understanding how mutations in either channel can cause a form of idiopathic generalized epilepsy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9677360", "endSection": "abstract"}, {"offsetInBeginSection": 139, "offsetInEndSection": 295, "text": "Mutations in KCNQ2- or KCNQ3-encoding genes cause benign familiar neonatal convulsions (BFNCs), a rare autosomal-dominant idiopathic epilepsy of the newborn ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16260777", "endSection": "abstract"}, {"offsetInBeginSection": 167, "offsetInEndSection": 336, "text": "Mutations in KCNQ2 or KCNQ3 that reduce the M-current are responsible for benign familial neonatal seizures, a rare autosomal dominant idiopathic epilepsy of the newborn ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19818940", "endSection": "abstract"}, {"offsetInBeginSection": 315, "offsetInEndSection": 499, "text": "This paper summarizes recent findings concerning sodium (SCN1A) and potassium channel (KCNQ2 and KCNQ3) dysfunctions in the pathogenesis of rare and common idiopathic epilepsies (IE). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19464834", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 216, "text": "Mutations in the voltage gated potassium channel gene KCNQ2 and the homologous gene KCNQ3 have been found to cause a rare monogenic subtype of idiopathic generalized epilepsy, the benign familial neonatal convulsions ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10363917", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 313, "text": "Mutations in the SCN1A gene are found in up to 80% of individuals with severe myoclonic epilepsy of infancy (SMEI), and mutations in KCNQ2 and KCNQ3 were identified in benign familial neonatal convulsions (BFNC) as well as in single families with Rolandic epilepsy (RE) and idiopathic generalized epilepsies (IGE) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19464834", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 314, "text": "Mutations in the SCN1A gene are found in up to 80% of individuals with severe myoclonic epilepsy of infancy (SMEI), and mutations in KCNQ2 and KCNQ3 were identified in benign familial neonatal convulsions (BFNC) as well as in single families with Rolandic epilepsy (RE) and idiopathic generalized epilepsies (IGE). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19464834", "endSection": "abstract"}, {"offsetInBeginSection": 226, "offsetInEndSection": 549, "text": "The involvement of KCNQ2 (Kv7.2) and KCNQ3 (Kv7.3) in a benign idiopathic neonatal epilepsy, KCNQ4 (Kv7.4) in a form of congenital deafness, and the discovery that neuronal KCNQ heteromultimers were among the molecular substrates of M-channels, resulted in a high level of interest for potential drug development strategies ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14640909", "endSection": "abstract"}, {"offsetInBeginSection": 333, "offsetInEndSection": 662, "text": "These include benign familial neonatal convulsions due to mutations in KCNQ2 or KCNQ3, generalized epilepsy with febrile seizures plus due to mutations in SCN1A, SCN2A, SCN1B, and GABRG2, autosomal-dominant juvenile myoclonic epilepsy (JME) due to a mutation in GABRA1 and mutations in CLCN2 associated with several IGE sub-types ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16302872", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 368, "text": "Juvenile idiopathic epilepsy (JIE) in Arabian foals resembles benign-familial neonatal convulsion (BFNC) syndrome, a rare idiopathic epilepsy of new-born humans. BFNC syndrome exhibits genetic heterogeneity, as has been hypothesised to occur in Arabian foals, and is known to be caused by mutations in the voltage-gated potassium channel subunit KCNQ2 and KCNQ3 genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23182620", "endSection": "abstract"}]}, {"body": "PBT2 has been tested for which disorder?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22747493", "http://www.ncbi.nlm.nih.gov/pubmed/22592705", "http://www.ncbi.nlm.nih.gov/pubmed/22403554", "http://www.ncbi.nlm.nih.gov/pubmed/21797865", "http://www.ncbi.nlm.nih.gov/pubmed/21739113", "http://www.ncbi.nlm.nih.gov/pubmed/21232050", "http://www.ncbi.nlm.nih.gov/pubmed/20545360", "http://www.ncbi.nlm.nih.gov/pubmed/20164561", "http://www.ncbi.nlm.nih.gov/pubmed/21504115", "http://www.ncbi.nlm.nih.gov/pubmed/19742190", "http://www.ncbi.nlm.nih.gov/pubmed/18953111", "http://www.ncbi.nlm.nih.gov/pubmed/18672400", "http://www.ncbi.nlm.nih.gov/pubmed/16370917", "http://www.ncbi.nlm.nih.gov/pubmed/18625454"], "triples": [], "ideal_answer": "It has performed very satisfactorily in toxicology and phase i clinical trials and is advancing as a disease-modifying candidate drug for alzheimer's disease.Intracellular translocation of zn and cu via the metal chaperone activity of pbt2 was more rigorously conducted and showed that after 12 weeks this compound appeared to be safe and well tolerated in people with mild alzheimer's dementia.Metalloproteinase modifiers such as pbt2 may be an important mechanism by which pbt2 improves cognitive function in people with ad.The second trial of pbt2 on biomarkers and cognition that are reported here translate into clinical effectiveness.Intracellular translocation of zn and cu via the metal chaperone activity of pbt2 improved cognition in a phase ii clinical trial with ad patients, and further clinical testing is currently underway.Intracellular translocation of zn and cu via the metal chaperone activity of pbt2 may be useful ad therapies, but current evidence gives no support to their immediate use in pre-symptomatic ad.Future trials that are larger and longer will establish if the effects of PBT2 on biomarkers and cognition that are reported here translate into clinical effectiveness.", "exact_answer": [["Alzheimer's disease"]], "concepts": [], "type": "factoid", "id": "54fc91e96ad7dcbc12000001", "snippets": [{"offsetInBeginSection": 1346, "offsetInEndSection": 1415, "text": "These findings further encourage larger-scale testing of PBT2 for AD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20164561", "endSection": "abstract"}, {"offsetInBeginSection": 157, "offsetInEndSection": 271, "text": "The leading compound in this class of therapeutic, PBT2, improved cognition in a clinical trial with AD patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21797865", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20164561", "endSection": "title"}, {"offsetInBeginSection": 2876, "offsetInEndSection": 2998, "text": "PBT2 improved cognition in a phase II clinical trial with AD patients, and further clinical testing is currently underway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22747493", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "The Alzheimer's therapeutic PBT2 promotes amyloid-\u03b2 degradation and GSK3 phosphorylation via a metal chaperone activity. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21797865", "endSection": "title"}, {"offsetInBeginSection": 2631, "offsetInEndSection": 2799, "text": "Future trials that are larger and longer will establish if the effects of PBT2 on biomarkers and cognition that are reported here translate into clinical effectiveness. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18672400", "endSection": "abstract"}, {"offsetInBeginSection": 1260, "offsetInEndSection": 1418, "text": "It has performed very satisfactorily in toxicology and Phase I clinical trials and is advancing as a disease-modifying candidate drug for Alzheimer's disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18953111", "endSection": "abstract"}, {"offsetInBeginSection": 94, "offsetInEndSection": 222, "text": "Recently, CQ and its analog PBT2 have shown encouraging effects in the animal and clinical trials for Alzheimer's disease (AD). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21504115", "endSection": "abstract"}, {"offsetInBeginSection": 1056, "offsetInEndSection": 1208, "text": "Metalloproteinase modifiers such as PBT2 may be useful AD therapies, but current evidence gives no support to their immediate use in pre-symptomatic AD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21739113", "endSection": "abstract"}, {"offsetInBeginSection": 2223, "offsetInEndSection": 2402, "text": "In the second trial a successor compound, PBT2, was compared with placebo in 78 participants with mild Alzheimer's dementia; all were included in the intention-to-treat analysis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22592705", "endSection": "abstract"}, {"offsetInBeginSection": 1212, "offsetInEndSection": 1401, "text": "The most advanced of these strategies is the so-called 'metal protein attenuating compound' approach, with the lead molecule PBT2 having successfully completed early phase clinical trials. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21232050", "endSection": "abstract"}, {"offsetInBeginSection": 1315, "offsetInEndSection": 1487, "text": "Intracellular translocation of Zn and Cu via the metal chaperone activity of PBT2 may be an important mechanism by which PBT2 improves cognitive function in people with AD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21797865", "endSection": "abstract"}, {"offsetInBeginSection": 3614, "offsetInEndSection": 3795, "text": "The second trial of PBT2 was more rigorously conducted and showed that after 12 weeks this compound appeared to be safe and well tolerated in people with mild Alzheimer's dementia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22592705", "endSection": "abstract"}, {"offsetInBeginSection": 1364, "offsetInEndSection": 1588, "text": "Small molecules targeting Abeta-metal interactions (e.g., PBT2) are currently advancing through clinical trials and show increasing promise as disease-modifying agents for Alzheimer's disease based on the \"metal hypothesis.\" ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18625454", "endSection": "abstract"}, {"offsetInBeginSection": 841, "offsetInEndSection": 1092, "text": "Experimental treatments potentially useful for Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's vaccine remains to be proven, and growth hormone secretagogue and tarenflurbil are likely ineffective. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19742190", "endSection": "abstract"}, {"offsetInBeginSection": 552, "offsetInEndSection": 830, "text": "The purpose of this mini-review is to highlight the emerging notion that metal chaperones, such as PBT2 (Prana Biotechnology), modulate a variety of critical pathways affecting key aspects of the AD cascade to provide a more \"holistic\" approach to the treatment of this disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22403554", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 257, "text": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18953111", "endSection": "abstract"}, {"offsetInBeginSection": 108, "offsetInEndSection": 448, "text": " A recent Phase IIa double-blind, randomized, placebo-controlled trial found that the 250 mg dose of PBT2 was well-tolerated, significantly lowered cerebrospinal fluid (CSF) levels of amyloid-beta42, and significantly improved executive function on a Neuro-psychological Test Battery (NTB) within 12 weeks of treatment in patients with AD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20164561", "endSection": "abstract"}]}, {"body": "How does long-range epigenetic silencing (LRES) occur?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21098650", "http://www.ncbi.nlm.nih.gov/pubmed/21737484", "http://www.ncbi.nlm.nih.gov/pubmed/17099711", "http://www.ncbi.nlm.nih.gov/pubmed/20736368", "http://www.ncbi.nlm.nih.gov/pubmed/20173741", "http://www.ncbi.nlm.nih.gov/pubmed/20442245", "http://www.ncbi.nlm.nih.gov/pubmed/19956686", "http://www.ncbi.nlm.nih.gov/pubmed/17613553", "http://www.ncbi.nlm.nih.gov/pubmed/22249255", "http://www.ncbi.nlm.nih.gov/pubmed/24035705", "http://www.ncbi.nlm.nih.gov/pubmed/22133303", "http://www.ncbi.nlm.nih.gov/pubmed/18403637"], "triples": [], "ideal_answer": "Epigenetic gene silencing ( lres ) this demonstrates that long-range epigenetic silencing ( lres ) occurs in developmental tumors as well as in adult tumors.Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing ( LRES ) reduces transcriptional plasticity.Ikaros hypermethylation occurred in the context of a novel long-range epigenetic silencing has always been envisaged as a local event silencing discrete genes, but recent data now indicates that large regions of chromosomes can be co-coordinately suppressed; a process termed long range epigenetic silencing ( lres ) region.Epigenetic gene silencing has always been envisaged as a local event silencing discrete genes, but recent data now indicates that large regions of chromosomes can be a frequent occurrence throughout the human genome.By creating an integrated prostate cancer epigenome map using tiling arrays, we show that contiguous regions of gene suppression commonly occur through long-range epigenetic silencing ( lres ) occurs in developmental tumors as well as in adult tumors.The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.The long-range epigenetic silencing ( lres ) reduces transcriptional plasticity.", "concepts": ["http://amigo.geneontology.org/amigo/term/GO:0010495"], "type": "summary", "id": "57092635cf1c325851000019", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18403637", "endSection": "title"}, {"offsetInBeginSection": 234, "offsetInEndSection": 335, "text": "The long-range epigenetic silencing (LRES) can be a frequent occurrence throughout the human genome. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20442245", "endSection": "abstract"}, {"offsetInBeginSection": 706, "offsetInEndSection": 811, "text": "Ikaros hypermethylation occurred in the context of a novel long-range epigenetic silencing (LRES) region. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21737484", "endSection": "abstract"}, {"offsetInBeginSection": 605, "offsetInEndSection": 725, "text": "This demonstrates that long-range epigenetic silencing (LRES) occurs in developmental tumors as well as in adult tumors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19956686", "endSection": "abstract"}, {"offsetInBeginSection": 1178, "offsetInEndSection": 1295, "text": "Consistent with LRES in colorectal cancer, we found regional epigenetic remodeling across 2q14.2 in prostate cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21098650", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20173741", "endSection": "title"}, {"offsetInBeginSection": 1517, "offsetInEndSection": 1646, "text": "Malignant regression of cancer cells by in vitro differentiation resulted in partial reversion of LRES and gain of CTCF binding. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24035705", "endSection": "abstract"}, {"offsetInBeginSection": 249, "offsetInEndSection": 405, "text": "It was recently reported that epigenetic suppression of gene expression can also extend to a whole region; this is known as long-range epigenetic silencing. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17099711", "endSection": "abstract"}, {"offsetInBeginSection": 121, "offsetInEndSection": 296, "text": "Long Range Epigenetic Silencing (LRES) is a mechanism of gene inactivation that affects multiple contiguous CpG islands and has been described in different human cancer types. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24035705", "endSection": "abstract"}, {"offsetInBeginSection": 145, "offsetInEndSection": 336, "text": "By creating an integrated prostate cancer epigenome map using tiling arrays, we show that contiguous regions of gene suppression commonly occur through long-range epigenetic silencing (LRES). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20173741", "endSection": "abstract"}, {"offsetInBeginSection": 612, "offsetInEndSection": 771, "text": "We were able to gain a comprehensive view of promoters with various CpG densities, including CpG Islands (CGIs), transcript bodies, and various repeat classes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22133303", "endSection": "abstract"}, {"offsetInBeginSection": 337, "offsetInEndSection": 511, "text": "We identified 47 LRES regions in prostate cancer, typically spanning about 2 Mb and harbouring approximately 12 genes, with a prevalence of tumour suppressor and miRNA genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20173741", "endSection": "abstract"}, {"offsetInBeginSection": 1663, "offsetInEndSection": 1899, "text": "genes in LRES regions are plastically regulated in cell differentiation and hyperproliferation, but are constrained to a coordinated repression by abolishing boundaries and the autonomous regulation of chromatin domains in cancer cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24035705", "endSection": "abstract"}, {"offsetInBeginSection": 958, "offsetInEndSection": 1187, "text": "We propose that consolidation or effective reduction of the cancer genome commonly occurs in domains through a combination of LRES and LOH or genomic deletion, resulting in reduced transcriptional plasticity within these regions. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20173741", "endSection": "abstract"}, {"offsetInBeginSection": 1027, "offsetInEndSection": 1249, "text": "Our results not only provide the first evidence that LRES can have functional specific effects in cancer but also identify several deregulated Ikaros targets that may contribute to progression in colorectal adenocarcinoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21737484", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 251, "text": "Loss of tumour suppressor gene function can occur as a result of epigenetic silencing of large chromosomal regions, referred to as long-range epigenetic silencing (LRES), and genome-wide analyses have revealed that LRES is present in many cancer types ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22249255", "endSection": "abstract"}, {"offsetInBeginSection": 1069, "offsetInEndSection": 1297, "text": "Discrete boundaries of the PCDH domain are delimited by abrupt changes in histone modifications; unmethylated genes flanking the LRES are associated with permissive marks which are absent from methylated genes within the domain. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19956686", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 260, "text": "Previously, we showed that gene suppression commonly occurs across chromosome 2q14.2 in colorectal cancer, through a process of long-range epigenetic silencing (LRES), involving a combination of DNA methylation and repressive histone modifications. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21098650", "endSection": "abstract"}, {"offsetInBeginSection": 261, "offsetInEndSection": 466, "text": "We now investigate whether LRES also occurs in prostate cancer across this 4-Mb region and whether differential DNA methylation of 2q14.2 genes could provide a regional panel of prostate cancer biomarkers. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21098650", "endSection": "abstract"}, {"offsetInBeginSection": 647, "offsetInEndSection": 897, "text": " Epigenetic gene silencing has always been envisaged as a local event silencing discrete genes, but recent data now indicates that large regions of chromosomes can be co-coordinately suppressed; a process termed long range epigenetic silencing (LRES) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17613553", "endSection": "abstract"}, {"offsetInBeginSection": 648, "offsetInEndSection": 900, "text": "We demonstrate that LRES also occurs in murine cancer in vivo and mimics the molecular features of the human phenomenon, namely, downregulation of gene expression, acquisition of inactive histone marks, and DNA hypermethylation of specific CpG islands. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24035705", "endSection": "abstract"}, {"offsetInBeginSection": 899, "offsetInEndSection": 1290, "text": "LRES can span megabases of DNA and involves broad heterochromatin formation accompanied by hypermethylation of clusters of contiguous CpG islands within the region. It is not clear if LRES is initiated by one critical gene target that spreads and conscripts innocent bystanders, analogous to large genetic deletions or if coordinate silencing of multiple genes is important in carcinogenesis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17613553", "endSection": "abstract"}, {"offsetInBeginSection": 649, "offsetInEndSection": 1064, "text": "Epigenetic gene silencing has always been envisaged as a local event silencing discrete genes, but recent data now indicates that large regions of chromosomes can be co-coordinately suppressed; a process termed long range epigenetic silencing (LRES). LRES can span megabases of DNA and involves broad heterochromatin formation accompanied by hypermethylation of clusters of contiguous CpG islands within the region. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17613553", "endSection": "abstract"}, {"offsetInBeginSection": 423, "offsetInEndSection": 899, "text": "We now know that tumour suppressor genes, with CpG island-associated promoters, are commonly hypermethylated and silenced in cancer, but we do not understood what triggers this process or when it occurs during carcinogenesis. Epigenetic gene silencing has always been envisaged as a local event silencing discrete genes, but recent data now indicates that large regions of chromosomes can be co-coordinately suppressed; a process termed long range epigenetic silencing (LRES). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17613553", "endSection": "abstract"}]}, {"body": "List interaction partners for the protein GATA1.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/16339652", "http://www.ncbi.nlm.nih.gov/pubmed/18844071"], "triples": [], "ideal_answer": "LMO2-C can bind endogenous GATA1Ldb-1, a known partner of GATA-1 our work describes, for the first time, distinct GATA-1 interactions with the essential hematopoietic factor Gfi-1b, the repressive MeCP1 complex, and the chromatin remodeling ACF complex, in addition to the known GATA-1 and GATA-1 complexes.", "exact_answer": [["LMO2-C"], ["Gfi-1b"], ["MeCP1 complex"], ["ACF/WCRF complex"], ["FOG-1"], ["TAL-1"], ["Ldb-1"]], "concepts": [], "type": "list", "id": "52e929eb98d0239505000023", "snippets": [{"offsetInBeginSection": 948, "offsetInEndSection": 980, "text": "LMO2-C can bind endogenous GATA1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18844071", "endSection": "abstract"}, {"offsetInBeginSection": 1345, "offsetInEndSection": 1377, "text": "Ldb-1, a known partner of GATA-1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16339652", "endSection": "abstract"}, {"offsetInBeginSection": 752, "offsetInEndSection": 1011, "text": "Our work describes, for the first time, distinct GATA-1 interactions with the essential hematopoietic factor Gfi-1b, the repressive MeCP1 complex, and the chromatin remodeling ACF/WCRF complex, in addition to the known GATA-1/FOG-1 and GATA-1/TAL-1 complexes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16339652", "endSection": "abstract"}]}, {"body": "What is the mode of inheritance of Acromicric dysplasia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22791552", "http://www.ncbi.nlm.nih.gov/pubmed/19396027", "http://www.ncbi.nlm.nih.gov/pubmed/11694546"], "triples": [], "ideal_answer": "Finally, wms is transmitted either by an autosomal dominant or an autosomal recessive ( ar ) mode of inheritance, distinct facial and skeleton features ( a hoarse voice and internal notch of the femoral head ).The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant or an autosomal recessive ( ar ) mode of inheritance.Ad has an autosomal dominant mode of inheritance.Finally, wms is transmitted either by an autosomal dominant mode of inheritance, gd by an autosomal recessive mode of inheritance and ad by an autosomal dominant mode of inheritance.", "exact_answer": ["autosomal dominant"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D040582", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001848"], "type": "factoid", "id": "53318685d6d3ac6a3400003d", "snippets": [{"offsetInBeginSection": 696, "offsetInEndSection": 840, "text": "AD has an autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22791552", "endSection": "abstract"}, {"offsetInBeginSection": 1332, "offsetInEndSection": 1507, "text": "The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant mode of inheritance. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11694546", "endSection": "abstract"}, {"offsetInBeginSection": 616, "offsetInEndSection": 830, "text": "Finally, WMS is transmitted either by an autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19396027", "endSection": "abstract"}]}, {"body": "Can RNAPolII function as an RNA-dependent RNA-polymerase?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23395899", "http://www.ncbi.nlm.nih.gov/pubmed/18004386", "http://www.ncbi.nlm.nih.gov/pubmed/15827195", "http://www.ncbi.nlm.nih.gov/pubmed/17132145", "http://www.ncbi.nlm.nih.gov/pubmed/16624367", "http://www.ncbi.nlm.nih.gov/pubmed/17855633", "http://www.ncbi.nlm.nih.gov/pubmed/15964997", "http://www.ncbi.nlm.nih.gov/pubmed/20943989"], "triples": [], "ideal_answer": "Identification of these ENL-associated proteins ( EAPs ) by mass spectrometry revealed enzymes with a known role in transcriptional elongation ( RNA polymerase II C-terminal domain kinase [ RNAPolII CTD ] positive transcription elongation factor b [ pTEFb ] ), and in chromatin modification ( histone-H3 methyltransferase DOT1L ) as well as other frequent MLL partners ( AF4, AF5q31, and LAF4 ), and polycomb group members ( RING1, CBX8, and BCoR ).Here is, however, have not been identified and the cellular function of the pol ii rdrp activity is unknown.Association of the influenza a virus rna-dependent rna polymerase with cellular rna polymerase ii ( rnapolii ) preinitiation complex recruitment and h3 lys 4 ( h3-k4 ) methylation at the xist promoter form the basis of the xist expression profiles that drives both imprinted and random xci.Here is, however, evidence that Pol II also possesses RNA-dependent RNA polymerase ( RdRP ) activity.Natural cellular rna substrates of mammalian pol ii, however, have not been identified and the cellular function of the pol ii rdrp activity.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012319"], "type": "yesno", "id": "571696d9cb4ef8864c000009", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "RNA polymerase II acts as an RNA-dependent RNA polymerase to extend and destabilize a non-coding RNA. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23395899", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 98, "text": "Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15827195", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 100, "text": "RNA polymerase II acts as an RNA-dependent RNA polymerase to extend and destabilize a non-coding RNA ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23395899", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 164, "text": "RNA polymerase II (Pol II) is a well-characterized DNA-dependent RNA polymerase, which has also been reported to have RNA-dependent RNA polymerase (RdRP) activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23395899", "endSection": "abstract"}, {"offsetInBeginSection": 766, "offsetInEndSection": 913, "text": ". Our studies provide compelling evidence that mammalian Pol II acts as an RdRP to control the stability of a cellular RNA by extending its 3'-end. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23395899", "endSection": "abstract"}, {"offsetInBeginSection": 126, "offsetInEndSection": 290, "text": "It is also well established that viral RNA-dependent RNA polymerase (vRNP) associates with cellular RNA polymerase II (Pol II), on which viral replication depends. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20943989", "endSection": "abstract"}, {"offsetInBeginSection": 1207, "offsetInEndSection": 1385, "text": "We conclude that influenza A virus replication requires RNAP-II activity not just to provide capped mRNA substrates but also to facilitate nuclear export of selected viral mRNAs. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17132145", "endSection": "abstract"}, {"offsetInBeginSection": 1171, "offsetInEndSection": 1341, "text": "The RdRP activity of Pol II provides a missing link in molecular evolution, because it suggests that Pol II evolved from an ancient replicase that duplicated RNA genomes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18004386", "endSection": "abstract"}, {"offsetInBeginSection": 793, "offsetInEndSection": 1017, "text": "The present findings provide a framework for further studies to elucidate the mechanistic principles of transcription by a viral RNA polymerase and have implications for the regulation of Pol II activities in infected cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15827195", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 170, "text": "Influenza A virus transcribes its segmented negative sense RNA genome in the nuclei of infected cells in a process long known to require host RNA polymerase II (RNAP-II). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17132145", "endSection": "abstract"}, {"offsetInBeginSection": 518, "offsetInEndSection": 737, "text": "We show that RNA polymerase II (RNAPolII) preinitiation complex recruitment and H3 Lys 4 (H3-K4) methylation at the Xist promoter form the basis of the Xist expression profiles that drives both imprinted and random XCI. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15964997", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 317, "text": "RNA polymerase II (Pol II) is a well-characterized DNA-dependent RNA polymerase, which has also been reported to have RNA-dependent RNA polymerase (RdRP) activity. Natural cellular RNA substrates of mammalian Pol II, however, have not been identified and the cellular function of the Pol II RdRP activity is unknown. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23395899", "endSection": "abstract"}, {"offsetInBeginSection": 90, "offsetInEndSection": 407, "text": "here is, however, evidence that Pol II also possesses RNA-dependent RNA polymerase (RdRP) activity. Pol II can use a homopolymeric RNA template, can extend RNA by several nucleotides in the absence of DNA, and has been implicated in the replication of the RNA genomes of hepatitis delta virus (HDV) and plant viroids. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18004386", "endSection": "abstract"}, {"offsetInBeginSection": 687, "offsetInEndSection": 985, "text": "Thus, influenza virus specifically interferes with Pol II elongation, but not Pol II initiation. We propose that influenza virus RNA polymerase, by binding to the CTD of initiating Pol II and subsequent cleavage of the capped 5' end of the nascent transcript, triggers premature Pol II termination. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16624367", "endSection": "abstract"}, {"offsetInBeginSection": 661, "offsetInEndSection": 1096, "text": "Identification of these ENL-associated proteins (EAPs) by mass spectrometry revealed enzymes with a known role in transcriptional elongation (RNA polymerase II C-terminal domain kinase [RNAPolII CTD] positive transcription elongation factor b [pTEFb]), and in chromatin modification (histone-H3 methyltransferase DOT1L) as well as other frequent MLL partners (AF4, AF5q31, and LAF4), and polycomb group members (RING1, CBX8, and BCoR). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17855633", "endSection": "abstract"}]}, {"body": "Which are the best treatment options to treat Helicobacter pylori?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23388847", "http://www.ncbi.nlm.nih.gov/pubmed/23021657", "http://www.ncbi.nlm.nih.gov/pubmed/22404517", "http://www.ncbi.nlm.nih.gov/pubmed/22322786", "http://www.ncbi.nlm.nih.gov/pubmed/20485704", "http://www.ncbi.nlm.nih.gov/pubmed/20429828", "http://www.ncbi.nlm.nih.gov/pubmed/19490560"], "ideal_answer": "The evidence in favour of bismuth compounds for treating infected children is still not clear.Equential therapy and quadruple therapy ( either bismuth-based or non-bismuth-based ) are the best current options to replace initial treatment with triple therapy.In patients with bleeding peptic ulcer, empirical treatment of h. pylori infection immediately after feeding is restarted is the most cost-effective strategy for preventing recurrent hemorrhage.Olecular tests can be used to detect H. pylori and clarithromycin and fluoroquinolone resistance in gastric biopsies without necessitating culture.Triple therapy and quadruple therapy ( either bismuth-based or non-bismuth-based ) are the best current options to replace initial treatment in many countries over the last decade, now has suboptimal results in many parts of the world.Triple therapy, which has been the mainstay of treatment of h. pylori infection immediately after feeding is restarted is the most cost-effective strategy for preventing recurrent hemorrhage.Treatment consisted of a one-week regimen containing a PPI twice daily, amoxicillin ( A ) 1 g twice daily and rifabutin ( R ) 300 mg once daily ( PPI-AR ).", "exact_answer": [["amoxicillin"], ["metronidazole"], ["claritromycin"], ["Proton pump inhibithors"], ["rifabutin"], ["Eudragit L100"]], "type": "list", "id": "518cb5ab310faafe08000008", "snippets": [{"offsetInBeginSection": 1366, "offsetInEndSection": 1460, "text": "The evidence in favour of bismuth compounds for treating infected children is still not clear. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22404517", "endSection": "sections.0"}, {"offsetInBeginSection": 829, "offsetInEndSection": 956, "text": "Pretreatment antibiotic susceptibility to metronidazole, clarithromycin and A was evaluated using a validated epsilometer test. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20485704", "endSection": "sections.0"}, {"offsetInBeginSection": 894, "offsetInEndSection": 1026, "text": "the multi-core chitosan microspheres could serve as a satisfactory vehicle for stomach-specific delivery of hydrophilic antibiotics. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22322786", "endSection": "sections.0"}, {"offsetInBeginSection": 620, "offsetInEndSection": 782, "text": "equential therapy and quadruple therapy (either bismuth-based or non-bismuth-based) are the best current options to replace initial treatment with triple therapy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23388847", "endSection": "sections.0"}, {"offsetInBeginSection": 323, "offsetInEndSection": 457, "text": "Chitosan microspheres with multiple Eudragit L100 cores were easily prepared by a new emulsification/coagulation encapsulating method. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22322786", "endSection": "sections.0"}, {"offsetInBeginSection": 181, "offsetInEndSection": 332, "text": "Triple therapy, which has been the mainstay of treatment in many countries over the last decade, now has suboptimal results in many parts of the world. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23388847", "endSection": "sections.0"}, {"offsetInBeginSection": 1527, "offsetInEndSection": 1721, "text": "In patients with bleeding peptic ulcer, empirical treatment of H. pylori infection immediately after feeding is restarted is the most cost-effective strategy for preventing recurrent hemorrhage. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19490560", "endSection": "sections.0"}, {"offsetInBeginSection": 499, "offsetInEndSection": 648, "text": "Treatment consisted of a one-week regimen containing a PPI twice daily, amoxicillin (A) 1 g twice daily and rifabutin (R) 300 mg once daily (PPI-AR). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20485704", "endSection": "sections.0"}, {"offsetInBeginSection": 289, "offsetInEndSection": 564, "text": "four different strategies for prevention of rebleeding in patients with peptic ulcer hemorrhage: 1) test for H. pylori and treatment, if positive; 2) proton pump inhibitor maintenance; 3) no preventive treatment; 4) empirical H. pylori eradication immediately after bleeding. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19490560", "endSection": "sections.0"}, {"offsetInBeginSection": 725, "offsetInEndSection": 1080, "text": "olecular tests can be used to detect H. pylori and clarithromycin and/or fluoroquinolone resistance in gastric biopsies without necessitating culture. In regions of high clarithromycin resistance, such as France, sequential treatment or bismuth-containing quadruple therapies are replacing standard triple therapies for the first-line empirical treatment. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23021657", "endSection": "sections.0"}, {"offsetInBeginSection": 911, "offsetInEndSection": 1225, "text": "Empirical H. pylori eradication was the dominant strategy: its estimated rate of recurrent bleeding was lower (6.1%) than those of strategies 1 (7.4%), 2 (11.1%), and 3 (18.4%) and it was the least expensive strategy. The results remained stable when variables were changed inside a wide range of plausible values. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19490560", "endSection": "sections.0"}]}, {"body": "List sclerostin interaction partners.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22206666", "http://www.ncbi.nlm.nih.gov/pubmed/20951118", "http://www.ncbi.nlm.nih.gov/pubmed/17002572", "http://www.ncbi.nlm.nih.gov/pubmed/15199066"], "triples": [], "ideal_answer": "Other full-length sclerostin-interacting proteins such as casein kinase ii and secreted frizzled related protein 4 that modulate wnt signaling were identified.We show that recombinant sclerostin, directly interacts with lrp5 but not lrp5g171v to modulate wnt activity.Several peptides derived from proteins such as phex, asporin and follistatin that regulate bone metabolism also bound sclerostin, sost, the gene affected in this disease, has been postulated to exert its activity by functioning as a bmp antagonist.We identified an interaction between sclerostin and the carboxyl-terminal portion of the receptor tyrosine-protein kinase erbB-3.Several peptides derived from proteins such as phex, asporin and follistatin that regulate bone density ligand, sclerostin, directly interacts with lrp5 but not lrp5g171v to modulate wnt activity.Bone density ligand, sclerostin and noggin bound to each other with high affinity ( k ( d ) = 2.92 nm ).", "exact_answer": [["alkaline phosphatase"], ["carbonic anhydrase"], ["gremlin-1"], ["fetuin A"], ["midkine"], ["annexin A1"], ["annexin A2"], ["collagen \u03b11"], ["casein kinase II"], ["secreted frizzled related protein 4"], ["Phex"], ["asporin"], ["follistatin"], ["erbB-3"], ["LRP5"], ["noggin"]], "concepts": [], "type": "list", "id": "570a6d03cf1c325851000025", "snippets": [{"offsetInBeginSection": 321, "offsetInEndSection": 450, "text": "We identified an interaction between sclerostin and the carboxyl-terminal portion of the receptor tyrosine-protein kinase erbB-3. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20951118", "endSection": "abstract"}, {"offsetInBeginSection": 197, "offsetInEndSection": 300, "text": "We show that recombinant sclerostin and noggin bound to each other with high affinity (K(D) = 2.92 nm). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15199066", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17002572", "endSection": "title"}, {"offsetInBeginSection": 419, "offsetInEndSection": 690, "text": "Sclerostin, SOST, the gene affected in this disease, has been postulated to exert its activity by functioning as a BMP antagonist. However, recent evidence indicates that SOST is highly related to Wise, which can also modulate the Wnt pathway by binding to LRP5 and LRP6. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17002572", "endSection": "abstract"}, {"offsetInBeginSection": 641, "offsetInEndSection": 1277, "text": " Several previously unidentified full-length sclerostin-interacting proteins such as alkaline phosphatase, carbonic anhydrase, gremlin-1, fetuin A, midkine, annexin A1 and A2, and collagen \u03b11, which have established roles in bone formation or resorption processes, were bound to the sclerostin-MBP amylose resin but not to the MBP amylose resin. Other full-length sclerostin-interacting proteins such as casein kinase II and secreted frizzled related protein 4 that modulate Wnt signaling were identified. Several peptides derived from proteins such as Phex, asporin and follistatin that regulate bone metabolism also bound sclerostin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22206666", "endSection": "abstract"}]}, {"body": "Under which conditions does AMPK phosphorylate TSC2?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19245654", "http://www.ncbi.nlm.nih.gov/pubmed/18439900", "http://www.ncbi.nlm.nih.gov/pubmed/14651849", "http://www.ncbi.nlm.nih.gov/pubmed/24173372", "http://www.ncbi.nlm.nih.gov/pubmed/15261145", "http://www.ncbi.nlm.nih.gov/pubmed/17041622", "http://www.ncbi.nlm.nih.gov/pubmed/16483933"], "triples": [], "ideal_answer": "Ampk phosphorylation of the tsc2 tumor suppressor contributes to suppression of mtorc1 ampk is a highly conserved sensor of cellular energy status that is activated under conditions of low intracellular atp.Under energy status that is activated under conditions, the amp-activated protein kinase ( ampk ) phosphorylates tsc2 and enhances its activity.Conversely, energy depletion reduces rheb-gtp charging through the ability of the adenosine monophosphate-activated protein kinase to phosphorylate tsc2, and p53.Phosphorylation of tsc2 by ampk also induces cell size control in response to energy deprivation.In addition, ampk also induces cell cycle arrest or apoptosis through several tumor suppressors including lkb1 is required for repression of mtor under low atp conditions in cultured cells in an ampk- and tsc2-dependent manner, and p53.Here, we report that lkb1 is required for translation regulation and cell size control in response to energy deprivation.Under energy starvation conditions in cultured cells in an ampk- and tsc2-dependent manner, and that lkb1 null mefs and the hamartomatous gastrointestinal polyps from lkb1 mutant mice show elevated signaling downstream of mtor.", "concepts": [], "type": "summary", "id": "56cd765b5795f9a73e000038", "snippets": [{"offsetInBeginSection": 389, "offsetInEndSection": 512, "text": "Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2 and enhances its activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14651849", "endSection": "abstract"}, {"offsetInBeginSection": 482, "offsetInEndSection": 569, "text": "Hypoxia results in energy starvation and activation of the AMPK/TSC2/Rheb/mTOR pathway. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16483933", "endSection": "abstract"}, {"offsetInBeginSection": 288, "offsetInEndSection": 442, "text": "AMPK phosphorylation of the TSC2 tumor suppressor contributes to suppression of mTORC1; however, TSC2-deficient cells remain responsive to energy stress. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18439900", "endSection": "abstract"}, {"offsetInBeginSection": 1811, "offsetInEndSection": 2113, "text": "Conversely, energy depletion reduces Rheb-GTP charging through the ability of the adenosine monophosphate-activated protein kinase to phosphorylate TSC2 and stimulate its Rheb-GTPase activating function, as well as by HIFalpha-mediated transcriptional responses that act upstream of the TSC1/2 complex. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17041622", "endSection": "abstract"}, {"offsetInBeginSection": 390, "offsetInEndSection": 640, "text": "Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2 and enhances its activity. Phosphorylation of TSC2 by AMPK is required for translation regulation and cell size control in response to energy deprivation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14651849", "endSection": "abstract"}, {"offsetInBeginSection": 982, "offsetInEndSection": 1155, "text": "AMPK directly phosphorylates at least two proteins to induce rapid suppression of mTORC1 activity, the TSC2 tumour suppressor and the critical mTORC1 binding subunit raptor. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19245654", "endSection": "abstract"}, {"offsetInBeginSection": 254, "offsetInEndSection": 512, "text": "Here, we describe that TSC2 is regulated by cellular energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2 and enhances its activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14651849", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 238, "text": "The AMP-activated serine/threonine protein kinase (AMPK) is a sensor of cellular energy status found in all eukaryotes that is activated under conditions of low intracellular ATP following stresses such as nutrient deprivation or hypoxia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19245654", "endSection": "abstract"}, {"offsetInBeginSection": 276, "offsetInEndSection": 511, "text": "TSC2 is regulated by cellular energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2 and enhances its activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14651849", "endSection": "abstract"}, {"offsetInBeginSection": 138, "offsetInEndSection": 403, "text": "Once activated under the various metabolic stress conditions, AMPK regulates a multitude of metabolic pathways to balance cellular energy. In addition, AMPK also induces cell cycle arrest or apoptosis through several tumor suppressors including LKB1, TSC2, and p53. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24173372", "endSection": "abstract"}, {"offsetInBeginSection": 647, "offsetInEndSection": 925, "text": "Here, we report that LKB1 is required for repression of mTOR under low ATP conditions in cultured cells in an AMPK- and TSC2-dependent manner, and that Lkb1 null MEFs and the hamartomatous gastrointestinal polyps from Lkb1 mutant mice show elevated signaling downstream of mTOR. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15261145", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 374, "text": "AMPK is a highly conserved sensor of cellular energy status that is activated under conditions of low intracellular ATP. AMPK responds to energy stress by suppressing cell growth and biosynthetic processes, in part through its inhibition of the rapamycin-sensitive mTOR (mTORC1) pathway. AMPK phosphorylation of the TSC2 tumor suppressor contributes to suppression of mTORC1 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18439900", "endSection": "abstract"}]}, {"body": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/8519147", "http://www.ncbi.nlm.nih.gov/pubmed/11109603", "http://www.ncbi.nlm.nih.gov/pubmed/19723768", "http://www.ncbi.nlm.nih.gov/pubmed/19242563", "http://www.ncbi.nlm.nih.gov/pubmed/11331153"], "triples": [], "ideal_answer": "Currently the method of choice for cerebrospinal fluid detection is qualitative determination of beta-2-transferrin.A tc-99m diethyltriaminepentacetic acid radionuclide cisternography ( rnc ) showed the accumulation of radioactivity in the area of the subarachnoid space, the poor migration of the isotope over the convexities, and the early appearance of kidney and bladder activity unenhanced ( three-dimensional constructive interference in steady state ( 3d-ciss ) ) and contrast-enhanced mr cisternography ( ce-mrc ) in detecting the localisation of cerebrospinal fluid ( csf ) leak.In conclusion, 3d-ciss is a non-invasive and reliable technique, and should be the first-choice method of choice for investigation of this condition.In conclusion, 3d-ciss is a non-invasive and reliable technique, and should be the first-choice method to localise csf leak in patients with rhinorrhoea the diagnostic work-up included lumbar tapping and measurement of csf opening pressure, radioisotope cisternography, brain and spinal magnetic resonance imaging ( mri ), and computed tomography ( ct ) myelography.", "exact_answer": [["CT cisternography", "CTC"], ["three-dimensional constructive interference in steady state", "3D-CISS"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002555", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015170", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002559", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002558", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008919", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001826", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003952", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D059906"], "type": "list", "id": "5326300fd6d3ac6a34000005", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 74, "text": "CT cisternography in the investigation of cerebrospinal fluid rhinorrhoea. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8519147", "endSection": "title"}, {"offsetInBeginSection": 432, "offsetInEndSection": 527, "text": "surgery the use of intrathecal sodium-fluorescein improves visualisation of the site of leakage ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11109603", "endSection": "abstract"}, {"offsetInBeginSection": 775, "offsetInEndSection": 903, "text": "CTC is an accurate, well-tolerated procedure and should be regarded as the method of choice for investigation of this condition. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8519147", "endSection": "abstract"}, {"offsetInBeginSection": 88, "offsetInEndSection": 204, "text": "Currently the method of choice for cerebrospinal fluid detection is qualitative determination of beta-2-transferrin. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11109603", "endSection": "abstract"}, {"offsetInBeginSection": 1265, "offsetInEndSection": 1390, "text": " In conclusion, 3D-CISS is a non-invasive and reliable technique, and should be the first-choice method to localise CSF leak. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19723768", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 135, "text": "The contribution of 3D-CISS and contrast-enhanced MR cisternography in detecting cerebrospinal fluid leak in patients with rhinorrhoea. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19723768", "endSection": "title"}, {"offsetInBeginSection": 63, "offsetInEndSection": 287, "text": "unenhanced (three-dimensional constructive interference in steady state (3D-CISS)) and contrast-enhanced MR cisternography (CE-MRC) in detecting the localisation of cerebrospinal fluid (CSF) leak in patients with rhinorrhoea ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19723768", "endSection": "abstract"}, {"offsetInBeginSection": 252, "offsetInEndSection": 461, "text": "The diagnostic work-up included lumbar tapping and measurement of CSF opening pressure, radioisotope cisternography, brain and spinal magnetic resonance imaging (MRI), and computed tomography (CT) myelography. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19242563", "endSection": "abstract"}, {"offsetInBeginSection": 97, "offsetInEndSection": 362, "text": "A Tc-99m diethyltriaminepentacetic acid radionuclide cisternography (RNC) showed the accumulation of radioactivity in the area of the subarachnoid space, the poor migration of the isotope over the convexities, and the early appearance of kidney and bladder activity ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11331153", "endSection": "abstract"}]}, {"body": "Which are currently available software tools for detecting rare codon clusters in coding sequences?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22467916", "http://www.ncbi.nlm.nih.gov/pubmed/22199385", "http://www.ncbi.nlm.nih.gov/pubmed/20167116", "http://www.ncbi.nlm.nih.gov/pubmed/18923675", "http://www.ncbi.nlm.nih.gov/pubmed/10689191", "http://www.ncbi.nlm.nih.gov/pubmed/18457591"], "ideal_answer": "Latcom, a new web tool, which offers several alternative methods for 'rare codon cluster' ( rcc ) identificationLatcom : a web server for visualizing rare codon clusters and produces a user-friendly html output.Three RCC detection schemes are implemented : the recently described % MinMax algorithm and a simplified sliding window approach, along with a novel modification of a linear-time algorithm for the detection of maximally scoring subsequences tailored to the RCC detection problem this makes it possible to correlate the position of clusters of rare codons in a gene, predicted to cause a translational pause, with the position of hydrophobic stretches in the encoded protein, predicted to span a membrane or to act as a cleavable signal for targeting to the secretory pathway.We present latcom : a web server for visualizing rare codon clusters in coding sequences the pause software has been developed as a new tool to study translational control over protein targeting.Our program sherlocc, detects statistically relevant conserved rare codon cluster' ( rcc ) identification", "exact_answer": [["LaTcOm"], ["%MinMax"], ["PAUSE"], ["Sherlocc"], ["Sliding Window", "RiboTempo"]], "type": "list", "id": "51be411b047fa84d1d000006", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 76, "text": "LaTcOm: a web server for visualizing rare codon clusters in coding sequences ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22199385", "endSection": "title"}, {"offsetInBeginSection": 631, "offsetInEndSection": 755, "text": "Our program Sherlocc, detects statistically relevant conserved rare codon clusters and produces a user-friendly HTML output. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22467916", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 133, "text": "We present LaTcOm, a new web tool, which offers several alternative methods for 'rare codon cluster' (RCC) identification ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22199385", "endSection": "sections.0"}, {"offsetInBeginSection": 209, "offsetInEndSection": 485, "text": "three RCC detection schemes are implemented: the recently described %MinMax algorithm and a simplified sliding window approach, along with a novel modification of a linear-time algorithm for the detection of maximally scoring subsequences tailored to the RCC detection problem ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22199385", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 403, "text": "The PAUSE software has been developed as a new tool to study translational control over protein targeting. This makes it possible to correlate the position of clusters of rare codons in a gene, predicted to cause a translational pause, with the position of hydrophobic stretches in the encoded protein, predicted to span a membrane or to act as a cleavable signal for targeting to the secretory pathway. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10689191", "endSection": "sections.0"}]}, {"body": "How many tissue kallikrein genes are present in the human genome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/1697365", "http://www.ncbi.nlm.nih.gov/pubmed/11006094", "http://www.ncbi.nlm.nih.gov/pubmed/21741862", "http://www.ncbi.nlm.nih.gov/pubmed/20354523", "http://www.ncbi.nlm.nih.gov/pubmed/20103546", "http://www.ncbi.nlm.nih.gov/pubmed/17210241", "http://www.ncbi.nlm.nih.gov/pubmed/16829021", "http://www.ncbi.nlm.nih.gov/pubmed/16800744", "http://www.ncbi.nlm.nih.gov/pubmed/16800742", "http://www.ncbi.nlm.nih.gov/pubmed/15588589", "http://www.ncbi.nlm.nih.gov/pubmed/15015574", "http://www.ncbi.nlm.nih.gov/pubmed/14710225", "http://www.ncbi.nlm.nih.gov/pubmed/12925213", "http://www.ncbi.nlm.nih.gov/pubmed/12727843", "http://www.ncbi.nlm.nih.gov/pubmed/12725528", "http://www.ncbi.nlm.nih.gov/pubmed/12439720", "http://www.ncbi.nlm.nih.gov/pubmed/12439719", "http://www.ncbi.nlm.nih.gov/pubmed/11522960", "http://www.ncbi.nlm.nih.gov/pubmed/11478802", "http://www.ncbi.nlm.nih.gov/pubmed/21072173", "http://www.ncbi.nlm.nih.gov/pubmed/23093268", "http://www.ncbi.nlm.nih.gov/pubmed/21596022", "http://www.ncbi.nlm.nih.gov/pubmed/20574445", "http://www.ncbi.nlm.nih.gov/pubmed/20180637", "http://www.ncbi.nlm.nih.gov/pubmed/18627305", "http://www.ncbi.nlm.nih.gov/pubmed/17275179", "http://www.ncbi.nlm.nih.gov/pubmed/16800725", "http://www.ncbi.nlm.nih.gov/pubmed/16170411", "http://www.ncbi.nlm.nih.gov/pubmed/15516960", "http://www.ncbi.nlm.nih.gov/pubmed/15192120", "http://www.ncbi.nlm.nih.gov/pubmed/11258672", "http://www.ncbi.nlm.nih.gov/pubmed/11177570", "http://www.ncbi.nlm.nih.gov/pubmed/10662548"], "ideal_answer": "Kallikrein gene families have been identified previously in genomes of the human, the mouse, and the rat, and individual kallikrein-like genes in normal and cancerous ovarian tissues and cell lines.Project to perform in silico analyses of the expression pattern of the 15 human klk genes represent the largest contiguous group of proteases within the human genome.The tissue kallikrein family of serine proteases ( hk1-hk15 encoded by the genes klk1-klk15 ) is involved in several cancer-related processes.Tissue kallikreins are a cluster of 15 serine protease genes located in the chromosomal band 19q13.4, a non-randomly rearranged region in many solid tumors, including pancreatic cancer.Human tissue kallikrein gene family consists of 15 genes represent the largest contiguous group of proteases within the human genome.Human kallikreins are a group of closely related serine proteinases that are represented by multigene families in mice and rats.The tissue kallikrein gene family consists of 15 genes tandemly arranged on human chromosome 19q13.4.", "exact_answer": ["15"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007610", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020840"], "type": "factoid", "id": "511a3573df1ebcce7d000018", "snippets": [{"offsetInBeginSection": 106, "offsetInEndSection": 186, "text": "that forms the largest cluster of contiguous protease genes in the human genome. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21596022", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 65, "text": "The human kallikrein gene family consists of 15 serine proteases. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11522960", "endSection": "sections.0"}, {"offsetInBeginSection": 779, "offsetInEndSection": 899, "text": "In this review, we describe the organization of the kallikrein locus and the structure of kallikrein genes and proteins. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20103546", "endSection": "sections.0"}, {"offsetInBeginSection": 246, "offsetInEndSection": 352, "text": "Human tissue kallikrein genes represent the largest contiguous group of proteases within the human genome. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17275179", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 101, "text": "The tissue kallikrein gene family consists of 15 genes tandemly arranged on human chromosome 19q13.4. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16800742", "endSection": "sections.0"}, {"offsetInBeginSection": 434, "offsetInEndSection": 555, "text": "We have recently characterized the human kallikrein gene locus on chromosome 19q13.4, which includes 15 kallikrein genes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11478802", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Tissue kallikreins are a group of closely related serine proteinases that are represented by multigene families in mice and rats. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1697365", "endSection": "sections.0"}, {"offsetInBeginSection": 190, "offsetInEndSection": 317, "text": "The human tissue kallikrein gene family is the largest contiguous family of proteases in the human genome, containing 15 genes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18627305", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 180, "text": "Kallikrein gene families have been identified previously in genomes of the human, the mouse, and the rat, and individual kallikrein-like genes have been found in many more species. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16829021", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 146, "text": "The human tissue kallikrein family of serine proteases (hK1-hK15 encoded by the genes KLK1-KLK15) is involved in several cancer-related processes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16800744", "endSection": "sections.0"}, {"offsetInBeginSection": 102, "offsetInEndSection": 224, "text": "Tissue kallikrein genes (KLKs) are found on chromosome 19q13.3-4 as a gene cluster encoding 15 different serine proteases. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12925213", "endSection": "sections.0"}, {"offsetInBeginSection": 1075, "offsetInEndSection": 1221, "text": "Our map specifies the distance between genes to one base pair accuracy, the relative location, and the direction of transcription of all 15 genes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11006094", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 155, "text": "The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific expression profiles and putative proteolytic functions. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20103546", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "The human tissue Kallikrein family consists of 15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer prognosis. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21741862", "endSection": "sections.0"}, {"offsetInBeginSection": 305, "offsetInEndSection": 450, "text": "Project to perform in silico analyses of the expression pattern of the 15 human KLK genes in normal and cancerous ovarian tissues and cell lines. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12727843", "endSection": "sections.0"}, {"offsetInBeginSection": 205, "offsetInEndSection": 382, "text": "The 15 human and 24 mouse kallikreins have been implicated in pathophysiology of brain, kidney, and respiratory and reproductive systems and often are used as cancer biomarkers. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17210241", "endSection": "sections.0"}, {"offsetInBeginSection": 85, "offsetInEndSection": 250, "text": "Novel kallikrein genes were cloned recently, and it was shown that the human kallikrein family contains 15 genes tandemly aligned on chromosomal locus 19q13.3-q13.4. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12725528", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 184, "text": "Human kallikreins are a cluster of 15 serine protease genes located in the chromosomal band 19q13.4, a non-randomly rearranged region in many solid tumors, including pancreatic cancer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15015574", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 193, "text": "Kallikrein-related peptidases (KLKs) constitute a family of 15 highly conserved serine proteases encoded by the largest uninterrupted cluster of protease-encoding genes within the human genome. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20180637", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 210, "text": "Human tissue kallikreins (hKs), which are encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiological roles. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15516960", "endSection": "sections.0"}, {"offsetInBeginSection": 293, "offsetInEndSection": 531, "text": "The human tissue kallikrein and kallikrein-related peptidases (KLKs), encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiological roles. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23093268", "endSection": "sections.0"}]}, {"body": "Does the Oncotype DX test work with paraffin embedded tissues?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23074401", "http://www.ncbi.nlm.nih.gov/pubmed/18922117", "http://www.ncbi.nlm.nih.gov/pubmed/17463177", "http://www.ncbi.nlm.nih.gov/pubmed/17140367", "http://www.ncbi.nlm.nih.gov/pubmed/17039265", "http://www.ncbi.nlm.nih.gov/pubmed/16361546"], "triples": [{"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A7572812", "o": "Paraffin"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0030415", "o": "http://linkedlifedata.com/resource/umls/label/A9424108"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17999423", "o": "Paraffin"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8438050", "o": "PARAFFIN"}, {"p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", "s": "http://linkedlifedata.com/resource/umls/label/A16755941", "o": "http://www.w3.org/2008/05/skos-xl#Label"}], "ideal_answer": "We used paraffin-embedded core biopsies from a completed phase ii trial to identify genes that correlate with response to primary chemotherapy.In addition to the individual genes that correlate with response to primary chemotherapy.Oncotype dx is a clinically validated, high-complexity, multianalyte reverse transcription-pcr genomic test that predicts the likelihood of breast cancer recurrence in early-stage, node-negative, estrogen receptor-positive breast cancer.One such strategy is the 21-gene assay ( oncotype dx ), which is currently in commercial use in the usa.We therefore investigated the analytical performance of the assay.One advantage of this test is the use of paraffin-embedded blocks instead of previous methods, which required fresh frozen tissue.In addition to the individual genes, the correlation of the Oncotype DX Recurrence Score with pCR was examined rNA was extracted from paraffin blocks", "exact_answer": "Yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016612"], "type": "yesno", "id": "514a0f0ad24251bc05000052", "snippets": [{"offsetInBeginSection": 377, "offsetInEndSection": 415, "text": "RNA was extracted from paraffin blocks ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16361546", "endSection": "sections.0"}, {"offsetInBeginSection": 512, "offsetInEndSection": 578, "text": "We therefore investigated the analytical performance of the assay. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17463177", "endSection": "sections.0"}, {"offsetInBeginSection": 55, "offsetInEndSection": 114, "text": "to develop the 21-gene Recurrence Score assay (Oncotype DX) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16361546", "endSection": "sections.0"}, {"offsetInBeginSection": 590, "offsetInEndSection": 700, "text": "In addition to the individual genes, the correlation of the Oncotype DX Recurrence Score with pCR was examined ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17039265", "endSection": "sections.0"}, {"offsetInBeginSection": 119, "offsetInEndSection": 263, "text": "We used paraffin-embedded core biopsies from a completed phase II trial to identify genes that correlate with response to primary chemotherapy. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17039265", "endSection": "sections.0"}, {"offsetInBeginSection": 12, "offsetInEndSection": 250, "text": "Oncotype DX is a clinically validated, high-complexity, multianalyte reverse transcription-PCR genomic test that predicts the likelihood of breast cancer recurrence in early-stage, node-negative, estrogen receptor-positive breast cancer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17463177", "endSection": "sections.0"}, {"offsetInBeginSection": 726, "offsetInEndSection": 960, "text": "One such strategy is the 21-gene assay (Oncotype DX), which is currently in commercial use in the USA. One advantage of this test is the use of paraffin-embedded blocks instead of previous methods, which required fresh frozen tissue. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17140367", "endSection": "sections.0"}, {"offsetInBeginSection": 588, "offsetInEndSection": 848, "text": "Assays used a pooled RNA sample from fixed paraffin-embedded tissues to evaluate the analytical performance of a 21-gene panel with respect to amplification efficiency, precision, linearity, and dynamic range, as well as limits of detection and quantification. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17463177", "endSection": "sections.0"}, {"offsetInBeginSection": 211, "offsetInEndSection": 546, "text": "Oncotype DXtrade mark, is a diagnostic test comprised of a 21-gene assay applied to paraffin-embedded breast cancer tissue, which allows physicians to predict subgroups of hormone-receptor-positive, node-negative patients who may benefit from hormonal therapy alone or require adjuvant chemotherapy to attain the best survival outcome. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18922117", "endSection": "sections.0"}, {"offsetInBeginSection": 2732, "offsetInEndSection": 3135, "text": "The Oncotype-DX Breast Cancer Assay (Genomic Health, Redwood City, CA) quantifies gene expression for 21 genes in breast cancer tissue by performing reverse transcription polymerase chain reaction (RT-PCR) on formalin-fixed paraffin-embedded (FFPE) tumour blocks that are obtained during initial surgery (lumpectomy, mastectomy, or core biopsy) of women with early breast cancer that is newly diagnosed. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23074401", "endSection": "sections.0"}]}, {"body": "Where does CTCF colocalize with cohesin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23150255", "http://www.ncbi.nlm.nih.gov/pubmed/22780989", "http://www.ncbi.nlm.nih.gov/pubmed/21628529", "http://www.ncbi.nlm.nih.gov/pubmed/20219941", "http://www.ncbi.nlm.nih.gov/pubmed/19109133", "http://www.ncbi.nlm.nih.gov/pubmed/21606361", "http://www.ncbi.nlm.nih.gov/pubmed/19369356", "http://www.ncbi.nlm.nih.gov/pubmed/18219272", "http://www.ncbi.nlm.nih.gov/pubmed/20159591", "http://www.ncbi.nlm.nih.gov/pubmed/21550623"], "triples": [], "ideal_answer": "Here we report that cohesins colocalize with CTCF at two additional imprinted loci, cTCF colocalizes with cohesin but not RNA Polymerase II.The differential binding of cohesin to ctcf and colocalization with cohesins also varied across the cell cycle.In human cells, pol iii genes and transcription factors have also been shown to colocalize with cohesin and the transcription regulator and genome organizer ccctc-binding factor ( ctcf ).Subcellular distribution of ctcf, we performed chromatin immunoprecipitation for the cohesin subunit rad21 and found lineage and stage-specific rad21 recruitment to ctcf in all ig loci.Subcellular distribution of ctcf sites may promote multiple loop formation and thus effective v ( d ) j recombination finally, we observe that the presence of mirrored ctcf binding events at promoters and their nearby cohesin-bound enhancers is associated with elevated expression levels.", "exact_answer": [["In imprinted and repressed, highly compacted loci that are prone to recombination events."]], "concepts": ["http://amigo.geneontology.org/amigo/term/GO:0008278", "http://www.uniprot.org/uniprot/CTCF_HUMAN", "http://www.uniprot.org/uniprot/CTCF_RAT"], "type": "factoid", "id": "56c5c7915795f9a73e000004", "snippets": [{"offsetInBeginSection": 416, "offsetInEndSection": 499, "text": "Here we report that cohesins colocalize with CTCF at two additional imprinted loci, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21628529", "endSection": "abstract"}, {"offsetInBeginSection": 369, "offsetInEndSection": 426, "text": "CTCF colocalizes with cohesin but not RNA Polymerase II. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21550623", "endSection": "abstract"}, {"offsetInBeginSection": 415, "offsetInEndSection": 542, "text": "Here we report that cohesins colocalize with CTCF at two additional imprinted loci, the Dlk1-Dio3 and the Kcnq1/Kcnq1ot1 loci. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21628529", "endSection": "abstract"}, {"offsetInBeginSection": 1072, "offsetInEndSection": 1173, "text": "Subcellular distribution of CTCF and colocalization with cohesins also varied across the cell cycle. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356", "endSection": "abstract"}, {"offsetInBeginSection": 1406, "offsetInEndSection": 1532, "text": "We conclude that cohesins interact with CTCF in mid-S phase and repress CTCF-regulated genes in a cell cycle-dependent manner. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356", "endSection": "abstract"}, {"offsetInBeginSection": 1144, "offsetInEndSection": 1283, "text": "Results of these experiments demonstrate an unappreciated role for CTCF and cohesins in the repression of imprinted genes in somatic cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21628529", "endSection": "abstract"}, {"offsetInBeginSection": 235, "offsetInEndSection": 383, "text": "Here, we show in different cell types that cohesin functionally behaves as a tissue-specific transcriptional regulator, independent of CTCF binding. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20219941", "endSection": "abstract"}, {"offsetInBeginSection": 687, "offsetInEndSection": 881, "text": "Because cohesin can colocalize with CTCF, we performed chromatin immunoprecipitation for the cohesin subunit Rad21 and found lineage and stage-specific Rad21 recruitment to CTCF in all Ig loci. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19109133", "endSection": "abstract"}, {"offsetInBeginSection": 1060, "offsetInEndSection": 1202, "text": "We conclude that cohesin subunits associate with viral and cellular CTCF sites involved in complex gene regulation and chromatin organization. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18219272", "endSection": "abstract"}, {"offsetInBeginSection": 98, "offsetInEndSection": 306, "text": "Recently, cohesins have been implicated in transcriptional regulation and insulation through genome-wide colocalization with the insulator protein CTCF, including involvement at the imprinted H19/Igf2 locus. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21628529", "endSection": "abstract"}, {"offsetInBeginSection": 1232, "offsetInEndSection": 1402, "text": "Finally, we observe that the presence of mirrored CTCF binding events at promoters and their nearby cohesin-bound enhancers is associated with elevated expression levels. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22780989", "endSection": "abstract"}, {"offsetInBeginSection": 954, "offsetInEndSection": 1139, "text": "In human cells, Pol III genes and transcription factors have also been shown to colocalize with cohesin and the transcription regulator and genome organizer CCCTC-binding factor (CTCF). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23150255", "endSection": "abstract"}, {"offsetInBeginSection": 698, "offsetInEndSection": 871, "text": " To determine the functional importance of the binding of CTCF and cohesins at the three imprinted loci, CTCF and cohesins were depleted in mouse embryonic fibroblast cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21628529", "endSection": "abstract"}, {"offsetInBeginSection": 626, "offsetInEndSection": 789, "text": "These numerous CTCF/cohesin sites potentially form the bases of the multiloop rosette structures at the Igh locus that compact during Ig heavy chain rearrangement. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21606361", "endSection": "abstract"}, {"offsetInBeginSection": 666, "offsetInEndSection": 887, "text": " In contrast to regions of the genome where cohesin and CTCF colocalize, CNC sites coincide with the binding of master regulators and enhancer-markers and are significantly associated with liver-specific expressed genes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22780989", "endSection": "abstract"}, {"offsetInBeginSection": 691, "offsetInEndSection": 1010, "text": "Because cohesin can colocalize with CTCF, we performed chromatin immunoprecipitation for the cohesin subunit Rad21 and found lineage and stage-specific Rad21 recruitment to CTCF in all Ig loci. The differential binding of cohesin to CTCF sites may promote multiple loop formation and thus effective V(D)J recombination. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19109133", "endSection": "abstract"}, {"offsetInBeginSection": 348, "offsetInEndSection": 560, "text": "To investigate cohesin-non-CTCF (CNC) binding events in vivo we mapped cohesin and CTCF, as well as a collection of tissue-specific and ubiquitous transcriptional regulators using ChIP-seq in primary mouse liver. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22780989", "endSection": "abstract"}, {"offsetInBeginSection": 598, "offsetInEndSection": 834, "text": "By use of human hepatocellular carcinoma cells (HepG2), we found that liver-specific transcription factors colocalize with cohesin independently of CTCF at liver-specific targets that are distinct from those found in breast cancer cells ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20219941", "endSection": "abstract"}, {"offsetInBeginSection": 449, "offsetInEndSection": 626, "text": "ChIP sequencing was performed on pro-B cells, revealing colocalization of CTCF and Rad21 binding at ~60 sites throughout the V(H) region and 2 other sites within the Igh locus. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21606361", "endSection": "abstract"}, {"offsetInBeginSection": 450, "offsetInEndSection": 705, "text": "Here, we show that ATRX, MeCP2, and cohesin, chromatin regulators implicated in ATR-X, RTT, and CdLS syndromes, respectively, interact in the brain and colocalize at the H19 imprinting control region (ICR) with preferential binding on the maternal allele. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20159591", "endSection": "abstract"}, {"offsetInBeginSection": 384, "offsetInEndSection": 596, "text": "By performing matched genome-wide binding assays (ChIP-seq) in human breast cancer cells (MCF-7), we discovered thousands of genomic sites that share cohesin and estrogen receptor alpha (ER) yet lack CTCF binding ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20219941", "endSection": "abstract"}, {"offsetInBeginSection": 1246, "offsetInEndSection": 1526, "text": "Together, our data show that cohesin cobinds across the genome with transcription factors independently of CTCF, plays a functional role in estrogen-regulated transcription, and may help to mediate tissue-specific transcriptional responses via long-range chromosomal interactions. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20219941", "endSection": "abstract"}, {"offsetInBeginSection": 1533, "offsetInEndSection": 1788, "text": "We propose that the CTCF-cohesin complex plays a critical role in regulating the cell cycle control of viral gene expression during latency and that failure to maintain cell cycle control of latent transcripts inhibits host cell proliferation and survival ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356", "endSection": "abstract"}, {"offsetInBeginSection": 685, "offsetInEndSection": 1004, "text": " Because cohesin can colocalize with CTCF, we performed chromatin immunoprecipitation for the cohesin subunit Rad21 and found lineage and stage-specific Rad21 recruitment to CTCF in all Ig loci. The differential binding of cohesin to CTCF sites may promote multiple loop formation and thus effective V(D)J recombination ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19109133", "endSection": "abstract"}]}, {"body": "Name triad of Wernicke encephalopathy.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24379094", "http://www.ncbi.nlm.nih.gov/pubmed/25550705", "http://www.ncbi.nlm.nih.gov/pubmed/25515801", "http://www.ncbi.nlm.nih.gov/pubmed/24620429", "http://www.ncbi.nlm.nih.gov/pubmed/24099834", "http://www.ncbi.nlm.nih.gov/pubmed/10328278", "http://www.ncbi.nlm.nih.gov/pubmed/23935638", "http://www.ncbi.nlm.nih.gov/pubmed/14644703", "http://www.ncbi.nlm.nih.gov/pubmed/3469966", "http://www.ncbi.nlm.nih.gov/pubmed/19571457", "http://www.ncbi.nlm.nih.gov/pubmed/9417174", "http://www.ncbi.nlm.nih.gov/pubmed/7424767", "http://www.ncbi.nlm.nih.gov/pubmed/22332852", "http://www.ncbi.nlm.nih.gov/pubmed/21121997", "http://www.ncbi.nlm.nih.gov/pubmed/21519777", "http://www.ncbi.nlm.nih.gov/pubmed/17595443"], "triples": [], "ideal_answer": "Wernicke's encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia.In 25 ( 35 % ) of the patients diagnosed only at postmortem examination ( 41.9 % ) confirms that wernicke & apos; s encephalopathy is a triad of ophthalmoplegia, ataxia and confusion, was foundWernicke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia but is not seen in a majority of patients.Wernicke & apos; s encephalopathy clinical triad ( mental status changes, ocular signs, and ataxia ) at neurologic onset; nine eventually demonstrated this triad.Only six presented with the wernicke & apos; s encephalopathy clinical triad consists of encephalopathy, oculomotor dysfunction and gait ataxia but is not seen in a majority of patients.Wernicke & apos; s encephalopathy with ocular symptoms, ataxia and confusion seen in alcoholics with dietary vitamin b1 ( thiamine ) deficiency the high rate of patients the classic triad of wernicke & apos; s encephalopathy is underdiagnosed in children.", "exact_answer": [["ophthalmoplegia"], ["ataxia"], ["confusion"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014899", "http://www.disease-ontology.org/api/metadata/DOID:2384"], "type": "list", "id": "56be143eef6e394741000009", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "Wernicke encephalopathy (WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia, ataxia, and mental confusion ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9417174", "endSection": "abstract"}, {"offsetInBeginSection": 145, "offsetInEndSection": 277, "text": "Wernicke's encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23935638", "endSection": "abstract"}, {"offsetInBeginSection": 896, "offsetInEndSection": 1023, "text": "The classic triad consists of encephalopathy, oculomotor dysfunction and gait ataxia but is not seen in a majority of patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25515801", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Wernicke's encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25550705", "endSection": "abstract"}, {"offsetInBeginSection": 315, "offsetInEndSection": 442, "text": "After frequent vomiting, he presented with mental status changes, ocular abnormalities, and truncal ataxia (the classic triad). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24620429", "endSection": "abstract"}, {"offsetInBeginSection": 187, "offsetInEndSection": 345, "text": "It was found that only 0.4% of the population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia, and ataxia ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3469966", "endSection": "abstract"}, {"offsetInBeginSection": 164, "offsetInEndSection": 300, "text": "In 25/73 (35%) of the patients the classic triad of Wernicke&apos;s encephalopathy with ocular symptoms, ataxia and confusion, was found ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22332852", "endSection": "abstract"}, {"offsetInBeginSection": 330, "offsetInEndSection": 484, "text": "It was found that only 0.4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia, and ataxia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3469966", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 143, "text": "Wernicke's encephalopathy is a triad of ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24099834", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 147, "text": "Wernicke&apos;s encephalopathy is a triad of ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24099834", "endSection": "abstract"}, {"offsetInBeginSection": 150, "offsetInEndSection": 324, "text": "In the classical form it is characterized by a typical triad (confusion, oculomotor disturbance and ataxia), however, in the majority of the cases only confusion is present. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24379094", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 171, "text": "Wernicke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19571457", "endSection": "abstract"}, {"offsetInBeginSection": 275, "offsetInEndSection": 447, "text": "The classical triad of clinical symptoms described by Wernicke (gait ataxia, ophthalmoplegia, and confusion) are found in only a third of patients upon initial examination. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14644703", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 194, "text": "Wernicke&apos;s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21519777", "endSection": "abstract"}, {"offsetInBeginSection": 1123, "offsetInEndSection": 1303, "text": "Only six presented with the Wernicke's encephalopathy clinical triad (mental status changes, ocular signs, and ataxia) at neurologic onset; nine eventually demonstrated this triad. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10328278", "endSection": "abstract"}, {"offsetInBeginSection": 213, "offsetInEndSection": 425, "text": "The triad of Wernicke&apos;s encephalopathy--global confusional state, ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine treatment ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7424767", "endSection": "abstract"}, {"offsetInBeginSection": 409, "offsetInEndSection": 617, "text": "The triad of Wernicke's encephalopathy--global confusional state, ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine treatment. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7424767", "endSection": "abstract"}, {"offsetInBeginSection": 359, "offsetInEndSection": 589, "text": "Wernicke&apos;s encephalopathy (WE) is a serious, potentially fatal, neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia, and confusion ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17595443", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 244, "text": "Wernicke&apos;s encephalopathy is a metabolic disorder caused by deficiency of thiamine (vitamin B1) seen in alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia, ophthalmoplegia, and altered mental status ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21121997", "endSection": "abstract"}, {"offsetInBeginSection": 973, "offsetInEndSection": 1309, "text": "Only six presented with the Wernicke&apos;s encephalopathy clinical triad (mental status changes, ocular signs, and ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41.9%) confirms that Wernicke&apos;s encephalopathy is underdiagnosed in children. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10328278", "endSection": "abstract"}]}, {"body": "Is the PTPN22 gene a biomarker for Rheumatoid Arthritis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23242182", "http://www.ncbi.nlm.nih.gov/pubmed/22661644", "http://www.ncbi.nlm.nih.gov/pubmed/22427951", "http://www.ncbi.nlm.nih.gov/pubmed/21784728", "http://www.ncbi.nlm.nih.gov/pubmed/21752868", "http://www.ncbi.nlm.nih.gov/pubmed/21614018", "http://www.ncbi.nlm.nih.gov/pubmed/21607711", "http://www.ncbi.nlm.nih.gov/pubmed/21545847", "http://www.ncbi.nlm.nih.gov/pubmed/21542789", "http://www.ncbi.nlm.nih.gov/pubmed/21360494", "http://www.ncbi.nlm.nih.gov/pubmed/20921970", "http://www.ncbi.nlm.nih.gov/pubmed/20604892", "http://www.ncbi.nlm.nih.gov/pubmed/20560812", "http://www.ncbi.nlm.nih.gov/pubmed/20498205", "http://www.ncbi.nlm.nih.gov/pubmed/20398001", "http://www.ncbi.nlm.nih.gov/pubmed/20353580", "http://www.ncbi.nlm.nih.gov/pubmed/20061955", "http://www.ncbi.nlm.nih.gov/pubmed/20032229", "http://www.ncbi.nlm.nih.gov/pubmed/20017985", "http://www.ncbi.nlm.nih.gov/pubmed/19950324", "http://www.ncbi.nlm.nih.gov/pubmed/19856886", "http://www.ncbi.nlm.nih.gov/pubmed/19648126", "http://www.ncbi.nlm.nih.gov/pubmed/19445664", "http://www.ncbi.nlm.nih.gov/pubmed/19404967", "http://www.ncbi.nlm.nih.gov/pubmed/19365265", "http://www.ncbi.nlm.nih.gov/pubmed/19324521", "http://www.ncbi.nlm.nih.gov/pubmed/20707220", "http://www.ncbi.nlm.nih.gov/pubmed/19034456", "http://www.ncbi.nlm.nih.gov/pubmed/18812394", "http://www.ncbi.nlm.nih.gov/pubmed/18648537", "http://www.ncbi.nlm.nih.gov/pubmed/18535030", "http://www.ncbi.nlm.nih.gov/pubmed/18462498", "http://www.ncbi.nlm.nih.gov/pubmed/18398946", "http://www.ncbi.nlm.nih.gov/pubmed/18305142", "http://www.ncbi.nlm.nih.gov/pubmed/18240242", "http://www.ncbi.nlm.nih.gov/pubmed/18156150", "http://www.ncbi.nlm.nih.gov/pubmed/17666451", "http://www.ncbi.nlm.nih.gov/pubmed/17341507", "http://www.ncbi.nlm.nih.gov/pubmed/16380915", "http://www.ncbi.nlm.nih.gov/pubmed/16320352", "http://www.ncbi.nlm.nih.gov/pubmed/16309943", "http://www.ncbi.nlm.nih.gov/pubmed/16257177", "http://www.ncbi.nlm.nih.gov/pubmed/15883854"], "triples": [{"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3793", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PTPN22"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PTPN22", "o": "PTPN22"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3793", "o": "Rheumatoid arthritis, susceptibility to, 180300"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PTPN22", "o": "http://www.dbpedia.org/resource/PTPN22"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/999", "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PTPN22"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/999", "o": "http://www4.wiwiss.fu-berlin.de/sider/resource/side_effects/C0003873"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://data.linkedct.org/resource/condition/11608", "o": "Condition #11608 (Rheumatoid Arthritis)"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PTPN22", "o": "PTPN22"}, {"p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/name", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/999", "o": "Rheumatoid_arthritis"}, {"p": "http://data.linkedct.org/resource/linkedct/condition_name", "s": "http://data.linkedct.org/resource/condition/11608", "o": "Rheumatoid Arthritis"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://data.linkedct.org/resource/condition/11608", "o": "http://dbpedia.org/resource/Rheumatoid_arthritis"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://data.linkedct.org/resource/condition/11608", "o": "http://yago.org/resource/Rheumatoid_arthritis"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/PTPN22", "o": "http://www.dbpedia.org/resource/PTPN22"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/999", "o": "http://www.dbpedia.org/resource/Rheumatoid_arthritis"}], "ideal_answer": "Our data depict a model that can reconcile the conflicting observations on the functional impact of the C1858T SNP and also suggest that PTPN22.6 is a novel biomarker of rheumatoid arthritis.Association of the PTPN22 gene ( -1123G > C ) polymorphism with rheumatoid arthritis in Chinese patients these genes include PTPN22, TRAF1-C5, PADI4, STAT4 auto-antibodies, HLA and PTPN22 : susceptibility markers for rheumatoid arthritis the C1858T allele of the PTPN22 gene has been reported to confer risk for RA weak evidence for an effect at the PTPN22 locus was also observed pTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis : results from the ESPOIR cohort", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001172", "http://www.disease-ontology.org/api/metadata/DOID:7148", "http://www.disease-ontology.org/api/metadata/DOID:676", "http://www.disease-ontology.org/api/metadata/DOID:11042", "http://www.disease-ontology.org/api/metadata/DOID:1586", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001171", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015415", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005258", "http://www.uniprot.org/uniprot/PTN22_HUMAN", "http://www.uniprot.org/uniprot/PTN22_MOUSE", "http://www.uniprot.org/uniprot/SERPH_HUMAN", "http://www.uniprot.org/uniprot/SAST_HUMAN"], "type": "yesno", "id": "52e7870a98d023950500001a", "snippets": [{"offsetInBeginSection": 1237, "offsetInEndSection": 1428, "text": "Our data depict a model that can reconcile the conflicting observations on the functional impact of the C1858T SNP and also suggest that PTPN22.6 is a novel biomarker of rheumatoid arthritis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22427951", "endSection": "abstract"}, {"offsetInBeginSection": 1361, "offsetInEndSection": 1422, "text": "No association of the PTPN22 gene with mortality was detected ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18240242", "endSection": "abstract"}, {"offsetInBeginSection": 2330, "offsetInEndSection": 2393, "text": "No gene-gene interaction was observed between PTPN22 and HLA-SE ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18462498", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 80, "text": "Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18156150", "endSection": "title"}, {"offsetInBeginSection": 426, "offsetInEndSection": 504, "text": "HLA-DRB1 and the R620W single-nucleotide polymorphism of PTPN22 were genotyped ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21360494", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 99, "text": "PTPN22, PADI-4, and CTLA-4 have been associated with risk for rheumatoid arthritis (RA) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18462498", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 76, "text": "The C1858T allele of the PTPN22 gene has been reported to confer risk for RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19034456", "endSection": "abstract"}, {"offsetInBeginSection": 1506, "offsetInEndSection": 1575, "text": "Our analyses have confirmed previous findings for genes PTPN22 and C5 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20017985", "endSection": "abstract"}, {"offsetInBeginSection": 908, "offsetInEndSection": 973, "text": "Weak evidence for an effect at the PTPN22 locus was also observed ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20921970", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Association of the PTPN22 gene (-1123G > C) polymorphism with rheumatoid arthritis in Chinese patients ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20604892", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "Functional polymorphisms of PTPN22 and FcgR genes in Tunisian patients with rheumatoid arthritis ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20707220", "endSection": "title"}, {"offsetInBeginSection": 327, "offsetInEndSection": 398, "text": "We found strong evidence of an association of PTPN22 620W allele and RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20707220", "endSection": "abstract"}, {"offsetInBeginSection": 1253, "offsetInEndSection": 1357, "text": "Homozygous and heterozygous carriers of the PTPN22 1858T allele had a decreased probability of remission ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20032229", "endSection": "abstract"}, {"offsetInBeginSection": 1421, "offsetInEndSection": 1506, "text": "Lack of association of common variants in PTPN22 with RA in Han Chinese was confirmed ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21784728", "endSection": "abstract"}, {"offsetInBeginSection": 263, "offsetInEndSection": 343, "text": "Several other genes, including PTPN22 and PADI4, show modest association with RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21607711", "endSection": "abstract"}, {"offsetInBeginSection": 1986, "offsetInEndSection": 2105, "text": "A significant multiplicative interaction between PTPN22 and smoking for more than 10 pack-years was observed (P = 0.04) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18462498", "endSection": "abstract"}, {"offsetInBeginSection": 1239, "offsetInEndSection": 1376, "text": "Similarly, the presence or absence of the HLA-DRB1 shared epitope or the RA-associated PTPN22 allele had no influence on this association ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18812394", "endSection": "abstract"}, {"offsetInBeginSection": 922, "offsetInEndSection": 1065, "text": "In addition, evidence of a significant interaction between the shared epitope and the risk allele of PTPN22 was observed only in these patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21360494", "endSection": "abstract"}, {"offsetInBeginSection": 549, "offsetInEndSection": 702, "text": "In addition, how the overall activity of PTPN22 is regulated and how the R-to-W conversion contributes to rheumatoid arthritis is still poorly understood ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22427951", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 171, "text": "Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17341507", "endSection": "title"}, {"offsetInBeginSection": 1187, "offsetInEndSection": 1329, "text": "In logistic regression analysis, ACPA predicted RA-development independent of PTPN22, while the PTPN22 polymorphism had no independent effect. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17341507", "endSection": "abstract"}, {"offsetInBeginSection": 981, "offsetInEndSection": 1085, "text": "Association studies support a role for several genes, including TNFR2, PADI4, SLC22A4, RUNX1, and PTPN22 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16309943", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 153, "text": "PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21752868", "endSection": "title"}, {"offsetInBeginSection": 1647, "offsetInEndSection": 1767, "text": "In our Slovak population, HLA-DRB1 alleles as well as SNPs in STAT4 and PTPN22 genes showed a strong association with RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19445664", "endSection": "abstract"}, {"offsetInBeginSection": 847, "offsetInEndSection": 992, "text": " Recently a number of convincing candidate genes have begun to emerge and an update has been provided for three of these: PTPN22, CTLA-4 and MIF. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16257177", "endSection": "abstract"}, {"offsetInBeginSection": 514, "offsetInEndSection": 627, "text": "Among these genes, PTPN22 plays an outstanding role. CD40, STAT4, PRM1, and TNFAIP3 also seem to be of relevance. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21542789", "endSection": "abstract"}, {"offsetInBeginSection": 858, "offsetInEndSection": 1014, "text": "In conclusion, we have confirmed that PTPN22 620W allele is associated with Tunisian RA but does not constitute a factor influencing clinical manifestations ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20707220", "endSection": "abstract"}, {"offsetInBeginSection": 1291, "offsetInEndSection": 1413, "text": "Genetic markers such as shared epitope alleles and PTPN22 1858T variant increase the relative risk for disease development ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19365265", "endSection": "abstract"}, {"offsetInBeginSection": 11, "offsetInEndSection": 205, "text": "Anti-citrullinated peptide antibodies (ACPA) and the C1858T missense single-nucleotide polymorphism (SNP) in the PTPN22 gene are both associated with the development of rheumatoid arthritis (RA) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17341507", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 155, "text": "HLA-DRB1 shared epitope (HLA-SE), PTPN22 and CTLA4 alleles are associated with cyclic citrullinated peptide (CCP) and rheumatoid arthritis (RA) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17666451", "endSection": "abstract"}, {"offsetInBeginSection": 119, "offsetInEndSection": 281, "text": "Although some genetic risk factors for RA are well-established, most notably HLA-DRB1 and PTPN22, these markers do not fully account for the observed heritability ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18648537", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 187, "text": "Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16380915", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 182, "text": "Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18535030", "endSection": "title"}, {"offsetInBeginSection": 747, "offsetInEndSection": 894, "text": "Therefore, the CC genotype and C allele of the -1123G > C in the PTPN22 gene may be used as a genetic marker for the predisposition of RA in Chines ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20604892", "endSection": "abstract"}, {"offsetInBeginSection": 1224, "offsetInEndSection": 1442, "text": "The combination of the T variant of the 1858 polymorphism of the PTPN22 gene in combination with the presence of anti-CCP antibodies, preferentially in a SE-positive individual, is associated with the development of RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18156150", "endSection": "abstract"}, {"offsetInBeginSection": 593, "offsetInEndSection": 745, "text": "These data suggest, the CC genotype and C allele of the -1123G > C in the PTPN22 gene are associated with an increased risk for RA in Chinese population ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20604892", "endSection": "abstract"}, {"offsetInBeginSection": 1656, "offsetInEndSection": 1823, "text": "Lastly, in combination with the other two known genetic risk factors, HLA-DRB1 and PTPN22, the variants reported here generate more than a 45-fold RA-risk differential ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18648537", "endSection": "abstract"}, {"offsetInBeginSection": 964, "offsetInEndSection": 1138, "text": "However, we were able to replicate the association signals between RA and HLA-DRB1 alleles, STAT4 (rs7574865), PTPN22 (rs2476601) and OLIG3/TNFAIP3 (rs10499194 and rs6920220) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19445664", "endSection": "abstract"}, {"offsetInBeginSection": 155, "offsetInEndSection": 303, "text": "Currently, 5 loci (HLA, PTPN22, TRAF1/C5, TNFAIP3, and STAT4) have been consistently reported, whereas others have been observed less systematically ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19404967", "endSection": "abstract"}, {"offsetInBeginSection": 876, "offsetInEndSection": 990, "text": " PTPN22 620W risk allele was associated with ACPA production [odds ratio (OR)\u2009=\u20092.21, 95% CI 1.4, 3.4, P\u2009<\u20090.0001] ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21752868", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 183, "text": "Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17666451", "endSection": "title"}, {"offsetInBeginSection": 1437, "offsetInEndSection": 1606, "text": "A longer duration of breastfeeding increased the risk of developing RA, especially among individuals seropositive for ACPA or IgM-RF or carrying the PTPN22 1858T variant ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20560812", "endSection": "abstract"}, {"offsetInBeginSection": 594, "offsetInEndSection": 808, "text": "Progress has been made in determining the relative contributions and the interaction of the shared epitope, PTPN22 and smoking in conferring the risk of anticitrullinated protein antibodies-positive and negative RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20061955", "endSection": "abstract"}, {"offsetInBeginSection": 802, "offsetInEndSection": 989, "text": "We found strong evidence of an association of PTPN22 with the development of anti-citrulline antibody-positive RA (odds ratio [OR] 1.49; P=.00002), using previously untested EIRA samples. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16380915", "endSection": "abstract"}, {"offsetInBeginSection": 582, "offsetInEndSection": 779, "text": "Particularly, ACPAs in combination with human leukocyte antigen-shared epitope alleles and PTPN22 1858T carriage increased the relative risks of developing RA compared with not having these factors ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19365265", "endSection": "abstract"}, {"offsetInBeginSection": 11, "offsetInEndSection": 242, "text": "To evaluate the predictive values for disease progression of various antibodies against citrullinated peptide proteins (ACPA) and their relation to PTPN22 1858C/T polymorphism and HLA-DRB1 alleles in early rheumatoid arthritis (RA) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18398946", "endSection": "abstract"}, {"offsetInBeginSection": 2408, "offsetInEndSection": 2635, "text": "After adjusting for smoking and reproductive factors, PTPN22 was associated with RA risk among Caucasian women in these cohorts. We found both additive and multiplicative interactions between PTPN22 and heavy cigarette smoking. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18462498", "endSection": "abstract"}, {"offsetInBeginSection": 892, "offsetInEndSection": 1089, "text": "Other variants in potentially pathogenic genes located in non-MHC regions have been implicated by recently performed genome wide analysis studies. These genes include PTPN22, TRAF1-C5, PADI4, STAT4 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21545847", "endSection": "abstract"}, {"offsetInBeginSection": 1298, "offsetInEndSection": 1516, "text": " Exploration of our data set with clinically relevant subsets of RA reveals that PTPN22 is associated with an earlier age at disease onset (P=.004) and that PTPN22 has a stronger effect in males than in females (P=.03) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16380915", "endSection": "abstract"}, {"offsetInBeginSection": 1011, "offsetInEndSection": 1209, "text": "The combination of the PTPN22 1858T variant and anti-CCP antibodies gave a high specificity for the disease, and was significantly associated with RA (P = 8.86 x 10(-5), OR 10.05, 95% CI 1.88-53.73) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18156150", "endSection": "abstract"}, {"offsetInBeginSection": 1521, "offsetInEndSection": 1744, "text": "This study identifies MMEL1 and CTLA4 as RA susceptibility genes, provides suggestive evidence of association for a further six loci in the Han Chinese population and confirms lack of PTPN22 association in Asian populations ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21784728", "endSection": "abstract"}, {"offsetInBeginSection": 133, "offsetInEndSection": 384, "text": "As well as the major susceptibility gene HLA-DRB1, recent genome-wide and candidate-gene studies reported additional evidence for association of single nucleotide polymorphism (SNP) markers in the PTPN22, STAT4, OLIG3/TNFAIP3 and TRAF1/C5 loci with RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19445664", "endSection": "abstract"}, {"offsetInBeginSection": 1248, "offsetInEndSection": 1485, "text": "PTPN22 1858T, TNFRII 196R and HLA-SE alleles do not improve the predictive value of RF and ACPA for RA diagnosis in our cohort, and do not contribute to an earlier diagnosis in undifferentiated patients initially negative for RF and ACPA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18535030", "endSection": "abstract"}, {"offsetInBeginSection": 1711, "offsetInEndSection": 1960, "text": " Given the strong statistical power to replicate a true-positive association in this study, our results provide support for PTPN22, CTLA4, and PADI4 as RA susceptibility genes and demonstrate novel associations with clinically relevant subsets of RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16380915", "endSection": "abstract"}, {"offsetInBeginSection": 546, "offsetInEndSection": 776, "text": "Patients were analysed for anti-MCV and anti-cyclic citrullinated peptide (CCP), and were genotyped for human leukocyte antigen (HLA)-DRB1 \"shared epitope\" (SE) and protein tyrosine phosphatase, non-receptor type 22 (PTPN22) 1858T ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19648126", "endSection": "abstract"}, {"offsetInBeginSection": 204, "offsetInEndSection": 425, "text": "Recent genome-wide association studies (GWAS) on RA identified known and novel susceptibility genes like HLA-DRB1, PTPN22, STAT4, TRAF1/C5, OLIG3/TNFAIP3, CD40, CCL21, MMEL1-TNFRSF14, CDK6, PRKCQ, IL2RB, and KIF5A-PIP4K2C ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20398001", "endSection": "abstract"}, {"offsetInBeginSection": 745, "offsetInEndSection": 997, "text": "Fifty-five percent of the FDRs had > or =1 copy of the shared epitope, 20% had > or =1 copy of the PTPN22 polymorphism, and approximately 16% were positive for rheumatoid factor (RF; including isotypes) and/or anti-cyclic citrullinated peptide antibody ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19950324", "endSection": "abstract"}, {"offsetInBeginSection": 321, "offsetInEndSection": 663, "text": "However, inconsistent results of the contributions of non-HLA susceptibility genes have been described, with the exception of a few genes repeatedly associated with RA-susceptibility, such as PTPN22 gene in populations of European ancestry and PADI4 gene in populations of Asian ancestry, revealing the presence of genetic heterogeneity in RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19324521", "endSection": "abstract"}, {"offsetInBeginSection": 75, "offsetInEndSection": 353, "text": "A C-to-T single nucleotide polymorphism (SNP) located at position 1858 of human PTPN22 cDNA and converting an arginine (R620) to tryptophan (W620) confers the highest risk of rheumatoid arthritis among non-HLA genetic variations that are known to be associated with this disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22427951", "endSection": "abstract"}, {"offsetInBeginSection": 1166, "offsetInEndSection": 1413, "text": "Combined longitudinal analysis of the 2 cohorts suggests further association of several loci with Larsen score (KIF5A, PTPN22, AFF3, TAGAP) and therefore a significant accumulation of RA severity markers among RA susceptibility markers (p = 0.016) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23242182", "endSection": "abstract"}, {"offsetInBeginSection": 1028, "offsetInEndSection": 1320, "text": "A non-intronic marker at TNFAIP3, GIN1/C5orf30, STAT4, ANKRD55/IL6ST, BLK and PTPN22 showed association with RA susceptibility, irrespective of the serological status, the latter three markers remaining significantly associated with anti-CCP negative RA, after correction for multiple testing ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22661644", "endSection": "abstract"}, {"offsetInBeginSection": 992, "offsetInEndSection": 1262, "text": "Hormonal treatment exposition and smoking were found to act with a protective effect against ACPA production (OR\u2009=\u20090.44, 95% CI 0.3, 0.7, P\u2009=\u20090.001) and early bone erosion (OR\u2009=\u20090.56, 95% CI 0.4-0.8, P\u2009=\u20090.003), respectively, and independently of HLADR and PTPN22 status ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21752868", "endSection": "abstract"}, {"offsetInBeginSection": 11, "offsetInEndSection": 338, "text": "The disease association of the common 1858C>T Arg620Trp (rs2476601) nonsynonymous single nucleotide polymorphism (SNP) of protein tyrosine phosphatase; nonreceptor type 22 (PTPN22) on chromosome 1p13 has been confirmed in type 1 diabetes and also in other autoimmune diseases, including rheumatoid arthritis and Graves' disease ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18305142", "endSection": "abstract"}, {"offsetInBeginSection": 1183, "offsetInEndSection": 1496, "text": "After quality control, 3209 patients and 3692 controls were included in the study. Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20498205", "endSection": "abstract"}, {"offsetInBeginSection": 1020, "offsetInEndSection": 1302, "text": "In a multiple logistic regression analysis, increasing time of breastfeeding (OR 9.5, 95% CI 2.14-42.43 for \u2265 17 months), seropositivity for ACPAs (OR 19.5, 95% CI 4.47-84.81), and carriage of the PTPN22 1858T variant (OR 3.2, 95% CI 1.36-7.54) remained significant predictors of RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20560812", "endSection": "abstract"}, {"offsetInBeginSection": 11, "offsetInEndSection": 415, "text": "Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16320352", "endSection": "abstract"}, {"offsetInBeginSection": 370, "offsetInEndSection": 744, "text": "Cox proportional hazards regression models were used to assess the association of the HLA-DRB1 (including the shared epitope [SE]) and PTPN22 genes with the risk of death from all causes and from cardiovascular disease (CVD) and to assess the interactions between SE, smoking, and anti-cyclic citrullinated peptide (anti-CCP) status, adjusted by age at symptom onset and sex ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18240242", "endSection": "abstract"}, {"offsetInBeginSection": 677, "offsetInEndSection": 980, "text": "In the total RA inception cohort, the HLA-DRB1 shared epitope (per-allele odds ratio (OR) = 2.1, trend P < 0.0001), PTPN22 (per-allele OR = 1.5, trend P < 0.0001), OLIG3/TNFAIP3 locus (per-allele OR = 1.2, trend P = 0.009) and TRAF1/C5 locus (per-allele OR = 1.1, trend P = 0.04) were associated with RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20353580", "endSection": "abstract"}, {"offsetInBeginSection": 454, "offsetInEndSection": 817, "text": " RA patients (n=333) and controls (n=490) from the Cree/Ojibway NAN population in Central Canada were HLA-DRB1 typed and tested for 21 single-nucleotide polymorphisms (SNPs) that have previously been associated with RA, including PTPN22, TRAF1-C5, CTLA4, PADI4, STAT4, FCRL3, CCL21, MMEL1-TNFRSF14, CDK6, PRKCQ, KIF5A-PIP4K2C, IL2RB, TNFAIP3, IL10-1082G/A and REL ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21614018", "endSection": "abstract"}, {"offsetInBeginSection": 1277, "offsetInEndSection": 1631, "text": "Additionally, SNPs rs7574865STAT4 (P = 9.2*10-6; OR = 1.71, 95% CI = 1.35 - 2.18) and rs2476601PTPN22 (P = 9.5*10-4; OR = 1.67, 95% CI = 1.23 - 2.26) were associated with susceptibility to RA, whereas after permutation testing OLIG3/TNFAIP3 SNPs rs10499194 and rs6920220 missed our criteria for significance (Pcorr = 0.114 and Pcorr = 0.180, respectively ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19445664", "endSection": "abstract"}, {"offsetInBeginSection": 796, "offsetInEndSection": 1109, "text": "Although SNPs in PADI4 had similar allele frequency among three groups [maximal difference 11%; (P >0.05)], the other three loci revealed statistically significant allele frequency differences (maximal difference 39% (P <0.00001), 13% (P <0.00001), and 8% (P <0.00001) in SLC22A4, PDCD1, and PTPN22, respectively) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15883854", "endSection": "abstract"}, {"offsetInBeginSection": 347, "offsetInEndSection": 747, "text": "As an effect several new genes have been recognized as an HLA-independent genetic risk factors of RA. PTPN22 gene polymorphism, C5/TRAF1 genes region polymorphism and TNFAIP3-OLIG3 genes region polymorphism(s) are among newly identified and already confirmed genetic risk factors, whereas STAT 4, CTLA4, PADI4 and IRF5 genes polymorphisms are listed among probable RA development genetic risk factors ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19856886", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 467, "text": "Several multiple, large-scale, genetic studies on autoimmune-disease-associated SNPs have been reported recently: peptidylarginine deiminase type 4 (PADI4) in rheumatoid arthritis (RA); solute carrier family 22 members 4 and 5 (SLC22A4 and 5) in RA and Crohn's disease (CD); programmed cell death 1 (PDCD1) in systemic lupus erythematosus (SLE), type 1 diabetes mellitus (T1D), and RA; and protein tyrosine phosphatase nonreceptor type 22 (PTPN22) in T1D, RA, and SLE ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15883854", "endSection": "abstract"}]}, {"body": "Is marijuana use associated with increased risk for stroke?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23299821", "http://www.ncbi.nlm.nih.gov/pubmed/23160887", "http://www.ncbi.nlm.nih.gov/pubmed/22150621", "http://www.ncbi.nlm.nih.gov/pubmed/22107013", "http://www.ncbi.nlm.nih.gov/pubmed/18025032", "http://www.ncbi.nlm.nih.gov/pubmed/17432216", "http://www.ncbi.nlm.nih.gov/pubmed/16832776", "http://www.ncbi.nlm.nih.gov/pubmed/15801396", "http://www.ncbi.nlm.nih.gov/pubmed/15716544", "http://www.ncbi.nlm.nih.gov/pubmed/15297005", "http://www.ncbi.nlm.nih.gov/pubmed/15060269", "http://www.ncbi.nlm.nih.gov/pubmed/12412838", "http://www.ncbi.nlm.nih.gov/pubmed/11811864", "http://www.ncbi.nlm.nih.gov/pubmed/11462796", "http://www.ncbi.nlm.nih.gov/pubmed/8944217", "http://www.ncbi.nlm.nih.gov/pubmed/1992832"], "ideal_answer": "Case 2 presented aphasia shortly after marijuana smoking.Although several mechanisms exist by which marijuana use might contribute to the development of chronic cardiovascular conditions or acutely trigger cardiovascular events, there are psychomotor stimulants, such as amphetamine and cocaine.Three adolescent males had similar presentations of headache, fluctuating level of consciousness or lethargy, visual disturbance, and variable ataxia after self-administration of marijuana use might contribute to the development of chronic cardiovascular conditions or acutely trigger cardiovascular events, there are few data regarding marijuana use and cardiovascular disease outcomes.Cannabis use may be associated with drug misuse.Episodic marijuana use may be associated with ischaemic stroke in young patients, but its mechanism is unclear.Episodic marijuana use may represent a risk factor for stroke in childhood, particularly in the posterior circulation.We reported two cases of young stroke associated with drug misuse.The illicit drugs more commonly associated with stroke are psychomotor stimulants, such as amphetamine and cocaine.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002188", "http://www.disease-ontology.org/api/metadata/DOID:3455", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020521", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012306", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008385", "http://www.disease-ontology.org/api/metadata/DOID:9505", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002189", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012307"], "type": "yesno", "id": "5149e23dd24251bc0500004b", "snippets": [{"offsetInBeginSection": 243, "offsetInEndSection": 319, "text": "Marijuana may trigger a myocardial infarction and have a vasospastic effect. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15801396", "endSection": "sections.0"}, {"offsetInBeginSection": 928, "offsetInEndSection": 984, "text": "Chronic marijuana smoking, however, seems to reduce CBF. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1992832", "endSection": "sections.0"}, {"offsetInBeginSection": 587, "offsetInEndSection": 654, "text": "Thus, chronic abuse of marijuana might be a risk factor for stroke. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11462796", "endSection": "sections.0"}, {"offsetInBeginSection": 596, "offsetInEndSection": 697, "text": "Cannabis use may be associated with ischaemic stroke in young patients, but its mechanism is unclear. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15716544", "endSection": "sections.0"}, {"offsetInBeginSection": 245, "offsetInEndSection": 343, "text": "We describe a patient who suffered three ischaemic strokes immediately after cannabis consumption. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15716544", "endSection": "sections.0"}, {"offsetInBeginSection": 93, "offsetInEndSection": 238, "text": "Cannabis is the most widely consumed among the illicit drugs worldwide, but it has only exceptionally been associated to cerebrovascular disease. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16832776", "endSection": "sections.0"}, {"offsetInBeginSection": 409, "offsetInEndSection": 523, "text": "The review of the literature on this topic reveals another 18 patients with stroke in association to cannabis use. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16832776", "endSection": "sections.0"}, {"offsetInBeginSection": 1132, "offsetInEndSection": 1250, "text": "Episodic marijuana use may represent a risk factor for stroke in childhood, particularly in the posterior circulation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15060269", "endSection": "sections.0"}, {"offsetInBeginSection": 558, "offsetInEndSection": 673, "text": "Marijuana may have accelerated stroke onset, but essential cause of stroke in this case must be protein S mutation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17432216", "endSection": "sections.0"}, {"offsetInBeginSection": 97, "offsetInEndSection": 244, "text": "Despite the fact that cannabis is the most widely used illicit drug, there are only a few reports associating its use with cerebrovascular disease. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15716544", "endSection": "sections.0"}, {"offsetInBeginSection": 248, "offsetInEndSection": 395, "text": "We here describe 2 young patients (26 and 29 years, respectively) who suffered from ischemic stroke in temporal relation with cannabis consumption. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16832776", "endSection": "sections.0"}, {"offsetInBeginSection": 467, "offsetInEndSection": 628, "text": "This case suggests that marijuana smoking may increase the risk of arterial thrombosis in otherwise healthy individuals who are heterozygous for factor V Leiden. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11811864", "endSection": "sections.0"}, {"offsetInBeginSection": 573, "offsetInEndSection": 725, "text": "Although a causal relationship is difficult to establish due to the widespread use of cannabis, this drug may play an etiologic role in ischemic stroke. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16832776", "endSection": "sections.0"}, {"offsetInBeginSection": 305, "offsetInEndSection": 504, "text": "The illicit drugs more commonly associated with stroke are psychomotor stimulants, such as amphetamine and cocaine. Less commonly implicated are opioids and psychotomimetic drugs, including cannabis. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23299821", "endSection": "sections.0"}, {"offsetInBeginSection": 734, "offsetInEndSection": 923, "text": "Three adolescent males had similar presentations of headache, fluctuating level of consciousness or lethargy, visual disturbance, and variable ataxia after self-administration of marijuana. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15060269", "endSection": "sections.0"}, {"offsetInBeginSection": 1386, "offsetInEndSection": 1611, "text": "Patients in Adelaide are more likely to be obese, to be misusing marijuana and amphetamines, to suffer a cardioembolic event and to have a stroke that concurrently affects both the anterior and posterior cerebral circulation. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22107013", "endSection": "sections.0"}, {"offsetInBeginSection": 282, "offsetInEndSection": 466, "text": "Reported here is the case of a previously healthy young man who smoked marijuana on a daily basis and had an occipital lobe stroke; he was found to be heterozygous for factor V Leiden. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11811864", "endSection": "sections.0"}, {"offsetInBeginSection": 95, "offsetInEndSection": 292, "text": "A right occipital ischemic stroke occurred in a 37-year-old Albanese man with a previously uneventful medical history, 15 min after having smoked a cigarette with approximately 250 mg of marijuana. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15297005", "endSection": "sections.0"}, {"offsetInBeginSection": 511, "offsetInEndSection": 741, "text": "RCVS was spontaneous in 37% of patients and secondary in the 63% others, to postpartum in 5 and to exposure to various vasoactive substances in 37, mainly cannabis, selective serotonin-recapture inhibitors and nasal decongestants. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18025032", "endSection": "sections.0"}, {"offsetInBeginSection": 904, "offsetInEndSection": 1159, "text": "Although several mechanisms exist by which marijuana use might contribute to the development of chronic cardiovascular conditions or acutely trigger cardiovascular events, there are few data regarding marijuana/THC use and cardiovascular disease outcomes. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12412838", "endSection": "sections.0"}, {"offsetInBeginSection": 716, "offsetInEndSection": 1019, "text": "Therefore, as the family history for cerebrovascular events, blood pressure, clotting tests, examinations for thrombophilia, vasculitis, extracranial and intracranial arteries and cardiac investigations were normal or respectively negative, the stroke was attributed to the chronic cannabis consumption. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15297005", "endSection": "sections.0"}, {"offsetInBeginSection": 565, "offsetInEndSection": 805, "text": "Among 326 patients (184 males), the most frequent stroke risk factors overall were dyslipidaemia (187), smoking (161), hypertension (105) and obesity (92). Fifty-one patients used illicit drugs, mostly comprising marijuana and amphetamines. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22107013", "endSection": "sections.0"}, {"offsetInBeginSection": 219, "offsetInEndSection": 463, "text": "We reported two cases of young stroke associated with drug misuse. Case 1 used amphetamine, cocaine, marijuana and LSD for few yaers, and developed occlusion of a middle cerebral artery. Case 2 presented aphasia shortly after marijuana smoking. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17432216", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 279, "text": "A 22-year-old man with a five-year history of drug and alcohol abuse presented with a left hemiparesis preceded by three transient ischaemic attacks, two of which occurred whilst smoking cannabis. Substance abuse was the only identifiable risk factor for cerebrovascular disease. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8944217", "endSection": "sections.0"}, {"offsetInBeginSection": 1687, "offsetInEndSection": 2185, "text": "Research directions might include more studies of cardiovascular disease outcomes and relationships of marijuana with cardiovascular risk factors, studies of metabolic and physiologic effects of chronic marijuana use that may affect cardiovascular disease risk, increased understanding of the role of the cannabinoid receptor system in cardiovascular regulation, and studies to determine if there is a therapeutic role for cannabinoids in blood pressure control or for neuroprotection after stroke. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12412838", "endSection": "sections.0"}]}, {"body": "How many and which are the different isoforms for the ryanodine receptor?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24521037", "http://www.ncbi.nlm.nih.gov/pubmed/20961976", "http://www.ncbi.nlm.nih.gov/pubmed/19503748", "http://www.ncbi.nlm.nih.gov/pubmed/18221109", "http://www.ncbi.nlm.nih.gov/pubmed/18005397", "http://www.ncbi.nlm.nih.gov/pubmed/17707769", "http://www.ncbi.nlm.nih.gov/pubmed/17526017", "http://www.ncbi.nlm.nih.gov/pubmed/14592807"], "triples": [], "ideal_answer": "Generally, three ryanodine receptor isoforms ( RyR1-RyR3 ) are known; in excitable cells such as skeletal and cardiac myocytes excitation-contraction coupling is an important intermediate step between initiation of the action potential and induction of contraction.Among the three ryr isoforms of the sr ca2+ release channels, or ryanodine receptors ( ryrs ), have been isolated ( ryr1, ryr2, and ryr3 ).Ryrs are the largest known ion channels ( > 2mda ) and exist as three different isoforms ( ryr 1-3 ), skeletal ( ryr1 ) and cardiac muscle ( ryr2 ) isoforms of ryanodine receptor calcium channelsRyrs are the largest known ion channels ( > 2mda ) and exist as three ryr isoforms, ryr3 is preferentially expressed in the brain especially in the hippocampus and striatum.This process is predominantly controlled by ca ( 2+ ) release from the sarcoplasmic reticulum via the ryanodine receptors ( ryrs ), have been isolated ( ryr1, ryr2, and ryr3 ).", "exact_answer": [["Ryanodine Receptor type 1", "RyR1"], ["Ryanodine Receptor type 2", "RyR2"], ["Ryanodine Receptor type 3", "RyR3"]], "concepts": [], "type": "list", "id": "54db7217c4c6ce8e1d000003", "snippets": [{"offsetInBeginSection": 570, "offsetInEndSection": 574, "text": "RyR3 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17526017", "endSection": "abstract"}, {"offsetInBeginSection": 547, "offsetInEndSection": 560, "text": "RyR1 and RyR2 ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17526017", "endSection": "abstract"}, {"offsetInBeginSection": 286, "offsetInEndSection": 315, "text": "There are three RyR isoforms, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17707769", "endSection": "abstract"}, {"offsetInBeginSection": 252, "offsetInEndSection": 320, "text": "Generally, three ryanodine receptor isoforms (RyR1-RyR3) are known; ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18005397", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "Skeletal (RyR1) and cardiac muscle (RyR2) isoforms of ryanodine receptor calcium channels ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24521037", "endSection": "abstract"}, {"offsetInBeginSection": 262, "offsetInEndSection": 393, "text": "Three different isoforms of the SR Ca2+ release channels, or ryanodine receptors (RyRs), have been isolated (RyR1, RyR2, and RyR3). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14592807", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 100, "text": "Ryanodine receptor (RyR) is a Ca(2+) channel that mediates Ca(2+) release from intracellular stores. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17707769", "endSection": "abstract"}, {"offsetInBeginSection": 168, "offsetInEndSection": 446, "text": "Ryanodine receptors (RyRs) are a family of intracellular calcium release channels that mediate calcium-induced calcium release from the endoplasmic reticulum. Among the three RyR isoforms, RyR3 is preferentially expressed in the brain especially in the hippocampus and striatum. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19503748", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 240, "text": "Ryanodine receptors (RyRs) are intracellular Ca(2+) channels that mediate the release of calcium from internal stores and therefore play an important role in Ca(2+) signaling and homeostasis. Three RyR isoforms have been described thus far, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17526017", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 335, "text": "Ryanodine receptors (RyRs) are located in the sarcoplasmic/endoplasmic reticulum membrane and are responsible for the release of Ca(2+) from intracellular stores during excitation-contraction coupling in both cardiac and skeletal muscle. RyRs are the largest known ion channels (> 2MDa) and exist as three mammalian isoforms (RyR 1-3), ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20961976", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 573, "text": "In excitable cells such as skeletal and cardiac myocytes excitation-contraction coupling is an important intermediate step between initiation of the action potential and induction of contraction. This process is predominantly controlled by Ca(2+) release from the sarcoplasmic reticulum via the ryanodine receptor. This very large protein (MW 560 kDa) exists as a homotetramer (~2.2 MDa) and is expressed in three isoforms: RyR1, expressed in skeletal muscle; RyR2, expressed in cardiac muscle; and RyR3, expressed in various cells at lower levels than the other isoforms. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18221109", "endSection": "abstract"}]}, {"body": "Which compound is a specific inhibitor for Nox1 and Nox4?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21419746", "http://www.ncbi.nlm.nih.gov/pubmed/20558727", "http://www.ncbi.nlm.nih.gov/pubmed/25656366", "http://www.ncbi.nlm.nih.gov/pubmed/22806357", "http://www.ncbi.nlm.nih.gov/pubmed/24511132"], "triples": [], "ideal_answer": "The efficacy of the nox1 inhibitor of nox1- and nox4-containing nadph oxidase activity, attenuated ros generation and atherosclerosis and decreased cd44 and ha expression in atherosclerotic lesions importantly, administration of the most specific nox1 inhibitor, gkt137831 on the manifestations of dn was studied in ove26 mice, a model of type 1 diabetes.Basal nad ( p ) h oxidase activity was blocked by gkt136901 ( nox1 inhibitor ) and by nox1 sirna in wky cells and by sinox1 and sinox2 in shr.Gkt136901, a specific inhibitor of nox1- and nox4-containing nadph oxidase activity, attenuated ros generation and atherosclerosis and decreased cd44 and ha expression in atherosclerotic lesions importantly, administration of the most specific nox1 inhibitor, gkt137831, replicated these renoprotective effects of nox4 deletion.The efficacy of the nox1 inhibitor gkt137831 on the manifestations of dn was studied in ove26 mice, a model of type 1 diabetes.", "exact_answer": [["GKT136901"]], "concepts": ["http://www.uniprot.org/uniprot/NOX1_MOUSE", "http://www.uniprot.org/uniprot/NOX1_RAT", "http://www.uniprot.org/uniprot/NOX4_MOUSE", "http://www.uniprot.org/uniprot/NOX4_RAT", "http://www.uniprot.org/uniprot/NOX4_HUMAN", "http://www.uniprot.org/uniprot/NOX4_PONAB"], "type": "factoid", "id": "56c865d25795f9a73e000016", "snippets": [{"offsetInBeginSection": 849, "offsetInEndSection": 985, "text": "Importantly, administration of the most specific Nox1/4 inhibitor, GKT137831, replicated these renoprotective effects of Nox4 deletion. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24511132", "endSection": "abstract"}, {"offsetInBeginSection": 849, "offsetInEndSection": 983, "text": "Importantly, administration of the most specific Nox1/4 inhibitor, GKT137831, replicated these renoprotective effects of Nox4 deletion ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24511132", "endSection": "abstract"}, {"offsetInBeginSection": 137, "offsetInEndSection": 270, "text": "The efficacy of the Nox1/Nox4 inhibitor GKT137831 on the manifestations of DN was studied in OVE26 mice, a model of type 1 diabetes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25656366", "endSection": "abstract"}, {"offsetInBeginSection": 137, "offsetInEndSection": 268, "text": "The efficacy of the Nox1/Nox4 inhibitor GKT137831 on the manifestations of DN was studied in OVE26 mice, a model of type 1 diabetes ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25656366", "endSection": "abstract"}, {"offsetInBeginSection": 366, "offsetInEndSection": 504, "text": "Basal NAD(P)H oxidase activity was blocked by GKT136901 (Nox1/4 inhibitor) and by Nox1 siRNA in WKY cells and by siNOX1 and siNOX2 in SHR. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21419746", "endSection": "abstract"}, {"offsetInBeginSection": 1565, "offsetInEndSection": 1761, "text": "GKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH oxidase activity, attenuated ROS generation and atherosclerosis and decreased CD44 and HA expression in atherosclerotic lesions. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20558727", "endSection": "abstract"}, {"offsetInBeginSection": 1565, "offsetInEndSection": 1759, "text": "GKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH oxidase activity, attenuated ROS generation and atherosclerosis and decreased CD44 and HA expression in atherosclerotic lesions ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20558727", "endSection": "abstract"}, {"offsetInBeginSection": 376, "offsetInEndSection": 579, "text": "At both doses, GKT137831 inhibited NADPH oxidase activity, superoxide generation, and hydrogen peroxide production in the renal cortex from diabetic mice without affecting Nox1 or Nox4 protein expression ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25656366", "endSection": "abstract"}]}, {"body": "Which molecule is targeted by the drug Gevokizumab?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24194526", "http://www.ncbi.nlm.nih.gov/pubmed/23729309", "http://www.ncbi.nlm.nih.gov/pubmed/23041424", "http://www.ncbi.nlm.nih.gov/pubmed/22699287", "http://www.ncbi.nlm.nih.gov/pubmed/22084392", "http://www.ncbi.nlm.nih.gov/pubmed/21154167", "http://www.ncbi.nlm.nih.gov/pubmed/21048425", "http://www.ncbi.nlm.nih.gov/pubmed/25108619", "http://www.ncbi.nlm.nih.gov/pubmed/25079039"], "triples": [], "ideal_answer": "Most recently, rising evidence reports on the use of adalimumab, etanercept, and golimumab, while use of anti-interleukin ( IL ) -1 agents ( anakinra, canakinumab, gevokizumab ), IL-6 blockers ( tocilizumab ), and rituximab ( depleting anti-CD20 antibody ) is also increasing.", "exact_answer": [["IL-1\u03b2"]], "concepts": [], "type": "factoid", "id": "550e828c71445a662f000002", "snippets": [{"offsetInBeginSection": 131, "offsetInEndSection": 202, "text": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1\u03b2 antibody ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22699287", "endSection": "abstract"}, {"offsetInBeginSection": 129, "offsetInEndSection": 202, "text": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1\u03b2 antibody. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22699287", "endSection": "abstract"}, {"offsetInBeginSection": 283, "offsetInEndSection": 360, "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2 monoclonal antibodies. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23041424", "endSection": "abstract"}, {"offsetInBeginSection": 286, "offsetInEndSection": 361, "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2 monoclonal antibodies ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23041424", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 129, "text": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1\u03b2 antibody with differential receptor-modulating properties. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24194526", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 124, "text": "One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1\u03b2. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23041424", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "Gevokizumab, an anti-IL-1\u03b2 mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21154167", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 166, "text": "Interleukin-1\u03b2-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22084392", "endSection": "title"}, {"offsetInBeginSection": 1575, "offsetInEndSection": 1763, "text": "These data indicate, therefore, that gevokizumab is a unique inhibitor of IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24194526", "endSection": "abstract"}, {"offsetInBeginSection": 587, "offsetInEndSection": 771, "text": "To meet these challenges, we developed XOMA 052 (gevokizumab), a potent anti-IL-1\u03b2 neutralizing antibody that was designed in silico and humanized using Human Engineering\u2122 technology. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21048425", "endSection": "abstract"}, {"offsetInBeginSection": 280, "offsetInEndSection": 533, "text": "Gevokizumab is a potent anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2 signaling through an allosteric mechanism. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24194526", "endSection": "abstract"}, {"offsetInBeginSection": 131, "offsetInEndSection": 341, "text": "This pilot study aimed to evaluate the safety, pharmacokinetics and clinical activity of XOMA 052 (gevokizumab), a recombinant humanised anti-interleukin 1\u03b2 antibody, in Beh\u00e7et's disease patients with uveitis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22084392", "endSection": "abstract"}, {"offsetInBeginSection": 1603, "offsetInEndSection": 1815, "text": "In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23041424", "endSection": "abstract"}, {"offsetInBeginSection": 1484, "offsetInEndSection": 1751, "text": "Most recently, rising evidence reports on the use of adalimumab, etanercept, and golimumab, while use of anti-interleukin (IL)-1 agents (anakinra, canakinumab, gevokizumab), IL-6 blockers (tocilizumab), and rituximab (depleting anti-CD20 antibody) is also increasing. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23729309", "endSection": "abstract"}, {"offsetInBeginSection": 265, "offsetInEndSection": 590, "text": "XOMA is developing gevokizumab (XOMA-052), an IgG2 humanized mAb against human IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity for IL-1\u03b2 and a long t1/2, which would allow for once-monthly dosing and offer a considerable advantage for patients over agents requiring more frequent dosing. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21154167", "endSection": "abstract"}, {"offsetInBeginSection": 721, "offsetInEndSection": 1080, "text": "In the present study, we measured the impact of gevokizumab on the IL-1\u03b2 system using Schild analysis and surface plasmon resonance studies, both of which demonstrated that gevokizumab decreases the binding affinity of IL-1\u03b2 for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24194526", "endSection": "abstract"}, {"offsetInBeginSection": 504, "offsetInEndSection": 927, "text": "Gevokizumab is claimed to be a regulatory therapeutic antibody that modulates IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2 signaling is affected by both canakinumab and gevokizumab was not yet experimentally determined. We have analyzed the crystal structures of canakinumab and gevokizumab antibody binding fragment (Fab) as well as of their binary complexes with IL-1\u03b2. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23041424", "endSection": "abstract"}]}, {"body": "Which protein phosphatases have been found to dephosphorylate phospholamban?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/1849481", "http://www.ncbi.nlm.nih.gov/pubmed/9350040"], "triples": [], "ideal_answer": "These results are consistent with the views that protein phosphatase 1 is capable of dephosphorylating membrane-associated phospholamban when it is phosphorylated by protein kinase a, but not by calcium kinase, and that under certain conditions, calcium protein phosphatase ( protein phosphatase 2b ) is also able to dephosphorylate pln phosphorylated by protein kinase a. additionally, the observations show that protein phosphatase 1 is extremely active against the three protein kinase a substrates ( m ( r ) 23, 19 and 17 kda ) that were present in the isolated microsomes and whose state of phosphorylation was particularly affected in the presence of dimethylsulfoxide.At physiological concentrations of free mg2+ ( 1 mm ), protein phosphatase 1 ( pp1 ) accounted for the remainder of the activity in these fractions towards either ser-16 ( the residue labelled by camp-dependent protein kinase, pk-a ) or thr-17 ( the residue phosphorylated by an sr-associated ca2+ protein kinase ).", "exact_answer": [["Protein Phosphatase 1", "PP1"], ["Protein phosphatase 2A", "PP2A"], ["Protein Phosphatase 2C", "PP2C"], ["Protein Phosphatase 2B", "PP2B"]], "concepts": [], "type": "list", "id": "5506a7a48e1671127b000008", "snippets": [{"offsetInBeginSection": 1184, "offsetInEndSection": 1586, "text": "These results are consistent with the views that protein phosphatase 1 is capable of dephosphorylating membrane-associated phospholamban when it is phosphorylated by protein kinase A, but not by calcium/calmodulin kinase, and that under certain conditions, calcium/calmodulin-stimulated protein phosphatase (protein phosphatase 2B) is also able to dephosphorylate PLN phosphorylated by protein kinase A ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9350040", "endSection": "abstract"}, {"offsetInBeginSection": 1184, "offsetInEndSection": 1885, "text": "These results are consistent with the views that protein phosphatase 1 is capable of dephosphorylating membrane-associated phospholamban when it is phosphorylated by protein kinase A, but not by calcium/calmodulin kinase, and that under certain conditions, calcium/calmodulin-stimulated protein phosphatase (protein phosphatase 2B) is also able to dephosphorylate PLN phosphorylated by protein kinase A. Additionally, the observations show that protein phosphatase 1 is extremely active against the three protein kinase A substrates (M(r) 23, 19 and 17 kDa) that were present in the isolated microsomes and whose state of phosphorylation was particularly affected in the presence of dimethylsulfoxide. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9350040", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 785, "text": "The protein phosphatases which dephosphorylate native, sarcoplasmic reticulum (SR)-associated phospholamban were studied in cardiac muscle extracts and in a Triton fraction prepared by detergent extraction of myofibrils, the latter fraction containing 70-80% of the SR-associated proteins present in the tissue. At physiological concentrations of free Mg2+ (1 mM), protein phosphatase 1 (PP1) accounted for approximately 70% of the total phospholamban phosphatase activity in these fractions towards either Ser-16 (the residue labelled by cAMP-dependent protein kinase, PK-A) or Thr-17 (the residue phosphorylated by an SR-associated Ca2+/calmodulin-dependent protein kinase). Protein phosphatase 2A (PP2A) and protein phosphatase 2C (PP2C) accounted for the remainder of the activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1849481", "endSection": "abstract"}]}, {"body": "What is the most prominent sequence consensus for the polyadenylation site?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/1915889", "http://www.ncbi.nlm.nih.gov/pubmed/1993703", "http://www.ncbi.nlm.nih.gov/pubmed/6194440", "http://www.ncbi.nlm.nih.gov/pubmed/7901430", "http://www.ncbi.nlm.nih.gov/pubmed/1712333", "http://www.ncbi.nlm.nih.gov/pubmed/2513486"], "ideal_answer": "Two AATAAA hexanucleotide sequences are present in the 2092 nucleotide interval.The early poly ( A ) consensus signal was mutated from AAUAAA to UGUAAA the first one functions as the major polyA signal the results demonstrate that the intact AAUAAA is not required for RNA polyadenylation but is required for the cleavage step preceding polyadenylation to occur efficiently the cannonical polyadenylation signal sequence AATAAA two AATAAA motifs are coded in the last exon of this gene functional polyadenylation [ poly ( A ) ] sites consist of two sequence elements, the AAUAAA and G box signals, that closely flank the site of mRNA 3'-end formation", "exact_answer": [["AATAAA"], ["AAUAAA"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D026723", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011061", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D039221", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D039104", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016384", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011063", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012313", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0043631", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=1900363"], "type": "list", "id": "5133b9455274a5fb0700000c", "snippets": [{"offsetInBeginSection": 364, "offsetInEndSection": 417, "text": "the cannonical polyadenylation signal sequence AATAAA ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1915889", "endSection": "sections.0"}, {"offsetInBeginSection": 464, "offsetInEndSection": 532, "text": "the early poly(A) consensus signal was mutated from AAUAAA to UGUAAA ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7901430", "endSection": "sections.0"}, {"offsetInBeginSection": 1178, "offsetInEndSection": 1235, "text": "Two AATAAA motifs are coded in the last exon of this gene ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1993703", "endSection": "sections.0"}, {"offsetInBeginSection": 849, "offsetInEndSection": 944, "text": "the appropriate spacing of the AAUAAA and G/U box signals is critical for poly(A) site function ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1712333", "endSection": "sections.0"}, {"offsetInBeginSection": 236, "offsetInEndSection": 407, "text": "The results demonstrate that the intact AAUAAA is not required for RNA polyadenylation but is required for the cleavage step preceding polyadenylation to occur efficiently ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6194440", "endSection": "sections.0"}, {"offsetInBeginSection": 189, "offsetInEndSection": 320, "text": " Two AATAAA hexanucleotide sequences are present in the 2092 nucleotide interval. The first one functions as the major polyA signal ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2513486", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 161, "text": "Functional polyadenylation [poly(A)] sites consist of two sequence elements, the AAUAAA and G/U box signals, that closely flank the site of mRNA 3'-end formation ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1712333", "endSection": "sections.0"}]}, {"body": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24458521"], "triples": [], "ideal_answer": "Progressive elevation in fibronectin levels was observed in longitudinal samples from 22 dmd patients followed up for a period of 6 months up to 4 years.Fibronectin levels may constitute a promising biomarker to monitor disease progression in dmd patientsFibronectin is a serum biomarker for duchenne muscular dystrophy there was a significant increase in fibronectin levels in dmd patients followed up for a period of 6 months up to 4 years.Fibronectin is a serum biomarker for Duchenne muscular dystrophy there was a significant increase in fibronectin levels in DMD patients compared to age-matched controls.This study suggests that serum fibronectin levels may constitute a promising biomarker to monitor disease progression in dmd patients with becker muscular dystrophy, bethlem myopathy, or myasthenia gravis were comparable to control levels.", "exact_answer": "yes", "concepts": [], "type": "yesno", "id": "5715c16dcb4ef8864c000004", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 66, "text": "Fibronectin is a serum biomarker for Duchenne muscular dystrophy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 64, "text": "Fibronectin is a serum biomarker for Duchenne muscular dystrophy ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "title"}, {"offsetInBeginSection": 755, "offsetInEndSection": 859, "text": "There was a significant increase in fibronectin levels in DMD patients compared to age-matched controls. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 1152, "offsetInEndSection": 1286, "text": "This study suggests that serum fibronectin levels may constitute a promising biomarker to monitor disease progression in DMD patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 1222, "offsetInEndSection": 1355, "text": "This study suggests that serum fibronectin levels may constitute a promising biomarker to monitor disease progression in DMD patients ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 997, "offsetInEndSection": 1150, "text": "Progressive elevation in fibronectin levels was observed in longitudinal samples from 22 DMD patients followed up for a period of 6 months up to 4 years. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 756, "offsetInEndSection": 997, "text": "There was a significant increase in fibronectin levels in DMD patients compared to age-matched controls. Fibronectin levels in patients with Becker muscular dystrophy, Bethlem myopathy, or myasthenia gravis were comparable to control levels. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 1152, "offsetInEndSection": 1381, "text": "This study suggests that serum fibronectin levels may constitute a promising biomarker to monitor disease progression in DMD patients. \u00a9 2014 The Authors PROTEOMICS - Clinical Applications Published by Wiley-VCH Verlag GmbH & Co. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 1034, "offsetInEndSection": 1356, "text": "Progressive elevation in fibronectin levels was observed in longitudinal samples from 22 DMD patients followed up for a period of 6 months up to 4 years.CONCLUSION AND CLINICAL RELEVANCE: This study suggests that serum fibronectin levels may constitute a promising biomarker to monitor disease progression in DMD patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 861, "offsetInEndSection": 1151, "text": "Fibronectin levels in patients with Becker muscular dystrophy, Bethlem myopathy, or myasthenia gravis were comparable to control levels. Progressive elevation in fibronectin levels was observed in longitudinal samples from 22 DMD patients followed up for a period of 6 months up to 4 years. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 998, "offsetInEndSection": 1286, "text": "Progressive elevation in fibronectin levels was observed in longitudinal samples from 22 DMD patients followed up for a period of 6 months up to 4 years. This study suggests that serum fibronectin levels may constitute a promising biomarker to monitor disease progression in DMD patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}, {"offsetInBeginSection": 792, "offsetInEndSection": 1186, "text": "There was a significant increase in fibronectin levels in DMD patients compared to age-matched controls. Fibronectin levels in patients with Becker muscular dystrophy, Bethlem myopathy, or myasthenia gravis were comparable to control levels. Progressive elevation in fibronectin levels was observed in longitudinal samples from 22 DMD patients followed up for a period of 6 months up to 4 years ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24458521", "endSection": "abstract"}]}, {"body": "What colonoscopy findings have been reported in autism", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19214283", "http://www.ncbi.nlm.nih.gov/pubmed/16003132", "http://www.ncbi.nlm.nih.gov/pubmed/11241044", "http://www.ncbi.nlm.nih.gov/pubmed/11007230"], "triples": [], "ideal_answer": "There have been several reports of a link between autism and chronic gastrointestinal symptoms.This is consistent with increasing evidence for gut epithelial dysfunction in autism.The data support the hypothesis that lnh is a significant pathological finding in asd children.Differences in age at colonoscopy and diet do not account for these changes.Ileo-colonoscopy was performed in 21 consecutively evaluated children with autistic spectrum disorders and bowel symptoms colonic LNH was present in 18 of 60 ( 30 % ) autistic enterocolitis : fact or fiction?", "concepts": [], "type": "summary", "id": "5509ce9ec2af5d5b70000001", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 40, "text": "Autistic enterocolitis: fact or fiction? ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19214283", "endSection": "title"}, {"offsetInBeginSection": 2061, "offsetInEndSection": 2171, "text": "A new variant of inflammatory bowel disease is present in this group of children with developmental disorders. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11007230", "endSection": "abstract"}, {"offsetInBeginSection": 234, "offsetInEndSection": 355, "text": "Ileo-colonoscopy was performed in 21 consecutively evaluated children with autistic spectrum disorders and bowel symptoms ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11241044", "endSection": "abstract"}, {"offsetInBeginSection": 444, "offsetInEndSection": 614, "text": "One hundred and forty-eight consecutive children with ASD (median age 6 years; range 2-16; 127 male) with gastrointestinal symptoms were investigated by ileo-colonoscopy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16003132", "endSection": "abstract"}, {"offsetInBeginSection": 1453, "offsetInEndSection": 1685, "text": "Immunohistochemistry confirms a distinct lymphocytic colitis in autistic spectrum disorders in which the epithelium appears particularly affected. This is consistent with increasing evidence for gut epithelial dysfunction in autism. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11241044", "endSection": "abstract"}, {"offsetInBeginSection": 1265, "offsetInEndSection": 1412, "text": "Ileal LNH was present in 54 of 58 (93%) affected children and in five of 35 (14.3%) controls (p < 0.001). Colonic LNH was present in 18 of 60 (30%) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11007230", "endSection": "abstract"}, {"offsetInBeginSection": 315, "offsetInEndSection": 565, "text": "There have been several reports of a link between autism and chronic gastrointestinal symptoms. Endoscopy trials have demonstrated a higher prevalence of nonspecific colitis, lymphoid hyperplasia and focally enhanced gastritis compared with controls. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19214283", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 258, "text": "Intestinal mucosal pathology, characterized by ileo-colonic lymphoid nodular hyperplasia (LNH) and mild acute and chronic inflammation of the colorectum, small bowel and stomach, has been reported in children with autistic spectrum disorder (ASD) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16003132", "endSection": "abstract"}, {"offsetInBeginSection": 2160, "offsetInEndSection": 2487, "text": "Ileo-colonic LNH is a characteristic pathological finding in children with ASD and gastrointestinal symptoms, and is associated with mucosal inflammation. Differences in age at colonoscopy and diet do not account for these changes. The data support the hypothesis that LNH is a significant pathological finding in ASD children. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16003132", "endSection": "abstract"}, {"offsetInBeginSection": 440, "offsetInEndSection": 751, "text": " Ileocolonoscopy and biopsy were performed on 60 affected children (median age 6 yr, range 3-16; 53 male). Developmental diagnoses were autism (50 patients), Asperger's syndrome (five), disintegrative disorder (two), attention deficit hyperactivity disorder (ADHD) (one), schizophrenia (one), and dyslexia (one) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11007230", "endSection": "abstract"}]}, {"body": "What is a disordered protein?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26015579", "http://www.ncbi.nlm.nih.gov/pubmed/26417545", "http://www.ncbi.nlm.nih.gov/pubmed/26301226", "http://www.ncbi.nlm.nih.gov/pubmed/26195786", "http://www.ncbi.nlm.nih.gov/pubmed/25715079", "http://www.ncbi.nlm.nih.gov/pubmed/25387963", "http://www.ncbi.nlm.nih.gov/pubmed/25968230"], "triples": [], "ideal_answer": "The critical biological roles of these proteins undergo significant conformational transitions to well folded forms only on binding to partner.Intrinsically disordered proteins lack stable tertiary and secondary structures under physiological conditions in vitro.The intrinsically disordered protein ( idp ) stathmin plays an important regulatory role in cytoskeletal maintenance through its helical binding partner.The critical biological roles of these proteins, despite not adopting a well-defined fold, encouraged structural biologists to revisit their views on the protein structure-function paradigm.The intrinsically disordered segments of proteins where the conformational flexibility is conserved across homologs, and therefore potentially functional.Discons is an openly accessible sequence analysis tool that identifies and highlights structurally disordered proteins where the conformational flexibility is conserved across homologs, and therefore potentially functional.Discons is an openly accessible sequence analysis tool that identifies and highlights structurally disordered proteins ( idps ) frequently function in protein interaction networks that regulate crucial cellular signaling pathways.However, it lacks a stable fold in the absence of its binding to tubulin and microtubules.", "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016485"], "type": "summary", "id": "56d12d643975bb303a000014", "snippets": [{"offsetInBeginSection": 1419, "offsetInEndSection": 1655, "text": "DisCons is an openly accessible sequence analysis tool that identifies and highlights structurally disordered segments of proteins where the conformational flexibility is conserved across homologs, and therefore potentially functional. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25968230", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 243, "text": "The intrinsically disordered protein (IDP) stathmin plays an important regulatory role in cytoskeletal maintenance through its helical binding to tubulin and microtubules. However, it lacks a stable fold in the absence of its binding partner. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25715079", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 253, "text": "Intrinsically disordered proteins lack stable tertiary and/or secondary structures under physiological conditions in vitro. Intrinsically disordered proteins undergo significant conformational transitions to well folded forms only on binding to partner. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25387963", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 275, "text": "Intrinsically disordered proteins (IDPs) frequently function in protein interaction networks that regulate crucial cellular signaling pathways. Many IDPs undergo transitions from disordered conformational ensembles to folded structures upon binding to their cellular targets. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26195786", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 334, "text": "Intrinsically disordered proteins (IDPs) are ubiquitously involved in cellular processes and often implicated in human pathological conditions. The critical biological roles of these proteins, despite not adopting a well-defined fold, encouraged structural biologists to revisit their views on the protein structure-function paradigm. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26301226", "endSection": "abstract"}]}, {"body": "What is the Drosophila melanogaster Groucho protein?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24086079", "http://www.ncbi.nlm.nih.gov/pubmed/22319573", "http://www.ncbi.nlm.nih.gov/pubmed/22305159", "http://www.ncbi.nlm.nih.gov/pubmed/21666599", "http://www.ncbi.nlm.nih.gov/pubmed/21429299", "http://www.ncbi.nlm.nih.gov/pubmed/20405012", "http://www.ncbi.nlm.nih.gov/pubmed/19956621", "http://www.ncbi.nlm.nih.gov/pubmed/19250647", "http://www.ncbi.nlm.nih.gov/pubmed/19101520", "http://www.ncbi.nlm.nih.gov/pubmed/18721877", "http://www.ncbi.nlm.nih.gov/pubmed/18254933", "http://www.ncbi.nlm.nih.gov/pubmed/18034187", "http://www.ncbi.nlm.nih.gov/pubmed/17643306", "http://www.ncbi.nlm.nih.gov/pubmed/17624551", "http://www.ncbi.nlm.nih.gov/pubmed/16508633", "http://www.ncbi.nlm.nih.gov/pubmed/15861397"], "triples": [], "ideal_answer": "Although a repressor could function by recruiting just a single co-repressor, many can recruit more than one, with drosophila groucho ( gro ) protein was the founding member of the family of transcriptional co-repressor proteins that now includes the transducin-like enhancer of split ( tle ) and grorelated gene ( grg ) proteins in vertebrate the groucho family of corepressor proteins groucho ( gro ) is a drosophila melanogaster transcriptional corepressor groucho proteins are global corepressors that are recruited to target promoters by different families of dna-binding repressors.Drosophila groucho ( gro ), we identified the transcriptional co-repressor xtle1 as an ephrinb1 interacting protein.The drosophila brinker ( brk ) recruiting the co-repressors ctbp and groucho ( gro ), we identified the transcriptional co-repressor proteins that now includes the transducin-like enhancer of split ( tle ) and grorelated gene ( grg ) proteins in vertebrate the groucho family of corepressor proteins groucho ( gro ) is a drosophila melanogaster transcriptional corepressor groucho proteins are global corepressors that are recruited to target promoters by different families of dna-binding repressors.", "exact_answer": [["Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011506", "http://www.uniprot.org/uniprot/GROU_DROME", "http://www.uniprot.org/uniprot/TLE1_DANRE", "http://www.uniprot.org/uniprot/TLE2_DANRE", "http://www.uniprot.org/uniprot/TLE1_MOUSE", "http://www.uniprot.org/uniprot/TLE4_XENLA", "http://www.uniprot.org/uniprot/TLE4_MOUSE", "http://www.uniprot.org/uniprot/TLE6_MOUSE", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0003674"], "type": "factoid", "id": "54f608f85f206a0c06000007", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 70, "text": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20405012", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 46, "text": "The Groucho/Tle family of corepressor proteins ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17624551", "endSection": "abstract"}, {"offsetInBeginSection": 281, "offsetInEndSection": 378, "text": "We identified the transcriptional co-repressor xTLE1/Groucho as an EphrinB1 interacting protein. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21429299", "endSection": "abstract"}, {"offsetInBeginSection": 195, "offsetInEndSection": 250, "text": "Groucho (Gro)/TLE, a global developmental corepressor, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16508633", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 86, "text": "Drosophila Groucho (Gro) is the founding member of a family of metazoan corepressors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22305159", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "The Groucho (Gro)/transducin-like enhancer of split family of transcriptional corepressors ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18034187", "endSection": "abstract"}, {"offsetInBeginSection": 389, "offsetInEndSection": 475, "text": "Tcf3 requires corepressor molecules such as Groucho (Gro)/TLE and HDAC1 for activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21666599", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "Groucho/TLE proteins are global corepressors that are recruited to target promoters by different families of DNA-binding repressors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18721877", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 126, "text": "The proteins termed TLE in humans, Grg in mice and Groucho in Drosophila constitute a family of transcriptional corepressors. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15861397", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 185, "text": "Groucho (Gro) is a Drosophila corepressor required by numerous DNA-binding repressors, many of which are distributed in gradients and provide positional information during development. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22319573", "endSection": "abstract"}, {"offsetInBeginSection": 168, "offsetInEndSection": 361, "text": "Although a repressor could function by recruiting just a single co-repressor, many can recruit more than one, with Drosophila Brinker (Brk) recruiting the co-repressors CtBP and Groucho (Gro), ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24086079", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 226, "text": "The Drosophila Groucho (Gro) protein was the founding member of the family of transcriptional co-repressor proteins that now includes the transducin-like enhancer of split (TLE) and Grorelated gene (Grg) proteins in vertebrate ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18254933", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 251, "text": "Transcriptional co-repressors of the Groucho/transducin-like Enhancer of split (Gro/TLE) family regulate the expression of a variety of genes and are involved in numerous developmental processes in both invertebrate and vertebrate species. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19956621", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 269, "text": "Groucho proteins are abundant and broadly expressed nuclear factors that lack intrinsic DNA-binding activity but can interact with a variety of DNA-binding proteins. The recruitment of Groucho to specific gene regulatory sequences results in transcriptional repression. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17643306", "endSection": "abstract"}]}, {"body": "Which enzyme is inhibited by Imetelstat?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25627551", "http://www.ncbi.nlm.nih.gov/pubmed/24409321", "http://www.ncbi.nlm.nih.gov/pubmed/25441685", "http://www.ncbi.nlm.nih.gov/pubmed/25120190", "http://www.ncbi.nlm.nih.gov/pubmed/24097866", "http://www.ncbi.nlm.nih.gov/pubmed/21062983", "http://www.ncbi.nlm.nih.gov/pubmed/23545855", "http://www.ncbi.nlm.nih.gov/pubmed/22906540", "http://www.ncbi.nlm.nih.gov/pubmed/20048334", "http://www.ncbi.nlm.nih.gov/pubmed/26332546", "http://www.ncbi.nlm.nih.gov/pubmed/26332545"], "triples": [], "ideal_answer": "Purpose : imetelstat inhibited telomerase activity in both subpopulations.Imetelstat is a covalently-lipidated 13-mer thiophosphoramidate oligonucleotide that acts as a potent specific inhibitor of telomerase activity in both subpopulations.A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.This enzyme is expressed in approximately 90 % of human tumors, but not in the majority of normal somatic cells.Our results suggest that imetelstat-mediated depletion of CSCs may offer an alternative mechanism by which telomerase inhibition may be exploited for cancer therapy.Imetelstat inhibits esophageal cancer cell growth and increases radiation-induced dna breaks.Telomerase antagonist imetelstat inhibited proliferation and self-renewal by shortening telomeres and inducing senescence in vitro.", "exact_answer": [["telomerase"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004791"], "type": "factoid", "id": "56c048acef6e39474100001c", "snippets": [{"offsetInBeginSection": 1004, "offsetInEndSection": 1068, "text": "Imetelstat inhibited telomerase activity in both subpopulations. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25627551", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 75, "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26332546", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 71, "text": "A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26332545", "endSection": "title"}, {"offsetInBeginSection": 303, "offsetInEndSection": 423, "text": "Our results showed that imetelstat inhibited telomerase activity in a dose-dependent manner in esophageal cancer cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22906540", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 83, "text": "Imetelstat (a telomerase antagonist) exerts off\u2011target effects on the cytoskeleton. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23545855", "endSection": "title"}, {"offsetInBeginSection": 298, "offsetInEndSection": 390, "text": "We evaluated the effect of the telomerase inhibitor imetelstat in preclinical models of MRT. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25441685", "endSection": "abstract"}, {"offsetInBeginSection": 1603, "offsetInEndSection": 1712, "text": "Imetelstat inhibited proliferation and self-renewal by shortening telomeres and inducing senescence in vitro. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25120190", "endSection": "abstract"}, {"offsetInBeginSection": 199, "offsetInEndSection": 334, "text": "GRN163L (Imetelstat) is a lipid-conjugated N3'\u2192P5' thio-phosphoramidate oligonucleotide that blocks the template region of telomerase. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24409321", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24409321", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 145, "text": "PURPOSE: Imetelstat is a covalently-lipidated 13-mer thiophosphoramidate oligonucleotide that acts as a potent specific inhibitor of telomerase. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24097866", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22906540", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 106, "text": "The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21062983", "endSection": "title"}, {"offsetInBeginSection": 1128, "offsetInEndSection": 1278, "text": "The activity of imetelstat as a single agent suggests that further studies of telomerase inhibitors in combination with other agents may be warranted. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25441685", "endSection": "abstract"}, {"offsetInBeginSection": 603, "offsetInEndSection": 770, "text": "When breast and pancreatic cancer cell lines were treated with imetelstat in vitro, telomerase activity in the bulk tumor cells and CSC subpopulations were inhibited. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21062983", "endSection": "abstract"}, {"offsetInBeginSection": 455, "offsetInEndSection": 603, "text": "In this study, we investigated the effects of imetelstat (GRN163L), a potent telomerase inhibitor, on both the bulk cancer cells and putative CSCs. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21062983", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 154, "text": "BACKGROUND: Imetelstat, a 13-mer oligonucleotide that is covalently modified with lipid extensions, competitively inhibits telomerase enzymatic activity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26332546", "endSection": "abstract"}, {"offsetInBeginSection": 130, "offsetInEndSection": 303, "text": "We sought to evaluate the potential of the thio-phosphoramidate oligonucleotide inhibitor of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22906540", "endSection": "abstract"}, {"offsetInBeginSection": 116, "offsetInEndSection": 479, "text": "This enzyme is expressed in approximately 90% of human tumors, but not in the majority of normal somatic cells. imetelstat sodium (GRN163L), is a 13-mer oligonucleotide N3'\u2192P5' thio-phosphoramidate lipid conjugate, which represents the latest generation of telomerase inhibitors targeting the template region of the human functional telomerase RNA (hTR) subunit. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23545855", "endSection": "abstract"}, {"offsetInBeginSection": 546, "offsetInEndSection": 733, "text": "The GBM tumor-initiating cells were treated with imetelstat and examined for the effects on telomerase activity levels, telomere length, proliferation, clonogenicity, and differentiation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20048334", "endSection": "abstract"}, {"offsetInBeginSection": 946, "offsetInEndSection": 1202, "text": "Imetelstat inhibited telomerase activity in both subpopulations. Moreover, imetelstat alone and in combination with trastuzumab reduced the CSC fraction and inhibited CSC functional ability, as shown by decreased mammosphere counts and invasive potential. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25627551", "endSection": "abstract"}, {"offsetInBeginSection": 1537, "offsetInEndSection": 1702, "text": "Our results suggest that imetelstat-mediated depletion of CSCs may offer an alternative mechanism by which telomerase inhibition may be exploited for cancer therapy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21062983", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 168, "text": "The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25627551", "endSection": "title"}, {"offsetInBeginSection": 271, "offsetInEndSection": 443, "text": "Telomerase is reactivated in tumor cells, including CSCs, but has limited activity in normal tissues, providing potential for telomerase inhibition in anti-cancer therapy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25627551", "endSection": "abstract"}, {"offsetInBeginSection": 443, "offsetInEndSection": 635, "text": "The purpose of this study was to investigate the effects of a telomerase antagonistic oligonucleotide, imetelstat (GRN163L), on CSC and non-CSC populations of HER2(+) breast cancer cell lines. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25627551", "endSection": "abstract"}, {"offsetInBeginSection": 171, "offsetInEndSection": 470, "text": "Imetelstat is a 13-mer lipid-conjugated oligonucleotide that targets the RNA template of human telomerase reverse transcriptase.METHODS: We sought to obtain preliminary information on the therapeutic activity and safety of imetelstat in patients with high-risk or intermediate-2-risk myelofibrosis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26332545", "endSection": "abstract"}, {"offsetInBeginSection": 622, "offsetInEndSection": 875, "text": "Treatment with imetelstat resulted in inhibition of telomerase activity, marked telomere shortening, and activation of the DNA damage response pathway, as measured by formation of \u03b3-H2AX nuclear foci, phosphorylation of ATM, and phosphorylation of TP53. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25441685", "endSection": "abstract"}, {"offsetInBeginSection": 863, "offsetInEndSection": 1121, "text": " Imetelstat, a phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase inhibition on proliferation and tumorigenicity in established cell lines (BXD-1425EPN, R254), a primary TIC line (E520) and xenograft models of pediatric ependymoma. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25120190", "endSection": "abstract"}, {"offsetInBeginSection": 1214, "offsetInEndSection": 1537, "text": "Differences between telomerase activity expression levels or telomere length of CSCs and bulk tumor cells in these cell lines did not correlate with the increased sensitivity of CSCs to imetelstat, suggesting a mechanism of action independent of telomere shortening for the effects of imetelstat on the CSC subpopulations. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21062983", "endSection": "abstract"}]}, {"body": "What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/3558369", "http://www.ncbi.nlm.nih.gov/pubmed/18567810", "http://www.ncbi.nlm.nih.gov/pubmed/12787669", "http://www.ncbi.nlm.nih.gov/pubmed/11087417", "http://www.ncbi.nlm.nih.gov/pubmed/7473738", "http://www.ncbi.nlm.nih.gov/pubmed/23528166", "http://www.ncbi.nlm.nih.gov/pubmed/16606828", "http://www.ncbi.nlm.nih.gov/pubmed/16472822", "http://www.ncbi.nlm.nih.gov/pubmed/8441637", "http://www.ncbi.nlm.nih.gov/pubmed/21163962", "http://www.ncbi.nlm.nih.gov/pubmed/16926025", "http://www.ncbi.nlm.nih.gov/pubmed/16681387", "http://www.ncbi.nlm.nih.gov/pubmed/9925782", "http://www.ncbi.nlm.nih.gov/pubmed/9576871", "http://www.ncbi.nlm.nih.gov/pubmed/9207015", "http://www.ncbi.nlm.nih.gov/pubmed/8772199", "http://www.ncbi.nlm.nih.gov/pubmed/8441638", "http://www.ncbi.nlm.nih.gov/pubmed/1598200", "http://www.ncbi.nlm.nih.gov/pubmed/6884360"], "triples": [{"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_413849585033007", "o": "Cytosine-C5 specific DNA methyltransferase"}], "ideal_answer": "The target ( methylatable ) cytosine, if flipped out of the double helical dna ( cytosine-5 ) -methyltransferases involves attack of the c6 of substrate cytosines by an enzyme nucleophile and formation of a transient covalent adduct.Therefore, covalent complex formation is not essential in the reaction mechanism of Dnmt3a.The target ( methylatable ) cytosine, if flipped out of the double helical dna as seen for dna methyltransferases that generate 5-methylcytosine, would fit into the concave active site next to the adomet.These two methyltransferases recognize CpG and GCGC sequences, respectively, and transfer a methyl group to the C5 atom of cytosine ( C ).Our studies reveal that the catalytic mechanism by which dna cytosine methyltransferases methylate the 5-position of dna cytosine residues in specific sequence contexts.All DNA ( cytosine-5 ) -methyltransferases contain a single conserved cysteine.2'-deoxyoligonucleotides with 5-fluorocytosine residues incorporated at specific positions of the nucleotide sequence are tools of great potential in the study of the catalytic properties of the dna cytosine methyltransferases methylate the 5-position of dna cytosine residues in specific sequence contexts.", "concepts": ["http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0009008", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0003886", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004248", "http://www.uniprot.org/uniprot/DCM_ECOLI", "http://www.uniprot.org/uniprot/CMT1_DICDI", "http://www.uniprot.org/uniprot/DCM_ECO57", "http://www.uniprot.org/uniprot/DNMT_FRG3G", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0051719", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0051720"], "type": "summary", "id": "515da5b5298dcd4e5100000f", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 58, "text": "Kinetic and catalytic mechanism of HhaI methyltransferase. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3558369", "endSection": "title"}, {"offsetInBeginSection": 797, "offsetInEndSection": 893, "text": "Hydroxide at 10(-7) mole fraction (pH = 7) is shown to be sufficient for the required catalysis. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16606828", "endSection": "sections.0"}, {"offsetInBeginSection": 79, "offsetInEndSection": 201, "text": "The enzyme has Mr 130 000, and introduces methyl groups from S-adenosylmethionine into the 5 position of cytosines in DNA. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6884360", "endSection": "sections.0"}, {"offsetInBeginSection": 467, "offsetInEndSection": 603, "text": "These two methyltransferases recognize CpG and GCGC sequences, respectively, and transfer a methyl group to the C5 atom of cytosine (C). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16681387", "endSection": "sections.0"}, {"offsetInBeginSection": 1331, "offsetInEndSection": 1482, "text": "Our results point to a possible connection between the catalytic mechanism of C5 Mtases and of enzymes that transfer methyl groups to N(4) of cytosine. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11087417", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 174, "text": "Catalytic mechanism of DNA-(cytosine-C5)-methyltransferases revisited: covalent intermediate formation is not essential for methyl group transfer by the murine Dnmt3a enzyme. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12787669", "endSection": "title"}, {"offsetInBeginSection": 1062, "offsetInEndSection": 1268, "text": "Our studies reveal that the catalytic mechanism of DNA (cytosine-5)-methyltransferases involves attack of the C6 of substrate cytosines by an enzyme nucleophile and formation of a transient covalent adduct. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3558369", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 258, "text": "Most prokaryotic (cytosine-5)-DNA methyltransferases increase the frequency of deamination at the cytosine targeted for methylation in vitro in the absence of the cofactor S-adenosylmethionine (AdoMet) or the reaction product S-adenosylhomocysteine (AdoHcy). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9576871", "endSection": "sections.0"}, {"offsetInBeginSection": 1077, "offsetInEndSection": 1268, "text": "R130A displayed a strong reduction in catalytic activity and a complete change in flanking sequence preferences, indicating that Arg130 has an important role in the DNA interaction of Dnmt3a. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16472822", "endSection": "sections.0"}, {"offsetInBeginSection": 642, "offsetInEndSection": 844, "text": "The target (methylatable) cytosine, if flipped out of the double helical DNA as seen for DNA methyltransferases that generate 5-methylcytosine, would fit into the concave active site next to the AdoMet. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9207015", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 223, "text": "All DNA (cytosine-5)-methyltransferases contain a single conserved cysteine. It has been proposed that this cysteine initiates catalysis by attacking the C6 of cytosine and thereby activating the normally inert C5 position. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8441637", "endSection": "sections.0"}, {"offsetInBeginSection": 244, "offsetInEndSection": 462, "text": "These methylation patterns are established and maintained by DNA cytosine-5 methyltransferase (MTase), a approximately 1500 amino acid enzyme containing a regulatory N-terminal domain and a catalytic C-terminal domain. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8772199", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 230, "text": "Previous X-ray crystallographic studies have revealed that the catalytic domain of a DNA methyltransferase (Mtase) generating C5-methylcytosine bears a striking structural similarity to that of a Mtase generating N6-methyladenine. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7473738", "endSection": "sections.0"}, {"offsetInBeginSection": 536, "offsetInEndSection": 730, "text": "In contrast, enzyme variants carrying E-->A, E-->D or E-->Q exchanges of the ENV glutamate are catalytically almost inactive, demonstrating that this residue has a central function in catalysis. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12787669", "endSection": "sections.0"}, {"offsetInBeginSection": 985, "offsetInEndSection": 1228, "text": "Spontaneous and reversible proton transfer between a conserved Glu in the active site and cytosine N3 at the transition state was observed in our simulations, revealing the chemical participation of this Glu residue in the catalytic mechanism. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23528166", "endSection": "sections.0"}, {"offsetInBeginSection": 1116, "offsetInEndSection": 1348, "text": "We propose that correct positioning of the flipped base and the cofactor and binding to the transition state of methyl group transfer are the most important roles of the Dnmt3a enzyme in the catalytic cycle of methyl group transfer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12787669", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 301, "text": "The mechanism of DNA cytosine-5-methylation catalyzed by the bacterial M.HhaI enzyme has been considered as a stepwise nucleophilic addition of Cys-81-S- to cytosine C6 followed by C5 nucleophilic replacement of the methyl of S-adenosyl-L-methionine to produce 5-methyl-6-Cys-81-S-5,6-dihydrocytosine. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16606828", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 308, "text": "2'-Deoxyoligonucleotides with 5-fluorocytosine residues incorporated at specific positions of the nucleotide sequence are tools of great potential in the study of the catalytic mechanism by which DNA cytosine methyltransferases methylate the 5-position of DNA cytosine residues in specific sequence contexts. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1598200", "endSection": "sections.0"}, {"offsetInBeginSection": 1546, "offsetInEndSection": 1840, "text": "While Asn167 might contribute to the positioning of residues from motif VI, according to structural data Arg202 has a role in catalysis of cytosine-C5 methyltransferases. The R295A variant was catalytically inactive most likely because of destabilization of the hinge sub-domain of the protein. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16472822", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 234, "text": "On the basis of amino acid sequence alignments and structural data of related enzymes, we have performed a mutational analysis of 14 amino acid residues in the catalytic domain of the murine Dnmt3a DNA-(cytosine C5)-methyltransferase. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16472822", "endSection": "sections.0"}, {"offsetInBeginSection": 485, "offsetInEndSection": 749, "text": "These results lend strong support to a catalytic mechanism in which an enzyme sulfhydryl group undergoes Michael addition to the C5-C6 double bond, thus activating position C-5 of the substrate DNA cytosine residue for electrophilic attack by the methyl donor SAM. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8441638", "endSection": "sections.0"}, {"offsetInBeginSection": 1024, "offsetInEndSection": 1348, "text": "Therefore, covalent complex formation is not essential in the reaction mechanism of Dnmt3a. We propose that correct positioning of the flipped base and the cofactor and binding to the transition state of methyl group transfer are the most important roles of the Dnmt3a enzyme in the catalytic cycle of methyl group transfer. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12787669", "endSection": "sections.0"}, {"offsetInBeginSection": 616, "offsetInEndSection": 938, "text": "We demonstrate that Phe50 (motif I) and Glu74 (motif II) are important for AdoMet binding and catalysis. D96A (motif III) showed reduced AdoMet binding but increased activity under conditions of saturation with S-adenosyl-L-methionine (AdoMet), indicating that the contact of Asp96 to AdoMet is not required for catalysis. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16472822", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 383, "text": "Kinetic and catalytic properties of the DNA (cytosine-5)-methyltransferase HhaI are described. With poly(dG-dC) as substrate, the reaction proceeds by an equilibrium (or processive) ordered Bi-Bi mechanism in which DNA binds to the enzyme first, followed by S-adenosylmethionine (AdoMet). After methyl transfer, S-adenosylhomocysteine (AdoHcy) dissociates followed by methylated DNA. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3558369", "endSection": "sections.0"}, {"offsetInBeginSection": 0, "offsetInEndSection": 367, "text": "Co-transfections of reporter plasmids and plasmids encoding the catalytic domain of the murine Dnmt3a DNA methyltransferase lead to inhibition of reporter gene expression. As Dnmt3a mutants with C-->A and E-->A exchanges in the conserved PCQ and ENV motifs in the catalytic center of the enzyme also cause repression, we checked for their catalytic activity in vitro. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12787669", "endSection": "sections.0"}]}, {"body": "Are mutations in the STXBP1 gene associated with epilepsy?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24315539", "http://www.ncbi.nlm.nih.gov/pubmed/24189369", "http://www.ncbi.nlm.nih.gov/pubmed/24170257", "http://www.ncbi.nlm.nih.gov/pubmed/24095819", "http://www.ncbi.nlm.nih.gov/pubmed/23531706", "http://www.ncbi.nlm.nih.gov/pubmed/23409955", "http://www.ncbi.nlm.nih.gov/pubmed/22787626", "http://www.ncbi.nlm.nih.gov/pubmed/22787616", "http://www.ncbi.nlm.nih.gov/pubmed/22722545", "http://www.ncbi.nlm.nih.gov/pubmed/22709267", "http://www.ncbi.nlm.nih.gov/pubmed/22612257", "http://www.ncbi.nlm.nih.gov/pubmed/22596016", "http://www.ncbi.nlm.nih.gov/pubmed/21967765", "http://www.ncbi.nlm.nih.gov/pubmed/21762454", "http://www.ncbi.nlm.nih.gov/pubmed/21770924", "http://www.ncbi.nlm.nih.gov/pubmed/21753172", "http://www.ncbi.nlm.nih.gov/pubmed/21364700", "http://www.ncbi.nlm.nih.gov/pubmed/21062273", "http://www.ncbi.nlm.nih.gov/pubmed/20887371", "http://www.ncbi.nlm.nih.gov/pubmed/20887364", "http://www.ncbi.nlm.nih.gov/pubmed/20876469", "http://www.ncbi.nlm.nih.gov/pubmed/20845763", "http://www.ncbi.nlm.nih.gov/pubmed/20493457", "http://www.ncbi.nlm.nih.gov/pubmed/19557857", "http://www.ncbi.nlm.nih.gov/pubmed/18469812", "http://www.ncbi.nlm.nih.gov/pubmed/21204804", "http://www.ncbi.nlm.nih.gov/pubmed/21277190"], "triples": [], "ideal_answer": "Mutations and deletions in the stxbp1 gene are associated with ohtahara syndrome, also known as \"early infantile epileptic encephalopathy de novo heterozygous mutations in migrating partial seizures of infancy.This is the first case report showing that stxbp1 mutations caused west syndrome, also known as \"early infantile epileptic encephalopathy de novo scn1a mutations in migrating partial seizures of infancy.A novel mutation in STXBP1 gene in a child with epileptic encephalopathy and an atypical electroclinical pattern.Folinic acid responsive epilepsy in ohtahara syndrome caused by stxbp1 mutation causes focal seizures with neonatal onset.A novel stxbp1 mutations caused west syndrome from the onset of epilepsy.Here we show that de novo heterozygous mutations in the gene encoding STXBP1, also known as MUNC18-1, which is essential in synaptic vesicle release in multiple species, cause OS", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009154", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004829", "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D059645", "http://www.uniprot.org/uniprot/STXB1_PONAB", "http://www.disease-ontology.org/api/metadata/DOID:1826"], "type": "yesno", "id": "550748a3bde8548216000001", "snippets": [{"offsetInBeginSection": 621, "offsetInEndSection": 704, "text": "and STXBP1-related West/Ohtahara syndromes, are due to a mutation in a unique gene. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22787626", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20887364", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 65, "text": "De novo SCN1A mutations in migrating partial seizures of infancy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21753172", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 66, "text": "A novel STXBP1 mutation causes focal seizures with neonatal onset. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22596016", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 80, "text": "Folinic acid responsive epilepsy in Ohtahara syndrome caused by STXBP1 mutation. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24315539", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "A novel mutation in STXBP1 gene in a child with epileptic encephalopathy and an atypical electroclinical pattern. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24170257", "endSection": "title"}, {"offsetInBeginSection": 720, "offsetInEndSection": 829, "text": "This is the first case report showing that STXBP1 mutations caused West syndrome from the onset of epilepsy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21204804", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 104, "text": "De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18469812", "endSection": "title"}, {"offsetInBeginSection": 10, "offsetInEndSection": 148, "text": "e novo STXBP1 mutations have been found in individuals with early infantile epileptic encephalopathy with suppression-burst pattern (EIEE) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20887364", "endSection": "abstract"}, {"offsetInBeginSection": 1105, "offsetInEndSection": 1278, "text": "STXBP1 haploinsufficiency results in progressive encephalopathy characterized by intellectual disability and may be accompanied by epilepsy, movement disorders, and autism. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22722545", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 170, "text": "Mutations in STXBP1 have been identified in a subset of patients with early onset epileptic encephalopathy (EE), but the full phenotypic spectrum remains to be delineated ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23409955", "endSection": "abstract"}, {"offsetInBeginSection": 176, "offsetInEndSection": 368, "text": "ed with severe developmental delay and poor prognosis. Mutations and deletions in the STXBP1 gene are associated with Ohtahara syndrome, also known as \"early infantile epileptic encephalopathy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23531706", "endSection": "abstract"}, {"offsetInBeginSection": 1876, "offsetInEndSection": 2087, "text": "Mutations in STXBP1 are relatively frequent in patients with infantile epileptic encephalopathies. STXBP1-related encephalopathy may present as drug-responsive infantile spasms with focal/lateralized discharges. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21762454", "endSection": "abstract"}, {"offsetInBeginSection": 204, "offsetInEndSection": 382, "text": "Here we show that de novo heterozygous mutations in the gene encoding STXBP1, also known as MUNC18-1, which is essential in synaptic vesicle release in multiple species, cause OS ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22787616", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 242, "text": "Mutations of the syntaxin binding protein 1 (STXBP1) have been associated with severe infantile epileptic encephalopathies (Ohtahara syndrome and West syndrome), but also with moderate to severe cognitive impairment and nonsyndromic epilepsy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22596016", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 246, "text": "Mutations in STXBP1 gene, encoding the syntaxin binding protein 1, have been recently described in Ohtahara syndrome, or early infantile epileptic encephalopathy with suppression-burst pattern, and in other early-onset epileptic encephalopathies. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24170257", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 278, "text": "STXBP1 (MUNC18.1), encoding syntaxin binding protein 1, has been reported in Ohtahara syndrome, a rare epileptic encephalopathy with suppression burst pattern on EEG, in patients with infantile spasms and in a few patients with nonsyndromic mental retardation without epilepsy. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24095819", "endSection": "abstract"}]}, {"body": "Which are the cardiac effects of thyronamines?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22073124", "http://www.ncbi.nlm.nih.gov/pubmed/20880963", "http://www.ncbi.nlm.nih.gov/pubmed/19016324", "http://www.ncbi.nlm.nih.gov/pubmed/18954857", "http://www.ncbi.nlm.nih.gov/pubmed/18486124", "http://www.ncbi.nlm.nih.gov/pubmed/17579492", "http://www.ncbi.nlm.nih.gov/pubmed/17204552", "http://www.ncbi.nlm.nih.gov/pubmed/20739399"], "triples": [], "ideal_answer": "In conclusion, trace amines and thyronamines are negative chronotropy, negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria, and reduction of fat mass.Functional effects have been observed after administration of exogenous t ( 1 ) am : in the isolated heart, a negative inotropic and chronotropic action was produced, and the resistance to ischemic injury was increased, possibly as a consequence of an action on intracellular calcium homeostasis.Intraperitoneal or central injection of 3-t ( 1 ) am or t ( 0 ) am into mice, rats, or djungarian hamsters caused various prompt effects, such as metabolic depression, hypothermia, negative inotropic agents.In conclusion, trace amines and thyronamines are negative inotropic agents.Functional effects, such as metabolic depression, hypothermia, negative chronotropy, negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria, and the resistance to ischemic injury was increased, possibly as a consequence of an action on intracellular calcium homeostasis.", "exact_answer": [["negative inotropism"], ["negative chronotropy"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006331", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002302", "http://www.biosemantics.org/jochem#4251308"], "type": "list", "id": "532c12f2d6d3ac6a3400001d", "snippets": [{"offsetInBeginSection": 1523, "offsetInEndSection": 1599, "text": "In conclusion, trace amines and thyronamines are negative inotropic agents. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18486124", "endSection": "abstract"}, {"offsetInBeginSection": 329, "offsetInEndSection": 620, "text": "Functional effects have been observed after administration of exogenous T(1)AM: in the isolated heart, a negative inotropic and chronotropic action was produced, and the resistance to ischemic injury was increased, possibly as a consequence of an action on intracellular calcium homeostasis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19016324", "endSection": "abstract"}, {"offsetInBeginSection": 641, "offsetInEndSection": 947, "text": "Intraperitoneal or central injection of 3-T(1)AM or T(0)AM into mice, rats, or Djungarian hamsters caused various prompt effects, such as metabolic depression, hypothermia, negative chronotropy, negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria, and reduction of fat mass. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880963", "endSection": "abstract"}]}, {"body": "What is the mechanism of action of geldanamycin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23986774", "http://www.ncbi.nlm.nih.gov/pubmed/23701727", "http://www.ncbi.nlm.nih.gov/pubmed/21525416", "http://www.ncbi.nlm.nih.gov/pubmed/20534344", "http://www.ncbi.nlm.nih.gov/pubmed/18001136", "http://www.ncbi.nlm.nih.gov/pubmed/15971989", "http://www.ncbi.nlm.nih.gov/pubmed/9817749"], "triples": [], "ideal_answer": "Geldanamycin ( ga ) and 17-allylamino-17- demethoxygeldanamycin ( 17aag ), novel solid-phase immunoassays have been validated using a time-resolved fluorescence ( trf ) end point.Using the standard inhibitors of the adenosine triphosphatase ( atpase ) activity of hsp90 inhibition in secondary cell-based assays has been shown and applied to the novel hsp90 inhibitor cct018159.Geldanamycin is an antibiotic originally discovered based on its ability to bind heat-shock protein 90-containing multimolecular complexes.A recent crystal structure of the NH2-terminal domain of yeast Hsp90 established the presence of a conserved nucleotide binding site that is identical with the binding site of geldanamycin, a specific inhibitor of Hsp90.It can also induce the inhibition or even degradation of partner proteins dissociated from the 90 kDa chaperone and, eventually, can cause apoptosis, for instance, in PC12 cells.Geldanamycin ( hsp90 inhibitor ) their utility for confirming the mechanism of action of hsp90 inhibition in secondary cell-based assays has been shown and applied to the novel solid-phase immunoassays have been validated using a time-resolved fluorescence ( trf ) end point.This interaction can lead to the disruption of heat-shock protein 90.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D045504", "http://www.biosemantics.org/jochem#4250710", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020228"], "type": "summary", "id": "5319a73cb166e2b806000026", "snippets": [{"offsetInBeginSection": 932, "offsetInEndSection": 962, "text": "Geldanamycin (HSP90 inhibitor) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23986774", "endSection": "abstract"}, {"offsetInBeginSection": 414, "offsetInEndSection": 446, "text": "the Hsp90 inhibitor geldanamycin ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18001136", "endSection": "abstract"}, {"offsetInBeginSection": 569, "offsetInEndSection": 743, "text": "The functional significance of nucleotide binding by Hsp90 has remained unclear. Here we present evidence for a slow but clearly detectable ATPase activity in purified Hsp90. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9817749", "endSection": "abstract"}, {"offsetInBeginSection": 656, "offsetInEndSection": 849, "text": "An Hsp90 ATPase inhibitor, geldanamycin, inhibits luciferase reactivation demonstrating the importance of the ATP-dependent chaperone activity of E. coli Hsp90 during client protein remodeling. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21525416", "endSection": "abstract"}, {"offsetInBeginSection": 372, "offsetInEndSection": 568, "text": "Unique proteome patterns were observed in HeLa cells treated with the HSP90 inhibitor geldanamycin, and were similar to the patterns induced by radicicol, a structurally different HSP90 inhibitor. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20534344", "endSection": "abstract"}, {"offsetInBeginSection": 348, "offsetInEndSection": 568, "text": "A recent crystal structure of the NH2-terminal domain of yeast Hsp90 established the presence of a conserved nucleotide binding site that is identical with the binding site of geldanamycin, a specific inhibitor of Hsp90. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9817749", "endSection": "abstract"}, {"offsetInBeginSection": 187, "offsetInEndSection": 575, "text": "Geldanamycin is an antibiotic originally discovered based on its ability to bind heat-shock protein 90. This interaction can lead to the disruption of heat-shock protein 90-containing multimolecular complexes. It can also induce the inhibition or even degradation of partner proteins dissociated from the 90 kDa chaperone and, eventually, can cause apoptosis, for instance, in PC12 cells. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23701727", "endSection": "abstract"}, {"offsetInBeginSection": 572, "offsetInEndSection": 1342, "text": "The molecular chaperone heat-shock protein (Hsp) 90 is an important anticancer drug target because it maintains the conformation, stability, and function of many important oncogenic client proteins, including those involved with signal transduction, cell proliferation, survival, differentiation, motility angiogenesis, and metastasis. Using the standard inhibitors of the adenosine triphosphatase (ATPase) activity of Hsp90, geldanamycin (GA) and 17-allylamino-17- demethoxygeldanamycin (17AAG), novel solid-phase immunoassays have been validated using a time-resolved fluorescence (TRF) end point. Their utility for confirming the mechanism of action of Hsp90 inhibition in secondary cell-based assays has been shown and applied to the novel Hsp90 inhibitor CCT018159. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15971989", "endSection": "abstract"}]}, {"body": "Which is the most widely used anti-TNF drug?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22379032", "http://www.ncbi.nlm.nih.gov/pubmed/21881980", "http://www.ncbi.nlm.nih.gov/pubmed/19854715", "http://www.ncbi.nlm.nih.gov/pubmed/21177290", "http://www.ncbi.nlm.nih.gov/pubmed/18420660"], "ideal_answer": "Two of them received etanercept and the remainder adalimumab.45 cases were collected of non-TB OIs in 43 patients receiving infliximab ( n=29 ), adalimumab ( n=10 ) or etanercept ( n=4 )Higher rates are observed with anti-tnf abs ( e.g., infliximab ) as compared with tnf receptor fusion protein ( etanercept ).", "exact_answer": ["Etanercept"], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D023201", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D044966", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000894", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D053199", "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016756"], "type": "factoid", "id": "512d0e635274a5fb07000005", "snippets": [{"offsetInBeginSection": 140, "offsetInEndSection": 201, "text": "Two of them received etanercept and the remainder adalimumab. ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21881980", "endSection": "sections.0"}, {"offsetInBeginSection": 128, "offsetInEndSection": 249, "text": "higher rates are observed with anti-TNF Abs (e.g., infliximab) as compared with TNF receptor fusion protein (etanercept). ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22379032", "endSection": "sections.0"}, {"offsetInBeginSection": 542, "offsetInEndSection": 661, "text": "45 cases were collected of non-TB OIs in 43 patients receiving infliximab (n=29), adalimumab (n=10) or etanercept (n=4) ", "beginSection": "sections.0", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21177290", "endSection": "sections.0"}]}, {"body": "What is the association between number of pregnancies and rheumatoid arthritis", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23070994", "http://www.ncbi.nlm.nih.gov/pubmed/22012422", "http://www.ncbi.nlm.nih.gov/pubmed/12839599", "http://www.ncbi.nlm.nih.gov/pubmed/10342392", "http://www.ncbi.nlm.nih.gov/pubmed/2819350"], "triples": [], "ideal_answer": "A larger number of pregnancies, and pregnancy outcome are not strongly associated with the risk of developing ra in women of childbearing age.Most other published studies find no association between nulliparity and RA.We found an inverse correlation between the number of pregnancies and age at onset of ra since the landmark study on rheumatoid arthritis, many reports have suggested that physiological changes during pregnancy often induce remission of systemic and cutaneous inflammatory diseases.It appears that infertility, the number of pregnancies and children, however, were significantly higher in controls thus, a true association could have been missed.A larger number of pregnancies and late menopause show a protective effect, delaying the onset of the disease.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001172", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011247"], "type": "summary", "id": "52f892782059c6d71c000039", "snippets": [{"offsetInBeginSection": 867, "offsetInEndSection": 949, "text": "Number of pregnancies and children, however, were significantly higher in controls ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2819350", "endSection": "abstract"}, {"offsetInBeginSection": 1000, "offsetInEndSection": 1088, "text": "We found an inverse correlation between the number of pregnancies and age at onset of RA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22012422", "endSection": "abstract"}, {"offsetInBeginSection": 1230, "offsetInEndSection": 1309, "text": "In this unique population, greater parity significantly reduced the odds of RA; ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070994", "endSection": "abstract"}, {"offsetInBeginSection": 1201, "offsetInEndSection": 1311, "text": "A larger number of pregnancies and late menopause show a protective effect, delaying the onset of the disease. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22012422", "endSection": "abstract"}, {"offsetInBeginSection": 1857, "offsetInEndSection": 2021, "text": "Literature review shows that at best, there are weak negative associations between current estrogen use and RA, and no association with nulliparity and infertility. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10342392", "endSection": "abstract"}, {"offsetInBeginSection": 12, "offsetInEndSection": 205, "text": "Since the landmark study on rheumatoid arthritis, many reports have suggested that physiological changes during pregnancy often induce remission of systemic and cutaneous inflammatory diseases. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12839599", "endSection": "abstract"}, {"offsetInBeginSection": 1310, "offsetInEndSection": 1628, "text": "an early age at first birth increased the odds, and the postpartum period was confirmed as high risk for RA onset. The protective effect of repeated exposure to the ameliorating hormonal and immunological changes of pregnancy may counterbalance the effect of early exposure to the postpartum reversal of these changes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070994", "endSection": "abstract"}, {"offsetInBeginSection": 2035, "offsetInEndSection": 2494, "text": "It appears that infertility, the number of pregnancies, and pregnancy outcome are not strongly associated with the risk of developing RA in women of childbearing age. However, in this study there may have been selection biases in the women with RA and the controls that differentially could have affected their reproductive outcomes. Thus, a true association could have been missed. Most other published studies find no association between nulliparity and RA. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10342392", "endSection": "abstract"}]}, {"body": "Is mitofusin 2 a receptor for parkin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23958438", "http://www.ncbi.nlm.nih.gov/pubmed/23845246", "http://www.ncbi.nlm.nih.gov/pubmed/23620051", "http://www.ncbi.nlm.nih.gov/pubmed/22914740", "http://www.ncbi.nlm.nih.gov/pubmed/22807239", "http://www.ncbi.nlm.nih.gov/pubmed/21252228", "http://www.ncbi.nlm.nih.gov/pubmed/19076450", "http://www.ncbi.nlm.nih.gov/pubmed/20871098"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A1378212", "o": "C111567"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A8256703"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A1378212"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A1378212"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8256703", "o": "parkin protein"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A8256703", "o": "5004-0064"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A8256703"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A1378212"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A1378212"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8256703", "o": "parkin protein"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A1378212", "o": "MeSH"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A8256703"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A1378212"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C0673396", "o": "http://linkedlifedata.com/resource/umls/label/A1378212"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A8256703", "o": "parkin protein"}, {"p": "http://purl.uniprot.org/core/ecName", "s": "http://linkedlifedata.com/resource/#_4337545A483800B", "o": "3.6.5.-"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4337545A483800B", "o": "Mitofusin 2"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "true"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/#_4F39353134300020"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F39353134300020", "o": "Mitofusin-2"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/#_4F39353134300021"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F39353134300021", "o": "Transmembrane GTPase MFN2"}, {"p": "http://purl.uniprot.org/core/reviewed", "s": "http://purl.uniprot.org/uniprot/Q811U4", "o": "true"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q811U4", "o": "http://linkedlifedata.com/resource/#_5138313155340016"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_5138313155340017", "o": "Transmembrane GTPase MFN1"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q811U4", "o": "http://linkedlifedata.com/resource/#_5138313155340017"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_5138313155340016", "o": "Mitofusin-1"}, {"p": "http://linkedlifedata.com/resource/relationontology/hasLocalization", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/geneontology/id/GO:0005829"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/#_4F39353134300020"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F39353134300020", "o": "Mitofusin-2"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/#_4F39353134300021"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F39353134300021", "o": "Transmembrane GTPase MFN2"}, {"p": "http://www.w3.org/2004/02/skos/core#prefLabel", "s": "http://linkedlifedata.com/resource/geneontology/id/GO:0005829", "o": "cytosol"}, {"p": "http://purl.uniprot.org/core/citation", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://purl.uniprot.org/citations/16710414"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/#_4F39353134300020"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F39353134300020", "o": "Mitofusin-2"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/#_4F39353134300021"}, {"p": "http://purl.uniprot.org/core/name", "s": "http://purl.uniprot.org/citations/16710414", "o": "Nature"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F39353134300021", "o": "Transmembrane GTPase MFN2"}, {"p": "http://www.w3.org/2004/02/skos/core#exactMatch", "s": "http://purl.uniprot.org/pubmed/16710414", "o": "http://purl.uniprot.org/pubmed/16710414"}, {"p": "http://purl.uniprot.org/core/isolatedFrom", "s": "http://purl.uniprot.org/uniprot/Q811U4", "o": "http://purl.uniprot.org/tissues/1050"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/Q811U4", "o": "http://linkedlifedata.com/resource/#_5138313155340016"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_5138313155340017", "o": "Transmembrane GTPase MFN1"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/Q811U4", "o": "http://linkedlifedata.com/resource/#_5138313155340017"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_5138313155340016", "o": "Mitofusin-1"}, {"p": "http://www.w3.org/2000/01/rdf-schema#label", "s": "http://purl.uniprot.org/tissues/1050", "o": "Tongue"}, {"p": "http://purl.uniprot.org/core/mnemonic", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "MFN2_HUMAN"}, {"p": "http://purl.uniprot.org/core/recommendedName", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/#_4F39353134300020"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F39353134300020", "o": "Mitofusin-2"}, {"p": "http://purl.uniprot.org/core/alternativeName", "s": "http://purl.uniprot.org/uniprot/O95140", "o": "http://linkedlifedata.com/resource/#_4F39353134300021"}, {"p": "http://purl.uniprot.org/core/fullName", "s": "http://linkedlifedata.com/resource/#_4F39353134300021", "o": "Transmembrane GTPase MFN2"}], "ideal_answer": "Mfn2 functions as a mitochondrial fusion protein mitofusin 2 serves as a receptor for parkin translocation to damaged mitochondria.Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac mitochondria.Recent work demonstrates that a phosphorylated form of the mitochondrial fusion protein mitofusin 2 serves as a receptor for parkin recruitment to damaged mitochondria.Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1 manner upon induction of mitophagy we show that the mitochondrial outer membrane guanosine triphosphatase mitofusin ( Mfn ) 2 mediates Parkin recruitment to damaged mitochondria.", "exact_answer": "yes", "concepts": ["http://www.uniprot.org/uniprot/MFN2_RAT", "http://www.uniprot.org/uniprot/MFN2_HUMAN", "http://www.uniprot.org/uniprot/MFN2_MOUSE", "http://www.uniprot.org/uniprot/MARF_DROME", "http://www.uniprot.org/uniprot/PACRG_HUMAN", "http://www.uniprot.org/uniprot/PACRG_MOUSE"], "type": "yesno", "id": "5318352fb166e2b806000011", "snippets": [{"offsetInBeginSection": 1087, "offsetInEndSection": 1201, "text": "Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac mitochondria. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23620051", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20871098", "endSection": "title"}, {"offsetInBeginSection": 421, "offsetInEndSection": 563, "text": "We show that the mitochondrial outer membrane guanosine triphosphatase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged mitochondria. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23620051", "endSection": "abstract"}, {"offsetInBeginSection": 113, "offsetInEndSection": 283, "text": "Recent work demonstrates that a phosphorylated form of the mitochondrial fusion protein Mitofusin 2 serves as a receptor for Parkin translocation to damaged mitochondria. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23845246", "endSection": "abstract"}]}, {"body": "What are the main benefits of pharmacophore models?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24294969", "http://www.ncbi.nlm.nih.gov/pubmed/24287559", "http://www.ncbi.nlm.nih.gov/pubmed/24245803", "http://www.ncbi.nlm.nih.gov/pubmed/24212027", "http://www.ncbi.nlm.nih.gov/pubmed/24140950", "http://www.ncbi.nlm.nih.gov/pubmed/24119198", "http://www.ncbi.nlm.nih.gov/pubmed/24112046", "http://www.ncbi.nlm.nih.gov/pubmed/22192589", "http://www.ncbi.nlm.nih.gov/pubmed/23662282", "http://www.ncbi.nlm.nih.gov/pubmed/20838973"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A1308602", "o": "CRISP Thesaurus"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0599740", "o": "http://linkedlifedata.com/resource/umls/label/A1308602"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1308603", "o": "pharmacophore"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0599740", "o": "http://linkedlifedata.com/resource/umls/label/A1308603"}, {"p": "http://www.w3.org/2004/02/skos/core#note", "s": "http://linkedlifedata.com/resource/umls/label/A1308603", "o": "CRISP Thesaurus"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0599740", "o": "http://linkedlifedata.com/resource/umls/label/A1308602"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1308603", "o": "pharmacophore"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0599740", "o": "http://linkedlifedata.com/resource/umls/label/A1308603"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A1308603", "o": "2573-1500"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0599740", "o": "http://linkedlifedata.com/resource/umls/label/A1308602"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A1308603", "o": "pharmacophore"}, {"p": "http://linkedlifedata.com/resource/umls/altMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C0599740", "o": "http://linkedlifedata.com/resource/umls/label/A1308603"}], "ideal_answer": "Hit compound 8 was identified as an inhibitor of tankyrases through a combination of substructure searching of the Amgen compound collection based on a minimal binding pharmacophore hypothesis and high-throughput screening.Significantly, the most active antileishmanial benzothiophenes lack the pharmacophore for estrogen receptor activity and therefore address potential concerns about the undesirable effects of using selective estrogen receptor modulators in women and children with leishmaniasis.Parts of compounds with high docking scores have been reported to have the related pharmacological activity from the literatures.Hit compound 8 was identified as an inhibitor of tankyrases through a combination of substructure searching of the amgen compound collection based on a minimal binding pharmacophore models were generated though six known inos inhibitors and validated by a test database.", "exact_answer": [["They represent chemical functions valid not only for the existing bounds but also for unknown molecules."], ["Due their simplicity they are proper for large scale virtual screening"], ["They are comprehensive and editable, so by changing chemical feature contains information can be easily trace back."]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015195", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003198", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008956", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008954", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008961"], "type": "list", "id": "532c0ac4d6d3ac6a3400001a", "snippets": [{"offsetInBeginSection": 2, "offsetInEndSection": 255, "text": "series of novel diastereoisomeric \u03c3 ligands 3 was designed, synthesized and pharmacologically evaluated. The highly rigid [4.3.3]propellane scaffold was used to fix the three dimensional orientation of the pharmacophoric moieties required for \u03c3 affinity ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24140950", "endSection": "abstract"}, {"offsetInBeginSection": 777, "offsetInEndSection": 1190, "text": "the primary structural features required for estrogen receptor binding, the phenols, are not required for inhibiting parasitic growth. Significantly, the most active antileishmanial benzothiophenes lack the pharmacophore for estrogen receptor activity and therefore address potential concerns about the undesirable effects of using selective estrogen receptor modulators in women and children with leishmaniasis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24119198", "endSection": "abstract"}, {"offsetInBeginSection": 149, "offsetInEndSection": 561, "text": "To discover novel RNAP inhibitors, a pharmacophore based on the alignment of described inhibitors was used for virtual screening. In an optimization process of hit compounds, novel derivatives with improved in vitro potency were discovered. Investigations concerning the molecular mechanism of RNAP inhibition reveal that they prevent the protein-protein interaction (PPI) between \u03c3(70) and the RNAP core enzyme. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24112046", "endSection": "abstract"}, {"offsetInBeginSection": 327, "offsetInEndSection": 850, "text": "Hit compound 8 was identified as an inhibitor of tankyrases through a combination of substructure searching of the Amgen compound collection based on a minimal binding pharmacophore hypothesis and high-throughput screening. Herein we report the structure- and property-based optimization of compound 8 leading to the identification of more potent and selective tankyrase inhibitors 22 and 49 with improved pharmacokinetic properties in rodents, which are well suited as tool compounds for further in vivo validation studies ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24294969", "endSection": "abstract"}, {"offsetInBeginSection": 143, "offsetInEndSection": 988, "text": "This study was performed to identify natural iNOS inhibitors from traditional Chinese herbs through a combination of pharmacophore modeling, molecular docking and virtual screening. First, the pharmacophore models were generated though six known iNOS inhibitors and validated by a test database. The pharmacophore model_017 showed good performance in external validation and was employed to screen Traditional Chinese Medicine Database (Version 2009), which resulting in a hit list of 498 compounds with matching score (QFIT) above 40. Then, the hits were subjected to molecular docking for further refinement. An empirical scoring function was used to evaluate the affinity of the compounds and the target protein. Parts of compounds with high docking scores have been reported to have the related pharmacological activity from the literatures. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24212027", "endSection": "abstract"}]}, {"body": "Can DMSO as an additive improve proteomic analysis results?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23975139", "http://www.ncbi.nlm.nih.gov/pubmed/18926777"], "triples": [], "ideal_answer": "Introducing to the 80 % formic acid injection solution an organic solvent such as acetonitrile or acetonitrile-DMSO induced further retention selectivity, we report that low percentages of dimethylsulfoxide ( DMSO ) in liquid chromatography solvents lead to a strong enhancement of electrospray ionization of peptides, improving the sensitivity of protein identification in bottom-up proteomics by up to tenfold.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004121", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020543", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D040901", "http://www.biosemantics.org/jochem#4275915"], "type": "summary", "id": "52d8466298d0239505000006", "snippets": [{"offsetInBeginSection": 597, "offsetInEndSection": 750, "text": "Introducing to the 80% formic acid injection solution an organic solvent such as acetonitrile or acetonitrile-DMSO induced further retention selectivity, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18926777", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 256, "text": "We report that low percentages of dimethylsulfoxide (DMSO) in liquid chromatography solvents lead to a strong enhancement of electrospray ionization of peptides, improving the sensitivity of protein identification in bottom-up proteomics by up to tenfold. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23975139", "endSection": "abstract"}]}, {"body": "What was the aim of the HAMLET clinical trial?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23943217", "http://www.ncbi.nlm.nih.gov/pubmed/23868265", "http://www.ncbi.nlm.nih.gov/pubmed/17400593", "http://www.ncbi.nlm.nih.gov/pubmed/16965617", "http://www.ncbi.nlm.nih.gov/pubmed/14723030", "http://www.ncbi.nlm.nih.gov/pubmed/19269254", "http://www.ncbi.nlm.nih.gov/pubmed/17303527"], "triples": [], "ideal_answer": "Methods : we assessed clinical outcomes, costs, and cost-effectiveness for the first 3 years in patients who were randomized to surgical decompression or best medical treatment within 48 hours after symptom onset in the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial.Surgical decompression for space-occupying hemispheric infarction, who were enrolled in the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial within 4 days after stroke onset, were followed up at 3 years.Surgical decompression for space-occupying cerebral infarction : outcomes at 3 years in the randomized HAMLET trial.The aim of hamlet was to assess the effect of decompressive surgery within 4 days of the onset of symptoms in patients participating in the randomised trial of paracetamol ( acetaminophen ) in stroke ( pais ).", "concepts": [], "type": "summary", "id": "54d776453706e89528000018", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET). ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16965617", "endSection": "title"}, {"offsetInBeginSection": 331, "offsetInEndSection": 494, "text": "The aim of HAMLET was to assess the effect of decompressive surgery within 4 days of the onset of symptoms in patients with space-occupying hemispheric infarction. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19269254", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23868265", "endSection": "title"}, {"offsetInBeginSection": 381, "offsetInEndSection": 577, "text": "This study is designed to compare the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16965617", "endSection": "abstract"}, {"offsetInBeginSection": 375, "offsetInEndSection": 717, "text": "The 'Hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial' (HAMLET) is a newly-conceived randomised multi-centre clinical trial that compares the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14723030", "endSection": "abstract"}, {"offsetInBeginSection": 172, "offsetInEndSection": 413, "text": "METHODS: Patients with space-occupying hemispheric infarction, who were enrolled in the Hemicraniectomy After Middle cerebral artery infarction with Life-threatening Edema Trial within 4 days after stroke onset, were followed up at 3 years. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23868265", "endSection": "abstract"}, {"offsetInBeginSection": 263, "offsetInEndSection": 622, "text": "We studied differences in recall of information and in appreciation of the informed consent procedure between representatives included in the Hemicraniectomy After Middle cerebral artery infarction with Life-threatening Edema Trial (HAMLET) and representatives of patients participating in the randomised trial of Paracetamol (Acetaminophen) In Stroke (PAIS). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17400593", "endSection": "abstract"}, {"offsetInBeginSection": 212, "offsetInEndSection": 531, "text": "METHODS: We assessed clinical outcomes, costs, and cost-effectiveness for the first 3 years in patients who were randomized to surgical decompression or best medical treatment within 48 hours after symptom onset in the Hemicraniectomy After Middle Cerebral Artery Infarction With Life-Threatening Edema Trial (HAMLET). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23943217", "endSection": "abstract"}]}, {"body": "Can we use prodrug amifostine to protect healthy cell during chemotherapy?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23626702", "http://www.ncbi.nlm.nih.gov/pubmed/19956889", "http://www.ncbi.nlm.nih.gov/pubmed/18204866", "http://www.ncbi.nlm.nih.gov/pubmed/17661222", "http://www.ncbi.nlm.nih.gov/pubmed/20021044", "http://www.ncbi.nlm.nih.gov/pubmed/16267025", "http://www.ncbi.nlm.nih.gov/pubmed/16116597", "http://www.ncbi.nlm.nih.gov/pubmed/16015542", "http://www.ncbi.nlm.nih.gov/pubmed/15330181", "http://www.ncbi.nlm.nih.gov/pubmed/15064010", "http://www.ncbi.nlm.nih.gov/pubmed/12538828", "http://www.ncbi.nlm.nih.gov/pubmed/12469164", "http://www.ncbi.nlm.nih.gov/pubmed/11336600", "http://www.ncbi.nlm.nih.gov/pubmed/10963843", "http://www.ncbi.nlm.nih.gov/pubmed/10731970", "http://www.ncbi.nlm.nih.gov/pubmed/10553165", "http://www.ncbi.nlm.nih.gov/pubmed/10348266", "http://www.ncbi.nlm.nih.gov/pubmed/9703784", "http://www.ncbi.nlm.nih.gov/pubmed/8783671", "http://www.ncbi.nlm.nih.gov/pubmed/8656260", "http://www.ncbi.nlm.nih.gov/pubmed/9099346", "http://www.ncbi.nlm.nih.gov/pubmed/10808697", "http://www.ncbi.nlm.nih.gov/pubmed/17602063", "http://www.ncbi.nlm.nih.gov/pubmed/8952658", "http://www.ncbi.nlm.nih.gov/pubmed/9389935", "http://www.ncbi.nlm.nih.gov/pubmed/15345895", "http://www.ncbi.nlm.nih.gov/pubmed/11368288"], "triples": [{"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17889382", "o": "N0000022033"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A17889382"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17889382", "o": "AMIFOSTINE/MANNITOL"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A12102802"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A17985952"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A17985952", "o": "N0000022033"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A17889382"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17889382", "o": "AMIFOSTINE/MANNITOL"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A12102802"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A17985952"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A12102802", "o": "4024028"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A17889382"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A17889382", "o": "AMIFOSTINE/MANNITOL"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A12102802"}, {"p": "http://www.w3.org/2008/05/skos-xl#altLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1874179", "o": "http://linkedlifedata.com/resource/umls/label/A17985952"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A10488633", "o": "377092"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1251303", "o": "http://linkedlifedata.com/resource/umls/label/A10488633"}, {"p": "http://linkedlifedata.com/resource/umls/prefMetaMap", "s": "http://linkedlifedata.com/resource/umls/id/C1251303", "o": "http://linkedlifedata.com/resource/umls/label/A10488633"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A10488633", "o": "Amifostine Injectable Solution"}, {"p": "http://www.w3.org/2004/02/skos/core#notation", "s": "http://linkedlifedata.com/resource/umls/label/A10414743", "o": "330576"}, {"p": "http://www.w3.org/2008/05/skos-xl#literalForm", "s": "http://linkedlifedata.com/resource/umls/label/A10414743", "o": "Amifostine 50 MG/ML"}, {"p": "http://www.w3.org/2008/05/skos-xl#prefLabel", "s": "http://linkedlifedata.com/resource/umls/id/C1126264", "o": "http://linkedlifedata.com/resource/umls/label/A10414743"}], "ideal_answer": "Amifostine alone is inactive chemically, but active metabolite amifostine WR-1065 has been assumed to protect the healthy tissues during antineoplastic therapy by bounding of anticancer drug, causing their detoxification and eliminating the free radicals generated during radiation and cytostatic therapy cYP ), a commonly prescribed chemotherapy drug, has multiple adverse side effects including alteration of taste.Amifostine was developed to protect the healthy tissues during antineoplastic therapy by bounding of anticancer drug, causing their detoxification and eliminating the free radicals generated during radiation exposure doxorubicin induces apoptosis in germ line stem cells in the immature rat testis and amifostine can not protect against this cytotoxicity radioprotective effects including alteration of taste.Amifostine prevented benzene-induced bone marrow and spleen cell apoptosis and rescinded the inhibition of cell proliferation induced by benzene exposure.Amifostine is a cytoprotective agent that was previously shown to be effective in preventing chemotherapy-induced mucositis and nephrotoxicity.Amifostine was developed to protect normal tissues from radiation exposure doxorubicin induces apoptosis in germ line stem cells in the immature rat testis and amifostine can not protect against this cytotoxicity radioprotective effects of amifostine.", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019610", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004999", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004358", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020011", "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0005623", "http://www.biosemantics.org/jochem#4217067", "http://www.biosemantics.org/jochem#4277891"], "type": "summary", "id": "534289851eccfd0633000001", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 38, "text": "Radioprotective effects of amifostine. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10348266", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 40, "text": "Amifostine inhibits angiogenesis in vivo ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12538828", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 50, "text": "Amifostine-antioxidant drug in anticancer therapy. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20021044", "endSection": "title"}, {"offsetInBeginSection": 12, "offsetInEndSection": 86, "text": "Amifostine was developed to protect normal tissues from radiation exposure ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16116597", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 76, "text": "Amifostine protects bone marrow from benzene-induced hematotoxicity in mice. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17661222", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 86, "text": "In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18204866", "endSection": "title"}, {"offsetInBeginSection": 11, "offsetInEndSection": 119, "text": "(AMF) has been shown to protect some normal tissues from acute effects of radiation therapy +/- chemotherapy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16015542", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 136, "text": "Doxorubicin induces apoptosis in germ line stem cells in the immature rat testis and amifostine cannot protect against this cytotoxicity ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16267025", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 231, "text": "Amifostine has shown to selectively protect normal tissues against cytotoxic and mutagenic effects of several anti-neoplastic drugs, such as alkylating agents, organoplatinum compounds, anthracyclines, taxanes, and ionising radiati ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12469164", "endSection": "abstract"}, {"offsetInBeginSection": 24, "offsetInEndSection": 305, "text": "Amifostine has been shown to protect against xerostomia induced by radiotherapy for head and neck cancer, but its impact on the therapeutic index is unknown. This is the first report focusing on amifostine related adverse effects leading to discontinuation of amifostine treatment. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15064010", "endSection": "abstract"}, {"offsetInBeginSection": 416, "offsetInEndSection": 725, "text": ". Amifostine alone is inactive chemically, but active metabolite amifostine WR-1065 has been assumed to protect the healthy tissues during antineoplastic therapy by bounding of anticancer drug, causing their detoxification and/or eliminating the free radicals generated during radiation and cytostatic therapy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20021044", "endSection": "abstract"}, {"offsetInBeginSection": 18, "offsetInEndSection": 451, "text": "CYP), a commonly prescribed chemotherapy drug, has multiple adverse side effects including alteration of taste. The effects on taste are a cause of concern for patients as changes in taste are often associated with loss of appetite, malnutrition, poor recovery and reduced quality of life. Amifostine is a cytoprotective agent that was previously shown to be effective in preventing chemotherapy-induced mucositis and nephrotoxicity. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23626702", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 466, "text": "Amifostine (Ethyoltrade mark, Alza Pharmaceuticals) is an inorganic thiophosphate cytoprotective agent known chemically as ethanethiol, 2-[3- aminopropyl)amino]dihydrogen phosphate. It is a prodrug of free thiol (WR-1065) that may act as a scavenger of free radicals generated in tissues exposed to cytotoxic drugs and binds to reactive metabolites of such drugs. Amifostine was originally developed as a radioprotective agent in a classified nuclear warfare project ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336600", "endSection": "abstract"}, {"offsetInBeginSection": 1041, "offsetInEndSection": 1538, "text": "Amifostine treatment in benzene-exposed mice significantly improved blood cell counts, and morphological and histopathological signs of hematotoxicity in the bone marrow as well as in the spleen. Moreover, amifostine prevented benzene-induced bone marrow and spleen cell apoptosis and rescinded the inhibition of cell proliferation induced by benzene exposure. Finally, amifostine significantly inhibited the levels of reactive oxidative species and lipid peroxidation induced by benzene exposure. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17661222", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 555, "text": "Preclinical studies demonstrate that amifostine has the potential to selectively protect normal tissues from the harmful effects of radiation without significantly protecting neoplastic tissue. The potential value of such an agent includes reducing treatment-related toxicity and the opportunity for radiation dose escalation in the curative treatment of cancer. An increasing number of human clinical trials have been conducted that define the toxicity profile and efficacy of radioprotection by amifostine when used during fractionated radiation therapy ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8783671", "endSection": "abstract"}]}, {"body": "Which is the main difference between Alu and B1 repeats?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20019790", "http://www.ncbi.nlm.nih.gov/pubmed/17407136", "http://www.ncbi.nlm.nih.gov/pubmed/9748291", "http://www.ncbi.nlm.nih.gov/pubmed/8036148", "http://www.ncbi.nlm.nih.gov/pubmed/7681065", "http://www.ncbi.nlm.nih.gov/pubmed/1549107", "http://www.ncbi.nlm.nih.gov/pubmed/1945845", "http://www.ncbi.nlm.nih.gov/pubmed/17852045", "http://www.ncbi.nlm.nih.gov/pubmed/2412135", "http://www.ncbi.nlm.nih.gov/pubmed/8576966", "http://www.ncbi.nlm.nih.gov/pubmed/3221855"], "triples": [], "ideal_answer": "Here we show that some members of the mouse b1 alu and murine b1 repeats have been selectively retained in the upstream and intronic regions of genes of specific functional classesFurthermore, the presence of alu-like structural motifs supports the hypothesis of the monophyletic origin of alu and b1 sequence is congruent to 130 nucleotides long and shows homology with the monomeric element.Furthermore, the presence of alu-like structural motifs supports the hypothesis of the monophyletic origin of alu and b1 repeats, i.e., from a common 7sl rna-derived retroposing monomeric units of the dimeric 300-nucleotide primate sequence.Furthermore, the presence of alu-like structural motifs supports the hypothesis of the monophyletic origin of alu sequence family encode a small cytoplasmic rna most human alu and b1 repeats are unique.Alus and b1s are short interspersed repeat elements ( sines ) derived from the 7sl rna-derived retroposing monomeric element.The modern B1 elements are similar to the left Alu monomer, but with a 9 bp deletion and a 29 bp duplication.Alus and b1s are short interspersed repeat elements ( sines ) derived from the 7sl rna gene.", "exact_answer": [["it is the mouse homolog to the left Alu monomer"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020087"], "type": "factoid", "id": "56ffd805cf1c32585100000a", "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 48, "text": "Most human Alu and murine B1 repeats are unique. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17407136", "endSection": "title"}, {"offsetInBeginSection": 101, "offsetInEndSection": 145, "text": "B1 is a murine homolog of the human SINE Alu ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1549107", "endSection": "abstract"}, {"offsetInBeginSection": 468, "offsetInEndSection": 565, "text": "Here we show that some members of the mouse B1 Alu sequence family encode a small cytoplasmic RNA ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2412135", "endSection": "abstract"}, {"offsetInBeginSection": 603, "offsetInEndSection": 732, "text": "A statistically reliable slowing down in the evolutionary rates of one of two monomers for the human Alu repeats has been proved. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3221855", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 126, "text": "Alu and b1 repeats have been selectively retained in the upstream and intronic regions of genes of specific functional classes ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20019790", "endSection": "title"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "B1 (Alu-equivalent) is a murine short interspersed element whose amplification probably involved an RNA intermediate ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1945845", "endSection": "abstract"}, {"offsetInBeginSection": 69, "offsetInEndSection": 178, "text": "The modern B1 elements are similar to the left Alu monomer, but with a 9 bp deletion and a 29 bp duplication. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8036148", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "A master sequence related to a free left Alu monomer (FLAM) at the origin of the B1 family in rodent genomes. ", "beginSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8036148", "endSection": "title"}, {"offsetInBeginSection": 650, "offsetInEndSection": 846, "text": "Furthermore, the presence of Alu-like structural motifs supports the hypothesis of the monophyletic origin of Alu and B1 repeats, i.e., from a common 7SL RNA-derived retroposing monomeric element. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8576966", "endSection": "abstract"}, {"offsetInBeginSection": 615, "offsetInEndSection": 778, "text": "we present evidence that Alu and B1 elements have been selectively retained in the upstream and intronic regions of genes belonging to specific functional classes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20019790", "endSection": "abstract"}, {"offsetInBeginSection": 567, "offsetInEndSection": 718, "text": "The mouse B1 sequence is congruent to 130 nucleotides long and shows homology with the monomeric units of the dimeric 300-nucleotide primate sequence. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2412135", "endSection": "abstract"}, {"offsetInBeginSection": 1062, "offsetInEndSection": 1221, "text": "The data demonstrate that a limited set of B1 sequences are expressed as processed RNA polymerase III-transcripts of a high degree of structural conservation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1945845", "endSection": "abstract"}, {"offsetInBeginSection": 221, "offsetInEndSection": 415, "text": "These RNAs have conserved a secondary structure motif also present in signal recognition particle (SRP) RNA despite substantial sequence divergence, whereas random B1 and Alu sequences have not. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7681065", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 231, "text": "Alus and B1s are short interspersed repeat elements (SINEs) derived from the 7SL RNA gene. Alus and B1s exist in the cytoplasm as non-coding RNA indicating that they are actively transcribed, but their function, if any, is unknown. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17852045", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 254, "text": "Alu and B1 repeats are mobile elements that originated in an initial duplication of the 7SL RNA gene prior to the primate-rodent split about 80 million years ago and currently account for a substantial fraction of the human and mouse genome, respectively ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20019790", "endSection": "abstract"}, {"offsetInBeginSection": 1084, "offsetInEndSection": 1388, "text": "Finally, the unexpected finding that Alu and B1 elements show similar biases in their distribution across functional classes, despite having spread independently in their respective genomes, further supports our claim that the extant instances of Alu and B1 elements are the result of positive selection. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20019790", "endSection": "abstract"}, {"offsetInBeginSection": 307, "offsetInEndSection": 572, "text": " The core sequences of these elements contain pol III promoters but must rely on fortuitous downstream oligo(dT) tracts for terminator function. We show that a B1-Alu gene differs markedly from a classical pol III gene (tRNAiMet) in terminator sequence requirements ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9748291", "endSection": "abstract"}]}, {"body": "Is there a relationship between thyroid hormone altered metabolism and coronary artery disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23470525", "http://www.ncbi.nlm.nih.gov/pubmed/22877896", "http://www.ncbi.nlm.nih.gov/pubmed/22724581", "http://www.ncbi.nlm.nih.gov/pubmed/21745107", "http://www.ncbi.nlm.nih.gov/pubmed/19650571", "http://www.ncbi.nlm.nih.gov/pubmed/19609889", "http://www.ncbi.nlm.nih.gov/pubmed/18497453", "http://www.ncbi.nlm.nih.gov/pubmed/17434631", "http://www.ncbi.nlm.nih.gov/pubmed/17222925", "http://www.ncbi.nlm.nih.gov/pubmed/14677810", "http://www.ncbi.nlm.nih.gov/pubmed/16649727", "http://www.ncbi.nlm.nih.gov/pubmed/16524858", "http://www.ncbi.nlm.nih.gov/pubmed/16507804", "http://www.ncbi.nlm.nih.gov/pubmed/21789282", "http://www.ncbi.nlm.nih.gov/pubmed/17614771", "http://www.ncbi.nlm.nih.gov/pubmed/9117915", "http://www.ncbi.nlm.nih.gov/pubmed/9709915", "http://www.ncbi.nlm.nih.gov/pubmed/23086805", "http://www.ncbi.nlm.nih.gov/pubmed/732079"], "triples": [], "ideal_answer": "Prevalence of chd was more common in hypothyroid and moderate sch patients with high tsh level ( p=0.026 ).The incidence of multi-vessel disease was higher in patients referred for coronary angiography suggest that variation of thyroid function within the statistical normal range may influence the presence and severity of coronary atherosclerosis.The incidence of multi-vessel disease was higher in patients with high tsh level did not predict coronary artery stenosis.These data in patients referred for coronary angiography suggest that variation of thyroid function within normal range could be a risk factor for cad.Also, this study suggests that elevated serum FT ( 4 ) levels even within normal range could be a risk factor for CAD.The multivariate analysis revealed that age ( or 2.39, p=0.001 ), diabetes ( or 3.74, p=0.001 ), creatinine ( or 2.06, p=0.008 ), and smoking ( or 1.85, p=0.045 ) were independent predictors for significant risk of chd at baseline and at follow-up.", "exact_answer": "yes", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003324", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013963", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D023921", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003331", "http://www.disease-ontology.org/api/metadata/DOID:3393", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013959", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013974", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014284"], "type": "yesno", "id": "531d1279b166e2b806000042", "snippets": [{"offsetInBeginSection": 1110, "offsetInEndSection": 1186, "text": " Prevalence of CHD was more common in hypothyroid and moderate SCH patients. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21745107", "endSection": "abstract"}, {"offsetInBeginSection": 2114, "offsetInEndSection": 2263, "text": "The present meta-analysis indicates that sub-clinical hypothyroidism is associated with both, a significant risk of CHD at baseline and at follow-up. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17434631", "endSection": "abstract"}, {"offsetInBeginSection": 2580, "offsetInEndSection": 2784, "text": "These data in patients referred for coronary angiography suggest that variation of thyroid function within the statistical normal range may influence the presence and severity of coronary atherosclerosis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/14677810", "endSection": "abstract"}, {"offsetInBeginSection": 1594, "offsetInEndSection": 1829, "text": "FT3 levels within the normal range were inversely correlated with the presence and severity of CAD. Moreover, lower FT3 concentrations were correlated with the Gensini score and independently predicted the presence and severity of CAD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22877896", "endSection": "abstract"}, {"offsetInBeginSection": 1516, "offsetInEndSection": 1747, "text": "The results showed that higher levels of TSH within the reference range were independently associated with the presence of CAD only among subjects less than or equal to 65 years old, suggesting age might influence the relationship. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23470525", "endSection": "abstract"}, {"offsetInBeginSection": 1556, "offsetInEndSection": 1766, "text": "Our study showed that FT(4) levels were associated with the presence and the severity of CAD. Also, this study suggests that elevated serum FT(4) levels even within normal range could be a risk factor for CAD. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497453", "endSection": "abstract"}, {"offsetInBeginSection": 922, "offsetInEndSection": 1221, "text": "High TSH within the reference range was associated with increased risk of coronary death in women (P(trend) 0\u00b7005), but not in men. The risk of coronary death was also increased among women with subclinical hypothyroidism or subclinical hyperthyroidism, compared to women with TSH of 0\u00b750-1\u00b74 mU/l. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22724581", "endSection": "abstract"}, {"offsetInBeginSection": 687, "offsetInEndSection": 962, "text": "Lower fT3 levels were predictive of both single-vessel (p = 0.012) and multivessel (p = 0.009) CAD. Through a multivariate logistic regression analysis, fT3 was still linked to the presence of CAD (hazard ratio [HR]: 0.48, 95% confidence interval [CI]: 0.34-0.68, p < 0.001). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19609889", "endSection": "abstract"}, {"offsetInBeginSection": 1657, "offsetInEndSection": 2003, "text": "The angiographic results were as follows: significant coronary disease (SH 28.1% vs. non-SH 43.8%; p=0.087); three-vessel disease (9.4% vs. 9.9%; p=0.919); two-vessel disease (12.5% vs. 13.4%; p=0.892); single-vessel disease (6.3% vs. 29.5%; p=0.051); minimal lesions (9.4% vs. 10.9%; p=0.794); and no coronary disease (62.4% vs, 45.3%; p=0.064). ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19650571", "endSection": "abstract"}, {"offsetInBeginSection": 916, "offsetInEndSection": 1398, "text": "The incidence of multi-vessel disease was higher in patients with high TSH level (p=0.026). TSH level showed a significant correlation with age (r=0.109, p=0.044) and Gensini's score (r=0.117, p=0.045). The multivariate analysis revealed that age (OR 2.39, p=0.001), diabetes (OR 3.74, p=0.001), creatinine (OR 2.06, p=0.008), and smoking (OR 1.85, p=0.045) were independent predictors for significant coronary artery disease, but TSH level did not predict coronary artery stenosis. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17222925", "endSection": "abstract"}]}, {"body": "What is the frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18504270", "http://www.ncbi.nlm.nih.gov/pubmed/15450411", "http://www.ncbi.nlm.nih.gov/pubmed/12410959", "http://www.ncbi.nlm.nih.gov/pubmed/10886029", "http://www.ncbi.nlm.nih.gov/pubmed/10700191", "http://www.ncbi.nlm.nih.gov/pubmed/3863118", "http://www.ncbi.nlm.nih.gov/pubmed/509687"], "triples": [], "ideal_answer": "Theoretical considerations and empirical analysis suggest that the per-base mutation frequency for a fractionated-dose treatment protocol is on the order of 1 sequence change per 10 ( 5 ) bp the mutation frequency increased linearly with mnu or enu concentration ( 0.01 -- 2.0 mm ); mean values were 2800 and 840 mutants per 10 ( 6 ) clonable cells per mm, respectively the enu-induced mutation frequency in blmtm3brd homozygous, heterozygous, and wild mice were 54 x 10 ( -5 ), 35 x 10 ( -5 ), and 25 x 10 ( -5 ) mutants, respectively the mutation frequency induced by a 400 mg dosage of ethylnitrosourea is 12 times the maximal mutation frequency achievable with a single exposure to x-rays and 36 times that reported for procarbazine, the most effective chemical mutagen previously known for mouse stem-cell spermatogonia mutation frequencies per nucleotide based on mutant spectra from this study and published literature.", "exact_answer": ["1/100000"], "concepts": ["http://www.biosemantics.org/jochem#4249285", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017354", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D059645", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005038", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009154", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016296"], "type": "factoid", "id": "533ba85ffd9a95ea0d000008", "snippets": [{"offsetInBeginSection": 523, "offsetInEndSection": 694, "text": "Specific locus tests designed to detect recessive mutations showed that ENU is the most efficient mutagen in mouse with an approximate mutation rate of 1 in 1,000 gametes. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10700191", "endSection": "abstract"}, {"offsetInBeginSection": 966, "offsetInEndSection": 1153, "text": "Theoretical considerations and empirical analysis suggest that the per-base mutation frequency for a fractionated-dose treatment protocol is on the order of 1 sequence change per 10(5) bp ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10886029", "endSection": "abstract"}, {"offsetInBeginSection": 1667, "offsetInEndSection": 1831, "text": "The ENU-induced mutation frequency in Blmtm3Brd homozygous, heterozygous, and wild mice were 54 x 10(-5), 35 x 10(-5), and 25 x 10(-5) mutants/plaques, respectively ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15450411", "endSection": "abstract"}, {"offsetInBeginSection": 820, "offsetInEndSection": 991, "text": "The mutation frequency increased linearly with MNU or ENU concentration (0.01--2.0 mM); mean values were 2800 and 840 mutants per 10(6) clonable cells per mM, respectively ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/509687", "endSection": "abstract"}, {"offsetInBeginSection": 609, "offsetInEndSection": 900, "text": "The mutation frequency induced by a 400 mg/kg dosage of ethylnitrosourea is 12 times the maximal mutation frequency achievable with a single exposure to x-rays and 36 times that reported for procarbazine, the most effective chemical mutagen previously known for mouse stem-cell spermatogonia ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3863118", "endSection": "abstract"}, {"offsetInBeginSection": 1285, "offsetInEndSection": 1504, "text": "Unlike spontaneous chromosome damage, spontaneous mutant frequencies did not differ significantly among homozygous, heterozygous, and wild-type mice (3.2 x 10(-5), 3.1 x 10(-5), and 3.1 x 10(-5), respectively; P > 0.05) ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15450411", "endSection": "abstract"}, {"offsetInBeginSection": 888, "offsetInEndSection": 1130, "text": "mutation frequencies per nucleotide based on mutant spectra from this study and published literature. We found this frequency in control spleen to be similar for lacI (3.8 +/- 0.7 x 10(-8)) and PhiX174 (3.1 +/- 1.2 x 10(-8)) at 6 weeks of age ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18504270", "endSection": "abstract"}]}, {"body": "What is the molecular pathogenesis of Spinal Muscular Atrophy?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24112438", "http://www.ncbi.nlm.nih.gov/pubmed/23740936", "http://www.ncbi.nlm.nih.gov/pubmed/18572081"], "triples": [], "ideal_answer": "A mouse model of spinal muscular atrophy, in which the number of Gems is decreased, shows fewer subsets U snRNAs.Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness.It is caused by homozygous disruption of the survival motor neurons, atrophy of skeletal muscles, and generalised weakness.It is caused by homozygous disruption of the survival motor neuron 1 ( smn1 ) gene by deletion, conversion, or mutation.The number of gems and a subset of u snrnas decrease in spinal muscular atrophy is an autosomal recessive neurodegenerative disease, gems contribute to the biogenesis of uridine-rich small nuclear rna ( u snrna ), a component of splicing machinery.TDP-43 associates with nuclear bodies including Gemini of coiled bodies ( GEMs ).", "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009134", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014897", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D055533", "http://www.disease-ontology.org/api/metadata/DOID:12377", "http://www.disease-ontology.org/api/metadata/DOID:0050529", "http://www.disease-ontology.org/api/metadata/DOID:12376", "http://www.disease-ontology.org/api/metadata/DOID:0060160", "http://www.disease-ontology.org/api/metadata/DOID:318", "http://www.disease-ontology.org/api/metadata/DOID:0050530"], "type": "summary", "id": "52f124a12059c6d71c000006", "snippets": [{"offsetInBeginSection": 1031, "offsetInEndSection": 1144, "text": "A mouse model of spinal muscular atrophy, in which the number of Gems is decreased, shows fewer subsets U snRNAs. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24112438", "endSection": "abstract"}, {"offsetInBeginSection": 0, "offsetInEndSection": 309, "text": "Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness. It is caused by homozygous disruption of the survival motor neuron 1 (SMN1) gene by deletion, conversion, or mutation. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18572081", "endSection": "abstract"}, {"offsetInBeginSection": 210, "offsetInEndSection": 514, "text": "TDP-43 associates with nuclear bodies including Gemini of coiled bodies (GEMs). GEMs contribute to the biogenesis of uridine-rich small nuclear RNA (U snRNA), a component of splicing machinery. The number of GEMs and a subset of U snRNAs decrease in spinal muscular atrophy, a lower motor neuron disease, ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23740936", "endSection": "abstract"}]}, {"body": "Which drugs affect insulin resistance in obesity?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23176795", "http://www.ncbi.nlm.nih.gov/pubmed/22292446", "http://www.ncbi.nlm.nih.gov/pubmed/22275759", "http://www.ncbi.nlm.nih.gov/pubmed/23808738", "http://www.ncbi.nlm.nih.gov/pubmed/24072084", "http://www.ncbi.nlm.nih.gov/pubmed/22878697", "http://www.ncbi.nlm.nih.gov/pubmed/23619228", "http://www.ncbi.nlm.nih.gov/pubmed/23820981", "http://www.ncbi.nlm.nih.gov/pubmed/22435392", "http://www.ncbi.nlm.nih.gov/pubmed/22412882", "http://www.ncbi.nlm.nih.gov/pubmed/21276223", "http://www.ncbi.nlm.nih.gov/pubmed/19236237", "http://www.ncbi.nlm.nih.gov/pubmed/21270237", "http://www.ncbi.nlm.nih.gov/pubmed/18925326", "http://www.ncbi.nlm.nih.gov/pubmed/17437648", "http://www.ncbi.nlm.nih.gov/pubmed/22247785", "http://www.ncbi.nlm.nih.gov/pubmed/23144896", "http://www.ncbi.nlm.nih.gov/pubmed/24090942", "http://www.ncbi.nlm.nih.gov/pubmed/23735317", "http://www.ncbi.nlm.nih.gov/pubmed/23702383", "http://www.ncbi.nlm.nih.gov/pubmed/17482151", "http://www.ncbi.nlm.nih.gov/pubmed/21440024", "http://www.ncbi.nlm.nih.gov/pubmed/9374813", "http://www.ncbi.nlm.nih.gov/pubmed/22983924"], "triples": [], "ideal_answer": "He positive effects of ace inhibitor drugs, particularly on hypertriglyceridemia and insulin resistance through the amelioration of ovx-induced metabolic dysfunction, and the gsea approach may be useful in proposing putative targets related to insulin resistance.He positive effects of ACE inhibitor drugs, particularly on hypertriglyceridemia and insulin resistance, might bring them forth as first-line drugs in the treatment of obese and hypertensive children.Enistein treatment could help reduce insulin resistance through the amelioration of OVX-induced metabolic dysfunction, and the GSEA approach may be useful in proposing putative targets related to insulin resistance.", "exact_answer": [["Enistein"], ["ACE inhibitors"]], "concepts": ["http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007333", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009765", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019440", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007328", "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D061385", "http://www.disease-ontology.org/api/metadata/DOID:9970", "http://www.disease-ontology.org/api/metadata/DOID:14221", "http://www.uniprot.org/uniprot/INS_CAIMO"], "type": "list", "id": "52e7b7cb98d023950500001c", "snippets": [{"offsetInBeginSection": 1274, "offsetInEndSection": 1475, "text": "he positive effects of ACE inhibitor drugs, particularly on hypertriglyceridemia and insulin resistance, might bring them forth as first-line drugs in the treatment of obese and hypertensive children. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24072084", "endSection": "abstract"}, {"offsetInBeginSection": 1481, "offsetInEndSection": 1696, "text": "enistein treatment could help reduce insulin resistance through the amelioration of OVX-induced metabolic dysfunction, and the GSEA approach may be useful in proposing putative targets related to insulin resistance. ", "beginSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23176795", "endSection": "abstract"}]}]}